[
{"id":"1","symbol": "AAU","name": "Almaden Minerals Ltd. Common Shares","price": 1.41,"dollarChange": 0.11,"percentChange": 8.47,"open": 1.34,"high": 1.435,"low":1.31,"volume": 478079,"avgVol": 363618.916667,"sharesShort": 18742,"shortPercent": 0.020870,"marketCap": 131744593,"float": 89805481,"headlines":{"data":[{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Minerals reports 1Q loss","publication_date":"2017-05-11 22:42:47 +0000","summary":"The Vancouver, British Columbia-based company said it had a loss of 2 cents per share. In the final minutes of trading on Thursday, the company's shares hit $1.30. A year ago, they were trading at $1.19. ...","url":"http://finance.yahoo.com/news/almaden-minerals-reports-1q-loss-224247410.html?.tsrc=rss"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Minerals Ltd. Announces $15 Million Bought Deal Private Placement","publication_date":"2017-05-05 12:08:35 +0000","summary":"NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESAlmaden Minerals Ltd. is pleased to announce that it has entered into an agreement with Sprott...","url":"http://finance.yahoo.com/news/almaden-minerals-ltd-announces-15-120835880.html?.tsrc=rss"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Tuesday Sector Leaders: Music & Electronics Stores, Precious Metals","publication_date":"2017-04-11 18:55:05 +0000","summary":"In trading on Tuesday music amp electronics stores shares were relative leaders up on the day by about 2 5 Leading the group were shares of Voxx International VOXX up about 8 1 and shares of Conns CONN up about 4 2 on the day Also showing relative strength are","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mgVqlFxeuWU/tuesday-sector-leaders-music-electronics-stores-precious-metals-cm772870"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"6:05 pm Almaden Minerals reports 41% after-tax IRR from pre-feasibility study, updated resource/production target of 2019 for the Ixtaca Precious Metals Project","publication_date":"2017-04-03 22:05:00 +0000","summary":"6:05 pm Almaden Minerals reports 41% after-tax IRR from pre-feasibility study, updated resource/production target of 2019 for the Ixtaca Precious Metals Project","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#aau"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Reports 41% After-Tax IRR From Pre-Feasibility Study, Updated Resource and Production Target of 2019 for the Ixtaca Precious Metals Project, Mexico","publication_date":"2017-04-03 21:59:56 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. is pleased to report positive results of the independent Pre-Feasibility Study and resource update prepared in accordance with National Instrument 43-101 (\"NI...","url":"http://finance.yahoo.com/news/almaden-reports-41-tax-irr-215956872.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Reports 41% After-Tax IRR From Pre-Feasibility Study, Updated Resource and Production Target of 2019 for the Ixtaca Precious Metals Project, Mexico","publication_date":"2017-04-03 21:59:56 +0000","summary":"Almaden Minerals Ltd. is pleased to report positive results of the independent Pre-Feasibility Study and resource update prepared in accordance with National Instrument 43-101 (\"NI...","url":"http://finance.yahoo.com/news/almaden-reports-41-tax-irr-215956872.html?.tsrc=rss"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Friday Sector Leaders: Waste Management, Precious Metals","publication_date":"2017-03-31 19:58:56 +0000","summary":"In trading on Friday waste management shares were relative leaders up on the day by about 5 1 Leading the group were shares of TRC Companies TRR up about 45 8 and shares of Stericycle SRCL up about 2 1 on the day Also showing relative strength are precious metals shares","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y9YwWWfdOUQ/friday-sector-leaders-waste-management-precious-metals-cm768510"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Files Form 20-F Documentation","publication_date":"2017-03-30 22:40:56 +0000","summary":"Almaden Minerals Ltd. announces that its Form 20-F for the fiscal year ended December 31, 2016 has been filed with the U.S. Securities and Exchange Commission. The Form 20-F and the Company's...","url":"http://finance.yahoo.com/news/almaden-files-form-20-f-224056672.html?.tsrc=rss"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Files Form 20-F Documentation","publication_date":"2017-03-30 22:40:56 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. announces that its Form 20-F for the fiscal year ended December 31, 2016 has been filed with the U.S. Securities and Exchange Commission. The Form 20-F and the Company's...","url":"http://finance.yahoo.com/news/almaden-files-form-20-f-224056672.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Drills Further New High Grade Mineralisation Within and Outside Amended PEA Pit, Hits 41.45 Meters of 1.52 g/t Gold, 117.3 g/t Silver Including 4.60 Meters of 6.68 g/t Gold and 565.4 g/t Silver","publication_date":"2017-02-08 13:30:00 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. is pleased to announce further assay results from Almaden's ongoing exploration and development program at the Company's Tuligtic project, Mexico. Results reported today...","url":"http://finance.yahoo.com/news/almaden-drills-further-high-grade-133000629.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Drills Further New High Grade Mineralisation Within and Outside Amended PEA Pit, Hits 41.45 Meters of 1.52 g/t Gold, 117.3 g/t Silver Including 4.60 Meters of 6.68 g/t Gold and 565.4 g/t Silver","publication_date":"2017-02-08 13:30:00 +0000","summary":"Almaden Minerals Ltd. is pleased to announce further assay results from Almaden's ongoing exploration and development program at the Company's Tuligtic project, Mexico. Results reported today...","url":"http://finance.yahoo.com/news/almaden-drills-further-high-grade-133000629.html?.tsrc=rss"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Minerals Ltd. Announces Closing of $3.4 Million Non-Brokered Private Placement","publication_date":"2017-02-07 21:30:00 +0000","summary":"Almaden Minerals Ltd. is pleased to announce that it has closed a non-brokered private placement involving the issuance of 2,519,407 units at $1.35 per Unit. Each Unit consists of one...","url":"http://finance.yahoo.com/news/almaden-minerals-ltd-announces-closing-213000387.html?.tsrc=rss"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Minerals Ltd. Announces Closing of $3.4 Million Non-Brokered Private Placement","publication_date":"2017-02-07 21:30:00 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. is pleased to announce that it has closed a non-brokered private placement involving the issuance of 2,519,407 units at $1.35 per Unit. Each Unit consists of one...","url":"http://finance.yahoo.com/news/almaden-minerals-ltd-announces-closing-213000387.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Drills Further New High Grade Mineralisation Within and Outside Amended PEA Pit, Hits 105.00 Meters of 1.20 g/t Gold, 87.1 g/t Silver and 38.60 Meters of 1.08 g/t Gold and 106.2 g/t Silver","publication_date":"2017-01-18 21:11:57 +0000","summary":"Almaden Minerals Ltd. is pleased to announce further assay results from Almaden's ongoing exploration and development program at the Company's Tuligtic project, Mexico. Results reported today...","url":"http://finance.yahoo.com/news/almaden-drills-further-high-grade-211157850.html?.tsrc=rss"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Drills Further New High Grade Mineralisation Within and Outside Amended PEA Pit, Hits 105.00 Meters of 1.20 g/t Gold, 87.1 g/t Silver and 38.60 Meters of 1.08 g/t Gold and 106.2 g/t Silver","publication_date":"2017-01-18 21:11:57 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. is pleased to announce further assay results from Almaden's ongoing exploration and development program at the Company's Tuligtic project, Mexico. Results reported today...","url":"http://finance.yahoo.com/news/almaden-drills-further-high-grade-211157850.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Wednesday Sector Leaders: Precious Metals, Textiles","publication_date":"2016-12-28 19:57:33 +0000","summary":"In trading on Wednesday precious metals shares were relative leaders up on the day by about 0 7 Leading the group were shares of Almaden Minerals AAU up about 8 2 and shares of Alexco Resource AXU up about 6 4 on the day Also showing relative strength are textiles shares","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/64lVRvIHxRk/wednesday-sector-leaders-precious-metals-textiles-cm727110"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"December 22nd, 2016 Almaden Drills Further New High Grade Mineralisation Within and Outside Amended PEA Pit, Hits 30.35m of 1.92 g/t Gold, 62.1 g/t Silver and 8.50m of 2.56 g/t Gold and 357.0 g/t Silver","publication_date":"2016-12-22 22:38:05 +0000","summary":"[at noodls] - NEWS RELEASE December 22nd, 2016 Trading Symbols: TSX: AMM; NYSE MKT: AAU www.almadenminerals.com ALMADEN DRILLS FURTHER NEW HIGH GRADE MINERALISATION WITHIN AND OUTSIDE AMENDED PEA PIT, HITS 30.35 METERS ...","url":"http://www.publicnow.com/view/7AA31568EC2DD9BA27CBB9C51C688A11567F182F"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Drills Further New High Grade Mineralisation Within and Outside Amended Pea Pit, Hits 30.35 Meters of 1.92 g/t Gold, 62.1 g/t Silver and 8.50 Meters of 2.56 g/t Gold and 357.0 g/t Silver","publication_date":"2016-12-22 21:48:15 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. is pleased to announce further assay results from Almaden's ongoing exploration and development program at the Company's Tuligtic project, Mexico. Results reported today...","url":"http://finance.yahoo.com/news/almaden-drills-further-high-grade-214815041.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Drills Further New High Grade Mineralisation Within and Outside Amended Pea Pit, Hits 30.35 Meters of 1.92 g/t Gold, 62.1 g/t Silver and 8.50 Meters of 2.56 g/t Gold and 357.0 g/t Silver","publication_date":"2016-12-22 21:48:15 +0000","summary":"Almaden Minerals Ltd. is pleased to announce further assay results from Almaden's ongoing exploration and development program at the Company's Tuligtic project, Mexico. Results reported today...","url":"http://finance.yahoo.com/news/almaden-drills-further-high-grade-214815041.html?.tsrc=rss"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Minerals Ltd. :AAU-US: Earnings Analysis: Q3, 2016 By the Numbers : December 1, 2016","publication_date":"2016-12-01 13:45:59 +0000","summary":"Almaden Minerals Ltd. :AAU-US: Earnings Analysis: Q3, 2016 By the Numbers : December 1, 2016","url":"http://www.capitalcube.com/blog/index.php/almaden-minerals-ltd-aau-us-earnings-analysis-q3-2016-by-the-numbers-december-1-2016/"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Minerals Ltd. :AAU-US: Earnings Analysis: Q3, 2016 By the Numbers : December 1, 2016","publication_date":"2016-12-01 13:45:59 +0000","summary":"Categories: Yahoo Finance Get free summary analysis Almaden Minerals Ltd. reports financial results for the quarter ended September 30, 2016. Analysis Summary numbers: Revenues of USD 0 million, Net Earnings of USD -0.70 million. The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless. AAU-US‘s earnings ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/feaf7e51-e3e7-38a0-b90b-07158a0e2eff/almaden-minerals-ltd-aau-us-earnings-analysis-q3-2016-by-the-numbers-december-1-2016?yptr=yahoo&.tsrc=rss"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Drills Further New High Grade Mineralisation Within and Outside Amended PEA Pit, Hits 15.80 Meters of 4.31 g/t Gold, 98.0 g/t Silver and 14.20 Meters of 3.08 g/t Gold and 161.2 g/t Silver","publication_date":"2016-11-29 21:08:45 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. is pleased to announce further assay results from Almaden's ongoing exploration and development program at the Company's Tuligtic project, Mexico. Results reported today...","url":"http://finance.yahoo.com/news/almaden-drills-further-high-grade-210845900.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Wednesday Sector Laggards: Precious Metals, Water Utilities","publication_date":"2016-11-23 20:03:52 +0000","summary":"In trading on Wednesday precious metals shares were relative laggards down on the day by about 4 Helping drag down the group were shares of Almaden Minerals AAU off about 8 7 and shares of Exeter Resources XRA down about 8 5 on the day Also lagging the market Wednesday","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jAJnJPCJv6o/wednesday-sector-laggards-precious-metals-water-utilities-cm713474"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Minerals reports 3Q loss","publication_date":"2016-11-08 20:56:42 +0000","summary":"Almaden Minerals reports 3Q loss","url":"http://sg.finance.yahoo.com/news/almaden-minerals-reports-3q-loss-205642242.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Companies in the Metals and Mining Sector Were Mixed","publication_date":"2016-11-08 15:05:44 +0000","summary":"Companies in the Metals and Mining Sector Were Mixed","url":"http://marketrealist.com/2016/11/performance-companies-metals-mining-sector-november-7/?utm_source=yahoo&utm_medium=feed"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"October 31st, 2016 Almaden Provides Ixtaca Pre-Feasibility Program and Metallurgical Update: Confirms 90% Recoveries for Gold and Silver in Limestone with Reduced Leach Reagent Comsumptions","publication_date":"2016-11-02 18:50:03 +0000","summary":"[at noodls] - NEWS RELEASE October 31, 2016 Trading Symbols: TSX: AMM, NYSE MKT: AAU www.almadenminerals.com ALMADEN PROVIDES IXTACA PRE-FEASIBILITY PROGRAM AND METALLURGICAL UPDATE: CONFIRMS 90% RECOVERIES FOR GOLD ...","url":"http://www.publicnow.com/view/28A888FE06BEE82F220ABC3480E07E864EAA6E31"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Provides Ixtaca Pre-Feasibility Program and Metallurgical Update: Confirms 90% Recoveries for Gold and Silver in Limestone With Reduced Leach Reagent Consumptions","publication_date":"2016-10-31 12:30:00 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. is pleased to report on the Company's 100% owned Ixtaca gold-silver deposit located in Puebla State, Mexico and the progress of its on-going Pre-Feasibility level...","url":"http://finance.yahoo.com/news/almaden-provides-ixtaca-pre-feasibility-123000681.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"October 12th, 2016 Almaden Drills Further New High Grade Mineralisation Within and Outside Amended PEA Pit, Hits 14.40 meters of 3.57 g/t Gold, 146.9 g/t Silver and 0.50 meters of 0.75 g/t Gold and 1335.0 g/t Silver Respectively","publication_date":"2016-10-13 03:50:04 +0000","summary":"[at noodls] - NEWS RELEASE October 12th, 2016 Trading Symbols: TSX: AMM; NYSE MKT: AAU www.almadenminerals.com ALMADEN DRILLS FURTHER NEW HIGH GRADE MINERALISATION WITHIN AND OUTSIDE AMENDED PEA PIT, HITS 14.40 METERS ...","url":"http://www.publicnow.com/view/C218663D83818598CBA105D867B4ADC7A1AAE56E"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Drills Further New High Grade Mineralisation Within and Outside Amended Pea Pit, Hits 14.40 Meters of 3.57 G/T Gold, 146.9 G/T Silver and 0.50 Meters of 0.75 G/T Gold and 1335.0 G/T Silver Respectively","publication_date":"2016-10-12 20:30:00 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. is pleased to announce further assay results from Almaden's ongoing exploration and development program at the Company's Tuligtic project, Mexico. Results from drill holes...","url":"http://finance.yahoo.com/news/almaden-drills-further-high-grade-203000980.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"September 13th, 2016 Almaden Hits Further High Grade Mineralisation Outside of Amended PEA Pit, Hits 5.50 meters of 5.06 g/t Gold, 219.6 g/t Silver","publication_date":"2016-09-13 16:18:04 +0000","summary":"[at noodls] - NEWS RELEASE September 13th, 2016 Trading Symbols: TSX: AMM; NYSE MKT: AAU www.almadenminerals.com ALMADEN HITS FURTHER HIGH GRADE MINERALISATION OUTSIDE OF AMENDED PEA PIT, HITS 5.50 METERS OF 5.06 G/T ...","url":"http://www.publicnow.com/view/9E8D67A406D52C0C7E255954884B27AEEA10BB37"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Hits Further High Grade Mineralisation Outside of Amended PEA Pit, Hits 5.50 Meters of 5.06 g/t Gold, 219.6 g/t Silver","publication_date":"2016-09-13 11:30:00 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. is pleased to announce assay results from Almaden's ongoing exploration and development program at the Company's Tuligtic project, Mexico. Results from drill holes...","url":"http://finance.yahoo.com/news/almaden-hits-further-high-grade-113000763.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Thursday Sector Laggards: Precious Metals, Textiles","publication_date":"2016-09-08 19:17:06 +0000","summary":"In trading on Thursday precious metals shares were relative laggards down on the day by about 1 6 Helping drag down the group were shares of Almaden Minerals AAU down about 6 4 and shares of DRDGOLD DRD down about 5 5 on the day Also lagging the market Thursday are","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pmqZtB2PjvU/thursday-sector-laggards-precious-metals-textiles-cm676447"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Performance of Companies in Energy, Mining Sectors on September 7","publication_date":"2016-09-07 22:00:51 +0000","summary":"Performance of Companies in Energy, Mining Sectors on September 7","url":"http://marketrealist.com/2016/09/performance-companies-energy-mining-sector-september-7/?utm_source=yahoo&utm_medium=feed"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Tuesday Sector Leaders: Precious Metals, Drugs","publication_date":"2016-09-06 20:17:07 +0000","summary":"In trading on Tuesday precious metals shares were relative leaders up on the day by about 5 Leading the group were shares of Tanzanian Royalty Exploration Company TRX up about 14 1 and shares of Almaden Minerals AAU up about 12 9 on the day Also showing relative strength","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/07-op_tPYPE/tuesday-sector-leaders-precious-metals-drugs-cm675192"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Wednesday Sector Laggards: Precious Metals, Non-Precious Metals & Non-Metallic Mining Stocks","publication_date":"2016-08-24 18:43:06 +0000","summary":"In trading on Wednesday, precious metals shares were relative laggards, down on the day by about 5.1%. Helping drag down the group were shares of Almaden Minerals ( AAU ), down about 9.6% and shares of Endeavour Silver (","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y8qU83ELJ_I/wednesday-sector-laggards-precious-metals-non-precious-metals-non-metallic-mining-stocks-cm669689"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Performance of Companies in the Metals and Mining Sector on August 16","publication_date":"2016-08-16 21:58:04 +0000","summary":"[at Market Realist] - On Tuesday, August 16, the stocks related to base metals gained whereas the precious metal–related stocks remain stable.","url":"http://marketrealist.com/2016/08/performance-companies-metals-mining-sector-august-16/?utm_source=yahoo&utm_medium=feed"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"August 11th, 2016 Almaden Announces Resignation of Director and Appointment of New Director","publication_date":"2016-08-13 03:41:06 +0000","summary":"[at noodls] - NEWS RELEASE August 11th, 2016 Trading Symbols: TSX: AMM; NYSE MKT: AAU www.almadenminerals.com ALMADEN ANNOUNCES RESIGNATION OF DIRECTOR AND APPOINTMENT OF NEW DIRECTOR Almaden Minerals Ltd. (\"Almaden\" ...","url":"http://www.publicnow.com/view/3B20C48A0CB4DD5883B60D1A617C3C88DA7E0730"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Announces Resignation of Director and Appointment of New Director","publication_date":"2016-08-11 13:00:00 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. announces that Dr. Joe Montgomery has resigned from the Board of Directors. He has served the Board faithfully since 1999. Management and the Board of Directors would like...","url":"http://finance.yahoo.com/news/almaden-announces-resignation-director-appointment-130000610.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Announces Resignation of Director and Appointment of New Director","publication_date":"2016-08-11 13:00:00 +0000","summary":"Almaden Minerals Ltd. announces that Dr. Joe Montgomery has resigned from the Board of Directors. He has served the Board faithfully since 1999. Management and the Board of Directors would like...","url":"http://finance.yahoo.com/news/almaden-announces-resignation-director-appointment-130000610.html?.tsrc=rss"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"August 10th, 2016 Almaden Confirms High Grade Vein Zone Outside of Amended PEA Pit, Hits 1.0m of 6.19 g/t Gold, 1250 g/t Silver withing Broad Zone of Veining Returning 70.43 meters of 0.44 g/t Gold and 54 g/t Silver","publication_date":"2016-08-10 16:21:05 +0000","summary":"[at noodls] - NEWS RELEASE August 10th, 2016 Trading Symbols: TSX: AMM; NYSE MKT: AAU www.almadenminerals.com ALMADEN CONFIRMS HIGH GRADE VEIN ZONE OUTSIDE OF AMENDED PEA PIT, HITS 1.0 METER OF 6.19 G/T GOLD, 1250 G/T ...","url":"http://www.publicnow.com/view/BCC8AE233B19EF3CEDCAB866D21D34B73EA7548B"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Confirms High Grade Vein Zone Outside of Amended PEA Pit, Hits 1.0 Meter of 6.19 g/t Gold, 1250 g/t Silver Within Broad Zone of Veining Returning 70.43 Meters of 0.44 g/t Gold and 54 g/t Silver","publication_date":"2016-08-10 12:30:00 +0000","summary":"Almaden Minerals Ltd. is pleased to announce assay results from Almaden's ongoing exploration and development program at the Company's Tuligtic project, Mexico. Drill hole TU-16-318A was...","url":"http://finance.yahoo.com/news/almaden-confirms-high-grade-vein-123000035.html?.tsrc=rss"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Confirms High Grade Vein Zone Outside of Amended PEA Pit, Hits 1.0 Meter of 6.19 g/t Gold, 1250 g/t Silver Within Broad Zone of Veining Returning 70.43 Meters of 0.44 g/t Gold and 54 g/t Silver","publication_date":"2016-08-10 12:30:00 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. is pleased to announce assay results from Almaden's ongoing exploration and development program at the Company's Tuligtic project, Mexico. Drill hole TU-16-318A was...","url":"http://finance.yahoo.com/news/almaden-confirms-high-grade-vein-123000035.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Minerals reports 2Q loss","publication_date":"2016-08-09 10:43:50 +0000","summary":"Almaden Minerals reports 2Q loss","url":"http://sg.finance.yahoo.com/news/almaden-minerals-reports-2q-loss-104350424.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Announces Warrant Exercise Generating Proceeds of $6.9 Million","publication_date":"2016-07-19 12:30:00 +0000","summary":"Almaden Minerals Ltd. is pleased to report that a total of $6,914,080 has been raised through the exercise of 4,376,000 warrants with an exercise price of $1.58 and expiry date of July 17,...","url":"http://finance.yahoo.com/news/almaden-announces-warrant-exercise-generating-123000612.html?.tsrc=rss"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Announces Warrant Exercise Generating Proceeds of $6.9 Million","publication_date":"2016-07-19 12:30:00 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. is pleased to report that a total of $6,914,080 has been raised through the exercise of 4,376,000 warrants with an exercise price of $1.58 and expiry date of July 17,...","url":"http://finance.yahoo.com/news/almaden-announces-warrant-exercise-generating-123000612.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"July 7th, 2016 Almadex Minerals Limited Sells Common Shares of Gold Mountain Mining Corp.","publication_date":"2016-07-11 16:53:01 +0000","summary":"[at noodls] - 6ab975b4-7e7f-4494-b8fe-94c1b0a4c194.pdf NEWS RELEASE July 7, 2016 Trading Symbols: TSX-V: AMZ; OTCQB: AXDDF www.almadexminerals.com ALMADEX MINERALS LIMITED SELLS COMMON SHARES OF GOLD MOUNTAIN MINING ...","url":"http://www.publicnow.com/view/FC1BDCC330FE31D5225C92C029B4B8D20AE6F7A7"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"June 29th, 2016 Almaden Announces Results of Annual General Meeting","publication_date":"2016-06-30 15:51:04 +0000","summary":"[at noodls] - NR MP/wjw amendments (00058775).DOCX NEWS RELEASE June 29th, 2016 Trading Symbols: TSX: AMM; NYSE MKT: AAU www.almadenminerals.com ALMADEN ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING VANCOUVER, B.C. Almaden ...","url":"http://www.publicnow.com/view/C736927867B8234ED5059A18522B1F0000DE1722"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Announces Results of Annual General Meeting","publication_date":"2016-06-29 23:30:00 +0000","summary":"Almaden Minerals Ltd. is pleased to provide the results of its Annual General Meeting held on June 29, 2016.All of the matters submitted to the shareholders for approval as set out in the...","url":"http://finance.yahoo.com/news/almaden-announces-results-annual-general-233000179.html?.tsrc=rss"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Announces Results of Annual General Meeting","publication_date":"2016-06-29 23:30:00 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. is pleased to provide the results of its Annual General Meeting held on June 29, 2016.All of the matters submitted to the shareholders for approval as set out in the...","url":"http://finance.yahoo.com/news/almaden-announces-results-annual-general-233000179.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"May 25th, 2016 Almaden Minerals Ltd. Announces Closing of $4.4 Million Non-Brokered Private Placement","publication_date":"2016-06-16 08:29:02 +0000","summary":"[at noodls] - AML - Draft Closing News Release - No Tranches w/JF Comments (00075981).DOCX NEWS RELEASE May 25, 2016 Trading Symbols: TSX: AMM, NYSE MKT: AAU www.almadenminerals.com ALMADEN MINERALS LTD. ANNOUNCES CLOSING ...","url":"http://www.publicnow.com/view/2D7D753D7A1025B090A7F25FE43AD6D19F0C12FF"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"June 13th, 2016 Almaden Provides Ixtaca Project Update","publication_date":"2016-06-16 08:29:02 +0000","summary":"[at noodls] - NR MP/wjw amendments (00058775).DOCX NEWS RELEASE June 13th, 2016 Trading Symbols: TSX: AMM; NYSE MKT: AAU www.almadenminerals.com ALMADEN PROVIDES IXTACA PROJECT UPDATE Vancouver, B.C. Almaden Minerals ...","url":"http://www.publicnow.com/view/FBBCC243CD783EAED23A2ECB11D148748913847C"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Provides Ixtaca Project Update","publication_date":"2016-06-13 20:05:00 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. is pleased to report on the on-going development and exploration activities at the Company's 100% owned Tuligtic project and the Ixtaca gold-silver deposit located in...","url":"http://finance.yahoo.com/news/almaden-provides-ixtaca-project-200500433.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Provides Ixtaca Project Update","publication_date":"2016-06-13 20:05:00 +0000","summary":"Almaden Minerals Ltd. is pleased to report on the on-going development and exploration activities at the Company's 100% owned Tuligtic project and the Ixtaca gold-silver deposit located in...","url":"http://finance.yahoo.com/news/almaden-provides-ixtaca-project-200500433.html?.tsrc=rss"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Minerals Ltd. Announces Closing of $4.4 Million Non-Brokered Private Placement","publication_date":"2016-05-25 20:00:00 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. is pleased to announce that it has closed a non-brokered private placement involving the issuance of 3,229,082 units at $1.35 per Unit. Each Unit consists of one...","url":"http://finance.yahoo.com/news/almaden-minerals-ltd-announces-closing-200000916.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Wednesday Sector Leaders: Precious Metals, Agriculture & Farm Products","publication_date":"2016-05-11 17:27:31 +0000","summary":"In trading on Wednesday, precious metals shares were relative leaders, up on the day by about 2.2%. Leading the group were shares of Almaden Minerals, up about 10.9% and shares of Vista Gold Corporation up about 8.7% on","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xkS7JtmDEhQ/wednesday-sector-leaders-precious-metals-agriculture-farm-products-cm619746"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"StreetSweeper's Short Thesis On Almaden: Stock Is 'Fool's Gold'","publication_date":"2016-04-19 15:38:47 +0000","summary":"Shares of Almaden Minerals Ltd. (NYSE: AAU ) were trading higher by more than 9 percent on Tuesday, despite The Street Sweeper stating in a new research report the company's stock is \"fool's gold.\" ...","url":"http://finance.yahoo.com/news/streetsweepers-short-thesis-almaden-stock-153847966.html?.tsrc=rss"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"StreetSweeper's Short Thesis On Almaden: Stock Is 'Fool's Gold'","publication_date":"2016-04-19 15:38:47 +0000","summary":"StreetSweeper's Short Thesis On Almaden: Stock Is 'Fool's Gold'","url":"http://finance.yahoo.com/news/streetsweepers-short-thesis-almaden-stock-153847966.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Files Amended Technical Report","publication_date":"2016-04-13 23:49:45 +0000","summary":"Almaden Minerals Ltd.   announces that as a result of a review by the British Columbia Securities Commission, we are issuing the following news release to clarify our disclosure. The review...","url":"http://finance.yahoo.com/news/almaden-files-amended-technical-report-234945132.html?.tsrc=rss"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Files Amended Technical Report","publication_date":"2016-04-13 23:49:45 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. announces that as a result of a review by the British Columbia Securities Commission, we are issuing the following news release to clarify our disclosure. The review...","url":"http://finance.yahoo.com/news/almaden-files-amended-technical-report-234945132.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Friday Sector Leaders: Precious Metals, Shipping Stocks","publication_date":"2016-04-08 19:00:15 +0000","summary":"In trading on Friday, precious metals shares were relative leaders, up on the day by about 4.4%. Leading the group were shares of Almaden Minerals ( AAU ), up about 14% and shares of Alexco Resource ( AXU )","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vx89_QgF8mw/friday-sector-leaders-precious-metals-shipping-stocks-cm603835"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Four Top Stocks: Investors Are Considering These on Friday April 8th","publication_date":"2016-04-08 16:33:00 +0000","summary":"MIAMI, FL / ACCESSWIRE / April 8, 2016 / Top Nasdaq Stocks is issuing a report on four stocks to watch. EGLE, COOL, AAU, and KTOVW have been added to our watch list today. Continue reading to find out ...","url":"http://finance.yahoo.com/news/four-top-stocks-investors-considering-163300800.html?.tsrc=rss"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Four Top Stocks: Investors Are Considering These on Friday April 8th","publication_date":"2016-04-08 16:33:00 +0000","summary":"[Accesswire] - MIAMI, FL / ACCESSWIRE / April 8, 2016 / Top Nasdaq Stocks is issuing a report on four stocks to watch. EGLE, COOL, AAU, and KTOVW have been added to our watch list today. Continue reading to find out ...","url":"http://finance.yahoo.com/news/four-top-stocks-investors-considering-163300800.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Compelling Gold and Silver Project at Almaden Minerals","publication_date":"2016-04-08 12:10:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / April 8, 2016 / Almaden Minerals Ltd. (NYSE MKT: AAU) is an exploration stage company engaged in the acquisition, exploration, development of mineral properties in Canada, the ...","url":"http://finance.yahoo.com/news/compelling-gold-silver-project-almaden-121000604.html?.tsrc=rss"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Compelling Gold and Silver Project at Almaden Minerals","publication_date":"2016-04-08 12:10:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / April 8, 2016 / Almaden Minerals Ltd. (NYSE MKT: AAU) is an exploration stage company engaged in the acquisition, exploration, development of mineral properties in Canada, the ...","url":"http://finance.yahoo.com/news/compelling-gold-silver-project-almaden-121000604.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Thursday Sector Leaders: Precious Metals, Drugs","publication_date":"2016-04-07 19:00:30 +0000","summary":"In trading on Thursday, precious metals shares were relative leaders, up on the day by about 2.4%. Leading the group were shares of Almaden Minerals ( AAU ), up about 35.2% and shares of Endeavour Silver Corporation ( EXK","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/st3dKLyrX0k/thursday-sector-leaders-precious-metals-drugs-cm603254"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"ALMADEN MINERALS LTD Financials","publication_date":"2016-04-07 17:04:27 +0000","summary":"ALMADEN MINERALS LTD Financials","url":"http://finance.yahoo.com/q/is?s=aau&annual"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Files Form 20-F Documentation","publication_date":"2016-03-31 21:51:07 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. announces that its Form 20-F for the fiscal year ended December 31, 2015 has been filed with the U.S. Securities and Exchange Commission. The Form 20-F and the Company's...","url":"http://finance.yahoo.com/news/almaden-files-form-20-f-215107765.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Hits 43.0 Meters of 2.26 g/t Au, 85.7 g/t Ag Including 12.75 Meters of 6.1 g/t Au and 158.5 g/t Ag in Ixtaca Zone Metallurgical / Infill Drillhole","publication_date":"2016-02-22 21:00:00 +0000","summary":"Almaden Hits 43.0 Meters of 2.26 g/t Au, 85.7 g/t Ag Including 12.75 Meters of 6.1 g/t Au and 158.5 g/t Ag in Ixtaca Zone Metallurgical / Infill Drillhole","url":"http://finance.yahoo.com/news/almaden-hits-43-0-meters-210000363.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Files Updated Preliminary Economic Assessment Technical Report for Its Ixtaca Gold-Silver Deposit, Mexico","publication_date":"2016-01-22 22:26:56 +0000","summary":"Almaden Files Updated Preliminary Economic Assessment Technical Report for Its Ixtaca Gold-Silver Deposit, Mexico","url":"http://finance.yahoo.com/news/almaden-files-updated-preliminary-economic-222656570.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Minerals' CEO Morgan Poliquin Interviewed by The Gold Report","publication_date":"2016-01-15 14:00:00 +0000","summary":"Almaden Minerals' CEO Morgan Poliquin Interviewed by The Gold Report","url":"http://finance.yahoo.com/news/almaden-minerals-ceo-morgan-poliquin-140000866.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Announces Change of Auditor","publication_date":"2016-01-15 01:09:17 +0000","summary":"Almaden Announces Change of Auditor","url":"http://finance.yahoo.com/news/almaden-announces-change-auditor-010917090.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"ALMADEN MINERALS LTD Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits","publication_date":"2016-01-05 20:03:35 +0000","summary":"ALMADEN MINERALS LTD Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/160105/aau8-k.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Announces Ixtaca Gold-Silver Deposit PEA Update Showing Significant Capital Savings Using the Rock Creek Mill","publication_date":"2015-12-09 21:14:09 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. is pleased to report positive results from an updated National Instrument 43-101 compliant Preliminary Economic Assessment on its 100% owned Ixtaca...","url":"http://finance.yahoo.com/news/almaden-announces-ixtaca-gold-silver-211409008.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Minerals Ltd. Announces Closing of $3,380,000 Non-Brokered Private Placement","publication_date":"2015-11-17 21:17:00 +0000","summary":"[Marketwired] - Almaden Minerals Ltd. is pleased to announce that it has closed a non-brokered private placement involving the issuance of 4,506,666 units at $0.75 per Unit. Each Unit consists of one...","url":"http://finance.yahoo.com/news/almaden-minerals-ltd-announces-closing-211700069.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Files Amended 2014 Technical Report","publication_date":"2015-11-09 22:18:45 +0000","summary":"Almaden Files Amended 2014 Technical Report","url":"http://finance.yahoo.com/news/almaden-files-amended-2014-technical-221845465.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Almaden Enters Into Mill Purchase Option Agreement; Significantly Reduces Capital Cost of Ixtaca \"Ramp-Up\" Scenario","publication_date":"2015-10-19 20:00:00 +0000","summary":"Almaden Enters Into Mill Purchase Option Agreement; Significantly Reduces Capital Cost of Ixtaca \"Ramp-Up\" Scenario","url":"http://finance.yahoo.com/news/almaden-enters-mill-purchase-option-200000202.html"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Tuesday Sector Leaders: Precious Metals, Agriculture & Farm Products","publication_date":"2015-01-20 21:26:31 +0000","summary":"In trading on Tuesday, precious metals shares were relative leaders, up on the day by about 3.9%. Leading the group were shares of Golden Star Resources ( GSS ), up about 21.3% and shares of Almaden Minerals ( AAU","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kkvMbUmZ9Mw/tuesday-sector-leaders-precious-metals-agriculture-farm-products-cm434603"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Friday Sector Laggards: Precious Metals, Oil & Gas Exploration & Production Stocks","publication_date":"2014-10-31 19:20:40 +0000","summary":"In trading on Friday, precious metals shares were relative laggards, down on the day by about 4%. Helping drag down the group were shares of Kinross Gold ( KGC ), off about 10.4% and shares of Almaden Minerals (","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZIa4QcAMhzU/friday-sector-laggards-precious-metals-oil-gas-exploration-production-stocks-cm408869"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Wednesday Sector Laggards: Precious Metals, Oil & Gas Exploration & Production Stocks","publication_date":"2014-10-22 22:21:07 +0000","summary":"In trading on Wednesday, precious metals shares were relative laggards, down on the day by about 3%. Helping drag down the group were shares of Coeur Mining ( CDE ), down about 12.4% and shares of Almaden Minerals (","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F78FAIsXOvU/wednesday-sector-laggards-precious-metals-oil-gas-exploration-production-stocks-cm405198"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Wednesday Sector Leaders: Precious Metals, Real Estate Stocks","publication_date":"2014-07-09 19:25:56 +0000","summary":"In trading on Wednesday, precious metals shares were relative leaders, up on the day by about 1.7%. Leading the group were shares of Almaden Minerals ( AAU ), up about 9.1% and shares of Exeter Resources ( XRA )","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gRtK8rG3OR4/wednesday-sector-leaders-precious-metals-real-estate-stocks-cm368815"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"Wednesday Sector Laggards: Precious Metals, Waste Management Stocks","publication_date":"2014-02-26 21:55:17 +0000","summary":"In trading on Wednesday, precious metals shares were relative laggards, down on the day by about 2.9%. Helping drag down the group were shares of Almaden Minerals ( AAU ), down about 7.6% and shares of Rio Alto Mining","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qUwCArtAWHQ/wednesday-sector-laggards-precious-metals-waste-management-stocks-cm330339"},{"ticker":"AAU","figi_ticker":"AAU:US","figi":"BBG000DGFSY4","title":"5 Cheap Gold Stocks To Buy Now","publication_date":"2010-10-26 21:28:28 +0000","summary":"If you've been watching the rapid rise of gold prices (and what investor hasn't recently), you've probably been on the prowl for mining and gold stocks to play the upside of this precious metal. Large-cap gold&#160; stocks like Barrick Gold (NYSE: ABX ), AngloGold (NYSE: AU ) and","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ByMLmrq6AUg/5-cheap-gold-stocks-to-buy-now-cm42153"}],"result_count":82,"page_size":100,"current_page":1,"total_pages":1,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"1.3101"},{"x":"1494596100","y":"1.3201"},{"x":"1494596400","y":"1.32"},{"x":"1494596700","y":"1.32"},{"x":"1494597000","y":"1.32"},{"x":"1494597300","y":"1.3262"},{"x":"1494597600","y":"1.32"},{"x":"1494597900","y":"1.32"},{"x":"1494598200","y":"1.3589"},{"x":"1494598500","y":"1.37"},{"x":"1494598800","y":"1.3601"},{"x":"1494599100","y":"1.3599999999999999"},{"x":"1494599400","y":"1.3799000000000001"},{"x":"1494600000","y":"1.3900000000000001"},{"x":"1494600300","y":"1.38"},{"x":"1494600900","y":"1.38"},{"x":"1494601200","y":"1.385"},{"x":"1494601500","y":"1.3900000000000001"},{"x":"1494601800","y":"1.4"},{"x":"1494602100","y":"1.38"},{"x":"1494602400","y":"1.385"},{"x":"1494602700","y":"1.385"},{"x":"1494603000","y":"1.4"},{"x":"1494603300","y":"1.395"},{"x":"1494603600","y":"1.3801"},{"x":"1494603900","y":"1.3858"},{"x":"1494604200","y":"1.3801"},{"x":"1494604500","y":"1.3801"},{"x":"1494604800","y":"1.3801"},{"x":"1494605100","y":"1.3700999999999999"},{"x":"1494605400","y":"1.3700999999999999"},{"x":"1494605700","y":"1.375"},{"x":"1494606000","y":"1.3700999999999999"},{"x":"1494606300","y":"1.3700999999999999"},{"x":"1494606600","y":"1.3700999999999999"},{"x":"1494606900","y":"1.3700999999999999"},{"x":"1494607200","y":"1.37"},{"x":"1494607500","y":"1.37"},{"x":"1494607800","y":"1.37"},{"x":"1494608100","y":"1.37"},{"x":"1494608400","y":"1.37"},{"x":"1494608700","y":"1.37"},{"x":"1494609000","y":"1.37"},{"x":"1494609300","y":"1.37"},{"x":"1494609600","y":"1.37"},{"x":"1494609900","y":"1.37"},{"x":"1494610200","y":"1.3601"},{"x":"1494610500","y":"1.365"},{"x":"1494610800","y":"1.365"},{"x":"1494611100","y":"1.3601"},{"x":"1494611400","y":"1.3601"},{"x":"1494611700","y":"1.3652"},{"x":"1494612000","y":"1.3601"},{"x":"1494612300","y":"1.3601"},{"x":"1494612600","y":"1.365"},{"x":"1494612900","y":"1.3601"},{"x":"1494613200","y":"1.3601"},{"x":"1494613500","y":"1.3700999999999999"},{"x":"1494614100","y":"1.3700999999999999"},{"x":"1494614400","y":"1.3700999999999999"},{"x":"1494614700","y":"1.3700999999999999"},{"x":"1494615000","y":"1.3700999999999999"},{"x":"1494615300","y":"1.37"},{"x":"1494615600","y":"1.365"},{"x":"1494615900","y":"1.38"},{"x":"1494616200","y":"1.37"},{"x":"1494616500","y":"1.37"},{"x":"1494616800","y":"1.37"},{"x":"1494617100","y":"1.38"},{"x":"1494617400","y":"1.38"},{"x":"1494617700","y":"1.4"},{"x":"1494618000","y":"1.3900000000000001"},{"x":"1494618300","y":"1.43"},{"x":"1494618600","y":"1.4259"},{"x":"1494618900","y":"1.41"} ], "color":"#03a9f4"}]},
{"id":"2","symbol": "ATEC","name": "Alphatec Holdings Inc","price": 2.12,"dollarChange": 0.18,"percentChange": 8.72,"open": 1.967,"high": 2.2,"low":1.967,"volume": 483681,"avgVol": 125265.050000,"sharesShort": 1495440,"shortPercent": 24.889437,"marketCap": 21984138,"float": 6008332,"headlines":{"data":[{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Edited Transcript of ATEC earnings conference call or presentation 11-May-17 8:30pm GMT","publication_date":"2017-05-11 23:16:02 +0000","summary":"Q1 2017 Alphatec Holdings Inc Earnings Call","url":"http://finance.yahoo.com/news/edited-transcript-atec-earnings-conference-231602158.html?.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec reports 1Q loss","publication_date":"2017-05-11 21:50:44 +0000","summary":"The Carlsbad, California-based company said it had a loss of 61 cents per share. Losses, adjusted to account for discontinued operations, were 60 cents per share. The medical equipment and supplies holding ...","url":"http://finance.yahoo.com/news/alphatec-reports-1q-loss-215044436.html?.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings Reports First Quarter 2017 Financial Results","publication_date":"2017-05-11 20:05:00 +0000","summary":"CARLSBAD, Calif., May 11, 2017-- Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today recent corporate highlights and financial ...","url":"http://finance.yahoo.com/news/alphatec-holdings-reports-first-quarter-200500857.html?.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Investor Network: Alphatec Holdings, Inc. to Host Earnings Call","publication_date":"2017-05-11 16:05:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / May 11, 2017 / Alphatec Holdings, Inc. (NASDAQ: ATEC ) will be discussing their earnings results in their Q1 Earnings Call to be held May 11, 2017 at 4:30 PM Eastern Time. To ...","url":"http://finance.yahoo.com/news/investor-network-alphatec-holdings-inc-160500957.html?.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings to Report First Quarter 2017 Financial Results on May 11, 2017","publication_date":"2017-05-08 13:00:00 +0000","summary":"CARLSBAD, Calif., May 08, 2017-- Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that the Company plans to release its first ...","url":"http://finance.yahoo.com/news/alphatec-holdings-report-first-quarter-130000673.html?.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETFs with exposure to Alphatec Holdings, Inc. : May 3, 2017","publication_date":"2017-05-03 19:36:26 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alphatec Holdings, Inc. Here are 5 ETFs with the largest exposure to ATEC-US. Comparing the performance and risk of Alphatec Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/620318d9-4679-34b7-bd43-3368fbb6adda/etfs-with-exposure-to-alphatec-holdings-inc-may-3-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETFs with exposure to Alphatec Holdings, Inc. : April 20, 2017","publication_date":"2017-04-20 18:12:59 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alphatec Holdings, Inc. Here are 5 ETFs with the largest exposure to ATEC-US. Comparing the performance and risk of Alphatec Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/7ae4d6a1-25d9-315a-a6c7-768c8f9cd98f/etfs-with-exposure-to-alphatec-holdings-inc-april-20-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETFs with exposure to Alphatec Holdings, Inc. : April 10, 2017","publication_date":"2017-04-10 17:43:02 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alphatec Holdings, Inc. Here are 5 ETFs with the largest exposure to ATEC-US. Comparing the performance and risk of Alphatec Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/fb4e2142-0405-3b60-954d-c25a30666bb9/etfs-with-exposure-to-alphatec-holdings-inc-april-10-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings, Inc. :ATEC-US: Earnings Analysis: Q4, 2016 By the Numbers : April 7, 2017","publication_date":"2017-04-07 19:00:10 +0000","summary":"Categories: Yahoo FinanceGet free summary analysis Alphatec Holdings, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Alphatec Holdings, Inc. – Medtronic plc (MDT-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 27.09 million, Net Earnings of USD -10.23 million. ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/44baac13-2895-3cf9-852b-8ada821ce080/alphatec-holdings-inc-atec-us-earnings-analysis-q4-2016-by-the-numbers-april-7-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Spine Launches Battalion™ Lateral System with Squadron™ Retractor to support Minimally Invasive Lateral Access Procedures","publication_date":"2017-04-07 12:35:00 +0000","summary":"Opens up new $500 M market opportunity in one of the fastest growing segments in spine Squadron™ Lateral Retractor designed to improve patient outcomes All surgeon customers participating in limited market ...","url":"http://finance.yahoo.com/news/alphatec-spine-launches-battalion-lateral-123500572.html?.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Spine Adds Experienced Spine Executives to Sales Leadership Team","publication_date":"2017-04-05 20:35:00 +0000","summary":"James Duffy and Greg Rhinehart Named Area Vice Presidents of Sales New leaders add significant spine-industry experience in building and leading dedicated sales channels CARLSBAD, Calif., April 05, 2017-- ...","url":"http://finance.yahoo.com/news/alphatec-spine-adds-experienced-spine-203500326.html?.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 10-K, Annual Report","publication_date":"2017-03-31 10:16:23 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 10-K, Annual Report","url":"http://biz.yahoo.com/e/170331/atec10-k.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity S","publication_date":"2017-03-29 20:07:26 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity S","url":"http://biz.yahoo.com/e/170329/atec8-k.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Completes its Senior Leadership Team with Appointment of Brian Snider, Executive Vice President, Strategic Marketing and Product Development","publication_date":"2017-03-24 12:35:00 +0000","summary":"Chris Ryan Named Area Vice President of Sales, U.S. Central region New leaders add significant spine-industry experience to build brand awareness and drive market adoption of Alphatec products CARLSBAD, ...","url":"http://finance.yahoo.com/news/alphatec-completes-senior-leadership-team-123500995.html?.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Completes its Senior Leadership Team with Appointment of Brian Snider, Executive Vice President, Strategic Marketing and Product Development","publication_date":"2017-03-24 12:35:00 +0000","summary":"[GlobeNewswire] - Chris Ryan Named Area Vice President of Sales, U.S. Central region New leaders add significant spine-industry experience to build brand awareness and drive market adoption of Alphatec products CARLSBAD, ...","url":"http://finance.yahoo.com/news/alphatec-completes-senior-leadership-team-123500995.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide","publication_date":"2017-03-23 19:43:19 +0000","summary":"Toward the end of trading Thursday the Dow traded up 0 29 percent to 20 721 07 while the NASDAQ rose 0 17 percent to 5 831 32 The S amp P also rose gaining 0 22 percent to 2 353 52 Leading and Lagging Sectors Thursday afternoon the financial sector proved to be a source","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lWQ99L2-5Mc/mid-afternoon-market-update-cancer-genetics-gains-after-q4-results-heat-biologics-shares-slide-cm764886"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge","publication_date":"2017-03-23 17:13:17 +0000","summary":"Midway through trading Thursday the Dow traded up 0 32 percent to 20 727 99 while the NASDAQ rose 0 23 percent to 5 834 77 The S amp P also rose gaining 0 32 percent to 2 356 05 Leading and Lagging Sectors On Thursday the financial sector proved to be a source of strength for","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qr8m4v5bhJs/mid-day-market-update-dow-rises-over-50-points-tandem-diabetes-care-shares-plunge-cm764820"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Mid-Morning Market Update: Markets Mostly Flat; Conagra Profit Beats Estimates","publication_date":"2017-03-23 15:43:16 +0000","summary":"Following the market opening Thursday the Dow traded up 0 02 percent to 20 666 07 while the NASDAQ fell 0 03 percent to 5 820 06 The S amp P also rose gaining 0 05 percent to 2 349 65 Leading and Lagging Sectors Thursday morning the financial sector proved to be a source","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4Q05Ldf8Du0/mid-morning-market-update-markets-mostly-flat-conagra-profit-beats-estimates-cm764744"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"9:14 am Alphatec enters $18.9 mln private placement of common stock, Series A Convertible Preferred Stock and warrants exercisable for common stock","publication_date":"2017-03-23 13:14:00 +0000","summary":"9:14 am Alphatec enters $18.9 mln private placement of common stock, Series A Convertible Preferred Stock and warrants exercisable for common stock","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#atec"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings Announces $18.9 Million Private Placement","publication_date":"2017-03-23 13:13:22 +0000","summary":"[GlobeNewswire] - CARLSBAD, Calif., March 23, 2017-- Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that it has entered into a definitive securities ...","url":"http://finance.yahoo.com/news/alphatec-holdings-announces-18-9-131322580.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings Announces $18.9 Million Private Placement","publication_date":"2017-03-23 13:13:22 +0000","summary":"CARLSBAD, Calif., March 23, 2017-- Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that it has entered into a definitive securities ...","url":"http://finance.yahoo.com/news/alphatec-holdings-announces-18-9-131322580.html?.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition","publication_date":"2017-03-16 10:10:50 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition","url":"http://biz.yahoo.com/e/170316/atec8-k.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec reports 4Q loss","publication_date":"2017-03-15 21:52:49 +0000","summary":"On a per-share basis, the Carlsbad, California-based company said it had a loss of 56 cents. Losses, adjusted to account for discontinued operations, came to $1.21 per share. The medical equipment and ...","url":"http://finance.yahoo.com/news/alphatec-reports-4q-loss-215249974.html?.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec reports 4Q loss","publication_date":"2017-03-15 21:52:49 +0000","summary":"Alphatec reports 4Q loss","url":"http://sg.finance.yahoo.com/news/alphatec-reports-4q-loss-215249104.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings Announces Fourth Quarter and Full Year 2016 Financial Results","publication_date":"2017-03-15 20:45:00 +0000","summary":"[GlobeNewswire] - CARLSBAD, Calif., March 15, 2017-- Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today financial results for the fourth quarter ...","url":"http://finance.yahoo.com/news/alphatec-holdings-announces-fourth-quarter-204500775.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings Announces Fourth Quarter and Full Year 2016 Financial Results","publication_date":"2017-03-15 20:45:00 +0000","summary":"CARLSBAD, Calif., March 15, 2017-- Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today financial results for the fourth quarter ...","url":"http://finance.yahoo.com/news/alphatec-holdings-announces-fourth-quarter-204500775.html?.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta","publication_date":"2017-03-09 21:07:50 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta","url":"http://biz.yahoo.com/e/170309/atec8-k.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib","publication_date":"2017-03-06 21:56:42 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib","url":"http://biz.yahoo.com/e/170306/atec8-k.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Spine Appoints Jeffrey G. Black as Chief Financial Officer","publication_date":"2017-03-06 21:37:00 +0000","summary":"CARLSBAD, Calif., March 06, 2017-- Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that it continues its investment in new executive talent with the hiring of Jeffrey G. ...","url":"http://finance.yahoo.com/news/alphatec-spine-appoints-jeffrey-g-213700407.html?.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Spine Appoints Jeffrey G. Black as Chief Financial Officer","publication_date":"2017-03-06 21:37:00 +0000","summary":"[GlobeNewswire] - CARLSBAD, Calif., March 06, 2017-- Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that it continues its investment in new executive talent with the hiring of Jeffrey G. ...","url":"http://finance.yahoo.com/news/alphatec-spine-appoints-jeffrey-g-213700407.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec’s Arsenal™ Deformity Adolescent Scoliosis (AIS) System Launched in Limited Markets in the U.S.","publication_date":"2017-02-28 21:37:00 +0000","summary":"[GlobeNewswire] - CARLSBAD, Calif., Feb. 28, 2017-- Alphatec Spine, Inc.,, a global provider of spinal fusion technologies, announced today that the Company has launched its new Arsenal Deformity Adolescent Idiopathic Scoliosis ...","url":"http://finance.yahoo.com/news/alphatec-arsenal-deformity-adolescent-scoliosis-213700525.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec’s Arsenal™ Deformity Adolescent Scoliosis (AIS) System Launched in Limited Markets in the U.S.","publication_date":"2017-02-28 21:37:00 +0000","summary":"CARLSBAD, Calif., Feb. 28, 2017-- Alphatec Spine, Inc.,, a global provider of spinal fusion technologies, announced today that the Company has launched its new Arsenal Deformity Adolescent Idiopathic Scoliosis ...","url":"http://finance.yahoo.com/news/alphatec-arsenal-deformity-adolescent-scoliosis-213700525.html?.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2017-02-14 18:49:30 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","url":"http://biz.yahoo.com/e/170214/atec8-k.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Spine Announces Appointment of David H. Mowry to its Board of Directors","publication_date":"2017-02-14 13:00:00 +0000","summary":"[GlobeNewswire] - CARLSBAD, Calif., Feb. 14, 2017-- Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that its board of directors has appointed ...","url":"http://finance.yahoo.com/news/alphatec-spine-announces-appointment-david-130000909.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Spine Announces Appointment of David H. Mowry to its Board of Directors","publication_date":"2017-02-14 13:00:00 +0000","summary":"CARLSBAD, Calif., Feb. 14, 2017-- Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that its board of directors has appointed ...","url":"http://finance.yahoo.com/news/alphatec-spine-announces-appointment-david-130000909.html?.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2017-01-26 13:02:07 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","url":"http://biz.yahoo.com/e/170126/atec8-k.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETFs with exposure to Alphatec Holdings, Inc. : January 20, 2017","publication_date":"2017-01-20 17:51:32 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Alphatec Holdings, Inc. Here are 5 ETFs with the largest exposure to ATEC-US. Comparing the performance and risk of Alphatec Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/67fc10ca-2cdd-33f8-a921-65ba16c5f325/etfs-with-exposure-to-alphatec-holdings-inc-january-20-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETFs with exposure to Alphatec Holdings, Inc. : January 20, 2017","publication_date":"2017-01-20 17:51:32 +0000","summary":"ETFs with exposure to Alphatec Holdings, Inc. : January 20, 2017","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-alphatec-holdings-inc-january-20-2017/"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETFs with exposure to Alphatec Holdings, Inc. : December 22, 2016","publication_date":"2016-12-22 15:24:43 +0000","summary":"ETFs with exposure to Alphatec Holdings, Inc. : December 22, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-alphatec-holdings-inc-december-22-2016/"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Slides on Management Changes","publication_date":"2016-12-12 21:07:10 +0000","summary":"Alphatec Slides on Management Changes","url":"http://finance.yahoo.com/news/alphatec-slides-management-changes-210710382.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Slides on Management Changes","publication_date":"2016-12-12 21:07:10 +0000","summary":"Alphatec Holdings, Inc. (NASDAQ: ATEC) watched its shares slide on Monday after the company reported that it was making changes to its executive team. The main change was that Terry Rich was appointed ...","url":"http://finance.yahoo.com/news/alphatec-slides-management-changes-210710382.html?.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib","publication_date":"2016-12-12 14:06:03 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib","url":"http://biz.yahoo.com/e/161212/atec8-k.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings Announces Board and Executive Leadership Changes","publication_date":"2016-12-12 13:30:00 +0000","summary":"[GlobeNewswire] - Experienced Orthopedics and Spine Executive, Terry M. Rich, joins as CEO and Board Member Mortimer Berkowitz III appointed Chairman of the Board New Commercial Leadership Team Hired. CARLSBAD, Calif., ...","url":"http://finance.yahoo.com/news/alphatec-holdings-announces-board-executive-133000332.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETFs with exposure to Alphatec Holdings, Inc. : December 6, 2016","publication_date":"2016-12-06 15:59:27 +0000","summary":"ETFs with exposure to Alphatec Holdings, Inc. : December 6, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-alphatec-holdings-inc-december-6-2016/"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETFs with exposure to Alphatec Holdings, Inc. : December 6, 2016","publication_date":"2016-12-06 15:59:27 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Alphatec Holdings, Inc. Here are 5 ETFs with the largest exposure to ATEC-US. Comparing the performance and risk of Alphatec Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/aed1320a-fc29-3732-8843-409be542c10f/etfs-with-exposure-to-alphatec-holdings-inc-december-6-2016?yptr=yahoo&.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Financials","publication_date":"2016-11-17 18:04:10 +0000","summary":"ALPHATEC HOLDINGS, INC. Financials","url":"http://finance.yahoo.com/q/is?s=atec"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETFs with exposure to Alphatec Holdings, Inc. : November 16, 2016","publication_date":"2016-11-16 17:40:55 +0000","summary":"ETFs with exposure to Alphatec Holdings, Inc. : November 16, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-alphatec-holdings-inc-november-16-2016/"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETFs with exposure to Alphatec Holdings, Inc. : November 16, 2016","publication_date":"2016-11-16 17:40:55 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Alphatec Holdings, Inc. Here are 5 ETFs with the largest exposure to ATEC-US. Comparing the performance and risk of Alphatec Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/b827b062-d935-34be-bc0f-3350a5327b30/etfs-with-exposure-to-alphatec-holdings-inc-november-16-2016?yptr=yahoo&.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings, Inc. :ATEC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016","publication_date":"2016-11-15 16:28:19 +0000","summary":"Categories: Yahoo Finance Get free summary analysis Alphatec Holdings, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Alphatec Holdings, Inc. – Orthofix International NV, NuVasive, Inc., Globus Medical, Inc. Class A, Stryker Corporation, K2M Group Holdings, Inc., Xtant Medical Holdings, Inc., Integra LifeSciences Holdings Corporation, ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/3c9e5bc8-9659-3c9d-8f2c-2816b4683af7/alphatec-holdings-inc-atec-us-earnings-analysis-q3-2016-by-the-numbers-november-15-2016?yptr=yahoo&.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings, Inc. :ATEC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016","publication_date":"2016-11-15 16:28:19 +0000","summary":"Alphatec Holdings, Inc. :ATEC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016","url":"http://www.capitalcube.com/blog/index.php/alphatec-holdings-inc-atec-us-earnings-analysis-q3-2016-by-the-numbers-november-15-2016/"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec reports 3Q loss","publication_date":"2016-11-09 23:01:30 +0000","summary":"Alphatec reports 3Q loss","url":"http://sg.finance.yahoo.com/news/alphatec-reports-3q-loss-230130969.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report","publication_date":"2016-11-09 22:09:29 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report","url":"http://biz.yahoo.com/e/161109/atec10-q.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings Announces Third Quarter 2016 Revenue and Financial Results","publication_date":"2016-11-09 21:41:20 +0000","summary":"[at noodls] - CARLSBAD, Calif., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today financial ...","url":"http://www.publicnow.com/view/C1AEB65A833991E24534398A299CAA2820231D88"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Spine to Showcase New Minimally Invasive (MIS) and Complex Spine Products at the Upcoming 31st Annual North American Spine Society (NASS) Meeting in Boston","publication_date":"2016-10-18 20:15:00 +0000","summary":"[GlobeNewswire] - CARLSBAD, Calif., Oct. 18, 2016-- Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that it will introduce several new products, ...","url":"http://finance.yahoo.com/news/alphatec-spine-showcase-minimally-invasive-201500491.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETF’s with exposure to Alphatec Holdings, Inc. : October 7, 2016","publication_date":"2016-10-07 13:44:12 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Alphatec Holdings, Inc. Here are 5 ETF’s with the largest exposure to ATEC-US. Comparing the performance and risk of Alphatec Holdings, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/9e147e57-65a4-37d1-9396-26747be8259d/etfs-with-exposure-to-alphatec-holdings-inc-october-7-2016?yptr=yahoo&.tsrc=rss"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETF’s with exposure to Alphatec Holdings, Inc. : October 7, 2016","publication_date":"2016-10-07 13:44:12 +0000","summary":"ETF’s with exposure to Alphatec Holdings, Inc. : October 7, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-alphatec-holdings-inc-october-7-2016/"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib","publication_date":"2016-10-05 21:32:02 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib","url":"http://biz.yahoo.com/e/161005/atec8-k.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings Announces Company Updates","publication_date":"2016-10-05 21:28:06 +0000","summary":"[at noodls] - CARLSBAD, Calif., Oct. 05, 2016 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, today announced changes ...","url":"http://www.publicnow.com/view/9AED61E83BD75097DDD2AFCC2D2D4283D46F2029"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETF’s with exposure to Alphatec Holdings, Inc. : September 19, 2016","publication_date":"2016-09-19 13:44:47 +0000","summary":"ETF’s with exposure to Alphatec Holdings, Inc. : September 19, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-alphatec-holdings-inc-september-19-2016/"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2016-09-16 12:32:00 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","url":"http://biz.yahoo.com/e/160916/atec8-k.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statem","publication_date":"2016-09-15 21:20:18 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statem","url":"http://biz.yahoo.com/e/160915/atec8-k.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings Announces Company Updates","publication_date":"2016-09-15 20:38:02 +0000","summary":"[at noodls] - Company Names Chairman Leslie H. Cross as Interim CEO Regains Compliance with Nasdaq Listing Requirements CARLSBAD, Calif., Sept. 15, 2016 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the ...","url":"http://www.publicnow.com/view/FFF1003CB006914C54069D2B7395D76F356EA429"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Def","publication_date":"2016-09-08 21:28:44 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Def","url":"http://biz.yahoo.com/e/160908/atec8-k.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Globus Medical (GMED) Closes Alphatec Buyout, Stock Gains","publication_date":"2016-09-05 13:18:01 +0000","summary":"Globus Medical (GMED) Closes Alphatec Buyout, Stock Gains","url":"http://finance.yahoo.com/news/globus-medical-gmed-closes-alphatec-131801397.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Close Update: U.S. Stocks Strengthen as Rate Hike Chances Dip After Jobs Data","publication_date":"2016-09-02 20:56:53 +0000","summary":"Stocks in the U S were trading stronger by the close on Friday after key jobs data that came in below analysts expectations seemed to curb the chances of an interest rate increase this month Stocks in the U S were trading stronger by the close on Friday after key jobs data that came in","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZOrYcjKqgxY/close-update-us-stocks-strengthen-as-rate-hike-chances-dip-after-jobs-data-cm674334"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Health Care Sector Update for 09/02/2016: ALR,ATEC,GMED,ELTP","publication_date":"2016-09-02 20:17:09 +0000","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 09 JNJ 0 09 PFE 0 17 PFE 0 17 MRK 0 52 MRK 0 52 ABT 0 05 ABT 0 05 AMGN 0 34 AMGN 0 34 Health care stocks were trading on the plus side today with the NYSE Health Care Index climbing about 0 4 although shares of health","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kIG39QHp13o/health-care-sector-update-for-09022016-alratecgmedeltp-cm674307"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Health Care Sector Update for 09/02/2016: BIIB,ATEC,GMED,ELTP","publication_date":"2016-09-02 17:56:54 +0000","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 05 JNJ 0 05 PFE 0 16 PFE 0 16 MRK 0 69 MRK 0 69 ABT 0 14 ABT 0 14 AMGN 0 55 AMGN 0 55 Health care stocks were mostly trading on the plus side today with the NYSE Health Care Index climbing about 0 4 while shares of health","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6SOwi1d_e08/health-care-sector-update-for-09022016-biibatecgmedeltp-cm674252"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Midday Update: Goldilocks Jobs Report Drives Wall Street Higher","publication_date":"2016-09-02 17:17:33 +0000","summary":"Stocks were trading higher Friday as Wall Street applauded the lackluster August labor market report since it will likely keep the Federal Reserve sidelined at their Federal Open Market Committee meeting later this month which still doesn t indicate sluggish economic growth Stocks were","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o1zkMaNYFOw/midday-update-goldilocks-jobs-report-drives-wall-street-higher-cm674227"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings Completes Sale of International Business to Globus Medical","publication_date":"2016-09-01 20:43:03 +0000","summary":"[at noodls] - CARLSBAD, Calif., Sept. 01, 2016 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, today announced the completion ...","url":"http://www.publicnow.com/view/FC77F2A2E2F9FFD892BA15028158C682450BCB4F"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings Completes Sale of International Business to Globus Medical","publication_date":"2016-09-01 20:23:09 +0000","summary":"[GlobeNewswire] - CARLSBAD, Calif., Sept. 01, 2016-- Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, today announced the completion of the previously announced ...","url":"http://finance.yahoo.com/news/alphatec-holdings-completes-sale-international-202309876.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Globus Medical Completes Acquisition of Alphatec’s International Business","publication_date":"2016-09-01 20:15:00 +0000","summary":"[GlobeNewswire] - AUDUBON, Pa., Sept. 01, 2016-- Globus Medical, Inc., a leading musculoskeletal implant manufacturer, today announced that it has successfully completed the previously announced acquisition of the international ...","url":"http://finance.yahoo.com/news/globus-medical-completes-acquisition-alphatec-201500893.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financia","publication_date":"2016-08-24 21:27:42 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financia","url":"http://biz.yahoo.com/e/160824/atec8-k.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings Announces One-for-Twelve Reverse Stock Split","publication_date":"2016-08-24 15:59:00 +0000","summary":"[GlobeNewswire] - CARLSBAD, Calif., Aug. 24, 2016-- Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, today announced the effectiveness of a one-for-twelve ...","url":"http://finance.yahoo.com/news/alphatec-holdings-announces-one-twelve-155900028.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders","publication_date":"2016-08-23 10:04:59 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders","url":"http://biz.yahoo.com/e/160823/atec8-k.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETF’s with exposure to Alphatec Holdings, Inc. : August 15, 2016","publication_date":"2016-08-15 14:12:45 +0000","summary":"ETF’s with exposure to Alphatec Holdings, Inc. : August 15, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-alphatec-holdings-inc-august-15-2016/"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Other Events","publication_date":"2016-08-15 12:49:23 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Other Events","url":"http://biz.yahoo.com/e/160815/atec8-k.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings, Inc. :ATEC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016","publication_date":"2016-08-12 15:32:39 +0000","summary":"Alphatec Holdings, Inc. :ATEC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016","url":"http://www.capitalcube.com/blog/index.php/alphatec-holdings-inc-atec-us-earnings-analysis-q2-2016-by-the-numbers-august-12-2016/"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report","publication_date":"2016-08-09 21:18:22 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report","url":"http://biz.yahoo.com/e/160809/atec10-q.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Health Care Sector Update for 07/27/2016: MDGS,REPH,ILMN","publication_date":"2016-07-27 20:21:46 +0000","summary":"Top Health Care Stocks JNJ 0.20% PFE +0.16% MRK 0.32% ABT +0.50% AMGN +1.77% Health care stocks were moderately higher in late trade after reversing earlier declines. The NYSE Health Care Index was climbing about 0.3% in recent trade","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G8xKK8LS2a8/health-care-sector-update-for-07272016-mdgsrephilmn-cm655951"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Health Care Sector Update for 07/27/2016: UHS,REPH,ILMN","publication_date":"2016-07-27 17:22:51 +0000","summary":"Top Health Care Stocks JNJ 0.37% PFE 0.19% MRK 0.58% ABT 0.01% AMGN +0.81% Health care stocks were narrowly mixed Wednesday afternoon, with the NYSE Health Care Index slumping about 0.1% while shares of health care companies in the","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D1jna9bZBeA/health-care-sector-update-for-07272016-uhsrephilmn-cm655832"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings Announces Sale of International Business to Globus Medical","publication_date":"2016-07-26 20:58:07 +0000","summary":"[at noodls] - CARLSBAD, Calif., July 26, 2016 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that ...","url":"http://www.publicnow.com/view/A3BEB8A17FACDBE54598D2ED2E794EE25D048499"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Fin","publication_date":"2016-07-26 20:38:55 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Fin","url":"http://biz.yahoo.com/e/160726/atec8-k.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Globus Medical Announces the Acquisition of Alphatec’s International Business","publication_date":"2016-07-26 20:30:00 +0000","summary":"[GlobeNewswire] - AUDUBON, Pa., July 26, 2016-- Globus Medical, Inc., a leading musculoskeletal implant manufacturer, today announced that it has entered into an agreement to acquire the international operations and distribution ...","url":"http://finance.yahoo.com/news/globus-medical-announces-acquisition-alphatec-203000021.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETF’s with exposure to Alphatec Holdings, Inc. : July 25, 2016","publication_date":"2016-07-25 16:51:05 +0000","summary":"ETF’s with exposure to Alphatec Holdings, Inc. : July 25, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-alphatec-holdings-inc-july-25-2016/"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETF’s with exposure to Alphatec Holdings, Inc. : July 6, 2016","publication_date":"2016-07-06 18:07:28 +0000","summary":"ETF’s with exposure to Alphatec Holdings, Inc. : July 6, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-alphatec-holdings-inc-july-6-2016/"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Zimmer's LDR Deal Could Force Others to Grow a Dealmaking Spine","publication_date":"2016-06-24 11:00:00 +0000","summary":"Zimmer's LDR Deal Could Force Others to Grow a Dealmaking Spine","url":"https://www.thestreet.com/story/13617005/1/zimmer-s-ldr-deal-could-force-others-to-grow-a-dealmaking-spine.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETF’s with exposure to Alphatec Holdings, Inc. : June 7, 2016","publication_date":"2016-06-07 21:28:04 +0000","summary":"ETF’s with exposure to Alphatec Holdings, Inc. : June 7, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-alphatec-holdings-inc-june-7-2016/"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Triggering Events That Accelerate or Increase a Direct Financial Obligati","publication_date":"2016-06-06 21:17:14 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Triggering Events That Accelerate or Increase a Direct Financial Obligati","url":"http://biz.yahoo.com/e/160606/atec8-k.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings, Inc. :ATEC-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016","publication_date":"2016-05-26 15:16:38 +0000","summary":"Alphatec Holdings, Inc. :ATEC-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016","url":"http://www.capitalcube.com/blog/index.php/alphatec-holdings-inc-atec-us-earnings-analysis-q1-2016-by-the-numbers-may-26-2016/"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2016-05-20 12:41:16 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","url":"http://biz.yahoo.com/e/160520/atec8-k.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"AMETEK (AME) Posts In Line Q1 Earnings, Misses Revenues","publication_date":"2016-04-28 19:08:44 +0000","summary":"AMETEK Inc. 's AME first quarter 2016 earnings of 57 cents per share matched the Zacks Consensus Estimate. Earnings decreased 9.9% sequentially and 9.8% year over year. Revenues of $944.4 million missed the Zacks Consensus estimate of $964.5 million","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9WTR_TSKf8E/ametek-ame-posts-in-line-q1-earnings-misses-revenues-cm613313"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETF’s with exposure to Alphatec Holdings, Inc. : April 27, 2016","publication_date":"2016-04-27 16:27:23 +0000","summary":"ETF’s with exposure to Alphatec Holdings, Inc. : April 27, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-alphatec-holdings-inc-april-27-2016/"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETF’s with exposure to Alphatec Holdings, Inc. : April 17, 2016","publication_date":"2016-04-17 14:41:51 +0000","summary":"ETF’s with exposure to Alphatec Holdings, Inc. : April 17, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-alphatec-holdings-inc-april-17-2016/"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ETF’s with exposure to Alphatec Holdings, Inc. : March 24, 2016","publication_date":"2016-03-24 21:45:40 +0000","summary":"ETF’s with exposure to Alphatec Holdings, Inc. : March 24, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-alphatec-holdings-inc-march-24-2016/"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings, Inc. :ATEC-US: Earnings Analysis: Q4, 2015 By the Numbers","publication_date":"2016-03-23 14:11:03 +0000","summary":"Alphatec Holdings, Inc. :ATEC-US: Earnings Analysis: Q4, 2015 By the Numbers","url":"http://www.capitalcube.com/blog/index.php/alphatec-holdings-inc-atec-us-earnings-analysis-q4-2015-by-the-numbers/"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec Holdings, Inc. :ATEC-US: Earnings Analysis: 2015 By the Numbers","publication_date":"2016-03-22 18:01:58 +0000","summary":"Alphatec Holdings, Inc. :ATEC-US: Earnings Analysis: 2015 By the Numbers","url":"http://www.capitalcube.com/blog/index.php/alphatec-holdings-inc-atec-us-earnings-analysis-2015-by-the-numbers/"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta","publication_date":"2016-03-21 21:05:08 +0000","summary":"ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta","url":"http://biz.yahoo.com/e/160321/atec8-k.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Alphatec reports 4Q loss","publication_date":"2016-03-15 21:29:36 +0000","summary":"Alphatec reports 4Q loss","url":"http://sg.finance.yahoo.com/news/alphatec-reports-4q-loss-212936461.html"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"New Strong Buy Stocks for March 11th","publication_date":"2016-03-14 12:46:20 +0000","summary":"Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) list today Alphatec Holdings IncATECAspen Technology, Inc.AZPNAtlantic Power CorpATBazaarvoice IncBVBenefitfocus IncBNFTView the entire Zacks Rank #1 List . Want the latest recommendations from Zacks Investment Research? Today,","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a8jygRNNeBs/new-strong-buy-stocks-for-march-11th-cm592033"},{"ticker":"ATEC","figi_ticker":"ATEC:US","figi":"BBG000BBM7Y5","title":"Sunoco Logistics' Mariner East 1 Pipeline Nears Completion","publication_date":"2016-03-11 20:45:22 +0000","summary":"Sunoco Logistics Partners L.P.SXL reported that its Mariner East 1 pipeline, which is the first big pipeline between Washington County and a Philadelphia distribution center, will soon be fully operational. The pipeline has started shipping both ethane and propane","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hv6AnlfRnJ0/sunoco-logistics-mariner-east-1-pipeline-nears-completion-cm592157"}],"result_count":120,"page_size":100,"current_page":1,"total_pages":2,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"1.99"},{"x":"1494596100","y":"2"},{"x":"1494596400","y":"2.0499"},{"x":"1494596700","y":"2.0582"},{"x":"1494597000","y":"2.05"},{"x":"1494597300","y":"2.0499"},{"x":"1494597600","y":"2.03"},{"x":"1494597900","y":"2.03"},{"x":"1494598200","y":"2.03"},{"x":"1494598500","y":"2.03"},{"x":"1494598800","y":"2.05"},{"x":"1494599100","y":"2.08"},{"x":"1494599400","y":"2.0921"},{"x":"1494599700","y":"2.09"},{"x":"1494600000","y":"2.08"},{"x":"1494600300","y":"2.07"},{"x":"1494600600","y":"2.04"},{"x":"1494600900","y":"2.06"},{"x":"1494601200","y":"2.09"},{"x":"1494601500","y":"2.095"},{"x":"1494601800","y":"2.12"},{"x":"1494602400","y":"2.1"},{"x":"1494602700","y":"2.11"},{"x":"1494603000","y":"2.11"},{"x":"1494603300","y":"2.11"},{"x":"1494603600","y":"2.1"},{"x":"1494603900","y":"2.1"},{"x":"1494604200","y":"2.11"},{"x":"1494604500","y":"2.11"},{"x":"1494604800","y":"2.11"},{"x":"1494605100","y":"2.11"},{"x":"1494605400","y":"2.11"},{"x":"1494605700","y":"2.11"},{"x":"1494606000","y":"2.11"},{"x":"1494606300","y":"2.11"},{"x":"1494606600","y":"2.11"},{"x":"1494606900","y":"2.11"},{"x":"1494607200","y":"2.13"},{"x":"1494607500","y":"2.13"},{"x":"1494608100","y":"2.11"},{"x":"1494608400","y":"2.11"},{"x":"1494608700","y":"2.13"},{"x":"1494609000","y":"2.14"},{"x":"1494609300","y":"2.11"},{"x":"1494609600","y":"2.15"},{"x":"1494609900","y":"2.16"},{"x":"1494610200","y":"2.15"},{"x":"1494610500","y":"2.17"},{"x":"1494611100","y":"2.2"},{"x":"1494611400","y":"2.16"},{"x":"1494611700","y":"2.15"},{"x":"1494612000","y":"2.15"},{"x":"1494612300","y":"2.15"},{"x":"1494612600","y":"2.16"},{"x":"1494612900","y":"2.1601"},{"x":"1494613200","y":"2.17"},{"x":"1494613500","y":"2.17"},{"x":"1494613800","y":"2.2"},{"x":"1494614100","y":"2.16"},{"x":"1494614400","y":"2.2"},{"x":"1494614700","y":"2.18"},{"x":"1494615000","y":"2.1758"},{"x":"1494615600","y":"2.16"},{"x":"1494615900","y":"2.16"},{"x":"1494616200","y":"2.1473"},{"x":"1494616500","y":"2.05"},{"x":"1494616800","y":"2.05"},{"x":"1494617100","y":"2.11"},{"x":"1494617400","y":"2.1"},{"x":"1494618300","y":"2.11"},{"x":"1494618600","y":"2.11"},{"x":"1494618900","y":"2.1173"},{"x":"1494619200","y":"2.12"} ], "color":"#03a9f4"}]},
{"id":"3","symbol": "ATHX","name": "Athersys Inc","price": 1.52,"dollarChange": 0.1,"percentChange": 6.3,"open": 1.43,"high": 1.55,"low":1.42,"volume": 652572,"avgVol": 1428848.833333,"sharesShort": 4997005,"shortPercent": 4.489002,"marketCap": 164748590,"float": 111316615,"headlines":{"data":[{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys, Inc. :ATHX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017","publication_date":"2017-05-12 15:52:55 +0000","summary":"Categories: Yahoo FinanceGet free summary analysis Athersys, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Athersys, Inc. – Vericel Corporation, Orexigen Therapeutics, Inc., Amgen Inc., Johnson & Johnson, United States Lime & Minerals, Inc., Bristol-Myers Squibb Company, Pfizer Inc. and Arena Pharmaceuticals, Inc. (VCEL-US, ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/340e4dae-0260-3706-bcb7-9b6a8ac8216c/athersys-inc-athx-us-earnings-analysis-q1-2017-by-the-numbers-may-12-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Edited Transcript of ATHX earnings conference call or presentation 9-May-17 8:30pm GMT","publication_date":"2017-05-11 01:31:18 +0000","summary":"Q1 2017 Athersys Inc Earnings Call","url":"http://finance.yahoo.com/news/edited-transcript-athx-earnings-conference-120857181.html?.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys Reports First Quarter 2017 Results","publication_date":"2017-05-09 20:05:00 +0000","summary":"Company announces Fast Track Designation by FDA for Stroke Program and other progress. Management to host conference call at 4:30pm EDT today. CLEVELAND, May 09, 2017-- Athersys, Inc. today announced its ...","url":"http://finance.yahoo.com/news/athersys-reports-first-quarter-2017-200500892.html?.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys to Host First Quarter Financial Results Call","publication_date":"2017-04-10 15:00:00 +0000","summary":"CLEVELAND, April 10, 2017-- Athersys, Inc. will release its first quarter 2017 financial results at approximately 4:00 PM Eastern Time on Tuesday, May 9, 2017, and will host a conference call shortly thereafter ...","url":"http://finance.yahoo.com/news/athersys-host-first-quarter-financial-150000172.html?.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Can the Rally in Athersys (ATHX) Shares Continue?","publication_date":"2017-03-31 19:01:25 +0000","summary":"Athersys Inc ATHX has been on the move lately as the stock has risen by 62 4 in the past four weeks and it is currently trading well above its 20 Day SMA This is a pretty solid move higher but the question that has to be on investors minds right now is can this trend continue","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kzpAwBhnRM0/can-the-rally-in-athersys-athx-shares-continue-cm768481"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Here's What Might Be Pushing Up Shares of Athersys, Inc. Today","publication_date":"2017-03-31 18:00:29 +0000","summary":"What happened Shares of Athersys Inc NASDAQ ATHX a clinical stage biotech developing off the shelf stem cell products jumped Monday 160 morning Despite a lack of significant news the small cap stock 160 was up 12 1 as of 10 48 a m EDT following a positive note from","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9TrjNIz3VTs/heres-what-might-be-pushing-up-shares-of-athersys-inc-today-cm768413"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Can the Rally in Athersys (ATHX) Shares Continue?","publication_date":"2017-03-31 16:46:04 +0000","summary":"Athersys, Inc. (ATHX) has been on the move lately as the stock has risen by 62.4% in the past four weeks, and it is currently trading well above its 20-Day SMA","url":"http://finance.yahoo.com/news/rally-athersys-athx-shares-continue-164604832.html?.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Can the Rally in Athersys (ATHX) Shares Continue?","publication_date":"2017-03-31 16:46:04 +0000","summary":"Can the Rally in Athersys (ATHX) Shares Continue?","url":"http://finance.yahoo.com/news/rally-athersys-athx-shares-continue-164604832.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Here's What Might Be Pushing Up Shares of Athersys, Inc. Today","publication_date":"2017-03-31 16:21:00 +0000","summary":"Here's What Might Be Pushing Up Shares of Athersys, Inc. Today","url":"https://www.fool.com/investing/2017/03/31/heres-what-might-be-pushing-up-shares-of-athersys.aspx"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Here's What Might Be Pushing Up Shares of Athersys, Inc. Today","publication_date":"2017-03-31 16:21:00 +0000","summary":"An investment bank analyst predicts off-the-hook gains from Athersys' &quot;off-the-shelf&quot; stem cell treatments.","url":"http://finance.yahoo.com/r/4230774e-c529-39b8-8657-35873223c431/heres-what-might-be-pushing-up-shares-of-athersys.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Gainers & Losers Of Mar.30: XBIO, PRAN, AKER, TNXP, HALO...","publication_date":"2017-03-30 23:02:00 +0000","summary":"Gainers & Losers Of Mar.30: XBIO, PRAN, AKER, TNXP, HALO...","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/087akXeCg3Q/gainers--losers-of-mar30-xbio-pran-aker-tnxp-halo-20170330-01491"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Is the Options Market Predicting a Spike in Athersys (ATHX) Stock?","publication_date":"2017-03-30 15:04:49 +0000","summary":"Investors in Athersys Inc ATHX need to pay close attention to the stock based on moves in the options market lately That is because the April 21 st 2017 1 Call had some of the highest implied volatility of all equity options today What is Implied Volatility Implied volatility","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GJ-5r9LwRCA/is-the-options-market-predicting-a-spike-in-athersys-athx-stock-cm767702"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Tonix Pharmaceuticals and Athersys Advance as FDA Clinical Trials Move Forward","publication_date":"2017-03-30 13:30:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 30, 2017 / The two companies posted nice gains as each company is showing signs of bringing their product to market as their products garner the attention of investors ...","url":"http://finance.yahoo.com/news/tonix-pharmaceuticals-athersys-advance-fda-133000978.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Tonix Pharmaceuticals and Athersys Advance as FDA Clinical Trials Move Forward","publication_date":"2017-03-30 13:30:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / March 30, 2017 / The two companies posted nice gains as each company is showing signs of bringing their product to market as their products garner the attention of investors ...","url":"http://finance.yahoo.com/news/tonix-pharmaceuticals-athersys-advance-fda-133000978.html?.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Is the Options Market Predicting a Spike in Athersys (ATHX) Stock?","publication_date":"2017-03-30 12:32:12 +0000","summary":"Is the Options Market Predicting a Spike in Athersys (ATHX) Stock?","url":"http://finance.yahoo.com/news/options-market-predicting-spike-athersys-123212472.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Is the Options Market Predicting a Spike in Athersys (ATHX) Stock?","publication_date":"2017-03-30 12:32:12 +0000","summary":"Investors in Athersys, Inc. (ATHX) need to pay close attention to the stock based on moves in the options market lately.","url":"http://finance.yahoo.com/news/options-market-predicting-spike-athersys-123212472.html?.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys (ATHX) Stock Rallies as William Blair Initiates Coverage","publication_date":"2017-03-29 23:59:30 +0000","summary":"Shares of Athersys Inc ATHX surged significantly in the post market trading on Mar 28 after research firm William Blair initiated a coverage on the stock with an outperform rating Share Price Movement Shares of the Athersys have performed better than the Zacks","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NN4nyuX3MVc/athersys-athx-stock-rallies-as-william-blair-initiates-coverage-cm767530"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Close Update: Stock Mixed as Wall Street Pauses Before More Fed-Speak, GDP Revision","publication_date":"2017-03-29 21:18:52 +0000","summary":"The major averages were mixed at Wednesday s close with the Dow Jones Industrial Average more than 40 points below Tuesday s close but the S amp P 500 and Nasdaq staying on the plus side for a third day on strength in energy and technology shares Wall Street was mostly treading water on","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AdDomXoBfPk/close-update-stock-mixed-as-wall-street-pauses-before-more-fed-speak-gdp-revision-cm767488"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys (ATHX) Stock Rallies as William Blair Initiates Coverage","publication_date":"2017-03-29 21:18:00 +0000","summary":"Shares of Athersys, Inc. ATHX surged significantly in the post market trading on Mar 28 after research firm William Blair initiated a coverage on the stock with an outperform rating. Share Price Movement ...","url":"http://finance.yahoo.com/r/cf716bed-28e3-349a-8a74-a4908569bd17/athersys-athx-stock-rallies-william-blair-initiates-coverage?partner=YahooSA&yptr=yahoo&.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys (ATHX) Stock Rallies as William Blair Initiates Coverage","publication_date":"2017-03-29 21:18:00 +0000","summary":"Athersys (ATHX) Stock Rallies as William Blair Initiates Coverage","url":"http://www.investopedia.com/partner/zacks/athersys-athx-stock-rallies-william-blair-initiates-coverage/?partner=YahooSA"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys to Present at Needham Healthcare Conference on April 4","publication_date":"2017-03-29 20:00:00 +0000","summary":"CLEVELAND, March 29, 2017-- Athersys, Inc. announced today that Gil Van Bokkelen, Chairman and CEO, will present a corporate overview at the 16 th Annual Needham Healthcare Conference at The Westin New ...","url":"http://finance.yahoo.com/news/athersys-present-needham-healthcare-conference-200000693.html?.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys to Present at Needham Healthcare Conference on April 4","publication_date":"2017-03-29 20:00:00 +0000","summary":"[GlobeNewswire] - CLEVELAND, March 29, 2017-- Athersys, Inc. announced today that Gil Van Bokkelen, Chairman and CEO, will present a corporate overview at the 16 th Annual Needham Healthcare Conference at The Westin New ...","url":"http://finance.yahoo.com/news/athersys-present-needham-healthcare-conference-200000693.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Midday Update: Averages Mixed as Wall Street Waits For Direction From Fed Speakers, Q4 GDP","publication_date":"2017-03-29 17:19:07 +0000","summary":"The benchmark averages were mixed at midday on Wednesday with the Dow Jones Industrial Average slipping into negative territory while the S amp P 500 and Nasdaq were clinging onto modest gains After breaking a long running losing streak on Tuesday Wall Street was treading water ahead","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OmcYiilRbOI/midday-update-averages-mixed-as-wall-street-waits-for-direction-from-fed-speakers-q4-gdp-cm767357"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"ETFs with exposure to Athersys, Inc. : March 27, 2017","publication_date":"2017-03-27 19:49:37 +0000","summary":"ETFs with exposure to Athersys, Inc. : March 27, 2017","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-athersys-inc-march-27-2017/"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"ETFs with exposure to Athersys, Inc. : March 27, 2017","publication_date":"2017-03-27 19:49:37 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Athersys, Inc. Here are 5 ETFs with the largest exposure to ATHX-US. Comparing the performance and risk of Athersys, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/4f8f4241-750f-3d52-9fd5-47faa065b950/etfs-with-exposure-to-athersys-inc-march-27-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"12.3% of VTWV Holdings Seeing Recent Insider Buys","publication_date":"2017-03-22 15:06:50 +0000","summary":"A look at the weighted underlying holdings of the Vanguard Russell 2000 Value ETF VTWV shows an impressive 12 3 of holdings on a weighted basis have experienced insider buying within the past six months Athersys Inc Symbol ATHX which makes up 4 29 of the Vanguard Russell","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0UEdqN7JbNY/123-of-vtwv-holdings-seeing-recent-insider-buys-cm764031"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys, Inc. :ATHX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017","publication_date":"2017-03-20 15:43:11 +0000","summary":"Athersys, Inc. :ATHX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017","url":"http://www.capitalcube.com/blog/index.php/athersys-inc-athx-us-earnings-analysis-q4-2016-by-the-numbers-march-20-2017/"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys, Inc. :ATHX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017","publication_date":"2017-03-20 15:43:11 +0000","summary":"Categories: Yahoo Finance Get free summary analysis Athersys, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Athersys, Inc. – Vericel Corporation, Amgen Inc., Johnson & Johnson, Bristol-Myers Squibb Company, Sanofi Sponsored ADR, Pfizer Inc. and Arena Pharmaceuticals, Inc. (VCEL-US, AMGN-US, JNJ-US, BMY-US, SNY-US, PFE-US and ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/3ff2764d-c9a7-3712-9a0d-7155a9556135/athersys-inc-athx-us-earnings-analysis-q4-2016-by-the-numbers-march-20-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"6:31 am Athersys announces that clinical investigators have published results from Athersys' Phase 2 trial of MultiStem cell therapy for treating ischemic stroke patients in the peer-reviewed journal The Lancet Neurology","publication_date":"2017-03-20 10:31:00 +0000","summary":"6:31 am Athersys announces that clinical investigators have published results from Athersys' Phase 2 trial of MultiStem cell therapy for treating ischemic stroke patients in the peer-reviewed journal The Lancet Neurology","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#athx"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Two New Publications Highlight the Potential for MultiStem® Treatment of Ischemic Stroke","publication_date":"2017-03-20 10:30:00 +0000","summary":"CLEVELAND, March 20, 2017-- Athersys, Inc. announced today that clinical investigators have published results from Athersys’ Phase 2 trial of MultiStem cell therapy for treating ischemic stroke patients ...","url":"http://finance.yahoo.com/news/two-publications-highlight-potential-multistem-103000270.html?.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Two New Publications Highlight the Potential for MultiStem® Treatment of Ischemic Stroke","publication_date":"2017-03-20 10:30:00 +0000","summary":"[GlobeNewswire] - CLEVELAND, March 20, 2017-- Athersys, Inc. announced today that clinical investigators have published results from Athersys’ Phase 2 trial of MultiStem cell therapy for treating ischemic stroke patients ...","url":"http://finance.yahoo.com/news/two-publications-highlight-potential-multistem-103000270.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"ATHERSYS, INC / NEW Financials","publication_date":"2017-03-16 17:04:12 +0000","summary":"ATHERSYS, INC / NEW Financials","url":"http://finance.yahoo.com/q/is?s=athx"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Forget Gilead, Buy These Small-Cap Biotech Stocks Instead","publication_date":"2017-03-16 00:06:27 +0000","summary":"Biotech bigwig Gilead Sciences Inc GILD had a tough time in 2016 Although the company s fourth quarter results beat expectations the guidance for 2017 was disappointing Gilead s share price movement in the last one year shows that the stock underperformed the Zacks","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PBkUbXmSJtU/forget-gilead-buy-these-small-cap-biotech-stocks-instead-cm761433"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Forget Gilead, Buy These Small-Cap Biotech Stocks Instead","publication_date":"2017-03-15 21:40:09 +0000","summary":"Forget Gilead, Buy These Small-Cap Biotech Stocks Instead","url":"http://finance.yahoo.com/news/forget-gilead-buy-small-cap-214009160.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys, Inc. :ATHX-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017","publication_date":"2017-03-15 17:51:54 +0000","summary":"Categories: Yahoo Finance Get free summary analysis Athersys, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Athersys, Inc. – Vericel Corporation, Amgen Inc., Johnson & Johnson, Pfizer Inc., Sanofi Sponsored ADR, Bristol-Myers Squibb Company, RTI Surgical, Inc. and Arena Pharmaceuticals, Inc. (VCEL-US, AMGN-US, JNJ-US, PFE-US, ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/dc4c53a5-20f3-3d67-8594-b76f5b8ab346/athersys-inc-athx-us-earnings-analysis-2016-by-the-numbers-march-15-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys, Inc. :ATHX-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017","publication_date":"2017-03-15 17:51:54 +0000","summary":"Athersys, Inc. :ATHX-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017","url":"http://www.capitalcube.com/blog/index.php/athersys-inc-athx-us-earnings-analysis-2016-by-the-numbers-march-15-2017/"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"ATHERSYS, INC / NEW Files SEC form 10-K, Annual Report","publication_date":"2017-03-10 22:23:43 +0000","summary":"ATHERSYS, INC / NEW Files SEC form 10-K, Annual Report","url":"http://biz.yahoo.com/e/170310/athx10-k.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Edited Transcript of ATHX earnings conference call or presentation 9-Mar-17 9:30pm GMT","publication_date":"2017-03-09 23:30:39 +0000","summary":"Edited Transcript of ATHX earnings conference call or presentation 9-Mar-17 9:30pm GMT","url":"http://finance.yahoo.com/news/edited-transcript-athx-earnings-conference-233039738.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Edited Transcript of ATHX earnings conference call or presentation 9-Mar-17 9:30pm GMT","publication_date":"2017-03-09 23:30:39 +0000","summary":"Q4 2016 Athersys Inc Earnings Call","url":"http://finance.yahoo.com/news/edited-transcript-athx-earnings-conference-233039738.html?.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys Reports Financial Results for Fourth Quarter, Full Year 2016","publication_date":"2017-03-09 21:05:00 +0000","summary":"Company also announces priority review designation obtained by Healios in Japan-accelerating potential approval pathway for MultiStem ® clinical program for ischemic stroke. Management to host conference ...","url":"http://finance.yahoo.com/news/athersys-reports-financial-results-fourth-210500348.html?.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys Reports Financial Results for Fourth Quarter, Full Year 2016","publication_date":"2017-03-09 21:05:00 +0000","summary":"[GlobeNewswire] - Company also announces priority review designation obtained by Healios in Japan-accelerating potential approval pathway for MultiStem ® clinical program for ischemic stroke. Management to host conference ...","url":"http://finance.yahoo.com/news/athersys-reports-financial-results-fourth-210500348.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"ATHERSYS, INC / NEW Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib","publication_date":"2017-03-09 21:03:31 +0000","summary":"ATHERSYS, INC / NEW Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib","url":"http://biz.yahoo.com/e/170309/athx8-k.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Earnings Reaction History: Athersys, Inc., 28.6% Follow-Through Indicator, 5.7% Sensitive","publication_date":"2017-03-09 20:13:07 +0000","summary":"Expected Earnings Release 03 09 2017 After hoursExpected Earnings Release 03 09 2017 After hours Avg Extended Hours Dollar Volume 81 211Avg Extended Hours Dollar Volume 81 211 Athersys Inc ATHX is due to issue its quarterly earnings report in the upcoming extended hours","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1RyuI3N2pg8/earnings-reaction-history-athersys-inc-286-follow-through-indicator-57-sensitive-cm758780"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Q4 2016 Athersys Inc Earnings Release - After Market Close","publication_date":"2017-03-09 12:07:03 +0000","summary":"Q4 2016 Athersys Inc Earnings Release - After Market Close","url":"http://biz.yahoo.com/research/earncal/20170309.html?t=athx"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Overview of MultiStem® Clinical Trial in Japan Presentation at International Stroke Conference 2017","publication_date":"2017-02-23 12:00:00 +0000","summary":"CLEVELAND, Feb. 23, 2017-- Athersys, Inc. announced today a presentation featuring its MultiStem ® cell therapy treatment for ischemic stroke at the International Stroke Conference 2017 this week in Houston. ...","url":"http://finance.yahoo.com/news/overview-multistem-clinical-trial-japan-120000993.html?.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Overview of MultiStem® Clinical Trial in Japan Presentation at International Stroke Conference 2017","publication_date":"2017-02-23 12:00:00 +0000","summary":"[GlobeNewswire] - CLEVELAND, Feb. 23, 2017-- Athersys, Inc. announced today a presentation featuring its MultiStem ® cell therapy treatment for ischemic stroke at the International Stroke Conference 2017 this week in Houston. ...","url":"http://finance.yahoo.com/news/overview-multistem-clinical-trial-japan-120000993.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys to Host Year-End 2016 Financial Results Call","publication_date":"2017-02-14 14:30:00 +0000","summary":"CLEVELAND, Feb. 14, 2017-- Athersys, Inc. will release its year-end 2016 financial results at approximately 4:00 PM Eastern Time on Thursday, March 9, 2017, and will host a conference call shortly thereafter ...","url":"http://finance.yahoo.com/news/athersys-host-end-2016-financial-143000086.html?.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys to Host Year-End 2016 Financial Results Call","publication_date":"2017-02-14 14:30:00 +0000","summary":"[GlobeNewswire] - CLEVELAND, Feb. 14, 2017-- Athersys, Inc. will release its year-end 2016 financial results at approximately 4:00 PM Eastern Time on Thursday, March 9, 2017, and will host a conference call shortly thereafter ...","url":"http://finance.yahoo.com/news/athersys-host-end-2016-financial-143000086.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Coverage initiated on Athersys by Needham","publication_date":"2017-02-07 12:26:43 +0000","summary":"Coverage initiated on Athersys by Needham","url":"http://finance.yahoo.com/q/ud?s=ATHX"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys Announces Closing of Public Offering of Common Stock","publication_date":"2017-02-01 21:05:00 +0000","summary":"[GlobeNewswire] - CLEVELAND, Feb. 01, 2017-- Athersys, Inc. today announced the closing of its previously announced underwritten public offering of 22,772,300 shares of its common stock, par value $0.001 per share, at a ...","url":"http://finance.yahoo.com/news/athersys-announces-closing-public-offering-210500227.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys Announces Closing of Public Offering of Common Stock","publication_date":"2017-02-01 21:05:00 +0000","summary":"CLEVELAND, Feb. 01, 2017-- Athersys, Inc. today announced the closing of its previously announced underwritten public offering of 22,772,300 shares of its common stock, par value $0.001 per share, at a ...","url":"http://finance.yahoo.com/news/athersys-announces-closing-public-offering-210500227.html?.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Wednesday 2/1 Insider Buying Report: ANAB, ATHX","publication_date":"2017-02-01 17:33:47 +0000","summary":"As the saying goes there are many possible reasons for an insider to sell a stock but only one reason to buy they expect to make money So let s look at two noteworthy recent insider buys At Anaptysbio ANAB a filing with the SEC revealed that on Tuesday Director Nicholas","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YKmYuHYvoSw/wednesday-21-insider-buying-report-anab-athx-cm741633"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"ATHERSYS, INC / NEW Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2017-02-01 14:24:27 +0000","summary":"ATHERSYS, INC / NEW Files SEC form 8-K, Other Events, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170201/athx8-k.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys, Inc. (ATHX) Down, Maybe An Opportunity?","publication_date":"2017-01-31 12:10:34 +0000","summary":"Athersys, Inc. (ATHX) Down, Maybe An Opportunity?","url":"http://www.insidermonkey.com/blog/athersys-inc-athx-down-maybe-an-opportunity-528280/"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys, Inc. (ATHX) Down, Maybe An Opportunity?","publication_date":"2017-01-31 12:10:34 +0000","summary":"At the end of last week, Athersys, Inc. (NASDAQ:ATHX) announced a public offering that will see it distribute just shy of 20 million shares at $1.01 a share. Gross proceeds are expected to be around $20 million, meaning the company should net around $18 million on the raise. As we might’ve expected, Athersys has taken […]","url":"http://finance.yahoo.com/r/798589a3-27af-36f3-bc7a-975f95bf7a1f/athersys-inc-athx-down-maybe-an-opportunity-528280?yptr=yahoo&.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys Launches $20M Public Stock Offering","publication_date":"2017-01-30 17:10:00 +0000","summary":"Athersys expects to make $20 million from its public offering of 19.8 million common shares.","url":"http://finance.yahoo.com/r/c2f56915-4c99-39e8-85e6-5ef34d0258cd/athersys-launches-20m-public-offering-athx?partner=YahooSA&yptr=yahoo&.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys Launches $20M Public Stock Offering","publication_date":"2017-01-30 17:10:00 +0000","summary":"Athersys Launches $20M Public Stock Offering","url":"http://www.investopedia.com/news/athersys-launches-20m-public-offering-athx/?partner=YahooSA"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Mid-Afternoon Market Update: Celestica Rises On Earnings Beat; KEYW Shares Slide","publication_date":"2017-01-27 21:56:26 +0000","summary":"Toward the end of trading Friday the Dow traded down 0 10 percent to 20 079 89 while the NASDAQ declined 0 03 percent to 5 653 54 The S amp P also fell dropping 0 20 percent to 2 292 16 Leading and Lagging Sectors Healthcare shares gained around 0 78 percent in trading on","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Nw3gjROmedg/mid-afternoon-market-update-celestica-rises-on-earnings-beat-keyw-shares-slide-cm739657"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Health Care Sector Update for 01/27/2017: ATHX,MATN,NOVN","publication_date":"2017-01-27 21:11:01 +0000","summary":"Top Health Care StocksTop Health Care Stocks JNJ 1 19 JNJ 1 19 PFE 0 49 PFE 0 49 MRK 0 27 MRK 0 27 ABT 0 84 ABT 0 84 AMGN 2 86 AMGN 2 86 Health care stocks helped to limit losses for the broader markets on Friday with the NYSE Health Care Index rising over 0 7 while shares","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2j2jVXjfP68/health-care-sector-update-for-01272017-athxmatnnovn-cm739620"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Mid-Day Market Update: Crude Oil Down 2%; Stonegate Mortgage Shares Spike Higher","publication_date":"2017-01-27 18:56:24 +0000","summary":"Midway through trading Friday the Dow traded down 0 01 percent to 20 099 19 while the NASDAQ gained 0 01 percent to 5 655 69 The S amp P also fell dropping 0 08 percent to 2 294 89 Leading and Lagging Sectors Healthcare shares gained around 0 69 percent in trading on","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hfQ9MF67M7U/mid-day-market-update-crude-oil-down-2-stonegate-mortgage-shares-spike-higher-cm739549"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Mid-Morning Market Update: Markets Mostly Flat; Alphabet Profit Misses Views","publication_date":"2017-01-27 15:56:23 +0000","summary":"Following the market opening Friday the Dow traded up 0 05 percent to 20 110 27 while the NASDAQ declined 0 01 percent to 5 654 70 The S amp P also fell dropping 0 06 percent to 2 295 21 Leading and Lagging Sectors Technology shares gained around 0 36 percent in trading on","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u4HuOT6rFhg/mid-morning-market-update-markets-mostly-flat-alphabet-profit-misses-views-cm739412"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys Announces Pricing of Public Offering of Common Stock","publication_date":"2017-01-27 14:00:28 +0000","summary":"[GlobeNewswire] - CLEVELAND, Jan. 27, 2017-- Athersys, Inc. today announced the pricing of its previously announced underwritten public offering of 19,802,000 shares of its common stock, par value $0.001 per share, at a ...","url":"http://finance.yahoo.com/news/athersys-announces-pricing-public-offering-140028269.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys Announces Pricing of Public Offering of Common Stock","publication_date":"2017-01-27 14:00:28 +0000","summary":"CLEVELAND, Jan. 27, 2017-- Athersys, Inc. today announced the pricing of its previously announced underwritten public offering of 19,802,000 shares of its common stock, par value $0.001 per share, at a ...","url":"http://finance.yahoo.com/news/athersys-announces-pricing-public-offering-140028269.html?.tsrc=rss"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys Announces Proposed Public Offering of Common Stock","publication_date":"2017-01-26 21:28:51 +0000","summary":"[GlobeNewswire] - CLEVELAND, Jan. 26, 2017-- Athersys, Inc. announced today that it intends to offer for sale shares of its common stock, par value $0.001 per share, in an underwritten public offering pursuant to its effective ...","url":"http://finance.yahoo.com/news/athersys-announces-proposed-public-offering-212851510.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"[$$] Four Biotech Picks for Cures Law","publication_date":"2017-01-26 21:20:00 +0000","summary":"[$$] Four Biotech Picks for Cures Law","url":"http://www.barrons.com/articles/four-biotech-picks-for-cures-law-1485465612?mod=yahoobarrons&ru=yahoo"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys Subsidiary and Leading Animal Health Company Enter Into Research and Option Agreement for Cell Therapy","publication_date":"2017-01-18 11:00:00 +0000","summary":"[GlobeNewswire] - CLEVELAND, Jan. 18, 2017-- Athersys, Inc. announced today that through its Belgian subsidiary, ReGenesys BVBA, it has entered into an agreement with a global leader in the animal health business segment ...","url":"http://finance.yahoo.com/news/athersys-subsidiary-leading-animal-health-110000867.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"ATHERSYS, INC / NEW Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2017-01-13 21:37:05 +0000","summary":"ATHERSYS, INC / NEW Files SEC form 8-K, Change in Directors or Principal Officers","url":"http://biz.yahoo.com/e/170113/athx8-k.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"ETFs with exposure to Athersys, Inc. : December 29, 2016","publication_date":"2016-12-29 18:29:10 +0000","summary":"ETFs with exposure to Athersys, Inc. : December 29, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-athersys-inc-december-29-2016/"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Ironwood, Allergan Report Positive Linzess IBS-C Study Data","publication_date":"2016-12-23 16:01:24 +0000","summary":"Ironwood Pharmaceuticals Inc IRWD and Allergan plc AGN announced encouraging top line data from a phase IIb study on the colonic release 1 CR1 formulation of Linzess linaclotide for the treatment of adult patients suffering from irritable bowel syndrome with constipation IBS C In","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uemYRp_wn8k/ironwood-allergan-report-positive-linzess-ibs-c-study-data-cm725670"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Ironwood, Allergan Report Positive Linzess IBS-C Study Data","publication_date":"2016-12-23 13:35:01 +0000","summary":"Ironwood, Allergan Report Positive Linzess IBS-C Study Data","url":"http://finance.yahoo.com/news/ironwood-allergan-report-positive-linzess-133501794.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Alexion Soliris Fails in Phase II/III Delayed Graft Function Study","publication_date":"2016-12-22 14:59:44 +0000","summary":"Alexion Pharmaceuticals Inc ALXN announced that Soliris has failed to meet the primary endpoint in a randomized parallel group double blind placebo controlled multi center phase II III study PROTECT We expect investors to react negatively to the news Alexion s year to date share","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OVD_91zg7co/alexion-soliris-fails-in-phase-iiiii-delayed-graft-function-study-cm724988"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Alexion Soliris Fails in Phase II/III Delayed Graft Function Study","publication_date":"2016-12-22 13:03:01 +0000","summary":"Alexion Soliris Fails in Phase II/III Delayed Graft Function Study","url":"http://finance.yahoo.com/news/alexion-soliris-fails-phase-ii-130301683.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Celgene (CELG) Otezla Approved in Japan for Two Indications","publication_date":"2016-12-21 16:01:51 +0000","summary":"Celgene Corporation CELG received encouraging news with the Japanese Ministry of Health Labor and Welfare granting full marketing authorization to its oral phosphodiesterase 4 PDE4 Otezla Otezla has been approved for the treatment of adults with plaque psoriasis with an inadequate","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HHTvF_w7Qps/celgene-celg-otezla-approved-in-japan-for-two-indications-cm724517"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Bristol-Myers, PsiOxus Ink Deal for Oncolytic Virus Therapy","publication_date":"2016-12-21 16:01:24 +0000","summary":"Bristol Myers Squibb Company BMY announced that it has entered into an agreement with PsiOxus Therapeutics Ltd under which it will gain exclusive worldwide rights to the latter s armed oncolytic virus candidate NG 348 currently in pre clinical development for the treatment of solid","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xv-I1EoMDE0/bristol-myers-psioxus-ink-deal-for-oncolytic-virus-therapy-cm724506"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Bristol-Myers, PsiOxus Ink Deal for Oncolytic Virus Therapy","publication_date":"2016-12-21 13:49:01 +0000","summary":"Bristol-Myers, PsiOxus Ink Deal for Oncolytic Virus Therapy","url":"http://finance.yahoo.com/news/bristol-myers-psioxus-ink-deal-134901467.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Celgene (CELG) Otezla Approved in Japan for Two Indications","publication_date":"2016-12-21 13:42:01 +0000","summary":"Celgene (CELG) Otezla Approved in Japan for Two Indications","url":"http://finance.yahoo.com/news/celgene-celg-otezla-approved-japan-134201359.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"How Iradimed Corp (IRMD) Stacks Up Against Its Peers","publication_date":"2016-12-15 23:13:03 +0000","summary":"How Iradimed Corp (IRMD) Stacks Up Against Its Peers","url":"http://www.insidermonkey.com/blog/how-iradimed-corp-irmd-stacks-up-against-its-peers-510866/"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"ETFs with exposure to Athersys, Inc. : December 13, 2016","publication_date":"2016-12-13 16:10:26 +0000","summary":"ETFs with exposure to Athersys, Inc. : December 13, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-athersys-inc-december-13-2016/"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Emergent BioSolutions (EBS) in Focus: Stock Rises 18.9%","publication_date":"2016-12-12 15:00:20 +0000","summary":"Emergent BioSolutions Inc EBS was a big mover last session as its shares rose almost 19 on the day The move came after the company announced a new contract with the Centers for Disease Control and Prevention CDC and a separate deal with the Biomedical Advanced Research and","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1KaCmmtx-HE/emergent-biosolutions-ebs-in-focus-stock-rises-189-cm720091"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Emergent BioSolutions (EBS) in Focus: Stock Rises 18.9%","publication_date":"2016-12-12 13:25:01 +0000","summary":"Emergent BioSolutions (EBS) in Focus: Stock Rises 18.9%","url":"http://finance.yahoo.com/news/emergent-biosolutions-ebs-focus-stock-132501432.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Roche Presents Positive Follicular Lymphoma Data on Gazvya","publication_date":"2016-12-06 23:57:09 +0000","summary":"Roche Holding AG RHHBY announced encouraging data from the pivotal phase III study GALLIUM which compared Gazyva plus chemotherapy followed by Gazyva alone head to head against MabThera plus chemotherapy followed by MabThera alone in patients with previously untreated follicular lymphoma","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D4kTUm83eSQ/roche-presents-positive-follicular-lymphoma-data-on-gazvya-cm717738"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Pfizer Leukemia Drug Meets Primary Endpoint in Phase III","publication_date":"2016-12-06 21:27:06 +0000","summary":"Pfizer Inc PFE and partner Avillion LLP announced that a phase III study BFORE evaluating its marketed drug Bosulif in the first line setting met the primary endpoint Results from the BFORE study demonstrated superiority of Bosulif bosutinib over Glivec for the first line treatment","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hZ-Axg8XSvY/pfizer-leukemia-drug-meets-primary-endpoint-in-phase-iii-cm717610"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Roche Presents Positive Follicular Lymphoma Data on Gazvya","publication_date":"2016-12-06 21:26:09 +0000","summary":"Roche Presents Positive Follicular Lymphoma Data on Gazvya","url":"http://finance.yahoo.com/news/roche-presents-positive-follicular-lymphoma-212609553.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Foamix Completes Enrolment in Phase III Acne Drug Studies","publication_date":"2016-11-30 16:59:09 +0000","summary":"Foamix Pharmaceuticals Ltd FOMX announced that it has completed patient enrollment in two phase III studies that will evaluate the efficacy and safety of one of its pipeline candidates FMX101 topical 4 minocycline foam for the treatment of moderate to severe acne In the study","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Up-Vni_j_Cc/foamix-completes-enrolment-in-phase-iii-acne-drug-studies-cm715764"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Aimmune Closes Enrolment in Phase III Peanut Allergy Study","publication_date":"2016-11-30 16:58:07 +0000","summary":"Aimmune Therapeutics Inc AIMT announced that it has completed global enrollment in the phase III PALISADE study on AR101 for the desensitization of patients with peanut allergy Aimmune anticipates top line data from the study in the fourth quarter of 2017 Positive data would allow","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4tO9CRu55KI/aimmune-closes-enrolment-in-phase-iii-peanut-allergy-study-cm715742"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"ETFs with exposure to Athersys, Inc. : November 29, 2016","publication_date":"2016-11-29 20:05:30 +0000","summary":"ETFs with exposure to Athersys, Inc. : November 29, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-athersys-inc-november-29-2016/"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Epizyme Tazemetostat Gets Fast Track Designation in U.S.","publication_date":"2016-11-29 15:58:23 +0000","summary":"Epizyme Inc s EPZM lead pipeline candidate tazemetostat an EZH2 inhibitor has received Fast Track designation in the U S for the treatment of patients with relapsed or refractory diffuse large B cell lymphoma DCBL whose tumors carry an EZH2 activating mutation This designation","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TvLKTO6CSuE/epizyme-tazemetostat-gets-fast-track-designation-in-us-cm715069"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Epizyme Tazemetostat Gets Fast Track Designation in U.S.","publication_date":"2016-11-29 13:56:01 +0000","summary":"Epizyme Tazemetostat Gets Fast Track Designation in U.S.","url":"http://finance.yahoo.com/news/epizyme-tazemetostat-gets-fast-track-135601592.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys, Inc. :ATHX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016","publication_date":"2016-11-28 15:22:31 +0000","summary":"Athersys, Inc. :ATHX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016","url":"http://www.capitalcube.com/blog/index.php/athersys-inc-athx-us-earnings-analysis-q3-2016-by-the-numbers-november-28-2016/"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Navidea Inks Deal to to Sell Lymphoseek to Cardinal Health","publication_date":"2016-11-25 16:05:58 +0000","summary":"Navidea Biopharmaceuticals Inc NAVB announced that it has entered into a definitive agreement to sell its Lymphoseek product to Cardinal Health CAH Lymphoseek is used for lymphatic mapping lymph node biopsy and the diagnosis of metastatic spread to lymph nodes for the staging of","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YIBaPksi-q8/navidea-inks-deal-to-to-sell-lymphoseek-to-cardinal-health-cm713946"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Navidea Inks Deal to to Sell Lymphoseek to Cardinal Health","publication_date":"2016-11-25 13:57:01 +0000","summary":"Navidea Inks Deal to to Sell Lymphoseek to Cardinal Health","url":"http://finance.yahoo.com/news/navidea-inks-deal-sell-lymphoseek-135701407.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"HCA Holdings Announces Share Repurchase Plan Worth $2B","publication_date":"2016-11-16 00:49:23 +0000","summary":"The board of directors of HCA Holdings Inc HCA recently authorized an additional share buyback program to return more value to its shareholders The latest authorization will allow the company to utilize up to 2 billion to repurchase its common stock With the new authorization","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XJsNBkRtdsU/hca-holdings-announces-share-repurchase-plan-worth-2b-cm709755"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"HCA Holdings Announces Share Repurchase Plan Worth $2B","publication_date":"2016-11-15 22:48:10 +0000","summary":"HCA Holdings Announces Share Repurchase Plan Worth $2B","url":"http://finance.yahoo.com/news/hca-holdings-announces-share-repurchase-224810162.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"New Strong Buy Stocks for November 14th","publication_date":"2016-11-14 17:31:38 +0000","summary":"Here are 5 stocks added to the Zacks Rank 1 Strong Buy List today Athersys Inc ATHX This biotechnology company has witnessed the Zacks Consensus Estimate for its current year earnings surging 21 7 over the last 30 days ATHERSYS INC Price and","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AkGCQF893Kc/new-strong-buy-stocks-for-november-14th-cm708767"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"New Strong Buy Stocks for November 14th","publication_date":"2016-11-14 13:49:01 +0000","summary":"New Strong Buy Stocks for November 14th","url":"http://finance.yahoo.com/news/strong-buy-stocks-november-14th-134901597.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys 3Q Loss $6M or 7 Cents a Share (ATHX)","publication_date":"2016-11-10 14:30:00 +0000","summary":"Athersys 3Q Loss $6M or 7 Cents a Share (ATHX)","url":"http://www.investopedia.com/news/athersys-3q-loss-7cshare-beats-street-athx/?partner=YahooSA"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Edited Transcript of ATHX earnings conference call or presentation 9-Nov-16 9:30pm GMT","publication_date":"2016-11-10 02:45:37 +0000","summary":"Edited Transcript of ATHX earnings conference call or presentation 9-Nov-16 9:30pm GMT","url":"http://finance.yahoo.com/news/edited-transcript-athx-earnings-conference-024537345.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys reports 3Q loss","publication_date":"2016-11-09 23:15:20 +0000","summary":"Athersys reports 3Q loss","url":"http://sg.finance.yahoo.com/news/athersys-reports-3q-loss-221120407.html"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"Athersys Reports Third Quarter 2016 Results","publication_date":"2016-11-09 21:21:21 +0000","summary":"[at noodls] - November 9, 2016 CLEVELAND, Nov. 09, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) today announced its financial results for the three months ended September 30, 2016. ... This is an abstract of ...","url":"http://www.publicnow.com/view/C6D62D09AC11FE9A87C4A10C23E10C6253270203"},{"ticker":"ATHX","figi_ticker":"ATHX:US","figi":"BBG000QBZBS3","title":"ATHERSYS, INC / NEW Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib","publication_date":"2016-11-09 21:03:38 +0000","summary":"ATHERSYS, INC / NEW Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib","url":"http://biz.yahoo.com/e/161109/athx8-k.html"}],"result_count":168,"page_size":100,"current_page":1,"total_pages":2,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"1.4201"},{"x":"1494596100","y":"1.425"},{"x":"1494596400","y":"1.43"},{"x":"1494596700","y":"1.435"},{"x":"1494597000","y":"1.44"},{"x":"1494597300","y":"1.44"},{"x":"1494597600","y":"1.44"},{"x":"1494597900","y":"1.45"},{"x":"1494598200","y":"1.45"},{"x":"1494598500","y":"1.4482"},{"x":"1494598800","y":"1.445"},{"x":"1494599100","y":"1.45"},{"x":"1494599700","y":"1.4625"},{"x":"1494600000","y":"1.47"},{"x":"1494600600","y":"1.465"},{"x":"1494600900","y":"1.467"},{"x":"1494601200","y":"1.4825"},{"x":"1494601500","y":"1.49"},{"x":"1494601800","y":"1.4899"},{"x":"1494602100","y":"1.495"},{"x":"1494602400","y":"1.4907"},{"x":"1494602700","y":"1.495"},{"x":"1494603000","y":"1.5"},{"x":"1494603300","y":"1.498"},{"x":"1494603600","y":"1.5"},{"x":"1494603900","y":"1.495"},{"x":"1494604200","y":"1.495"},{"x":"1494604500","y":"1.5"},{"x":"1494604800","y":"1.51"},{"x":"1494605100","y":"1.506"},{"x":"1494605400","y":"1.5"},{"x":"1494605700","y":"1.5064"},{"x":"1494606000","y":"1.52"},{"x":"1494606300","y":"1.5150000000000001"},{"x":"1494606600","y":"1.52"},{"x":"1494606900","y":"1.54"},{"x":"1494607200","y":"1.5350000000000001"},{"x":"1494607500","y":"1.5348000000000002"},{"x":"1494607800","y":"1.5287"},{"x":"1494608100","y":"1.52"},{"x":"1494608400","y":"1.53"},{"x":"1494608700","y":"1.5201"},{"x":"1494609000","y":"1.52"},{"x":"1494609300","y":"1.53"},{"x":"1494609600","y":"1.53"},{"x":"1494609900","y":"1.525"},{"x":"1494610200","y":"1.5205"},{"x":"1494610500","y":"1.53"},{"x":"1494610800","y":"1.525"},{"x":"1494611100","y":"1.54"},{"x":"1494611400","y":"1.53"},{"x":"1494611700","y":"1.5222"},{"x":"1494612000","y":"1.52"},{"x":"1494612300","y":"1.5299"},{"x":"1494612600","y":"1.525"},{"x":"1494612900","y":"1.54"},{"x":"1494613200","y":"1.54"},{"x":"1494613500","y":"1.53"},{"x":"1494613800","y":"1.54"},{"x":"1494614100","y":"1.54"},{"x":"1494614400","y":"1.5350000000000001"},{"x":"1494614700","y":"1.52"},{"x":"1494615000","y":"1.53"},{"x":"1494615300","y":"1.52"},{"x":"1494615600","y":"1.52"},{"x":"1494615900","y":"1.525"},{"x":"1494616200","y":"1.53"},{"x":"1494616500","y":"1.5201"},{"x":"1494616800","y":"1.53"},{"x":"1494617100","y":"1.53"},{"x":"1494617400","y":"1.52"},{"x":"1494617700","y":"1.53"},{"x":"1494618000","y":"1.53"},{"x":"1494618300","y":"1.52"},{"x":"1494618600","y":"1.52"},{"x":"1494618900","y":"1.53"},{"x":"1494619200","y":"1.52"} ], "color":"#03a9f4"}]},
{"id":"4","symbol": "CBAY","name": "CymaBay Therapeutics Inc","price": 3.94,"dollarChange": 0.32,"percentChange": 8.84,"open": 3.62,"high": 4.05,"low":3.6172,"volume": 438347,"avgVol": 389147.083333,"sharesShort": 706230,"shortPercent": 2.487374,"marketCap": 104083872,"float": 28392591,"headlines":{"data":[{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Reports First Quarter 2017 Financial Results and Provides Corporate Update","publication_date":"2017-05-11 20:01:00 +0000","summary":"NEWARK, Calif., May 11, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-reports-first-quarter-2017-200100608.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Investor Network: CymaBay Therapeutics, Inc. to Host Earnings Call","publication_date":"2017-05-11 19:00:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / May 11, 2017 / CymaBay Therapeutics, Inc. (NASDAQ: CBAY ) will be discussing their earnings results in their Q1 Earnings Call to be held May 11, 2017 at 4:30 PM Eastern Time. ...","url":"http://finance.yahoo.com/news/investor-network-cymabay-therapeutics-inc-190000854.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay to Report First Quarter 2017 Financial Results on Thursday, May 11","publication_date":"2017-05-04 12:00:00 +0000","summary":"NEWARK, Calif., May 04, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for specialty and orphan diseases with high unmet medical need, today ...","url":"http://finance.yahoo.com/news/cymabay-report-first-quarter-2017-120000235.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay to Present Data from its Phase 2 Proof-of-Concept Study of Seladelpar in Patients With Primary Biliary Cholangitis at the EASL Liver Meeting 2017","publication_date":"2017-04-13 12:00:00 +0000","summary":"NEWARK, Calif., April 13, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for specialty and orphan diseases with high unmet medical need, today ...","url":"http://finance.yahoo.com/news/cymabay-present-data-phase-2-120000971.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics to Present at Two Investor Conferences in April","publication_date":"2017-03-30 12:00:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., March 30, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies for specialty and orphan diseases with high unmet medical need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-therapeutics-present-two-investor-120000586.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics to Present at Two Investor Conferences in April","publication_date":"2017-03-30 12:00:00 +0000","summary":"NEWARK, Calif., March 30, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies for specialty and orphan diseases with high unmet medical need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-therapeutics-present-two-investor-120000586.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CYMABAY THERAPEUTICS, INC. Financials","publication_date":"2017-03-29 17:04:06 +0000","summary":"CYMABAY THERAPEUTICS, INC. Financials","url":"http://finance.yahoo.com/q/is?s=cbay"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2017-03-29 12:02:28 +0000","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","url":"http://biz.yahoo.com/e/170329/cbay8-k.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"8:01 am CymaBay Therapeutics announces that Harold Van Wart will retire as CEO; Sujal Shah named as interim CEO","publication_date":"2017-03-29 12:01:00 +0000","summary":"8:01 am CymaBay Therapeutics announces that Harold Van Wart will retire as CEO; Sujal Shah named as interim CEO","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#cbay"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Announces the Retirement of President and Chief Executive Officer, Harold Van Wart, Ph.D.","publication_date":"2017-03-29 12:00:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., March 29, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies for specialty and orphan diseases with high unmet medical need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-announces-retirement-president-chief-120000184.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Announces the Retirement of President and Chief Executive Officer, Harold Van Wart, Ph.D.","publication_date":"2017-03-29 12:00:00 +0000","summary":"NEWARK, Calif., March 29, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies for specialty and orphan diseases with high unmet medical need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-announces-retirement-president-chief-120000184.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Reports Fourth Quarter and Year End 2016 Financial Results","publication_date":"2017-03-23 20:01:00 +0000","summary":"NEWARK, Calif., March 23, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-reports-fourth-quarter-end-200100143.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Reports Fourth Quarter and Year End 2016 Financial Results","publication_date":"2017-03-23 20:01:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., March 23, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-reports-fourth-quarter-end-200100143.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"After-Hours Earnings Report for March 23, 2017 : MU, GME, KBH, ENV, OXM, SCVL, UPLD, SPWH, CBAY, NBY, VSTM, CYTX","publication_date":"2017-03-23 18:49:39 +0000","summary":"The following companies are expected to report earnings after hours on 03 23 2017 Visit our Earnings Calendar for a full list of expected earnings releases Micron Technology Inc MU is reporting for the quarter ending February 28 2017 The","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Sgu5UR9-wtk/after-hours-earnings-report-for-march-23-2017-mu-gme-kbh-env-oxm-scvl-upld-spwh-cbay-nby-vstm-cytx-cm764858"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Q4 2016 CymaBay Therapeutics Inc Earnings Release - Time Not Supplied","publication_date":"2017-03-23 11:07:06 +0000","summary":"Q4 2016 CymaBay Therapeutics Inc Earnings Release - Time Not Supplied","url":"http://biz.yahoo.com/research/earncal/20170323.html?t=cbay"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay to Report Fourth Quarter And Year End 2016 Financial Results on Thursday, March 23","publication_date":"2017-03-16 20:48:08 +0000","summary":"NEWARK, Calif., March 16, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-report-fourth-quarter-end-204808686.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay to Report Fourth Quarter And Year End 2016 Financial Results on Thursday, March 23","publication_date":"2017-03-16 20:48:08 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., March 16, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-report-fourth-quarter-end-204808686.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Will Cymabay Therapeutics (CBAY) Continue to Surge Higher?","publication_date":"2017-03-15 17:09:26 +0000","summary":"As of late it has definitely been a great time to be an investor in 160 Cymabay Therapeutics Inc CBAY The stock has moved higher by 73 8 in the past month while it is also above its 20 Day SMA too This combination of strong price performance and favorable technical could suggest","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y-sIcQDed6U/will-cymabay-therapeutics-cbay-continue-to-surge-higher-cm761220"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Will Cymabay Therapeutics (CBAY) Continue to Surge Higher?","publication_date":"2017-03-15 14:37:02 +0000","summary":"Will Cymabay Therapeutics (CBAY) Continue to Surge Higher?","url":"http://finance.yahoo.com/news/cymabay-therapeutics-cbay-continue-surge-143702459.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Will Cymabay Therapeutics (CBAY) Continue to Surge Higher?","publication_date":"2017-03-15 14:37:02 +0000","summary":"As of late, it has definitely been a great time to be an investor in Cymabay Therapeutics, Inc. (CBAY)","url":"http://finance.yahoo.com/news/cymabay-therapeutics-cbay-continue-surge-143702459.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Gainers & Losers Of Mar.9: CBAY, IMMU, TGTX, NSPR, TNDM...","publication_date":"2017-03-09 22:43:00 +0000","summary":"Gainers & Losers Of Mar.9: CBAY, IMMU, TGTX, NSPR, TNDM...","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MXg1EYtqzFA/gainers--losers-of-mar9-cbay-immu-tgtx-nspr-tndm-20170309-01447"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics to Present at Two Investor Conferences in March","publication_date":"2017-03-09 13:00:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., March 09, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-therapeutics-present-two-investor-130000997.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics to Present at Two Investor Conferences in March","publication_date":"2017-03-09 13:00:00 +0000","summary":"NEWARK, Calif., March 09, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-therapeutics-present-two-investor-130000997.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Zacks.com featured highlights: Apollo Investment, Ballard Power Systems, Cymabay Therapeutics, Fate Therpautics and Oclaro","publication_date":"2017-03-08 16:17:16 +0000","summary":"For Immediate Release Chicago IL March 08 2017 Stocks in this week s article include 160 Apollo Investment Corp NASDAQ AINV Free Report Ballard Power Systems NASDAQ BLDP Free Report Cymabay Therapeutics NASDAQ CBAY Free Report Fate","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PaAfQgrJ-P8/zackscom-featured-highlights-apollo-investment-ballard-power-systems-cymabay-therapeutics-fate-therpautics-and-oclaro-cm757863"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Zacks.com featured highlights: Apollo Investment, Ballard Power Systems, Cymabay Therapeutics, Fate Therpautics and Oclaro","publication_date":"2017-03-08 14:30:02 +0000","summary":"Zacks.com featured highlights: Apollo Investment, Ballard Power Systems, Cymabay Therapeutics, Fate Therpautics and Oclaro","url":"http://finance.yahoo.com/news/zacks-com-featured-highlights-apollo-143002874.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Zacks.com featured highlights: Apollo Investment, Ballard Power Systems, Cymabay Therapeutics, Fate Therpautics and Oclaro","publication_date":"2017-03-08 14:30:02 +0000","summary":"Zacks.com featured highlights: Apollo Investment, Ballard Power Systems, Cymabay Therapeutics, Fate Therpautics and Oclaro","url":"http://finance.yahoo.com/news/zacks-com-featured-highlights-apollo-143002874.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Explosive Stocks Under $10","publication_date":"2017-03-07 22:14:03 +0000","summary":"This screen is a bit of a departure from my normal stock screens Usually I require my screens to have a minimum price of 10 per share But I do at times scan for stocks under 10 And that s one of the screens I m running for myself right now Penny Stocks One dollar is a common","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kOBlTgGp2ss/explosive-stocks-under-10-cm757610"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Explosive Stocks Under $10","publication_date":"2017-03-07 19:41:07 +0000","summary":"Explosive Stocks Under $10","url":"http://finance.yahoo.com/news/explosive-stocks-under-10-194107205.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Explosive Stocks Under $10","publication_date":"2017-03-07 19:41:07 +0000","summary":"Explosive Stocks Under $10","url":"http://finance.yahoo.com/news/explosive-stocks-under-10-194107205.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Progenics Pharmaceuticals (PGNX) in Focus: Stock Gains 8.3%","publication_date":"2017-02-28 14:52:44 +0000","summary":"Progenics Pharmaceuticals PGNX was a big mover last session as the company saw its shares rise above 8 on the day The move came on solid volume with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VewejAy4JS0/progenics-pharmaceuticals-pgnx-in-focus-stock-gains-83-cm754158"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Gainers & Losers Of Feb.27: LJPC, NVAX, KTOV, CYCC, ARGS...","publication_date":"2017-02-27 22:33:00 +0000","summary":"Gainers & Losers Of Feb.27: LJPC, NVAX, KTOV, CYCC, ARGS...","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MYCJ86PzCsA/gainers--losers-of-feb27-ljpc-nvax-ktov-cycc-args-20170227-01773"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"The Zacks Analyst Blog Highlights: Cymabay Therapeutics, Attunity, Lumentum Holdings, Datawatch and Arconic","publication_date":"2017-02-22 15:53:34 +0000","summary":"For Immediate Release Chicago IL February 22 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NN_Mur1Q4z0/the-zacks-analyst-blog-highlights-cymabay-therapeutics-attunity-lumentum-holdings-datawatch-and-arconic-cm751213"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"The Zacks Analyst Blog Highlights: Cymabay Therapeutics, Attunity, Lumentum Holdings, Datawatch and Arconic","publication_date":"2017-02-22 14:30:02 +0000","summary":"The Zacks Analyst Blog Highlights: Cymabay Therapeutics, Attunity, Lumentum Holdings, Datawatch and Arconic","url":"http://finance.yahoo.com/news/zacks-analyst-blog-highlights-cymabay-143002614.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"The Zacks Analyst Blog Highlights: Cymabay Therapeutics, Attunity, Lumentum Holdings, Datawatch and Arconic","publication_date":"2017-02-22 14:30:02 +0000","summary":"The Zacks Analyst Blog Highlights: Cymabay Therapeutics, Attunity, Lumentum Holdings, Datawatch and Arconic","url":"http://finance.yahoo.com/news/zacks-analyst-blog-highlights-cymabay-143002614.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"5 Top Performers of Trump's First 30 Days in Office","publication_date":"2017-02-22 01:07:58 +0000","summary":"After a brief lull markets have again hit fresh highs Investors reaffirmed their faith in the promises of the new administration and the Trump Rally looks set to continue over the current week Meanwhile Trump celebrated his first month in office by indicating that these gains were","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CveD0TudIHs/5-top-performers-of-trumps-first-30-days-in-office-cm750976"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"5 Top Performers of Trump's First 30 Days in Office","publication_date":"2017-02-21 22:34:10 +0000","summary":"5 Top Performers of Trump's First 30 Days in Office","url":"http://finance.yahoo.com/news/5-top-performers-trumps-first-223410370.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"5 Top Performers of Trump's First 30 Days in Office","publication_date":"2017-02-21 22:34:10 +0000","summary":"Trump indicated these gains were largely attributable to the positive sentiment generated by his victory.","url":"http://finance.yahoo.com/news/5-top-performers-trumps-first-223410370.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Can The Uptrend Continue for Cymabay Therapeutics (CBAY)?","publication_date":"2017-02-14 17:19:54 +0000","summary":"Investors certainly have to be happy with Cymabay Therapeutics Inc CBAY and its short term performance After all the stock has jumped by 19 1 in the past 4 weeks and it is also above its 20 Day Simple Moving Average as well This is certainly a good trend but investors are probably","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QMpFflj_9fQ/can-the-uptrend-continue-for-cymabay-therapeutics-cbay-cm747705"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Can The Uptrend Continue for Cymabay Therapeutics (CBAY)?","publication_date":"2017-02-14 15:28:03 +0000","summary":"Investors certainly have to be happy with Cymabay Therapeutics, Inc. (CBAY) and its short term performance","url":"http://finance.yahoo.com/news/uptrend-continue-cymabay-therapeutics-cbay-152803572.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Can The Uptrend Continue for Cymabay Therapeutics (CBAY)?","publication_date":"2017-02-14 15:28:03 +0000","summary":"Can The Uptrend Continue for Cymabay Therapeutics (CBAY)?","url":"http://finance.yahoo.com/news/uptrend-continue-cymabay-therapeutics-cbay-152803572.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Cerner's EHR Platform to Enhance Health Care at San Juan NGO","publication_date":"2017-02-13 17:21:39 +0000","summary":"Leading provider of health care technology Cerner Corporation CERN announced that it recently entered into an agreement to provide San Juan Regional Medical Center with a new electronic health record EHR platform San Juan Regional Medical Center is a non profit acute care hospital and","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rvywCPYAflU/cerners-ehr-platform-to-enhance-health-care-at-san-juan-ngo-cm747142"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Cerner's EHR Platform to Enhance Health Care at San Juan NGO","publication_date":"2017-02-13 14:40:02 +0000","summary":"Cerner's EHR Platform to Enhance Health Care at San Juan NGO","url":"http://finance.yahoo.com/news/cerners-ehr-platform-enhance-health-144002124.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Cerner's EHR Platform to Enhance Health Care at San Juan NGO","publication_date":"2017-02-13 14:40:02 +0000","summary":"Cerner Corporation (CERN) announced that it recently entered into an agreement to provide San Juan Regional Medical Center with a new electronic health record platform.","url":"http://finance.yahoo.com/news/cerners-ehr-platform-enhance-health-144002124.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"5 Breakout Stocks for Superior Returns","publication_date":"2017-02-10 16:22:52 +0000","summary":"Utilizing a breakout investment strategy is a favored choice of active investors who are content only with returns superior to most other investments This approach involves homing in on stocks trading within a tight range and acquiring them when they move out of this band In keeping with","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3W-SuQZz1IQ/5-breakout-stocks-for-superior-returns-cm746305"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"5 Breakout Stocks for Superior Returns","publication_date":"2017-02-10 13:49:01 +0000","summary":"5 Breakout Stocks for Superior Returns","url":"http://finance.yahoo.com/news/5-breakout-stocks-superior-returns-134901482.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"5 Breakout Stocks for Superior Returns","publication_date":"2017-02-10 13:49:01 +0000","summary":"If properly implemented, such a strategy could deliver impressive returns.","url":"http://finance.yahoo.com/news/5-breakout-stocks-superior-returns-134901482.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Cymabay Therapeutics (CBAY) Rises: Stock Moves 9.2% Higher","publication_date":"2017-02-09 15:21:57 +0000","summary":"Cymabay Therapeutics Inc CBAY was a big mover last session as the company saw its shares rise over 9 on the day The move came on solid volume with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4mzl6Snn2gQ/cymabay-therapeutics-cbay-rises-stock-moves-92-higher-cm745390"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Cymabay Therapeutics (CBAY) Rises: Stock Moves 9.2% Higher","publication_date":"2017-02-09 13:30:01 +0000","summary":"Cymabay Therapeutics, Inc. (CBAY) shares rose over 9% in the last trading session.","url":"http://finance.yahoo.com/news/cymabay-therapeutics-cbay-rises-stock-133001545.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Cymabay Therapeutics (CBAY) Rises: Stock Moves 9.2% Higher","publication_date":"2017-02-09 13:30:01 +0000","summary":"Cymabay Therapeutics (CBAY) Rises: Stock Moves 9.2% Higher","url":"http://finance.yahoo.com/news/cymabay-therapeutics-cbay-rises-stock-133001545.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics to Present at the 2017 BIO CEO & Investor Conference","publication_date":"2017-02-07 13:00:00 +0000","summary":"NEWARK, Calif., Feb. 07, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-therapeutics-present-2017-bio-130000903.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics to Present at the 2017 BIO CEO & Investor Conference","publication_date":"2017-02-07 13:00:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Feb. 07, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-therapeutics-present-2017-bio-130000903.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2017-02-03 21:07:32 +0000","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170203/cbay8-k.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Health Care Sector Update for 02/02/2017: CBAY,BNTC,STML","publication_date":"2017-02-02 20:11:27 +0000","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 2 JNJ 0 2 PFE 0 09 PFE 0 09 MRK 3 2 MRK 3 2 ABT 0 7 ABT 0 7 AMGN 0 4 AMGN 0 4 Health care stocks were falling today with the NYSE Health Care Index NYP dropping about 0 3 while shares of health care companies in the S amp P","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/thXN_sIiexE/health-care-sector-update-for-02022017-cbaybntcstml-cm742462"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Announces Pricing of Public Offering of Common Stock","publication_date":"2017-02-02 14:15:00 +0000","summary":"NEWARK, Calif., Feb. 02, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for specialty and orphan diseases with high unmet need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-announces-pricing-public-offering-141500057.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Announces Pricing of Public Offering of Common Stock","publication_date":"2017-02-02 14:15:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Feb. 02, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for specialty and orphan diseases with high unmet need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-announces-pricing-public-offering-141500057.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Announces Proposed Public Offering of Common Stock","publication_date":"2017-02-01 21:01:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Feb. 01, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for specialty and orphan diseases with high unmet need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-announces-proposed-public-offering-210100357.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Announces Proposed Public Offering of Common Stock","publication_date":"2017-02-01 21:01:00 +0000","summary":"NEWARK, Calif., Feb. 01, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for specialty and orphan diseases with high unmet need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-announces-proposed-public-offering-210100357.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Gainers & Losers Of The Day: CALA, EVOK, EYEG, OCRX, TENX...","publication_date":"2017-01-30 21:59:00 +0000","summary":"Gainers & Losers Of The Day: CALA, EVOK, EYEG, OCRX, TENX...","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HbRYS0jPzc8/gainers--losers-of-the-day-cala-evok-eyeg-ocrx-tenx-20170130-01445"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics upgraded by H.C. Wainwright","publication_date":"2017-01-30 12:02:40 +0000","summary":"CymaBay Therapeutics upgraded by H.C. Wainwright","url":"http://finance.yahoo.com/q/ud?s=CBAY"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2017-01-24 11:15:17 +0000","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","url":"http://biz.yahoo.com/e/170124/cbay8-k.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics Announces Successful Completion of Scientific Advice Discussions with the European Medicines Agency for Arhalofenate","publication_date":"2017-01-05 13:00:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Jan. 05, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-successful-completion-130000455.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement","publication_date":"2017-01-05 11:04:50 +0000","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement","url":"http://biz.yahoo.com/e/170105/cbay8-k.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Health Care Sector Update for 01/04/2017: SNY,AMGN,REGN,CBAY,AGRX","publication_date":"2017-01-04 21:16:31 +0000","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 02 JNJ 0 02 PFE 1 05 PFE 1 05 MRK 1 31 MRK 1 31 ABT 0 08 ABT 0 08 AMGN 1 59 AMGN 1 59 Health care stocks still were mostly higher this afternoon with the NYSE Health Care Index climbing about 0 9 while shares of health","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1c17MhPzHGg/health-care-sector-update-for-01042017-snyamgnregncbayagrx-cm729543"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Surges & Plunges - EVOK, OREX, MRUS, IMGN, AGRX","publication_date":"2017-01-04 20:06:00 +0000","summary":"Surges & Plunges - EVOK, OREX, MRUS, IMGN, AGRX","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MsnHxYXcbE4/surges--plunges--evok-orex-mrus-imgn-agrx-20170104-01221"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Health Care Sector Update for 01/04/2017: EVOK,CBAY,AGRX","publication_date":"2017-01-04 19:16:29 +0000","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 29 JNJ 0 29 PFE 0 45 PFE 0 45 MRK 1 04 MRK 1 04 ABT 0 03 ABT 0 03 AMGN 1 01 AMGN 1 01 Health care stocks were mostly higher today with the NYSE Health Care Index climbing about 0 4 while shares of health care companies in","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GvPUjtHNMfI/health-care-sector-update-for-01042017-evokcbayagrx-cm729494"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Wednesday’s Top 5 Biopharma Movers","publication_date":"2017-01-04 17:15:23 +0000","summary":"A few biotech and pharma companies were on the move Wednesday, some making absolutely massive gains on the day, giving more credence to the Trump rally and positive sentiment for the health care sector ...","url":"http://finance.yahoo.com/news/wednesday-top-5-biopharma-movers-171523550.html?.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Wednesday’s Top 5 Biopharma Movers","publication_date":"2017-01-04 17:15:23 +0000","summary":"Wednesday’s Top 5 Biopharma Movers","url":"http://finance.yahoo.com/news/wednesday-top-5-biopharma-movers-171523550.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Taking A Look At CymaBay Therapeutics Inc (CBAY)’s Big Deal","publication_date":"2017-01-04 16:00:38 +0000","summary":"Taking A Look At CymaBay Therapeutics Inc (CBAY)’s Big Deal","url":"http://www.insidermonkey.com/blog/taking-a-look-at-cymabay-therapeutics-inc-cbays-big-deal-514541/"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Taking A Look At CymaBay Therapeutics Inc (CBAY)’s Big Deal","publication_date":"2017-01-04 16:00:38 +0000","summary":"CymaBay Therapeutics Inc (NASDAQ:CBAY) is running up on the news that it has scored an exclusive licensing agreement with Kowa Pharmaceuticals America, Inc. for the development and commercialization of its lead gout asset in the United States. For the tiny biotech, which carries a market capitalization of less than $50 million (although this is set […]","url":"http://finance.yahoo.com/r/1cd36ded-a56a-3a13-abd8-eba1a6976f10/taking-a-look-at-cymabay-therapeutics-inc-cbays-big-deal-514541?yptr=yahoo&.tsrc=rss"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Here’s Why Apple, Tesla, and Three Other Stocks Are Trending","publication_date":"2017-01-04 13:10:26 +0000","summary":"Here’s Why Apple, Tesla, and Three Other Stocks Are Trending","url":"http://www.insidermonkey.com/blog/heres-why-apple-tesla-and-three-other-stocks-are-trending-514481/"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"AGRX Fails To SECURE Investor Confidence, ITEK Hit Hard, CBAY Rises On Kowa Deal","publication_date":"2017-01-04 01:55:00 +0000","summary":"AGRX Fails To SECURE Investor Confidence, ITEK Hit Hard, CBAY Rises On Kowa Deal","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EQUoX5n_LN8/agrx-fails-to-secure-investor-confidence-itek-hit-hard-cbay-rises-on-kowa-deal-20170104-00025"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Announces Exclusive Licensing Agreement with Kowa Pharmaceuticals America, Inc. for the Development and Commercialization of Arhalofenate in the United States","publication_date":"2017-01-03 21:01:00 +0000","summary":"[GlobeNewswire] - —Kowa to fully fund development through NDA approval— CymaBay to receive up to $205 M in up-front and milestone payments— Conference call and webcast today at 4:30 pm ET. NEWARK, Calif., Jan. 03, 2017-- ...","url":"http://finance.yahoo.com/news/cymabay-announces-exclusive-licensing-agreement-210100730.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Pain Therapeutics, Inc. (PTIE): How Does It Compare Against Its Peers?","publication_date":"2016-12-17 00:54:58 +0000","summary":"Pain Therapeutics, Inc. (PTIE): How Does It Compare Against Its Peers?","url":"http://www.insidermonkey.com/blog/pain-therapeutics-inc-ptie-how-does-it-compare-against-its-peers-511434/"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2016-12-08 13:01:52 +0000","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","url":"http://biz.yahoo.com/e/161208/cbay8-k.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Announces the Appointments of Robert Booth, Ph.D. and Caroline Loewy to Its Board of Directors","publication_date":"2016-12-08 13:00:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Dec. 08, 2016-- CymaBay Therapeutics, Inc., today announced the appointment of Robert Booth, Ph.D. and Caroline Loewy to the company’ s Board of Directors, effective December 6, 2016.. ...","url":"http://finance.yahoo.com/news/cymabay-announces-appointments-robert-booth-130000087.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics Announces the Initiation of its Next Phase 2 Study of Seladelpar (MBX-8025) in Patients with Primary Biliary Cholangitis","publication_date":"2016-12-07 13:00:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Dec. 07, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat indications with high unmet medical need, today announced the initiation ...","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-initiation-next-130000320.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"Anthera Announces Leadership Transition in Preparation of Commercialization of Sollpura and Future Development of blisibimod for IgA Nephropathy","publication_date":"2016-12-06 21:10:00 +0000","summary":"[GlobeNewswire] - J. Craig Thompson promoted to Chief Executive Officer and appointed to the Board of Directors Paul F. Truex appointed as Executive Chairman of the Board Dr. Christopher Henney stepped down as Chairman ...","url":"http://finance.yahoo.com/news/anthera-announces-leadership-transition-preparation-211000003.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics Announces that the Recommended International Nonproprietary Name for MBX-8025 is Seladelpar","publication_date":"2016-12-06 13:00:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Dec. 06, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat indications with high unmet medical need, today announced that the World ...","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-recommended-international-130000523.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference","publication_date":"2016-11-28 13:00:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Nov. 28, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for indications with high unmet medical need, including rare and orphan ...","url":"http://finance.yahoo.com/news/cymabay-therapeutics-present-28th-annual-130000116.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay to Host Key Opinion Leader Meeting on Primary Biliary Cholangitis in New York City","publication_date":"2016-11-10 21:01:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Nov. 10, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for indications with high unmet medical need, including rare and orphan ...","url":"http://finance.yahoo.com/news/cymabay-host-key-opinion-leader-210100319.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics Announces U.S. Orphan Drug Designation for MBX-8025 for the Treatment of Primary Biliary Cholangitis","publication_date":"2016-11-10 13:00:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Nov. 10, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for indications with high unmet medical need, including rare and orphan ...","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-u-orphan-130000336.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CYMABAY THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report","publication_date":"2016-11-09 21:05:41 +0000","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report","url":"http://biz.yahoo.com/e/161109/cbay10-q.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Reports Third Quarter 2016 Financial Results","publication_date":"2016-11-09 21:01:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Nov. 09, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for indications with high unmet medical need, including rare and orphan ...","url":"http://finance.yahoo.com/news/cymabay-reports-third-quarter-2016-210100639.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics Announces a Newly Issued U.S. Patent for the Use of MBX-8025 as a Treatment for Primary Biliary Cholangitis (PBC)","publication_date":"2016-11-09 13:00:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Nov. 09, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for indications with high unmet medical need including rare and orphan ...","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-newly-issued-130000566.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay to Announce Third Quarter 2016 Financial Results on Wednesday, November 9","publication_date":"2016-11-02 12:00:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Nov. 02, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases with high unmet medical need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-announce-third-quarter-2016-120000583.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics Announces an Oral Late-Breaking Presentation of a Phase 2 Proof-of-Concept Study of MBX-8025 in Patients With Primary Biliary Cholangitis at the AASLD 2016 Liver Meeting","publication_date":"2016-10-20 18:41:42 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Oct. 20, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases with high unmet medical need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-oral-breaking-184142021.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics Announces that MBX-8025 has Received European Medicines Agency PRIority MEdicines (PRIME) Designation for the Treatment of Primary Biliary Cholangitis","publication_date":"2016-10-20 12:00:00 +0000","summary":"CymaBay Therapeutics Announces that MBX-8025 has Received European Medicines Agency PRIority MEdicines (PRIME) Designation for the Treatment of Primary Biliary Cholangitis","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-mbx-8025-120000951.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics Announces a Newly Issued U.S. Patent for MBX-8025 for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)","publication_date":"2016-10-11 12:00:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Oct. 11, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases with high unmet medical need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-newly-issued-120000908.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","publication_date":"2016-10-07 12:32:11 +0000","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/161007/cbay8-k.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics Announces an Oral Presentation Describing the Efficacy of MBX-8025 in a Preclincal Model of NASH at the AASLD 2016 Liver Meeting","publication_date":"2016-10-06 12:00:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Oct. 06, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases with high unmet medical need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-oral-presentation-120000852.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics Announces Plans to Initiate Its Next Phase 2 Study of MBX-8025 in Primary Biliary Cholangitis","publication_date":"2016-10-05 12:00:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Oct. 05, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases with high unmet medical need, today announced ...","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-plans-initiate-120000536.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics to Present at Rodman & Renshaw 18th Annual Global Investment Conference","publication_date":"2016-09-08 12:00:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Sept. 08, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies to treat diseases with high unmet medical need, today announced that ...","url":"http://finance.yahoo.com/news/cymabay-therapeutics-present-rodman-renshaw-120000125.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CYMABAY THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report","publication_date":"2016-08-09 20:06:07 +0000","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report","url":"http://biz.yahoo.com/e/160809/cbay10-q.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Reports Second Quarter 2016 Financial Results","publication_date":"2016-08-09 20:01:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Aug. 09, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies to treat diseases with high unmet medical need, today provided recent ...","url":"http://finance.yahoo.com/news/cymabay-reports-second-quarter-2016-200100305.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay to Announce Second Quarter 2016 Financial Results on Tuesday, August 9","publication_date":"2016-08-02 12:00:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., Aug. 02, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, today announced that ...","url":"http://finance.yahoo.com/news/cymabay-announce-second-quarter-2016-120000660.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Announces Participation at Cantor Fitzgerald Healthcare Conference on July 12th in New York","publication_date":"2016-07-07 12:00:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., July 07, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, today announced that ...","url":"http://finance.yahoo.com/news/cymabay-announces-participation-cantor-fitzgerald-120000248.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders","publication_date":"2016-06-06 20:33:05 +0000","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders","url":"http://biz.yahoo.com/e/160606/cbay8-k.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics Announces Top Line Efficacy and Safety Data From Its Phase 2 Study of Mbx-8025 in Patients With Primary Biliary Cholangitis (PBC)","publication_date":"2016-05-31 11:00:00 +0000","summary":"[GlobeNewswire] - Study stopped early after review of safety and efficacy data demonstrated clear proof-of-concept and opportunity for further dose reduction to optimize clinical safety and efficacy Large statistically ...","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-top-line-110000344.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure","publication_date":"2016-05-24 12:06:32 +0000","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure","url":"http://biz.yahoo.com/e/160524/cbay8-k.html"},{"ticker":"CBAY","figi_ticker":"CBAY:US","figi":"BBG005NJY3N2","title":"CymaBay Therapeutics to Present at UBS Global Healthcare Conference","publication_date":"2016-05-19 12:00:00 +0000","summary":"[GlobeNewswire] - NEWARK, Calif., May 19, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, today announced that ...","url":"http://finance.yahoo.com/news/cymabay-therapeutics-present-ubs-global-120000798.html"}],"result_count":121,"page_size":100,"current_page":1,"total_pages":2,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"3.659"},{"x":"1494596100","y":"3.69"},{"x":"1494596400","y":"3.6325"},{"x":"1494596700","y":"3.6799"},{"x":"1494597000","y":"3.65"},{"x":"1494597300","y":"3.65"},{"x":"1494597600","y":"3.64"},{"x":"1494597900","y":"3.7"},{"x":"1494598200","y":"3.9552"},{"x":"1494598500","y":"3.79"},{"x":"1494598800","y":"3.84"},{"x":"1494599100","y":"3.83"},{"x":"1494599400","y":"3.82"},{"x":"1494599700","y":"3.79"},{"x":"1494600000","y":"3.77"},{"x":"1494600300","y":"3.8124000000000002"},{"x":"1494600600","y":"3.9"},{"x":"1494600900","y":"3.9"},{"x":"1494601200","y":"3.875"},{"x":"1494601500","y":"3.865"},{"x":"1494601800","y":"3.89"},{"x":"1494602400","y":"3.89"},{"x":"1494602700","y":"3.99"},{"x":"1494603000","y":"4"},{"x":"1494603300","y":"4.02"},{"x":"1494603600","y":"4.03"},{"x":"1494603900","y":"3.9"},{"x":"1494604200","y":"3.975"},{"x":"1494604500","y":"3.99"},{"x":"1494604800","y":"3.98"},{"x":"1494605100","y":"3.87"},{"x":"1494605400","y":"3.96"},{"x":"1494605700","y":"3.98"},{"x":"1494606000","y":"3.93"},{"x":"1494606300","y":"3.86"},{"x":"1494606600","y":"3.86"},{"x":"1494606900","y":"3.89"},{"x":"1494607200","y":"3.975"},{"x":"1494607500","y":"3.955"},{"x":"1494607800","y":"3.89"},{"x":"1494608100","y":"3.96"},{"x":"1494608400","y":"3.89"},{"x":"1494608700","y":"3.91"},{"x":"1494609300","y":"3.87"},{"x":"1494609900","y":"3.88"},{"x":"1494610200","y":"3.89"},{"x":"1494610500","y":"3.89"},{"x":"1494610800","y":"3.9"},{"x":"1494611400","y":"3.93"},{"x":"1494611700","y":"3.95"},{"x":"1494612300","y":"3.98"},{"x":"1494612600","y":"3.96"},{"x":"1494612900","y":"3.9701"},{"x":"1494613200","y":"3.94"},{"x":"1494614100","y":"3.94"},{"x":"1494614400","y":"3.94"},{"x":"1494615000","y":"3.94"},{"x":"1494615300","y":"3.95"},{"x":"1494615600","y":"3.94"},{"x":"1494615900","y":"3.94"},{"x":"1494616200","y":"3.92"},{"x":"1494616500","y":"3.93"},{"x":"1494616800","y":"3.91"},{"x":"1494617100","y":"3.91"},{"x":"1494617400","y":"3.89"},{"x":"1494617700","y":"3.9"},{"x":"1494618000","y":"3.9"},{"x":"1494618300","y":"3.9159"},{"x":"1494618600","y":"3.95"},{"x":"1494618900","y":"3.95"},{"x":"1494619200","y":"3.94"} ], "color":"#03a9f4"}]},
{"id":"5","symbol": "DRRX","name": "Durect Corp","price": 1.21,"dollarChange": 0.11,"percentChange": 10,"open": 1.12,"high": 1.29,"low":1.08,"volume": 3763326,"avgVol": 778024.366667,"sharesShort": 2884103,"shortPercent": 2.031537,"marketCap": 124508805,"float": 141966536,"headlines":{"data":[{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corp. :DRRX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017","publication_date":"2017-05-12 15:11:01 +0000","summary":"Categories: Yahoo FinanceGet free summary analysis DURECT Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of DURECT Corp. – Zogenix, Inc., Impax Laboratories, Inc., Johnson & Johnson, Pfizer Inc., Pacira Pharmaceuticals, Inc., Heron Therapeutics Inc, Eli Lilly and Company and Corium International, Inc. (ZGNX-US, IPXL-US, ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/1c463d73-a594-33d1-b40f-ddfb5eb03059/durect-corp-drrx-us-earnings-analysis-q1-2017-by-the-numbers-may-12-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"The Life Sciences Report Examines DURECT and Sandoz's $293 Million Deal for POSIMIR","publication_date":"2017-05-11 12:45:00 +0000","summary":"DURECT Corp. and Sandoz AG, a division of Novartis, have signed a development and commercialization agreement for the U.S. for POSIMIR.Included in this article is: DURECT Corp.POSIMIR is DURECT Corp.'s ...","url":"http://finance.yahoo.com/news/life-sciences-report-examines-durect-124500681.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Edited Transcript of DRRX earnings conference call or presentation 10-May-17 8:30pm GMT","publication_date":"2017-05-11 11:55:34 +0000","summary":"Q1 2017 DURECT Corp Earnings Call","url":"http://finance.yahoo.com/news/edited-transcript-drrx-earnings-conference-064551427.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Durect reports 1Q loss","publication_date":"2017-05-10 21:34:28 +0000","summary":"The Cupertino, California-based company said it had a loss of 6 cents per share. The specialty pharmaceutical company posted revenue of $4.6 million in the period. In the final minutes of trading on Wednesday, ...","url":"http://finance.yahoo.com/news/durect-reports-1q-loss-213428216.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corporation Announces First Quarter 2017 Financial Results and Provides Corporate Update","publication_date":"2017-05-10 20:05:00 +0000","summary":"CUPERTINO, Calif., May 10, 2017 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended March 31, 2017 and provided a corporate update.   Total revenues ...","url":"http://finance.yahoo.com/news/durect-corporation-announces-first-quarter-200500262.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Today’s Research Reports on Stocks to Watch: Amyris and DURECT","publication_date":"2017-05-09 12:00:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / May 9, 2017 / U.S. markets were relatively muted Monday, trading in the red for most of the day before a last minute surge to close in the green. The Dow Jones Industrial Average ...","url":"http://finance.yahoo.com/news/today-research-reports-stocks-watch-120000067.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Gainers & Losers Of May 8: DRRX, CXRX, URGN, ARLX, TXMD...","publication_date":"2017-05-09 00:35:00 +0000","summary":"Gainers & Losers Of May 8: DRRX, CXRX, URGN, ARLX, TXMD...","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g4CTkd7tUrg/gainers--losers-of-may-8-drrx-cxrx-urgn-arlx-txmd-20170509-00006"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT(DRRX): A $293 Million Deal with Sandoz for POSIMIR® in the United States","publication_date":"2017-05-08 14:00:00 +0000","summary":"Earlier today (May 8, 2017), Durect  Corporation (DRRX) announced a development and commercialization agreement with Sandoz AG, a division of Novartis (NVS), to develop and market in the United States DURECT's POSIMIR® (SABER®-Bupivacaine), an investigational locally-acting, non-opioid analgesic intended to provide up to three days of continuous pain relief after surgery. Under the terms of the agreement, Sandoz will make an upfront payment to DURECT of $20 million, with the potential for up to an additional $43 million in development and regulatory milestones, up to an additional $230 million in sales based milestones, as well as a tiered double digit royalty on product sales in the United States.","url":"http://finance.yahoo.com/news/durect-drrx-293-million-deal-140000635.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT and Sandoz have Signed a $293 Million Development and Commercialization Agreement for POSIMIR® (SABER®-Bupivacaine) Covering the United States","publication_date":"2017-05-08 11:00:00 +0000","summary":"CUPERTINO, Calif., May 8, 2017 /PRNewswire/ -- DURECT Corporation (DRRX) today announced a development and commercialization agreement with Sandoz AG, a division of Novartis (NVS), to develop and market in the United States DURECT's POSIMIR® (SABER®-Bupivacaine), an investigational locally-acting, non-opioid analgesic intended to provide up to three days of continuous pain relief after surgery. Sandoz is a global leader in driving sustainable access to high-quality healthcare.  Sandoz's differentiated product portfolio includes a range of state-of-the-art technologies, formulations and devices. In the U.S., Sandoz Inc. has a dedicated hospital sales and marketing organization, with expertise and relationships, which will be employed to deliver POSIMIR to the market.","url":"http://finance.yahoo.com/news/durect-sandoz-signed-293-million-110000339.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corporation Invites You to Join its First Quarter 2017 Earnings Conference Call","publication_date":"2017-05-04 20:30:00 +0000","summary":"CUPERTINO, Calif., May 4, 2017 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) first quarter 2017 financial results press release, you are invited to listen to a conference call ...","url":"http://finance.yahoo.com/news/durect-corporation-invites-join-first-203000464.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"ETFs with exposure to DURECT Corp. : April 27, 2017","publication_date":"2017-04-27 19:56:01 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to DURECT Corp. Here are 5 ETFs with the largest exposure to DRRX-US. Comparing the performance and risk of DURECT Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/f11033b3-5366-3049-beac-7bda7e5b5bd0/etfs-with-exposure-to-durect-corp-april-27-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"The Life Sciences Report Examines How Trial Results Set Up DURECT Corp. for 'Exciting Year'","publication_date":"2017-04-27 12:45:00 +0000","summary":"Positive results in a Phase 1b trial of DURECT Corp.'s candidate for the treatment of nonalcoholic steatohepatitis , which were presented at the 2017 International Liver Congress, prompted comments from ...","url":"http://finance.yahoo.com/news/life-sciences-report-examines-trial-124500368.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"NASH: The next untapped pharma market gives investors many options","publication_date":"2017-04-24 17:52:43 +0000","summary":"Large drugmakers with piles of cash are on the hunt for promising medicines being developed by small companies to treat NASH, a progressive fatty liver disease poised to become the leading cause of liver ...","url":"http://finance.yahoo.com/news/nash-next-untapped-pharma-market-175243627.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Announces Presentation of Data from a Phase 1b Study of DUR-928 in Nonalcoholic Steatohepatitis (NASH) at The International Liver Congress™ 2017","publication_date":"2017-04-24 12:00:00 +0000","summary":"The study was a Phase 1b single dose ranging (50 mg and 200 mg), safety and pharmacokinetic (PK) study of orally-administered DUR-928 in two cohorts of biopsy-confirmed NASH patients and matched control subjects (MCS) (matched by age, BMI, and gender) with normal liver function.  Both cohorts consisted of 10 NASH patients and 6 MCS. In both cohorts, DUR-928 was well tolerated overall.","url":"http://finance.yahoo.com/news/durect-announces-presentation-data-phase-120000363.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"NASH: The next untapped pharma market gives investors many options","publication_date":"2017-04-24 11:00:00 +0000","summary":"Large drugmakers with piles of cash are on the hunt for promising medicines being developed by small companies to treat NASH, a progressive fatty liver disease poised to become the leading cause of liver transplants by 2020. With intense competition and pricing pressure eroding sales of medicines for diabetes, rheumatoid arthritis and other lucrative disease categories, and an already crowded field for developmental cancer drugs, big pharma sees NASH as an enormous new market for future profit that will accelerate a wave of deal making. Bristol-Myers Squibb also confirmed it is looking for additional assets to enhance its internally-developed NASH drugs.","url":"http://finance.yahoo.com/news/nash-next-untapped-pharma-market-110000335.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"NASH: The next untapped pharma market gives investors many options","publication_date":"2017-04-24 05:00:00 +0000","summary":"Large drugmakers with piles of cash are on the hunt for promising medicines being developed by small companies to treat NASH, a progressive fatty liver disease poised to become the leading cause of liver transplants by 2020. With intense competition and pricing pressure eroding sales of medicines for diabetes, rheumatoid arthritis and other lucrative disease categories, and an already crowded field for developmental cancer drugs, big pharma sees NASH as an enormous new market for future profit that will accelerate a wave of deal making. Bristol-Myers Squibb also confirmed it is looking for additional assets to enhance its internally-developed NASH drugs.","url":"http://finance.yahoo.com/news/nash-next-untapped-pharma-market-050000478.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT to Present Clinical Data at the International Liver Congress™ 2017","publication_date":"2017-04-17 12:00:00 +0000","summary":"CUPERTINO, Calif., April 17, 2017 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company actively developing new therapeutics based on its Epigenetic Regulator Program and proprietary ...","url":"http://finance.yahoo.com/news/durect-present-clinical-data-international-120000565.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT to Present at the H.C. Wainwright NASH Investor Conference","publication_date":"2017-04-03 11:30:00 +0000","summary":"CUPERTINO, Calif., April 3, 2017 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Jim Brown, President and Chief Executive Officer, will be presenting at the H.C. Wainwright NASH ...","url":"http://finance.yahoo.com/news/durect-present-h-c-wainwright-113000291.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT to Present at the H.C. Wainwright NASH Investor Conference","publication_date":"2017-04-03 11:30:00 +0000","summary":"[PR Newswire] - CUPERTINO, Calif., April 3, 2017 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Jim Brown, President and Chief Executive Officer, will be presenting at the H.C. Wainwright NASH ...","url":"http://finance.yahoo.com/news/durect-present-h-c-wainwright-113000291.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"The Life Sciences Report Interviews DURECT Corp. President and CEO James Brown","publication_date":"2017-03-30 12:45:00 +0000","summary":"[Marketwired] - DURECT Corp. has a pipeline of drugs for a wide range of indications, from NASH to psoriasis to postoperative pain. In this interview with The Life Sciences Report, Dr. James Brown, DURECT's President ...","url":"http://finance.yahoo.com/news/life-sciences-report-interviews-durect-124500077.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"The Life Sciences Report Interviews DURECT Corp. President and CEO James Brown","publication_date":"2017-03-30 12:45:00 +0000","summary":"DURECT Corp. has a pipeline of drugs for a wide range of indications, from NASH to psoriasis to postoperative pain. In this interview with The Life Sciences Report, Dr. James Brown, DURECT's President ...","url":"http://finance.yahoo.com/news/life-sciences-report-interviews-durect-124500077.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT CORP Files SEC form 10-K/A, Annual Report","publication_date":"2017-03-29 20:32:38 +0000","summary":"DURECT CORP Files SEC form 10-K/A, Annual Report","url":"http://biz.yahoo.com/e/170329/drrx10-k_a.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"ETFs with exposure to DURECT Corp. : March 27, 2017","publication_date":"2017-03-27 19:55:02 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to DURECT Corp. Here are 5 ETFs with the largest exposure to DRRX-US. Comparing the performance and risk of DURECT Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/c084cf83-3f7f-3fe1-bb3d-482587e5c85a/etfs-with-exposure-to-durect-corp-march-27-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"ETFs with exposure to DURECT Corp. : March 27, 2017","publication_date":"2017-03-27 19:55:02 +0000","summary":"ETFs with exposure to DURECT Corp. : March 27, 2017","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-durect-corp-march-27-2017/"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT CORP Financials","publication_date":"2017-03-21 17:04:09 +0000","summary":"DURECT CORP Financials","url":"http://finance.yahoo.com/q/is?s=drrx"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corp. :DRRX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017","publication_date":"2017-03-20 15:37:57 +0000","summary":"Categories: Yahoo Finance Get free summary analysis DURECT Corp. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of DURECT Corp. – Pain Therapeutics, Inc., Zogenix, Inc., Impax Laboratories, Inc., Johnson & Johnson, Pfizer Inc., Pacira Pharmaceuticals, Inc., Heron Therapeutics Inc, Eli Lilly and Company and Corium International, ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/d180919f-0b2a-3d6d-8bfb-0a064b615071/durect-corp-drrx-us-earnings-analysis-q4-2016-by-the-numbers-march-20-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corp. :DRRX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017","publication_date":"2017-03-20 15:37:57 +0000","summary":"DURECT Corp. :DRRX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017","url":"http://www.capitalcube.com/blog/index.php/durect-corp-drrx-us-earnings-analysis-q4-2016-by-the-numbers-march-20-2017/"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"How These Drug Makers Stocks are Faring? -- Orexigen Therapeutics, United Therapeutics, DURECT, and SciClone Pharma","publication_date":"2017-03-20 11:25:00 +0000","summary":"[PR Newswire] - Last Friday, shares in La Jolla, California headquartered Orexigen Therapeutics Inc. ended the session 3.76% lower at $4.10. The stock recorded a trading volume of 182,389 shares. The Company's shares have surged 141.18% in the previous three months and 135.63% on an YTD basis.","url":"http://finance.yahoo.com/news/drug-makers-stocks-faring-orexigen-112500115.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"How These Drug Makers Stocks are Faring? -- Orexigen Therapeutics, United Therapeutics, DURECT, and SciClone Pharma","publication_date":"2017-03-20 11:25:00 +0000","summary":"Last Friday, shares in La Jolla, California headquartered Orexigen Therapeutics Inc. ended the session 3.76% lower at $4.10. The stock recorded a trading volume of 182,389 shares. The Company's shares have surged 141.18% in the previous three months and 135.63% on an YTD basis.","url":"http://finance.yahoo.com/news/drug-makers-stocks-faring-orexigen-112500115.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corp. :DRRX-US: Earnings Analysis: 2016 By the Numbers : March 17, 2017","publication_date":"2017-03-17 14:05:47 +0000","summary":"DURECT Corp. :DRRX-US: Earnings Analysis: 2016 By the Numbers : March 17, 2017","url":"http://www.capitalcube.com/blog/index.php/durect-corp-drrx-us-earnings-analysis-2016-by-the-numbers-march-17-2017/"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT CORP Files SEC form 10-K, Annual Report","publication_date":"2017-03-15 21:05:31 +0000","summary":"DURECT CORP Files SEC form 10-K, Annual Report","url":"http://biz.yahoo.com/e/170315/drrx10-k.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Durect reports 4Q loss","publication_date":"2017-03-14 20:44:30 +0000","summary":"On a per-share basis, the Cupertino, California-based company said it had a loss of 6 cents. The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...","url":"http://finance.yahoo.com/news/durect-reports-4q-loss-204430099.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Durect reports 4Q loss","publication_date":"2017-03-14 20:44:30 +0000","summary":"Durect reports 4Q loss","url":"http://sg.finance.yahoo.com/news/durect-reports-4q-loss-204430450.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corp Earnings Call scheduled for 4:30 pm ET today","publication_date":"2017-03-14 20:30:00 +0000","summary":"DURECT Corp Earnings Call scheduled for 4:30 pm ET today","url":"http://biz.yahoo.com/cc/7/155907.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits","publication_date":"2017-03-14 20:17:07 +0000","summary":"DURECT CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170314/drrx8-k.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corporation Announces Fourth Quarter and Full Year 2016 Financial Results and Update of Programs","publication_date":"2017-03-14 20:02:00 +0000","summary":"[PR Newswire] - CUPERTINO, Calif., March 14, 2017 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today financial results for the three months and year ended December 31, 2016 and provided a corporate update. ...","url":"http://finance.yahoo.com/news/durect-corporation-announces-fourth-quarter-200200321.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corporation Announces Fourth Quarter and Full Year 2016 Financial Results and Update of Programs","publication_date":"2017-03-14 20:02:00 +0000","summary":"CUPERTINO, Calif., March 14, 2017 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today financial results for the three months and year ended December 31, 2016 and provided a corporate update. ...","url":"http://finance.yahoo.com/news/durect-corporation-announces-fourth-quarter-200200321.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"After-Hours Earnings Report for March 14, 2017 : HTHT, AKAO, CLDX, FOGO, NPTN, ARNA, CCXI, KURA, DRRX, CHMI, CNXR","publication_date":"2017-03-14 18:53:28 +0000","summary":"The following companies are expected to report earnings after hours on 03 14 2017 Visit our Earnings Calendar for a full list of expected earnings releases China Lodging Group Limited HTHT is reporting for the quarter ending December 31 2016 The","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W5n8NIuKPHM/after-hours-earnings-report-for-march-14-2017-htht-akao-cldx-fogo-nptn-arna-ccxi-kura-drrx-chmi-cnxr-cm760687"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Q4 2016 DURECT Corp Earnings Release - After Market Close","publication_date":"2017-03-14 11:07:03 +0000","summary":"Q4 2016 DURECT Corp Earnings Release - After Market Close","url":"http://biz.yahoo.com/research/earncal/20170314.html?t=drrx"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corporation Invites You to Join its Fourth Quarter 2016 Earnings Conference Call","publication_date":"2017-02-24 21:30:00 +0000","summary":"CUPERTINO, Calif., Feb. 24, 2017 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) fourth quarter 2016 financial results press release, you are invited to listen to a conference call ...","url":"http://finance.yahoo.com/news/durect-corporation-invites-join-fourth-213000211.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corporation Invites You to Join its Fourth Quarter 2016 Earnings Conference Call","publication_date":"2017-02-24 21:30:00 +0000","summary":"[PR Newswire] - CUPERTINO, Calif., Feb. 24, 2017 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) fourth quarter 2016 financial results press release, you are invited to listen to a conference call ...","url":"http://finance.yahoo.com/news/durect-corporation-invites-join-fourth-213000211.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DRRX: Update on DUR-928 Development Program","publication_date":"2017-02-15 17:00:00 +0000","summary":"By Grant Zeng, CFA NASDAQ:DRRX Among Durect’s (NASDAQ:DRRX) multiple candidates, DUR-928 may be the most promising one in our view because this compound has the potential to target multiple indications ...","url":"http://finance.yahoo.com/news/drrx-dur-928-development-program-170000098.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DRRX: Update on DUR-928 Development Program","publication_date":"2017-02-15 17:00:00 +0000","summary":"DRRX: Update on DUR-928 Development Program","url":"http://finance.yahoo.com/news/drrx-dur-928-development-program-170000098.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"AEZS Inches Closer To D-Day, EYEG Catches Investors' Eyes, MCRB On Watch","publication_date":"2017-01-31 03:00:00 +0000","summary":"AEZS Inches Closer To D-Day, EYEG Catches Investors' Eyes, MCRB On Watch","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gUAgYE_P7wI/aezs-inches-closer-to-dday-eyeg-catches-investors-eyes-mcrb-on-watch-20170131-00111"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2017-01-30 17:32:08 +0000","summary":"DURECT CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170130/drrx8-k.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"8:05 am Durect provides an update on the DUR-928 development program; DUR-928 may have broad applicability in several metabolic diseases such as NASH and other liver conditions","publication_date":"2017-01-30 13:05:00 +0000","summary":"8:05 am Durect provides an update on the DUR-928 development program; DUR-928 may have broad applicability in several metabolic diseases such as NASH and other liver conditions","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#drrx"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corporation Announces Update on DUR-928 Development Program","publication_date":"2017-01-30 13:00:00 +0000","summary":"CUPERTINO, Calif., Jan. 30, 2017 /PRNewswire/ -- DURECT Corporation (DRRX) today provided an update on the DUR-928 development program.  DUR-928, our Epigenetic Regulator Program's lead product candidate, is an endogenous, small molecule, new chemical entity (NCE), which may have broad applicability in several metabolic diseases such as nonalcoholic steatohepatitis (NASH) and other liver conditions, and in acute organ injuries such as acute kidney injury (AKI). An abstract for this study has been accepted and data from the study will be presented at the International Liver Congress™ 2017 organized by the European Association for the Study of the Liver (EASL) in Amsterdam, April 19-23, 2017.","url":"http://finance.yahoo.com/news/durect-corporation-announces-dur-928-130000372.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corporation Announces Update on DUR-928 Development Program","publication_date":"2017-01-30 13:00:00 +0000","summary":"[PR Newswire] - CUPERTINO, Calif., Jan. 30, 2017 /PRNewswire/ -- DURECT Corporation (DRRX) today provided an update on the DUR-928 development program. DUR-928, our Epigenetic Regulator Program's lead product candidate, is an endogenous, small molecule, new chemical entity (NCE), which may have broad applicability in several metabolic diseases such as nonalcoholic steatohepatitis (NASH) and other liver conditions, and in acute organ injuries such as acute kidney injury (AKI). An abstract for this study has been accepted and data from the study will be presented at the International Liver Congress™ 2017 organized by the European Association for the Study of the Liver (EASL) in Amsterdam, April 19-23, 2017.","url":"http://finance.yahoo.com/news/durect-corporation-announces-dur-928-130000372.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT CORP Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2017-01-11 21:43:03 +0000","summary":"DURECT CORP Files SEC form 8-K, Change in Directors or Principal Officers","url":"http://biz.yahoo.com/e/170111/drrx8-k.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"How DURECT Corporation (DRRX) Stacks Up Against Its Peers","publication_date":"2016-12-16 01:18:47 +0000","summary":"How DURECT Corporation (DRRX) Stacks Up Against Its Peers","url":"http://www.insidermonkey.com/blog/how-durect-corporation-drrx-stacks-up-against-its-peers-510728/"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"How DURECT Corporation (DRRX) Stacks Up Against Its Peers","publication_date":"2016-12-16 01:18:47 +0000","summary":"Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don’t publish. Small cap stocks -especially when they are screened well- can generate substantial outperformance versus a boring index fund. That’s why we analyze the […]","url":"http://finance.yahoo.com/r/a9c9e1f3-8413-367e-adee-2d0721b92580/how-durect-corporation-drrx-stacks-up-against-its-peers-510728?yptr=yahoo&.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"ETFs with exposure to DURECT Corp. : December 9, 2016","publication_date":"2016-12-09 17:14:15 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to DURECT Corp. Here are 5 ETFs with the largest exposure to DRRX-US. Comparing the performance and risk of DURECT Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/f2315f2f-1320-3d84-a312-d3f4abee34bc/etfs-with-exposure-to-durect-corp-december-9-2016?yptr=yahoo&.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"ETFs with exposure to DURECT Corp. : December 9, 2016","publication_date":"2016-12-09 17:14:15 +0000","summary":"ETFs with exposure to DURECT Corp. : December 9, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-durect-corp-december-9-2016/"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"ETF’s with exposure to DURECT Corp. : November 3, 2016","publication_date":"2016-11-03 16:01:11 +0000","summary":"ETF’s with exposure to DURECT Corp. : November 3, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-durect-corp-november-3-2016/"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"ETF’s with exposure to DURECT Corp. : November 3, 2016","publication_date":"2016-11-03 16:01:11 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to DURECT Corp. Here are 5 ETF’s with the largest exposure to DRRX-US. Comparing the performance and risk of DURECT Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/41bb508e-202f-385d-86ba-2891353086f2/etfs-with-exposure-to-durect-corp-november-3-2016?yptr=yahoo&.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"The Life Sciences Report Examines Why the Election Is Not as Relevant to Drug Stocks as You Might Believe","publication_date":"2016-11-03 13:00:00 +0000","summary":"Due to drug pricing controversies, there has been much concern about how the outcome of the upcoming election will affect pharmaceutical stocks. Dr. Len Yaffe of Stoc*Doc Partners sheds light on the issues ...","url":"http://finance.yahoo.com/news/life-sciences-report-examines-why-130000885.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"The Life Sciences Report Examines Why the Election Is Not as Relevant to Drug Stocks as You Might Believe","publication_date":"2016-11-03 13:00:00 +0000","summary":"[Marketwired] - Due to drug pricing controversies, there has been much concern about how the outcome of the upcoming election will affect pharmaceutical stocks. Dr. Len Yaffe of Stoc*Doc Partners sheds light on the issues ...","url":"http://finance.yahoo.com/news/life-sciences-report-examines-why-130000885.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corp. :DRRX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 2, 2016","publication_date":"2016-11-02 14:55:41 +0000","summary":"Categories: Yahoo Finance Get free summary analysis DURECT Corp. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of DURECT Corp. – Pain Therapeutics, Inc., Johnson & Johnson and Eli Lilly and Company (PTIE-US, JNJ-US and LLY-US) that have also reported for this period. Highlights Summary numbers: Revenues ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/b78e22aa-12ec-3f13-bd58-7e25fe70465b/durect-corp-drrx-us-earnings-analysis-q3-2016-by-the-numbers-november-2-2016?yptr=yahoo&.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corp. :DRRX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 2, 2016","publication_date":"2016-11-02 14:55:41 +0000","summary":"DURECT Corp. :DRRX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 2, 2016","url":"http://www.capitalcube.com/blog/index.php/durect-corp-drrx-us-earnings-analysis-q3-2016-by-the-numbers-november-2-2016/"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Durect (DRRX) Exited Third Quarter with Strong Balance Sheet","publication_date":"2016-11-01 19:00:00 +0000","summary":"Durect (DRRX) Exited Third Quarter with Strong Balance Sheet","url":"http://finance.yahoo.com/news/durect-drrx-exited-third-quarter-190000807.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Durect (DRRX) Exited Third Quarter with Strong Balance Sheet","publication_date":"2016-11-01 19:00:00 +0000","summary":"By Grant Zeng, CFA NASDAQ:DRRX Durect Exited Third Quarter with Strong Balance Sheet On October 31, Durect (NASDAQ:DRRX) announced its financial results for the third quarter of 2016 ended September 30. ...","url":"http://finance.yahoo.com/news/durect-drrx-exited-third-quarter-190000807.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT CORP Files SEC form 10-Q, Quarterly Report","publication_date":"2016-11-01 17:35:00 +0000","summary":"DURECT CORP Files SEC form 10-Q, Quarterly Report","url":"http://biz.yahoo.com/e/161101/drrx10-q.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits","publication_date":"2016-10-31 20:19:39 +0000","summary":"DURECT CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/161031/drrx8-k.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Durect reports 3Q loss","publication_date":"2016-10-31 20:17:26 +0000","summary":"Durect reports 3Q loss","url":"http://sg.finance.yahoo.com/news/durect-reports-3q-loss-201726476.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corporation Announces Update on DUR-928 Development Program","publication_date":"2016-10-31 20:13:24 +0000","summary":"[at noodls] - CUPERTINO, Calif., Oct. 31, 2016 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today provided an update on the DUR-928 development program including a description of data from the first cohort of a ...","url":"http://www.publicnow.com/view/AF301D759239CC4EC91211397C9A211FFCC5C4FD"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corporation Announces Third Quarter 2016 Financial Results and Update of Programs","publication_date":"2016-10-31 20:13:18 +0000","summary":"[at noodls] - CUPERTINO, Calif., Oct. 31, 2016 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today financial results for the third quarter of 2016. Total revenues were $3.7 million and net loss was $8.8 ...","url":"http://www.publicnow.com/view/DFAA4F8FAA4006946978FB9C8FEF05DCDAE1B8CE"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Q3 2016 DURECT Corp Earnings Release - After Market Close","publication_date":"2016-10-31 11:07:02 +0000","summary":"Q3 2016 DURECT Corp Earnings Release - After Market Close","url":"http://biz.yahoo.com/research/earncal/20161031.html?t=drrx"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corporation Invites You to Join its Third Quarter 2016 Earnings Conference Call","publication_date":"2016-10-21 20:49:03 +0000","summary":"[at noodls] - CUPERTINO, Calif., Oct. 21, 2016 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) third quarter 2016 financial results press release, you are invited to listen to a conference call ...","url":"http://www.publicnow.com/view/AEE14D22B05994D9C26781B121F9D7F85F4BFE69"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corporation Invites You to Join its Third Quarter 2016 Earnings Conference Call","publication_date":"2016-10-21 20:30:00 +0000","summary":"CUPERTINO, Calif., Oct. 21, 2016 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) third quarter 2016 financial results press release, you are invited to listen to a conference call ...","url":"http://finance.yahoo.com/news/durect-corporation-invites-join-third-203000257.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Wednesday Sector Laggards: Biotechnology, Drugs","publication_date":"2016-10-19 18:47:11 +0000","summary":"In trading on Wednesday biotechnology shares were relative laggards down on the day by about 1 Helping drag down the group were shares of Puma Biotechnology PBYI down about 16 6 and shares of Sangamo Biosciences SGMO down about 9 6 on the day Also lagging the","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eRUlFdVlonE/wednesday-sector-laggards-biotechnology-drugs-cm695522"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"The Life Sciences Report Examines How Analysts Keep Focus on DURECT's DUR-928","publication_date":"2016-10-07 13:00:00 +0000","summary":"The FDA's recent Complete Response Letter for Remoxy, which is licensed by DURECT Corp. to Pain Therapeutics, has not changed the view of several analysts who follow DURECT. They are focused on DUR-928 ...","url":"http://finance.yahoo.com/news/life-sciences-report-examines-analysts-130000244.html?.tsrc=rss"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"The Life Sciences Report Examines How Analysts Keep Focus on DURECT's DUR-928","publication_date":"2016-10-07 13:00:00 +0000","summary":"[Marketwired] - The FDA's recent Complete Response Letter for Remoxy, which is licensed by DURECT Corp. to Pain Therapeutics, has not changed the view of several analysts who follow DURECT. They are focused on DUR-928 ...","url":"http://finance.yahoo.com/news/life-sciences-report-examines-analysts-130000244.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"5 Stocks Insiders Love Right Now","publication_date":"2016-10-05 17:45:00 +0000","summary":"5 Stocks Insiders Love Right Now","url":"https://www.thestreet.com/story/13842793/1/5-stocks-insiders-love-right-now.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Insider Buying Slows as Trading Windows Begin to Shut: Performance Sports, DURECT, Natus Medical, Novavax and More","publication_date":"2016-10-02 14:15:53 +0000","summary":"Insider Buying Slows as Trading Windows Begin to Shut: Performance Sports, DURECT, Natus Medical, Novavax and More","url":"http://247wallst.com/investing/2016/10/02/insider-buying-slows-as-trading-windows-begin-to-shut-performance-sports-durect-natus-medical-novavax-and-more/"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Biotech Stocks Facing FDA Decision In October","publication_date":"2016-09-29 03:42:00 +0000","summary":"Biotech Stocks Facing FDA Decision In October","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZnJKegvZeFY/biotech-stocks-facing-fda-decision-in-october-20160929-00092"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"ETF’s with exposure to DURECT Corp. : September 27, 2016","publication_date":"2016-09-27 13:58:09 +0000","summary":"ETF’s with exposure to DURECT Corp. : September 27, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-durect-corp-september-27-2016/"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"ARRY Hits COLUMBUS Goals, KITE Flies After-hrs, FDA Places Hold On CVM Trial","publication_date":"2016-09-27 02:18:00 +0000","summary":"ARRY Hits COLUMBUS Goals, KITE Flies After-hrs, FDA Places Hold On CVM Trial","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KUQnhvR44UY/arry-hits-columbus-goals-kite-flies-afterhrs-fda-places-hold-on-cvm-trial-20160927-00041"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Durect Corp. (DRRX) Stock Tumbles on FDA Opioid Analgesic Drug Rejection","publication_date":"2016-09-26 19:21:00 +0000","summary":"Durect Corp. (DRRX) Stock Tumbles on FDA Opioid Analgesic Drug Rejection","url":"https://www.thestreet.com/story/13752144/1/durect-corp-drrx-stock-tumbles-on-fda-opioid-analgesic-drug-rejection.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Here's Why DURECT Corporation Is Tanking Today","publication_date":"2016-09-26 18:23:31 +0000","summary":"Image source Getty Images What happened Investors in DURECT Corporation NASDAQ DRRX a specialty pharmaceutical company that develops anti abuse drug technology are having a rough start to the trading week Shares are down by more than 32 as of 12 15 p m EDT after","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SLU3wScxNNc/heres-why-durect-corporation-is-tanking-today-cm684702"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Mid-Day Market Update: Crude Oil Up 3.3%; Chemtura Shares Surge Following Acquisition News","publication_date":"2016-09-26 18:16:11 +0000","summary":"Midway through trading Monday the Dow traded down 0 79 percent to 18 116 61 while the NASDAQ declined 0 79 percent to 5 264 04 The S amp P also fell dropping 0 69 percent to 2 149 82 Leading and Lagging Sectors On Monday basic materials shares rose 0 06 percent Meanwhile","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZVuWRW5lDQM/mid-day-market-update-crude-oil-up-33-chemtura-shares-surge-following-acquisition-news-cm684715"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2016-09-26 17:46:52 +0000","summary":"DURECT CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/160926/drrx8-k.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"5 Big-Volume Stocks You Should Stay Away From -- Plus 2 to Buy","publication_date":"2016-09-26 17:35:00 +0000","summary":"5 Big-Volume Stocks You Should Stay Away From -- Plus 2 to Buy","url":"https://www.thestreet.com/story/13752064/1/5-big-volume-stocks-you-should-stay-away-from-plus-2-to-buy.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"GW Pharmaceuticals (GWPH), Sally Beauty Holdings Inc. (SBH) & More: Why These Stocks Are Making Monster Moves","publication_date":"2016-09-26 17:21:16 +0000","summary":"GW Pharmaceuticals (GWPH), Sally Beauty Holdings Inc. (SBH) & More: Why These Stocks Are Making Monster Moves","url":"http://www.insidermonkey.com/blog/gw-pharmaceuticals-gwph-sally-beauty-holdings-inc-sbh-more-why-these-stocks-are-making-monster-moves-476940/"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Mid-Morning Market Update: Markets Open Lower; Cal-Maine Posts Wider-Than-Expected Loss","publication_date":"2016-09-26 15:11:27 +0000","summary":"Following the market opening Monday the Dow traded down 0 77 percent to 18 120 00 while the NASDAQ declined 0 76 percent to 5 265 61 The S amp P also fell dropping 0 65 percent to 2 150 56 Leading and Lagging Sectors Monday morning basic materials shares rose 0 10","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b4lkFj-IVxc/mid-morning-market-update-markets-open-lower-cal-maine-posts-wider-than-expected-loss-cm684495"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Pain Therapeutics receives FDA letter saying NDA for opioid analgesic can't be approved","publication_date":"2016-09-26 11:20:00 +0000","summary":"Pain Therapeutics receives FDA letter saying NDA for opioid analgesic can't be approved","url":"http://www.marketwatch.com/News/Story/Story.aspx?guid=6F28F10E-ECB2-4C0A-A9F5-6B074FA18855&siteid=yhoof2"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT's Licensee Pain Therapeutics Receives Complete Response Letter from FDA for REMOXY® ER (oxycodone) Extended-Release Capsules CII","publication_date":"2016-09-26 11:05:00 +0000","summary":"[PR Newswire] - CUPERTINO, Calif., Sept. 26, 2016 /PRNewswire/ -- DURECT Corporation (DRRX) today announced that its licensee, Pain Therapeutics (PTIE) has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for Pain Therapeutics' New Drug Application (NDA) for REMOXY® ER (oxycodone) extended-release capsules CII. Based on its review, the FDA has determined that the NDA cannot be approved in its present form and specifies additional actions and data that are needed for drug approval.","url":"http://finance.yahoo.com/news/durects-licensee-pain-therapeutics-receives-110500210.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Pain Therapeutics Gets CRL From FDA For REMOXY ER Extended-Release Capsules CII","publication_date":"2016-09-26 07:27:00 +0000","summary":"Pain Therapeutics Gets CRL From FDA For REMOXY ER Extended-Release Capsules CII","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kit_iBI_2Qo/pain-therapeutics-gets-crl-from-fda-for-remoxy-er-extendedrelease-capsules-cii-20160926-00274"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"FDA Approves AMGN's 1st Biosimilar, MRNS On Track, All Ears For DRRX, PTIE","publication_date":"2016-09-26 01:09:00 +0000","summary":"FDA Approves AMGN's 1st Biosimilar, MRNS On Track, All Ears For DRRX, PTIE","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xmAd31XN2xM/fda-approves-amgns-1st-biosimilar-mrns-on-track-all-ears-for-drrx-ptie-20160926-00017"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"ETF’s with exposure to DURECT Corp. : September 14, 2016","publication_date":"2016-09-14 14:03:06 +0000","summary":"ETF’s with exposure to DURECT Corp. : September 14, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-durect-corp-september-14-2016/"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"The Life Sciences Report Examines Three Shots on Goal in Q4/16 for DURECT Corp.","publication_date":"2016-09-09 13:00:00 +0000","summary":"[Marketwired] - With a trifecta of share-moving milestones anticipated in Q4/16, including possible FDA approval of abuse-resistant opioid Remoxy, Laidlaw & Co. Analyst Jim Molloy sees blue sky ahead for DURECT Corp. ...","url":"http://finance.yahoo.com/news/life-sciences-report-examines-three-130000371.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT to Present at the Rodman & Renshaw Global Investment Conference","publication_date":"2016-09-06 12:00:00 +0000","summary":"[PR Newswire] - CUPERTINO, Calif., Sept. 6, 2016 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Matt Hogan, Chief Financial Officer, will be presenting at the Rodman & Renshaw Global Investment ...","url":"http://finance.yahoo.com/news/durect-present-rodman-renshaw-global-120000122.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Biotech Stocks Facing FDA Decision In September","publication_date":"2016-08-30 03:06:00 +0000","summary":"Biotech Stocks Facing FDA Decision In September","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JLuJRoV-b_w/biotech-stocks-facing-fda-decision-in-september-20160830-00044"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"ETF’s with exposure to DURECT Corp. : August 29, 2016","publication_date":"2016-08-29 15:19:39 +0000","summary":"ETF’s with exposure to DURECT Corp. : August 29, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-durect-corp-august-29-2016/"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"Edited Transcript of DRRX earnings conference call or presentation 1-Aug-16 8:30pm GMT","publication_date":"2016-08-16 16:27:34 +0000","summary":"Edited Transcript of DRRX earnings conference call or presentation 1-Aug-16 8:30pm GMT","url":"http://finance.yahoo.com/news/edited-transcript-drrx-earnings-conference-162734721.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT CORP Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2016-08-09 20:08:15 +0000","summary":"DURECT CORP Files SEC form 8-K, Change in Directors or Principal Officers","url":"http://biz.yahoo.com/e/160809/drrx8-k.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"ETF’s with exposure to DURECT Corp. : August 8, 2016","publication_date":"2016-08-08 18:05:15 +0000","summary":"ETF’s with exposure to DURECT Corp. : August 8, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-durect-corp-august-8-2016/"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT Corp. :DRRX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016","publication_date":"2016-08-05 15:37:01 +0000","summary":"DURECT Corp. :DRRX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016","url":"http://www.capitalcube.com/blog/index.php/durect-corp-drrx-us-earnings-analysis-q2-2016-by-the-numbers-august-5-2016/"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DURECT CORP Files SEC form 10-Q, Quarterly Report","publication_date":"2016-08-02 19:34:05 +0000","summary":"DURECT CORP Files SEC form 10-Q, Quarterly Report","url":"http://biz.yahoo.com/e/160802/drrx10-q.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"DRRX: Update on Second Quarter Financials","publication_date":"2016-08-02 16:00:00 +0000","summary":"DRRX: Update on Second Quarter Financials","url":"http://finance.yahoo.com/news/drrx-second-quarter-financials-160000513.html"},{"ticker":"DRRX","figi_ticker":"DRRX:US","figi":"BBG000D2WP45","title":"SMA Data Endears IONS To Investors, PFE Opens Wallet, Busy Months Ahead For DRRX","publication_date":"2016-08-02 02:18:00 +0000","summary":"SMA Data Endears IONS To Investors, PFE Opens Wallet, Busy Months Ahead For DRRX","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lxLxQU9aNRk/sma-data-endears-ions-to-investors-pfe-opens-wallet-busy-months-ahead-for-drrx-20160802-00037"}],"result_count":136,"page_size":100,"current_page":1,"total_pages":2,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"1.1135"},{"x":"1494596100","y":"1.0813"},{"x":"1494596400","y":"1.11"},{"x":"1494596700","y":"1.1400000000000001"},{"x":"1494597000","y":"1.15"},{"x":"1494597300","y":"1.17"},{"x":"1494597600","y":"1.221"},{"x":"1494597900","y":"1.2019"},{"x":"1494598200","y":"1.215"},{"x":"1494598500","y":"1.21"},{"x":"1494598800","y":"1.2039"},{"x":"1494599100","y":"1.2"},{"x":"1494599400","y":"1.2"},{"x":"1494599700","y":"1.2748"},{"x":"1494600000","y":"1.2799"},{"x":"1494600300","y":"1.28"},{"x":"1494600600","y":"1.25"},{"x":"1494600900","y":"1.255"},{"x":"1494601200","y":"1.2599"},{"x":"1494601500","y":"1.27"},{"x":"1494601800","y":"1.27"},{"x":"1494602100","y":"1.27"},{"x":"1494602400","y":"1.26"},{"x":"1494602700","y":"1.25"},{"x":"1494603000","y":"1.26"},{"x":"1494603300","y":"1.255"},{"x":"1494603600","y":"1.275"},{"x":"1494603900","y":"1.2650000000000001"},{"x":"1494604200","y":"1.2699"},{"x":"1494604500","y":"1.2650000000000001"},{"x":"1494604800","y":"1.275"},{"x":"1494605100","y":"1.2684"},{"x":"1494605400","y":"1.255"},{"x":"1494605700","y":"1.275"},{"x":"1494606000","y":"1.26"},{"x":"1494606300","y":"1.25"},{"x":"1494606600","y":"1.24"},{"x":"1494606900","y":"1.24"},{"x":"1494607200","y":"1.24"},{"x":"1494607500","y":"1.226"},{"x":"1494607800","y":"1.24"},{"x":"1494608100","y":"1.25"},{"x":"1494608400","y":"1.24"},{"x":"1494608700","y":"1.2349999999999999"},{"x":"1494609000","y":"1.24"},{"x":"1494609300","y":"1.24"},{"x":"1494609600","y":"1.24"},{"x":"1494609900","y":"1.23"},{"x":"1494610200","y":"1.22"},{"x":"1494610500","y":"1.215"},{"x":"1494610800","y":"1.215"},{"x":"1494611100","y":"1.22"},{"x":"1494611400","y":"1.21"},{"x":"1494611700","y":"1.21"},{"x":"1494612000","y":"1.22"},{"x":"1494612300","y":"1.2349999999999999"},{"x":"1494612600","y":"1.2349999999999999"},{"x":"1494612900","y":"1.22"},{"x":"1494613200","y":"1.22"},{"x":"1494613500","y":"1.225"},{"x":"1494613800","y":"1.22"},{"x":"1494614100","y":"1.22"},{"x":"1494614400","y":"1.22"},{"x":"1494614700","y":"1.22"},{"x":"1494615000","y":"1.22"},{"x":"1494615300","y":"1.22"},{"x":"1494615600","y":"1.22"},{"x":"1494615900","y":"1.2199"},{"x":"1494616200","y":"1.21"},{"x":"1494616500","y":"1.2042"},{"x":"1494616800","y":"1.215"},{"x":"1494617100","y":"1.22"},{"x":"1494617400","y":"1.21"},{"x":"1494617700","y":"1.21"},{"x":"1494618000","y":"1.21"},{"x":"1494618300","y":"1.22"},{"x":"1494618600","y":"1.2165"},{"x":"1494618900","y":"1.21"},{"x":"1494619200","y":"1.21"} ], "color":"#03a9f4"}]},
{"id":"6","symbol": "ECYT","name": "Endocyte Inc","price": 2.9,"dollarChange": 0.4,"percentChange": 15.54,"open": 2.52,"high": 2.93,"low":2.5,"volume": 1373029,"avgVol": 354994.233333,"sharesShort": 1864866,"shortPercent": 4.558813,"marketCap": 97683010,"float": 40906833,"headlines":{"data":[{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Reports Narrower-than-Expected Loss in Q1","publication_date":"2017-05-11 12:18:12 +0000","summary":"Endocyte, Inc. (ECYT) reported a narrower-than-expected loss in the first quarter of 2017.","url":"http://finance.yahoo.com/news/endocyte-ecyt-reports-narrower-expected-121812741.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Edited Transcript of ECYT earnings conference call or presentation 10-May-17 12:30pm GMT","publication_date":"2017-05-11 01:06:19 +0000","summary":"Q1 2017 Endocyte Inc Earnings Call","url":"http://finance.yahoo.com/news/edited-transcript-ecyt-earnings-conference-211637693.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Reports Narrower than Expected Q1 Loss","publication_date":"2017-05-10 16:05:56 +0000","summary":"West Lafayette IN based Endocyte Inc ECYT is a development stage biopharmaceutical company focused on bringing targeted therapies for the treatment of cancer and inflammatory diseases to market The company uses its proprietary technology to create small molecule drug conjugates SMDCs","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N9rgxqTKM5k/endocyte-ecyt-reports-narrower-than-expected-q1-loss-cm787246"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Reports Narrower than Expected Q1 Loss","publication_date":"2017-05-10 13:33:01 +0000","summary":"Endocyte reported a loss per share of 27 cents per share while our consensus called for a loss of 28 cents per share.","url":"http://finance.yahoo.com/news/endocyte-ecyt-reports-narrower-expected-133301535.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte reports 1Q loss","publication_date":"2017-05-10 12:22:31 +0000","summary":"The West Lafayette, Indiana-based company said it had a loss of 27 cents per share. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...","url":"http://finance.yahoo.com/news/endocyte-reports-1q-loss-122231793.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte Reports First Quarter Financial Results and Provides Clinical and Pipeline Update","publication_date":"2017-05-10 12:00:00 +0000","summary":"WEST LAFAYETTE, Ind., May 10, 2017-- Endocyte, Inc., a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, today announced financial results ...","url":"http://finance.yahoo.com/news/endocyte-reports-first-quarter-financial-120000814.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Investor Network: Endocyte, Inc. to Host Earnings Call","publication_date":"2017-05-10 11:45:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / May 10, 2017 / Endocyte, Inc. (NASDAQ: ECYT ) will be discussing their earnings results in their Q1 Earnings Call to be held May 10, 2017 at 8:30 AM Eastern Time. To listen ...","url":"http://finance.yahoo.com/news/investor-network-endocyte-inc-host-114500999.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte Announces First Quarter 2017 Earnings Conference Call","publication_date":"2017-05-03 20:01:00 +0000","summary":"WEST LAFAYETTE, Ind., May 03, 2017-- Endocyte, Inc., announced today that the company will host a conference call on Wednesday, May 10th, at 8:30 a.m. EDT to discuss its first quarter financial results ...","url":"http://finance.yahoo.com/news/endocyte-announces-first-quarter-2017-200100707.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"What to Expect from Endocyte (ECYT) Stock for Q1 Earnings?","publication_date":"2017-05-01 20:03:08 +0000","summary":"Endocyte, Inc (ECYT) is expected to report first-quarter 2017 results on May 3.","url":"http://finance.yahoo.com/news/expect-endocyte-ecyt-stock-q1-200308521.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Screening for Net-Net Stocks in an Overvalued Market","publication_date":"2017-04-12 18:05:28 +0000","summary":"They may be hard to find at times, but they're there","url":"http://finance.yahoo.com/news/screening-net-net-stocks-overvalued-180528461.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Up 3.5% Since Earnings Report: Can It Continue?","publication_date":"2017-04-10 12:54:50 +0000","summary":"It has been about a month since the last earnings report for Endocyte Inc ECYT Shares have added about 3 5 in that time frame outperforming the market Will the recent positive trend continue leading up to the stock s next earnings release or is it due for a pullback Before we dive","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SeXx2IHgQSQ/endocyte-ecyt-up-35-since-earnings-report-can-it-continue-cm771922"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Up 3.5% Since Earnings Report: Can It Continue?","publication_date":"2017-04-10 11:10:11 +0000","summary":"Endocyte (ECYT) reported earnings 30 days ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.","url":"http://finance.yahoo.com/news/endocyte-ecyt-3-5-since-111011930.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte Presents Data at AACR Identifying Multiple Methods for Managing Severe Side Effects Resulting from CAR T-Cell Treatment","publication_date":"2017-04-05 12:00:00 +0000","summary":"-Late-breaking poster demonstrates that Endocyte’ s bi-specific adaptor molecules can mitigate or eliminate cytokine storms-. -Potential to meaningfully improve the safety and tolerability of CAR T-cell ...","url":"http://finance.yahoo.com/news/endocyte-presents-data-aacr-identifying-120000672.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"6:24 pm Endocyte announces presentations at American Association for Cancer Research April 1-5 Meeting to include late-breaker highlighting Endocyte's next generation CAR T-cell therapeutic platform","publication_date":"2017-03-27 22:24:00 +0000","summary":"6:24 pm Endocyte announces presentations at American Association for Cancer Research April 1-5 Meeting to include late-breaker highlighting Endocyte's next generation CAR T-cell therapeutic platform","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#ecyt"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte Announces Presentations at American Association for Cancer Research (AACR) Annual Meeting 2017","publication_date":"2017-03-27 20:01:00 +0000","summary":"[GlobeNewswire] - WEST LAFAYETTE, Ind., March 27, 2017-- Endocyte, Inc., a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, today announced that eight posters ...","url":"http://finance.yahoo.com/news/endocyte-announces-presentations-american-association-200100519.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte Announces Presentations at American Association for Cancer Research (AACR) Annual Meeting 2017","publication_date":"2017-03-27 20:01:00 +0000","summary":"WEST LAFAYETTE, Ind., March 27, 2017-- Endocyte, Inc., a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, today announced that eight posters ...","url":"http://finance.yahoo.com/news/endocyte-announces-presentations-american-association-200100519.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte, Inc. :ECYT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017","publication_date":"2017-03-21 15:29:48 +0000","summary":"Categories: Yahoo Finance Get free summary analysis Endocyte, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Endocyte, Inc. – Amgen Inc., Johnson & Johnson, Merck & Co., Inc., General Electric Company, AbbVie, Inc. and Nektar Therapeutics (AMGN-US, JNJ-US, MRK-US, GE-US, ABBV-US and NKTR-US) that have ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/15ae7f3f-df76-3cc2-b589-7463e96e271d/endocyte-inc-ecyt-us-earnings-analysis-q4-2016-by-the-numbers-march-21-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte, Inc. :ECYT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017","publication_date":"2017-03-21 15:29:48 +0000","summary":"Endocyte, Inc. :ECYT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017","url":"http://www.capitalcube.com/blog/index.php/endocyte-inc-ecyt-us-earnings-analysis-q4-2016-by-the-numbers-march-21-2017/"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"ENDOCYTE INC Financials","publication_date":"2017-03-17 17:04:09 +0000","summary":"ENDOCYTE INC Financials","url":"http://finance.yahoo.com/q/is?s=ecyt"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"5 Cheap Breakout Stocks for Superb Returns","publication_date":"2017-03-16 15:09:52 +0000","summary":"One of the most popular methods utilized by active investors is to select breakout stocks The technique identifies those stocks whose prices are fluctuating within a specific band In case a stock falls below the floor of this band it may be time to offload it from your portfolio However","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2bcGVOaKj9M/5-cheap-breakout-stocks-for-superb-returns-cm761726"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"5 Cheap Breakout Stocks for Superb Returns","publication_date":"2017-03-16 13:23:01 +0000","summary":"The technique identifies those stocks whose prices are fluctuating within a specific band.","url":"http://finance.yahoo.com/news/5-cheap-breakout-stocks-superb-132301578.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"5 Cheap Breakout Stocks for Superb Returns","publication_date":"2017-03-16 13:23:01 +0000","summary":"5 Cheap Breakout Stocks for Superb Returns","url":"http://finance.yahoo.com/news/5-cheap-breakout-stocks-superb-132301578.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte, Inc. :ECYT-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017","publication_date":"2017-03-15 17:55:05 +0000","summary":"Endocyte, Inc. :ECYT-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017","url":"http://www.capitalcube.com/blog/index.php/endocyte-inc-ecyt-us-earnings-analysis-2016-by-the-numbers-march-15-2017/"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte, Inc. :ECYT-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017","publication_date":"2017-03-15 17:55:05 +0000","summary":"Categories: Yahoo Finance Get free summary analysis Endocyte, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Endocyte, Inc. – Amgen Inc., Johnson & Johnson, Merck & Co., Inc., General Electric Company, AbbVie, Inc. and Nektar Therapeutics (AMGN-US, JNJ-US, MRK-US, GE-US, ABBV-US and NKTR-US) that have ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/bdf0d76f-5982-3c76-b638-8f221bd93d07/endocyte-inc-ecyt-us-earnings-analysis-2016-by-the-numbers-march-15-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Reports Wider-than-Expected Loss in Q4","publication_date":"2017-03-15 00:06:09 +0000","summary":"Endocyte Inc ECYT reported a fourth quarter 2016 loss of 26 cents per share wider than both the Zacks Consensus Estimate of a loss of 25 cents and the year ago loss of 23 cents Collaboration revenues on the other hand remained flat at 0 012 million during the quarter Endocyte s","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kecdYUM26rE/endocyte-ecyt-reports-wider-than-expected-loss-in-q4-cm760831"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Reports Wider-than-Expected Loss in Q4","publication_date":"2017-03-14 22:16:10 +0000","summary":"Endocyte, Inc. (ECYT) reported a fourth-quarter 2016 loss of 26 cents per share, wider than both the Zacks Consensus Estimate of a loss of 25 cents and the year-ago loss of 23 cents.","url":"http://finance.yahoo.com/news/endocyte-ecyt-reports-wider-expected-221610177.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Reports Wider-than-Expected Loss in Q4","publication_date":"2017-03-14 22:16:10 +0000","summary":"Endocyte (ECYT) Reports Wider-than-Expected Loss in Q4","url":"http://finance.yahoo.com/news/endocyte-ecyt-reports-wider-expected-221610177.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Shares March Higher, Can It Continue?","publication_date":"2017-03-14 16:07:39 +0000","summary":"Endocyte Inc ECYT has been on the move lately as the stock has risen by 20 2 in the past four weeks and it is currently trading well above its 20 Day SMA This is a pretty solid move higher but the question that has to be on investors minds right now is can this trend continue","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SVNCVaheHAk/endocyte-ecyt-shares-march-higher-can-it-continue-cm760531"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Shares March Higher, Can It Continue?","publication_date":"2017-03-14 14:16:02 +0000","summary":"Endocyte (ECYT) Shares March Higher, Can It Continue?","url":"http://finance.yahoo.com/news/endocyte-ecyt-shares-march-higher-141602347.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Shares March Higher, Can It Continue?","publication_date":"2017-03-14 14:16:02 +0000","summary":"Endocyte, Inc. (ECYT) has been on the move lately as the stock has risen by 20.2% in the past four weeks, and it is currently trading well above its 20-Day SMA","url":"http://finance.yahoo.com/news/endocyte-ecyt-shares-march-higher-141602347.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"ENDOCYTE INC Files SEC form 10-K, Annual Report","publication_date":"2017-03-13 20:23:06 +0000","summary":"ENDOCYTE INC Files SEC form 10-K, Annual Report","url":"http://biz.yahoo.com/e/170313/ecyt10-k.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Edited Transcript of ECYT earnings conference call or presentation 10-Mar-17 1:30pm GMT","publication_date":"2017-03-13 01:09:05 +0000","summary":"Edited Transcript of ECYT earnings conference call or presentation 10-Mar-17 1:30pm GMT","url":"http://finance.yahoo.com/news/edited-transcript-ecyt-earnings-conference-010905659.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Edited Transcript of ECYT earnings conference call or presentation 10-Mar-17 1:30pm GMT","publication_date":"2017-03-13 01:09:05 +0000","summary":"Q4 2016 Endocyte Inc Earnings Call","url":"http://finance.yahoo.com/news/edited-transcript-ecyt-earnings-conference-010905659.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Reports a Wider Q4 Loss","publication_date":"2017-03-11 00:19:08 +0000","summary":"West Lafayette IN based Endocyte Inc ECYT is a development stage biopharmaceutical company focused on bringing targeted therapies for the treatment of cancer and inflammatory diseases to market The company uses its proprietary technology to create small molecule drug conjugates SMDCs","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UZNUS2Q5_eM/endocyte-ecyt-reports-a-wider-q4-loss-cm759569"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Reports a Wider Q4 Loss","publication_date":"2017-03-10 13:52:01 +0000","summary":"Endocyte (ECYT) Reports a Wider Q4 Loss","url":"http://finance.yahoo.com/news/endocyte-ecyt-reports-wider-q4-145202336.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Reports a Wider Q4 Loss","publication_date":"2017-03-10 13:52:01 +0000","summary":"Endocyte reported a loss per share of 26 cents per share while our consensus called for a loss of 25 cents per share.","url":"http://finance.yahoo.com/news/endocyte-ecyt-reports-wider-q4-145202336.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte reports 4Q loss","publication_date":"2017-03-10 13:20:52 +0000","summary":"Endocyte reports 4Q loss","url":"http://sg.finance.yahoo.com/news/endocyte-reports-4q-loss-132052995.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte reports 4Q loss","publication_date":"2017-03-10 13:20:52 +0000","summary":"On a per-share basis, the West Lafayette, Indiana-based company said it had a loss of 26 cents. The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks ...","url":"http://finance.yahoo.com/news/endocyte-reports-4q-loss-132052788.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"ENDOCYTE INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial S","publication_date":"2017-03-10 13:16:04 +0000","summary":"ENDOCYTE INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial S","url":"http://biz.yahoo.com/e/170310/ecyt8-k.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte Reports Fourth Quarter and Year End 2016 Financial Results and Provides Clinical and Pipeline Update","publication_date":"2017-03-10 13:05:00 +0000","summary":"[GlobeNewswire] - WEST LAFAYETTE, Ind., March 10, 2017-- Endocyte, Inc., a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, today announced financial results ...","url":"http://finance.yahoo.com/news/endocyte-reports-fourth-quarter-end-130500278.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte Reports Fourth Quarter and Year End 2016 Financial Results and Provides Clinical and Pipeline Update","publication_date":"2017-03-10 13:05:00 +0000","summary":"WEST LAFAYETTE, Ind., March 10, 2017-- Endocyte, Inc., a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, today announced financial results ...","url":"http://finance.yahoo.com/news/endocyte-reports-fourth-quarter-end-130500278.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte and Seattle Children’s Research Institute to Collaborate on Endocyte’s Small Molecule Drug Conjugate Bi-Specific Adaptor Molecules for CAR T-cell Therapies","publication_date":"2017-03-10 13:00:00 +0000","summary":"[GlobeNewswire] - Collaboration pairs leading SMDC technology with recognized CAR T-cell research expert. Plans to develop next generation CAR T-cell therapeutic platform with potential for improved safety and efficacy ...","url":"http://finance.yahoo.com/news/endocyte-seattle-children-research-institute-130000072.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte and Seattle Children’s Research Institute to Collaborate on Endocyte’s Small Molecule Drug Conjugate Bi-Specific Adaptor Molecules for CAR T-cell Therapies","publication_date":"2017-03-10 13:00:00 +0000","summary":"Collaboration pairs leading SMDC technology with recognized CAR T-cell research expert. Plans to develop next generation CAR T-cell therapeutic platform with potential for improved safety and efficacy ...","url":"http://finance.yahoo.com/news/endocyte-seattle-children-research-institute-130000072.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Earnings Reaction History: Endocyte, Inc., 100.0% Follow-Through Indicator, 12.4% Sensitive","publication_date":"2017-03-10 11:53:05 +0000","summary":"Expected Earnings Release 03 10 2017 PremarketExpected Earnings Release 03 10 2017 Premarket Avg Extended Hours Dollar Volume 1 067 605Avg Extended Hours Dollar Volume 1 067 605 Endocyte Inc ECYT is due to issue its quarterly earnings report in the upcoming extended hours","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v6-zRIWswoA/earnings-reaction-history-endocyte-inc-1000-follow-through-indicator-124-sensitive-cm759008"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte Announces Fourth Quarter and Full Year 2016 Earnings Conference Call","publication_date":"2017-03-02 13:00:00 +0000","summary":"[GlobeNewswire] - WEST LAFAYETTE, Ind., March 02, 2017-- Endocyte, Inc., announced today that the company will host a conference call on Friday, March 10th, at 8:30 a.m. EST to discuss its fourth quarter and full year financial ...","url":"http://finance.yahoo.com/news/endocyte-announces-fourth-quarter-full-130000896.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte Announces Fourth Quarter and Full Year 2016 Earnings Conference Call","publication_date":"2017-03-02 13:00:00 +0000","summary":"WEST LAFAYETTE, Ind., March 02, 2017-- Endocyte, Inc., announced today that the company will host a conference call on Friday, March 10th, at 8:30 a.m. EST to discuss its fourth quarter and full year financial ...","url":"http://finance.yahoo.com/news/endocyte-announces-fourth-quarter-full-130000896.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte to Present at the Cowen and Company 37th Annual Health Care Conference","publication_date":"2017-03-01 21:01:00 +0000","summary":"[GlobeNewswire] - WEST LAFAYETTE, Ind., March 01, 2017-- Endocyte, Inc., a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, today announced that the company’ ...","url":"http://finance.yahoo.com/news/endocyte-present-cowen-company-37th-210100419.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte to Present at the Cowen and Company 37th Annual Health Care Conference","publication_date":"2017-03-01 21:01:00 +0000","summary":"WEST LAFAYETTE, Ind., March 01, 2017-- Endocyte, Inc., a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, today announced that the company’ ...","url":"http://finance.yahoo.com/news/endocyte-present-cowen-company-37th-210100419.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) to Post Q4 Earnings: What's in the Cards?","publication_date":"2017-02-23 23:49:26 +0000","summary":"Endocyte Inc ECYT is expected to report fourth quarter 2016 results on Mar 1 The company has an impressive track record having beaten estimates on three of the trailing four quarters and reporting in line results in the remaining quarter Overall the company has recorded an average","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EmH81ji40XM/endocyte-ecyt-to-post-q4-earnings-whats-in-the-cards-cm752446"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) to Post Q4 Earnings: What's in the Cards?","publication_date":"2017-02-23 21:43:09 +0000","summary":"Endocyte (ECYT) to Post Q4 Earnings: What's in the Cards?","url":"http://finance.yahoo.com/news/endocyte-ecyt-post-q4-earnings-214309313.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) to Post Q4 Earnings: What's in the Cards?","publication_date":"2017-02-23 21:43:09 +0000","summary":"Endocyte, Inc (ECYT) is expected to report fourth-quarter 2016 results on Mar 1. The company has an impressive track record, having beaten estimates on three of the trailing four quarters and reporting in-line results in the remaining quarter","url":"http://finance.yahoo.com/news/endocyte-ecyt-post-q4-earnings-214309313.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"ENDOCYTE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits","publication_date":"2017-02-21 21:07:09 +0000","summary":"ENDOCYTE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170221/ecyt8-k.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte Appoints Michael T. Andriole as Chief Financial Officer","publication_date":"2017-02-21 13:00:00 +0000","summary":"[GlobeNewswire] - WEST LAFAYETTE, Ind., Feb. 21, 2017-- Endocyte, Inc., a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, today announced that Michael ...","url":"http://finance.yahoo.com/news/endocyte-appoints-michael-t-andriole-130000788.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Valeant Streamlines Portfolio with Skincare Brands Sale","publication_date":"2017-01-11 23:57:41 +0000","summary":"Beleaguered Valeant Pharmaceuticals International Inc VRX announced that it has entered into an agreement to sell its CeraVe AcneFree and AMBI skincare brands to L Oréal for 1 3 billion in cash Shares of Valeant underperformed the Zacks classified Medical Drugs in the last 12","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FLZL628lYxU/valeant-streamlines-portfolio-with-skincare-brands-sale-cm732490"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Valeant Streamlines Portfolio with Skincare Brands Sale","publication_date":"2017-01-11 21:42:09 +0000","summary":"Beleaguered Valeant Pharmaceuticals International, Inc. (VRX) announced that it has entered into an agreement to sell its CeraVe, AcneFree and AMBI skincare brands to L'Or??al for $1.3 billion in cash.","url":"http://finance.yahoo.com/news/valeant-streamlines-portfolio-skincare-brands-214209103.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Valeant Streamlines Portfolio with Skincare Brands Sale","publication_date":"2017-01-11 21:42:09 +0000","summary":"Valeant Streamlines Portfolio with Skincare Brands Sale","url":"http://finance.yahoo.com/news/valeant-streamlines-portfolio-skincare-brands-214209103.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Valeant to Sell Dendreon Unit to Sanpower for $820 Million","publication_date":"2017-01-10 16:53:21 +0000","summary":"Beleaguered Valeant Pharmaceuticals International Inc VRX announced that its affiliate has entered into a definitive agreement to sell all the outstanding equity interests in Dendreon Pharmaceuticals Inc to the China based Sanpower Group Co Ltd Shares of Valeant underperformed","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W0wGuzC1p6Q/valeant-to-sell-dendreon-unit-to-sanpower-for-820-million-cm731677"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Valeant to Sell Dendreon Unit to Sanpower for $820 Million","publication_date":"2017-01-10 14:49:02 +0000","summary":"Beleaguered Valeant Pharmaceuticals International, Inc. (VRX) announced that it will sell all the outstanding equity interests in Dendreon Pharmaceuticals, Inc. to the China based Sanpower Group Co., Ltd.","url":"http://finance.yahoo.com/news/valeant-sell-dendreon-unit-sanpower-144902932.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Valeant to Sell Dendreon Unit to Sanpower for $820 Million","publication_date":"2017-01-10 14:49:02 +0000","summary":"Valeant to Sell Dendreon Unit to Sanpower for $820 Million","url":"http://finance.yahoo.com/news/valeant-sell-dendreon-unit-sanpower-144902932.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Is Valeant (VRX) Fated for Terrible 2017 As Well?","publication_date":"2017-01-03 22:38:02 +0000","summary":"Shares of Valeant Pharmaceuticals Inc VRX slumped 85 3 in 2016 eroding a chunk of shareholders net worth Shares of Valeant underperformed the Zacks classified Medical Drugs industry 2016 as well taking into account a decline of 22 9 for the industry Once an acquisition","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u64kNE56hho/is-valeant-vrx-fated-for-terrible-2017-as-well-cm728932"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Is Valeant (VRX) Fated for Terrible 2017 As Well?","publication_date":"2017-01-03 20:22:08 +0000","summary":"Is Valeant (VRX) Fated for Terrible 2017 As Well?","url":"http://finance.yahoo.com/news/valeant-vrx-fated-terrible-2017-202208831.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Is Valeant (VRX) Fated for Terrible 2017 As Well?","publication_date":"2017-01-03 20:22:08 +0000","summary":"Shares of Valeant Pharmaceuticals, Inc. (VRX) slumped 85.3% in 2016, eroding a chunk of shareholders' net worth.","url":"http://finance.yahoo.com/news/valeant-vrx-fated-terrible-2017-202208831.html?.tsrc=rss"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"How Endocyte, Inc. (ECYT) Stacks Up Against Its Peers","publication_date":"2016-12-16 02:08:37 +0000","summary":"How Endocyte, Inc. (ECYT) Stacks Up Against Its Peers","url":"http://www.insidermonkey.com/blog/how-endocyte-inc-ecyt-stacks-up-against-its-peers-510693/"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"ETFs with exposure to Endocyte, Inc. : December 14, 2016","publication_date":"2016-12-14 17:59:03 +0000","summary":"ETFs with exposure to Endocyte, Inc. : December 14, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-endocyte-inc-december-14-2016/"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Mission Therapeutics Appoints Colin Goddard as Chairman","publication_date":"2016-12-05 08:00:00 +0000","summary":"[PR Newswire] - Mission Therapeutics, a drug discovery and development company focused on selectively targeting deubiquitylating enzymes (DUBs) to treat cancer, neurodegenerative and other diseases, announces that Dr Colin Goddard has been appointed as non-executive Chairman, effective January 1st 2017. Dr Colin Goddard joined the board of Mission Therapeutics as a non-executive Director in July 2015. Michael Moore, Mission's Founder Chairman, will continue on the board and transition to the role of Deputy Chairman.","url":"http://finance.yahoo.com/news/mission-therapeutics-appoints-colin-goddard-080000234.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte to Present at the IASLC 17th World Conference on Lung Cancer","publication_date":"2016-12-01 13:01:00 +0000","summary":"[GlobeNewswire] - WEST LAFAYETTE, Ind., Dec. 01, 2016-- Endocyte, Inc., a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, today announced that data from ...","url":"http://finance.yahoo.com/news/endocyte-present-iaslc-17th-world-130100270.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"ETFs with exposure to Endocyte, Inc. : November 29, 2016","publication_date":"2016-11-29 20:10:47 +0000","summary":"ETFs with exposure to Endocyte, Inc. : November 29, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-endocyte-inc-november-29-2016/"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte, Inc. :ECYT-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016","publication_date":"2016-11-28 15:54:47 +0000","summary":"Endocyte, Inc. :ECYT-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016","url":"http://www.capitalcube.com/blog/index.php/endocyte-inc-ecyt-us-earnings-analysis-q3-2016-by-the-numbers-november-28-2016/"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Stock Up on Lower-than-Expected Q3 Loss","publication_date":"2016-11-11 15:16:31 +0000","summary":"Endocyte Inc ECYT reported a third quarter 2016 loss of 21 cents per share narrower than both the Zacks Consensus Estimate of a loss of 27 cents and the year ago loss of 24 cents The company s shares gained 3 following the release of its quarterly results","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3Hgh0rSSP94/endocyte-ecyt-stock-up-on-lower-than-expected-q3-loss-cm707715"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Stock Up on Lower-than-Expected Q3 Loss","publication_date":"2016-11-11 13:08:01 +0000","summary":"Endocyte (ECYT) Stock Up on Lower-than-Expected Q3 Loss","url":"http://finance.yahoo.com/news/endocyte-ecyt-stock-lower-expected-130801143.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte reports 3Q loss","publication_date":"2016-11-09 21:46:53 +0000","summary":"Endocyte reports 3Q loss","url":"http://sg.finance.yahoo.com/news/endocyte-reports-3q-loss-214653719.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte Reports Third Quarter 2016 Financial Results","publication_date":"2016-11-09 21:21:22 +0000","summary":"[at noodls] - - Confirmed Maximum Dose for EC1169 and Initiated Expansion Phase in Prostate Cancer Patients - - First Confirmed RECIST Partial Response Observed in EC1169 Dose Escalation Reported at European Society ...","url":"http://www.publicnow.com/view/6785336B69151E7D05FEEEE80BF91B1E1A7035E9"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"ENDOCYTE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits","publication_date":"2016-11-09 21:17:28 +0000","summary":"ENDOCYTE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/161109/ecyt8-k.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Earnings Reaction History: Endocyte, Inc., 80.0% Follow-Through Indicator, 12.1% Sensitive","publication_date":"2016-11-09 12:13:32 +0000","summary":"Expected Earnings Release 11 09 2016 After hoursExpected Earnings Release 11 09 2016 After hours Avg Extended Hours Dollar Volume 1 077 912Avg Extended Hours Dollar Volume 1 077 912 Endocyte Inc ECYT is due to issue its quarterly earnings report in the upcoming extended","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Am9iIlRKivU/earnings-reaction-history-endocyte-inc-800-follow-through-indicator-121-sensitive-cm706183"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte Announces Third Quarter 2016 Earnings Conference Call","publication_date":"2016-11-02 20:10:39 +0000","summary":"[at noodls] - WEST LAFAYETTE, Ind., Nov. 02, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc., (NASDAQ:ECYT) announced today that the company will host a conference call on Wednesday, Nov. 9th, at 4:30 p.m. EST to discuss its ...","url":"http://www.publicnow.com/view/8EA0E43856947E07114D732BC723F375DF1097FE"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte to Present at the 25th Annual Credit Suisse Healthcare Conference","publication_date":"2016-11-01 20:01:00 +0000","summary":"[GlobeNewswire] - WEST LAFAYETTE, Ind., Nov. 01, 2016-- Endocyte, Inc., a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy today announced that the company’ ...","url":"http://finance.yahoo.com/news/endocyte-present-25th-annual-credit-200100162.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT): Can the Stock Surprise in Q3 Earnings?","publication_date":"2016-10-28 14:33:50 +0000","summary":"Endocyte Inc ECYT is expected to report third quarter 2016 results on Nov 1 The company has an impressive track record having beaten estimates on three of the trailing four quarters and missing the same once Overall the company has recorded an average positive surprise of 7 44 In","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j55Kib51j-E/endocyte-ecyt-can-the-stock-surprise-in-q3-earnings-cm700179"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT): Can the Stock Surprise in Q3 Earnings?","publication_date":"2016-10-28 13:34:01 +0000","summary":"Endocyte (ECYT): Can the Stock Surprise in Q3 Earnings?","url":"http://finance.yahoo.com/news/endocyte-ecyt-stock-surprise-q3-133401118.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"ENDOCYTE INC Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2016-10-20 20:31:59 +0000","summary":"ENDOCYTE INC Files SEC form 8-K, Change in Directors or Principal Officers","url":"http://biz.yahoo.com/e/161020/ecyt8-k.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"ENDOCYTE INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","publication_date":"2016-10-11 12:32:10 +0000","summary":"ENDOCYTE INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/161011/ecyt8-k.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte Presents Data on Two Lead Clinical Programs at European Society for Medical Oncology (ESMO) 2016 Congress","publication_date":"2016-10-10 12:00:00 +0000","summary":"[GlobeNewswire] - WEST LAFAYETTE, Ind., Oct. 10, 2016-- Endocyte, Inc., a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, presented poster updates on its ...","url":"http://finance.yahoo.com/news/endocyte-presents-data-two-lead-120000546.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte Announces Presentations at the European Society for Medical Oncology (ESMO)","publication_date":"2016-09-29 20:20:05 +0000","summary":"[at noodls] - WEST LAFAYETTE, Ind., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized ...","url":"http://www.publicnow.com/view/1790ACBB5BEB51665AB908E56FE69000FFE4BA6E"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Catches Eye: Stock Adds 5.8% in Session","publication_date":"2016-09-28 13:22:30 +0000","summary":"Endocyte Inc ECYT was a big mover last session as its shares rose almost 6 on the day The move came on solid volume too with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above the volatile price range","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3x5R65eMaz8/endocyte-ecyt-catches-eye-stock-adds-58-in-session-cm685864"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Catches Eye: Stock Adds 5.8% in Session","publication_date":"2016-09-28 12:25:12 +0000","summary":"Endocyte (ECYT) Catches Eye: Stock Adds 5.8% in Session","url":"http://finance.yahoo.com/news/endocyte-ecyt-catches-eye-stock-122512803.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Sum Up The Parts: Russell 2000 Has 11% Upside","publication_date":"2016-09-21 15:23:05 +0000","summary":"The financial media loves to get predictions from experts about where they think a given stock market index is headed Some experts look at technical analysis patterns others look at valuation metrics others apply a broad macro view of the economy In this article we present another","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1S3VttzYhCw/sum-up-the-parts-russell-2000-has-11-upside-cm682586"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte to Present at the Ladenburg Thalmann 2016 Healthcare Conference","publication_date":"2016-09-20 20:01:00 +0000","summary":"[GlobeNewswire] - WEST LAFAYETTE, Ind., Sept. 20, 2016-- Endocyte, Inc., a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, today announced that the company’ ...","url":"http://finance.yahoo.com/news/endocyte-present-ladenburg-thalmann-2016-200100024.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"INVESTIndiana announces executive presentation schedule","publication_date":"2016-09-06 14:00:00 +0000","summary":"[GlobeNewswire] - Lineup highlights health sciences, banking, energy, high-tech and manufacturing Conference features inaugural Indiana Public Company of the Year Award Central Indiana Corporate Partnership CEO David Johnson's ...","url":"http://finance.yahoo.com/news/investindiana-announces-executive-presentation-schedule-140000261.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"ETF’s with exposure to Endocyte, Inc. : September 2, 2016","publication_date":"2016-09-02 13:55:50 +0000","summary":"ETF’s with exposure to Endocyte, Inc. : September 2, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-endocyte-inc-september-2-2016/"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte Announces Presentations at the 252nd American Chemical Society National Meeting & Exposition","publication_date":"2016-08-15 20:01:00 +0000","summary":"[GlobeNewswire] - WEST LAFAYETTE, Ind., Aug. 15, 2016-- Endocyte, Inc., a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, today announced that five posters ...","url":"http://finance.yahoo.com/news/endocyte-announces-presentations-252nd-american-200100592.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"ETF’s with exposure to Endocyte, Inc. : August 15, 2016","publication_date":"2016-08-15 14:21:06 +0000","summary":"ETF’s with exposure to Endocyte, Inc. : August 15, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-endocyte-inc-august-15-2016/"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte, Inc. :ECYT-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016","publication_date":"2016-08-12 15:09:32 +0000","summary":"Endocyte, Inc. :ECYT-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016","url":"http://www.capitalcube.com/blog/index.php/endocyte-inc-ecyt-us-earnings-analysis-q2-2016-by-the-numbers-august-12-2016/"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte to Present at the 2016 Wedbush PacGrow Healthcare Conference","publication_date":"2016-08-09 20:01:00 +0000","summary":"[GlobeNewswire] - WEST LAFAYETTE, Ind., Aug. 09, 2016-- Endocyte, Inc., a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, today announced that the company’ ...","url":"http://finance.yahoo.com/news/endocyte-present-2016-wedbush-pacgrow-200100654.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Q2 Loss Wider than Expected (Revised)","publication_date":"2016-08-09 11:16:53 +0000","summary":"Endocyte, Inc.ECYT reported a second quarter 2016 loss of 33 cents per share, wider than both the Zacks Consensus Estimate of a loss of 26 cents and the year ago loss of 25 cents. On the other hand, the","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9edhoNESOy4/endocyte-ecyt-q2-loss-wider-than-expected-revised-cm662242"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Q2 Loss Wider than Expected (Revised)","publication_date":"2016-08-09 09:31:09 +0000","summary":"Endocyte (ECYT) Q2 Loss Wider than Expected (Revised)","url":"http://finance.yahoo.com/news/endocyte-ecyt-q2-loss-wider-093109224.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"ENDOCYTE INC Files SEC form 10-Q, Quarterly Report","publication_date":"2016-08-05 18:15:15 +0000","summary":"ENDOCYTE INC Files SEC form 10-Q, Quarterly Report","url":"http://biz.yahoo.com/e/160805/ecyt10-q.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Edited Transcript of ECYT earnings conference call or presentation 4-Aug-16 8:30pm GMT","publication_date":"2016-08-05 16:55:03 +0000","summary":"Edited Transcript of ECYT earnings conference call or presentation 4-Aug-16 8:30pm GMT","url":"http://finance.yahoo.com/news/edited-transcript-ecyt-earnings-conference-165503985.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Reports Narrower-than-Expected Loss in Q2","publication_date":"2016-08-05 15:37:19 +0000","summary":"Endocyte, Inc.ECYT reported a second quarter 2016 loss of 25 cents per share, narrower than both the Zacks Consensus Estimate of a loss of 26 cents and the year ago loss of 33 cents. Endocyte Inc. (ECYT) Street Actual","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mWCqjJjuTD8/endocyte-ecyt-reports-narrower-than-expected-loss-in-q2-cm661125"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte (ECYT) Reports Narrower-than-Expected Loss in Q2","publication_date":"2016-08-05 13:55:01 +0000","summary":"Endocyte (ECYT) Reports Narrower-than-Expected Loss in Q2","url":"http://finance.yahoo.com/news/endocyte-ecyt-reports-narrower-expected-135501422.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte reports 2Q loss","publication_date":"2016-08-04 21:59:38 +0000","summary":"Endocyte reports 2Q loss","url":"http://sg.finance.yahoo.com/news/endocyte-reports-2q-loss-215938488.html"},{"ticker":"ECYT","figi_ticker":"ECYT:US","figi":"BBG0014V5D28","title":"Endocyte Reports Second Quarter 2016 Financial Results","publication_date":"2016-08-04 20:33:21 +0000","summary":"[at noodls] - - Reached Maximum Tolerated Dose in Twice Weekly Dosing Schedule with EC1456 - - Initiating EC1456 Expansion Cohort in Targeted Population of Folate Receptor-Positive Non-Small Cell Lung Cancer Patients ...","url":"http://www.publicnow.com/view/CB8530ED3DDF632BE9A3D8187D3FEA7BA1B5FFCB"}],"result_count":139,"page_size":100,"current_page":1,"total_pages":2,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"2.539"},{"x":"1494596100","y":"2.54"},{"x":"1494596400","y":"2.59"},{"x":"1494596700","y":"2.57"},{"x":"1494597000","y":"2.62"},{"x":"1494597300","y":"2.6046"},{"x":"1494597600","y":"2.61"},{"x":"1494597900","y":"2.59"},{"x":"1494598200","y":"2.605"},{"x":"1494598500","y":"2.62"},{"x":"1494598800","y":"2.68"},{"x":"1494599100","y":"2.6526"},{"x":"1494599400","y":"2.6654"},{"x":"1494599700","y":"2.665"},{"x":"1494600000","y":"2.64"},{"x":"1494600300","y":"2.6465"},{"x":"1494600600","y":"2.6407"},{"x":"1494600900","y":"2.6499"},{"x":"1494601200","y":"2.64"},{"x":"1494601500","y":"2.66"},{"x":"1494601800","y":"2.74"},{"x":"1494602100","y":"2.7407"},{"x":"1494602400","y":"2.7416"},{"x":"1494602700","y":"2.7199999999999998"},{"x":"1494603000","y":"2.7199999999999998"},{"x":"1494603300","y":"2.7465"},{"x":"1494603600","y":"2.7735"},{"x":"1494603900","y":"2.7967"},{"x":"1494604200","y":"2.77"},{"x":"1494604500","y":"2.775"},{"x":"1494604800","y":"2.75"},{"x":"1494605100","y":"2.765"},{"x":"1494605400","y":"2.7708"},{"x":"1494605700","y":"2.7800000000000002"},{"x":"1494606000","y":"2.77"},{"x":"1494606300","y":"2.77"},{"x":"1494606600","y":"2.77"},{"x":"1494606900","y":"2.77"},{"x":"1494607200","y":"2.775"},{"x":"1494607800","y":"2.7777"},{"x":"1494608100","y":"2.7800000000000002"},{"x":"1494608400","y":"2.775"},{"x":"1494608700","y":"2.77"},{"x":"1494609000","y":"2.7800000000000002"},{"x":"1494609300","y":"2.7732"},{"x":"1494609600","y":"2.7885999999999997"},{"x":"1494609900","y":"2.79"},{"x":"1494610200","y":"2.79"},{"x":"1494610500","y":"2.81"},{"x":"1494610800","y":"2.8207"},{"x":"1494611100","y":"2.8501"},{"x":"1494611400","y":"2.8365"},{"x":"1494611700","y":"2.815"},{"x":"1494612000","y":"2.814"},{"x":"1494612300","y":"2.8289"},{"x":"1494612600","y":"2.83"},{"x":"1494612900","y":"2.83"},{"x":"1494613200","y":"2.835"},{"x":"1494613500","y":"2.84"},{"x":"1494613800","y":"2.835"},{"x":"1494614100","y":"2.85"},{"x":"1494614400","y":"2.88"},{"x":"1494614700","y":"2.84"},{"x":"1494615000","y":"2.85"},{"x":"1494615300","y":"2.855"},{"x":"1494615600","y":"2.86"},{"x":"1494615900","y":"2.86"},{"x":"1494616200","y":"2.85"},{"x":"1494616500","y":"2.84"},{"x":"1494616800","y":"2.83"},{"x":"1494617100","y":"2.8501"},{"x":"1494617400","y":"2.86"},{"x":"1494617700","y":"2.92"},{"x":"1494618000","y":"2.87"},{"x":"1494618300","y":"2.91"},{"x":"1494618600","y":"2.9"},{"x":"1494618900","y":"2.9"},{"x":"1494619200","y":"2.9"} ], "color":"#03a9f4"}]},
{"id":"7","symbol": "EGLT","name": "Egalet Corp","price": 3.03,"dollarChange": 0.28,"percentChange": 10.19,"open": 2.93,"high": 3.09,"low":2.76,"volume": 942878,"avgVol": 288994.566667,"sharesShort": 5864860,"shortPercent": 22.896081,"marketCap": 97652287,"float": 25615126,"headlines":{"data":[{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Corp. :EGLT-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017","publication_date":"2017-05-12 15:24:44 +0000","summary":"Categories: Yahoo FinanceGet free summary analysis Egalet Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Egalet Corp. – Zogenix, Inc., Nektar Therapeutics, Recro Pharma, Inc., Flexion Therapeutics, Inc., Kindred Biosciences, Inc. and Trevena, Inc. (ZGNX-US, NKTR-US, REPH-US, FLXN-US, KIN-US and TRVN-US) that have also ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/12964c3e-db8f-3063-ae26-08ee770f59bf/egalet-corp-eglt-us-earnings-analysis-q1-2017-by-the-numbers-may-12-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Panel of Leading Pain Management Specialists Highlight Potential Role of Abuse-Deterrent Formulations of Opioids and Non-Narcotics to Help Curb Misuse and Abuse at Egalet Investor Day","publication_date":"2017-05-11 11:20:00 +0000","summary":"WAYNE, Pa., May 11, 2017 /PRNewswire/ -- Egalet Corporation (EGLT) (\"Egalet\"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, hosted a panel discussion as part of its investor event on May 10, 2017, featuring three leading pain management specialists. Egalet has three approved products: ARYMO® ER (morphine sulfate) extended-release tablets for oral use only –CII, developed using Egalet's proprietary Guardian™ Technology, OXAYDO® (oxycodone HCI, USP) tablets for oral use only –CII and SPRIX® (ketorolac tromethamine) Nasal Spray.","url":"http://finance.yahoo.com/news/panel-leading-pain-management-specialists-112000452.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet reports 1Q loss","publication_date":"2017-05-10 10:22:51 +0000","summary":"On a per-share basis, the Wayne, Pennsylvania-based company said it had a loss of $1.02. The pain medicine maker posted revenue of $5.4 million in the period. The company's shares closed at $2.96. A year ...","url":"http://finance.yahoo.com/news/egalet-reports-1q-loss-102251973.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Reports First Quarter 2017 Financial Results","publication_date":"2017-05-10 10:02:00 +0000","summary":"WAYNE, Pa., May 10, 2017 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) (\"Egalet\"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing ...","url":"http://finance.yahoo.com/news/egalet-reports-first-quarter-2017-100200335.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet to Report First Quarter 2017 Financial Results During Investor Day on May 10, 2017 in New York","publication_date":"2017-04-26 10:02:00 +0000","summary":"WAYNE, Pa., April 26, 2017 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) (\"Egalet\"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing ...","url":"http://finance.yahoo.com/news/egalet-report-first-quarter-2017-100200055.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Announces U.S. Food and Drug Administration Acceptance of File for Prior Approval Supplement for OXAYDO® (oxycodone HCl, USP) tablets C-II 10 mg and 15 mg Dosage Strengths","publication_date":"2017-04-18 10:23:00 +0000","summary":"WAYNE, Pa., April 18, 2017 /PRNewswire/ -- Egalet Corporation (EGLT) (\"Egalet\"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, today announced that the submission of a prior approval supplement (PAS) for OXAYDO® (oxycodone HCl, USP) tablets C-II, seeking approval of 10 mg and 15 mg dosage strengths, has been  accepted for filing by the U.S. Food and Drug Administration (FDA).  The submission is based on a pharmacokinetic study demonstrating bioequivalence (BE) of OXAYDO®  to its reference drug, Roxicodone® (oxycodone hydrochloride tablets USP) at the 15 mg dosage strength. \"With the growing need for medications that are designed to discourage abuse, Egalet is committed to providing healthcare professionals with medications in a range of clinically relevant dosage strengths to enable them to effectively manage their patients living with acute and chronic pain,\" said Jeffrey Dayno, chief medical officer at Egalet.","url":"http://finance.yahoo.com/news/egalet-announces-u-food-drug-102300651.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Corporation Announces Changes to Board of Directors","publication_date":"2017-04-10 20:02:00 +0000","summary":"WAYNE, Pa., April 10, 2017 /PRNewswire/ -- Egalet Corporation (EGLT) (\"Egalet\"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, today announced that Jean-Francois Formela, MD has resigned from Egalet's board of directors. Andrea Heslin Smiley, chief executive officer of VMS BioMarketing, will take Dr. Formela's board seat and Elaine Hochberg, former chief commercial officer for Forest Laboratories, has been added to the board.","url":"http://finance.yahoo.com/news/egalet-corporation-announces-changes-board-200200835.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet to Participate in Spring Investor Conferences","publication_date":"2017-04-03 10:02:00 +0000","summary":"[PR Newswire] - WAYNE, Penn., April 3, 2017 /PRNewswire/ -- Egalet Corporation (EGLT) (\"Egalet\"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, today announced that the company will participate in investor conferences through presentations, panels and one-on-one meetings this spring. Egalet, a fully integrated specialty pharmaceutical company, is focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions. Egalet has three approved products: ARYMO™ ER (morphine sulfate) extended-release tablets for oral use only –CII, developed using Egalet's proprietary Guardian™ Technology, OXAYDO® (oxycodone HCI, USP) tablets for oral use only –CII and SPRIX® (ketorolac tromethamine) Nasal Spray.","url":"http://finance.yahoo.com/news/egalet-participate-spring-investor-conferences-100200421.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet to Participate in Spring Investor Conferences","publication_date":"2017-04-03 10:02:00 +0000","summary":"WAYNE, Penn., April 3, 2017 /PRNewswire/ -- Egalet Corporation (EGLT) (\"Egalet\"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, today announced that the company will participate in investor conferences through presentations, panels and one-on-one meetings this spring. Egalet, a fully integrated specialty pharmaceutical company, is focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions. Egalet has three approved products: ARYMO™ ER (morphine sulfate) extended-release tablets for oral use only –CII, developed using Egalet's proprietary Guardian™ Technology, OXAYDO® (oxycodone HCI, USP) tablets for oral use only –CII and SPRIX® (ketorolac tromethamine) Nasal Spray.","url":"http://finance.yahoo.com/news/egalet-participate-spring-investor-conferences-100200421.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Deploys Salesforce to Begin Educating Healthcare Providers about ARYMO™ ER","publication_date":"2017-03-30 10:02:00 +0000","summary":"WAYNE, Pa., March 30, 2017 /PRNewswire/ -- Egalet Corporation (EGLT) (\"Egalet\"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, today announced that one of the company's specialty sales forces has begun promotion of ARYMO™ ER (morphine sulfate) extended-release tablets for oral use only –CII. Egalet executives will commemorate the product's official launch by ringing the Nasdaq Stock Market closing bell today. ARYMO ER was approved by the U.S. Food and Drug Administration (FDA) on January 9, 2017 in three dosage strengths: 15 mg, 30 mg and 60 mg, and is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.","url":"http://finance.yahoo.com/news/egalet-deploys-salesforce-begin-educating-100200091.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Deploys Salesforce to Begin Educating Healthcare Providers about ARYMO™ ER","publication_date":"2017-03-30 10:02:00 +0000","summary":"[PR Newswire] - WAYNE, Pa., March 30, 2017 /PRNewswire/ -- Egalet Corporation (EGLT) (\"Egalet\"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, today announced that one of the company's specialty sales forces has begun promotion of ARYMO™ ER (morphine sulfate) extended-release tablets for oral use only –CII. Egalet executives will commemorate the product's official launch by ringing the Nasdaq Stock Market closing bell today. ARYMO ER was approved by the U.S. Food and Drug Administration (FDA) on January 9, 2017 in three dosage strengths: 15 mg, 30 mg and 60 mg, and is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.","url":"http://finance.yahoo.com/news/egalet-deploys-salesforce-begin-educating-100200091.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"The FDA News That Put The Wind Beneath Egalet Stock's Wings","publication_date":"2017-03-29 18:35:41 +0000","summary":"The FDA News That Put The Wind Beneath Egalet Stock's Wings","url":"http://finance.yahoo.com/news/fda-news-put-wind-beneath-183541414.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"The FDA News That Put The Wind Beneath Egalet Stock's Wings","publication_date":"2017-03-29 18:35:41 +0000","summary":"Amid a raging opioid epidemic, Egalet Corp (NASDAQ: EGLT ) soared as high as 13 percent Wednesday after the U.S. Food and Drug Administration permitted it to distribute promotional material highlighting ...","url":"http://finance.yahoo.com/news/fda-news-put-wind-beneath-183541414.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Can Tout Abuse-Deterrent Opioid Painkiller","publication_date":"2017-03-29 15:25:00 +0000","summary":"Egalet Can Tout Abuse-Deterrent Opioid Painkiller","url":"http://www.investopedia.com/news/egalet-can-tout-abusedeterrent-opioid-painkiller-eglt/?partner=YahooSA"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Can Tout Abuse-Deterrent Opioid Painkiller","publication_date":"2017-03-29 15:25:00 +0000","summary":"The FDA is allowing Egalet to promote the abuse-deterrent properties of its opioid painkiller Arymo.","url":"http://finance.yahoo.com/r/06aadfbc-e3fb-3395-9607-f97513315242/egalet-can-tout-abusedeterrent-opioid-painkiller-eglt?partner=YahooSA&yptr=yahoo&.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Corporation (Nasdaq: EGLT) to Ring The Nasdaq Stock Market Closing Bell","publication_date":"2017-03-29 14:48:10 +0000","summary":"[GlobeNewswire] - What: Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, will visit the ...","url":"http://finance.yahoo.com/news/egalet-corporation-nasdaq-eglt-ring-144810227.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Corporation (Nasdaq: EGLT) to Ring The Nasdaq Stock Market Closing Bell","publication_date":"2017-03-29 14:48:10 +0000","summary":"What: Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, will visit the ...","url":"http://finance.yahoo.com/news/egalet-corporation-nasdaq-eglt-ring-144810227.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"EGALET CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2017-03-29 11:33:21 +0000","summary":"EGALET CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170329/eglt8-k.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"6:03 am Egalet: FDA does not object to Egalet's distribution of promotional materials and communications to healthcare professionals regarding the abuse-deterrent properties of ARYMO ER release tablets for oral use only -CII via the intrana","publication_date":"2017-03-29 10:03:00 +0000","summary":"6:03 am Egalet: FDA does not object to Egalet's distribution of promotional materials and communications to healthcare professionals regarding the abuse-deterrent properties of ARYMO ER release tablets for oral use only -CII via the intrana","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#eglt"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Announces U.S. Food and Drug Administration Does Not Object to Egalet's Distribution of Materials and Communications to Healthcare Professionals Regarding Abuse-Deterrent Properties of ARYMO™ ER via Intranasal Route","publication_date":"2017-03-29 10:02:00 +0000","summary":"[PR Newswire] - WAYNE, Pa., March 29, 2017 /PRNewswire/ -- Egalet Corporation (EGLT) (\"Egalet\"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, today announced the U.S. Food and Drug Administration (FDA) does not object to Egalet's distribution of promotional materials and communications to healthcare professionals regarding the abuse-deterrent properties of ARYMO™ ER (morphine sulfate) extended-release tablets for oral use only –CII via the intranasal route. The materials will be based on data, submitted to FDA as part of its original new drug application (NDA), from in vitro laboratory studies which characterized the physicochemical abuse-deterrent properties of ARYMO ER and from the Category 2/3 intranasal human abuse liability study.","url":"http://finance.yahoo.com/news/egalet-announces-u-food-drug-100200822.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Announces U.S. Food and Drug Administration Does Not Object to Egalet's Distribution of Materials and Communications to Healthcare Professionals Regarding Abuse-Deterrent Properties of ARYMO™ ER via Intranasal Route","publication_date":"2017-03-29 10:02:00 +0000","summary":"WAYNE, Pa., March 29, 2017 /PRNewswire/ -- Egalet Corporation (EGLT) (\"Egalet\"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, today announced the U.S. Food and Drug Administration (FDA) does not object to Egalet's distribution of promotional materials and communications to healthcare professionals regarding the abuse-deterrent properties of ARYMO™ ER (morphine sulfate) extended-release tablets for oral use only –CII via the intranasal route. The materials will be based on data, submitted to FDA as part of its original new drug application (NDA), from in vitro laboratory studies which characterized the physicochemical abuse-deterrent properties of ARYMO ER and from the Category 2/3 intranasal human abuse liability study.","url":"http://finance.yahoo.com/news/egalet-announces-u-food-drug-100200822.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders it Has Filed a Complaint to Recover Losses Suffered by Investors in Egalet Corporation, Sets Lead Plaintiff Deadline of March 28, 2017 - EGLT","publication_date":"2017-03-28 14:34:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / March 28, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Egalet Corporation ...","url":"http://finance.yahoo.com/news/deadline-today-levi-korsinsky-llp-143400354.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders it Has Filed a Complaint to Recover Losses Suffered by Investors in Egalet Corporation, Sets Lead Plaintiff Deadline of March 28, 2017 - EGLT","publication_date":"2017-03-28 14:34:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 28, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Egalet Corporation ...","url":"http://finance.yahoo.com/news/deadline-today-levi-korsinsky-llp-143400354.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Egalet Corporation (EGLT) & Lead Plaintiff Deadline - March 28, 2017","publication_date":"2017-03-28 14:10:00 +0000","summary":"NEW YORK, March 28, 2017-- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Egalet Corporation and certain of its officers, ...","url":"http://finance.yahoo.com/news/deadline-alert-bronstein-gewirtz-grossman-141000138.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Egalet Corporation (EGLT) & Lead Plaintiff Deadline - March 28, 2017","publication_date":"2017-03-28 14:10:00 +0000","summary":"[GlobeNewswire] - NEW YORK, March 28, 2017-- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Egalet Corporation and certain of its officers, ...","url":"http://finance.yahoo.com/news/deadline-alert-bronstein-gewirtz-grossman-141000138.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-03-25 00:50:24 +0000","summary":"[GlobeNewswire] - LOS ANGELES, March 24, 2017-- Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Egalet Corporation. Investors who purchased or otherwise acquired Egalet shares ...","url":"http://finance.yahoo.com/news/important-investor-alert-lundin-law-005024965.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-03-25 00:50:24 +0000","summary":"LOS ANGELES, March 24, 2017-- Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Egalet Corporation. Investors who purchased or otherwise acquired Egalet shares ...","url":"http://finance.yahoo.com/news/important-investor-alert-lundin-law-005024965.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Egalet Corporation - EGLT","publication_date":"2017-03-24 20:40:00 +0000","summary":"NEW YORK, March 24, 2017 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Egalet Corporation securities (NASDAQ: ...","url":"http://finance.yahoo.com/news/equity-alert-rosen-law-firm-204000296.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Egalet Corporation - EGLT","publication_date":"2017-03-24 20:40:00 +0000","summary":"[PR Newswire] - NEW YORK, March 24, 2017 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Egalet Corporation securities (NASDAQ: ...","url":"http://finance.yahoo.com/news/equity-alert-rosen-law-firm-204000296.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed a Complaint to Recover Losses Suffered by Investors in Egalet Corporation","publication_date":"2017-03-24 17:17:00 +0000","summary":"[PR Newswire] - NEW YORK, March 24, 2017 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Egalet Corporation (\"Egalet\") ...","url":"http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-171700523.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed a Complaint to Recover Losses Suffered by Investors in Egalet Corporation","publication_date":"2017-03-24 17:17:00 +0000","summary":"NEW YORK, March 24, 2017 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Egalet Corporation (\"Egalet\") ...","url":"http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-171700523.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Blog Coverage Egalet Receives New US and International Patents for Guardian(TM) Technology","publication_date":"2017-03-24 12:15:00 +0000","summary":"Upcoming AWS Coverage on ACADIA Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / March 24, 2017 / Active Wall St. blog coverage looks at the headline from Egalet Corp. (NASDAQ: EGLT ) as ...","url":"http://finance.yahoo.com/news/blog-coverage-egalet-receives-us-121500385.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Blog Coverage Egalet Receives New US and International Patents for Guardian(TM) Technology","publication_date":"2017-03-24 12:15:00 +0000","summary":"[Accesswire] - Upcoming AWS Coverage on ACADIA Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / March 24, 2017 / Active Wall St. blog coverage looks at the headline from Egalet Corp. (NASDAQ: EGLT ) as ...","url":"http://finance.yahoo.com/news/blog-coverage-egalet-receives-us-121500385.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Gets 4 New Patents for Guardian Technology","publication_date":"2017-03-23 15:05:00 +0000","summary":"Egalet secured 4 new patents in the US, Europe, Australia and Canada for its Guardian Technology.","url":"http://finance.yahoo.com/r/50d0c6af-b610-3f41-8e26-d0729b68e2b3/egalet-gets-4-patents-guardian-technology-eglt?partner=YahooSA&yptr=yahoo&.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Gets 4 New Patents for Guardian Technology","publication_date":"2017-03-23 15:05:00 +0000","summary":"Egalet Gets 4 New Patents for Guardian Technology","url":"http://www.investopedia.com/news/egalet-gets-4-patents-guardian-technology-eglt/?partner=YahooSA"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Announces Issuance of New U.S. and International Patents for Guardian™ Technology","publication_date":"2017-03-23 10:02:00 +0000","summary":"[PR Newswire] - WAYNE, Pa., March 23, 2017 /PRNewswire/ -- Egalet Corporation (EGLT) (\"Egalet\"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, today announced the issuance of new U.S. and international patents for Egalet's proprietary Guardian™ Technology. The United States Patent and Trademark Office (USPTO) has issued patent number 9,549,899 covering ARYMO™ ER (morphine sulfate) extended-release tablets for oral use only –CII developed using Egalet's proprietary Guardian Technology. European patent number 2393487 has been issued to Egalet and offers protection of products developed using Guardian Technology.","url":"http://finance.yahoo.com/news/egalet-announces-issuance-u-international-100200519.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Announces Issuance of New U.S. and International Patents for Guardian™ Technology","publication_date":"2017-03-23 10:02:00 +0000","summary":"WAYNE, Pa., March 23, 2017 /PRNewswire/ -- Egalet Corporation (EGLT) (\"Egalet\"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, today announced the issuance of new U.S. and international patents for Egalet's proprietary Guardian™ Technology. The United States Patent and Trademark Office (USPTO) has issued patent number 9,549,899 covering ARYMO™ ER (morphine sulfate) extended-release tablets for oral use only –CII developed using Egalet's proprietary Guardian Technology. European patent number 2393487 has been issued to Egalet and offers protection of products developed using Guardian Technology.","url":"http://finance.yahoo.com/news/egalet-announces-issuance-u-international-100200519.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-03-21 15:25:00 +0000","summary":"[Accesswire] - IRVINE, CA / ACCESSWIRE / March 21, 2017 / Khang & Khang LLP (the \"Firm\") announces the filing of a class action lawsuit against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/investor-notice-khang-khang-llp-152500789.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-03-21 15:25:00 +0000","summary":"IRVINE, CA / ACCESSWIRE / March 21, 2017 / Khang & Khang LLP (the \"Firm\") announces the filing of a class action lawsuit against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/investor-notice-khang-khang-llp-152500789.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"EGLT INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Egalet Corporation and a Lead Plaintiff Deadline of March 28, 2017","publication_date":"2017-03-21 14:14:24 +0000","summary":"[GlobeNewswire] - NEW YORK, March 21, 2017-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of Pennsylvania on behalf of investors who purchased ...","url":"http://finance.yahoo.com/news/eglt-investor-alert-law-offices-141424657.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"EGLT INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Egalet Corporation and a Lead Plaintiff Deadline of March 28, 2017","publication_date":"2017-03-21 14:14:24 +0000","summary":"NEW YORK, March 21, 2017-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of Pennsylvania on behalf of investors who purchased ...","url":"http://finance.yahoo.com/news/eglt-investor-alert-law-offices-141424657.html?.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Pain Therapeutics’ Remoxy ER Secures FDA Regulatory Guidance (PTIE,EGLT)","publication_date":"2017-03-21 09:17:00 +0000","summary":"Pain Therapeutics’ Remoxy ER Secures FDA Regulatory Guidance (PTIE,EGLT)","url":"http://www.investopedia.com/news/pain-therapeutics-remoxy-er-secures-fda-regulatory-guidance-ptie-eglt/?partner=YahooSA"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Pain Therapeutics’ Remoxy ER Secures FDA Regulatory Guidance (PTIE,EGLT)","publication_date":"2017-03-21 09:17:00 +0000","summary":"Following the positive update, Pain Therapeutics stock spiked by around 61% to hit $1.10 per share during after hours trading on Monday.","url":"http://finance.yahoo.com/r/dbc299bd-d2f2-33a6-b158-0842ade0f2bc/pain-therapeutics-remoxy-er-secures-fda-regulatory-guidance-ptie-eglt?partner=YahooSA&yptr=yahoo&.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Nektar Pharma Opioid Drug Shows Promise In Phase 3","publication_date":"2017-03-20 17:41:00 +0000","summary":"Nektar Therapeutics' opioid drug NKTR-181 reported positive results in a late-stage study.","url":"http://finance.yahoo.com/r/76181889-b9e5-332f-b8a7-49173a00d540/nektar-opioid-drug-does-well-study-nktr-eglt?partner=YahooSA&yptr=yahoo&.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Nektar Pharma Opioid Drug Shows Promise In Phase 3","publication_date":"2017-03-20 17:41:00 +0000","summary":"Nektar Pharma Opioid Drug Shows Promise In Phase 3","url":"http://www.investopedia.com/news/nektar-opioid-drug-does-well-study-nktr-eglt/?partner=YahooSA"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Corp. :EGLT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017","publication_date":"2017-03-20 15:33:24 +0000","summary":"Categories: Yahoo Finance Get free summary analysis Egalet Corp. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Egalet Corp. – Zogenix, Inc., Nektar Therapeutics, Elite Pharmaceuticals, Inc., Flexion Therapeutics, Inc., Kindred Biosciences, Inc. and Trevena, Inc. (ZGNX-US, NKTR-US, ELTP-US, FLXN-US, KIN-US and TRVN-US) that have also ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/d394a1cb-f408-3da3-a9e3-11816e47ba02/egalet-corp-eglt-us-earnings-analysis-q4-2016-by-the-numbers-march-20-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Corp. :EGLT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017","publication_date":"2017-03-20 15:33:24 +0000","summary":"Egalet Corp. :EGLT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017","url":"http://www.capitalcube.com/blog/index.php/egalet-corp-eglt-us-earnings-analysis-q4-2016-by-the-numbers-march-20-2017/"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Egalet Corporation (EGLT) and Lead Plaintiff Deadline - March 28, 2017","publication_date":"2017-03-20 14:11:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 20, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/deadline-alert-bronstein-gewirtz-grossman-141100694.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-03-20 14:10:00 +0000","summary":"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / March 20, 2017 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/shareholder-notice-lundin-law-pc-141000674.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Egalet Corporation of Class Action Lawsuit and Upcoming Deadline - EGLT","publication_date":"2017-03-18 00:00:00 +0000","summary":"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Egalet Corporation of Class Action Lawsuit and Upcoming Deadline - EGLT","url":"http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-000000227.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"EGALET CORP Financials","publication_date":"2017-03-17 17:04:09 +0000","summary":"EGALET CORP Financials","url":"http://finance.yahoo.com/q/is?s=eglt"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed a Complaint to Recover Losses Suffered by Investors in Egalet Corporation","publication_date":"2017-03-17 15:30:00 +0000","summary":"[GlobeNewswire] - NEW YORK, March 17, 2017-- The following statement is being issued by Levi & Korsinsky, LLP:. To: All persons or entities who purchased or otherwise acquired shares of Egalet Corporation between December ...","url":"http://finance.yahoo.com/news/investor-alert-levi-korsinsky-llp-153000344.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Corp. :EGLT-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017","publication_date":"2017-03-15 17:54:09 +0000","summary":"Egalet Corp. :EGLT-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017","url":"http://www.capitalcube.com/blog/index.php/egalet-corp-eglt-us-earnings-analysis-2016-by-the-numbers-march-15-2017/"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-03-15 15:28:00 +0000","summary":"[Accesswire] - IRVINE, CA / ACCESSWIRE / March 15, 2017 / Khang & Khang LLP (the \"Firm\") announces the filing of a class action lawsuit against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/shareholder-alert-khang-khang-llp-152800386.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"How Endo's FDA Committee Vote Affects Egalet","publication_date":"2017-03-15 14:38:55 +0000","summary":"How Endo's FDA Committee Vote Affects Egalet","url":"http://finance.yahoo.com/news/endos-fda-committee-vote-affects-143855600.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Egalet Corporation (EGLT) and Lead Plaintiff Deadline - March 28, 2017","publication_date":"2017-03-15 14:17:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 15, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-141700287.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-03-14 16:19:00 +0000","summary":"[Accesswire] - LOS ANGELES, CA/ ACCESSWIRE / March 14, 2017 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/investor-alert-lundin-law-pc-161900304.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Pawar Law Group Announces Filing of Securities Class Action Lawsuit Against Egalet Corporation - EGLT","publication_date":"2017-03-14 00:57:00 +0000","summary":"Pawar Law Group Announces Filing of Securities Class Action Lawsuit Against Egalet Corporation - EGLT","url":"http://finance.yahoo.com/news/pawar-law-group-announces-filing-005700614.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"EGALET CORP Files SEC form 10-K, Annual Report","publication_date":"2017-03-13 21:23:38 +0000","summary":"EGALET CORP Files SEC form 10-K, Annual Report","url":"http://biz.yahoo.com/e/170313/eglt10-k.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"For Egalet, Clinical Delays Outweigh Solid Q4 And Arymo Launch","publication_date":"2017-03-13 17:45:04 +0000","summary":"For Egalet, Clinical Delays Outweigh Solid Q4 And Arymo Launch","url":"http://finance.yahoo.com/news/egalet-clinical-delays-outweigh-solid-174504750.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Gets Grilled On Earnings Call By Unverified Caller","publication_date":"2017-03-13 16:26:39 +0000","summary":"Egalet Gets Grilled On Earnings Call By Unverified Caller","url":"http://finance.yahoo.com/news/egalet-gets-grilled-earnings-call-162639717.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-03-13 15:53:00 +0000","summary":"[Accesswire] - IRVINE, CA / ACCESSWIRE / March 13, 2017 / Khang & Khang LLP (the \"Firm\") announces the filing of a class action lawsuit against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/important-investor-alert-khang-khang-155300568.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed a Complaint to Recover Losses Suffered by Investors in Egalet Corporation","publication_date":"2017-03-13 14:38:00 +0000","summary":"[Business Wire] - The following statement is being issued by Levi & Korsinsky, LLP:","url":"http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-143800957.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-03-11 23:17:00 +0000","summary":"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / March 11, 2017 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/important-shareholder-alert-lundin-law-231700137.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Egalet Corporation of Class Action Lawsuit and Upcoming Deadline - EGLT","publication_date":"2017-03-11 01:05:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 10, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Egalet Corporation (\"Egalet\" or the \"Company\") (NASDAQ: EGLT) ...","url":"http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-010500168.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"EGLT ALERT: Rosen Law Firm Reminds Egalet Corporation Investors of Important Deadline in Class Action – EGLT","publication_date":"2017-03-10 20:47:15 +0000","summary":"[GlobeNewswire] - NEW YORK, March 10, 2017-- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Egalet Corporation securities from December 15, 2015 through January 9, 2017, inclusive of the important ...","url":"http://finance.yahoo.com/news/eglt-alert-rosen-law-firm-204715754.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"And the winner is? Who took home life sciences industry awards last night","publication_date":"2017-03-10 18:20:09 +0000","summary":"And the winner is? Who took home life sciences industry awards last night","url":"http://www.bizjournals.com/philadelphia/news/2017/03/10/and-the-winner-is-who-took-home-life-sciences.html?ana=yahoo"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-03-10 15:50:00 +0000","summary":"[Accesswire] - IRVINE, CA / ACCESSWIRE / March 10, 2017 / Khang & Khang LLP (the \"Firm\") announces the filing of a class action lawsuit against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/important-shareholder-alert-khang-khang-155000591.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Egalet Corporation (EGLT) and Lead Plaintiff Deadline: March 28, 2017","publication_date":"2017-03-09 15:02:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 9, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-150200725.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"EGALET CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits","publication_date":"2017-03-09 12:32:26 +0000","summary":"EGALET CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170309/eglt8-k.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Q4 2016 Egalet Corp Earnings Release - Before Market Open","publication_date":"2017-03-09 12:07:02 +0000","summary":"Q4 2016 Egalet Corp Earnings Release - Before Market Open","url":"http://biz.yahoo.com/research/earncal/20170309.html?t=eglt"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet reports 4Q loss","publication_date":"2017-03-09 11:16:29 +0000","summary":"Egalet reports 4Q loss","url":"http://sg.finance.yahoo.com/news/egalet-reports-4q-loss-111629057.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet Reports Fourth Quarter and Full Year 2016 Financial Results","publication_date":"2017-03-09 11:02:00 +0000","summary":"[PR Newswire] - WAYNE, Pa., March 9, 2017 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) (\"Egalet\"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing ...","url":"http://finance.yahoo.com/news/egalet-reports-fourth-quarter-full-110200574.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-03-08 16:57:00 +0000","summary":"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / March 8, 2017 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/important-investor-alert-lundin-law-165700439.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"EGLT SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Egalet Corporation and a Lead Plaintiff Deadline of March 28, 2017","publication_date":"2017-03-08 15:34:00 +0000","summary":"[Business Wire] - The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of Pennsylvania on behalf of investors who purchased Egalet Corporation securities between December 15, 2015 and January 9, 2017.","url":"http://finance.yahoo.com/news/eglt-shareholder-alert-law-offices-153400269.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet to Present at Several Upcoming Scientific Conferences","publication_date":"2017-03-07 11:03:00 +0000","summary":"[PR Newswire] - WAYNE, Pa., March 7, 2017 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) (\"Egalet\"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing ...","url":"http://finance.yahoo.com/news/egalet-present-several-upcoming-scientific-110300235.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"EGALET CORP Files SEC form 8-K, Entry into a Material Definitive Agreement","publication_date":"2017-03-06 21:20:09 +0000","summary":"EGALET CORP Files SEC form 8-K, Entry into a Material Definitive Agreement","url":"http://biz.yahoo.com/e/170306/eglt8-k.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-03-06 16:57:00 +0000","summary":"[Accesswire] - IRVINE, CA / ACCESSWIRE / March 6, 2017 / Khang & Khang LLP (the \"Firm\") announces the filing of a class action lawsuit against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/important-investor-alert-khang-khang-165700982.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Egalet Corporation of Class Action Lawsuit and Upcoming Deadline – EGLT","publication_date":"2017-03-04 01:15:00 +0000","summary":"[GlobeNewswire] - NEW YORK, March 03, 2017-- Pomerantz LLP announces that a class action lawsuit has been filed against Egalet Corporation and certain of its officers. The class action, filed in United States District Court, ...","url":"http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-011500366.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"EGLT INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Egalet Corporation and a Lead Plaintiff Deadline of March 28, 2017","publication_date":"2017-03-03 17:00:00 +0000","summary":"[PR Newswire] - NEW YORK, March 3, 2017 /PRNewswire/ -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of Pennsylvania on behalf of investors ...","url":"http://finance.yahoo.com/news/eglt-investor-alert-law-offices-170000806.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Egalet Corporation To Contact The Firm","publication_date":"2017-03-03 14:00:00 +0000","summary":"[Business Wire] - The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf of purchasers of Egalet Corporation securities during the period between December 15, 2015 and January 9, 2017, inclusive .","url":"http://finance.yahoo.com/news/deadline-alert-brower-piven-alerts-140000047.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-02-28 19:30:00 +0000","summary":"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / February 28, 2017 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/important-shareholder-alert-lundin-law-193000828.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Egalet Corporation (EGLT) and Lead Plaintiff Deadline: March 28, 2017","publication_date":"2017-02-28 15:18:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / February 28, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-151800797.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-02-27 17:03:00 +0000","summary":"[Accesswire] - IRVINE, CA / ACCESSWIRE / February 27, 2017 / Khang & Khang LLP (the \"Firm\") announces the filing of a class action lawsuit against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/important-shareholder-alert-khang-khang-170300796.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed a Complaint to Recover Losses Suffered by Investors in Egalet Corporation","publication_date":"2017-02-27 16:39:00 +0000","summary":"[Business Wire] - The following statement is being issued by Levi & Korsinsky, LLP:","url":"http://finance.yahoo.com/news/investor-alert-levi-korsinsky-llp-163900375.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-02-25 01:02:00 +0000","summary":"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / February 24, 2017 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/important-investor-alert-lundin-law-010200254.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Egalet Corporation of Class Action Lawsuit and Upcoming Deadline - EGLT","publication_date":"2017-02-25 00:45:00 +0000","summary":"[PR Newswire] - NEW YORK, Feb. 24, 2017 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Egalet Corporation (\"Egalet\" or the \"Company\") (NASDAQ: EGLT) and ...","url":"http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-004500732.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"Egalet to Host Conference Call and Webcast to Discuss Fourth Quarter and Year-End 2016 Financial Results on March 9, 2017","publication_date":"2017-02-23 11:02:00 +0000","summary":"[PR Newswire] - WAYNE, Pa., Feb. 23, 2017 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) (\"Egalet\"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing ...","url":"http://finance.yahoo.com/news/egalet-host-conference-call-webcast-110200221.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-02-22 22:59:00 +0000","summary":"[Accesswire] - IRVINE, CA / ACCESSWIRE / February 22, 2017 / Khang & Khang LLP (the \"Firm\") announces the filing of a class action lawsuit against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/important-investor-alert-khang-khang-225900603.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"EGLT SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Egalet Corporation and a Lead Plaintiff Deadline of March 28, 2017","publication_date":"2017-02-22 16:05:00 +0000","summary":"[Business Wire] - The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of Pennsylvania on behalf of investors who purchased Egalet Corporation securities between December 15, 2015 and January 9, 2017.","url":"http://finance.yahoo.com/news/eglt-shareholder-alert-law-offices-160500725.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-02-22 03:12:00 +0000","summary":"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / February 21, 2017 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/important-shareholder-alert-lundin-law-031200831.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Egalet Corporation (EGLT) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit","publication_date":"2017-02-21 19:26:44 +0000","summary":"[GlobeNewswire] - STEVENSON, Md., Feb. 21, 2017-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ...","url":"http://finance.yahoo.com/news/shareholder-alert-brower-piven-encourages-192644996.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-02-20 23:25:00 +0000","summary":"[Accesswire] - IRVINE, CA / ACCESSWIRE / February 20, 2017 / Khang & Khang LLP (the \"Firm\") announces the filing of a class action lawsuit against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/important-equity-alert-khang-khang-232500564.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Egalet Corporation – EGLT","publication_date":"2017-02-20 20:56:48 +0000","summary":"[GlobeNewswire] - NEW YORK, Feb. 20, 2017-- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Egalet Corporation securities from December 15, 2015 ...","url":"http://finance.yahoo.com/news/equity-alert-rosen-law-firm-205648836.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"EQUITY ALERT: Lundin Law PC Announces an Investigation of Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-02-20 15:39:00 +0000","summary":"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / February 20, 2017 / Lundin Law PC , a shareholder rights firm, announces that it is investigating claims against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/equity-alert-lundin-law-pc-153900151.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Egalet Corporation (EGLT) & Lead Plaintiff Deadline: March 28, 2017","publication_date":"2017-02-20 15:10:00 +0000","summary":"[GlobeNewswire] - NEW YORK, Feb. 20, 2017-- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Egalet Corporation and certain of its officers, ...","url":"http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-151000738.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-02-17 17:07:00 +0000","summary":"[Accesswire] - IRVINE, CA / ACCESSWIRE / February 17, 2017 / Khang & Khang LLP (the \"Firm\") announces the filing of a class action lawsuit against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/important-investor-alert-khang-khang-170700233.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"EGLT INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Egalet Corporation and a Lead Plaintiff Deadline of March 28, 2017","publication_date":"2017-02-17 16:38:00 +0000","summary":"[GlobeNewswire] - NEW YORK, Feb. 17, 2017-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of Pennsylvania on behalf of investors who purchased ...","url":"http://finance.yahoo.com/news/eglt-investor-alert-law-offices-163800297.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"INVESTOR ALERT: Lundin Law PC Announces an Investigation of Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-02-17 16:27:00 +0000","summary":"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / February 17, 2017 / Lundin Law PC , a shareholder rights firm, announces that it is investigating claims against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/investor-alert-lundin-law-pc-162700125.html"},{"ticker":"EGLT","figi_ticker":"EGLT:US","figi":"BBG005F2K9T4","title":"IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-02-15 15:43:00 +0000","summary":"[Accesswire] - IRVINE, CA / ACCESSWIRE / February 15, 2017 / Khang & Khang LLP (the \"Firm\") announces the filing of a class action lawsuit against Egalet Corporation (\"Egalet\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/important-equity-alert-khang-khang-154300569.html"}],"result_count":269,"page_size":100,"current_page":1,"total_pages":3,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"2.8901"},{"x":"1494596100","y":"2.84"},{"x":"1494596400","y":"2.89"},{"x":"1494596700","y":"2.9"},{"x":"1494597000","y":"2.9"},{"x":"1494597300","y":"2.95"},{"x":"1494597600","y":"2.9699999999999998"},{"x":"1494597900","y":"2.92"},{"x":"1494598200","y":"2.91"},{"x":"1494598500","y":"2.96"},{"x":"1494598800","y":"2.96"},{"x":"1494599100","y":"2.935"},{"x":"1494599400","y":"2.9299"},{"x":"1494599700","y":"2.93"},{"x":"1494600000","y":"2.89"},{"x":"1494600300","y":"2.91"},{"x":"1494600600","y":"2.94"},{"x":"1494600900","y":"2.9"},{"x":"1494601200","y":"2.95"},{"x":"1494601500","y":"2.9699999999999998"},{"x":"1494601800","y":"2.95"},{"x":"1494602100","y":"2.94"},{"x":"1494602400","y":"2.9251"},{"x":"1494602700","y":"2.91"},{"x":"1494603000","y":"2.91"},{"x":"1494603300","y":"2.9699"},{"x":"1494603600","y":"2.95"},{"x":"1494604200","y":"2.95"},{"x":"1494604500","y":"2.98"},{"x":"1494604800","y":"2.98"},{"x":"1494605100","y":"2.98"},{"x":"1494605400","y":"2.98"},{"x":"1494605700","y":"2.98"},{"x":"1494606000","y":"2.98"},{"x":"1494606300","y":"2.98"},{"x":"1494606600","y":"2.98"},{"x":"1494606900","y":"2.98"},{"x":"1494607200","y":"2.98"},{"x":"1494607500","y":"2.98"},{"x":"1494607800","y":"2.98"},{"x":"1494608100","y":"2.98"},{"x":"1494608400","y":"2.98"},{"x":"1494608700","y":"2.98"},{"x":"1494609000","y":"2.98"},{"x":"1494609300","y":"2.9699999999999998"},{"x":"1494609600","y":"2.9699999999999998"},{"x":"1494609900","y":"2.98"},{"x":"1494610200","y":"2.98"},{"x":"1494610500","y":"2.9699999999999998"},{"x":"1494610800","y":"2.98"},{"x":"1494611100","y":"2.98"},{"x":"1494611400","y":"2.99"},{"x":"1494611700","y":"2.9895"},{"x":"1494612000","y":"2.9899"},{"x":"1494612300","y":"2.99"},{"x":"1494612600","y":"3.02"},{"x":"1494612900","y":"3.07"},{"x":"1494613200","y":"3.07"},{"x":"1494613500","y":"3.0708"},{"x":"1494613800","y":"3.05"},{"x":"1494614100","y":"3.0402"},{"x":"1494614400","y":"3.08"},{"x":"1494614700","y":"3.04"},{"x":"1494615000","y":"3.0401"},{"x":"1494615300","y":"3.02"},{"x":"1494615600","y":"3.04"},{"x":"1494615900","y":"3.05"},{"x":"1494616200","y":"3.04"},{"x":"1494616500","y":"3.02"},{"x":"1494616800","y":"3.04"},{"x":"1494617100","y":"3.04"},{"x":"1494617400","y":"3.09"},{"x":"1494617700","y":"3.08"},{"x":"1494618000","y":"3"},{"x":"1494618300","y":"3.04"},{"x":"1494618600","y":"3.04"},{"x":"1494618900","y":"3.035"},{"x":"1494619200","y":"3.03"} ], "color":"#03a9f4"}]},
{"id":"8","symbol": "FOLD","name": "Amicus Therapeutics Inc","price": 7.35,"dollarChange": 0.48,"percentChange": 6.99,"open": 6.85,"high": 7.36,"low":6.8100000000000005,"volume": 1732078,"avgVol": 2558237.300000,"sharesShort": 36967851,"shortPercent": 26.213161,"marketCap": 1096251156,"float": 141027825,"headlines":{"data":[{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Edited Transcript of FOLD earnings conference call or presentation 9-May-17 12:30pm GMT","publication_date":"2017-05-10 12:36:03 +0000","summary":"Q1 2017 Amicus Therapeutics Inc Earnings Call","url":"http://finance.yahoo.com/news/edited-transcript-fold-earnings-conference-182145276.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics to Present at Two Upcoming Investor Conferences","publication_date":"2017-05-10 11:30:00 +0000","summary":"CRANBURY, N.J., May 10, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of rare and orphan diseases, today announced that Chip Baird, Chief Financial Officer, will present at ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-present-two-upcoming-113000677.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"ETFs with exposure to Amicus Therapeutics, Inc. : May 9, 2017","publication_date":"2017-05-09 20:37:23 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Amicus Therapeutics, Inc. Here are 5 ETFs with the largest exposure to FOLD-US. Comparing the performance and risk of Amicus Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/d50f1b0e-256e-3940-ac2b-0ae259793a54/etfs-with-exposure-to-amicus-therapeutics-inc-may-9-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics reports 1Q loss","publication_date":"2017-05-09 12:57:27 +0000","summary":"On a per-share basis, the Cranbury, New Jersey-based company said it had a loss of 39 cents. The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-reports-1q-loss-125727729.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Investor Network: Amicus Therapeutics, Inc. to Host Earnings Call","publication_date":"2017-05-09 12:15:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / May 9, 2017 / Amicus Therapeutics, Inc. (NASDAQ: FOLD ) will be discussing their earnings results in their Q1 Earnings Call to be held May 9, 2017 at 8:30 AM Eastern Time. To ...","url":"http://finance.yahoo.com/news/investor-network-amicus-therapeutics-inc-121500946.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Announces First Quarter 2017 Financial Results and Corporate Updates","publication_date":"2017-05-09 11:30:00 +0000","summary":"100+ Fabry Disease Patients Now on Reimbursed Galafold in the EU. On Target to Reach 300 Patients on Galafold by Year-End 2017. Additional Important Phase 1/ 2 Pompe Clinical Data Expected in 2 Q17 and ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-announces-first-quarter-113000383.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics, Inc. – Value Analysis (NASDAQ:FOLD) : May 8, 2017","publication_date":"2017-05-08 21:53:05 +0000","summary":"Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Amicus Therapeutics, Inc. a score of 13. Our analysis is based on comparing Amicus Therapeutics, Inc. with the following peers – Protalix Biotherapeutics, Inc., Biogen Inc., BioMarin Pharmaceutical Inc., Esperion Therapeutics, Inc., GlaxoSmithKline plc Sponsored ADR, Shire PLC Sponsored ADR, Novo Nordisk A/S Sponsored ADR Class B ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/f42f1075-1993-3f50-957a-6f6a3ec23e16/amicus-therapeutics-inc-value-analysis-nasdaqfold-may-8-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : FOLD-US : May 5, 2017","publication_date":"2017-05-05 12:56:51 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Amicus Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/90bdeac3-1cf2-35d9-be70-f7e7b8870869/amicus-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-fold-us-may-5-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics to Announce First Quarter 2017 Financial Results on May 9, 2017","publication_date":"2017-05-02 20:01:00 +0000","summary":"CRANBURY, N.J., May 02, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of rare and orphan diseases, today announced a conference call and live audio webcast on Tuesday, May ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-announce-first-quarter-200100631.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Launches Galafold™ (Migalastat) for Treatment of Fabry Disease in France","publication_date":"2017-05-02 11:30:00 +0000","summary":"CRANBURY, N.J. and PARIS, May 02, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of rare and orphan diseases, has commenced the commercial launch of the precision medicine ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-launches-galafold-migalastat-113000983.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"InPlay from Briefing.com","publication_date":"2017-04-28 16:55:57 +0000","summary":"InPlay from Briefing.com","url":"http://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Honors Fabry Disease Awareness Month and International Pompe Day","publication_date":"2017-04-06 12:15:00 +0000","summary":"CRANBURY, N.J., April 06, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of rare and orphan diseases, is supporting several activities during Fabry Disease Awareness Month ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-honors-fabry-disease-121500438.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2017-04-03 12:01:51 +0000","summary":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170403/fold8-k.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study","publication_date":"2017-04-03 11:30:00 +0000","summary":"Target Exceeded with More than 160 Patients Enrolled. Top-Line Data on Track for 3 Q17. CRANBURY, N.J., April 03, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-completes-enrollment-essence-113000514.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study","publication_date":"2017-04-03 11:30:00 +0000","summary":"[GlobeNewswire] - Target Exceeded with More than 160 Patients Enrolled. Top-Line Data on Track for 3 Q17. CRANBURY, N.J., April 03, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-completes-enrollment-essence-113000514.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"After Hours Most Active for Mar 20, 2017 : LYG, BAC, GM, MTG, MPC, HPQ, INTC, AAPL, CSCO, FOLD, MSFT, ARRY","publication_date":"2017-03-20 20:56:16 +0000","summary":"The NASDAQ 100 After Hours Indicator is down 25 to 5 413 06 The total After hours volume is currently 34 505 353 shares traded The following are the most active stocks for the after hours session Lloyds Banking Group Plc LYG is 0 01 at 3 49 with 10 780 719","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oh9nw22e0l4/after-hours-most-active-for-mar-20-2017-lyg-bac-gm-mtg-mpc-hpq-intc-aapl-csco-fold-msft-arry-cm763155"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Today's Research Reports on Biotech Stocks to Watch: Amicus Therapeutics and Sarepta Therapeutics","publication_date":"2017-03-17 13:30:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / March 17, 2017 / There has been significant interest in both companies by investment rating firms and individual investors over the past quarter. The interest is not necessarily ...","url":"http://finance.yahoo.com/news/todays-research-reports-biotech-stocks-133000563.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Today's Research Reports on Biotech Stocks to Watch: Amicus Therapeutics and Sarepta Therapeutics","publication_date":"2017-03-17 13:30:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 17, 2017 / There has been significant interest in both companies by investment rating firms and individual investors over the past quarter. The interest is not necessarily ...","url":"http://finance.yahoo.com/news/todays-research-reports-biotech-stocks-133000563.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Are These 2 Biotechs Diamonds in the Rough?","publication_date":"2017-03-16 14:41:00 +0000","summary":"Are These 2 Biotechs Diamonds in the Rough?","url":"https://www.fool.com/investing/2017/03/16/are-these-2-biotechs-diamonds-in-the-rough.aspx"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Are These 2 Biotechs Diamonds in the Rough?","publication_date":"2017-03-16 14:41:00 +0000","summary":"Do Adamas Pharmaceuticals and Amicus Therapeutics have the potential to power your portfolio higher?","url":"http://finance.yahoo.com/r/cd208925-e80f-3f8b-89ac-95dc717bd515/are-these-2-biotechs-diamonds-in-the-rough.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Perceptive Advisors Llc Buys Neurocrine Biosciences, Aclaris Therapeutics, Galapagos NV, Sells ...","publication_date":"2017-03-11 00:11:24 +0000","summary":"Perceptive Advisors Llc New Purchases GLPG AVDL ACOR IRTC CTMX BCRX ATRS JAZZ ALNY PPHMP Added Positions NBIX ACRS FOLD ANIP AVXS GBT ARDX VBIV ZGNX XNCR Reduced Positions SRPT AERI CRBP ABMD SUPN AGEN BPMC NDRM AGTC","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EnI2WYygFWA/perceptive-advisors-llc-buys-neurocrine-biosciences-aclaris-therapeutics-galapagos-nv-sells-cm759336"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"4:04 pm Amicus Therapeutics commences the commercial launch of the precision medicine Galafold in Italy following the final publication of reimbursement guidelines by the Ministry of Health","publication_date":"2017-03-08 21:04:00 +0000","summary":"4:04 pm Amicus Therapeutics commences the commercial launch of the precision medicine Galafold in Italy following the final publication of reimbursement guidelines by the Ministry of Health","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#fold"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Launches Galafold™ (Migalastat) for Treatment of Fabry Disease in Italy","publication_date":"2017-03-08 21:01:00 +0000","summary":"CRANBURY, N.J. and MILAN, Italy, March 08, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of rare and orphan diseases, has commenced the commercial launch of the precision ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-launches-galafold-migalastat-210100794.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Launches Galafold™ (Migalastat) for Treatment of Fabry Disease in Italy","publication_date":"2017-03-08 21:01:00 +0000","summary":"[GlobeNewswire] - CRANBURY, N.J. and MILAN, Italy, March 08, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of rare and orphan diseases, has commenced the commercial launch of the precision ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-launches-galafold-migalastat-210100794.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2017-03-08 12:47:27 +0000","summary":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170308/fold8-k.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Harry Boxer’s six biotechnology stocks to watch","publication_date":"2017-03-07 18:55:50 +0000","summary":"Harry Boxer’s six biotechnology stocks to watch","url":"http://www.marketwatch.com/News/Story/Story.aspx?guid=30E80700-0362-11E7-918D-62B4A59FE2AC&siteid=yhoof2"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Harry Boxer’s six biotechnology stocks to watch","publication_date":"2017-03-07 18:55:50 +0000","summary":"TG Therapeutics, Concert Pharmaceuticals, Kite Pharma and three other companies soared as much as 90%.","url":"http://finance.yahoo.com/r/c1390f09-319b-30ce-9657-4111d62738db/Story.aspx?guid=30E80700-0362-11E7-918D-62B4A59FE2AC&siteid=yhoof2&yptr=yahoo&.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"AMICUS THERAPEUTICS INC Financials","publication_date":"2017-03-07 18:04:14 +0000","summary":"AMICUS THERAPEUTICS INC Financials","url":"http://finance.yahoo.com/q/is?s=fold"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Four biotech stocks surging on optimism about drug trials, product launches","publication_date":"2017-03-03 14:09:44 +0000","summary":"Harry Boxer highlights bluebird bio, Amicus Therapeutics, Kite Pharma and NeuroDerm.","url":"http://finance.yahoo.com/r/6afbc72a-eb16-3e86-a3ee-a58bf2516d97/Story.aspx?guid=9F140324-FF74-11E6-AB63-2E992CB9A6D8&siteid=yhoof2&yptr=yahoo&.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Four biotech stocks surging on optimism about drug trials, product launches","publication_date":"2017-03-03 14:09:44 +0000","summary":"Four biotech stocks surging on optimism about drug trials, product launches","url":"http://www.marketwatch.com/News/Story/Story.aspx?guid=9F140324-FF74-11E6-AB63-2E992CB9A6D8&siteid=yhoof2"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Biotechs Breaking Out On Drug Development News","publication_date":"2017-03-02 20:34:00 +0000","summary":"Biotechs Breaking Out On Drug Development News","url":"http://www.forbes.com/sites/greatspeculations/2017/03/02/biotechs-breaking-out-on-drug-development-news/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Biotechs Breaking Out On Drug Development News","publication_date":"2017-03-02 20:34:00 +0000","summary":"Here are four biotech stocks breaking out on positive developments related to their drugs.","url":"http://finance.yahoo.com/r/cb14183c-b47f-3fb0-a3a9-6e66ac835dd4/biotechs-breaking-out-on-drug-development-news?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"4 Biotech Stocks Breaking Out On Positive Drug Developments","publication_date":"2017-03-02 18:47:47 +0000","summary":"Here are four biotech stocks breaking out on positive developments related to their drugs. bluebird bio, Inc. ( BLUE ) has popped about 20 points in a week to Wednesday's close of $92.80.  On Wednesday alone, it rose $5.15 on over 1 million shares traded, closing just a dime off the high. The company announced","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hwjOnrl12Hc/4-biotech-stocks-breaking-out-on-positive-drug-developments-cm755572"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics, Inc. (FOLD) Could Be The Force That Brings Change To The FDA","publication_date":"2017-03-02 18:15:06 +0000","summary":"Amicus Therapeutics, Inc. (FOLD) Could Be The Force That Brings Change To The FDA","url":"http://www.insidermonkey.com/blog/amicus-therapeutics-inc-fold-could-be-the-force-that-brings-change-to-the-fda-563277/"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics, Inc. (FOLD) Could Be The Force That Brings Change To The FDA","publication_date":"2017-03-02 18:15:06 +0000","summary":"President Donald Trump in his inaugural speech to a joint session of Congress characterized the approval process of drugs at the U.S. Food and Drug Administration as burdensome and slow. Trump used the example of the now 20-year-old Megan Crowley who was diagnosed with a rare disease known as Pompe Disease at the age of […]","url":"http://finance.yahoo.com/r/68f16602-4b94-3367-af7d-c94129875cba/amicus-therapeutics-inc-fold-could-be-the-force-that-brings-change-to-the-fda-563277?yptr=yahoo&.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Dow Soars Above 21,000 for the First Time in History: Today's Reports on Clean Energy Fuels and Amicus Therapeutics","publication_date":"2017-03-02 14:30:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / March 2, 2017 / U.S. markets skyrocketed to record highs Wednesday as President Trump's speech to Congress provided an optimistic view for the U.S. economy and as Federal Reserve ...","url":"http://finance.yahoo.com/news/dow-soars-above-21-000-143000059.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Dow Soars Above 21,000 for the First Time in History: Today's Reports on Clean Energy Fuels and Amicus Therapeutics","publication_date":"2017-03-02 14:30:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 2, 2017 / U.S. markets skyrocketed to record highs Wednesday as President Trump's speech to Congress provided an optimistic view for the U.S. economy and as Federal Reserve ...","url":"http://finance.yahoo.com/news/dow-soars-above-21-000-143000059.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics to Present at Upcoming Investor Conferences","publication_date":"2017-03-02 12:30:00 +0000","summary":"CRANBURY, N.J., March 02, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced that management will present at two upcoming ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-present-upcoming-investor-123000473.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics to Present at Upcoming Investor Conferences","publication_date":"2017-03-02 12:30:00 +0000","summary":"[GlobeNewswire] - CRANBURY, N.J., March 02, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced that management will present at two upcoming ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-present-upcoming-investor-123000473.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Edited Transcript of FOLD earnings conference call or presentation 1-Mar-17 1:30pm GMT","publication_date":"2017-03-02 04:22:28 +0000","summary":"Edited Transcript of FOLD earnings conference call or presentation 1-Mar-17 1:30pm GMT","url":"http://finance.yahoo.com/news/edited-transcript-fold-earnings-conference-042228106.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Edited Transcript of FOLD earnings conference call or presentation 1-Mar-17 1:30pm GMT","publication_date":"2017-03-02 04:22:28 +0000","summary":"Q4 2016 Amicus Therapeutics Inc Earnings Call","url":"http://finance.yahoo.com/news/edited-transcript-fold-earnings-conference-042228106.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Pompe drug lauded by Trump costs $300,000 a year","publication_date":"2017-03-01 23:43:34 +0000","summary":"[Reuters] - President Donald Trump told Congress on Tuesday that more needs to be done to bring down \"artificially high\" prices for prescription drugs, while at the same time praising a drug that turns out to cost $300,000 per year. During the televised address, Trump acknowledged in the audience Megan Crowley, a college student who has Pompe disease - a rare muscle disorder that can be treated with an expensive enzyme replacement therapy. \"But our slow and burdensome approval process at the Food and Drug Administration keeps too many advances, like the one that saved Megan's life, from reaching those in need,\" the president said.","url":"http://finance.yahoo.com/news/pompe-drug-lauded-trump-costs-234334222.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Why Amicus Therapeutics, Inc. Jumped Higher Today","publication_date":"2017-03-01 23:13:31 +0000","summary":"What happened Amicus Therapeutics NASDAQ FOLD ended the day up 17 after the company s CEO John Crowley and his daughter Megan who has Pompe disease were highlighted during President Donald Trump s address to Congress last night The biotech also announced fourth","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y0cyuxoKu44/why-amicus-therapeutics-inc-jumped-higher-today-cm755094"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Trump's latest comments are 'constructive' for drug industry: Amicus Therapeutics CEO","publication_date":"2017-03-01 22:51:14 +0000","summary":"Amicus Therapeutics CEO Crowley is optimistic about Trump's plans to work with the pharma industry, proposing change for good.","url":"http://finance.yahoo.com/news/trumps-latest-comments-constructive-drug-225114019.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Trump's latest comments are 'constructive' for drug industry: Amicus Therapeutics CEO","publication_date":"2017-03-01 22:51:14 +0000","summary":"Trump's latest comments are 'constructive' for drug industry: Amicus Therapeutics CEO","url":"http://www.cnbc.com/id/104313935?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104313935"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Gainers & Losers Of Mar.1: DVAX, SKLN, FOLD, IPXL, QASM...","publication_date":"2017-03-01 22:30:00 +0000","summary":"Gainers & Losers Of Mar.1: DVAX, SKLN, FOLD, IPXL, QASM...","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y9kCsjH6u6c/gainers--losers-of-mar1-dvax-skln-fold-ipxl-qasm-20170301-01997"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics CEO: Trump constructive for our indus...","publication_date":"2017-03-01 21:52:00 +0000","summary":"John Crowley, Amicus Therapeutics CEO, discusses the slowdown of the company's Galafold launch, FDA regulation and outlook under President Trump.","url":"http://finance.yahoo.com/video/amicus-therapeutics-ceo-trump-constructive-215200604.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics CEO: Trump constructive for our indus...","publication_date":"2017-03-01 21:52:00 +0000","summary":"Amicus Therapeutics CEO: Trump constructive for our indus...","url":"http://finance.yahoo.com/video/amicus-therapeutics-ceo-trump-constructive-215200604.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Why Amicus Therapeutics, Inc. Jumped Higher Today","publication_date":"2017-03-01 21:50:00 +0000","summary":"The biotech could benefit from a softer FDA.","url":"http://finance.yahoo.com/r/dd530139-c059-3d49-a04c-3d8a8fa99a56/why-amicus-therapeutics-inc-jumped-higher-today.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Why Amicus Therapeutics, Inc. Jumped Higher Today","publication_date":"2017-03-01 21:50:00 +0000","summary":"Why Amicus Therapeutics, Inc. Jumped Higher Today","url":"http://www.fool.com/investing/2017/03/01/why-amicus-therapeutics-inc-jumped-higher-today.aspx"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Bullish Two Hundred Day Moving Average Cross - FOLD","publication_date":"2017-03-01 18:12:46 +0000","summary":"In trading on Wednesday shares of Amicus Therapeutics Inc Symbol FOLD crossed above their 200 day moving average of 6 56 changing hands as high as 7 49 per share Amicus Therapeutics Inc shares are currently trading up about 10 8 on the day The chart below shows the one year performance","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/09HsslhTuWs/bullish-two-hundred-day-moving-average-cross-fold-cm754938"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"4 Biopharma Stocks Moving the Market on Wednesday","publication_date":"2017-03-01 16:35:58 +0000","summary":"These are some of the biggest biopharma stocks moving on Wednesday, as markets have hit new intraday highs, continuing to climb in the wake of the White House announcements.","url":"http://finance.yahoo.com/news/4-biopharma-stocks-moving-market-163558646.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"4 Biopharma Stocks Moving the Market on Wednesday","publication_date":"2017-03-01 16:35:58 +0000","summary":"4 Biopharma Stocks Moving the Market on Wednesday","url":"http://finance.yahoo.com/news/4-biopharma-stocks-moving-market-163558646.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Trump wants to upend the 'slow and burdensome' drug approval process at the FDA — here's what the agency actually does","publication_date":"2017-03-01 15:38:31 +0000","summary":"Trump wants to upend the 'slow and burdensome' drug approval process at the FDA — here's what the agency actually does","url":"http://finance.yahoo.com/news/trump-wants-upend-slow-burdensome-153831678.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E","publication_date":"2017-03-01 14:16:44 +0000","summary":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E","url":"http://biz.yahoo.com/e/170301/fold8-k.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus CEO John Crowley, Not His Daughter Megan, Might Compel Trump to Make Big Changes at FDA","publication_date":"2017-03-01 13:12:00 +0000","summary":"Absent specific policy details, Trump's speech leaves investors guessing about his real plans for the FDA and the drug approval process. He has not yet named an FDA commissioner.","url":"http://finance.yahoo.com/r/34404a38-6985-36a5-a855-554b4ed74957/amicus-ceo-john-crowley-not-his-daughter-megan-might-compel-trump-to-make-big-changes-at-fda.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus CEO John Crowley, Not His Daughter Megan, Might Compel Trump to Make Big Changes at FDA","publication_date":"2017-03-01 13:12:00 +0000","summary":"Amicus CEO John Crowley, Not His Daughter Megan, Might Compel Trump to Make Big Changes at FDA","url":"https://www.thestreet.com/story/14021048/1/amicus-ceo-john-crowley-not-his-daughter-megan-might-compel-trump-to-make-big-changes-at-fda.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Q4 2016 Amicus Therapeutics Inc Earnings Release - Before Market Open","publication_date":"2017-03-01 12:07:03 +0000","summary":"Q4 2016 Amicus Therapeutics Inc Earnings Release - Before Market Open","url":"http://biz.yahoo.com/research/earncal/20170301.html?t=fold"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Announces Full-Year 2016 Financial Results and Corporate Updates","publication_date":"2017-03-01 12:00:00 +0000","summary":"[GlobeNewswire] - Growing Momentum for EU Galafold Launch for Fabry Disease Tracking Toward 300 Patients by Year-End 2017. Target Enrollment Achieved in Phase 1/ 2 Pompe Study– Additional Data Expected in 2 Q17 and 3 Q17. ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-announces-full-2016-120000170.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Announces Full-Year 2016 Financial Results and Corporate Updates","publication_date":"2017-03-01 12:00:00 +0000","summary":"Growing Momentum for EU Galafold Launch for Fabry Disease Tracking Toward 300 Patients by Year-End 2017. Target Enrollment Achieved in Phase 1/ 2 Pompe Study– Additional Data Expected in 2 Q17 and 3 Q17. ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-announces-full-2016-120000170.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Launches Galafold in UK","publication_date":"2017-02-28 14:55:00 +0000","summary":"Amicus rolled out its Fabry disease drug Galafold in the UK.","url":"http://finance.yahoo.com/r/ef9c2d3b-cdc3-3ee3-9cd4-f6f0914c159a/amicus-therapeutics-launches-galafold-uk-fold?partner=YahooSA&yptr=yahoo&.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Launches Galafold in UK","publication_date":"2017-02-28 14:55:00 +0000","summary":"Amicus Therapeutics Launches Galafold in UK","url":"http://www.investopedia.com/news/amicus-therapeutics-launches-galafold-uk-fold/?partner=YahooSA"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Launches Galafold™ (Migalastat) for Treatment of Fabry Disease in the United Kingdom","publication_date":"2017-02-27 13:00:00 +0000","summary":"National Institute for Health and Care Excellence Publishes Final Guidance Covering Reimbursement of Galafold for Fabry Disease. CRANBURY, N.J., Feb. 27, 2017-- Amicus Therapeutics, a global biotechnology ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-launches-galafold-migalastat-130000116.html?.tsrc=rss"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Launches Galafold™ (Migalastat) for Treatment of Fabry Disease in the United Kingdom","publication_date":"2017-02-27 13:00:00 +0000","summary":"[GlobeNewswire] - National Institute for Health and Care Excellence Publishes Final Guidance Covering Reimbursement of Galafold for Fabry Disease. CRANBURY, N.J., Feb. 27, 2017-- Amicus Therapeutics, a global biotechnology ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-launches-galafold-migalastat-130000116.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Could 2017 Prove to be a Bull Market for Biotechs? Today's Reports on Depomed and Amicus Therapeutics","publication_date":"2017-02-23 14:30:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / February 23, 2017 / The Biotech Industry has posted some impressive gains since election result and the rally has continued for the larger part of this year. Both the iShares ...","url":"http://finance.yahoo.com/news/could-2017-prove-bull-market-143000749.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"These Small Biotechs Are Poised to Go Higher","publication_date":"2017-02-23 11:00:00 +0000","summary":"These Small Biotechs Are Poised to Go Higher","url":"http://www.investopedia.com/news/these-small-biotechs-are-poised-go-higher-gbt-vsar/?partner=YahooSA"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics to Announce Full-Year 2016 Financial Results and Corporate Updates on March 1, 2017","publication_date":"2017-02-22 22:36:53 +0000","summary":"[GlobeNewswire] - CRANBURY, N.J., Feb. 22, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced a conference call and live audio webcast ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-announce-full-2016-223653907.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2017-02-16 12:17:42 +0000","summary":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170216/fold8-k.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Presents Additional Positive Preliminary Phase 1/2 Data at WORLDSymposium™ 2017","publication_date":"2017-02-16 00:30:00 +0000","summary":"[GlobeNewswire] - Biomarkers of Muscle Damage Demonstrate Improving Trends in Majority of Patients. Biomarker of Key Disease Substrate Demonstrates Improving Trend in All Patients. Safety Data Continue to Show No Infusion-Associated ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-presents-additional-positive-003000920.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Updates Migalastat Drug","publication_date":"2017-02-15 17:49:00 +0000","summary":"Amicus Therapeutics Updates Migalastat Drug","url":"http://www.investopedia.com/news/amicus-posts-positive-update-migalastat-fold/?partner=YahooSA"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2017-02-15 13:42:16 +0000","summary":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170215/fold8-k.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Presents Important New Scientific Findings and Preclinical Data for Pompe Program at WORLDSymposium™ 2017","publication_date":"2017-02-15 12:30:00 +0000","summary":"[GlobeNewswire] - Scientific Findings Reveal that Cellular Damage Alters Trafficking for Key Proteins Involved in Muscle Membrane Integrity and Muscle Repair. Preclinical Studies Demonstrate Reversal of Cellular Damage ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-presents-important-scientific-123000767.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Highlights New Fabry Program Data at WORLDSymposium™ 2017","publication_date":"2017-02-15 00:30:00 +0000","summary":"[GlobeNewswire] - New Phase 3 Retrospective Analysis Shows Correlation between Reduction in Disease Substrate and Improved Diarrhea in Fabry Patients with Amenable Mutations treated with Migalastat. Supportive Study for ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-highlights-fabry-program-003000100.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2017-02-09 21:03:24 +0000","summary":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers","url":"http://biz.yahoo.com/e/170209/fold8-k.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics to Present at the Leerink Partners 6th Annual Global Healthcare Conference","publication_date":"2017-02-06 12:30:00 +0000","summary":"[GlobeNewswire] - CRANBURY, N.J., Feb. 06, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced that Chip Baird, Chief Financial Officer, ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-present-leerink-partners-123000888.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Biotech Premarket Movers: Amicus Therapeutics, Nantkwest and Organovo","publication_date":"2017-01-24 14:26:00 +0000","summary":"Biotech Premarket Movers: Amicus Therapeutics, Nantkwest and Organovo","url":"https://www.thestreet.com/story/13963644/1/biotech-premarket-movers-amicus-therapeutics-nantkwest-and-organovo.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Announces Presentations and Posters at 13th Annual WORLDSymposium™ 2017","publication_date":"2017-01-24 12:30:00 +0000","summary":"[GlobeNewswire] - CRANBURY, N.J., Jan. 24, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced that 3 oral presentations and 9 posters highlighting ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-announces-presentations-posters-123000112.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics upgraded by Robert W. Baird","publication_date":"2017-01-24 11:48:44 +0000","summary":"Amicus Therapeutics upgraded by Robert W. Baird","url":"http://finance.yahoo.com/q/ud?s=FOLD"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Tuesday Sector Laggards: Drugs, Biotechnology Stocks","publication_date":"2017-01-17 19:36:58 +0000","summary":"In trading on Tuesday drugs shares were relative laggards down on the day by about 2 4 Helping drag down the group were shares of Alcobra ADHD off about 49 9 and shares of Concert Pharmaceuticals CNCE off about 13 7 on the day Also lagging the market Tuesday","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S14gvhTV0Bk/tuesday-sector-laggards-drugs-biotechnology-stocks-cm734384"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Mid-Day Market Update: Clayton Williams Energy Surges On Acquisition News; Christopher & Banks Shares Slide","publication_date":"2017-01-17 18:47:02 +0000","summary":"Midway through trading Tuesday the Dow traded down 0 27 percent to 19 831 39 while the NASDAQ declined 0 54 percent to 5 543 93 The S amp P also fell dropping 0 29 percent to 2 268 01 Leading and Lagging Sectors Non cyclical consumer goods amp services shares gained around 1","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v-jMGE0xX0c/mid-day-market-update-clayton-williams-energy-surges-on-acquisition-news-christopher-banks-shares-slide-cm734389"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Friday's ETF Movers: XBI, GDXJ","publication_date":"2017-01-13 19:37:37 +0000","summary":"In trading on Friday the SPDR S amp P Biotech ETF XBI is outperforming other ETFs up about 1 9 on the day Components of that ETF showing particular strength include shares of Amicus Therapeutics FOLD up about 9 8 and shares of Array Biopharma ARRY up about 8 8 on the","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GMOI-mdCAYA/fridays-etf-movers-xbi-gdxj-cm733435"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Provides Full-Year 2017 Strategic Outlook and Financial Guidance","publication_date":"2017-01-09 12:30:00 +0000","summary":"[GlobeNewswire] - Strong Momentum for Galafold Launch in Europe and Multiple Global Regulatory Submissions Ahead. Additional Data from Pompe Phase 1/ 2 Clinical Study and Top-Line Data from Phase 3 Epidermolysis Bullosa ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-provides-full-2017-123000960.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,","publication_date":"2017-01-09 12:08:13 +0000","summary":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,","url":"http://biz.yahoo.com/e/170109/fold8-k.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Huge Energy Trade Kicks Off 2017 Insider Buying: DCP Midstream, Och-Ziff Capital, TransEnterix, Amicus Therapeutics and More","publication_date":"2017-01-08 15:10:56 +0000","summary":"Huge Energy Trade Kicks Off 2017 Insider Buying: DCP Midstream, Och-Ziff Capital, TransEnterix, Amicus Therapeutics and More","url":"http://finance.yahoo.com/news/huge-energy-trade-kicks-off-151056231.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"After Hours Most Active for Jan 4, 2017 : CC, IDXX, ABT, MT, STJ, BAC, MSFT, PK, QQQ, EBAY, FOLD, INTC","publication_date":"2017-01-04 21:56:29 +0000","summary":"The NASDAQ 100 After Hours Indicator is down 1 61 to 4 935 6 The total After hours volume is currently 36 360 338 shares traded The following are the most active stocks for the after hours session Chemours Company The CC is 0 06 at 22 15 with 17 634 647","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6NMzbGf3s5o/after-hours-most-active-for-jan-4-2017-cc-idxx-abt-mt-stj-bac-msft-pk-qqq-ebay-fold-intc-cm729571"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"National Institute for Health and Care Excellence (NICE) Issues Final Positive Recommendation for Galafold™ (migalastat) for Fabry Disease in England","publication_date":"2017-01-04 13:33:19 +0000","summary":"[at noodls] - January 4, 2017 Reimbursement Secured for Patients in England Commercial Launch in England, Wales and Northern Ireland Anticipated in Early 2017 CRANBURY, N.J., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Amicus ...","url":"http://www.publicnow.com/view/C26868CFA78CE5F5BEFD716D2E1A4E11E37248F7"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"National Institute for Health and Care Excellence (NICE) Issues Final Positive Recommendation for Galafold™ (migalastat) for Fabry Disease in England","publication_date":"2017-01-04 12:30:00 +0000","summary":"[GlobeNewswire] - Reimbursement Secured for Patients in England. Commercial Launch in England, Wales and Northern Ireland Anticipated in Early 2017. CRANBURY, N.J., Jan. 04, 2017-- Amicus Therapeutics, a global biotechnology ...","url":"http://finance.yahoo.com/news/national-institute-health-care-excellence-123000377.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"5 Stocks Insiders Love Right Now","publication_date":"2017-01-01 17:40:00 +0000","summary":"5 Stocks Insiders Love Right Now","url":"https://www.thestreet.com/story/13938062/1/5-stocks-insiders-love-right-now.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib","publication_date":"2016-12-30 21:20:19 +0000","summary":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib","url":"http://biz.yahoo.com/e/161230/fold8-k.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Trump, Interest Rates And Biotech Investing In 2017","publication_date":"2016-12-23 16:22:00 +0000","summary":"Trump, Interest Rates And Biotech Investing In 2017","url":"http://www.forbes.com/sites/stephenbrozak/2016/12/23/trump-interest-rates-and-biotech-investing-in-2017/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference","publication_date":"2016-12-23 12:30:00 +0000","summary":"[GlobeNewswire] - CRANBURY, N.J., Dec. 23, 2016-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced that John F. Crowley, Chairman and Chief ...","url":"http://finance.yahoo.com/news/amicus-therapeutics-present-35th-annual-123000817.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Abercrombie, OvaScience Slide Into Thursday’s 52-Week Low Club","publication_date":"2016-12-22 21:04:17 +0000","summary":"Abercrombie, OvaScience Slide Into Thursday’s 52-Week Low Club","url":"http://247wallst.com/investing/2016/12/22/369341/"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics, Inc. (FOLD) Announces The Closure Of Its Senior Convertible Notes","publication_date":"2016-12-22 19:02:55 +0000","summary":"Amicus Therapeutics, Inc. (FOLD) Announces The Closure Of Its Senior Convertible Notes","url":"http://www.insidermonkey.com/blog/amicus-therapeutics-inc-fold-announces-the-closure-of-its-senior-convertible-notes-512813/"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Def","publication_date":"2016-12-21 22:28:58 +0000","summary":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Def","url":"http://biz.yahoo.com/e/161221/fold8-k.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Announces Closing of Offering of Senior Convertible Notes and Exercise in Full of Option to Purchase Additional Notes","publication_date":"2016-12-21 22:12:06 +0000","summary":"[at noodls] - December 21, 2016 CRANBURY, N.J., Dec. 21, 2016 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of rare and orphan diseases, announced the closing ...","url":"http://www.publicnow.com/view/2C224BE221209335F334F9A87858A37D11D0921E"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Today's Reports on Biotech Movers Ariad Pharmaceuticals and Amicus Therapeutics","publication_date":"2016-12-21 14:15:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 21, 2016 / After many years of impressive gains for investors the Biotech Industry has experienced downward pressure in 2016. The iShares NASDAQ Biotechnology Index ...","url":"http://finance.yahoo.com/news/todays-reports-biotech-movers-ariad-141500749.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Abercrombie & Fitch, Hanesbrands Dip into Friday’s 52-Week Low Club","publication_date":"2016-12-16 21:04:24 +0000","summary":"Abercrombie & Fitch, Hanesbrands Dip into Friday’s 52-Week Low Club","url":"http://247wallst.com/investing/2016/12/16/abercrombie-fitch-hanesbrands-dip-into-fridays-52-week-low-club/"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2016-12-16 11:03:32 +0000","summary":"AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/161216/fold8-k.html"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Amicus Therapeutics Announces Pricing of Offering of Convertible Senior Notes","publication_date":"2016-12-16 01:58:18 +0000","summary":"[at noodls] - December 15, 2016 CRANBURY, N.J., Dec. 15, 2016 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of rare and orphan diseases, today announced that ...","url":"http://www.publicnow.com/view/22AC6891BE78CC0155889A04AD09C711F0F5DA1E"},{"ticker":"FOLD","figi_ticker":"FOLD:US","figi":"BBG000PLF6N0","title":"Health Care Sector Update for 12/15/2016: FOLD,CBIO,PFE,PACB","publication_date":"2016-12-15 19:36:34 +0000","summary":"Top Health Care StocksTop Health Care Stocks Health care stocks were moderately higher in early afternoon trade with the NYSE Health Care Index rising about 0 4 while shares of health care companies in the S amp P 500 were up about 0 4 as a group Health care stocks were moderately higher","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U1O1ArTpQD4/health-care-sector-update-for-12152016-foldcbiopfepacb-cm722138"}],"result_count":240,"page_size":100,"current_page":1,"total_pages":3,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"6.85"},{"x":"1494596100","y":"6.855"},{"x":"1494596400","y":"6.9"},{"x":"1494596700","y":"7.01"},{"x":"1494597000","y":"7.06"},{"x":"1494597300","y":"7.15"},{"x":"1494597600","y":"7.11"},{"x":"1494597900","y":"7.08"},{"x":"1494598200","y":"7.12"},{"x":"1494598500","y":"7.165"},{"x":"1494598800","y":"7.1518"},{"x":"1494599100","y":"7.12"},{"x":"1494599400","y":"7.105"},{"x":"1494599700","y":"7.125"},{"x":"1494600000","y":"7.115"},{"x":"1494600300","y":"7.12"},{"x":"1494600600","y":"7.11"},{"x":"1494600900","y":"7.1"},{"x":"1494601200","y":"7.12"},{"x":"1494601500","y":"7.15"},{"x":"1494601800","y":"7.165"},{"x":"1494602100","y":"7.14"},{"x":"1494602400","y":"7.14"},{"x":"1494602700","y":"7.135"},{"x":"1494603000","y":"7.15"},{"x":"1494603300","y":"7.155"},{"x":"1494603600","y":"7.14"},{"x":"1494603900","y":"7.15"},{"x":"1494604200","y":"7.19"},{"x":"1494604500","y":"7.21"},{"x":"1494604800","y":"7.21"},{"x":"1494605100","y":"7.205"},{"x":"1494605400","y":"7.24"},{"x":"1494605700","y":"7.255"},{"x":"1494606000","y":"7.24"},{"x":"1494606300","y":"7.2146"},{"x":"1494606600","y":"7.22"},{"x":"1494606900","y":"7.195"},{"x":"1494607200","y":"7.2101"},{"x":"1494607500","y":"7.22"},{"x":"1494607800","y":"7.225"},{"x":"1494608100","y":"7.22"},{"x":"1494608400","y":"7.22"},{"x":"1494608700","y":"7.215"},{"x":"1494609000","y":"7.245"},{"x":"1494609300","y":"7.24"},{"x":"1494609600","y":"7.26"},{"x":"1494609900","y":"7.24"},{"x":"1494610200","y":"7.225"},{"x":"1494610500","y":"7.225"},{"x":"1494610800","y":"7.22"},{"x":"1494611100","y":"7.24"},{"x":"1494611400","y":"7.23"},{"x":"1494611700","y":"7.24"},{"x":"1494612000","y":"7.24"},{"x":"1494612300","y":"7.21"},{"x":"1494612600","y":"7.24"},{"x":"1494612900","y":"7.255"},{"x":"1494613200","y":"7.25"},{"x":"1494613500","y":"7.24"},{"x":"1494613800","y":"7.24"},{"x":"1494614100","y":"7.25"},{"x":"1494614400","y":"7.26"},{"x":"1494614700","y":"7.275"},{"x":"1494615000","y":"7.295"},{"x":"1494615300","y":"7.285"},{"x":"1494615600","y":"7.28"},{"x":"1494615900","y":"7.28"},{"x":"1494616200","y":"7.29"},{"x":"1494616500","y":"7.29"},{"x":"1494616800","y":"7.305"},{"x":"1494617100","y":"7.305"},{"x":"1494617400","y":"7.29"},{"x":"1494617700","y":"7.3"},{"x":"1494618000","y":"7.32"},{"x":"1494618300","y":"7.335"},{"x":"1494618600","y":"7.35"},{"x":"1494618900","y":"7.36"},{"x":"1494619200","y":"7.35"} ], "color":"#03a9f4"}]},
{"id":"9","symbol": "GERN","name": "Geron Corp","price": 2.87,"dollarChange": 0.19,"percentChange": 7.09,"open": 2.66,"high": 2.99,"low":2.645,"volume": 4858018,"avgVol": 1862697.383333,"sharesShort": 33604098,"shortPercent": 21.111269,"marketCap": 407490864,"float": 159176119,"headlines":{"data":[{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron (GERN) Q1 Loss In Line, Focus Remains on Imetelstat","publication_date":"2017-05-10 14:06:20 +0000","summary":"Geron Corporation GERN reported a loss of 5 cents per share in the first quarter of 2017 in line with the Zacks Consensus Estimate In the year ago quarter the company had recorded a loss of 6 cents So far this year Geron s shares have outperformed the Zacks classified Medical","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K2nXldknu0o/geron-gern-q1-loss-in-line-focus-remains-on-imetelstat-cm787051"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron reports 1Q loss","publication_date":"2017-05-09 22:26:27 +0000","summary":"On a per-share basis, the Menlo Park, California-based company said it had a loss of 5 cents. The drugmaker posted revenue of $537,000 in the period. In the final minutes of trading on Tuesday, the company's ...","url":"http://finance.yahoo.com/news/geron-reports-1q-loss-222627216.html?.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Corporation Reports First Quarter 2017 Financial Results and Recent Events","publication_date":"2017-05-09 20:05:00 +0000","summary":"MENLO PARK, Calif., May 09, 2017-- Geron Corporation today reported financial results for the first quarter ended March 31, 2017 and recent events.. For the first quarter of 2017, the company reported ...","url":"http://finance.yahoo.com/news/geron-corporation-reports-first-quarter-200500795.html?.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Annual Meeting Of Stockholders At 7:00 PM ET","publication_date":"2017-05-09 15:00:00 +0000","summary":"Geron Annual Meeting Of Stockholders At 7:00 PM ET","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B5GKhPOKOXU/geron-annual-meeting-of-stockholders-at-700-pm-et-20170509-01477"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"3 Biotech Stocks Projected to Grow Their EPS by at Least 415% in 2018","publication_date":"2017-05-04 15:59:10 +0000","summary":"There are few industries as hit and miss as biotech In many instances the deck is stacked against biotech companies succeeding Most discovery stage preclinical and clinical trials fail to meet the mark meaning most discoveries made in a lab won t make it to pharmacy shelves","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1TN0ZO4lncI/3-biotech-stocks-projected-to-grow-their-eps-by-at-least-415-in-2018-cm784149"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"This Major Catalyst Sent Geron Corporation Shares Higher by 13% in April","publication_date":"2017-05-03 20:51:36 +0000","summary":"What happened Shares of Geron NASDAQ GERN a clinical stage developer of cancer therapeutics surged 13 in April according to data from S amp P Global Market Intelligence One major catalyst provided the foundation for Geron s excellent month a long awaited clinical","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eWbuTsiep8s/this-major-catalyst-sent-geron-corporation-shares-higher-by-13-in-april-cm783547"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Johnson & Johnson's 5% Dividend Increase Offers a Big Clue About Its Future","publication_date":"2017-05-03 13:29:17 +0000","summary":"It s that time of the year again when Johnson amp Johnson s NYSE JNJ shareholders eagerly await their annual raise in the form of a higher dividend payout On Thursday April 27 J amp J obliged once more It really shouldn t come as any surprise that Johnson amp","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0aNKxZ8kwQw/johnson-johnsons-5-dividend-increase-offers-a-big-clue-about-its-future-cm783261"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron (GERN) Q1 Earnings: What's in Store for the Stock?","publication_date":"2017-05-01 16:31:49 +0000","summary":"Geron Corporation GERN is expected to report first quarter 2017 results on May 4 In the last reported quarter the company recorded a positive earnings surprise of 16 67 Let s see how things are shaping up for the upcoming announcement Geron s shares outperformed the Zacks","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xJgKB0UTBOY/geron-gern-q1-earnings-whats-in-store-for-the-stock-cm782078"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Faruqi & Faruqi, LLP Announces a Proposed Class Action Settlement Involving All Persons who Purchased or Acquired Geron Common Stock between December 10, 2012 and March 11, 2014","publication_date":"2017-05-01 11:59:00 +0000","summary":"TO: ALL PERSONS WHO PURCHASED OR OTHERWISE ACQUIRED THE COMMON STOCK OF GERON CORPORATION (\"GERON\") FROM DECEMBER 10, 2012 THROUGH AND INCLUDING MARCH 11, 2014 (\"CLASS\"). You may obtain copies of a detailed Notice of Pendency and Settlement of Class Action (\"Settlement Notice\") and a copy of the Proof of Claim and Release form by writing to Geron Corporation Securities Litigation, c/o Claims Administrator, P.O. Box 4153, Portland, OR 97208-4153, visiting the website www.GeronCorporationSecuritiesLitigation.com, e-mailing the Claims Administrator at questions@GeronCorporationSecuritiesLitigation.com, or calling the Claims Administrator toll free at 1-844-299-2263.","url":"http://finance.yahoo.com/news/faruqi-faruqi-llp-announces-proposed-115900054.html?.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Will Geron (GERN) Continue to Surge Higher?","publication_date":"2017-04-28 13:29:53 +0000","summary":"As of late it has definitely been a great time to be an investor in Geron Corporation GERN The stock has moved higher by 14 7 in the past month while it is also above its 20 Day SMA too This combination of strong price performance and favorable technical could suggest that the stock may","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1zCqjL4sf00/will-geron-gern-continue-to-surge-higher-cm780913"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron 2017 Annual Meeting of Stockholders to be Held on May 9","publication_date":"2017-04-25 11:30:00 +0000","summary":"First Quarter 2017 Financial Results Expected Same Day. MENLO PARK, Calif., April 25, 2017-- Geron Corporation will hold its 2017 Annual Meeting of Stockholders, on Tuesday, May 9, 2017, at 4:00 p.m. PDT.. ...","url":"http://finance.yahoo.com/news/geron-2017-annual-meeting-stockholders-113000749.html?.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"This $26 Billion Company Is the Market's Most Overpriced Biotech Stock","publication_date":"2017-04-20 19:04:14 +0000","summary":"Despite learning on Monday that the FDA rejected baricitinib 160 shares of biotech behemoth Incyte NASDAQ INCY have been on a roll Over the past year Incyte s stock is up 64 over five years it s up 450 and since March of 2009 160 its shares are up nearly 5 300 Not","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mtjxa2yq-5c/this-26-billion-company-is-the-markets-most-overpriced-biotech-stock-cm776599"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Top Ranked Momentum Stocks to Buy for April 18th","publication_date":"2017-04-18 17:04:27 +0000","summary":"Here are four stocks with buy rank and strong momentum characteristics for investors to consider today April 18th Constellation Brands Inc STZ This international beverage alcohol companyhas a Zacks Rank 1 Strong Buy and witnessedthe Zacks Consensus Estimate for its current","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t1zcvU8srXk/top-ranked-momentum-stocks-to-buy-for-april-18th-cm775383"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"3 Stocks Ripe for a Buyout","publication_date":"2017-04-15 12:54:11 +0000","summary":"Buyouts can produce sizable returns on capital in fairly short time periods However the next red hot buyout target isn t always easy to identify ahead of time Of course it s never wise to buy a stock simply because you think it might be acquired But a company with a strong","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UlW_X1ojsO0/3-stocks-ripe-for-a-buyout-cm774309"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Biotech Stock Roundup: Geron Gains on Interim Data, OncoMed Slumps on Pipeline Setback","publication_date":"2017-04-12 13:58:25 +0000","summary":"Several companies including Geron GERN and OncoMed OMED provided key pipeline updates this week While Geron s shares were up this week OncoMed s shares plunged and hit a 52 week low Recap of the Week s Most Important Stories Geron Up on Interim Data Geron s shares were up 19","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BQjIj_WyhI0/biotech-stock-roundup-geron-gains-on-interim-data-oncomed-slumps-on-pipeline-setback-cm773101"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Stock Rises after Positive Interim Update on Imetelstat","publication_date":"2017-04-11 16:56:15 +0000","summary":"Shares of Geron Corporation GERN increased almost 20 on Monday after it provided a positive update on two late stage studies for imetelstat its lead pipeline candidate So far this year Geron s shares have outperformed the Zacks classified Medical Biomedical and Genetics industry","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z-weIOO9m5Q/geron-stock-rises-after-positive-interim-update-on-imetelstat-cm772784"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Today's Research Reports on Biotech Stocks to Watch: Cytori Therapeutics and Geron","publication_date":"2017-04-11 11:30:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / April 11, 2017 / Cytori Therapeutics advanced 25.55% to close at $1.72 on Monday. The stock traded between $1.71 and $2.08 on a large volume spike of 17.7 million shares traded. ...","url":"http://finance.yahoo.com/news/todays-research-reports-biotech-stocks-113000237.html?.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Gainers & Losers Of Apr.10: CYTX, AXON, GERN, OMED, TXMD...","publication_date":"2017-04-10 22:30:00 +0000","summary":"Gainers & Losers Of Apr.10: CYTX, AXON, GERN, OMED, TXMD...","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AyISGMvTwB0/gainers--losers-of-apr10-cytx-axon-gern-omed-txmd-20170410-01258"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Why Knight Transportation, Geron, and Rent-A-Center Jumped Today","publication_date":"2017-04-10 21:54:51 +0000","summary":"Monday started the week on a positive note for the stock market which climbed to modest gains as investors looked forward to learning more from corporate America as earnings season ramps up The weekend failed to deliver any negative surprises on the geopolitical front and even news","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PoFLJoD4Irs/why-knight-transportation-geron-and-rent-a-center-jumped-today-cm772372"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron’s Imetelstat Reports Positive Interim Data","publication_date":"2017-04-10 16:17:00 +0000","summary":"Positive interim update from two clinical trials of imetelstat drugs spiked Geron's stock price 20%","url":"http://finance.yahoo.com/r/7a9509f4-6bfd-3a55-beed-bafd66fe775b/gerons-imetelstat-posts-positive-interim-data-gern?partner=YahooSA&yptr=yahoo&.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Why Geron Corporation Stock Is Surging Higher Today","publication_date":"2017-04-10 13:59:00 +0000","summary":"Geron&apos;s imetelstat passes a critical test.","url":"http://finance.yahoo.com/r/8ca80a58-3ae1-35b0-bf1a-b0a32d02fdde/why-geron-corporation-stock-is-surging-higher-toda.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Pre-Market Most Active for Apr 10, 2017 : BBL, GERN, AKRX, NVO, BAC, MT, XIV, BHP, CHK, TSLA, QQQ, ASML","publication_date":"2017-04-10 12:53:52 +0000","summary":"The NASDAQ 100 Pre Market Indicator is up 6 41 to 5 424 78 The total Pre Market volume is currently 3 863 307 shares traded The following are the most active stocks for the pre market session BHP Billiton plc BBL is 1 25 at 33 10 with 486 055 shares traded BBL","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QxvMU1KSS-0/pre-market-most-active-for-apr-10-2017-bbl-gern-akrx-nvo-bac-mt-xiv-bhp-chk-tsla-qqq-asml-cm771938"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Announces Completion of Second Internal Data Reviews for Imetelstat Trials Being Conducted by Janssen","publication_date":"2017-04-10 11:30:00 +0000","summary":"Both IMerge and IMbark Continue in Lower Risk Myelodysplastic Syndromes and Relapsed or Refractory Myelofibrosis. Conference Call Scheduled for 8:00 a.m. EDT Today, April 10. MENLO PARK, Calif., April ...","url":"http://finance.yahoo.com/news/geron-announces-completion-second-internal-113000277.html?.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"AKRX Confirms Acquisition Talks, CBIO Plunges, Be All Ears For GERN","publication_date":"2017-04-09 19:30:00 +0000","summary":"AKRX Confirms Acquisition Talks, CBIO Plunges, Be All Ears For GERN","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PxysMOkMLBc/akrx-confirms-acquisition-talks-cbio-plunges-be-all-ears-for-gern-20170409-00034"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Announces Conference Call on April 10 at 8:00 A.M. Eastern Time","publication_date":"2017-04-09 12:00:00 +0000","summary":"MENLO PARK, Calif., April 09, 2017-- Geron Corporation will host a conference call on April 10, 2017, at 8:00 a.m. Eastern Time to provide an update on the ongoing imetelstat Phase 2/ 3 trial in myelodysplastic ...","url":"http://finance.yahoo.com/news/geron-announces-conference-call-april-120000914.html?.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"ETFs with exposure to Geron Corp. : April 7, 2017","publication_date":"2017-04-07 20:37:23 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Geron Corp. Here are 5 ETFs with the largest exposure to GERN-US. Comparing the performance and risk of Geron Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/bd09ebf6-b6bf-3a67-b7d9-96357893679d/etfs-with-exposure-to-geron-corp-april-7-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : April 6, 2017","publication_date":"2017-04-06 12:26:48 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Geron Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/06788540-34d1-3e55-a246-46ea167144d7/geron-corp-breached-its-50-day-moving-average-in-a-bearish-manner-gern-us-april-6-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Reports Imetelstat Presentation at American Association for Cancer Research Annual Meeting","publication_date":"2017-04-05 11:30:00 +0000","summary":"MENLO PARK, Calif., April 05, 2017-- Geron Corporation today announced a poster presentation by Janssen Research & Development, LLC describing non-clinical data on the telomerase inhibitor imetelstat at ...","url":"http://finance.yahoo.com/news/geron-reports-imetelstat-presentation-american-113000361.html?.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"ETFs with exposure to Geron Corp. : March 27, 2017","publication_date":"2017-03-27 19:57:31 +0000","summary":"ETFs with exposure to Geron Corp. : March 27, 2017","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-geron-corp-march-27-2017/"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"ETFs with exposure to Geron Corp. : March 27, 2017","publication_date":"2017-03-27 19:57:31 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Geron Corp. Here are 5 ETFs with the largest exposure to GERN-US. Comparing the performance and risk of Geron Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/b6bac957-cb77-34b4-baea-8b5182b26960/etfs-with-exposure-to-geron-corp-march-27-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Corp. breached its 50 day moving average in a Bullish Manner : GERN-US : March 27, 2017","publication_date":"2017-03-27 12:06:22 +0000","summary":"Geron Corp. breached its 50 day moving average in a Bullish Manner : GERN-US : March 27, 2017","url":"http://www.capitalcube.com/blog/index.php/geron-corp-breached-its-50-day-moving-average-in-a-bullish-manner-gern-us-march-27-2017/"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"4 Biotech Stocks With Jaw-Dropping Growth Potential","publication_date":"2017-03-21 18:59:02 +0000","summary":"If you re searching for growth stocks with the potential to produce life changing returns on capital I think the biotechs Agenus Inc NASDAQ AGEN Amarin Corp NASDAQ AMRN Cara Therapeutics NASDAQ CARA and Geron Corp NASDAQ GERN 160 are all","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p9zukuXVvY4/4-biotech-stocks-with-jaw-dropping-growth-potential-cm763369"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Today's Research Reports on Stocks to Watch: Geron and Galena Biopharma","publication_date":"2017-03-20 13:30:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 20, 2017 / As both Geron and Galena Biopharma show signs of biotech life with their FDA trial advancements, the stocks also have a common problem – how to convince investors ...","url":"http://finance.yahoo.com/news/todays-research-reports-stocks-watch-133000738.html"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Today's Research Reports on Stocks to Watch: Geron and Galena Biopharma","publication_date":"2017-03-20 13:30:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / March 20, 2017 / As both Geron and Galena Biopharma show signs of biotech life with their FDA trial advancements, the stocks also have a common problem – how to convince investors ...","url":"http://finance.yahoo.com/news/todays-research-reports-stocks-watch-133000738.html?.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Corp. :GERN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017","publication_date":"2017-03-17 13:02:34 +0000","summary":"Geron Corp. :GERN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017","url":"http://www.capitalcube.com/blog/index.php/geron-corp-gern-us-earnings-analysis-q4-2016-by-the-numbers-march-17-2017/"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Corp. :GERN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017","publication_date":"2017-03-17 13:02:34 +0000","summary":"Categories: Yahoo Finance Get free summary analysis Geron Corp. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Geron Corp. – Gilead Sciences, Inc., CTI BioPharma Corp., Bio-Techne Corporation, Immunomedics, Inc. and Incyte Corporation (GILD-US, CTIC-US, TECH-US, IMMU-US and INCY-US) that have also reported for this period. ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/d8c166f3-317c-3c43-88c6-d376876a4a52/geron-corp-gern-us-earnings-analysis-q4-2016-by-the-numbers-march-17-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Corp. :GERN-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017","publication_date":"2017-03-15 18:08:18 +0000","summary":"Geron Corp. :GERN-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017","url":"http://www.capitalcube.com/blog/index.php/geron-corp-gern-us-earnings-analysis-2016-by-the-numbers-march-15-2017/"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Corp. :GERN-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017","publication_date":"2017-03-15 18:08:18 +0000","summary":"Categories: Yahoo Finance Get free summary analysis Geron Corp. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Geron Corp. – Gilead Sciences, Inc., Bio-Techne Corporation, Immunomedics, Inc., CTI BioPharma Corp. and Incyte Corporation (GILD-US, TECH-US, IMMU-US, CTIC-US and INCY-US) that have also reported for this period. ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/7e3e412c-ea44-3cf8-bba9-a9f6a6b4b078/geron-corp-gern-us-earnings-analysis-2016-by-the-numbers-march-15-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : March 15, 2017","publication_date":"2017-03-15 12:48:31 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Geron Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/7279ebb9-2936-3880-a12f-db71483288aa/geron-corp-breached-its-50-day-moving-average-in-a-bearish-manner-gern-us-march-15-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : March 15, 2017","publication_date":"2017-03-15 12:48:31 +0000","summary":"Geron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : March 15, 2017","url":"http://www.capitalcube.com/blog/index.php/geron-corp-breached-its-50-day-moving-average-in-a-bearish-manner-gern-us-march-15-2017/"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"GERON CORP Financials","publication_date":"2017-03-07 18:04:14 +0000","summary":"GERON CORP Financials","url":"http://finance.yahoo.com/q/is?s=gern"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Biotech Premarket Movers: Innoviva, Akebia, Geron","publication_date":"2017-03-07 14:28:00 +0000","summary":"Biotech Premarket Movers: Innoviva, Akebia, Geron","url":"https://www.thestreet.com/story/14029973/1/biotech-premarket-movers-innoviva-akebia-geron.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Edited Transcript of GERN earnings conference call or presentation 1-Mar-17 9:30pm GMT","publication_date":"2017-03-03 20:19:15 +0000","summary":"Q4 2016 Geron Corp Earnings Call","url":"http://finance.yahoo.com/news/edited-transcript-gern-earnings-conference-201915335.html?.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Edited Transcript of GERN earnings conference call or presentation 1-Mar-17 9:30pm GMT","publication_date":"2017-03-03 20:19:15 +0000","summary":"Edited Transcript of GERN earnings conference call or presentation 1-Mar-17 9:30pm GMT","url":"http://finance.yahoo.com/news/edited-transcript-gern-earnings-conference-201915335.html"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"GERON CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2017-03-03 12:31:22 +0000","summary":"GERON CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170303/gern8-k.html"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron (GERN) Q4 Loss Narrows; Focus Remains on Imetelstat","publication_date":"2017-03-02 17:15:47 +0000","summary":"Geron Corporation GERN reported a loss of 5 cents per share in the fourth quarter of 2016 flat year over year but narrower than the Zacks Consensus Estimate of a loss of 6 cents FindTheCompany Graphiq Shares rose 2 4 in after hours trading on Wednesday However","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JQfoLUzm-ng/geron-gern-q4-loss-narrows-focus-remains-on-imetelstat-cm755469"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Announces Presentation at American Association for Cancer Research Annual Meeting","publication_date":"2017-03-02 12:30:00 +0000","summary":"MENLO PARK, Calif., March 02, 2017-- Geron Corporation today announced an abstract submitted by Janssen Research & Development, LLC describing non-clinical data on imetelstat has been accepted for presentation ...","url":"http://finance.yahoo.com/news/geron-announces-presentation-american-association-123000983.html?.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Announces Presentation at American Association for Cancer Research Annual Meeting","publication_date":"2017-03-02 12:30:00 +0000","summary":"[GlobeNewswire] - MENLO PARK, Calif., March 02, 2017-- Geron Corporation today announced an abstract submitted by Janssen Research & Development, LLC describing non-clinical data on imetelstat has been accepted for presentation ...","url":"http://finance.yahoo.com/news/geron-announces-presentation-american-association-123000983.html"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Corp Earnings Call scheduled for 4:30 pm ET today","publication_date":"2017-03-01 21:30:00 +0000","summary":"Geron Corp Earnings Call scheduled for 4:30 pm ET today","url":"http://biz.yahoo.com/cc/5/155835.html"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"GERON CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits","publication_date":"2017-03-01 21:13:10 +0000","summary":"GERON CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170301/gern8-k.html"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"4:08 pm Geron reports EPS in-line, misses on revs","publication_date":"2017-03-01 21:08:00 +0000","summary":"4:08 pm Geron reports EPS in-line, misses on revs","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#gern"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Corporation Reports Fourth Quarter and Annual 2016 Financial Results","publication_date":"2017-03-01 21:05:00 +0000","summary":"[GlobeNewswire] - MENLO PARK, Calif., March 01, 2017-- Geron Corporation today reported financial results for the fourth quarter and year ended December 31, 2016 and recent events. Fourth Quarter and Year-End 2016 Results. ...","url":"http://finance.yahoo.com/news/geron-corporation-reports-fourth-quarter-210500241.html"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Corporation Reports Fourth Quarter and Annual 2016 Financial Results","publication_date":"2017-03-01 21:05:00 +0000","summary":"MENLO PARK, Calif., March 01, 2017-- Geron Corporation today reported financial results for the fourth quarter and year ended December 31, 2016 and recent events. Fourth Quarter and Year-End 2016 Results. ...","url":"http://finance.yahoo.com/news/geron-corporation-reports-fourth-quarter-210500241.html?.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"GERON CORP Files SEC form 10-K, Annual Report","publication_date":"2017-03-01 21:00:20 +0000","summary":"GERON CORP Files SEC form 10-K, Annual Report","url":"http://biz.yahoo.com/e/170301/gern10-k.html"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Q4 16 Earnings Conference Call At 4:30 PM ET","publication_date":"2017-03-01 14:59:00 +0000","summary":"Geron Q4 16 Earnings Conference Call At 4:30 PM ET","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tiXfnMfAbI4/geron-q4-16-earnings-conference-call-at-430-pm-et-20170301-01396"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Q4 2016 Geron Corp Earnings Release - After Market Close","publication_date":"2017-03-01 12:07:03 +0000","summary":"Q4 2016 Geron Corp Earnings Release - After Market Close","url":"http://biz.yahoo.com/research/earncal/20170301.html?t=gern"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Drug Stocks Q4 Earnings Lineup for Mar 1: MYL, KERX & More","publication_date":"2017-02-28 13:51:22 +0000","summary":"With the curtains almost down on the Q4 earnings season we believe this quarter has turned out to be a good one with growth on track to be the highest in the last two years As of Feb 17 2017 411 S amp P 500 members accounting for 88 4 of the index s total market capitalization have","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G_ZaqJbYxoY/drug-stocks-q4-earnings-lineup-for-mar-1-myl-kerx-more-cm754034"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"3 All-or-Nothing Stocks We're Closely Watching","publication_date":"2017-02-23 19:51:55 +0000","summary":"The value proposition of some stocks can be boiled down to a single catalyst or overarching macroeconomic theme These 160 so called all or nothing stocks can generate jaw dropping returns on capital in exceedingly short periods of time but also come with the very real risk of a","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KBAcdrzNQu4/3-all-or-nothing-stocks-were-closely-watching-cm752264"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2016 Financial Results","publication_date":"2017-02-22 12:30:00 +0000","summary":"[GlobeNewswire] - MENLO PARK, Calif., Feb. 22, 2017-- Geron Corporation will announce its financial results for the fourth quarter and year ended December 31, 2016, on Wednesday, March 1, 2017, after the market close. Geron’ ...","url":"http://finance.yahoo.com/news/geron-announces-conference-call-discuss-123000489.html"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2016 Financial Results","publication_date":"2017-02-22 12:30:00 +0000","summary":"MENLO PARK, Calif., Feb. 22, 2017-- Geron Corporation will announce its financial results for the fourth quarter and year ended December 31, 2016, on Wednesday, March 1, 2017, after the market close. Geron’ ...","url":"http://finance.yahoo.com/news/geron-announces-conference-call-discuss-123000489.html?.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron (GERN) Q4 Earnings: What's in Store for the Stock?","publication_date":"2017-02-17 15:55:45 +0000","summary":"Geron Corporation GERN is expected to report fourth quarter 2016 results next week In the last reported quarter the company recorded a positive earnings surprise of 66 67 Let s see how things are shaping up for the upcoming announcement Geron s shares outperformed the","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QYFMwqfTFxQ/geron-gern-q4-earnings-whats-in-store-for-the-stock-cm749540"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron (GERN) Q4 Earnings: What's in Store for the Stock?","publication_date":"2017-02-17 14:10:02 +0000","summary":"Geron (GERN) Q4 Earnings: What's in Store for the Stock?","url":"http://finance.yahoo.com/news/geron-gern-q4-earnings-whats-141002066.html"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"No Joke: Johnson & Johnson Could Grow Sales by 5% (or More) Annually Over the Next Decade","publication_date":"2017-02-15 14:18:32 +0000","summary":"For many investors Johnson amp Johnson NYSE JNJ is the quintessential set it and forget it investment in the healthcare arena It s the largest publicly traded healthcare company by a mile and its business structure J amp J is comprised of more than 250 different","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pwK5qlirDmc/no-joke-johnson-johnson-could-grow-sales-by-5-or-more-annually-over-the-next-decade-cm748086"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"No Joke: Johnson & Johnson Could Grow Sales by 5% (or More) Annually Over the Next Decade","publication_date":"2017-02-15 13:10:16 +0000","summary":"No Joke: Johnson & Johnson Could Grow Sales by 5% (or More) Annually Over the Next Decade","url":"http://www.fool.com/investing/2017/02/15/no-joke-johnson-johnson-could-grow-sales-by-5-or-m.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"GERON CORP Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2017-02-10 22:16:43 +0000","summary":"GERON CORP Files SEC form 8-K, Change in Directors or Principal Officers","url":"http://biz.yahoo.com/e/170210/gern8-k.html"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"4 Stocks Under $4 That Could Double","publication_date":"2017-02-09 17:20:11 +0000","summary":"It s just like the old idiom says Good things come in small packages Stocks with a very low share price usually 5 and under are often cast aside by investors as being far too risky In some instances investment firms and hedge funds will refrain from buying or owning stock in","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MDU-yL7EHJs/4-stocks-under-4-that-could-double-cm745554"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"4 Stocks Under $4 That Could Double","publication_date":"2017-02-09 16:05:07 +0000","summary":"These stocks may be small, but they could pack quite a punch for your portfolio.","url":"http://finance.yahoo.com/r/5df83fd5-7a48-3160-bc2a-6960d321cbe3/4-stocks-under-4-that-could-double.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2&yptr=yahoo&.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Forget Anavex Life Sciences Corp.: These 2 Biotech Stocks Are Better Buys","publication_date":"2017-02-02 15:45:14 +0000","summary":"Forget Anavex Life Sciences Corp.: These 2 Biotech Stocks Are Better Buys","url":"http://www.fool.com/investing/2017/02/01/forget-anavex-life-sciences-corp-these-2-biotech-s.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Forget Anavex Life Sciences Corp.: These 2 Biotech Stocks Are Better Buys","publication_date":"2017-02-01 17:33:49 +0000","summary":"Investors are right to focus on potential Alzheimer s disease drugs because of the huge market but Anavex Life Sciences Corp NASDAQ AVXL is an awfully long way from from the finish line with its lead candidate Clinical stage biotech stocks are inherently risky but I d like to","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SsTqLg6e0PY/forget-anavex-life-sciences-corp-these-2-biotech-stocks-are-better-buys-cm741643"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Forget Celldex Therapeutics, Inc.: These 2 Stocks Are Better Buys","publication_date":"2017-02-01 14:34:01 +0000","summary":"If ultra high risk high reward biotech stocks are your thing then Celldex Therapeutics NASDAQ CLDX is probably on your radar right now This beaten down biotech stock after all could blast northward in a hurry if its experimental 160 triple negative breast","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PCmmYD-cZnQ/forget-celldex-therapeutics-inc-these-2-stocks-are-better-buys-cm741322"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Forget Celldex Therapeutics, Inc.: These 2 Stocks Are Better Buys","publication_date":"2017-02-01 13:14:27 +0000","summary":"Agenus and Geron both have jaw-dropping growth potential that may outweigh their sizable risk profiles.","url":"http://finance.yahoo.com/r/e71a291f-4e28-3cc9-aab7-31af2e95bbd8/forget-celldex-therapeutics-inc-these-2-stocks-are.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2&yptr=yahoo&.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Forget Celldex Therapeutics, Inc.: These 2 Stocks Are Better Buys","publication_date":"2017-02-01 13:14:27 +0000","summary":"Forget Celldex Therapeutics, Inc.: These 2 Stocks Are Better Buys","url":"http://www.fool.com/investing/2017/02/01/forget-celldex-therapeutics-inc-these-2-stocks-are.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"5 Small-Cap Biotech Stocks to Buy in February","publication_date":"2017-01-26 21:28:51 +0000","summary":"5 Small-Cap Biotech Stocks to Buy in February","url":"http://www.fool.com/investing/2017/01/25/5-small-cap-biotech-stocks-to-buy-in-february.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"5 Small-Cap Biotech Stocks to Buy in February","publication_date":"2017-01-25 22:32:04 +0000","summary":"Looking to add a few thrills to your investing portfolio Small cap biotech stocks should be a good place to start They come with significant risks but the potential rewards are great Here s why Celldex Therapeutics NASDAQ CLDX Geron NASDAQ GERN Halozyme","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fqiiWgVFwR8/5-small-cap-biotech-stocks-to-buy-in-february-cm738331"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"3 Beaten-Down Biotech Stocks You Can Buy Right Now","publication_date":"2017-01-19 17:58:02 +0000","summary":"What goes up must come down But what about the other way around That could be the case for three beaten down biotech stocks Celldex Therapeutics NASDAQ CLDX Geron NASDAQ GERN and Vertex Pharmaceuticals NASDAQ VRTX Here s why buying these biotech stocks","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BmQxdkPYbXY/3-beaten-down-biotech-stocks-you-can-buy-right-now-cm735531"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : January 12, 2017","publication_date":"2017-01-12 12:50:52 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Geron Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/7aa4fd11-d6c3-32bd-9031-5ac2a853eb26/geron-corp-breached-its-50-day-moving-average-in-a-bearish-manner-gern-us-january-12-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : January 12, 2017","publication_date":"2017-01-12 12:50:52 +0000","summary":"Geron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : January 12, 2017","url":"http://www.capitalcube.com/blog/index.php/geron-corp-breached-its-50-day-moving-average-in-a-bearish-manner-gern-us-january-12-2017/"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Biotech Industry Off to a Strong Start in 2017 Latest Reports on Halozyme Therapeutics and Geron","publication_date":"2017-01-09 14:30:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / January 9, 2017 / The Biotech Industry has had a strong start to the year after a rocky 2016. The iShares NASDAQ Biotechnology Index ETF ( IBB ) and the SPDR S&P Biotech ETF ...","url":"http://finance.yahoo.com/news/biotech-industry-off-strong-start-143000493.html?.tsrc=rss"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Biotech Industry Off to a Strong Start in 2017 Latest Reports on Halozyme Therapeutics and Geron","publication_date":"2017-01-09 14:30:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / January 9, 2017 / The Biotech Industry has had a strong start to the year after a rocky 2016. The iShares NASDAQ Biotechnology Index ETF ( IBB ) and the SPDR S&P Biotech ETF ...","url":"http://finance.yahoo.com/news/biotech-industry-off-strong-start-143000493.html"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"GERON CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Sta","publication_date":"2017-01-09 12:32:49 +0000","summary":"GERON CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Sta","url":"http://biz.yahoo.com/e/170109/gern8-k.html"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Friday's ETF Movers: XBI, GDXJ","publication_date":"2017-01-06 19:48:57 +0000","summary":"In trading on Friday the SPDR S amp P Biotech ETF XBI is outperforming other ETFs up about 1 7 on the day Components of that ETF showing particular strength include shares of Geron GERN up about 6 8 and shares of Momenta Pharmaceuticals MNTA up about 6 1 on the day","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EEnuCUcDR9s/fridays-etf-movers-xbi-gdxj-cm730537"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"3 Reasons Geron Corporation Plunged 57% in 2016","publication_date":"2017-01-05 15:39:59 +0000","summary":"Image source Getty Images What happened Shares of Geron Corporation NASDAQ GERN a clinical stage biotechnology company focused on development treatments to fight cancer plunged a whopping 57 in 2016 according to data from S amp P Global Market Intelligence","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6iCa5gnrq7I/3-reasons-geron-corporation-plunged-57-in-2016-cm729765"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"3 Reasons Geron Corporation Plunged 57% in 2016","publication_date":"2017-01-05 13:27:08 +0000","summary":"3 Reasons Geron Corporation Plunged 57% in 2016","url":"http://www.fool.com/investing/2017/01/05/3-reasons-geron-corporation-plunged-57-in-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"ETFs with exposure to Geron Corp. : December 29, 2016","publication_date":"2016-12-29 18:58:55 +0000","summary":"ETFs with exposure to Geron Corp. : December 29, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-geron-corp-december-29-2016/"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"4 Biotech Stocks to Buy in January","publication_date":"2016-12-27 13:52:18 +0000","summary":"4 Biotech Stocks to Buy in January","url":"http://www.fool.com/investing/2016/12/26/4-biotech-stocks-to-buy-in-january.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"4 Biotech Stocks to Buy in January","publication_date":"2016-12-26 14:58:07 +0000","summary":"When an entire sector goes on sale it tends to create bargains There s no doubt that the biotech sector has the blue light special flashing right now as it has massively underperformed the S amp P 500 year to date Knowing that we asked a team of healthcare contributors","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NflNs50fciM/4-biotech-stocks-to-buy-in-january-cm726063"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Corp. breached its 50 day moving average in a Bullish Manner : GERN-US : December 26, 2016","publication_date":"2016-12-26 12:27:00 +0000","summary":"Geron Corp. breached its 50 day moving average in a Bullish Manner : GERN-US : December 26, 2016","url":"http://www.capitalcube.com/blog/index.php/geron-corp-breached-its-50-day-moving-average-in-a-bullish-manner-gern-us-december-26-2016/"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"3 Stocks Under $10 to Buy in 2017","publication_date":"2016-12-19 16:00:39 +0000","summary":"Image source The Motley Fool If you ve got 10 burning a hole in your pocket I have some stock ideas for you I ve been highlighting attractive opportunities in low priced stocks since my original 5 Stocks Under 10 column nearly 16 years ago and I ve seen plenty of stocks","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TgCGART5AJA/3-stocks-under-10-to-buy-in-2017-cm723231"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Corp. – Value Analysis (NASDAQ:GERN) : December 19, 2016","publication_date":"2016-12-19 15:38:39 +0000","summary":"Geron Corp. – Value Analysis (NASDAQ:GERN) : December 19, 2016","url":"http://www.capitalcube.com/blog/index.php/geron-corp-value-analysis-nasdaqgern-december-19-2016/"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"3 Stocks Under $10 to Buy in 2017","publication_date":"2016-12-19 14:07:00 +0000","summary":"3 Stocks Under $10 to Buy in 2017","url":"http://www.fool.com/investing/2016/12/19/3-stocks-under-10-to-buy-in-2017.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Johnson & Johnson Wisely Bids Adieu to Actelion","publication_date":"2016-12-16 17:58:40 +0000","summary":"Image source Getty Images The courtship is officially over As reported by the Associated Press on Tuesday Dec 13 Johnson amp Johnson NYSE JNJ is no longer actively pursuing Swiss drugmaker Actelion NASDAQOTH ALIOF after making two separate bids for the lung","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7p4a5FZ5eGg/johnson-johnson-wisely-bids-adieu-to-actelion-cm722628"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Corp. breached its 50 day moving average in a Bullish Manner : GERN-US : December 16, 2016","publication_date":"2016-12-16 12:07:27 +0000","summary":"Geron Corp. breached its 50 day moving average in a Bullish Manner : GERN-US : December 16, 2016","url":"http://www.capitalcube.com/blog/index.php/geron-corp-breached-its-50-day-moving-average-in-a-bullish-manner-gern-us-december-16-2016/"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Could Geron Corporation Be a Millionaire-Maker Stock?","publication_date":"2016-12-13 17:22:03 +0000","summary":"Could Geron Corporation Be a Millionaire-Maker Stock?","url":"http://www.fool.com/investing/2016/12/12/could-geron-corporation-be-a-millionaire-maker-sto.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Could Geron Corporation Be a Millionaire-Maker Stock?","publication_date":"2016-12-12 17:58:35 +0000","summary":"Image source Getty Images Investors have been on a wild ride with Geron Corporation NASDAQ GERN in the last five years Its lead and only drug imetelstat has enjoyed all the ups and downs of clinical development Promising results in late 2013 for oncology indications","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ev4zYLZ7eG0/could-geron-corporation-be-a-millionaire-maker-stock-cm720227"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"ETFs with exposure to Geron Corp. : December 12, 2016","publication_date":"2016-12-12 16:04:45 +0000","summary":"ETFs with exposure to Geron Corp. : December 12, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-geron-corp-december-12-2016/"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"3 Beaten-Up Biotech Stocks: Are They Bargains?","publication_date":"2016-12-10 16:05:04 +0000","summary":"3 Beaten-Up Biotech Stocks: Are They Bargains?","url":"http://www.fool.com/investing/2016/12/09/3-beaten-up-biotech-stocks-are-they-bargains-2.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"3 Beaten-Up Biotech Stocks: Are They Bargains?","publication_date":"2016-12-09 17:58:23 +0000","summary":"Looking for cheap biotech stocks Shares of ACADIA Pharmaceuticals NASDAQ ACAD Agenus Inc NASDAQ AGEN and Geron Corp NASDAQ GERN have all taken big hits over the past few months Image source Getty Images There are reasons to suspect all","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QHpJx3kLxNw/3-beaten-up-biotech-stocks-are-they-bargains-cm719395"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"4 Small-Cap Stocks Worth Buying in 2017","publication_date":"2016-12-07 13:56:37 +0000","summary":"Image source Getty Images A common misconception about small cap stocks is that they re volatile and risky With quite a few small caps stocks receiving very little coverage from Wall Street there aren t enough analysts to argue against that perception However the reality is","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7M31N1FF4Uk/4-small-cap-stocks-worth-buying-in-2017-cm717821"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"4 Small-Cap Stocks Worth Buying in 2017","publication_date":"2016-12-07 12:46:07 +0000","summary":"4 Small-Cap Stocks Worth Buying in 2017","url":"http://www.fool.com/investing/2016/12/07/4-small-cap-stocks-worth-buying-in-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GERN","figi_ticker":"GERN:US","figi":"BBG000GX1891","title":"Geron Reports Imetelstat Presentations at American Society of Hematology Annual Meeting","publication_date":"2016-12-06 21:01:00 +0000","summary":"[GlobeNewswire] - MENLO PARK, Calif., Dec. 06, 2016-- Geron Corporation today announced four presentations of exploratory preclinical and clinical data related to the imetelstat program at the 58th American Society of Hematology ...","url":"http://finance.yahoo.com/news/geron-reports-imetelstat-presentations-american-210100655.html"}],"result_count":340,"page_size":100,"current_page":1,"total_pages":4,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"2.6522"},{"x":"1494596100","y":"2.6622"},{"x":"1494596400","y":"2.8"},{"x":"1494596700","y":"2.85"},{"x":"1494597000","y":"2.83"},{"x":"1494597300","y":"2.83"},{"x":"1494597600","y":"2.8369999999999997"},{"x":"1494597900","y":"2.8548"},{"x":"1494598200","y":"2.875"},{"x":"1494598500","y":"2.91"},{"x":"1494598800","y":"2.9101"},{"x":"1494599100","y":"2.9099"},{"x":"1494599400","y":"2.87"},{"x":"1494599700","y":"2.9051"},{"x":"1494600000","y":"2.9050000000000002"},{"x":"1494600300","y":"2.91"},{"x":"1494600600","y":"2.93"},{"x":"1494600900","y":"2.9599"},{"x":"1494601200","y":"2.98"},{"x":"1494601500","y":"2.981"},{"x":"1494601800","y":"2.9372"},{"x":"1494602100","y":"2.955"},{"x":"1494602400","y":"2.9699999999999998"},{"x":"1494602700","y":"2.93"},{"x":"1494603000","y":"2.9101"},{"x":"1494603300","y":"2.9"},{"x":"1494603600","y":"2.9115"},{"x":"1494603900","y":"2.91"},{"x":"1494604200","y":"2.93"},{"x":"1494604500","y":"2.94"},{"x":"1494604800","y":"2.94"},{"x":"1494605100","y":"2.92"},{"x":"1494605400","y":"2.92"},{"x":"1494605700","y":"2.93"},{"x":"1494606000","y":"2.935"},{"x":"1494606300","y":"2.945"},{"x":"1494606600","y":"2.92"},{"x":"1494606900","y":"2.93"},{"x":"1494607200","y":"2.93"},{"x":"1494607500","y":"2.96"},{"x":"1494607800","y":"2.96"},{"x":"1494608100","y":"2.96"},{"x":"1494608400","y":"2.95"},{"x":"1494608700","y":"2.9565"},{"x":"1494609000","y":"2.95"},{"x":"1494609300","y":"2.955"},{"x":"1494609600","y":"2.95"},{"x":"1494609900","y":"2.94"},{"x":"1494610200","y":"2.93"},{"x":"1494610500","y":"2.93"},{"x":"1494610800","y":"2.925"},{"x":"1494611100","y":"2.935"},{"x":"1494611400","y":"2.94"},{"x":"1494611700","y":"2.95"},{"x":"1494612000","y":"2.945"},{"x":"1494612300","y":"2.945"},{"x":"1494612600","y":"2.94"},{"x":"1494612900","y":"2.94"},{"x":"1494613200","y":"2.935"},{"x":"1494613500","y":"2.87"},{"x":"1494613800","y":"2.83"},{"x":"1494614100","y":"2.924"},{"x":"1494614400","y":"2.915"},{"x":"1494614700","y":"2.891"},{"x":"1494615000","y":"2.9"},{"x":"1494615300","y":"2.89"},{"x":"1494615600","y":"2.89"},{"x":"1494615900","y":"2.88"},{"x":"1494616200","y":"2.87"},{"x":"1494616500","y":"2.87"},{"x":"1494616800","y":"2.885"},{"x":"1494617100","y":"2.87"},{"x":"1494617400","y":"2.87"},{"x":"1494617700","y":"2.85"},{"x":"1494618000","y":"2.875"},{"x":"1494618300","y":"2.875"},{"x":"1494618600","y":"2.885"},{"x":"1494618900","y":"2.87"},{"x":"1494619200","y":"2.87"} ], "color":"#03a9f4"}]},
{"id":"10","symbol": "GPL","name": "Great Panther Silver Limited Ordinary Shares (Canada)","price": 1.3,"dollarChange": 0.11,"percentChange": 8.34,"open": 1.23,"high": 1.32,"low":1.22,"volume": 2125257,"avgVol": 1710483.300000,"sharesShort": 231504,"shortPercent": 0.137894,"marketCap": 209387421,"float": 167885538,"headlines":{"data":[{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Why Agnico Eagle Mines Limited and Coeur Mining, Inc. Were up 12% in April and Great Panther Silver Plummeted 23%","publication_date":"2017-05-05 13:20:00 +0000","summary":"Agnico Eagle and Coeur each had a good month, but Great Panther had a disastrous one, here&apos;s what&apos;s behind the difference.","url":"http://finance.yahoo.com/r/fbfcca1a-9cd9-3f9a-916c-0a49e2eb610b/why-agnico-eagle-mines-limited-and-coeur-mining-in.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther posts 1Q profit","publication_date":"2017-05-03 22:55:26 +0000","summary":"On a per-share basis, the Vancouver, British Columbia-based company said it had net income of 2 cents. The silver mining company posted revenue of $12.4 million in the period. In the final minutes of trading ...","url":"http://finance.yahoo.com/news/great-panther-posts-1q-profit-225526934.html?.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver Reports First Quarter 2017 Financial Results","publication_date":"2017-05-03 22:30:00 +0000","summary":"TSX: GPR NYSE MKT: GPL VANCOUVER, May 3, 2017 /PRNewswire/ - GREAT PANTHER SILVER LIMITED (TSX: GPR) (NYSE MKT: GPL) (\"Great Panther\"; or the \"Company\") today reported financial results ...","url":"http://finance.yahoo.com/news/great-panther-silver-reports-first-223000126.html?.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver Reports First Quarter 2017 Financial Results","publication_date":"2017-05-03 22:30:00 +0000","summary":"Great Panther Silver Reports First Quarter 2017 Financial Results","url":"http://finance.yahoo.com/news/great-panther-silver-reports-first-223000644.html?.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Friday Sector Leaders: Precious Metals, Non-Precious Metals & Non-Metallic Mining Stocks","publication_date":"2017-04-28 18:27:17 +0000","summary":"In trading on Friday precious metals shares were relative leaders up on the day by about 1 9 Leading the group were shares of Agnico Eagle Mines AEM up about 9 4 and shares of Great Panther Silver GPL up about 7 8 on the day Also showing relative strength are non","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GsioAfRUi9Q/friday-sector-leaders-precious-metals-non-precious-metals-non-metallic-mining-stocks-cm781350"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Friday's ETF Movers: GDXJ, IYZ","publication_date":"2017-04-28 18:26:59 +0000","summary":"In trading on Friday the Junior Gold Miners ETF GDXJ is outperforming other ETFs up about 3 5 on the day Components of that ETF showing particular strength include shares of Great Panther Silver GPL up about 7 8 and shares of Endeavour Silver EXK up about 5 8 on the","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/draki2G1P_U/fridays-etf-movers-gdxj-iyz-cm781346"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver to Announce First Quarter Financial Results on May 3, 2017","publication_date":"2017-04-26 12:30:00 +0000","summary":"CONFERENCE CALL AND WEBCAST ON MAY 4, 2017 TSX: GPR NYSE MKT: GPL VANCOUVER, April 26, 2017 /PRNewswire/ - GREAT PANTHER SILVER LIMITED (TSX: GPR; NYSE MKT: GPL) (\"Great Panther\", the \"Company\") ...","url":"http://finance.yahoo.com/news/great-panther-silver-announce-first-123000648.html?.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Here's Why Great Panther Silver Ltd. Shares Tarnished and Lost As Much As 11%","publication_date":"2017-04-26 00:06:28 +0000","summary":"What happened Shares of Great Panther Silver NYSEMKT GPL a mid tier silver and gold mining company dipped as much as 11 during Tuesday s trading session The reason for the drop can be attributed to weakness in the underlying precious metals perpetrated by an ongoing","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vZ23onfT_Q8/heres-why-great-panther-silver-ltd-shares-tarnished-and-lost-as-much-as-11-cm779156"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Here&apos;s Why Great Panther Silver Ltd. Shares Tarnished and Lost As Much As 11%","publication_date":"2017-04-25 21:59:00 +0000","summary":"French election fallout continues to take its toll on precious-metal miners.","url":"http://finance.yahoo.com/r/1e6aa538-8e00-3a1b-b170-369b7e47d9c4/heres-why-great-panther-silver-ltd-shares-tarnishe.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver Limited Appoints Board Director","publication_date":"2017-04-13 12:30:00 +0000","summary":"Great Panther Silver Limited Appoints Board Director","url":"http://finance.yahoo.com/news/great-panther-silver-limited-appoints-123000865.html?.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver Reports First Quarter 2017 Production Results","publication_date":"2017-04-11 12:00:00 +0000","summary":"Great Panther Silver Reports First Quarter 2017 Production Results","url":"http://finance.yahoo.com/news/great-panther-silver-reports-first-120000008.html?.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"ETFs with exposure to Great Panther Silver Ltd. : April 7, 2017","publication_date":"2017-04-07 20:42:15 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Great Panther Silver Ltd. Here are 5 ETFs with the largest exposure to GPL-US. Comparing the performance and risk of Great Panther Silver Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/0b549515-c83f-31bf-ac20-44a63d608890/etfs-with-exposure-to-great-panther-silver-ltd-april-7-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver announces management changes","publication_date":"2017-04-05 12:30:00 +0000","summary":"Mr. Archer co-founded Great Panther Silver in 2004 and has led the Company's successful growth into a respected primary silver producer.  He has positioned Great Panther with a strong balance sheet, a strong base of operations in Mexico, and significant growth opportunity in Peru.  In this regard, the Company is well placed to capitalize on growth opportunities with its existing assets and through acquisitions.  \"As Great Panther embarks on the next phase of its growth into a mid-tier producer, I believe that this is the right time for the Company to transition to new leadership,\" stated Mr. Archer. In addition, the Company is pleased to announce the appointment of Samuel Mah, P.Eng.","url":"http://finance.yahoo.com/news/great-panther-silver-announces-management-123000228.html?.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"3 Top Silver Stocks to Buy in 2017","publication_date":"2017-03-25 13:59:28 +0000","summary":"Silver is an interesting precious metal Like gold it s a store of wealth but silver gets used a lot more than gold in industrial applications For investors that means a more stable demand profile for silver stocks like Silver Wheaton Corp NYSE SLW and miners like Pan","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HP6MMyioXzQ/3-top-silver-stocks-to-buy-in-2017-cm765585"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"3 Top Silver Stocks to Buy in 2017","publication_date":"2017-03-25 12:10:00 +0000","summary":"3 Top Silver Stocks to Buy in 2017","url":"https://www.fool.com/investing/2017/03/25/3-top-silver-stocks-to-buy-in-2017.aspx"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"3 Top Silver Stocks to Buy in 2017","publication_date":"2017-03-25 12:10:00 +0000","summary":"Silver prices have rebounded from their lows, and these three silver stocks still have material investor appeal.","url":"http://finance.yahoo.com/r/7e35c955-874c-3ed2-9792-764f884f6251/3-top-silver-stocks-to-buy-in-2017.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Top Ranked Momentum Stocks to Buy for March 16th","publication_date":"2017-03-16 17:09:06 +0000","summary":"Here are four stocks with buy rank and strong momentum characteristics for investors to consider today March 16th Central European Media Enterprises Ltd CETV This entertainment and media company has a Zacks Rank 2 Buy and witnessedthe Zacks Consensus Estimate for its current","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BfyxHB208gc/top-ranked-momentum-stocks-to-buy-for-march-16th-cm761814"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Top Ranked Momentum Stocks to Buy for March 16th","publication_date":"2017-03-16 14:05:02 +0000","summary":"Top Ranked Momentum Stocks to Buy for March 16th","url":"http://finance.yahoo.com/news/top-ranked-momentum-stocks-buy-140502561.html?.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Top Ranked Momentum Stocks to Buy for March 16th","publication_date":"2017-03-16 14:05:02 +0000","summary":"Top Ranked Momentum Stocks to Buy for March 16th","url":"http://finance.yahoo.com/news/top-ranked-momentum-stocks-buy-140502561.html"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"The Gold Report Interviews Great Panther Silver's CEO Bob Archer","publication_date":"2017-03-15 13:00:00 +0000","summary":"[Marketwired] - Great Panther Silver Limited's modus operandi is to buy a past-producing mine, get it up and running as quickly as possible, and use the cash flow to fund more acquisitions, says CEO Bob Archer in this ...","url":"http://finance.yahoo.com/news/gold-report-interviews-great-panther-130000153.html"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"The Gold Report Interviews Great Panther Silver's CEO Bob Archer","publication_date":"2017-03-15 13:00:00 +0000","summary":"Great Panther Silver Limited's modus operandi is to buy a past-producing mine, get it up and running as quickly as possible, and use the cash flow to fund more acquisitions, says CEO Bob Archer in this ...","url":"http://finance.yahoo.com/news/gold-report-interviews-great-panther-130000153.html?.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver Ltd. :GPL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 14, 2017","publication_date":"2017-03-14 16:51:01 +0000","summary":"Great Panther Silver Ltd. :GPL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 14, 2017","url":"http://www.capitalcube.com/blog/index.php/great-panther-silver-ltd-gpl-us-earnings-analysis-q4-2016-by-the-numbers-march-14-2017/"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver Ltd. :GPL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 14, 2017","publication_date":"2017-03-14 16:51:01 +0000","summary":"Categories: Yahoo Finance Get free summary analysis Great Panther Silver Ltd. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Great Panther Silver Ltd. – Endeavour Silver Corp., Silvercorp Metals Inc., Silver Standard Resources Inc., Pan American Silver Corp., First Majestic Silver Corp. and Hecla Mining Company ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/1886efe2-9791-3df3-a52c-f41bf1db766e/great-panther-silver-ltd-gpl-us-earnings-analysis-q4-2016-by-the-numbers-march-14-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Zacks Investment Ideas feature highlights: Alamos Gold, Avino Silver, Fortuna Silver and Great Panther Silver","publication_date":"2017-03-14 15:09:16 +0000","summary":"For Immediate Release Chicago IL March 14 2017 Today Zacks Investment Ideas feature highlights Features Alamos Gold NYSE AGI Free Report Avino Silver NYSEMKT ASM Free Report Fortuna Silver NYSE FSM Free Report and Great","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QgJFcOhlfsM/zacks-investment-ideas-feature-highlights-alamos-gold-avino-silver-fortuna-silver-and-great-panther-silver-cm760447"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Zacks Investment Ideas feature highlights: Alamos Gold, Avino Silver, Fortuna Silver and Great Panther Silver","publication_date":"2017-03-14 13:30:01 +0000","summary":"Zacks Investment Ideas feature highlights: Alamos Gold, Avino Silver, Fortuna Silver and Great Panther Silver","url":"http://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-133001381.html?.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Zacks Investment Ideas feature highlights: Alamos Gold, Avino Silver, Fortuna Silver and Great Panther Silver","publication_date":"2017-03-14 13:30:01 +0000","summary":"Zacks Investment Ideas feature highlights: Alamos Gold, Avino Silver, Fortuna Silver and Great Panther Silver","url":"http://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-133001381.html"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Bitcoin Crash Creates Golden Opportunity","publication_date":"2017-03-12 07:10:04 +0000","summary":"I ve been wrong about my timing of the silver and gold trade twice now Once to my followers in Momentum Trader and another time in a much more public way on Bloomberg the end of last year My fundamental investment thesis surrounding gold hasn t been wrong just my timing And now with","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aKLURXREyiU/bitcoin-crash-creates-golden-opportunity-cm759695"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Bitcoin Crash Creates Golden Opportunity","publication_date":"2017-03-12 00:33:12 +0000","summary":"Bitcoin Crash Creates Golden Opportunity","url":"http://finance.yahoo.com/news/bitcoin-crash-creates-golden-opportunity-013301848.html?.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Bitcoin Crash Creates Golden Opportunity","publication_date":"2017-03-12 00:33:12 +0000","summary":"Bitcoin Crash Creates Golden Opportunity","url":"http://finance.yahoo.com/news/bitcoin-crash-creates-golden-opportunity-013301848.html"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Top Ranked Momentum Stocks to Buy for March 8th","publication_date":"2017-03-08 18:14:45 +0000","summary":"Here are four stocks with buy rank and strong momentum characteristics for investors to consider today March 8th Compania Cervecerías Unidas S A CCU This Chilean multinational beverage companyhas a Zacks Rank 2 Buy and witnessedthe Zacks Consensus Estimate for its current year","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/quWsOTn4B24/top-ranked-momentum-stocks-to-buy-for-march-8th-cm758065"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Top Ranked Momentum Stocks to Buy for March 8th","publication_date":"2017-03-08 15:41:03 +0000","summary":"Top Ranked Momentum Stocks to Buy for March 8th","url":"http://finance.yahoo.com/news/top-ranked-momentum-stocks-buy-154103304.html"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Friday's ETF Movers: ILF, GDXJ","publication_date":"2017-03-03 19:13:01 +0000","summary":"In trading on Friday the iShares Latin America 40 ETF is outperforming other ETFs up about 1 7 on the day Components of that ETF showing particular strength include shares of Companhia Energetica de Minas up about 4 5 and shares of Embraer up about 3 2 on the day And","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5iQKA72im00/fridays-etf-movers-ilf-gdxj-cm756106"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther reports 4Q loss","publication_date":"2017-02-28 00:55:51 +0000","summary":"Great Panther reports 4Q loss","url":"http://sg.finance.yahoo.com/news/great-panther-reports-4q-loss-005551221.html"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther reports 4Q loss","publication_date":"2017-02-28 00:55:51 +0000","summary":"The Vancouver, British Columbia-based company said it had a loss of 1 cent per share. The silver mining company posted revenue of $12.5 million in the period. For the year, the company reported that its ...","url":"http://finance.yahoo.com/news/great-panther-reports-4q-loss-005551711.html?.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver Reports Fiscal Year 2016 Financial Results","publication_date":"2017-02-27 23:51:00 +0000","summary":"[PR Newswire] - TSX: GPR NYSE MKT: GPL VANCOUVER, Feb. 27, 2017 /PRNewswire/ - GREAT PANTHER SILVER LIMITED (TSX: GPR) (NYSE MKT: GPL) (\"Great Panther\"; or the \"Company\") today reported financial results ...","url":"http://finance.yahoo.com/news/great-panther-silver-reports-fiscal-235100838.html"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver Reports Fiscal Year 2016 Financial Results","publication_date":"2017-02-27 23:51:00 +0000","summary":"Great Panther Silver Reports Fiscal Year 2016 Financial Results","url":"http://finance.yahoo.com/news/great-panther-silver-reports-fiscal-235100012.html?.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"10:10 am Great Panther Silver updates the Mineral Resource Estimate for its Guanajuato Mine Complex","publication_date":"2017-02-21 15:10:00 +0000","summary":"10:10 am Great Panther Silver updates the Mineral Resource Estimate for its Guanajuato Mine Complex","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#gpl"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver updates Mineral Resource Estimate at the Guanajuato Mine Complex","publication_date":"2017-02-21 15:07:00 +0000","summary":"Great Panther Silver updates Mineral Resource Estimate at the Guanajuato Mine Complex","url":"http://finance.yahoo.com/news/great-panther-silver-updates-mineral-150700161.html?.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver updates Mineral Resource Estimate at the Guanajuato Mine Complex","publication_date":"2017-02-21 15:07:00 +0000","summary":"TSX: GPR NYSE MKT: GPL VANCOUVER , Feb. 21, 2017 /PRNewswire/ - GREAT PANTHER SILVER LIMITED (TSX: GPR; NYSE MKT: GPL) (\"Great Panther\"; the \"Company\") announces an updated Mineral ...","url":"http://finance.yahoo.com/news/great-panther-silver-updates-mineral-150700866.html?.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver updates Mineral Resource Estimate at the Guanajuato Mine Complex","publication_date":"2017-02-21 15:07:00 +0000","summary":"[CNW Group] - Great Panther Silver updates Mineral Resource Estimate at the Guanajuato Mine Complex","url":"http://finance.yahoo.com/news/great-panther-silver-updates-mineral-150700161.html"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"4 Stocks Under $4 That Could Double","publication_date":"2017-02-09 16:05:07 +0000","summary":"These stocks may be small, but they could pack quite a punch for your portfolio.","url":"http://finance.yahoo.com/r/5df83fd5-7a48-3160-bc2a-6960d321cbe3/4-stocks-under-4-that-could-double.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2&yptr=yahoo&.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"4 Stocks Under $4 That Could Double","publication_date":"2017-02-09 16:05:07 +0000","summary":"4 Stocks Under $4 That Could Double","url":"http://www.fool.com/investing/2017/02/09/4-stocks-under-4-that-could-double.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver to announce fiscal year 2016 financial results on February 27, 2017","publication_date":"2017-02-08 13:30:00 +0000","summary":"[CNW Group] - Great Panther Silver to announce fiscal year 2016 financial results on February 27, 2017","url":"http://finance.yahoo.com/news/great-panther-silver-announce-fiscal-133000235.html"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver to announce fiscal year 2016 financial results on February 27, 2017","publication_date":"2017-02-08 13:30:00 +0000","summary":"CONFERENCE  CALL  AND  WEBCAST  ON  FEBRUARY  28,  2017 TSX: GPR NYSE MKT: GPL VANCOUVER, Feb. 8, 2017 /PRNewswire/ - GREAT PANTHER SILVER LIMITED (TSX: GPR; NYSE MKT: GPL) (\"Great Panther\", ...","url":"http://finance.yahoo.com/news/great-panther-silver-announce-fiscal-133000228.html?.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Friday's ETF Movers: GDXJ, EMLP","publication_date":"2017-01-27 22:32:11 +0000","summary":"In trading on Friday the Junior Gold Miners ETF GDXJ is outperforming other ETFs up about 1 5 on the day Components of that ETF showing particular strength include shares of Guyana Goldfields GUY CA up about 4 7 and shares of Great Panther Silver GPL up about 4 1 on the","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b14o4cR0ubI/fridays-etf-movers-gdxj-emlp-cm739648"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Top 3 Silver Stocks for 2017","publication_date":"2017-01-26 17:57:00 +0000","summary":"Top 3 Silver Stocks for 2017","url":"http://www.investopedia.com/investing/silver-stocks/?partner=YahooSA"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Top 3 Silver Stocks for 2017","publication_date":"2017-01-26 17:57:00 +0000","summary":"These three silver stocks should beat their peers going into 2017.","url":"http://finance.yahoo.com/r/69f10ccb-bf80-3130-b181-b59e716cfb30/silver-stocks?partner=YahooSA&yptr=yahoo&.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Monday's ETF Movers: GDXJ, OIH","publication_date":"2017-01-23 19:31:10 +0000","summary":"In trading on Monday the Junior Gold Miners ETF GDXJ is outperforming other ETFs up about 2 4 on the day Components of that ETF showing particular strength include shares of Seabridge Gold SA up about 4 7 and shares of Great Panther Silver GPL up about 4 2 on the","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BOEQcuoVQaQ/mondays-etf-movers-gdxj-oih-cm736904"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"The 3 Biggest Surprises From Silver Stocks in 2016","publication_date":"2017-01-13 17:39:32 +0000","summary":"Image source Getty Images Downtrend no more Silver ended a three year slide in 2016 with physical silver increasing by roughly 15 from where it began the year Nonetheless ending the year at 15 90 per ounce is still a far cry from the 48 28 per ounce closing high struck in","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6ExO7Rt-e9Y/the-3-biggest-surprises-from-silver-stocks-in-2016-cm733368"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"The 3 Biggest Surprises From Silver Stocks in 2016","publication_date":"2017-01-13 15:55:24 +0000","summary":"Silver stocks had a great year, but that doesn't mean things went as planned.","url":"http://finance.yahoo.com/r/0b23c7ae-3bdb-3d29-98c7-330fcc148200/the-3-biggest-surprises-from-silver-stocks-in-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2&yptr=yahoo&.tsrc=rss"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"The 3 Biggest Surprises From Silver Stocks in 2016","publication_date":"2017-01-13 15:55:24 +0000","summary":"The 3 Biggest Surprises From Silver Stocks in 2016","url":"http://www.fool.com/investing/2017/01/13/the-3-biggest-surprises-from-silver-stocks-in-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver Reports Fourth Quarter and Annual 2016 Production Results and Provides 2017 Outlook","publication_date":"2017-01-11 13:30:00 +0000","summary":"[PR Newswire] - TSX: GPR NYSE MKT: GPL VANCOUVER, Jan. 11, 2017 /PRNewswire/ - GREAT PANTHER SILVER LIMITED (TSX: GPR; NYSE MKT: GPL) (\"Great Panther\"; the \"Company\") announces its fourth quarter (\"Q4\") ...","url":"http://finance.yahoo.com/news/great-panther-silver-reports-fourth-133000534.html"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Why Great Panther Silver Rose 11% While First Majestic Silver and Hecla Mining Fell Over 13% in December","publication_date":"2017-01-06 21:50:00 +0000","summary":"Image source Great Panther Limited What happened Shares of First Majestic Silver Corp NYSE AG fell 14 last month Hecla Mining Company s NYSE HL stock declined 13 and fellow silver miner Great Panther Silver NYSEMKT GPL saw its shares advance 11 What","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wb77Mrt-Dpc/why-great-panther-silver-rose-11-while-first-majestic-silver-and-hecla-mining-fell-over-13-in-december-cm730587"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Why Great Panther Silver Rose 11% While First Majestic Silver and Hecla Mining Fell Over 13% in December","publication_date":"2017-01-06 19:57:11 +0000","summary":"Why Great Panther Silver Rose 11% While First Majestic Silver and Hecla Mining Fell Over 13% in December","url":"http://www.fool.com/investing/2017/01/06/great-panther-silver-rose-first-majestic-hecla-fel.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"ETFs with exposure to Great Panther Silver Ltd. : January 4, 2017","publication_date":"2017-01-04 16:02:57 +0000","summary":"ETFs with exposure to Great Panther Silver Ltd. : January 4, 2017","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-great-panther-silver-ltd-january-4-2017/"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"6 Top Performing Stocks of the Best ETF of 2016","publication_date":"2016-12-29 16:58:35 +0000","summary":"Precious metals like gold and silver enjoyed a bullish run this year as global uncertainty Brexit concerns and financial market instability bolstered demand for precious metals especially in the first half of 2016 However gold lost its luster in the second half on a strong greenback","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Um8MbbiEqUE/6-top-performing-stocks-of-the-best-etf-of-2016-cm727435"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"3 Top Silver Stocks to Buy in 2017","publication_date":"2016-12-29 15:07:45 +0000","summary":"3 Top Silver Stocks to Buy in 2017","url":"http://www.fool.com/investing/2016/12/28/3-top-silver-stocks-to-buy-in-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"3 Top Silver Stocks to Buy in 2017","publication_date":"2016-12-28 17:00:12 +0000","summary":"Image source Getty Images It s been quite the ride for silver in 2016 After dipping below 14 per ounce early this year and touching a low that hadn t been seen since the Great Recession physical silver prices were at one point briefly up more than 50 by midyear Since","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2qOlSg9lCls/3-top-silver-stocks-to-buy-in-2017-cm726956"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"ETFs with exposure to Great Panther Silver Ltd. : December 23, 2016","publication_date":"2016-12-23 17:45:29 +0000","summary":"ETFs with exposure to Great Panther Silver Ltd. : December 23, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-great-panther-silver-ltd-december-23-2016/"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver Ltd Pins Its Future on the Ability to Relive the Past","publication_date":"2016-12-22 17:59:48 +0000","summary":"Image source Getty Images Great Panther Silver NYSEMKT GPL has a knack for resurrecting dormant precious metals mines and returning them back to their former glory The company built its current Mexican mining business by acquiring past producing mines and returning them","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6qQcWIGd_sc/great-panther-silver-ltd-pins-its-future-on-the-ability-to-relive-the-past-cm725241"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver Ltd Pins Its Future on the Ability to Relive the Past","publication_date":"2016-12-22 16:21:08 +0000","summary":"Great Panther Silver Ltd Pins Its Future on the Ability to Relive the Past","url":"http://www.fool.com/investing/2016/12/22/great-panther-silver-ltd-pins-its-future-on-the-ab.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver to Acquire Coricancha Polymetallic Mine in Peru","publication_date":"2016-12-20 06:22:13 +0000","summary":"[at noodls] - TSX: GPR NYSE MKT: GPL VANCOUVER, Dec. 19, 2016 /CNW/ - GREAT PANTHER SILVER LIMITED (TSX: GPR; NYSE MKT: GPL) ('Great Panther' or the 'Company') announces that it has entered into an agreement with subsidiaries ...","url":"http://www.publicnow.com/view/1AF09E1C57298BCE5E4A7169C0060E61055DB61D"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Monday Sector Leaders: Rental, Leasing, & Royalty, Precious Metals","publication_date":"2016-12-12 21:57:22 +0000","summary":"In trading on Monday rental leasing amp royalty shares were relative leaders up on the day by about 1 1 Leading the group were shares of Network 1 Technologies NTIP up about 6 2 and shares of Sandridge Permian Trust PER up about 4 9 on the day Also showing","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/06aBI3X6swg/monday-sector-leaders-rental-leasing-royalty-precious-metals-cm720376"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"9 Reasons Not to Fear Falling Silver Prices","publication_date":"2016-12-02 17:32:50 +0000","summary":"9 Reasons Not to Fear Falling Silver Prices","url":"http://www.fool.com/investing/2016/12/02/9-reasons-not-to-fear-falling-silver-prices.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"The Greatest Small-Cap Stocks You've Never Heard About","publication_date":"2016-12-02 14:02:08 +0000","summary":"The Greatest Small-Cap Stocks You've Never Heard About","url":"http://www.fool.com/investing/2016/12/02/the-greatest-small-cap-stocks-youve-never-heard-ab.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Here's Why Great Panther Silver Ltd's Stock Is Sinking Today","publication_date":"2016-12-01 18:19:07 +0000","summary":"Image source Great Panther Silver What happened Shares of Great Panther Silver NYSEMKT GPL sank on Thursday morning falling nearly 10 by 10 45 a m EST So what After reviewing its options Great Panther Silver has decided to suspend operations at","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W_2egLYdIq4/heres-why-great-panther-silver-ltds-stock-is-sinking-today-cm716495"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Here's Why Great Panther Silver Ltd's Stock Is Sinking Today","publication_date":"2016-12-01 16:37:52 +0000","summary":"Here's Why Great Panther Silver Ltd's Stock Is Sinking Today","url":"http://www.fool.com/investing/2016/12/01/heres-why-great-panther-silver-ltds-stock-is-sinki.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Temporarily Halts Processing at its Topia Mine to Facilitate Transition to New Tailings Facility","publication_date":"2016-12-01 15:21:21 +0000","summary":"[at noodls] - TSX: GPR NYSE MKT: GPL VANCOUVER, Dec. 1, 2016 /CNW/ - GREAT PANTHER SILVER LIMITED (TSX: GPR; NYSE MKT: GPL) ('Great Panther'; the 'Company') announces that, further to a review of its Topia Mine operations ...","url":"http://www.publicnow.com/view/01E2AF9D828B637CA05029678D614B46498FC666"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"3 Things Great Panther Silver Ltd's CEO Wants You to Know","publication_date":"2016-11-15 19:50:41 +0000","summary":"Image source Great Panther Silver Ltd Flickr Page Great Panther Silver NYSEMKT GPL recently reported excellent third quarter results thanks to strong precious metal prices Overall mine operating earnings jumped 64 while operating cash flows surged 160 254 However","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0bgnOZCoj2E/3-things-great-panther-silver-ltds-ceo-wants-you-to-know-cm709607"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"3 Things Great Panther Silver Ltd's CEO Wants You to Know","publication_date":"2016-11-15 18:24:06 +0000","summary":"3 Things Great Panther Silver Ltd's CEO Wants You to Know","url":"http://www.fool.com/investing/2016/11/15/3-things-great-panther-silver-ltds-ceo-wants-you-t.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Here's Why Gold and Silver Miners Are Getting Annihilated (and Why You Shouldn't Panic)","publication_date":"2016-11-11 22:28:38 +0000","summary":"Image source Getty Images Look out below Gold and silver mining stocks are getting annihilated following the announcement that career businessman Donald Trump will become our 45th president of the United States After initially surging to as high as 1 340 per ounce on the night","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zMTa6My5KzU/heres-why-gold-and-silver-miners-are-getting-annihilated-and-why-you-shouldnt-panic-cm708137"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"ETF’s with exposure to Great Panther Silver Ltd. : November 10, 2016","publication_date":"2016-11-10 17:27:50 +0000","summary":"ETF’s with exposure to Great Panther Silver Ltd. : November 10, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-great-panther-silver-ltd-november-10-2016/"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver Ltd. :GPL-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016","publication_date":"2016-11-08 15:30:41 +0000","summary":"Great Panther Silver Ltd. :GPL-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016","url":"http://www.capitalcube.com/blog/index.php/great-panther-silver-ltd-gpl-us-earnings-analysis-q3-2016-by-the-numbers-november-8-2016/"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Will Great Panther Silver (GPL) Continue to Surge Higher?","publication_date":"2016-11-04 15:13:36 +0000","summary":"As of late it has definitely been a great time to be an investor in Great Panther Silver Ltd GPL The stock has moved higher by 23 3 in the past month while it is also above its 20 Day SMA too This combination of strong price performance and favorable technical could suggest that the","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M8jk3kGNAxk/will-great-panther-silver-gpl-continue-to-surge-higher-cm704024"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Will Great Panther Silver (GPL) Continue to Surge Higher?","publication_date":"2016-11-04 13:23:01 +0000","summary":"Will Great Panther Silver (GPL) Continue to Surge Higher?","url":"http://finance.yahoo.com/news/great-panther-silver-gpl-continue-132301567.html"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver Ltd Cashes in on Strong Silver Prices This Quarter","publication_date":"2016-11-03 23:08:00 +0000","summary":"Image source Great Panther Silver Rising silver prices during the third quarter were a boon to Great Panther Silver NYSEMKT GPL which reported hearty growth in earnings and cash flow compared to the prior period This improvement came despite the fact that","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8eJ4hRlypxo/great-panther-silver-ltd-cashes-in-on-strong-silver-prices-this-quarter-cm703714"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver Ltd Cashes in on Strong Silver Prices This Quarter","publication_date":"2016-11-03 21:15:08 +0000","summary":"Great Panther Silver Ltd Cashes in on Strong Silver Prices This Quarter","url":"http://www.fool.com/investing/2016/11/03/great-panther-silver-ltd-cashes-in-on-strong-silve.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther posts 3Q profit","publication_date":"2016-11-03 09:07:45 +0000","summary":"Great Panther posts 3Q profit","url":"http://sg.finance.yahoo.com/news/great-panther-posts-3q-profit-090745340.html"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver Reports Third Quarter 2016 Financial Results","publication_date":"2016-11-03 00:27:03 +0000","summary":"[at noodls] - www.sedar.com. All shareholders can receive a hard copy of the Company's complete audited financial statements free of charge upon request. All financial information is prepared in accordance with IFRS, ...","url":"http://www.publicnow.com/view/27AED810FB6E63DF4B50A2F7C9EC7E3F9631C732"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"3 Terrible Reasons to Buy Great Panther Silver Ltd.","publication_date":"2016-10-31 16:18:12 +0000","summary":"Great Panther Silver Ltd NYSEMKT GPL 160 is a relatively small miner focused on silver as its name implies Generally rising precious metals prices have led the company s stock to an impressive 140 or so advance this year But there s a lot more to understand about this story","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jTi7SPzisJE/3-terrible-reasons-to-buy-great-panther-silver-ltd-cm701104"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"3 Terrible Reasons to Buy Great Panther Silver Ltd.","publication_date":"2016-10-31 14:18:47 +0000","summary":"3 Terrible Reasons to Buy Great Panther Silver Ltd.","url":"http://www.fool.com/investing/2016/10/31/3-terrible-reasons-to-buy-great-panther-silver-ltd.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"These Small-Cap Gold and Silver Miners Could Triple By 2020","publication_date":"2016-10-26 16:15:33 +0000","summary":"These Small-Cap Gold and Silver Miners Could Triple By 2020","url":"http://www.fool.com/investing/2016/10/26/these-small-cap-gold-and-silver-miners-could-tripl.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Zacks.com featured highlights: Galena Biopharma, Check Point Software Technologies, Sequans Communications S.A., CubeSmart and Great Panther Silver","publication_date":"2016-10-26 14:52:15 +0000","summary":"For Immediate Release Chicago IL October 26 2016 Stocks in this week s article include Galena Biopharma Inc NASDAQ GALE Free Report Check Point Software Technologies Ltd NASDAQ CHKP Free Report Sequans Communications S A NYSE SQNS Free","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aLieRaa7Kx0/zackscom-featured-highlights-galena-biopharma-check-point-software-technologies-sequans-communications-sa-cubesmart-and-great-panther-silver-cm698554"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"These Small-Cap Gold and Silver Miners Could Triple By 2020","publication_date":"2016-10-26 14:50:35 +0000","summary":"Image source Getty Images Patient long term investors have been rewarded with solid gains this year as the broad based S amp P 500 has advanced by more than 5 year to date But these gains are chickenfeed compared to what investors in gold and silver minig stocks have seen","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dXfQ539xP5Y/these-small-cap-gold-and-silver-miners-could-triple-by-2020-cm698443"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"5 Top-Ranked Stocks with Rising P/E for Blowout Gains","publication_date":"2016-10-25 12:24:55 +0000","summary":"One of the most common value investing patterns is to hunt for stocks with a low price to earnings P E ratio That s because this basic measure of how much investors are spending for 1 worth of earnings speaks of undervaluation The logic is simple a stock s current market price does","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bFtj-Lh-JrI/5-top-ranked-stocks-with-rising-pe-for-blowout-gains-cm697620"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"5 Top-Ranked Stocks with Rising P/E for Blowout Gains","publication_date":"2016-10-25 10:41:10 +0000","summary":"5 Top-Ranked Stocks with Rising P/E for Blowout Gains","url":"http://finance.yahoo.com/news/5-top-ranked-stocks-rising-104110427.html"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver to Announce Third Quarter 2016 Financial Results on November 2, 2016","publication_date":"2016-10-24 12:41:11 +0000","summary":"[at noodls] - CONFERENCE CALL AND WEBCAST ON NOVEMBER 3, 2016 TSX: GPR NYSE MKT: GPL VANCOUVER, Oct. 24, 2016 /CNW/ - GREAT PANTHER SILVER LIMITED (TSX: GPR; NYSE MKT: GPL) ('Great Panther', the 'Company') has scheduled ...","url":"http://www.publicnow.com/view/1DFA32A2B0DC90E05CFA90A73EC60D393984F69F"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Why Great Panther (GPL) Could Shock the Market Soon","publication_date":"2016-10-19 16:48:58 +0000","summary":"It commonly happens in stock investing that investors miss the chance of buying winning stocks that they knew would stand out Before they take the plunge others get to know the hidden potential and enter into these stocks pushing them out of reach So instead of repenting spotting","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XJFQYf1eVXc/why-great-panther-gpl-could-shock-the-market-soon-cm695420"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Why Great Panther (GPL) Could Shock the Market Soon","publication_date":"2016-10-19 14:49:02 +0000","summary":"Why Great Panther (GPL) Could Shock the Market Soon","url":"http://finance.yahoo.com/news/why-great-panther-gpl-could-144902377.html"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Is Great Panther Silver Ltd’s Slumping Production a Concern?","publication_date":"2016-10-14 15:43:12 +0000","summary":"Image source Great Panther Silver Limited via Flickr Great Panther Silver NYSEMKT GPL was one of several silver mining stocks that reported third quarter production this week Unfortunately its numbers were a bit of a disappointment after consolidated production","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-M1tulDujQ0/is-great-panther-silver-ltds-slumping-production-a-concern-cm693451"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Is Great Panther Silver Ltd’s Slumping Production a Concern?","publication_date":"2016-10-14 13:58:39 +0000","summary":"Is Great Panther Silver Ltd’s Slumping Production a Concern?","url":"http://www.fool.com/investing/2016/10/14/is-great-panther-silver-ltds-slumping-production-a.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver Reports Third Quarter 2016 Production Results","publication_date":"2016-10-12 12:43:04 +0000","summary":"[at noodls] - TSX: GPR NYSE MKT: GPL VANCOUVER, Oct. 12, 2016 /CNW/ - GREAT PANTHER SILVER LIMITED (TSX: GPR; NYSE MKT: GPL) ('Great Panther'; the 'Company') announces production results for the third quarter ('Q3') ...","url":"http://www.publicnow.com/view/8027BEBF6677F7E9F94F3275560756444994C2F7"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver Ltd's Stock Explained in 4 Charts","publication_date":"2016-10-05 17:45:20 +0000","summary":"Image source Great Panther Silver Ltd Great Panther Silver Ltd NYSEMKT GPL is a precious metals miner with a heavy bias as its name suggests toward panthers No seriously silver The stock is up nearly 170 so far this year Clearly silver s solid advance is part of","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uO_bjBR8oEQ/great-panther-silver-ltds-stock-explained-in-4-charts-cm689281"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Great Panther Silver Ltd's Stock Explained in 4 Charts","publication_date":"2016-10-05 17:29:38 +0000","summary":"Great Panther Silver Ltd's Stock Explained in 4 Charts","url":"http://www.fool.com/investing/2016/10/05/great-panther-silver-ltds-stock-explained-in-4-cha.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"5 Oct 16 – Full Year Trading Update","publication_date":"2016-10-05 07:48:03 +0000","summary":"[at noodls] - For immediate release 5 October 2016 Gooch & Housego PLC (\"G&H\" or the \"Company\") Full Year Trading Update \"Trading in line with expectations\" Gooch & Housego PLC (AIM: GHH), ...","url":"http://www.publicnow.com/view/519D6EDE3F24C614A3968FD49C6932D236C729D5"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"Gold and Silver Stocks Are Being Routed. Is Now the Time to Buy?","publication_date":"2016-10-04 20:44:44 +0000","summary":"Image source Getty Images Nothing goes up in a straight line which is what precious metal investors are finding out on Tuesday As of 2 30 p m EDT physical gold was down 39 an ounce to 1 272 its lowest level since the date of the Brexit vote By a similar token silver","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OcUWFS96YMo/gold-and-silver-stocks-are-being-routed-is-now-the-time-to-buy-cm688730"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"28 Sep 16 – TR1 Octopus","publication_date":"2016-09-28 14:49:06 +0000","summary":"[at noodls] - For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or the underlying issuer of existing shares ...","url":"http://www.publicnow.com/view/6B671214290FB117D211A51CCC364E8CB4552782"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"5 Top Silver Stocks to Buy","publication_date":"2016-09-26 13:10:36 +0000","summary":"5 Top Silver Stocks to Buy","url":"http://www.fool.com/investing/2016/09/25/5-top-silver-stocks-to-buy.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"5 Top Silver Stocks to Buy","publication_date":"2016-09-25 14:21:20 +0000","summary":"Image source Getty Images The price of silver is already up nearly 40 this year to just under 20 an ounce It might not be done going up with some suggesting that the next stop for silver is 30 an ounce If that is the case the top silver stocks to buy are the","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2szSMJG2U-w/5-top-silver-stocks-to-buy-cm684221"},{"ticker":"GPR","figi_ticker":"GPR:CT","figi":"BBG000CG1P94","title":"These 7 Silver Stocks Tarnished in August -- Here's Why","publication_date":"2016-09-07 15:19:02 +0000","summary":"Image source Getty Images It s been a tremendous year for investors in silver mining stocks but the month of August provided the first real blemish of the year The Global X Silver Miners ETF which is up 140 year to date through Sept 1 2016 wound up losing 15 of its","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YFHDVTCIOys/these-7-silver-stocks-tarnished-in-august-heres-why-cm675575"}],"result_count":152,"page_size":100,"current_page":1,"total_pages":2,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"1.24"},{"x":"1494596100","y":"1.25"},{"x":"1494596400","y":"1.25"},{"x":"1494596700","y":"1.245"},{"x":"1494597000","y":"1.25"},{"x":"1494597300","y":"1.25"},{"x":"1494597600","y":"1.245"},{"x":"1494597900","y":"1.24"},{"x":"1494598200","y":"1.25"},{"x":"1494598500","y":"1.26"},{"x":"1494598800","y":"1.2599"},{"x":"1494599100","y":"1.26"},{"x":"1494599400","y":"1.27"},{"x":"1494599700","y":"1.27"},{"x":"1494600000","y":"1.2650000000000001"},{"x":"1494600300","y":"1.26"},{"x":"1494600600","y":"1.2599"},{"x":"1494600900","y":"1.255"},{"x":"1494601200","y":"1.255"},{"x":"1494601500","y":"1.26"},{"x":"1494601800","y":"1.27"},{"x":"1494602100","y":"1.27"},{"x":"1494602400","y":"1.2694"},{"x":"1494602700","y":"1.27"},{"x":"1494603000","y":"1.2650000000000001"},{"x":"1494603300","y":"1.2650000000000001"},{"x":"1494603600","y":"1.27"},{"x":"1494603900","y":"1.27"},{"x":"1494604200","y":"1.27"},{"x":"1494604500","y":"1.28"},{"x":"1494604800","y":"1.28"},{"x":"1494605100","y":"1.28"},{"x":"1494605400","y":"1.275"},{"x":"1494605700","y":"1.2786"},{"x":"1494606000","y":"1.28"},{"x":"1494606300","y":"1.275"},{"x":"1494606600","y":"1.28"},{"x":"1494606900","y":"1.28"},{"x":"1494607200","y":"1.28"},{"x":"1494607500","y":"1.28"},{"x":"1494607800","y":"1.28"},{"x":"1494608100","y":"1.2757"},{"x":"1494608400","y":"1.28"},{"x":"1494608700","y":"1.28"},{"x":"1494609000","y":"1.28"},{"x":"1494609300","y":"1.275"},{"x":"1494609600","y":"1.275"},{"x":"1494609900","y":"1.275"},{"x":"1494610200","y":"1.275"},{"x":"1494610500","y":"1.28"},{"x":"1494610800","y":"1.28"},{"x":"1494611100","y":"1.28"},{"x":"1494611400","y":"1.28"},{"x":"1494611700","y":"1.28"},{"x":"1494612000","y":"1.28"},{"x":"1494612300","y":"1.28"},{"x":"1494612600","y":"1.28"},{"x":"1494612900","y":"1.275"},{"x":"1494613200","y":"1.29"},{"x":"1494613500","y":"1.2823"},{"x":"1494613800","y":"1.295"},{"x":"1494614100","y":"1.31"},{"x":"1494614400","y":"1.31"},{"x":"1494614700","y":"1.315"},{"x":"1494615000","y":"1.31"},{"x":"1494615300","y":"1.31"},{"x":"1494615600","y":"1.31"},{"x":"1494615900","y":"1.3"},{"x":"1494616200","y":"1.2964"},{"x":"1494616500","y":"1.296"},{"x":"1494616800","y":"1.29"},{"x":"1494617100","y":"1.29"},{"x":"1494617400","y":"1.3"},{"x":"1494617700","y":"1.3"},{"x":"1494618000","y":"1.2999"},{"x":"1494618300","y":"1.2999"},{"x":"1494618600","y":"1.31"},{"x":"1494618900","y":"1.3"} ], "color":"#03a9f4"}]},
{"id":"11","symbol": "GSAT","name": "Globalstar Inc","price": 2.3,"dollarChange": 0.39,"percentChange": 20.42,"open": 1.9,"high": 2.59,"low":1.9,"volume": 43531559,"avgVol": 5997262.833333,"sharesShort": 51359655,"shortPercent": 4.616938,"marketCap": 2132521248,"float": 1112418177,"headlines":{"data":[{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Why Globalstar, Inc. Stock Popped Today","publication_date":"2017-05-12 18:32:00 +0000","summary":"The satellite communications company jumped following renewed reports of a potential sale.","url":"http://finance.yahoo.com/r/541a3fd7-0fe7-35a6-92ad-de7955c70306/why-globalstar-inc-stock-popped-today.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar Works With Advisers to Explore Potential Sale","publication_date":"2017-05-12 16:44:07 +0000","summary":"Globalstar Inc., which won U.S. approval to use its satellite airwaves for mobile broadband service, is working with financial advisers on a potential sale, people familiar with the matter said.","url":"http://finance.yahoo.com/r/89ed5562-055b-3112-a55a-5a0cb23beda8/globalstar-said-to-work-with-advisers-to-explore-potential-sale?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"ETFs with exposure to Globalstar, Inc. : May 11, 2017","publication_date":"2017-05-11 20:46:01 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Globalstar, Inc. Here are 5 ETFs with the largest exposure to GSAT-US. Comparing the performance and risk of Globalstar, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/251a7327-829b-3800-bcac-9f745677727a/etfs-with-exposure-to-globalstar-inc-may-11-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar Shares Pull Back as Bidding War for Straight Path Ends","publication_date":"2017-05-11 14:38:00 +0000","summary":"Companies with niche wireless spectrum holdings are in demand as Verizon, AT&T and others look to speed up their wireless networks. Investors are adjusting expectations Thursday.","url":"http://finance.yahoo.com/r/60b8b9a3-e26a-3502-ad4d-1d57b9f0086e/globalstar-shares-pull-back-as-bidding-war-for-straight-path-ends.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Edited Transcript of GSAT earnings conference call or presentation 4-May-17 12:30pm GMT","publication_date":"2017-05-10 12:30:59 +0000","summary":"Q1 2017 Globalstar Inc Earnings Call","url":"http://finance.yahoo.com/news/edited-transcript-gsat-earnings-conference-233050868.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar, Inc. :GSAT-US: Earnings Analysis: Q1, 2017 By the Numbers : May 9, 2017","publication_date":"2017-05-09 14:54:19 +0000","summary":"Categories: Yahoo FinanceGet free summary analysis Globalstar, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Globalstar, Inc. – ORBCOMM Inc., Intelsat S.A., Inmarsat plc Unsponsored ADR, Iridium Communications Inc., DISH Network Corporation Class A and Pendrell Corporation (ORBC-US, I-US, IMASY-US, IRDM-US, DISH-US and PCO-US) ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/576df99d-b6cb-3306-80ae-d57a8d333218/globalstar-inc-gsat-us-earnings-analysis-q1-2017-by-the-numbers-may-9-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar reports 1Q loss","publication_date":"2017-05-04 11:49:35 +0000","summary":"The Covington, Louisiana-based company said it had a loss of 2 cents per share. The satellite communications company posted revenue of $24.7 million in the period. The company's shares closed at $1.80. ...","url":"http://finance.yahoo.com/news/globalstar-reports-1q-loss-114935104.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar Announces First Quarter 2017 Results","publication_date":"2017-05-04 11:30:00 +0000","summary":"COVINGTON, La., May 04, 2017-- Globalstar, Inc. today announced its financial results for the quarter ended March 31, 2017.. Jay Monroe, Chairman and Chief Executive Officer of Globalstar, commented,“ ...","url":"http://finance.yahoo.com/news/globalstar-announces-first-quarter-2017-113000006.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar Q1 Net Loss Narrows","publication_date":"2017-05-04 07:57:00 +0000","summary":"Globalstar Q1 Net Loss Narrows","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VdfifF_KFa4/globalstar-q1-net-loss-narrows-20170504-00695"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Could Globalstar be a Takeover Target","publication_date":"2017-05-01 12:00:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / May 1, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and micro-cap public companies is issuing a comprehensive ...","url":"http://finance.yahoo.com/news/could-globalstar-takeover-target-120000559.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar, Inc. Earnings Call Release Notice","publication_date":"2017-04-28 20:05:00 +0000","summary":"COVINGTON, La., April 28, 2017-- Globalstar, Inc. will announce its first quarter 2017 financial results on Thursday, May 4, 2017 before the market opens. The Company will conduct a conference call that ...","url":"http://finance.yahoo.com/news/globalstar-inc-earnings-call-release-200500125.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Expect Telecom M&A Talks to Get Loud as FCC Quiet Period Comes to a Close","publication_date":"2017-04-27 18:42:00 +0000","summary":"As of 6pm Thursday, Comcast, Dish, T-Mobile, AT&T, Verizon and others can resume strategic talks.","url":"http://finance.yahoo.com/r/8402cd89-790a-3fd4-a128-7db52caf4c72/as-fcc-quiet-period-ends-expect-m-amp-a-talks-to-get-loud.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Penny Stocks to Watch for May 2017","publication_date":"2017-04-27 16:42:00 +0000","summary":"These ten penny stocks trading on U.S. public exchanges could gain substantial ground in April 2017 and the coming months.","url":"http://finance.yahoo.com/r/8d9fbf67-09e0-3e5e-ad09-2a9217e051b4/top-penny-stocks?partner=YahooSA&yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Straight Path Shares Jump as It Announces Unsolicited Offer 'Superior' to AT&T's","publication_date":"2017-04-25 14:44:00 +0000","summary":"Shares of fellow niche spectrum owner Globalstar also gain, as Verizon declines to say whether it submitted the $1.8 billion bid.","url":"http://finance.yahoo.com/r/7623a1af-81a0-36e0-ad53-53f5baacbdc1/straight-path-says-1-8-billion-unsolicited-offer-is-superior-to-1-6-billion-sale-to-at-amp-t.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"SPOT Satellite Device Reaches Major Milestone With 5000 Rescues Worldwide","publication_date":"2017-04-19 12:30:00 +0000","summary":"COVINGTON, La., April 19, 2017-- SPOT, LLC, a wholly owned subsidiary of Globalstar, Inc. and a leader in satellite messaging and emergency notification technologies, announced today that its SPOT family ...","url":"http://finance.yahoo.com/news/spot-satellite-device-reaches-major-123000299.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"SPOT Satellite Devices Reach Major Milestone with 5,000 Rescues Worldwide","publication_date":"2017-04-19 12:30:00 +0000","summary":"Note to editors: There is an infographic associated with this press release.","url":"http://finance.yahoo.com/news/spot-satellite-devices-reach-major-123000936.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar Is on Life Support. Will It Survive?","publication_date":"2017-04-18 22:02:00 +0000","summary":"This satellite telecommunications company is taking steps to right the ship, but should investors bet on it?","url":"http://finance.yahoo.com/r/e7357f9a-b551-3d04-b746-398e4445a8da/globalstar-is-on-life-support-will-it-survive.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Why Shares of Globalstar Surged Today","publication_date":"2017-04-17 20:57:00 +0000","summary":"A possible bidding war for Straight Path Communications has lit a fire under the satellite services stock.","url":"http://finance.yahoo.com/r/f6c21085-793f-3e1c-855e-fc7e240d32e7/why-shares-of-globalstar-surged-today.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar Stock Jumps Amid Talk of Straight Path Bidding War","publication_date":"2017-04-17 16:05:00 +0000","summary":"The satellite communications company also owns some desirable wireless spectrum.","url":"http://finance.yahoo.com/r/4f2224f7-cf2d-30d4-aa06-8fef4cbb9a6d/globalstar-stock-jumps-amid-talk-of-straight-path-bidding-war.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"AT&T's Spectrum Spree Draws Attention to Globalstar, Ligado and Dish","publication_date":"2017-04-12 13:34:00 +0000","summary":"Spectrum acquisitions continue as wireless carriers prepare for 5G, the Internet of things","url":"http://finance.yahoo.com/r/8f0f0c0e-0675-3fed-a877-d3ed25a59654/at-amp-t-s-spectrum-spree-draws-attention-to-globalstar-ligado-and-dish.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"InPlay from Briefing.com","publication_date":"2017-04-11 21:56:20 +0000","summary":"InPlay from Briefing.com","url":"http://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"University of Miami Continues to Rely on SPOT for Oceanic Flow Study in the Gulf of Mexico","publication_date":"2017-04-11 21:05:00 +0000","summary":"COVINGTON, La., April 11, 2017-- Globalstar, Inc. announced today that the University of Miami Rosenstiel School of Marine and Atmospheric Science will be deploying 550 SPOT Trace satellite trackers in ...","url":"http://finance.yahoo.com/news/university-miami-continues-rely-spot-210500350.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"After AT&T Buys Straight Path, Globalstar Could Be the Next Telecom Takeover Target","publication_date":"2017-04-10 21:55:21 +0000","summary":"Globalstar Inc s GSAT stock skyrocketed 15 Monday morning on buyout speculation after AT amp T T purchased Straight Path Communications STRP for a 162 premium Globalstar s fun in the sun faded quickly after the initial wave of takeover speculation died down but a buyout could still be","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HY_FU28W5sk/after-att-buys-straight-path-globalstar-could-be-the-next-telecom-takeover-target-cm772370"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"After AT&T Buys Straight Path, Globalstar Could Be the Next Telecom Takeover Target","publication_date":"2017-04-10 19:58:07 +0000","summary":"Globalstar, Inc.&apos;s (GSAT) stock skyrocketed 15% Monday morning on buyout speculation after AT&T (T) purchased Straight Path Communications (STRP) for a 162% premium. Globalstar&apos;s fun in the sun faded quickly after the initial wave of takeover speculation died down, but a buyout could still be on the horizon.","url":"http://finance.yahoo.com/news/t-buys-straight-path-globalstar-195807325.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"ETFs with exposure to Globalstar, Inc. : April 7, 2017","publication_date":"2017-04-07 20:42:56 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Globalstar, Inc. Here are 5 ETFs with the largest exposure to GSAT-US. Comparing the performance and risk of Globalstar, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/8ff7ef79-9a40-39e1-9803-621a3fe1a675/etfs-with-exposure-to-globalstar-inc-april-7-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Yippy, Inc. (YIPI) to Support Globalstar's (GSAT) Software Services Initiative to Market the Worldwide Distribution of Yippy's Data Compression Software and Associated Technologies","publication_date":"2017-04-07 12:30:00 +0000","summary":"Yippy recently completed the production level environment for Globalstar's Generation 2 network and exceeded performance requirements.  Subsequently, Yippy presented a plan to the executives of Globalstar which proposed top line growth for both organizations as a result of the distribution of Yippy's software offerings to other service providers and their subscribers worldwide.","url":"http://finance.yahoo.com/news/yippy-inc-yipi-support-globalstars-123000046.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar to Launch New Satellite Software Services Using Yippy’s Compression Technology","publication_date":"2017-04-07 12:30:00 +0000","summary":"COVINGTON, La., April 07, 2017-- Globalstar, Inc. announced today that it will launch a new compression service for the satellite industry. The effort will include rolling out compression services developed ...","url":"http://finance.yahoo.com/news/globalstar-launch-satellite-software-services-123000561.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"1,200 Long-Distance Runners in the 2017 MARATHON DES SABLES to use SPOT Gen3 for Safety and Tracking","publication_date":"2017-04-06 13:30:00 +0000","summary":"COVINGTON, La., April 06, 2017-- Globalstar Inc., and its subsidiary Globalstar Europe Satellite Services, LTD., announced today that all competitors in this year’ s MARATHON DES SABLES will carry a small, ...","url":"http://finance.yahoo.com/news/1-200-long-distance-runners-133000256.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"ETFs with exposure to Globalstar, Inc. : March 27, 2017","publication_date":"2017-03-27 19:58:14 +0000","summary":"ETFs with exposure to Globalstar, Inc. : March 27, 2017","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-globalstar-inc-march-27-2017/"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"ETFs with exposure to Globalstar, Inc. : March 27, 2017","publication_date":"2017-03-27 19:58:14 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Globalstar, Inc. Here are 5 ETFs with the largest exposure to GSAT-US. Comparing the performance and risk of Globalstar, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/b293c609-e531-38cc-a5bc-425bf75dd054/etfs-with-exposure-to-globalstar-inc-march-27-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Columbia Pacific Advisors, LLC Buys Globalstar, Brookdale Senior Living, SPDR S&P Oil & ...","publication_date":"2017-03-25 00:58:09 +0000","summary":"Columbia Pacific Advisors LLC New Purchases XOP BBG FLIR WTI EMKR CSU CB AKAO HD VSH Added Positions GSAT BKD MDSY HK GEN EPE JONE COHR Reduced Positions RLH MRO GOOGL BREW SM AMZN IWM LPI CLR DVN Sold Out SPY FB VG","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sRI5K3H4fzE/columbia-pacific-advisors-llc-buys-globalstar-brookdale-senior-living-spdr-sp-oil-cm765536"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar, Inc. breached its 50 day moving average in a Bullish Manner : GSAT-US : March 20, 2017","publication_date":"2017-03-20 12:03:20 +0000","summary":"Globalstar, Inc. breached its 50 day moving average in a Bullish Manner : GSAT-US : March 20, 2017","url":"http://www.capitalcube.com/blog/index.php/globalstar-inc-breached-its-50-day-moving-average-in-a-bullish-manner-gsat-us-march-20-2017/"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar, Inc. breached its 50 day moving average in a Bullish Manner : GSAT-US : March 20, 2017","publication_date":"2017-03-20 12:03:20 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Globalstar, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/e00f7cdd-f0b8-3fdb-97d7-6070a988cd4f/globalstar-inc-breached-its-50-day-moving-average-in-a-bullish-manner-gsat-us-march-20-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Better Buy: Iridium Communications vs. Globalstar","publication_date":"2017-03-17 14:12:28 +0000","summary":"Iridium Communications NASDAQ IRDM and Globalstar NYSEMKT GSAT both operate telecommunications services powered by satellite The companies compete for a similar clientele servicing primarily government entities and corporations in need of service in hard to reach","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_LtxgMI6Oa4/better-buy-iridium-communications-vs-globalstar-cm762091"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Better Buy: Iridium Communications vs. Globalstar","publication_date":"2017-03-17 12:29:00 +0000","summary":"Iridium is in the lead in the satellite telecom business, but Globalstar is making headway. Which is the best bet?","url":"http://finance.yahoo.com/r/d7daeee4-8c7a-38ed-815d-432547c8954a/better-buy-iridium-communications-vs-globalstar.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Better Buy: Iridium Communications vs. Globalstar","publication_date":"2017-03-17 12:29:00 +0000","summary":"Better Buy: Iridium Communications vs. Globalstar","url":"https://www.fool.com/investing/2017/03/17/better-buy-iridium-communications-vs-globalstar.aspx"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar, Inc. :GSAT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017","publication_date":"2017-03-16 12:26:13 +0000","summary":"Globalstar, Inc. :GSAT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017","url":"http://www.capitalcube.com/blog/index.php/globalstar-inc-gsat-us-earnings-analysis-q4-2016-by-the-numbers-march-16-2017/"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar, Inc. :GSAT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017","publication_date":"2017-03-16 12:26:13 +0000","summary":"Categories: Yahoo Finance Get free summary analysis Globalstar, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Globalstar, Inc. – ORBCOMM Inc., Intelsat S.A., Inmarsat plc Unsponsored ADR, Iridium Communications Inc., EchoStar Corporation Class A, Comtech Telecommunications Corp. and DISH Network Corporation Class A (ORBC-US, I-US, ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/e3ce8aaf-37d1-3c1e-a7a4-74fcbcbe4332/globalstar-inc-gsat-us-earnings-analysis-q4-2016-by-the-numbers-march-16-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar CEO Inducted Into Satellite Hall of Fame for Lifesaving Technology","publication_date":"2017-03-09 15:30:00 +0000","summary":"COVINGTON, La., March 09, 2017-- Globalstar Chairman and Chief Executive Officer, Jay Monroe, has been inducted into the Society of Satellite Professionals International’ s Satellite Hall of Fame for his ...","url":"http://finance.yahoo.com/news/globalstar-ceo-inducted-satellite-hall-153000705.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar CEO Inducted Into Satellite Hall of Fame for Lifesaving Technology","publication_date":"2017-03-09 15:30:00 +0000","summary":"[GlobeNewswire] - COVINGTON, La., March 09, 2017-- Globalstar Chairman and Chief Executive Officer, Jay Monroe, has been inducted into the Society of Satellite Professionals International’ s Satellite Hall of Fame for his ...","url":"http://finance.yahoo.com/news/globalstar-ceo-inducted-satellite-hall-153000705.html"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"11:30 am GlobalStar and Inmarsat (<a href=\"/q?s=imasy\" name=\"imasy\">IMASY</a>) announce a new partnership to cross-sell their respective products and services","publication_date":"2017-03-08 16:30:00 +0000","summary":"11:30 am GlobalStar and Inmarsat (<a href=\"/q?s=imasy\" name=\"imasy\">IMASY</a>) announce a new partnership to cross-sell their respective products and services","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#gsat"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar and Inmarsat to Form Partnership to Cross-Sell Satellite Services","publication_date":"2017-03-08 16:30:00 +0000","summary":"[GlobeNewswire] - COVINGTON, La., March 08, 2017-- Globalstar and Inmarsat, two leading providers of mobile satellite and voice data communications services, announced today their intention to form a new partnership to ...","url":"http://finance.yahoo.com/news/globalstar-inmarsat-form-partnership-cross-163000688.html"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar and Inmarsat to Form Partnership to Cross-Sell Satellite Services","publication_date":"2017-03-08 16:30:00 +0000","summary":"COVINGTON, La., March 08, 2017-- Globalstar and Inmarsat, two leading providers of mobile satellite and voice data communications services, announced today their intention to form a new partnership to ...","url":"http://finance.yahoo.com/news/globalstar-inmarsat-form-partnership-cross-163000688.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar Announces Appointment of Kyle Pickens as Vice President of Strategy and Communications","publication_date":"2017-03-07 21:48:14 +0000","summary":"[GlobeNewswire] - COVINGTON, La., March 07, 2017-- Globalstar, Inc. today announced that Kyle Pickens has been appointed as Vice President of Strategy and Communications. Pickens will be responsible for the overall investor ...","url":"http://finance.yahoo.com/news/globalstar-announces-appointment-kyle-pickens-214814634.html"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar Announces Appointment of Kyle Pickens as Vice President of Strategy and Communications","publication_date":"2017-03-07 21:48:14 +0000","summary":"COVINGTON, La., March 07, 2017-- Globalstar, Inc. today announced that Kyle Pickens has been appointed as Vice President of Strategy and Communications. Pickens will be responsible for the overall investor ...","url":"http://finance.yahoo.com/news/globalstar-announces-appointment-kyle-pickens-214814634.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"ETFs with exposure to Globalstar, Inc. : March 6, 2017","publication_date":"2017-03-06 18:43:59 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Globalstar, Inc. Here are 5 ETFs with the largest exposure to GSAT-US. Comparing the performance and risk of Globalstar, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/6c333690-5278-34f3-b96d-5bd5d9b2baa2/etfs-with-exposure-to-globalstar-inc-march-6-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"ETFs with exposure to Globalstar, Inc. : March 6, 2017","publication_date":"2017-03-06 18:43:59 +0000","summary":"ETFs with exposure to Globalstar, Inc. : March 6, 2017","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-globalstar-inc-march-6-2017/"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar, Inc. :GSAT-US: Earnings Analysis: 2016 By the Numbers : March 1, 2017","publication_date":"2017-03-01 18:23:05 +0000","summary":"Globalstar, Inc. :GSAT-US: Earnings Analysis: 2016 By the Numbers : March 1, 2017","url":"http://www.capitalcube.com/blog/index.php/globalstar-inc-gsat-us-earnings-analysis-2016-by-the-numbers-march-1-2017/"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar, Inc. :GSAT-US: Earnings Analysis: 2016 By the Numbers : March 1, 2017","publication_date":"2017-03-01 18:23:05 +0000","summary":"Categories: Yahoo Finance Get free summary analysis Globalstar, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Globalstar, Inc. – Iridium Communications Inc., EchoStar Corporation Class A and DISH Network Corporation Class A (IRDM-US, SATS-US and DISH-US) that have also reported for this period. Highlights Gross ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/7dccf840-7668-38e7-ac5b-2e79b4c7501e/globalstar-inc-gsat-us-earnings-analysis-2016-by-the-numbers-march-1-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"GLOBALSTAR, INC. Financials","publication_date":"2017-03-01 18:04:10 +0000","summary":"GLOBALSTAR, INC. Financials","url":"http://finance.yahoo.com/q/is?s=gsat"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"GlobalStar upgraded by Chardan Capital Markets","publication_date":"2017-02-24 12:26:55 +0000","summary":"GlobalStar upgraded by Chardan Capital Markets","url":"http://finance.yahoo.com/q/ud?s=GSAT"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Edited Transcript of GSAT earnings conference call or presentation 23-Feb-17 10:00pm GMT","publication_date":"2017-02-24 03:22:33 +0000","summary":"Q4 2016 Globalstar Inc Earnings Call","url":"http://finance.yahoo.com/news/edited-transcript-gsat-earnings-conference-032233002.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Edited Transcript of GSAT earnings conference call or presentation 23-Feb-17 10:00pm GMT","publication_date":"2017-02-24 03:22:33 +0000","summary":"Edited Transcript of GSAT earnings conference call or presentation 23-Feb-17 10:00pm GMT","url":"http://finance.yahoo.com/news/edited-transcript-gsat-earnings-conference-032233002.html"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar reports 4Q loss","publication_date":"2017-02-24 00:07:31 +0000","summary":"On a per-share basis, the Covington, Louisiana-based company said it had a loss of 11 cents. The satellite communications company posted revenue of $24.4 million in the period. For the year, the company ...","url":"http://finance.yahoo.com/news/globalstar-reports-4q-loss-000731505.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar reports 4Q loss","publication_date":"2017-02-24 00:07:31 +0000","summary":"[AP] - On a per-share basis, the Covington, Louisiana-based company said it had a loss of 11 cents. The satellite communications company posted revenue of $24.4 million in the period. For the year, the company ...","url":"http://sg.finance.yahoo.com/news/globalstar-reports-4q-loss-000731442.html"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar Inc Earnings Call scheduled for 5:00 pm ET today","publication_date":"2017-02-23 22:00:00 +0000","summary":"Globalstar Inc Earnings Call scheduled for 5:00 pm ET today","url":"http://biz.yahoo.com/cc/1/155811.html"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"GLOBALSTAR, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits","publication_date":"2017-02-23 21:29:40 +0000","summary":"GLOBALSTAR, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170223/gsat8-k.html"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar Announces 2016 Fourth Quarter and Annual Results","publication_date":"2017-02-23 21:15:00 +0000","summary":"COVINGTON, La., Feb. 23, 2017-- Globalstar, Inc. today announced financial and operating results for the fourth quarter and year ended December 31, 2016.. Jay Monroe, Chairman and CEO of Globalstar, commented,“ ...","url":"http://finance.yahoo.com/news/globalstar-announces-2016-fourth-quarter-211500356.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar Announces 2016 Fourth Quarter and Annual Results","publication_date":"2017-02-23 21:15:00 +0000","summary":"[GlobeNewswire] - COVINGTON, La., Feb. 23, 2017-- Globalstar, Inc. today announced financial and operating results for the fourth quarter and year ended December 31, 2016.. Jay Monroe, Chairman and CEO of Globalstar, commented,“ ...","url":"http://finance.yahoo.com/news/globalstar-announces-2016-fourth-quarter-211500356.html"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar Q4 16 Earnings Conference Call At 5:00 PM ET","publication_date":"2017-02-23 14:59:00 +0000","summary":"Globalstar Q4 16 Earnings Conference Call At 5:00 PM ET","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2Bspxqx5Iko/globalstar-q4-16-earnings-conference-call-at-500-pm-et-20170223-01469"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Q4 2016 Globalstar Inc Earnings Release - After Market Close","publication_date":"2017-02-23 12:07:05 +0000","summary":"Q4 2016 Globalstar Inc Earnings Release - After Market Close","url":"http://biz.yahoo.com/research/earncal/20170223.html?t=gsat"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar, Inc. Earnings Call Release Notice","publication_date":"2017-02-17 21:30:00 +0000","summary":"COVINGTON, La., Feb. 17, 2017-- Globalstar, Inc. will announce its fourth quarter and annual 2016 financial results on Thursday, February 23, 2017 after the market’ s close. The Company will conduct a ...","url":"http://finance.yahoo.com/news/globalstar-inc-earnings-call-release-213000783.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar, Inc. Earnings Call Release Notice","publication_date":"2017-02-17 21:30:00 +0000","summary":"[GlobeNewswire] - COVINGTON, La., Feb. 17, 2017-- Globalstar, Inc. will announce its fourth quarter and annual 2016 financial results on Thursday, February 23, 2017 after the market’ s close. The Company will conduct a ...","url":"http://finance.yahoo.com/news/globalstar-inc-earnings-call-release-213000783.html"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"New Generation Advisors Llc Buys SandRidge Energy, Approach Resources, Sanchez Energy, Sells ...","publication_date":"2017-02-15 13:17:23 +0000","summary":"New Generation Advisors Llc New Purchases SD AREX SN CVEO BBG CXRX CZR HOS VRS ARCH Added Positions PSGLQ BLDR SBLK NIHD INSW AAL Reduced Positions FRP TRNC GSAT MHO ALLY TNP GCVRZ PGEM GNW ROIAK Sold Out ACW EURN FCH ESEA","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GyK8ylXTQ8w/new-generation-advisors-llc-buys-sandridge-energy-approach-resources-sanchez-energy-sells-cm748085"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar, Inc. breached its 50 day moving average in a Bearish Manner : GSAT-US : February 13, 2017","publication_date":"2017-02-13 12:42:32 +0000","summary":"Globalstar, Inc. breached its 50 day moving average in a Bearish Manner : GSAT-US : February 13, 2017","url":"http://www.capitalcube.com/blog/index.php/globalstar-inc-breached-its-50-day-moving-average-in-a-bearish-manner-gsat-us-february-13-2017/"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar, Inc. breached its 50 day moving average in a Bearish Manner : GSAT-US : February 13, 2017","publication_date":"2017-02-13 12:42:32 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Globalstar, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/674e0562-45f0-3ecf-9ac2-51ca13fbc246/globalstar-inc-breached-its-50-day-moving-average-in-a-bearish-manner-gsat-us-february-13-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"SPOT Satellite Devices Set New Safety Record with 274 Rescues in Canada in 2016","publication_date":"2017-02-07 12:00:00 +0000","summary":"Note to editors: There is a photo associated with this press release.","url":"http://finance.yahoo.com/news/spot-satellite-devices-set-safety-120000265.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"SPOT Satellite Devices Set New Safety Record with 274 Rescues in Canada in 2016","publication_date":"2017-02-07 12:00:00 +0000","summary":"[Marketwired] - Note to editors: There is a photo associated with this press release.","url":"http://finance.yahoo.com/news/spot-satellite-devices-set-safety-120000265.html"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"GLOBALSTAR, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2017-01-24 11:14:48 +0000","summary":"GLOBALSTAR, INC. Files SEC form 8-K, Change in Directors or Principal Officers","url":"http://biz.yahoo.com/e/170124/gsat8-k.html"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar Announces Departure of David Kagan","publication_date":"2017-01-23 22:00:00 +0000","summary":"COVINGTON, La., Jan. 23, 2017-- Globalstar, Inc. announced that David Kagan, the Company’ s President and Chief Operating Officer, will be leaving the Company in March 2017 to accept an exciting new opportunity ...","url":"http://finance.yahoo.com/news/globalstar-announces-departure-david-kagan-220000101.html?.tsrc=rss"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar Announces Departure of David Kagan","publication_date":"2017-01-23 22:00:00 +0000","summary":"[GlobeNewswire] - COVINGTON, La., Jan. 23, 2017-- Globalstar, Inc. announced that David Kagan, the Company’ s President and Chief Operating Officer, will be leaving the Company in March 2017 to accept an exciting new opportunity ...","url":"http://finance.yahoo.com/news/globalstar-announces-departure-david-kagan-220000101.html"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar to Attend Meetings with J.P. Morgan, Morgan Stanley and Cantor Fitzgerald","publication_date":"2017-01-19 17:22:27 +0000","summary":"[GlobeNewswire] - COVINGTON, La., Jan. 19, 2017-- Globalstar, Inc. announced today that the Company will present at a series of investor meetings hosted by J.P. Morgan, Morgan Stanley and Cantor Fitzgerald on January 30 ...","url":"http://finance.yahoo.com/news/globalstar-attend-meetings-j-p-172227015.html"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar Inc Conference Call to Discuss FCC Report and Order scheduled for 8:30 am ET today","publication_date":"2017-01-06 13:30:00 +0000","summary":"Globalstar Inc Conference Call to Discuss FCC Report and Order scheduled for 8:30 am ET today","url":"http://biz.yahoo.com/cc/7/154877.html"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar Investor Conference Call At 8:30 AM ET","publication_date":"2017-01-06 07:31:00 +0000","summary":"Globalstar Investor Conference Call At 8:30 AM ET","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fQ5cbzd16jk/globalstar-investor-conference-call-at-830-am-et-20170106-00080"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"S&P 500 Rose Due to the Telecom and Health Care Sector","publication_date":"2017-01-04 13:46:23 +0000","summary":"S&P 500 Rose Due to the Telecom and Health Care Sector","url":"http://marketrealist.com/2017/01/sp-500-pushed-higher-telecom-health-care-sector/?utm_source=yahoo&utm_medium=feed"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Why Globalstar, Endologix, and Lands' End Slumped Today","publication_date":"2016-12-28 02:56:54 +0000","summary":"Tuesday was a good day for the overall stock market as major market benchmarks climbed as much as half a percent during the day s trading session Dow 20 000 still didn t happen disappointing some post holiday revelers but traders appeared to be happy enough just leaving the market","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cCa1lvNX4K8/why-globalstar-endologix-and-lands-end-slumped-today-cm726713"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Why Globalstar, Endologix, and Lands' End Slumped Today","publication_date":"2016-12-28 01:03:00 +0000","summary":"Why Globalstar, Endologix, and Lands' End Slumped Today","url":"http://www.fool.com/investing/2016/12/27/why-globalstar-endologix-and-lands-end-slumped-tod.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar to Host Conference Call to Discuss FCC Report and Order","publication_date":"2016-12-27 20:02:08 +0000","summary":"[at noodls] - Covington, LA , December 27, 2016- Globalstar, Inc. (NYSE MKT: GSAT) will host a conference call on Friday, January 6 at 8:30 a.m. EST to discuss the recent adoption of the Report and Order by the Federal ...","url":"http://www.publicnow.com/view/588AE331C4DD1C1A66CD41DB73BD0DCB15BDEFE2"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"FCC ADOPTS GLOBALSTAR ORDER","publication_date":"2016-12-23 16:18:14 +0000","summary":"[at noodls] - Covington, LA , December 23, 2016- Globalstar, Inc. (NYSE MKT: GSAT) is very pleased to announce that the Federal Communications Commission adopted a Report and Order based on Globalstar's Revised Proposal ...","url":"http://www.publicnow.com/view/09F4AA3448346A05EDB1E197F227D4D6115CCE19"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"FCC Adopts Globalstar Order","publication_date":"2016-12-23 16:09:29 +0000","summary":"[GlobeNewswire] - COVINGTON, La., Dec. 23, 2016-- Globalstar, Inc. is very pleased to announce that the Federal Communications Commission adopted a Report and Order based on Globalstar's Revised Proposal for terrestrial ...","url":"http://finance.yahoo.com/news/fcc-adopts-globalstar-order-160929957.html"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Close Update: Wall Street Extends Slide to Second Day as Consumer Stocks Weigh","publication_date":"2016-12-22 21:57:07 +0000","summary":"Wall Street s post election rally took a pause for a second day on Thursday with the Dow Jones Industrial Average backing off from the key 20 000 level as consumer shares weighed on the benchmarks Wall Street s post election rally took a pause for a second day on Thursday with the Dow","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FfPOkM734n0/close-update-wall-street-extends-slide-to-second-day-as-consumer-stocks-weigh-cm725389"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Why Globalstar, Inc. Stock Skyrocketed Today","publication_date":"2016-12-22 20:57:42 +0000","summary":"Image source Globalstar Inc What happened Shares of Globalstar Inc NYSEMKT GSAT were up 26 5 as of 1 15 p m EST following favorable developments at the U S Federal Communications Commission FCC So what Recall Globalstar stock plunged last month after","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k6B8P4Uyvmw/why-globalstar-inc-stock-skyrocketed-today-cm725350"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Thursday's ETF Movers: VOX, VNQ","publication_date":"2016-12-22 19:57:22 +0000","summary":"In trading on Thursday the Vanguard Telecommunication Services ETF VOX is outperforming other ETFs up about 0 7 on the day Components of that ETF showing particular strength include shares of Globalstar GSAT up about 27 2 and shares of NII Holdings NIHD up about 4 on the","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F8NpXSlOAdc/thursdays-etf-movers-vox-vnq-cm725315"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Why Globalstar, Inc. Stock Skyrocketed Today","publication_date":"2016-12-22 19:17:00 +0000","summary":"Why Globalstar, Inc. Stock Skyrocketed Today","url":"http://www.fool.com/investing/2016/12/22/why-globalstar-inc-stock-skyrocketed-today.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Midday Update: Rally Pauses a Second Day After Data-Dump","publication_date":"2016-12-22 18:17:04 +0000","summary":"Stocks were quietly trading lower for a second day as Wall Street paused to digest a flurry of economic data and investors continued to retreat to the sidelines ahead of a long holiday weekend Weighed down by shares in the consumer and real estate sectors the Dow has stepped back further","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jMcosunmLFQ/midday-update-rally-pauses-a-second-day-after-data-dump-cm725254"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Mid-Morning Market Update: Markets Edge Lower; Conagra Earnings Top Views","publication_date":"2016-12-22 16:22:26 +0000","summary":"Following the market opening Thursday the Dow traded down 0 14 percent to 19 913 27 while the NASDAQ declined 0 22 percent to 5 459 29 The S amp P also fell dropping 0 21 percent to 2 260 47 Leading and Lagging Sectors Non cyclical consumer goods amp services shares","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_PTaWP5LUkE/mid-morning-market-update-markets-edge-lower-conagra-earnings-top-views-cm725187"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"IT Sector Awaits Trump’s Meeting with Silicon Valley CEOs","publication_date":"2016-12-21 13:29:53 +0000","summary":"IT Sector Awaits Trump’s Meeting with Silicon Valley CEOs","url":"http://marketrealist.com/2016/12/information-technology-sector-awaits-trump-silicon-valley-ceos-meeting/?utm_source=yahoo&utm_medium=feed"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar Rose as the FCC Reviews Its Revised Proposal","publication_date":"2016-12-20 13:56:38 +0000","summary":"Globalstar Rose as the FCC Reviews Its Revised Proposal","url":"http://marketrealist.com/2016/12/globalstar-surged-higher-fcc-reviews-revised-proposal/?utm_source=yahoo&utm_medium=feed"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Globalstar Earnings Review and Forward Outlook","publication_date":"2016-12-20 12:45:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 20, 2016 / Traders News Source, an equity research firm specializing in small and micro-cap securities is reviewing earnings, activity and the forward outlook for Globalstar, ...","url":"http://finance.yahoo.com/news/globalstar-earnings-review-forward-outlook-124500399.html"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Why Globalstar, Unisys, and Allied World Assurance Jumped Today","publication_date":"2016-12-20 00:57:13 +0000","summary":"The stock market bounced back on Monday regaining lost ground from Friday s session to finish higher Major market benchmarks were generally higher between 0 2 and 0 4 as bond yields fell while oil and gold prices stayed in a relatively tight range Yet even on what seemed like","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jSIZgQysaDE/why-globalstar-unisys-and-allied-world-assurance-jumped-today-cm723667"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Why Globalstar, Unisys, and Allied World Assurance Jumped Today","publication_date":"2016-12-19 23:01:00 +0000","summary":"Why Globalstar, Unisys, and Allied World Assurance Jumped Today","url":"http://www.fool.com/investing/2016/12/19/why-globalstar-unisys-and-allied-world-assurance-j.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Close Update: Geopolitical Events Trim Early Gains; Dow Misses 20,000 For Fifth Day","publication_date":"2016-12-19 21:56:55 +0000","summary":"Stocks closed modestly higher on Monday but off their session highs as geopolitical events spooked investors ahead of the holiday weekend The assassination of the Russian ambassador to Turkey followed by a vehicle attack on Berliners that killed nine people tugged the benchmark averages lower","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fqDda3Vqi_c/close-update-geopolitical-events-trim-early-gains-dow-misses-20000-for-fifth-day-cm723609"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Mid-Afternoon Market Update: Dow Gains Over 50 Points; Globalstar Shares Surge Following FCC News","publication_date":"2016-12-19 20:42:12 +0000","summary":"Toward the end of trading Monday the Dow traded up 0 26 percent to 19 895 29 while the NASDAQ rose 0 64 percent to 5 472 23 The S amp P also rose gaining 0 32 percent to 2 265 21 Leading and Lagging Sectors Technology shares gained around 0 86 percent in trading on","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/upd8KwsKPhc/mid-afternoon-market-update-dow-gains-over-50-points-globalstar-shares-surge-following-fcc-news-cm723583"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Monday Sector Leaders: Drugs, Communicationss Services","publication_date":"2016-12-19 19:57:26 +0000","summary":"In trading on Monday drugs shares were relative leaders up on the day by about 1 8 Leading the group were shares of Loxo Oncology LOXO up about 33 8 and shares of MannKind MNKD up about 16 3 on the day Also showing relative strength are communicationss services shares up","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4gWTZa3z_8I/monday-sector-leaders-drugs-communicationss-services-cm723511"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Monday's ETF Movers: VOX, GDXJ","publication_date":"2016-12-19 19:56:57 +0000","summary":"In trading on Monday the Vanguard Telecommunication Services ETF VOX is outperforming other ETFs up about 1 5 on the day Components of that ETF showing particular strength include shares of Globalstar GSAT up about 32 4 and shares of Iridium Communications IRDM up about 4","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SpCYRU5G-Qk/mondays-etf-movers-vox-gdxj-cm723504"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Technology Sector Update for 12/19/2016: GSAT,XGTI,ANY","publication_date":"2016-12-19 18:57:07 +0000","summary":"Top Tech StocksTop Tech Stocks MSFT 2 13 MSFT 2 13 AAPL 0 79 AAPL 0 79 IBM 0 05 IBM 0 05 CSCO 0 51 CSCO 0 51 GOOG 0 64 GOOG 0 64 Technology stocks overcame initial sluggishness on Monday and were again climbing in value today with shares of tech companies in the S amp P 500","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FYAy9LHZqRk/technology-sector-update-for-12192016-gsatxgtiany-cm723488"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Why Shares of Globalstar Inc. Rocketed Higher Today","publication_date":"2016-12-19 18:00:47 +0000","summary":"Image source Globalstar What happened Shares of satellite communications provider Globalstar NYSEMKT GSAT surged on Monday following news that the Federal Communications Commission FCC has drafted a new proposed order in response to a revised proposal that Globalstar filed","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AidxODqIU6k/why-shares-of-globalstar-inc-rocketed-higher-today-cm723421"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"How to Trade Monday's Most Active Stocks -- Globalstar, Hilton, Ford and More","publication_date":"2016-12-19 17:24:00 +0000","summary":"How to Trade Monday's Most Active Stocks -- Globalstar, Hilton, Ford and More","url":"https://www.thestreet.com/story/13931304/1/how-to-trade-monday-s-most-active-stocks-globalstar-hilton-ford-and-more.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"ETFs with exposure to Globalstar, Inc. : December 19, 2016","publication_date":"2016-12-19 16:43:06 +0000","summary":"ETFs with exposure to Globalstar, Inc. : December 19, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-globalstar-inc-december-19-2016/"},{"ticker":"GSAT","figi_ticker":"GSAT:US","figi":"BBG000K008L5","title":"Why Shares of Globalstar Inc. Rocketed Higher Today","publication_date":"2016-12-19 16:33:52 +0000","summary":"Why Shares of Globalstar Inc. Rocketed Higher Today","url":"http://www.fool.com/investing/2016/12/19/why-shares-of-globalstar-inc-rocketed-higher-today.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news"}],"result_count":200,"page_size":100,"current_page":1,"total_pages":2,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"1.9"},{"x":"1494596100","y":"1.9100000000000001"},{"x":"1494596400","y":"1.9300000000000002"},{"x":"1494596700","y":"1.9281000000000001"},{"x":"1494597000","y":"1.95"},{"x":"1494597300","y":"1.95"},{"x":"1494597600","y":"1.97"},{"x":"1494597900","y":"1.9744000000000002"},{"x":"1494598200","y":"1.9649999999999999"},{"x":"1494598500","y":"1.935"},{"x":"1494598800","y":"1.94"},{"x":"1494599100","y":"1.95"},{"x":"1494599400","y":"1.95"},{"x":"1494599700","y":"1.95"},{"x":"1494600000","y":"1.97"},{"x":"1494600300","y":"1.98"},{"x":"1494600600","y":"1.98"},{"x":"1494600900","y":"1.98"},{"x":"1494601200","y":"1.98"},{"x":"1494601500","y":"1.98"},{"x":"1494601800","y":"1.98"},{"x":"1494602100","y":"1.98"},{"x":"1494602400","y":"1.98"},{"x":"1494602700","y":"1.98"},{"x":"1494603000","y":"1.98"},{"x":"1494603300","y":"1.98"},{"x":"1494603600","y":"1.98"},{"x":"1494603900","y":"1.98"},{"x":"1494604200","y":"1.98"},{"x":"1494604500","y":"1.97"},{"x":"1494604800","y":"1.95"},{"x":"1494605100","y":"1.96"},{"x":"1494605400","y":"1.955"},{"x":"1494605700","y":"1.95"},{"x":"1494606000","y":"1.9449999999999998"},{"x":"1494606300","y":"1.94"},{"x":"1494606600","y":"1.92"},{"x":"1494606900","y":"1.92"},{"x":"1494607200","y":"2.35"},{"x":"1494607500","y":"2.36"},{"x":"1494607800","y":"2.245"},{"x":"1494608100","y":"2.2"},{"x":"1494608400","y":"2.1464"},{"x":"1494608700","y":"2.11"},{"x":"1494609000","y":"2.145"},{"x":"1494609300","y":"2.175"},{"x":"1494609600","y":"2.195"},{"x":"1494609900","y":"2.185"},{"x":"1494610200","y":"2.19"},{"x":"1494610500","y":"2.2"},{"x":"1494610800","y":"2.2298999999999998"},{"x":"1494611100","y":"2.26"},{"x":"1494611400","y":"2.2762000000000002"},{"x":"1494611700","y":"2.275"},{"x":"1494612000","y":"2.285"},{"x":"1494612300","y":"2.2928"},{"x":"1494612600","y":"2.32"},{"x":"1494612900","y":"2.35"},{"x":"1494613200","y":"2.43"},{"x":"1494613500","y":"2.44"},{"x":"1494613800","y":"2.46"},{"x":"1494614100","y":"2.48"},{"x":"1494614400","y":"2.479"},{"x":"1494614700","y":"2.505"},{"x":"1494615000","y":"2.5195"},{"x":"1494615300","y":"2.525"},{"x":"1494615600","y":"2.54"},{"x":"1494615900","y":"2.4699999999999998"},{"x":"1494616200","y":"2.415"},{"x":"1494616500","y":"2.372"},{"x":"1494616800","y":"2.42"},{"x":"1494617100","y":"2.38"},{"x":"1494617400","y":"2.3447"},{"x":"1494617700","y":"2.2715"},{"x":"1494618000","y":"2.33"},{"x":"1494618300","y":"2.36"},{"x":"1494618600","y":"2.375"},{"x":"1494618900","y":"2.3"} ], "color":"#03a9f4"}]},
{"id":"12","symbol": "HDP","name": "Hortonworks Inc","price": 13.42,"dollarChange": 0.87,"percentChange": 6.9399999999999995,"open": 12.55,"high": 13.56,"low":12.47,"volume": 1639255,"avgVol": 718516.150000,"sharesShort": 5742044,"shortPercent": 8.971990,"marketCap": 654286571,"float": 63999670,"headlines":{"data":[{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks to Participate in Upcoming Investor Conferences","publication_date":"2017-05-10 13:00:00 +0000","summary":"SANTA CLARA, Calif., May 10, 2017 /PRNewswire/ --  Hortonworks, Inc. ® (NASDAQ: HDP), a leading innovator of open and connected data platforms, today announced that members of its executive management ...","url":"http://finance.yahoo.com/news/hortonworks-participate-upcoming-investor-conferences-130000106.html?.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Edited Transcript of HDP earnings conference call or presentation 4-May-17 8:30pm GMT","publication_date":"2017-05-09 01:00:59 +0000","summary":"Q1 2017 Hortonworks Inc Earnings Call","url":"http://finance.yahoo.com/news/edited-transcript-hdp-earnings-conference-023654917.html?.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Has the Hadoop market turned a corner?","publication_date":"2017-05-08 12:00:00 +0000","summary":"The recent numbers from Cloudera and Hortonworks show positive signs toward the path to profitability. But as they aim for the black, they are finding themselves in a much broader Big Data market where ease and accessibility will determine whether they sink or swim.","url":"http://finance.yahoo.com/r/a3902464-e6b1-3b78-badd-6c2d9e3a4ae2/has-the-hadoop-market-turned-a-corner/#ftag=YHFb1d24ec?yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks, Inc. breached its 50 day moving average in a Bearish Manner : HDP-US : May 5, 2017","publication_date":"2017-05-05 13:15:59 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Hortonworks, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/27aed0cf-aecf-309b-a7a7-4c29de924807/hortonworks-inc-breached-its-50-day-moving-average-in-a-bearish-manner-hdp-us-may-5-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks Jumps 9% on Q1 Beat, In-Line Q2, Year Views","publication_date":"2017-05-04 22:43:00 +0000","summary":"Shares of Hortonworks (HDP), a distributor of the open-source Hadoop software program, are up 89 cents, or 9%, at $10.99, in late trading, after the company this afternoon reported Q1 revenue and earnings that topped analysts’ expectations, and forecast this quarter’s, and the full year’s revenue about in line with consensus. Hortonworks competes with Cloudera (CLDR), the startup that went public last week.","url":"http://finance.yahoo.com/r/725277bc-73dd-349c-b8f9-bed3061fc545/hortonworks-jumps-9-on-q1-beat-in-line-q2-year-views-1493934639?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks reports 1Q loss","publication_date":"2017-05-04 22:12:41 +0000","summary":"On a per-share basis, the Santa Clara, California-based company said it had a loss of 89 cents. Losses, adjusted for stock option expense and non-recurring costs, were 50 cents per share. The results beat ...","url":"http://finance.yahoo.com/news/hortonworks-reports-1q-loss-221241936.html?.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"MuleSoft sets 2017 revenue targets; Arista Networks, LogMeIn, Hortonworks, Zendesk report","publication_date":"2017-05-04 21:09:06 +0000","summary":"The latest batch of technology vendor earnings were solid as MuleSoft, Arista and others see strong demand ahead.","url":"http://finance.yahoo.com/r/f7ea7aee-8518-3b3e-ae00-b69d407a5a9c/mulesoft-sets-2017-revenue-targets-arista-networks-logmein-hortonworks-zendesk-report/#ftag=YHFb1d24ec?yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks Reports First Quarter 2017 Revenue of $56.0 Million, Up 35 Percent Year Over Year","publication_date":"2017-05-04 20:04:00 +0000","summary":"SANTA CLARA, Calif., May 4, 2017 /PRNewswire/ --  Hortonworks , Inc. ® (NASDAQ: HDP), a leading innovator of open and connected data platforms, today announced financial results for the first quarter of ...","url":"http://finance.yahoo.com/news/hortonworks-reports-first-quarter-2017-200400324.html?.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Why investors are paying a premium for Cloudera over its top rival","publication_date":"2017-04-28 22:43:46 +0000","summary":"Investors give Cloudera a much higher multiple than they give Hortonworks as the Hadoop wars heat up.","url":"http://finance.yahoo.com/r/852f6c11-c10c-3e29-ad5e-f177ccde3be4/104435837?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104435837&yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Intel-backed Cloudera's stock jumps after it raises $225M in IPO","publication_date":"2017-04-28 20:30:51 +0000","summary":"Shares of Cloudera jumped by as much 26 percent after the database management business raised $225 million in an IPO that shaved more than $1 billion from its valuation. The Palo Alto company's stock rose as high as $19.31 in early trading on Friday and finished at $18.10, nearly 21 percent above its IPO price of $15. Intel (INTC) bought more shares in the IPO in order to hold its position as the biggest private stakeholder in Cloudera, owning a 19.4 percent of the company.","url":"http://finance.yahoo.com/r/a55828e7-6290-3e7a-8211-ac72d8288f25/intel-backed-clouderas-stock-jumps-after-it-raises.html?ana=yahoo&yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Big-data analytics company Cloudera surges in market debut","publication_date":"2017-04-28 14:51:20 +0000","summary":"Shares of Cloudera Inc surged as much as 24 percent in their stock market debut on Friday, the latest in a string of technology initial public offerings this year, giving the big-data analytics company a market value of about $2.3 billion. Cloudera's offering of 15 million shares was priced at $15 per share, above its expected range of $12-$14, and raised $225 million. Shares opened at $17.80 on the New York Stock Exchange and hit a high of $18.64 in early trading.","url":"http://finance.yahoo.com/news/big-data-analytics-company-cloudera-145120495.html?.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Cloudera raises $225M in IPO that tops targets but slashes valuation","publication_date":"2017-04-28 13:20:10 +0000","summary":"Data management platform provider Cloudera raised $225 million in its IPO after setting a price that topped its target range and gave it a preliminary valuation of about $1.9 billion. The Palo Alto-based company said it priced its shares at $15, far below the $30.92 a share paid by Intel when it invested $740 million in Cloudera in 2014. The valuation on the company in that round was $4.1 billion.","url":"http://finance.yahoo.com/r/979d9016-a813-36cc-a614-ffb597928d1d/cloudera-raises-225m-in-ipo-that-tops-targets-but.html?ana=yahoo&yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"On eve of Cloudera IPO, analysts offer ways to judge its success","publication_date":"2017-04-28 12:45:12 +0000","summary":"Most believe the price Cloudera sets on its IPO on Thursday will be well below what Intel Corp. paid when it invested in the Palo Alto-based Big Data company three years ago. At least one IPO analysis website says no. It argues the success of Cloudera’s offering should be measured against the $1.8 billion valuation that it was given by T. Rowe Price and Google Ventures when it raised a Series F round.","url":"http://finance.yahoo.com/r/fdacd18d-4c8f-3bc5-98c2-4e8b190660f7/cloudera-ipo.html?ana=yahoo&yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Cloudera&apos;s IPO: What Investors Need to Know","publication_date":"2017-04-27 14:29:00 +0000","summary":"The big data, analytics, software, and services firm is set to have a &quot;down round&quot; IPO. But is the current skepticism warranted?","url":"http://finance.yahoo.com/r/f43c06b2-429a-3b1c-b567-c90ec47c1a74/cloudera-ipo-what-investors-need-to-know.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks, Inc. – Value Analysis (NASDAQ:HDP) : April 25, 2017","publication_date":"2017-04-25 20:17:36 +0000","summary":"Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Hortonworks, Inc. a score of 15. Our analysis is based on comparing Hortonworks, Inc. with the following peers – Syntel, Inc, MobileIron, Inc., Workiva, Inc. Class A and RingCentral, Inc. Class A (SYNT-US, MOBL-US, WK-US and RNG-US). Investment Outlook Hortonworks, Inc. has a fundamental score of 15 ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/e28804c6-d477-340d-b741-c66419d2fb75/hortonworks-inc-value-analysis-nasdaqhdp-april-25-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Tech Today: Liking Xilinx, Cutting Criteo, Nikon Sues ASML, Challenges of Hadoop","publication_date":"2017-04-24 13:43:00 +0000","summary":"Here are some things going on today in your world of tech: Shares of Hadoop services firm Hortonworks (HDP) are up 9 cents, or 0.9%, at $10.21, in advance of the IPO this week of competitor Cloudera (CLDR). Mizuho’s Abhey Lamba, reiterating a Buy raging on Hortonworks stock, and a $13 price target, writes that after reading the S-1 for Cloudera’s offering, he notes some challenges facing Hortonworks and others in the Hadoop market, specifically that there’s little chance they’ll be profitable “anytime soon,” although he does expect pricing to improve for all, which “could help their performance over the next few years.\" Cloudera is expected to price its offering on Thursday evening. Shares of hard disk drive and NAND flash chip maker Western Digital (WDC) are up $1.41, or 1.8%, at $84.52, after the Nikkei Asian Review reported on Friday that the company may join with private equity shop Kohlberg Kravis Roberts and Japan’s Innovation Network Corp. to make a joint bid for Toshiba’s (6502JP) flash memory unit.","url":"http://finance.yahoo.com/r/d48431f2-323d-3bf6-a442-60f6b8bc4389/tech-today-liking-xilinx-cutting-criteo-nikon-sues-asml-challenges-of-hadoop?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks, Inc. breached its 50 day moving average in a Bearish Manner : HDP-US : April 24, 2017","publication_date":"2017-04-24 12:51:33 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Hortonworks, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/6a36c031-a236-33d7-a06a-54b7165e7fb1/hortonworks-inc-breached-its-50-day-moving-average-in-a-bearish-manner-hdp-us-april-24-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Four things to know about the Cloudera IPO","publication_date":"2017-04-19 10:53:07 +0000","summary":"Cloudera Inc., a data-software company, faces a cut in its $4.1 billion private valuation as it heads toward an initial public offering.","url":"http://finance.yahoo.com/r/5ce3c3a6-45e6-3c6d-8e54-fc0312f09357/Story.aspx?guid=272A7A1E-2382-11E7-B7EA-DA0AA5C59671&siteid=yhoof2&yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Four things to know about the Cloudera IPO","publication_date":"2017-04-19 10:53:07 +0000","summary":"Cloudera Inc., a data-software company, faces a cut in its $4.1 billion private valuation as it heads toward an initial public offering.","url":"http://finance.yahoo.com/news/four-things-know-cloudera-ipo-105307952.html?.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Cloudera targets IPO well below previous valuation estimates","publication_date":"2017-04-17 18:41:23 +0000","summary":"Cloudera on Monday set price targets for an IPO that would value the company at less than half what it was thought to be worth when Intel invested in it three years ago. The Palo Alto-based Big Data analytics software company said it plans to sell 17.3 million shares for between $12 and $14 each, which would raise up to $242 million. When Santa Clara chip giant Intel (INTC) invested $740 million in it in 2014, it was done at a valuation of $4.1 billion.","url":"http://finance.yahoo.com/r/bf7083df-be16-3460-8e55-1d3d58a827a3/clouderas-ipo-price-targets-set-wellbelow-private.html?ana=yahoo&yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Cloudera Sets IPO Pricing, Terms","publication_date":"2017-04-17 15:45:08 +0000","summary":"Big data software platform provider Cloudera has set terms for its coming IPO. The company plans to offer 15 million shares in an expected price range of $12 to $14. This is not particularly good news ...","url":"http://finance.yahoo.com/news/cloudera-sets-ipo-pricing-terms-154508580.html?.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks to Announce First Quarter 2017 Results on May 4, 2017","publication_date":"2017-04-13 12:00:00 +0000","summary":"SANTA CLARA, Calif., April 13, 2017 /PRNewswire/ -- Hortonworks, Inc. (HDP) will report results for its first quarter ended March 31, 2017 on May 4, 2017. The results will be included in a press release with accompanying financial information that will be released after market close and posted on the Hortonworks Investor Relations website. Hortonworks' executive management team will host a conference call on May 4, 2017 beginning at 1:30 p.m. PT (4:30 p.m. ET) to discuss financial results and business highlights.","url":"http://finance.yahoo.com/news/hortonworks-announce-first-quarter-2017-120000647.html?.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Data Works, Hadoop 3.0 is round the corner, and &apos;Horton Hatches the Egg&apos;","publication_date":"2017-04-07 16:26:07 +0000","summary":"What&apos;s coming in Hadoop 3.0? How is Hortonworks&apos; strategy evolving? And what are some examples of open-source powered innovation in big data use cases?","url":"http://finance.yahoo.com/r/c66ab39b-4afa-3174-9d8c-8c04e6bea120/data-works-hadoop-3-0-is-round-the-corner-and-horton-hatches-the-egg/#ftag=YHFb1d24ec?yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"IPOs: Why Big Data Cloudera's IPO May Fall Short","publication_date":"2017-04-06 10:00:00 +0000","summary":"Intel's investment stamped the company with a $4.1 billion value, but can growth keep up?","url":"http://finance.yahoo.com/r/bfd2ec78-f80d-32ca-bfc8-6cdbd84504b5/ipos-why-big-data-clouderas-ipo-may-fall-short-intc-hdp?partner=YahooSA&yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"ETFs with exposure to Hortonworks, Inc. : April 5, 2017","publication_date":"2017-04-05 20:51:23 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Hortonworks, Inc. Here are 5 ETFs with the largest exposure to HDP-US. Comparing the performance and risk of Hortonworks, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/2028aa5a-9bf2-383a-b748-522baece3c9c/etfs-with-exposure-to-hortonworks-inc-april-5-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks Leads the Industry in Performance and Customer Choice with HDP 2.6","publication_date":"2017-04-04 13:00:00 +0000","summary":"HDP is the industry's only true secure, enterprise-ready open source Apache™ Hadoop® distribution that addresses the complete needs of data-at-rest, powers real-time customer applications and delivers robust analytics that accelerate decision making and innovation. With HDP 2.6, customers benefit from interactive query in seconds, enhanced data science, enterprise-grade security and streamlined operations—in the cloud and on-premises—to harvest value from their data faster than previously possible. \"HDP 2.6 showcases the advantages of the open source community.","url":"http://finance.yahoo.com/news/hortonworks-leads-industry-performance-customer-130000361.html?.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks, Inc. breached its 50 day moving average in a Bullish Manner : HDP-US : April 3, 2017","publication_date":"2017-04-03 12:26:59 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Hortonworks, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/70786c16-bad2-3880-ae31-c1a1fc4539a5/hortonworks-inc-breached-its-50-day-moving-average-in-a-bullish-manner-hdp-us-april-3-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks, Inc. breached its 50 day moving average in a Bullish Manner : HDP-US : April 3, 2017","publication_date":"2017-04-03 12:26:59 +0000","summary":"Hortonworks, Inc. breached its 50 day moving average in a Bullish Manner : HDP-US : April 3, 2017","url":"http://www.capitalcube.com/blog/index.php/hortonworks-inc-breached-its-50-day-moving-average-in-a-bullish-manner-hdp-us-april-3-2017/"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"[$$] Cloudera Files for IPO","publication_date":"2017-03-31 20:53:09 +0000","summary":"Big-data software company Cloudera Inc. filed paperwork to go public on Friday, revealing a business that is growing quickly but possibly not fast enough to deliver gains to its big investor Intel Corp....","url":"http://finance.yahoo.com/r/728e1f57-4c45-3b99-afb2-642c6fae7506/cloudera-files-for-ipo-with-261-million-in-annual-revenue-1490989024?mod=yahoo_hs&yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"[$$] Cloudera Files for IPO","publication_date":"2017-03-31 20:53:09 +0000","summary":"[$$] Cloudera Files for IPO","url":"https://www.wsj.com/articles/cloudera-files-for-ipo-with-261-million-in-annual-revenue-1490989024?mod=yahoo_hs"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Cloudera files to raise up to $200M as IPO activity picks up","publication_date":"2017-03-31 19:51:20 +0000","summary":"Cloudera on Friday filed a prospectus for an IPO in which it hopes to raise up to $200 million as signals point to a busy second quarter for new public stock offerings. Others likely IPO candidates for this year that are listed in Renaissance's first quarter report are San Mateo-based sales management software company Apttus ( valued at about $1.3 billion ), San Francisco-based work-tracking software company Asana (valued at about $600 million) and San Jose cloud security business Zscaler.","url":"http://finance.yahoo.com/r/231a6e69-77dd-37eb-a86a-2856d1d9070f/cloudera-prospectus-expected-soon-as-ipo-activity.html?ana=yahoo&yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Cloudera files to raise up to $200M as IPO activity picks up","publication_date":"2017-03-31 19:51:20 +0000","summary":"Cloudera files to raise up to $200M as IPO activity picks up","url":"http://www.bizjournals.com/sanjose/news/2017/03/31/cloudera-prospectus-expected-soon-as-ipo-activity.html?ana=yahoo"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Soleo Communications Turns to Hortonworks for Real-Time Analytics","publication_date":"2017-03-30 13:00:00 +0000","summary":"[PR Newswire] - SANTA CLARA, Calif., March 30, 2017 /PRNewswire/ -- Hortonworks, Inc. ® (HDP), a leading innovator of open and connected data platforms, today announced that Soleo Communications, Inc., a market-leading local search and digital media company, is leveraging Hortonworks Data Platform (HDP®) and Hortonworks DataFlow (HDF™) to connect people and businesses together. Soleo bridges the space between the world of telephony and the world of Modern Data Applications. Every week, Soleo handles and routes millions of calls and searches for consumers trying to connect with local merchants.","url":"http://finance.yahoo.com/news/soleo-communications-turns-hortonworks-real-130000281.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Soleo Communications Turns to Hortonworks for Real-Time Analytics","publication_date":"2017-03-30 13:00:00 +0000","summary":"SANTA CLARA, Calif., March 30, 2017 /PRNewswire/ -- Hortonworks, Inc. ® (HDP), a leading innovator of open and connected data platforms, today announced that Soleo Communications, Inc., a market-leading local search and digital media company, is leveraging Hortonworks Data Platform (HDP®) and Hortonworks DataFlow (HDF™) to connect people and businesses together. Soleo bridges the space between the world of telephony and the world of Modern Data Applications. Every week, Soleo handles and routes millions of calls and searches for consumers trying to connect with local merchants.","url":"http://finance.yahoo.com/news/soleo-communications-turns-hortonworks-real-130000281.html?.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"HORTONWORKS, INC. Financials","publication_date":"2017-03-21 17:04:10 +0000","summary":"HORTONWORKS, INC. Financials","url":"http://finance.yahoo.com/q/is?s=hdp"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"HORTONWORKS, INC. Files SEC form 10-K, Annual Report","publication_date":"2017-03-15 20:14:17 +0000","summary":"HORTONWORKS, INC. Files SEC form 10-K, Annual Report","url":"http://biz.yahoo.com/e/170315/hdp10-k.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Clearsense Leverages Hortonworks to Drive Innovation in Healthcare","publication_date":"2017-03-02 14:00:00 +0000","summary":"[PR Newswire] - SANTA CLARA, Calif., March 2, 2017 /PRNewswire/ -- Hortonworks, Inc. ® (HDP), a leading innovator of open and connected data platforms, today announced that Clearsense, a developer of an advanced healthcare data ecosystem and data applications focused on improving outcomes, is leveraging Hortonworks Data Platform (HDP®) and Hortonworks DataFlow (HDF™) to capture value from Big Data produced by the healthcare industry. Clearsense was born out of a passion for helping healthcare organizations realize the promise of their data.","url":"http://finance.yahoo.com/news/clearsense-leverages-hortonworks-drive-innovation-140000750.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Clearsense Leverages Hortonworks to Drive Innovation in Healthcare","publication_date":"2017-03-02 14:00:00 +0000","summary":"SANTA CLARA, Calif., March 2, 2017 /PRNewswire/ -- Hortonworks, Inc. ® (HDP), a leading innovator of open and connected data platforms, today announced that Clearsense, a developer of an advanced healthcare data ecosystem and data applications focused on improving outcomes, is leveraging Hortonworks Data Platform (HDP®) and Hortonworks DataFlow (HDF™) to capture value from Big Data produced by the healthcare industry. Clearsense was born out of a passion for helping healthcare organizations realize the promise of their data.","url":"http://finance.yahoo.com/news/clearsense-leverages-hortonworks-drive-innovation-140000750.html?.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Cloudera may join this year's IPO lineup","publication_date":"2017-02-28 23:37:29 +0000","summary":"Cloudera may join this year's IPO lineup","url":"http://www.bizjournals.com/sanjose/news/2017/02/28/cloudera-ipo.html?ana=yahoo"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Cloudera may join this year's IPO lineup","publication_date":"2017-02-28 23:37:29 +0000","summary":"Big Data unicorn Cloudera has reportedly hired underwriters for an IPO that could happen by the end of the year. The Palo Alto-based company is eyeing a valuation of about $4.1 billion, according to a report in which Bloomberg cited unnamed sources . The company raised more than $1 billion since it was founded in 2008 and has been on IPO watch lists for a couple of years.","url":"http://finance.yahoo.com/r/1960d973-7377-34fa-8e36-9c187d7922bd/cloudera-ipo.html?ana=yahoo&yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks to Present at First Quarter 2017 Investor Conferences","publication_date":"2017-02-22 13:00:00 +0000","summary":"[PR Newswire] - SANTA CLARA, Calif., Feb. 22, 2017 /PRNewswire/ -- Hortonworks, Inc. ® (NASDAQ: HDP), a leading innovator of open and connected data platforms, today announced that members of its executive management ...","url":"http://finance.yahoo.com/news/hortonworks-present-first-quarter-2017-130000703.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks to Present at First Quarter 2017 Investor Conferences","publication_date":"2017-02-22 13:00:00 +0000","summary":"SANTA CLARA, Calif., Feb. 22, 2017 /PRNewswire/ --  Hortonworks, Inc. ® (NASDAQ: HDP), a leading innovator of open and connected data platforms, today announced that members of its executive management ...","url":"http://finance.yahoo.com/news/hortonworks-present-first-quarter-2017-130000703.html?.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks' Chris Sullivan Recognized as 2017 CRN® Channel Chief","publication_date":"2017-02-20 15:15:00 +0000","summary":"SANTA CLARA, Calif., Feb. 20, 2017 /PRNewswire/ -- Hortonworks, Inc. ® (HDP), a leading innovator of open and connected data platforms, announced today that CRN®, a brand of The Channel Company, has named Chris Sullivan, senior vice president of global channels and alliances at Hortonworks, to its prestigious list of 2017 Channel Chiefs. Channel Chief honorees are selected by CRN's editorial staff on the basis of their professional achievements, standing in the industry, dedication to the channel partner community and strategies for driving future growth and innovation. Each of the 2017 Channel Chiefs has demonstrated loyalty and ongoing support for the IT channel by consistently promoting, defending and executing outstanding channel partner programs.","url":"http://finance.yahoo.com/news/hortonworks-chris-sullivan-recognized-2017-151500528.html?.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks' Chris Sullivan Recognized as 2017 CRN® Channel Chief","publication_date":"2017-02-20 15:15:00 +0000","summary":"[PR Newswire] - SANTA CLARA, Calif., Feb. 20, 2017 /PRNewswire/ -- Hortonworks, Inc. ® (HDP), a leading innovator of open and connected data platforms, announced today that CRN®, a brand of The Channel Company, has named Chris Sullivan, senior vice president of global channels and alliances at Hortonworks, to its prestigious list of 2017 Channel Chiefs. Channel Chief honorees are selected by CRN's editorial staff on the basis of their professional achievements, standing in the industry, dedication to the channel partner community and strategies for driving future growth and innovation. Each of the 2017 Channel Chiefs has demonstrated loyalty and ongoing support for the IT channel by consistently promoting, defending and executing outstanding channel partner programs.","url":"http://finance.yahoo.com/news/hortonworks-chris-sullivan-recognized-2017-151500528.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Pinsight Media Chooses Hortonworks to Expand Data Cluster","publication_date":"2017-02-16 14:00:00 +0000","summary":"SANTA CLARA, Calif., Feb. 16, 2017 /PRNewswire/ -- Hortonworks, Inc. ® (HDP), a leading innovator of open and connected data platforms, today announced that Pinsight Media, a mobile data company, is leveraging Hortonworks Data Platform (HDP™), Hortonworks DataFlow (HDF™) and Hortonworks professional services to enhance how it ingests data from mobile network operators. To establish its first HDP cluster, Pinsight relied on the deep subject matter expertise of Hortonworks professional services.","url":"http://finance.yahoo.com/news/pinsight-media-chooses-hortonworks-expand-140000192.html?.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Pinsight Media Chooses Hortonworks to Expand Data Cluster","publication_date":"2017-02-16 14:00:00 +0000","summary":"[PR Newswire] - SANTA CLARA, Calif., Feb. 16, 2017 /PRNewswire/ -- Hortonworks, Inc. ® (HDP), a leading innovator of open and connected data platforms, today announced that Pinsight Media, a mobile data company, is leveraging Hortonworks Data Platform (HDP™), Hortonworks DataFlow (HDF™) and Hortonworks professional services to enhance how it ingests data from mobile network operators. To establish its first HDP cluster, Pinsight relied on the deep subject matter expertise of Hortonworks professional services.","url":"http://finance.yahoo.com/news/pinsight-media-chooses-hortonworks-expand-140000192.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks, Inc. :HDP-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017","publication_date":"2017-02-15 16:20:56 +0000","summary":"Hortonworks, Inc. :HDP-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017","url":"http://www.capitalcube.com/blog/index.php/hortonworks-inc-hdp-us-earnings-analysis-q4-2016-by-the-numbers-february-15-2017/"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks, Inc. :HDP-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017","publication_date":"2017-02-15 16:20:56 +0000","summary":"Categories: Yahoo Finance Get free summary analysis Hortonworks, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Hortonworks, Inc. – MobileIron, Inc. and RingCentral, Inc. Class A (MOBL-US and RNG-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 51.96 million, Net ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/e19f36cb-f74b-3e3b-b8fa-da5d405e5655/hortonworks-inc-hdp-us-earnings-analysis-q4-2016-by-the-numbers-february-15-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"IBM Delivers New Platform to help clients address storage challenges at massive scale","publication_date":"2017-02-14 21:03:00 +0000","summary":"[PR Newswire] - LAS VEGAS, Feb. 14, 2017 /PRNewswire/ -- (IBM PartnerWorld) -- IBM (NYSE: IBM ) and Hortonworks (NASDAQ: HDP) today announced the planned availability of Hortonworks Data Platform (HDP®) for IBM Elastic ...","url":"http://finance.yahoo.com/news/ibm-delivers-platform-help-clients-210300328.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"IBM Delivers New Platform to help clients address storage challenges at massive scale","publication_date":"2017-02-14 21:03:00 +0000","summary":"LAS VEGAS, Feb. 14, 2017 /PRNewswire/ -- (IBM PartnerWorld) -- IBM (NYSE: IBM ) and Hortonworks (NASDAQ: HDP) today announced the planned availability of Hortonworks Data Platform (HDP®) for IBM Elastic ...","url":"http://finance.yahoo.com/news/ibm-delivers-platform-help-clients-210300328.html?.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks, Inc. :HDP-US: Earnings Analysis: 2016 By the Numbers : February 13, 2017","publication_date":"2017-02-13 17:02:36 +0000","summary":"Hortonworks, Inc. :HDP-US: Earnings Analysis: 2016 By the Numbers : February 13, 2017","url":"http://www.capitalcube.com/blog/index.php/hortonworks-inc-hdp-us-earnings-analysis-2016-by-the-numbers-february-13-2017/"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Technology Sector Update for 02/10/2017: HDP,SWIR,RSYS","publication_date":"2017-02-10 21:37:44 +0000","summary":"Top Tech StocksTop Tech Stocks MSFT 0 02 MSFT 0 02 AAPL 0 15 AAPL 0 15 IBM 0 73 IBM 0 73 CSCO 0 10 CSCO 0 10 GOOG 0 50 GOOG 0 50 Technology stocks managed to scratch slim gains today with shares of tech companies in the S amp P 500 rising nearly 0 3 this afternoon Technology","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mrB9BvKOgK0/technology-sector-update-for-02102017-hdpswirrsys-cm746552"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks Stock Jumps On Strong Q4 Earnings, In-Line Guidance","publication_date":"2017-02-10 21:03:55 +0000","summary":"Hortonworks Stock Jumps On Strong Q4 Earnings, In-Line Guidance","url":"http://www.investors.com/news/technology/hortonworks-stock-jumps-on-strong-q4-earnings-report/"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks Stock Jumps On Strong Q4 Earnings, In-Line Guidance","publication_date":"2017-02-10 21:03:55 +0000","summary":"Shares of software developer Hortonworks soared after fourth-quarter earnings late Thursday topped expectations.","url":"http://finance.yahoo.com/r/e5323ff3-06ea-308f-a248-f9c276ac4104/hortonworks-stock-jumps-on-strong-q4-earnings-report?yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Edited Transcript of HDP earnings conference call or presentation 9-Feb-17 9:30pm GMT","publication_date":"2017-02-10 08:21:44 +0000","summary":"Q4 2016 Hortonworks Inc Earnings Call","url":"http://finance.yahoo.com/news/edited-transcript-hdp-earnings-conference-082144859.html?.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Edited Transcript of HDP earnings conference call or presentation 9-Feb-17 9:30pm GMT","publication_date":"2017-02-10 08:21:44 +0000","summary":"Edited Transcript of HDP earnings conference call or presentation 9-Feb-17 9:30pm GMT","url":"http://finance.yahoo.com/news/edited-transcript-hdp-earnings-conference-082144859.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks stock jumps after Q4 results beat expectations","publication_date":"2017-02-09 23:06:42 +0000","summary":"Shares of Hortonworks jumped as much as 15 percent in extended trading Thursday after the Big Data software company posted a smaller-than-expected fourth quarter loss. The Santa Clara company (HDP) said that loss, adjusted for one-time factors, was 50 cents a share on revenue of $52 million. Wall Street analysts had projected a loss of 60 cents a share on revenue of $48 million.","url":"http://finance.yahoo.com/r/8cd3135d-23a1-337b-9e30-9f81485b1067/hortonworks-stock-jumps-after-q4-results.html?ana=yahoo&yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks stock jumps after Q4 results beat expectations","publication_date":"2017-02-09 23:06:42 +0000","summary":"Hortonworks stock jumps after Q4 results beat expectations","url":"http://www.bizjournals.com/sanjose/news/2017/02/09/hortonworks-stock-jumps-after-q4-results.html?ana=yahoo"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks reports 4Q loss","publication_date":"2017-02-09 22:33:32 +0000","summary":"On a per-share basis, the Santa Clara, California-based company said it had a loss of 94 cents. Losses, adjusted for stock option expense and asset impairment costs, came to 50 cents per share. The results ...","url":"http://finance.yahoo.com/news/hortonworks-reports-4q-loss-223332157.html?.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks reports 4Q loss","publication_date":"2017-02-09 22:33:32 +0000","summary":"[AP] - On a per-share basis, the Santa Clara, California-based company said it had a loss of 94 cents. Losses, adjusted for stock option expense and asset impairment costs, came to 50 cents per share. The results ...","url":"http://sg.finance.yahoo.com/news/hortonworks-reports-4q-loss-223332277.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks: Hadoop Distributor Jumps 8% on Q4 Beat","publication_date":"2017-02-09 22:10:00 +0000","summary":"Software distributor Hortonworks (HDP), which supports the Hadoop data mining program, this afternoon reported Q4 revenue that topped analysts’ expectations, and a smaller-than-expected net loss, sending its shares surging in late trading. Revenue in the three months ended in December rose 39%, year over year, to $52 million, yielding a net loss of 50 cents, excluding some costs. Hortonworks’s deferred revenue rose 18%, quarter to quarter, to a total of $185.4 million.","url":"http://finance.yahoo.com/r/9a1cd048-eec3-3cf9-b3d4-22400b85a56e/hortonworks-hadoop-distributor-jumps-8-on-q4-beat?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks: Hadoop Distributor Jumps 8% on Q4 Beat","publication_date":"2017-02-09 22:10:00 +0000","summary":"Hortonworks: Hadoop Distributor Jumps 8% on Q4 Beat","url":"http://blogs.barrons.com/techtraderdaily/2017/02/09/hortonworks-hadoop-distributor-jumps-8-on-q4-beat/?mod=yahoobarrons&ru=yahoo"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks shares rally on narrower-than-expected loss","publication_date":"2017-02-09 21:47:35 +0000","summary":"Hortonworks shares rally on narrower-than-expected loss","url":"http://www.marketwatch.com/News/Story/Story.aspx?guid=49591AE3-DCF5-4E83-9341-F66E29DDDCD9&siteid=yhoof2"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks Inc Earnings Call scheduled for 4:30 pm ET today","publication_date":"2017-02-09 21:30:00 +0000","summary":"Hortonworks Inc Earnings Call scheduled for 4:30 pm ET today","url":"http://biz.yahoo.com/cc/6/155146.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"HORTONWORKS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit","publication_date":"2017-02-09 21:13:29 +0000","summary":"HORTONWORKS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit","url":"http://biz.yahoo.com/e/170209/hdp8-k.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"4:07 pm Hortonworks beats by $0.10, beats on revs; guides Q1 revs in-line; guides FY17 revs above consensus","publication_date":"2017-02-09 21:07:00 +0000","summary":"4:07 pm Hortonworks beats by $0.10, beats on revs; guides Q1 revs in-line; guides FY17 revs above consensus","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#hdp"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks Reports Record 2016 Revenue of $184.5 Million and Fourth Quarter Revenue of $52.0 Million","publication_date":"2017-02-09 21:04:00 +0000","summary":"[PR Newswire] - SANTA CLARA, Calif., Feb. 9, 2017 /PRNewswire/ -- Hortonworks, Inc. ® (NASDAQ: HDP), a leading innovator of open and connected data platforms, today announced financial results for the fourth quarter ...","url":"http://finance.yahoo.com/news/hortonworks-reports-record-2016-revenue-210400903.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Earnings Reaction History: HORTONWORKS INC, 50.0% Follow-Through Indicator, 12.5% Sensitive","publication_date":"2017-02-09 20:37:40 +0000","summary":"Expected Earnings Release 02 09 2017 After hoursExpected Earnings Release 02 09 2017 After hours Avg Extended Hours Dollar Volume 1 935 010Avg Extended Hours Dollar Volume 1 935 010 HORTONWORKS INC HDP is due to issue its quarterly earnings report in the upcoming extended","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5rjmMG0k5qM/earnings-reaction-history-hortonworks-inc-500-follow-through-indicator-125-sensitive-cm745796"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Q4 2016 Hortonworks Inc Earnings Release - After Market Close","publication_date":"2017-02-09 12:07:06 +0000","summary":"Q4 2016 Hortonworks Inc Earnings Release - After Market Close","url":"http://biz.yahoo.com/research/earncal/20170209.html?t=hdp"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks Enterprise Data Warehouse Optimization Solution Fast Tracks Customers to Modern Business Intelligence","publication_date":"2017-02-01 14:00:00 +0000","summary":"[PR Newswire] - SANTA CLARA, Calif., Feb. 1, 2017 /PRNewswire/ -- Hortonworks, Inc. ® (HDP), a leading innovator of open and connected data platforms, today announced its Enterprise Data Warehouse (EDW) Optimization Solution, the industry's only turnkey Hadoop-powered Business Intelligence (BI) solution. Available today, this solution from Hortonworks is powered by Hortonworks Data Platform (HDP®) and technology from partners Syncsort and AtScale. With the EDW Optimization Solution, customers can extend the value of existing EDW investments and overcome the challenges, risks and costs of introducing new solutions into legacy infrastructure.","url":"http://finance.yahoo.com/news/hortonworks-enterprise-data-warehouse-optimization-140000284.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks Delivers Data-Driven Digital Strategies for Customers","publication_date":"2017-01-31 14:00:00 +0000","summary":"[PR Newswire] - For marketers, this data is invaluable for shaping and promoting a brand or product, but unstructured data is difficult to process and analyze with legacy platforms. Hortonworks Data Platform (HDP) and Hortonworks DataFlow (HDF) bring all types of data from consumers to the point of analysis. Now advertisers can store new types of data, combine it with the data they already have and retain all data for much longer which ultimately boosts customer loyalty and return on investment.","url":"http://finance.yahoo.com/news/hortonworks-delivers-data-driven-digital-140000662.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Tech Today: Fitbit Plunges, Apple, EA on Tap, Goldman Likes NTAP","publication_date":"2017-01-30 15:48:00 +0000","summary":"Tech Today: Fitbit Plunges, Apple, EA on Tap, Goldman Likes NTAP","url":"http://blogs.barrons.com/techtraderdaily/2017/01/30/tech-today-fitbit-plunges-apple-ea-on-tap-goldman-likes-ntap/?mod=yahoobarrons&ru=yahoo"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks upgraded by Mizuho","publication_date":"2017-01-30 10:51:22 +0000","summary":"Hortonworks upgraded by Mizuho","url":"http://finance.yahoo.com/q/ud?s=HDP"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks Celebrates 2016 Partnerworks Award Winners and Announces Record Ecosystem Growth","publication_date":"2017-01-24 15:02:00 +0000","summary":"[PR Newswire] - SANTA CLARA, Calif., Jan. 24, 2017 /PRNewswire/ -- Hortonworks, Inc. ® (HDP), a leading innovator of open and connected data platforms, today announced its Partnerworks program has exceeded 2,100 members, illustrating strong demand for technologies that utilize data to transform business outcomes. Partnerworks is Hortonworks' global program to support and enable partners selling, implementing and innovating with Hortonworks to deliver integrated customer solutions for the datacenter and in the cloud.","url":"http://finance.yahoo.com/news/hortonworks-celebrates-2016-partnerworks-award-150200620.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks, Inc. breached its 50 day moving average in a Bearish Manner : HDP-US : January 20, 2017","publication_date":"2017-01-20 14:01:07 +0000","summary":"Hortonworks, Inc. breached its 50 day moving average in a Bearish Manner : HDP-US : January 20, 2017","url":"http://www.capitalcube.com/blog/index.php/hortonworks-inc-breached-its-50-day-moving-average-in-a-bearish-manner-hdp-us-january-20-2017/"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks to Announce Fourth Quarter and Fiscal Year 2016 Results on February 9, 2017","publication_date":"2017-01-18 13:00:00 +0000","summary":"[PR Newswire] - SANTA CLARA, Calif., Jan. 18, 2017 /PRNewswire/ -- Hortonworks, Inc. (HDP) will report results for its fourth quarter and fiscal year ended December 31, 2016 on February 9, 2017. The results will be included in a press release with accompanying financial information that will be released after market close and posted on the Hortonworks Investor Relations website. Hortonworks' executive management team will host a question and answer conference call on February 9, 2017 beginning at 1:30 p.m. PT (4:30 p.m. ET) to discuss financial results and business highlights.","url":"http://finance.yahoo.com/news/hortonworks-announce-fourth-quarter-fiscal-130000914.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"HORTONWORKS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial","publication_date":"2017-01-12 21:20:35 +0000","summary":"HORTONWORKS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial","url":"http://biz.yahoo.com/e/170112/hdp8-k.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks Appoints Rajnish Verma President and Chief Operating Officer","publication_date":"2017-01-12 21:10:00 +0000","summary":"[PR Newswire] - SANTA CLARA, Calif., Jan. 12, 2017 /PRNewswire/ -- Hortonworks® (HDP), a leading innovator of open and connected data platforms, today announced that it has appointed Raj Verma president and chief operating officer. Hortonworks recently celebrated exceeding 1,000 customers worldwide, having rapidly built its customer base across industries including healthcare, manufacturing, financial services, energy, telecommunications and public sector. Verma will be responsible for advancing Hortonworks' global sales strategy and execution, and will oversee sales, sales engineering, channel, professional services, training and marketing.","url":"http://finance.yahoo.com/news/hortonworks-appoints-rajnish-verma-president-211000164.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks and Neustar Co-Development to Deliver New Identity Management and Security for Internet of Things Devices","publication_date":"2017-01-11 14:00:00 +0000","summary":"[PR Newswire] - SANTA CLARA, Calif., Jan. 11, 2017 /PRNewswire/ -- Hortonworks, Inc. ® (HDP) today announced an open source technology collaboration with Neustar, Inc., a trusted, neutral provider of real-time information services, to create powerful, business-friendly security and identity management tools for Internet-of-Things (IoT) devices. Hortonworks' connected data platforms enable Neustar to extend its OneID® identity management to the open source community, utilizing Hortonworks Data Platform (HDP) and Hortonworks Data Flow (HDF), to enable the development of new industry-leading identity management and security solutions for IoT devices.","url":"http://finance.yahoo.com/news/hortonworks-neustar-co-development-deliver-140000644.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Clarity Solution Group Reaches Gold as a Hortonworks Consultant Partner","publication_date":"2017-01-09 16:00:00 +0000","summary":"[Marketwired] - Clarity Solution Group announced today that it has reached gold level as a certified Hortonworks® partner. To reach Gold level, a partner must prove its abilities by reaching a specific set of targets ...","url":"http://finance.yahoo.com/news/clarity-solution-group-reaches-gold-160000408.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks, Inc. – Value Analysis (NASDAQ:HDP) : January 5, 2017","publication_date":"2017-01-05 16:14:35 +0000","summary":"Hortonworks, Inc. – Value Analysis (NASDAQ:HDP) : January 5, 2017","url":"http://www.capitalcube.com/blog/index.php/hortonworks-inc-value-analysis-nasdaqhdp-january-5-2017/"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks, Inc. breached its 50 day moving average in a Bullish Manner : HDP-US : January 4, 2017","publication_date":"2017-01-04 13:35:00 +0000","summary":"Hortonworks, Inc. breached its 50 day moving average in a Bullish Manner : HDP-US : January 4, 2017","url":"http://www.capitalcube.com/blog/index.php/hortonworks-inc-breached-its-50-day-moving-average-in-a-bullish-manner-hdp-us-january-4-2017/"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Can A Stock Go From Worst To First? Needham Says Cray Can","publication_date":"2017-01-03 21:11:55 +0000","summary":"Can A Stock Go From Worst To First? Needham Says Cray Can","url":"http://www.investors.com/news/technology/can-a-stock-go-from-worst-to-first-needham-says-cray-can/"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"ETFs with exposure to Hortonworks, Inc. : December 30, 2016","publication_date":"2016-12-30 16:09:10 +0000","summary":"ETFs with exposure to Hortonworks, Inc. : December 30, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-hortonworks-inc-december-30-2016/"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"ETFs with exposure to Hortonworks, Inc. : December 19, 2016","publication_date":"2016-12-19 18:31:59 +0000","summary":"ETFs with exposure to Hortonworks, Inc. : December 19, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-hortonworks-inc-december-19-2016/"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks, Inc. breached its 50 day moving average in a Bullish Manner : HDP-US : December 14, 2016","publication_date":"2016-12-14 12:39:41 +0000","summary":"Hortonworks, Inc. breached its 50 day moving average in a Bullish Manner : HDP-US : December 14, 2016","url":"http://www.capitalcube.com/blog/index.php/hortonworks-inc-breached-its-50-day-moving-average-in-a-bullish-manner-hdp-us-december-14-2016/"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hadoop Summit Expands to Address Growing Data Ecosystem","publication_date":"2016-12-12 14:00:00 +0000","summary":"[PR Newswire] - SANTA CLARA, Calif., Dec. 12, 2016 /PRNewswire/ -- Hosts Hortonworks® (HDP) and Yahoo! today announced the expansion of Hadoop Summit to include DataWorks Summit to meet the demands of a growing and accelerating data ecosystem. DataWorks Summit and Hadoop Summit will spark conversation around today's modern data applications and the importance of a connected data architecture, of which Apache Hadoop and related technologies play integral roles. Starting with the 2017 conference in Munich, Germany on April 5-6, DataWorks Summit and Hadoop Summit will bring partners and customers together to discuss business transformations fueled by data and customer innovation.","url":"http://finance.yahoo.com/news/hadoop-summit-expands-address-growing-140000465.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Is Hortonworks Inc (HDP) Worthy of Your Portfolio?","publication_date":"2016-12-09 23:39:17 +0000","summary":"Is Hortonworks Inc (HDP) Worthy of Your Portfolio?","url":"http://www.insidermonkey.com/blog/is-hortonworks-inc-hdp-worthy-of-your-portfolio-502014/"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks: MapR Shows a Better Way, Says Cowen","publication_date":"2016-12-08 20:53:00 +0000","summary":"Hortonworks: MapR Shows a Better Way, Says Cowen","url":"http://blogs.barrons.com/techtraderdaily/2016/12/08/hortonworks-mapr-shows-a-better-way-says-cowen/?mod=yahoobarrons&ru=yahoo"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"United Network for Organ Sharing Chooses Hortonworks Data Platform to Help Save Lives","publication_date":"2016-12-06 15:26:00 +0000","summary":"[PR Newswire] - SANTA CLARA, Calif., Dec. 6, 2016 /PRNewswire/ -- Hortonworks, Inc. ® (HDP) today announced that United Network for Organ Sharing (UNOS), the private, non-profit organization managing the United States organ transplant system, is using Hortonworks Data Platform (HDP®) to help transplant professionals make more informed decisions when life-saving organs become available. The organization maintains data on every organ transplant performed in the United States since 1987, a substantial sum considering the nearly 31,000 transplanted organs in 2015 alone.","url":"http://finance.yahoo.com/news/united-network-organ-sharing-chooses-152600422.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"ETFs with exposure to Hortonworks, Inc. : December 5, 2016","publication_date":"2016-12-05 17:12:12 +0000","summary":"ETFs with exposure to Hortonworks, Inc. : December 5, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-hortonworks-inc-december-5-2016/"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"ETFs with exposure to Hortonworks, Inc. : November 23, 2016","publication_date":"2016-11-23 18:03:58 +0000","summary":"ETFs with exposure to Hortonworks, Inc. : November 23, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-hortonworks-inc-november-23-2016/"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks, Inc. :HDP-US: Earnings Analysis: Q3, 2016 By the Numbers : November 21, 2016","publication_date":"2016-11-21 16:12:23 +0000","summary":"Hortonworks, Inc. :HDP-US: Earnings Analysis: Q3, 2016 By the Numbers : November 21, 2016","url":"http://www.capitalcube.com/blog/index.php/hortonworks-inc-hdp-us-earnings-analysis-q3-2016-by-the-numbers-november-21-2016/"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks Advances Cloud Strategy with Availability of Hortonworks Data Cloud for Amazon Web Services","publication_date":"2016-11-15 14:18:10 +0000","summary":"[at noodls] - SANTA CLARA, Calif., Nov. 15, 2016 /PRNewswire/ -- Hortonworks, Inc. (NASDAQ: HDP), a leading innovator of open and connected data platforms, today announced the availability of Hortonworks Data Cloud ...","url":"http://www.publicnow.com/view/B4F6D81CD458A6CB7B39909E7DAAD8EC027E1AE0"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Blog Coverage Siemens AG Bulks up its Digital Muscle and Announces Acquisition of Software Firm Mentor Graphics","publication_date":"2016-11-15 13:15:00 +0000","summary":"[Accesswire] - Upcoming AWS Coverage on Hortonworks Post-Earnings Results LONDON, UK / ACCESSWIRE / November 15, 2016 / Active Wall St. blog coverage looks at the headline from Mentor Graphics Corp. (NASDAQ: MENT ). ...","url":"http://finance.yahoo.com/news/blog-coverage-siemens-ag-bulks-131500821.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Hortonworks Powers Modernization of Health Insurance Industry","publication_date":"2016-11-10 14:11:05 +0000","summary":"[at noodls] - SANTA CLARA, Calif., Nov. 10, 2016 /PRNewswire/ -- Hortonworks, Inc. ® (NASDAQ: HDP), a leading innovator of open and connected data platforms, today announced Health Care Service Corporation (HCSC) and ...","url":"http://www.publicnow.com/view/BFE891DBF3E38DB9C11DC4DBAA6318E8C8157309"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"HORTONWORKS, INC. Files SEC form 10-Q, Quarterly Report","publication_date":"2016-11-08 21:10:20 +0000","summary":"HORTONWORKS, INC. Files SEC form 10-Q, Quarterly Report","url":"http://biz.yahoo.com/e/161108/hdp10-q.html"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"ETF’s with exposure to Hortonworks, Inc. : November 8, 2016","publication_date":"2016-11-08 17:06:50 +0000","summary":"ETF’s with exposure to Hortonworks, Inc. : November 8, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-hortonworks-inc-november-8-2016/"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"'Mad Money' Lightning Round: I'm Avoiding ConforMIS","publication_date":"2016-11-08 11:00:00 +0000","summary":"'Mad Money' Lightning Round: I'm Avoiding ConforMIS","url":"https://www.thestreet.com/story/13695054/1/mad-money-lightning-round-i-m-avoiding-conformis.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"HDP","figi_ticker":"HDP:US","figi":"BBG001V8K4H6","title":"Cramer turns sour on this stock after it pushed back $1 billion in business","publication_date":"2016-11-07 23:50:54 +0000","summary":"Cramer turns sour on this stock after it pushed back $1 billion in business","url":"http://www.cnbc.com/id/104087381?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104087381"}],"result_count":202,"page_size":100,"current_page":1,"total_pages":3,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"12.551"},{"x":"1494596100","y":"12.58"},{"x":"1494596400","y":"12.56"},{"x":"1494596700","y":"12.61"},{"x":"1494597000","y":"12.64"},{"x":"1494597300","y":"12.73"},{"x":"1494597600","y":"12.73"},{"x":"1494597900","y":"12.7997"},{"x":"1494598200","y":"12.87"},{"x":"1494598500","y":"12.88"},{"x":"1494598800","y":"12.9"},{"x":"1494599100","y":"12.9"},{"x":"1494599400","y":"12.92"},{"x":"1494599700","y":"12.96"},{"x":"1494600000","y":"12.92"},{"x":"1494600300","y":"12.94"},{"x":"1494600600","y":"12.9537"},{"x":"1494600900","y":"12.97"},{"x":"1494601200","y":"12.97"},{"x":"1494601500","y":"12.97"},{"x":"1494601800","y":"12.97"},{"x":"1494602100","y":"12.97"},{"x":"1494602400","y":"12.9301"},{"x":"1494602700","y":"12.9325"},{"x":"1494603000","y":"12.955"},{"x":"1494603300","y":"12.975"},{"x":"1494603600","y":"13.07"},{"x":"1494603900","y":"13.0761"},{"x":"1494604200","y":"13.11"},{"x":"1494604500","y":"13.1501"},{"x":"1494604800","y":"13.16"},{"x":"1494605100","y":"13.19"},{"x":"1494605400","y":"13.22"},{"x":"1494605700","y":"13.28"},{"x":"1494606000","y":"13.27"},{"x":"1494606300","y":"13.29"},{"x":"1494606600","y":"13.31"},{"x":"1494606900","y":"13.2"},{"x":"1494607200","y":"13.26"},{"x":"1494607500","y":"13.301"},{"x":"1494607800","y":"13.283"},{"x":"1494608100","y":"13.3"},{"x":"1494608400","y":"13.31"},{"x":"1494608700","y":"13.316"},{"x":"1494609000","y":"13.31"},{"x":"1494609300","y":"13.32"},{"x":"1494609600","y":"13.37"},{"x":"1494609900","y":"13.39"},{"x":"1494610200","y":"13.365"},{"x":"1494610500","y":"13.37"},{"x":"1494610800","y":"13.42"},{"x":"1494611100","y":"13.4148"},{"x":"1494611400","y":"13.42"},{"x":"1494611700","y":"13.43"},{"x":"1494612000","y":"13.455"},{"x":"1494612300","y":"13.43"},{"x":"1494612600","y":"13.4"},{"x":"1494612900","y":"13.43"},{"x":"1494613200","y":"13.46"},{"x":"1494613500","y":"13.46"},{"x":"1494613800","y":"13.455"},{"x":"1494614100","y":"13.5275"},{"x":"1494614400","y":"13.5271"},{"x":"1494614700","y":"13.52"},{"x":"1494615000","y":"13.55"},{"x":"1494615300","y":"13.53"},{"x":"1494615600","y":"13.525"},{"x":"1494615900","y":"13.495"},{"x":"1494616200","y":"13.45"},{"x":"1494616500","y":"13.43"},{"x":"1494616800","y":"13.42"},{"x":"1494617100","y":"13.4211"},{"x":"1494617400","y":"13.42"},{"x":"1494617700","y":"13.39"},{"x":"1494618000","y":"13.36"},{"x":"1494618300","y":"13.4"},{"x":"1494618600","y":"13.39"},{"x":"1494618900","y":"13.44"},{"x":"1494619200","y":"13.42"} ], "color":"#03a9f4"}]},
{"id":"13","symbol": "INO","name": "Inovio Pharmaceuticals Inc","price": 7.14,"dollarChange": 0.39,"percentChange": 5.78,"open": 6.75,"high": 7.45,"low":6.725,"volume": 2846700,"avgVol": 770367.916667,"sharesShort": 9204381,"shortPercent": 12.333846,"marketCap": 469403911,"float": 74627013,"headlines":{"data":[{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals, Inc. :INO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017","publication_date":"2017-05-12 15:54:32 +0000","summary":"Categories: Yahoo FinanceGet free summary analysis Inovio Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Inovio Pharmaceuticals, Inc. – Novartis AG Sponsored ADR, Pfizer Inc., Johnson & Johnson, Arrowhead Pharmaceuticals, Inc., GlaxoSmithKline plc Sponsored ADR, Merck & Co., Inc. and DURECT Corporation (NVS-US, ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/47d214a2-cedd-3e63-8e3e-22f1bf0ced7a/inovio-pharmaceuticals-inc-ino-us-earnings-analysis-q1-2017-by-the-numbers-may-12-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio (INO) Q1 Loss Narrower Than Expected, Revenues Beat","publication_date":"2017-05-11 13:42:01 +0000","summary":"Inovio Pharmaceuticals, Inc. (INO) reported loss of 31 cents for the first quarter of 2017, narrower than the Zacks Consensus Estimate of a loss of 34 cents.","url":"http://finance.yahoo.com/news/inovio-ino-q1-loss-narrower-134201685.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio reports 1Q loss","publication_date":"2017-05-10 20:22:28 +0000","summary":"On a per-share basis, the Plymouth Meeting, Pennsylvania-based company said it had a loss of 31 cents. The drugmaker posted revenue of $10.4 million in the period. Inovio shares have dropped nearly 8 percent ...","url":"http://finance.yahoo.com/news/inovio-reports-1q-loss-202228627.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals Reports 2017 First Quarter Financial Results","publication_date":"2017-05-10 20:05:00 +0000","summary":"PLYMOUTH MEETING, Pa., May 10, 2017-- Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2017.. Total revenue was $10.4 million for the three months ended March ...","url":"http://finance.yahoo.com/news/inovio-pharmaceuticals-reports-2017-first-200500562.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Earnings Reaction History: Inovio Pharmaceuticals, Inc, 60.0% Follow-Through Indicator, 8.1% Sensitive","publication_date":"2017-05-10 19:40:35 +0000","summary":"Expected Earnings Release 05 10 2017 After hoursExpected Earnings Release 05 10 2017 After hours Avg Extended Hours Dollar Volume 595 421Avg Extended Hours Dollar Volume 595 421 Inovio Pharmaceuticals Inc INO is due to issue its quarterly earnings report in the","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5alxwOZLdpU/earnings-reaction-history-inovio-pharmaceuticals-inc-600-follow-through-indicator-81-sensitive-cm787451"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Provides Update on MedImmune Launch of Combination Trial for HPV-associated Head & Neck Cancer","publication_date":"2017-05-10 12:00:00 +0000","summary":"PLYMOUTH MEETING, Pa., May 10, 2017-- Inovio Pharmaceuticals, Inc. today announced MedImmune, AstraZeneca’ s global biologics research and development arm, will start a new clinical trial investigating ...","url":"http://finance.yahoo.com/news/inovio-provides-medimmune-launch-combination-120000238.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : INO-US : May 9, 2017","publication_date":"2017-05-09 12:53:54 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Inovio Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/7f1114a8-311a-3544-bc76-8bde1b4128bb/inovio-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-ino-us-may-9-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Biotech Movers: Horizon, OncoMed, Inovio","publication_date":"2017-05-08 13:29:00 +0000","summary":"Horizon Pharma, OncoMed Pharmaceuticals and Inovio Pharmaceuticals were among the biotech stock movers in early trading on Monday.","url":"http://finance.yahoo.com/r/f98ec19e-1470-3f45-9002-cde3b76d2c42/biotech-movers-horizon-oncomed-inovio.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio & Regeneron Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy","publication_date":"2017-05-08 11:30:00 +0000","summary":"PLYMOUTH MEETING, Pa. and TARRYTOWN, N.Y., May 08, 2017-- Inovio Pharmaceuticals, Inc. and Regeneron Pharmaceuticals, Inc. today announced a clinical study agreement for a phase 1 b/2a immuno-oncology ...","url":"http://finance.yahoo.com/news/inovio-regeneron-enter-immuno-oncology-113000168.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Regeneron and Inovio Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy","publication_date":"2017-05-08 11:30:00 +0000","summary":"TARRYTOWN, N.Y. and PLYMOUTH MEETING, Pa., May 8, 2017 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (REGN) and Inovio Pharmaceuticals, Inc. (INO) today announced a clinical study agreement for a Phase 1b/2a immuno-oncology trial. The study will be conducted by Inovio in patients with newly-diagnosed glioblastoma multiforme (GBM) and will evaluate Regeneron's PD-1 inhibitor, REGN2810, in combination with Inovio's INO-5401 T cell activating immunotherapy encoding multiple antigens and INO-9012, an immune activator encoding IL-12. The open-label trial, which is expected to begin later this year, is designed to evaluate the safety and efficacy of the combination therapy in approximately 50 patients.","url":"http://finance.yahoo.com/news/regeneron-inovio-enter-immuno-oncology-113000352.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"What's in the Cards for Inovio (INO) This Earnings Season?","publication_date":"2017-05-03 21:09:49 +0000","summary":"Inovio Pharmaceuticals Inc INO is scheduled to report first quarter 2017 results after market closes The company incurred a wider than expected loss in the last quarter In the last year Inovio s shares underperformed the Zacks classified Medical Biomed Genetics industry The stock","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zxJYDiyBuOo/whats-in-the-cards-for-inovio-ino-this-earnings-season-cm783820"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"What&apos;s in the Cards for Inovio (INO) This Earnings Season?","publication_date":"2017-05-03 20:28:08 +0000","summary":"Inovio Pharmaceuticals, Inc. (INO) is scheduled to report first-quarter 2017 results, after market closes. The company incurred wider-than-expected loss in the last quarter.","url":"http://finance.yahoo.com/news/apos-cards-inovio-ino-earnings-202808273.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals to Participate in Bank of America Merrill Lynch 2017 Healthcare Conference","publication_date":"2017-05-02 12:00:00 +0000","summary":"PLYMOUTH MEETING, Pa., May 02, 2017-- Inovio Pharmaceuticals, Inc. announced today that it will participate in the Bank of America Merrill Lynch 2017 Healthcare Conference May 16-18th, 2017 in Las Vegas, ...","url":"http://finance.yahoo.com/news/inovio-pharmaceuticals-participate-bank-america-120000608.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals, Inc. – Value Analysis (NASDAQ:INO) : April 26, 2017","publication_date":"2017-04-26 20:13:01 +0000","summary":"Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Inovio Pharmaceuticals, Inc. a score of 21. Our analysis is based on comparing Inovio Pharmaceuticals, Inc. with the following peers – Novartis AG Sponsored ADR, Pfizer Inc., Johnson & Johnson, Arrowhead Pharmaceuticals, Inc., GlaxoSmithKline plc Sponsored ADR, Merck & Co., Inc., Abeona Therapeutics, Inc., Cleveland BioLabs, Inc., ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/ffa9017d-1ce7-3956-8419-754a51ffb234/inovio-pharmaceuticals-inc-value-analysis-nasdaqino-april-26-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals to Report First Quarter 2017 Financial Results May 10, 2017","publication_date":"2017-04-26 12:00:00 +0000","summary":"PLYMOUTH MEETING, Pa., April 26, 2017-- Inovio Pharmaceuticals, Inc. announced today that it will host a conference call and live webcast to report its 2017 first quarter financial results on Wednesday, ...","url":"http://finance.yahoo.com/news/inovio-pharmaceuticals-report-first-quarter-120000959.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : INO-US : April 25, 2017","publication_date":"2017-04-25 12:59:15 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Inovio Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/84f329a6-8268-3ccc-a4dd-470aafabcd20/inovio-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-ino-us-april-25-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Why Is Inovio (INO) Down 2% Since the Last Earnings Report?","publication_date":"2017-04-25 11:05:11 +0000","summary":"Inovio Pharmaceuticals (INO) reported earnings 30 days ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.","url":"http://finance.yahoo.com/news/why-inovio-ino-down-2-110511056.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Initiates Phase 2 Efficacy Trial with VGX-3100 For HPV-Related Vulvar Pre-Cancers","publication_date":"2017-04-24 12:00:00 +0000","summary":"New study expands VGX-3100 program for evaluating therapeutic applications in HPV-related pre-cancers with high medical need. VGX-3100 previously demonstrated efficacy in regressing HPV-related cervical ...","url":"http://finance.yahoo.com/news/inovio-initiates-phase-2-efficacy-120000772.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals Stock History: From A to Zika","publication_date":"2017-04-18 20:24:00 +0000","summary":"From 1998 through today, Inovio Pharmaceuticals&apos; stock history has been largely a depressing one.","url":"http://finance.yahoo.com/r/e3d4ed19-ec35-31bc-a25c-e003d38b4174/inovio-pharmaceuticals-stock-history-from-a-to-zik.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio's Ebola Vaccine Positive in Expanded Phase I Study","publication_date":"2017-04-12 15:58:59 +0000","summary":"Inovio Pharmaceuticals Inc INO recently reported positive preliminary results from the expanded stage of its phase I study EBOV 001 The study was conducted to evaluate the company s Ebola DNA vaccine INO 4212 The company has enrolled an additional 125 patients in the study The","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UPPNC7jtFFk/inovios-ebola-vaccine-positive-in-expanded-phase-i-study-cm773271"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"This Survey's Bad News Could Be Good News for Inovio Pharmaceuticals, Inc.","publication_date":"2017-04-12 13:56:39 +0000","summary":"Bad news for some can be good news for others That could be the case with a survey the 160 National Center for Health Statistics NCHS published last week There was definitely some bad news about the prevalence of genital human papillomavirus HPV in Americans Here s why","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kn65P26-KOU/this-surveys-bad-news-could-be-good-news-for-inovio-pharmaceuticals-inc-cm773106"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio&apos;s Ebola Vaccine Positive in Expanded Phase I Study","publication_date":"2017-04-12 13:41:01 +0000","summary":"Inovio Pharmaceuticals, Inc. (INO) recently reported positive preliminary results from the expanded stage of its phase I study, EBOV-001.","url":"http://finance.yahoo.com/news/inovio-apos-ebola-vaccine-positive-134101730.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"This Survey&apos;s Bad News Could Be Good News for Inovio Pharmaceuticals, Inc.","publication_date":"2017-04-12 12:04:00 +0000","summary":"A surprisingly high number of Americans have HPV. That means the market for Inovio could be big -- if the company can achieve success with its experimental drugs.","url":"http://finance.yahoo.com/r/47edecb7-cfad-3829-afad-4335c78418f1/this-surveys-bad-news-could-be-good-news-for-inovi.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"FDA Approves 1st Drug For Tardive Dyskinesia, AGRX On Track, ITEK, AZRX On Watch","publication_date":"2017-04-11 22:40:00 +0000","summary":"FDA Approves 1st Drug For Tardive Dyskinesia, AGRX On Track, ITEK, AZRX On Watch","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3U2UdDfuC1I/fda-approves-1st-drug-for-tardive-dyskinesia-agrx-on-track-itek-azrx-on-watch-20170411-01284"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Stock Rises on Positive Results From Ebola Vaccine Tests","publication_date":"2017-04-11 13:34:00 +0000","summary":"The vaccine study showed that 95% of subjects generated an Ebola-specific antibody immune response.","url":"http://finance.yahoo.com/r/cf294752-0883-3640-84f8-99631c9eaa0d/inovio-stock-rises-on-positive-results-from-ebola-vaccine-tests.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Ebola Vaccine Demonstrates Robust Immune Responses with Favorable Safety Profile in Expanded Clinical Trial","publication_date":"2017-04-11 13:00:00 +0000","summary":"PLYMOUTH MEETING, Pa., April 11, 2017-- Inovio Pharmaceuticals, Inc. announced today preliminary results from the expanded stage of its phase I study, EBOV-001. The expanded study examined different regimens ...","url":"http://finance.yahoo.com/news/inovio-ebola-vaccine-demonstrates-robust-130000046.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Austrian biotech Themis launches Zika vaccine clinical trial","publication_date":"2017-04-11 11:00:03 +0000","summary":"Austrian biotech company Themis Bioscience said on Tuesday it had started a clinical trial of an experimental Zika vaccine in healthy volunteers, opening up another front in the race to prevent the spread of the mosquito-borne disease. Themis's product, which is based on measles immunisation technology, is the first vaccine containing attenuated, or weakened, live virus to reach the human testing phase. Multiple research groups, biotech firms and pharmaceutical companies are working on different Zika vaccine approaches, but only a few have so far advanced into clinical trials.","url":"http://finance.yahoo.com/news/austrian-biotech-themis-launches-zika-110003713.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"ETFs with exposure to Inovio Pharmaceuticals, Inc. : April 7, 2017","publication_date":"2017-04-07 20:52:29 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Inovio Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to INO-US. Comparing the performance and risk of Inovio Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/202961a0-884b-3c68-8cb7-bf6f4b061c5d/etfs-with-exposure-to-inovio-pharmaceuticals-inc-april-7-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : INO-US : March 30, 2017","publication_date":"2017-03-30 12:12:46 +0000","summary":"Inovio Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : INO-US : March 30, 2017","url":"http://www.capitalcube.com/blog/index.php/inovio-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-ino-us-march-30-2017/"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : INO-US : March 30, 2017","publication_date":"2017-03-30 12:12:46 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Inovio Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/3dca8329-8e23-3abc-8283-a493322a7676/inovio-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-ino-us-march-30-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"8:08 am Inovio Pharma announces that its academic and industry collaborators received a multi-year $6.95 mln grant from the NIH to develop a single or combination therapy using its PENNVAX-GP w/ the goal of attaining long-term HIV remission","publication_date":"2017-03-30 12:08:00 +0000","summary":"8:08 am Inovio Pharma announces that its academic and industry collaborators received a multi-year $6.95 mln grant from the NIH to develop a single or combination therapy using its PENNVAX-GP w/ the goal of attaining long-term HIV remission","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#ino"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio and Collaborators Receive NIH Grant to Evaluate HIV Immunotherapy PENNVAX®-GP’s Ability to Induce Remission of HIV Infection and End Lifetime of Drug Therapy","publication_date":"2017-03-30 12:00:00 +0000","summary":"[GlobeNewswire] - PLYMOUTH MEETING, Pa., March 30, 2017-- Inovio Pharmaceuticals, Inc. announced today that its academic and industry collaborators received a multi-year $6.95 million grant from the NIH’ s National Institute ...","url":"http://finance.yahoo.com/news/inovio-collaborators-receive-nih-grant-120000553.html"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio and Collaborators Receive NIH Grant to Evaluate HIV Immunotherapy PENNVAX®-GP’s Ability to Induce Remission of HIV Infection and End Lifetime of Drug Therapy","publication_date":"2017-03-30 12:00:00 +0000","summary":"PLYMOUTH MEETING, Pa., March 30, 2017-- Inovio Pharmaceuticals, Inc. announced today that its academic and industry collaborators received a multi-year $6.95 million grant from the NIH’ s National Institute ...","url":"http://finance.yahoo.com/news/inovio-collaborators-receive-nih-grant-120000553.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"ETFs with exposure to Inovio Pharmaceuticals, Inc. : March 27, 2017","publication_date":"2017-03-27 20:00:01 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Inovio Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to INO-US. Comparing the performance and risk of Inovio Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/5ed8cc82-9012-3e17-9d7c-909e7e017bcc/etfs-with-exposure-to-inovio-pharmaceuticals-inc-march-27-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"ETFs with exposure to Inovio Pharmaceuticals, Inc. : March 27, 2017","publication_date":"2017-03-27 20:00:01 +0000","summary":"ETFs with exposure to Inovio Pharmaceuticals, Inc. : March 27, 2017","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-inovio-pharmaceuticals-inc-march-27-2017/"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"INOVIO PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and","publication_date":"2017-03-24 20:08:24 +0000","summary":"INOVIO PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and","url":"http://biz.yahoo.com/e/170324/ino8-k.html"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"INOVIO PHARMACEUTICALS, INC. Financials","publication_date":"2017-03-21 17:04:10 +0000","summary":"INOVIO PHARMACEUTICALS, INC. Financials","url":"http://finance.yahoo.com/q/is?s=ino"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"George Bickerstaff Elected to Inovio’s Board of Directors","publication_date":"2017-03-21 12:00:00 +0000","summary":"[GlobeNewswire] - PLYMOUTH MEETING, Pa., March 21, 2017-- Inovio Pharmaceuticals, Inc. announced today the election of George Bickerstaff to its Board of Directors.. Bickerstaff is an internationally recognized expert in ...","url":"http://finance.yahoo.com/news/george-bickerstaff-elected-inovio-board-120000200.html"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"George Bickerstaff Elected to Inovio’s Board of Directors","publication_date":"2017-03-21 12:00:00 +0000","summary":"PLYMOUTH MEETING, Pa., March 21, 2017-- Inovio Pharmaceuticals, Inc. announced today the election of George Bickerstaff to its Board of Directors.. Bickerstaff is an internationally recognized expert in ...","url":"http://finance.yahoo.com/news/george-bickerstaff-elected-inovio-board-120000200.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Video-Taking Immunotherapy to the Next Level for Inovio Pharmaceuticals, Inc.","publication_date":"2017-03-20 19:09:40 +0000","summary":"Video-Taking Immunotherapy to the Next Level for Inovio Pharmaceuticals, Inc.","url":"http://www.companyspotlight.com/routers/headline/14361/10002/16625?cp_code=YAH1&1490036980"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals, Inc. :INO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017","publication_date":"2017-03-20 12:31:05 +0000","summary":"Categories: Yahoo Finance Get free summary analysis Inovio Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Inovio Pharmaceuticals, Inc. – Novartis AG Sponsored ADR, Pfizer Inc., Johnson & Johnson, Arrowhead Pharmaceuticals, Inc., GlaxoSmithKline plc Sponsored ADR, Merck & Co., Inc., Cleveland BioLabs, Inc., DURECT ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/7e3cab18-2b77-3700-bc47-bc61a50559be/inovio-pharmaceuticals-inc-ino-us-earnings-analysis-q4-2016-by-the-numbers-march-20-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals, Inc. :INO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017","publication_date":"2017-03-20 12:31:05 +0000","summary":"Inovio Pharmaceuticals, Inc. :INO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017","url":"http://www.capitalcube.com/blog/index.php/inovio-pharmaceuticals-inc-ino-us-earnings-analysis-q4-2016-by-the-numbers-march-20-2017/"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals, Inc. :INO-US: Earnings Analysis: 2016 By the Numbers : March 17, 2017","publication_date":"2017-03-17 14:07:34 +0000","summary":"Inovio Pharmaceuticals, Inc. :INO-US: Earnings Analysis: 2016 By the Numbers : March 17, 2017","url":"http://www.capitalcube.com/blog/index.php/inovio-pharmaceuticals-inc-ino-us-earnings-analysis-2016-by-the-numbers-march-17-2017/"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : INO-US : March 17, 2017","publication_date":"2017-03-17 12:16:34 +0000","summary":"Inovio Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : INO-US : March 17, 2017","url":"http://www.capitalcube.com/blog/index.php/inovio-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-ino-us-march-17-2017/"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : INO-US : March 17, 2017","publication_date":"2017-03-17 12:16:34 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Inovio Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/0ff3a840-8c04-30d1-bb40-cc1a708d3046/inovio-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-ino-us-march-17-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Gainers & Losers Of Mar.16: MCRB, PLSE, OCUL, PTCT, TROV...","publication_date":"2017-03-16 23:07:00 +0000","summary":"Gainers & Losers Of Mar.16: MCRB, PLSE, OCUL, PTCT, TROV...","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ovZg6avWJHo/gainers--losers-of-mar16-mcrb-plse-ocul-ptct-trov-20170316-01403"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Here's What Hurt Inovio Pharmaceuticals Inc. Stock Today","publication_date":"2017-03-16 22:06:49 +0000","summary":"What happened Shares of DNA based vaccine pioneer Inovio Pharmaceuticals Inc NASDAQ INO are under the weather after the company reported fourth quarter and full year earnings A wider than expected loss pushed the stock 11 1 lower as of 2 46 p m EDT during Thursday s","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OUCfij02HQo/heres-what-hurt-inovio-pharmaceuticals-inc-stock-today-cm761929"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Here's What Hurt Inovio Pharmaceuticals Inc. Stock Today","publication_date":"2017-03-16 20:07:00 +0000","summary":"A larger-than-expected loss has investors reexamining Inovio's development timeline.","url":"http://finance.yahoo.com/r/52fead1f-4036-3efc-9ac6-123955c08688/heres-what-hurt-inovio-pharmaceuticals-inc-stock-t.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Here's What Hurt Inovio Pharmaceuticals Inc. Stock Today","publication_date":"2017-03-16 20:07:00 +0000","summary":"Here's What Hurt Inovio Pharmaceuticals Inc. Stock Today","url":"https://www.fool.com/investing/2017/03/16/heres-what-hurt-inovio-pharmaceuticals-inc-stock-t.aspx"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Thursday Sector Laggards: Defense, Biotechnology Stocks","publication_date":"2017-03-16 19:06:39 +0000","summary":"In trading on Thursday defense shares were relative laggards down on the day by about 1 8 Helping drag down the group were shares of Arotech ARTX down about 19 5 and shares of Northrop Grumman NOC off about 1 1 on the day Also lagging the market Thursday are","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6xj3SDj6ZwI/thursday-sector-laggards-defense-biotechnology-stocks-cm761839"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio (INO) Q4 Loss Wider than Expected; Shares Decline","publication_date":"2017-03-16 17:07:57 +0000","summary":"Inovio Pharmaceuticals Inc INO reported a loss of 36 cents for the fourth quarter of 2016 The Zacks Consensus Estimate was of a loss of 29 cent per share In the year ago quarter the company had posted loss of 25 cents Shares fell 5 4 in after market trading In fact shares of Inovio","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/79cmzsSRnsc/inovio-ino-q4-loss-wider-than-expected-shares-decline-cm761774"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Stocks Close Modestly Lower Following Lackluster Session - U.S. Commentary","publication_date":"2017-03-16 16:14:00 +0000","summary":"Stocks Close Modestly Lower Following Lackluster Session - U.S. Commentary","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ysv32rDrf68/stocks-close-modestly-lower-following-lackluster-session--us-commentary-20170316-01121"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio (INO) Q4 Loss Wider than Expected; Shares Decline","publication_date":"2017-03-16 14:46:02 +0000","summary":"Inovio (INO) Q4 Loss Wider than Expected; Shares Decline","url":"http://finance.yahoo.com/news/inovio-ino-q4-loss-wider-144602911.html"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio (INO) Q4 Loss Wider than Expected; Shares Decline","publication_date":"2017-03-16 14:46:02 +0000","summary":"Inovio Pharmaceuticals, Inc. (INO) reported a loss of 36 cents for the fourth quarter of 2016.","url":"http://finance.yahoo.com/news/inovio-ino-q4-loss-wider-144602911.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Stocks Move Modestly Lower After Seeing Initial Strength - U.S. Commentary","publication_date":"2017-03-16 12:03:00 +0000","summary":"Stocks Move Modestly Lower After Seeing Initial Strength - U.S. Commentary","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GRGLKtX8ouo/stocks-move-modestly-lower-after-seeing-initial-strength--us-commentary-20170316-00845"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharma downgraded by Piper Jaffray","publication_date":"2017-03-16 10:47:27 +0000","summary":"Inovio Pharma downgraded by Piper Jaffray","url":"http://finance.yahoo.com/q/ud?s=INO"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio reports 4Q loss","publication_date":"2017-03-15 20:54:44 +0000","summary":"On a per-share basis, the Plymouth Meeting, Pennsylvania-based company said it had a loss of 36 cents. The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks ...","url":"http://finance.yahoo.com/news/inovio-reports-4q-loss-205444811.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio reports 4Q loss","publication_date":"2017-03-15 20:54:44 +0000","summary":"Inovio reports 4Q loss","url":"http://sg.finance.yahoo.com/news/inovio-reports-4q-loss-205444145.html"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals Reports 2016 Fourth Quarter and Year End Financial Results","publication_date":"2017-03-15 20:05:00 +0000","summary":"PLYMOUTH MEETING, Pa., March 15, 2017-- Inovio Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2016.. Total revenue was $8.5 million and $35.4 ...","url":"http://finance.yahoo.com/news/inovio-pharmaceuticals-reports-2016-fourth-200500184.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals Reports 2016 Fourth Quarter and Year End Financial Results","publication_date":"2017-03-15 20:05:00 +0000","summary":"[GlobeNewswire] - PLYMOUTH MEETING, Pa., March 15, 2017-- Inovio Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2016.. Total revenue was $8.5 million and $35.4 ...","url":"http://finance.yahoo.com/news/inovio-pharmaceuticals-reports-2016-fourth-200500184.html"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"INOVIO PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report","publication_date":"2017-03-15 19:39:34 +0000","summary":"INOVIO PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report","url":"http://biz.yahoo.com/e/170315/ino10-k.html"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"After-Hours Earnings Report for March 15, 2017 : ORCL, JBL, WSM, ALRM, GES, INO, HRTG, REI, PRMW, LFL, YRD, RMTI","publication_date":"2017-03-15 18:55:24 +0000","summary":"The following companies are expected to report earnings after hours on 03 15 2017 Visit our Earnings Calendar for a full list of expected earnings releases Oracle Corporation ORCL is reporting for the quarter ending February 28 2017 The computer","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vzm0SKGQzbQ/after-hours-earnings-report-for-march-15-2017-orcl-jbl-wsm-alrm-ges-ino-hrtg-rei-prmw-lfl-yrd-rmti-cm761293"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Earnings Reaction History: Inovio Pharmaceuticals, Inc, 63.6% Follow-Through Indicator, 7.4% Sensitive","publication_date":"2017-03-15 18:45:45 +0000","summary":"Expected Earnings Release 03 15 2017 After hoursExpected Earnings Release 03 15 2017 After hours Avg Extended Hours Dollar Volume 572 084Avg Extended Hours Dollar Volume 572 084 Inovio Pharmaceuticals Inc INO is due to issue its quarterly earnings report in the","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QJF77S81bP4/earnings-reaction-history-inovio-pharmaceuticals-inc-636-follow-through-indicator-74-sensitive-cm761310"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Williams-Sonoma Among 5 Earnings Plays That Could Squeeze the Shorts","publication_date":"2017-03-13 17:55:00 +0000","summary":"These heavily shorted stocks could get squeezed higher if they report positive earnings this week.","url":"http://finance.yahoo.com/r/05092bf6-a1c6-3c2c-aef7-2b352eb83bf4/williams-sonoma-among-5-earnings-plays-that-could-squeeze-the-shorts.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Williams-Sonoma Among 5 Earnings Plays That Could Squeeze the Shorts","publication_date":"2017-03-13 17:55:00 +0000","summary":"Williams-Sonoma Among 5 Earnings Plays That Could Squeeze the Shorts","url":"https://www.thestreet.com/story/14040477/1/williams-sonoma-among-5-earnings-plays-that-could-squeeze-the-shorts.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"4 Most Shorted Stocks Reporting Earnings This Week","publication_date":"2017-03-13 15:00:20 +0000","summary":"Quarterly earnings reports are often some of the most volatile catalysts of the year for stocks. But as much as the typical stock can jump on good or bad earnings, the stakes are even higher for stocks ...","url":"http://finance.yahoo.com/news/4-most-shorted-stocks-reporting-150020852.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"4 Most Shorted Stocks Reporting Earnings This Week","publication_date":"2017-03-13 15:00:20 +0000","summary":"4 Most Shorted Stocks Reporting Earnings This Week","url":"http://finance.yahoo.com/news/4-most-shorted-stocks-reporting-150020852.html"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"INOVIO PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2017-03-09 21:03:30 +0000","summary":"INOVIO PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","url":"http://biz.yahoo.com/e/170309/ino8-k.html"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2016 Financial Results on March 15, 2017","publication_date":"2017-03-09 13:00:00 +0000","summary":"PLYMOUTH MEETING, Pa., March 09, 2017-- Inovio Pharmaceuticals, Inc. announced today that it will host a conference call and live webcast to discuss its 2016 fourth quarter and year end financial results ...","url":"http://finance.yahoo.com/news/inovio-pharmaceuticals-report-fourth-quarter-130000374.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2016 Financial Results on March 15, 2017","publication_date":"2017-03-09 13:00:00 +0000","summary":"[GlobeNewswire] - PLYMOUTH MEETING, Pa., March 09, 2017-- Inovio Pharmaceuticals, Inc. announced today that it will host a conference call and live webcast to discuss its 2016 fourth quarter and year end financial results ...","url":"http://finance.yahoo.com/news/inovio-pharmaceuticals-report-fourth-quarter-130000374.html"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio (INO): What's in the Cards this Earnings Season?","publication_date":"2017-03-06 16:16:58 +0000","summary":"Inovio Pharmaceuticals Inc INO is expected to report fourth quarter 2016 results this month The company incurred wider than expected loss in the last quarter In the last one year Inovio s shares have underperformed the Zacks classified Medical Biomed Genetics industry Specifically","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OPBwHIeYKBs/inovio-ino-whats-in-the-cards-this-earnings-season-cm756569"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio (INO): What's in the Cards this Earnings Season?","publication_date":"2017-03-06 14:28:02 +0000","summary":"Inovio Pharmaceuticals, Inc. (INO) is expected to report fourth-quarter 2016 results this month. The company incurred wider-than-expected loss in the last quarter.","url":"http://finance.yahoo.com/news/inovio-ino-whats-cards-earnings-142802531.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio (INO): What's in the Cards this Earnings Season?","publication_date":"2017-03-06 14:28:02 +0000","summary":"Inovio (INO): What's in the Cards this Earnings Season?","url":"http://finance.yahoo.com/news/inovio-ino-whats-cards-earnings-142802531.html"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Universal Cancer Drug Shows High Potential","publication_date":"2017-02-28 17:42:00 +0000","summary":"Inovio Universal Cancer Drug Shows High Potential","url":"http://www.investopedia.com/news/inovio-universal-cancer-drug-shows-potential-ino/?partner=YahooSA"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Universal Cancer Drug Shows High Potential","publication_date":"2017-02-28 17:42:00 +0000","summary":"Inovio said its SynCon WT1 cancer immunotherapy demonstrated high potential in early-stage studies.","url":"http://finance.yahoo.com/r/88a34d73-21ef-3a70-b2e2-93372f55f545/inovio-universal-cancer-drug-shows-potential-ino?partner=YahooSA&yptr=yahoo&.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio's Zika and MERS Vaccines Look Promising","publication_date":"2017-02-27 18:15:00 +0000","summary":"Inovio's Zika and MERS Vaccines Look Promising","url":"http://www.investopedia.com/news/inovios-zika-and-mers-vaccines-show-promise-ino/?partner=YahooSA"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio's Zika and MERS Vaccines Look Promising","publication_date":"2017-02-27 18:15:00 +0000","summary":"Preliminary data from early-stage studies of Inivio's Zika and MERS vaccines are encouraging.","url":"http://finance.yahoo.com/r/1f4c4372-7830-3ab4-9190-6a8c652856d0/inovios-zika-and-mers-vaccines-show-promise-ino?partner=YahooSA&yptr=yahoo&.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio’s SynCon® WT1 Cancer Antigen Breaks Tolerance, Highlights Potential for Universal Cancer Immunotherapy","publication_date":"2017-02-27 12:00:00 +0000","summary":"[GlobeNewswire] - PLYMOUTH MEETING, Pa., Feb. 27, 2017-- Inovio Pharmaceuticals, Inc. today announced that its SynCon ® WT1 cancer immunotherapy was capable of breaking immune tolerance and inducing neo-antigen-like T cell ...","url":"http://finance.yahoo.com/news/inovio-syncon-wt1-cancer-antigen-120000155.html"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio’s SynCon® WT1 Cancer Antigen Breaks Tolerance, Highlights Potential for Universal Cancer Immunotherapy","publication_date":"2017-02-27 12:00:00 +0000","summary":"PLYMOUTH MEETING, Pa., Feb. 27, 2017-- Inovio Pharmaceuticals, Inc. today announced that its SynCon ® WT1 cancer immunotherapy was capable of breaking immune tolerance and inducing neo-antigen-like T cell ...","url":"http://finance.yahoo.com/news/inovio-syncon-wt1-cancer-antigen-120000155.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Biotech Movers: Cempra Flys High On Phase Three Results","publication_date":"2017-02-24 14:38:00 +0000","summary":"Other movers include Incyte, Achillion and Inovio.","url":"http://finance.yahoo.com/r/51fcd5e6-d435-3d65-9409-f395cee802a6/biotech-movers-cempra-flys-high-on-phase-three-results.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Biotech Movers: Cempra Flys High On Phase Three Results","publication_date":"2017-02-24 14:38:00 +0000","summary":"Biotech Movers: Cempra Flys High On Phase Three Results","url":"https://www.thestreet.com/story/14015290/1/biotech-movers-cempra-flys-high-on-phase-three-results.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Reports New Positive Clinical Data on Vaccine Advances in the Fight Against Emerging Infectious Diseases","publication_date":"2017-02-23 12:00:00 +0000","summary":"Significant immune responses observed in 100% of Zika-vaccinated subjects and 98% of MERS-vaccinated human subjects in separate phase I studies. Data reported at Coalition for Epidemic Preparedness Innovation ...","url":"http://finance.yahoo.com/news/inovio-reports-positive-clinical-data-120000736.html?.tsrc=rss"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Reports New Positive Clinical Data on Vaccine Advances in the Fight Against Emerging Infectious Diseases","publication_date":"2017-02-23 12:00:00 +0000","summary":"[GlobeNewswire] - Significant immune responses observed in 100% of Zika-vaccinated subjects and 98% of MERS-vaccinated human subjects in separate phase I studies. Data reported at Coalition for Epidemic Preparedness Innovation ...","url":"http://finance.yahoo.com/news/inovio-reports-positive-clinical-data-120000736.html"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : INO-US : February 22, 2017","publication_date":"2017-02-22 13:15:21 +0000","summary":"Inovio Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : INO-US : February 22, 2017","url":"http://www.capitalcube.com/blog/index.php/inovio-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-ino-us-february-22-2017/"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Better Buy: Novavax, Inc. vs. Inovio Pharmaceuticals","publication_date":"2017-02-16 18:10:31 +0000","summary":"Better Buy: Novavax, Inc. vs. Inovio Pharmaceuticals","url":"http://www.fool.com/investing/2017/02/16/better-buy-novavax-inc-vs-inovio-pharmaceuticals.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Better Buy: Novavax, Inc. vs. Inovio Pharmaceuticals","publication_date":"2017-02-16 16:56:12 +0000","summary":"According to the United Nations the global population is expected to rise by another 1 billion people by 2030 with the fastest growing segment being individuals aged 60 or older As a result the biopharmaceutical industry will need to come up with novel ways to prevent a concomitant","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Bs5-B20BGBw/better-buy-novavax-inc-vs-inovio-pharmaceuticals-cm748971"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Blog Coverage Inovio Inks Collaboration and License Deal with ApolloBio for Greater China","publication_date":"2017-02-14 13:15:00 +0000","summary":"[Accesswire] - Upcoming AWS Coverage on Bio-Techne Post-Earnings Results LONDON, UK / ACCESSWIRE / February 14, 2017 / Active Wall St. blog coverage looks at the headline from Inovio Pharmaceuticals, Inc. ( NASDAQ: INO ...","url":"http://finance.yahoo.com/news/blog-coverage-inovio-inks-collaboration-131500274.html"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Key Presenters At Leerink's Healthcare Conference","publication_date":"2017-02-13 20:52:10 +0000","summary":"Key Presenters At Leerink's Healthcare Conference","url":"http://finance.yahoo.com/news/key-presenters-leerinks-healthcare-conference-205210539.html"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"INOVIO PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2017-02-13 19:17:02 +0000","summary":"INOVIO PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170213/ino8-k.html"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Inks $35M Drug Deal With Chinese Biomed","publication_date":"2017-02-13 15:35:00 +0000","summary":"Inovio Inks $35M Drug Deal With Chinese Biomed","url":"http://www.investopedia.com/news/inovio-inks-35m-chinese-drug-license-deal-ino/?partner=YahooSA"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Potential $70M payday: Inovio enters into licensing, equity deals with Chinese drug firm","publication_date":"2017-02-13 13:35:09 +0000","summary":"Potential $70M payday: Inovio enters into licensing, equity deals with Chinese drug firm","url":"http://www.bizjournals.com/philadelphia/news/2017/02/13/inovio-apollobio-hpv-cervical-cancer-dna-immuno.html?ana=yahoo"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio and ApolloBio to Collaborate on Development and Commercialization of HPV Pre-cancer Immunotherapy VGX-3100 in Greater China","publication_date":"2017-02-13 11:00:00 +0000","summary":"[GlobeNewswire] - PLYMOUTH MEETING, Pa., Feb. 13, 2017-- Inovio Pharmaceuticals, Inc. today announced that it has entered into a collaboration and license agreement providing ApolloBio Corporation with the exclusive right ...","url":"http://finance.yahoo.com/news/inovio-apollobio-collaborate-development-commercialization-110000302.html"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharma To Present At BIO CEO & Investor Conference; Webcast At 10:00 AM","publication_date":"2017-02-13 09:00:00 +0000","summary":"Inovio Pharma To Present At BIO CEO & Investor Conference; Webcast At 10:00 AM","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cH6u51f3nIo/inovio-pharma-to-present-at-bio-ceo--investor-conference-webcast-at-1000-am-20170213-00680"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Better Buy: Inovio Pharmaceuticals vs. Incyte Corp.","publication_date":"2017-01-31 11:13:19 +0000","summary":"Better Buy: Inovio Pharmaceuticals vs. Incyte Corp.","url":"http://www.fool.com/investing/2017/01/30/better-buy-inovio-pharmaceuticals-vs-incyte-corp.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Better Buy: Inovio Pharmaceuticals vs. Incyte Corp.","publication_date":"2017-01-30 16:35:19 +0000","summary":"At one point last year shares of DNA based vaccine specialist Inovio Pharmaceuticals NASDAQ INO had more than doubled but development problems cut the biotech stock s gains back to about 26 5 over the past year Over the same period shares of Incyte Corp NASDAQ INCY","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0XpjB-3xp1U/better-buy-inovio-pharmaceuticals-vs-incyte-corp-cm740185"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences","publication_date":"2017-01-30 13:00:00 +0000","summary":"[GlobeNewswire] - PLYMOUTH MEETING, Pa., Jan. 30, 2017-- Inovio Pharmaceuticals, Inc. today announced that the Company will participate in the following upcoming investment conferences:. BIO CEO & Investor Conference Fireside ...","url":"http://finance.yahoo.com/news/inovio-pharmaceuticals-participate-upcoming-investment-130000715.html"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"Why Jim Cramer prefers the bank that can't seem to do anything right","publication_date":"2017-01-25 00:28:39 +0000","summary":"Why Jim Cramer prefers the bank that can't seem to do anything right","url":"http://www.cnbc.com/id/104237659?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104237659"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"More Innovation, Less Regulation: 2 Biotech Stocks That Could Soar in 2017","publication_date":"2017-01-12 15:09:54 +0000","summary":"More Innovation, Less Regulation: 2 Biotech Stocks That Could Soar in 2017","url":"http://www.fool.com/investing/2017/01/11/more-innovation-less-regulation-3-biotech-stocks-t.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"More Innovation, Less Regulation: 2 Biotech Stocks That Could Soar in 2017","publication_date":"2017-01-11 16:59:46 +0000","summary":"President elect Donald Trump s views on the FDA and its role as a gatekeeper for new medicines remain shrouded in mystery roughly two weeks before his inauguration But the decision to include the controversial billionaire and PayPal co founder Peter Thiel in his transition team","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aRd3xl1IMH8/more-innovation-less-regulation-2-biotech-stocks-that-could-soar-in-2017-cm732231"},{"ticker":"INO","figi_ticker":"INO:US","figi":"BBG000BK6YX5","title":"How Risky Is Inovio Pharmaceuticals, Inc.?","publication_date":"2017-01-05 18:38:52 +0000","summary":"Last year was extremely eventful for Inovio Pharmaceuticals Inc NASDAQ INO as it made headlines with a Zika virus candidate and suffered a regulatory setback Following the ups and downs the stock finished about 8 4 higher than it began 2016 but what about 2017 and","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Lx_CJw1cGIQ/how-risky-is-inovio-pharmaceuticals-inc-cm729971"}],"result_count":299,"page_size":100,"current_page":1,"total_pages":3,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"6.92"},{"x":"1494596100","y":"6.95"},{"x":"1494596400","y":"6.9"},{"x":"1494596700","y":"6.95"},{"x":"1494597000","y":"6.9699"},{"x":"1494597300","y":"7.0699"},{"x":"1494597600","y":"7.04"},{"x":"1494597900","y":"7.1"},{"x":"1494598200","y":"7.091"},{"x":"1494598500","y":"7.17"},{"x":"1494598800","y":"7.165"},{"x":"1494599100","y":"7.1236"},{"x":"1494599400","y":"7.14"},{"x":"1494599700","y":"7.19"},{"x":"1494600000","y":"7.1899"},{"x":"1494600300","y":"7.28"},{"x":"1494600600","y":"7.285"},{"x":"1494600900","y":"7.28"},{"x":"1494601200","y":"7.3"},{"x":"1494601500","y":"7.295"},{"x":"1494601800","y":"7.2501"},{"x":"1494602100","y":"7.285"},{"x":"1494602400","y":"7.305"},{"x":"1494602700","y":"7.3"},{"x":"1494603000","y":"7.3354"},{"x":"1494603300","y":"7.3499"},{"x":"1494603600","y":"7.355"},{"x":"1494603900","y":"7.38"},{"x":"1494604200","y":"7.38"},{"x":"1494604500","y":"7.28"},{"x":"1494604800","y":"7.34"},{"x":"1494605100","y":"7.3850999999999996"},{"x":"1494605400","y":"7.38"},{"x":"1494605700","y":"7.44"},{"x":"1494606000","y":"7.41"},{"x":"1494606300","y":"7.3835"},{"x":"1494606600","y":"7.36"},{"x":"1494606900","y":"7.395"},{"x":"1494607200","y":"7.45"},{"x":"1494607500","y":"7.4052"},{"x":"1494607800","y":"7.4"},{"x":"1494608100","y":"7.41"},{"x":"1494608400","y":"7.405"},{"x":"1494608700","y":"7.4"},{"x":"1494609000","y":"7.405"},{"x":"1494609300","y":"7.415"},{"x":"1494609600","y":"7.445"},{"x":"1494609900","y":"7.395"},{"x":"1494610200","y":"7.39"},{"x":"1494610500","y":"7.39"},{"x":"1494610800","y":"7.4"},{"x":"1494611100","y":"7.4"},{"x":"1494611400","y":"7.4"},{"x":"1494611700","y":"7.44"},{"x":"1494612000","y":"7.43"},{"x":"1494612300","y":"7.435"},{"x":"1494612600","y":"7.44"},{"x":"1494612900","y":"7.4"},{"x":"1494613200","y":"7.38"},{"x":"1494613500","y":"7.37"},{"x":"1494613800","y":"7.32"},{"x":"1494614100","y":"7.28"},{"x":"1494614400","y":"7.24"},{"x":"1494614700","y":"7.23"},{"x":"1494615000","y":"7.2667"},{"x":"1494615300","y":"7.2551"},{"x":"1494615600","y":"7.22"},{"x":"1494615900","y":"7.1518"},{"x":"1494616200","y":"7.23"},{"x":"1494616500","y":"7.2"},{"x":"1494616800","y":"7.14"},{"x":"1494617100","y":"7.18"},{"x":"1494617400","y":"7.18"},{"x":"1494617700","y":"7.13"},{"x":"1494618000","y":"7.155"},{"x":"1494618300","y":"7.17"},{"x":"1494618600","y":"7.13"},{"x":"1494618900","y":"7.13"},{"x":"1494619200","y":"7.14"} ], "color":"#03a9f4"}]},
{"id":"14","symbol": "ITCI","name": "Intra-Cellular Therapies Inc","price": 11.26,"dollarChange": 0.54,"percentChange": 5.04,"open": 10.74,"high": 11.58,"low":10.66,"volume": 803437,"avgVol": 941529.150000,"sharesShort": 5199551,"shortPercent": 12.684715,"marketCap": 600057185,"float": 40990681,"headlines":{"data":[{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Intra-Cellular Therapies, Inc. and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-05-11 22:39:00 +0000","summary":"Khang & Khang LLP announces that it is investigating claims against Intra-Cellular Therapies, Inc. concerning possible violations of federal securities laws.","url":"http://finance.yahoo.com/news/important-investor-alert-khang-khang-223900664.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"EQUITY ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Intra-Cellular Therapies, Inc. - ITCI","publication_date":"2017-05-11 20:31:00 +0000","summary":"NEW YORK, May 11, 2017 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces it is continuing to investigate potential securities claims on behalf of shareholders of Intra-Cellular ...","url":"http://finance.yahoo.com/news/equity-alert-rosen-law-firm-203100654.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular reports 1Q loss","publication_date":"2017-05-10 12:01:05 +0000","summary":"The New York-based company said it had a loss of 62 cents per share. The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a ...","url":"http://finance.yahoo.com/news/intra-cellular-reports-1q-loss-120105490.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies Reports First Quarter 2017 Financial Results and Provides Corporate Update","publication_date":"2017-05-10 11:30:00 +0000","summary":"NEW YORK, May 10, 2017-- Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system disorders, today announced its financial results ...","url":"http://finance.yahoo.com/news/intra-cellular-therapies-reports-first-113000887.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies Presents Data Supporting the Potential for Potent and Rapid Antidepressant Activity with Lumateperone","publication_date":"2017-05-08 11:00:00 +0000","summary":"NEW YORK, May 08, 2017-- Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system disorders, today announced it had two presentations ...","url":"http://finance.yahoo.com/news/intra-cellular-therapies-presents-data-110000701.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies To Present at the 19th Annual Conference of the International Society for Bipolar Disorders","publication_date":"2017-05-04 12:00:00 +0000","summary":"NEW YORK, May 04, 2017-- Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system disorders, today announced two presentations on ...","url":"http://finance.yahoo.com/news/intra-cellular-therapies-present-19th-120000360.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"ETFs with exposure to Intra-Cellular Therapies, Inc. : May 2, 2017","publication_date":"2017-05-02 20:12:29 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Intra-Cellular Therapies, Inc. Here are 5 ETFs with the largest exposure to ITCI-US. Comparing the performance and risk of Intra-Cellular Therapies, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/7f82f79e-67ff-3cc7-91f6-252b695dde58/etfs-with-exposure-to-intra-cellular-therapies-inc-may-2-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Intra-Cellular Therapies, Inc. and Advises Investors with Losses to Contact the Firm","publication_date":"2017-05-02 19:44:00 +0000","summary":"Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Intra-Cellular Therapies, Inc. concerning possible violations of federal securities laws.","url":"http://finance.yahoo.com/news/important-investor-alert-lundin-law-194400252.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Investor Alert: Kaplan Fox Announces Investigation Of Intra-Cellular Therapies, Inc.","publication_date":"2017-05-02 18:51:00 +0000","summary":"NEW YORK, May 2, 2017 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP ( www.kaplanfox.com ) is investigating claims on behalf of investors of Intra-Cellular Therapies, Inc. (\"Intra-Cellular Therapies\" ...","url":"http://finance.yahoo.com/news/investor-alert-kaplan-fox-announces-185100316.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Intra-Cellular Therapies, Inc.","publication_date":"2017-05-02 16:31:00 +0000","summary":"Goldberg Law PC announces that it is investigating Intra-Cellular Therapies, Inc. concerning possible violations of federal securities laws.","url":"http://finance.yahoo.com/news/investor-alert-goldberg-law-pc-163100564.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Gainers & Losers Of May 1: VTGN, VSTM, TOCA, NTRP, AEZS...","publication_date":"2017-05-01 22:14:00 +0000","summary":"Gainers & Losers Of May 1: VTGN, VSTM, TOCA, NTRP, AEZS...","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ocLhTKD4Xwo/gainers--losers-of-may-1-vtgn-vstm-toca-ntrp-aezs-20170501-01409"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Why Intra-Cellular Therapies, Wesco Aircraft Holdings, and Radius Health Slumped Today","publication_date":"2017-05-01 21:19:38 +0000","summary":"On a mixed day for the market, these stocks fell. Find out why.","url":"http://finance.yahoo.com/r/d6a737ea-49a4-3b7a-a81f-38dffa08e6ae/why-intra-cellular-therapies-wesco-aircraft-holdin.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"INTRA-CELLULAR INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Intra-Cellular Therapies, Inc. to Contact the Firm","publication_date":"2017-05-01 19:57:00 +0000","summary":"Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Intra-Cellular Therapies, Inc. .","url":"http://finance.yahoo.com/news/intra-cellular-investor-alert-faruqi-195700219.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Glancy Prongay & Murray LLP Commences Investigation on Behalf of Intra-Cellular Therapies, Inc. Limited Investors","publication_date":"2017-05-01 18:43:00 +0000","summary":"Glancy Prongay & Murray LLP announces an investigation on behalf of Intra-Cellular Therapies, Inc. investors concerning the Company and its officers’ possible violations of federal securities laws.","url":"http://finance.yahoo.com/news/glancy-prongay-murray-llp-commences-184300896.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Health Care Sector Update for 05/01/2017: ITCI,AMPE,AEZS","publication_date":"2017-05-01 17:46:12 +0000","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 32 JNJ 0 32 PFE 0 29 PFE 0 29 MRK 0 37 MRK 0 37 ABT 0 22 ABT 0 22 AMGN 0 14 AMGN 0 14 Health care stocks were edging higher Monday with the NYSE Health Care Index rising about 0 2 while shares of health care companies in","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uMfWwDVhl2I/health-care-sector-update-for-05012017-itciampeaezs-cm782158"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intra-Cellular Therapies, Inc. - ITCI","publication_date":"2017-05-01 17:14:00 +0000","summary":"NEW YORK, May 1, 2017 /PRNewswire/ --  Pomerantz LLP is investigating claims on behalf of investors of  Intra-Cellular Therapies, Inc. (\"Intra-Cellular\" or the \"Company\") (NASDAQ:  ...","url":"http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-171400118.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Intra-Cellular Therapies, Inc. (ITCI)","publication_date":"2017-05-01 17:07:00 +0000","summary":"NEW YORK, May 1, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Intra-Cellular Therapies, Inc. (\"Intra-Cellular\" ...","url":"http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-170700674.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Why Intra-Cellular Therapies Is Plunging","publication_date":"2017-05-01 16:13:00 +0000","summary":"Shares tumbled after the company provided investors with a regulatory update related to its lead compound.","url":"http://finance.yahoo.com/r/551d6773-2335-3066-b13a-7d64ef21425b/why-intra-cellular-therapies-is-plunging.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Intra-Cellular Therapies, Inc. – ITCI","publication_date":"2017-05-01 16:12:00 +0000","summary":"Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Intra-Cellular Therapies, Inc. resulting from allegations that Intra-Cellular Therapies may have issued materially misleading business information to the investing public.","url":"http://finance.yahoo.com/news/equity-alert-rosen-law-firm-161200583.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Evades Scrutiny on Schizophrenia Drug Safety, Shares Plunge","publication_date":"2017-05-01 15:22:00 +0000","summary":"Today's Intra-Cellular update was probably going to send the stock price falling regardless of how management acted, but the refusal to be transparent made a bad day even worse.","url":"http://finance.yahoo.com/r/271a055f-7e90-3a4a-9438-10ba4cc6c665/intra-cellular-evades-scrutiny-on-schizophrenia-drug-safety-shares-plunge.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Biotech Movers: Intra-Cellular Therapies, Organovo, Acorda","publication_date":"2017-05-01 13:45:00 +0000","summary":"Intra-Cellular Therapies, Organovo Holdings and Acorda Therapeutics were among the biotech stock movers in premarket trading on Monday.","url":"http://finance.yahoo.com/r/a72fbb8a-0ab8-3f2d-a75d-50aa5e318ca3/biotech-movers-intra-cellular-therapies-organovo-acorda.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Are Options Traders Betting on a Big Move in Intra-Cellular (ITCI) Stock?","publication_date":"2017-05-01 12:59:12 +0000","summary":"Investors in Intra-Cellular Therapies, Inc. (ITCI) need to pay close attention to the stock based on moves in the options market lately.","url":"http://finance.yahoo.com/news/options-traders-betting-big-move-125912617.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Pre-Market Most Active for May 1, 2017 : QQQ, TWTR, OCN, GLBL, ITCI, VIAV, RUN, VSLR, BAC, MU, CLF, X","publication_date":"2017-05-01 12:56:01 +0000","summary":"The NASDAQ 100 Pre Market Indicator is up 8 87 to 5 592 4 The total Pre Market volume is currently 3 583 748 shares traded The following are the most active stocks for the pre market session PowerShares QQQ Trust Series 1 QQQ is 0 43 at 136 42 with 1 696 060","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SewnN1y0cBs/pre-market-most-active-for-may-1-2017-qqq-twtr-ocn-glbl-itci-viav-run-vslr-bac-mu-clf-x-cm781848"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies Sinks on FDA Update","publication_date":"2017-05-01 12:50:36 +0000","summary":"Intra-Cellular Therapies saw its stock crumble early on Monday after the company provided an update on its plan to submit a New Drug Application for its treatment of schizophrenia.","url":"http://finance.yahoo.com/news/intra-cellular-therapies-sinks-fda-125036004.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies Provides Corporate Update On Schizophrenia Program","publication_date":"2017-05-01 11:30:00 +0000","summary":"NEW YORK, May 01, 2017-- Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system disorders, today provided a corporate update.. ...","url":"http://finance.yahoo.com/news/intra-cellular-therapies-provides-corporate-113000823.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies (ITCI) Has Dropped To A New Low On FDA News","publication_date":"2017-05-01 09:36:00 +0000","summary":"Intra-Cellular Therapies (ITCI) Has Dropped To A New Low On FDA News","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FywwruVh2ac/intracellular-therapies-itci-has-dropped-to-a-new-low-on-fda-news-20170501-00606"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"These 3 Stocks Could Prove Toxic to Your Portfolio","publication_date":"2017-04-14 12:55:46 +0000","summary":"Over the past three years shares of Seadrill Ltd NYSE SDRL Twitter NYSE TWTR and Intra Cellular Therapies NASDAQ ITCI 160 have fallen 84 42 and 69 from their peak prices And while these are three very different companies there s one thing they","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KEMrKoLz-Ec/these-3-stocks-could-prove-toxic-to-your-portfolio-cm774185"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"These 3 Stocks Could Prove Toxic to Your Portfolio","publication_date":"2017-04-14 11:41:00 +0000","summary":"Seadrill LTD, Twitter, and Intra-Cellular Therapies have all been toxic investments in recent years. Our contributors write to explain how it could get worse from here.","url":"http://finance.yahoo.com/r/ecd7159c-21a0-3568-82e5-0ca159a49189/these-3-stocks-could-prove-toxic-to-your-portfolio.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies, Inc. breached its 50 day moving average in a Bearish Manner : ITCI-US : April 10, 2017","publication_date":"2017-04-10 12:32:32 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Intra-Cellular Therapies, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/048f7b0a-b627-3dab-b121-7010942c8294/intra-cellular-therapies-inc-breached-its-50-day-moving-average-in-a-bearish-manner-itci-us-april-10-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Implied Volatility Surging for Intra-Cellular (ITCI) Stock Options","publication_date":"2017-04-03 14:39:24 +0000","summary":"Investors in Intra Cellular Therapies Inc ITCI need to pay close attention to the stock based on moves in the options market lately That is because the April 21 st 2017 12 50 Put had some of the highest implied volatility of all equity options today What is Implied","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qHr7MINYYxs/implied-volatility-surging-for-intra-cellular-itci-stock-options-cm768949"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Implied Volatility Surging for Intra-Cellular (ITCI) Stock Options","publication_date":"2017-04-03 12:47:12 +0000","summary":"Options traders are pricing in a big move for Intra-Cellular (ITCI) shares as it has huge implied volatility.","url":"http://finance.yahoo.com/news/implied-volatility-surging-intra-cellular-124712728.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Implied Volatility Surging for Intra-Cellular (ITCI) Stock Options","publication_date":"2017-04-03 12:47:12 +0000","summary":"Implied Volatility Surging for Intra-Cellular (ITCI) Stock Options","url":"http://finance.yahoo.com/news/implied-volatility-surging-intra-cellular-124712728.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Can The Uptrend Continue for Intra-Cellular Therapies (ITCI)?","publication_date":"2017-03-17 16:07:59 +0000","summary":"Investors certainly have to be happy with Intra Cellular Therapies Inc ITCI and its short term performance After all the stock has jumped by 18 4 in the past 4 weeks and it is also above its 20 Day Simple Moving Average as well This is certainly a good trend but investors are","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z_V_XaCLJOI/can-the-uptrend-continue-for-intra-cellular-therapies-itci-cm762236"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Can The Uptrend Continue for Intra-Cellular Therapies (ITCI)?","publication_date":"2017-03-17 14:12:02 +0000","summary":"Can The Uptrend Continue for Intra-Cellular Therapies (ITCI)?","url":"http://finance.yahoo.com/news/uptrend-continue-intra-cellular-therapies-141202641.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Can The Uptrend Continue for Intra-Cellular Therapies (ITCI)?","publication_date":"2017-03-17 14:12:02 +0000","summary":"Investors certainly have to be happy with Intra-Cellular Therapies, Inc. (ITCI) and its short term performance","url":"http://finance.yahoo.com/news/uptrend-continue-intra-cellular-therapies-141202641.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"5 Cheap Breakout Stocks for Superb Returns","publication_date":"2017-03-16 15:09:52 +0000","summary":"One of the most popular methods utilized by active investors is to select breakout stocks The technique identifies those stocks whose prices are fluctuating within a specific band In case a stock falls below the floor of this band it may be time to offload it from your portfolio However","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2bcGVOaKj9M/5-cheap-breakout-stocks-for-superb-returns-cm761726"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"5 Cheap Breakout Stocks for Superb Returns","publication_date":"2017-03-16 13:23:01 +0000","summary":"The technique identifies those stocks whose prices are fluctuating within a specific band.","url":"http://finance.yahoo.com/news/5-cheap-breakout-stocks-superb-132301578.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"5 Cheap Breakout Stocks for Superb Returns","publication_date":"2017-03-16 13:23:01 +0000","summary":"5 Cheap Breakout Stocks for Superb Returns","url":"http://finance.yahoo.com/news/5-cheap-breakout-stocks-superb-132301578.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"3 Stocks That Have Been Cut in Half in the Last 6 Months","publication_date":"2017-03-08 16:15:12 +0000","summary":"The S amp P 500 might be trading near an all time high but not every stock has benefited from the rally In fact Under Armour NYSE UA NYSE UAA StonMor Partners NYSE STON and Intra Cellular Therapies NASDAQ ITCI 160 have all fallen by more than 50","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DxDM0mbQQIQ/3-stocks-that-have-been-cut-in-half-in-the-last-6-months-cm757843"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"The 'Gnarly 9' Biotechs Will Test the FDA's Mettle","publication_date":"2017-03-08 15:26:00 +0000","summary":"The 'Gnarly 9' Biotechs Will Test the FDA's Mettle","url":"http://realmoney.thestreet.com/articles/03/08/2017/gnarly-9-biotechs-will-test-fdas-mettle?puc=yahoo&cm_ven=YAHOO"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"3 Stocks That Have Been Cut in Half in the Last 6 Months","publication_date":"2017-03-08 14:44:00 +0000","summary":"Its been a rough half-year to be an investor in Under Armour, StonMor Partners, and Intra-Cellular Therapies. Are these beaten-down stocks bargains, or could there be more pain ahead?","url":"http://finance.yahoo.com/r/28cdafbc-2aed-31fc-9845-cc3198703b6e/3-stocks-that-have-been-cut-in-half-in-the-last-6.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"3 Stocks That Have Been Cut in Half in the Last 6 Months","publication_date":"2017-03-08 14:44:00 +0000","summary":"3 Stocks That Have Been Cut in Half in the Last 6 Months","url":"http://www.fool.com/investing/2017/03/08/3-stocks-that-have-been-cut-in-half-in-the-last-6.aspx"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies, Inc. :ITCI-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017","publication_date":"2017-03-07 18:32:25 +0000","summary":"Intra-Cellular Therapies, Inc. :ITCI-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017","url":"http://www.capitalcube.com/blog/index.php/intra-cellular-therapies-inc-itci-us-earnings-analysis-q4-2016-by-the-numbers-march-7-2017/"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies, Inc. :ITCI-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017","publication_date":"2017-03-07 18:32:25 +0000","summary":"Categories: Yahoo Finance Get free summary analysis Intra-Cellular Therapies, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Intra-Cellular Therapies, Inc. – Applied Genetic Technologies Corp. and PDL BioPharma, Inc. (AGTC-US and PDLI-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/0d02f074-a567-3cc2-ac84-0c9d6f868713/intra-cellular-therapies-inc-itci-us-earnings-analysis-q4-2016-by-the-numbers-march-7-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"INTRA-CELLULAR THERAPIES, INC. Financials","publication_date":"2017-03-07 18:04:15 +0000","summary":"INTRA-CELLULAR THERAPIES, INC. Financials","url":"http://finance.yahoo.com/q/is?s=itci"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies, Inc. breached its 50 day moving average in a Bearish Manner : ITCI-US : March 6, 2017","publication_date":"2017-03-06 14:29:52 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Intra-Cellular Therapies, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/852d6074-258c-35cc-a0ed-cd30ddf97d0d/intra-cellular-therapies-inc-breached-its-50-day-moving-average-in-a-bearish-manner-itci-us-march-6-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies, Inc. breached its 50 day moving average in a Bearish Manner : ITCI-US : March 6, 2017","publication_date":"2017-03-06 14:29:52 +0000","summary":"Intra-Cellular Therapies, Inc. breached its 50 day moving average in a Bearish Manner : ITCI-US : March 6, 2017","url":"http://www.capitalcube.com/blog/index.php/intra-cellular-therapies-inc-breached-its-50-day-moving-average-in-a-bearish-manner-itci-us-march-6-2017/"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"7 Stocks Trending With Monster Volume","publication_date":"2017-03-02 12:00:00 +0000","summary":"Here's a technical look at how to play a number of stocks trending higher with strong volume.","url":"http://finance.yahoo.com/r/1709f472-7ddd-38af-8b7d-70fee5c0414a/7-stocks-trending-with-monster-volume.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"7 Stocks Trending With Monster Volume","publication_date":"2017-03-02 12:00:00 +0000","summary":"7 Stocks Trending With Monster Volume","url":"https://www.thestreet.com/story/14022901/1/7-stocks-trending-with-monster-volume.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Here's Why Intra-Cellular Therapies Inc.'s Shares Had a Greater Than 30% Intraday Swing","publication_date":"2017-03-02 00:13:32 +0000","summary":"What happened Shares of Intra Cellular Therapies NASDAQ ITCI a clinical stage biopharmaceutical company focused on the development of medicines to treat disorders of the central nervous system were taken for a wild ride on Wednesday After falling by as much as 20","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5pXmMOnB19g/heres-why-intra-cellular-therapies-incs-shares-had-a-greater-than-30-intraday-swing-cm755145"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Here's Why Intra-Cellular Therapies Inc.'s Shares Had a Greater Than 30% Intraday Swing","publication_date":"2017-03-01 22:12:00 +0000","summary":"From down 20% to up 13%, this pipeline update has investors on edge.","url":"http://finance.yahoo.com/r/98a24502-5635-3be9-9b45-b7ea05cc0452/heres-why-intra-cellular-therapies-incs-shares-had.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Here's Why Intra-Cellular Therapies Inc.'s Shares Had a Greater Than 30% Intraday Swing","publication_date":"2017-03-01 22:12:00 +0000","summary":"Here's Why Intra-Cellular Therapies Inc.'s Shares Had a Greater Than 30% Intraday Swing","url":"http://www.fool.com/investing/2017/03/01/heres-why-intra-cellular-therapies-incs-shares-had.aspx"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular reports 4Q loss","publication_date":"2017-03-01 12:39:29 +0000","summary":"On a per-share basis, the New York-based company said it had a loss of 64 cents. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research ...","url":"http://finance.yahoo.com/news/intra-cellular-reports-4q-loss-123929634.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular reports 4Q loss","publication_date":"2017-03-01 12:39:29 +0000","summary":"Intra-Cellular reports 4Q loss","url":"http://sg.finance.yahoo.com/news/intra-cellular-reports-4q-loss-123929990.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"INTRA-CELLULAR THERAPIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Finan","publication_date":"2017-03-01 12:07:58 +0000","summary":"INTRA-CELLULAR THERAPIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Finan","url":"http://biz.yahoo.com/e/170301/itci8-k.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2016 Financial Results and Provides Corporate Update","publication_date":"2017-03-01 12:00:00 +0000","summary":"[GlobeNewswire] - NEW YORK, March 01, 2017-- Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system disorders, today announced its financial results ...","url":"http://finance.yahoo.com/news/intra-cellular-therapies-reports-fourth-120000912.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2016 Financial Results and Provides Corporate Update","publication_date":"2017-03-01 12:00:00 +0000","summary":"NEW YORK, March 01, 2017-- Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system disorders, today announced its financial results ...","url":"http://finance.yahoo.com/news/intra-cellular-therapies-reports-fourth-120000912.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"5 Earnings Short-Squeeze Trade Ideas","publication_date":"2017-02-28 18:26:00 +0000","summary":"These heavily shorted stocks could get squeezed higher, if they report positive earnings this week.","url":"http://finance.yahoo.com/r/f4ad38ed-8e98-397a-a0f1-f5d5c2630faa/5-earnings-short-squeeze-trade-ideas.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"5 Earnings Short-Squeeze Trade Ideas","publication_date":"2017-02-28 18:26:00 +0000","summary":"5 Earnings Short-Squeeze Trade Ideas","url":"https://www.thestreet.com/story/14019385/1/5-earnings-short-squeeze-trade-ideas.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies to Present at the Cowen and Company 37th Annual Health Care Conference","publication_date":"2017-02-28 13:00:00 +0000","summary":"NEW YORK, Feb. 28, 2017-- Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system disorders, today announced that Sharon Mates, ...","url":"http://finance.yahoo.com/news/intra-cellular-therapies-present-cowen-130000797.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies to Present at the Cowen and Company 37th Annual Health Care Conference","publication_date":"2017-02-28 13:00:00 +0000","summary":"[GlobeNewswire] - NEW YORK, Feb. 28, 2017-- Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system disorders, today announced that Sharon Mates, ...","url":"http://finance.yahoo.com/news/intra-cellular-therapies-present-cowen-130000797.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2016 Financial Results Conference Call and Webcast","publication_date":"2017-02-22 13:00:00 +0000","summary":"NEW YORK, Feb. 22, 2017-- Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system disorders, today announced that it will host ...","url":"http://finance.yahoo.com/news/intra-cellular-therapies-host-fourth-130000703.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2016 Financial Results Conference Call and Webcast","publication_date":"2017-02-22 13:00:00 +0000","summary":"[GlobeNewswire] - NEW YORK, Feb. 22, 2017-- Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system disorders, today announced that it will host ...","url":"http://finance.yahoo.com/news/intra-cellular-therapies-host-fourth-130000703.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Noteworthy Monday Option Activity: SMG, ITCI, SBUX","publication_date":"2017-01-30 22:31:20 +0000","summary":"Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Scotts Miracle Gro Co Symbol SMG where a total of 1 954 contracts have traded so far representing approximately 195 400 underlying shares That amounts to about 50 8 of SMG s","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZTIIE8KKDBo/noteworthy-monday-option-activity-smg-itci-sbux-cm740482"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies, Inc. – Value Analysis (NASDAQ:ITCI) : January 19, 2017","publication_date":"2017-01-19 15:54:29 +0000","summary":"Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Intra-Cellular Therapies, Inc. a score of 14. Our analysis is based on comparing Intra-Cellular Therapies, Inc. with the following peers – Applied Genetic Technologies Corp., MediciNova, Inc., PDL BioPharma, Inc. and Immune Design Corp. (AGTC-US, MNOV-US, PDLI-US and IMDZ-US). Investment Outlook Intra-Cellular Therapies, Inc. has a fundamental ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/253ce959-66d1-3c34-a2e6-da4ad66357ef/intra-cellular-therapies-inc-value-analysis-nasdaqitci-january-19-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies, Inc. – Value Analysis (NASDAQ:ITCI) : January 19, 2017","publication_date":"2017-01-19 15:54:29 +0000","summary":"Intra-Cellular Therapies, Inc. – Value Analysis (NASDAQ:ITCI) : January 19, 2017","url":"http://www.capitalcube.com/blog/index.php/intra-cellular-therapies-inc-value-analysis-nasdaqitci-january-19-2017/"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies, Inc. breached its 50 day moving average in a Bearish Manner : ITCI-US : January 18, 2017","publication_date":"2017-01-18 14:45:42 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Intra-Cellular Therapies, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/3ec28030-fc25-3783-8c4f-4c52f079c0ae/intra-cellular-therapies-inc-breached-its-50-day-moving-average-in-a-bearish-manner-itci-us-january-18-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies, Inc. breached its 50 day moving average in a Bearish Manner : ITCI-US : January 18, 2017","publication_date":"2017-01-18 14:45:42 +0000","summary":"Intra-Cellular Therapies, Inc. breached its 50 day moving average in a Bearish Manner : ITCI-US : January 18, 2017","url":"http://www.capitalcube.com/blog/index.php/intra-cellular-therapies-inc-breached-its-50-day-moving-average-in-a-bearish-manner-itci-us-january-18-2017/"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"TESARO Varubi IV Gets Complete Response Letter in the U.S.","publication_date":"2017-01-13 14:39:56 +0000","summary":"TESARO Inc TSRO announced that it has received a Complete Response Letter CRL from the FDA regarding its New Drug Application NDA for Varubi IV rolapitant IV The company was seeking approval of rolapitant IV for the prevention of delayed nausea and vomiting associated with initial","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JZwBiNSsazw/tesaro-varubi-iv-gets-complete-response-letter-in-the-us-cm733154"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"TESARO Varubi IV Gets Complete Response Letter in the U.S.","publication_date":"2017-01-13 12:42:12 +0000","summary":"TESARO (TSRO) announced that it has received a Complete Response Letter from the FDA regarding its NDA for Varubi IV.","url":"http://finance.yahoo.com/news/tesaro-varubi-iv-gets-complete-124212187.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"TESARO Varubi IV Gets Complete Response Letter in the U.S.","publication_date":"2017-01-13 12:42:12 +0000","summary":"TESARO Varubi IV Gets Complete Response Letter in the U.S.","url":"http://finance.yahoo.com/news/tesaro-varubi-iv-gets-complete-124212187.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Gilead (GILD) HBV Drug Vemlidy Receives European Approval","publication_date":"2017-01-12 15:02:34 +0000","summary":"Gilead Sciences Inc GILD received encouraging news with the European Commission approving its hepatitis B virus HBV drug Vemlidy tenofovir alafenamide 25 mg as a once daily tablet for the treatment of chronic HBV infection in adults and adolescents aged 12 years and above weighing at","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0adFxfFw8dA/gilead-gild-hbv-drug-vemlidy-receives-european-approval-cm732611"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Gilead (GILD) HBV Drug Vemlidy Receives European Approval","publication_date":"2017-01-12 12:47:12 +0000","summary":"Gilead (GILD) HBV Drug Vemlidy Receives European Approval","url":"http://finance.yahoo.com/news/gilead-gild-hbv-drug-vemlidy-124712986.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"INTRA-CELLULAR THERAPIES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement","publication_date":"2017-01-10 22:17:33 +0000","summary":"INTRA-CELLULAR THERAPIES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement","url":"http://biz.yahoo.com/e/170110/itci8-k.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies to Present at the 35th Annual J.P. Morgan Healthcare Conference","publication_date":"2017-01-04 13:00:00 +0000","summary":"[GlobeNewswire] - NEW YORK, Jan. 04, 2017-- Intra-Cellular Therapies, Inc. a biopharmaceutical company focused on the development of therapeutics for central nervous system disorders, today announced that Sharon Mates, ...","url":"http://finance.yahoo.com/news/intra-cellular-therapies-present-35th-130000840.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Top Ranked Momentum Stocks to Buy for December 19th","publication_date":"2016-12-19 18:58:34 +0000","summary":"Here are four stocks with buy rank and strong momentum characteristics for investors to consider today December 19 th The Goldman Sachs Group Inc GS This investment banking securities and investment management company has a Zacks Rank 1 Strong Buy and seen the Zacks","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dzgENmTdnMA/top-ranked-momentum-stocks-to-buy-for-december-19th-cm723522"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Top Ranked Momentum Stocks to Buy for December 19th","publication_date":"2016-12-19 16:40:04 +0000","summary":"Top Ranked Momentum Stocks to Buy for December 19th","url":"http://finance.yahoo.com/news/top-ranked-momentum-stocks-buy-164004038.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Top Ranked Momentum Stocks to Buy for December 19th","publication_date":"2016-12-19 16:40:04 +0000","summary":"Top Ranked Momentum Stocks to Buy for December 19th","url":"http://finance.yahoo.com/news/top-ranked-momentum-stocks-buy-164004038.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Coverage initiated on Intra-Cellular Therapies by Cantor Fitzgerald","publication_date":"2016-12-16 13:00:08 +0000","summary":"Coverage initiated on Intra-Cellular Therapies by Cantor Fitzgerald","url":"http://finance.yahoo.com/q/ud?s=ITCI"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Why Intra-Cellular Therapies (ITCI) Could Be Positioned for a Surge","publication_date":"2016-12-12 16:58:57 +0000","summary":"Intra Cellular Therapies Inc ITCI is a biopharmaceutical that could be an interesting play for investors That is because not only does the stock have decent short term momentum but it is seeing solid activity on the earnings estimate revision front as well These positive earnings","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RqefFtF4Upc/why-intra-cellular-therapies-itci-could-be-positioned-for-a-surge-cm720133"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Why Intra-Cellular Therapies (ITCI) Could Be Positioned for a Surge","publication_date":"2016-12-12 14:50:02 +0000","summary":"Why Intra-Cellular Therapies (ITCI) Could Be Positioned for a Surge","url":"http://finance.yahoo.com/news/why-intra-cellular-therapies-itci-145002710.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Why Intra-Cellular Therapies (ITCI) Could Be Positioned for a Surge","publication_date":"2016-12-12 14:50:02 +0000","summary":"Intra-Cellular Therapies (ITCI) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision in addition to having decent short-term momentum.","url":"http://finance.yahoo.com/news/why-intra-cellular-therapies-itci-145002710.html?.tsrc=rss"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"10 Stocks Insiders and Hedge Funds Are Crazy About (part 1)","publication_date":"2016-12-02 22:39:04 +0000","summary":"10 Stocks Insiders and Hedge Funds Are Crazy About (part 1)","url":"http://www.insidermonkey.com/blog/10-stocks-insiders-and-hedge-funds-are-crazy-about-part-1-491438/"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Biotechs Aerie, Medicines Co., Tesaro Could Rocket, Or Be Bought: RBC","publication_date":"2016-12-01 21:52:32 +0000","summary":"Biotechs Aerie, Medicines Co., Tesaro Could Rocket, Or Be Bought: RBC","url":"http://www.investors.com/news/technology/biotechs-aerie-regeneron-tesaro-could-rocket-or-become-ma-fodder/"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Will Intra-Cellular Therapies (ITCI) Crush Estimates at Its Next Earnings Report?","publication_date":"2016-12-01 16:21:57 +0000","summary":"Looking for a stock that might be in a good position to beat earnings at its next report Consider Intra Cellular Therapies Inc ITCI a firm in the Medical Biomedical and Genetics industry which could be a great candidate for another beat This company has seen a nice streak of","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QVDpRP3vobU/will-intra-cellular-therapies-itci-crush-estimates-at-its-next-earnings-report-cm716348"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Will Intra-Cellular Therapies (ITCI) Crush Estimates at Its Next Earnings Report?","publication_date":"2016-12-01 13:35:01 +0000","summary":"Will Intra-Cellular Therapies (ITCI) Crush Estimates at Its Next Earnings Report?","url":"http://finance.yahoo.com/news/intra-cellular-therapies-itci-crush-133501668.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies to Present at the 55th Annual Meeting of the American College of Neuropsychopharmacology","publication_date":"2016-12-01 13:00:00 +0000","summary":"[GlobeNewswire] - NEW YORK, Dec. 01, 2016-- Intra-Cellular Therapies, Inc. a biopharmaceutical company focused on the development of therapeutics for central nervous system disorders, today announced two ITI-007 poster ...","url":"http://finance.yahoo.com/news/intra-cellular-therapies-present-55th-130000735.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies Inc (ITCI): Hedge Fund Sentiment Takes A Turn for the Worse","publication_date":"2016-11-28 22:43:27 +0000","summary":"Intra-Cellular Therapies Inc (ITCI): Hedge Fund Sentiment Takes A Turn for the Worse","url":"http://www.insidermonkey.com/blog/intra-cellular-therapies-inc-itci-hedge-fund-sentiment-takes-a-turn-for-the-worse-494075/"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies to Participate at Upcoming Investor Conferences","publication_date":"2016-11-23 13:21:06 +0000","summary":"[at noodls] - NEW YORK, Nov. 23, 2016 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system ('CNS') disorders, ...","url":"http://www.publicnow.com/view/C0D879747550C3585868F536640CD886286C1F1D"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular reports 3Q loss","publication_date":"2016-11-09 13:01:06 +0000","summary":"Intra-Cellular reports 3Q loss","url":"http://sg.finance.yahoo.com/news/intra-cellular-reports-3q-loss-130106395.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"INTRA-CELLULAR THERAPIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Finan","publication_date":"2016-11-09 12:16:51 +0000","summary":"INTRA-CELLULAR THERAPIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Finan","url":"http://biz.yahoo.com/e/161109/itci8-k.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies Reports Third Quarter 2016 Financial Results and Provides Corporate Update","publication_date":"2016-11-09 12:09:12 +0000","summary":"[at noodls] - NEW YORK, Nov. 09, 2016 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, ...","url":"http://www.publicnow.com/view/589D68057BD62FC1CB0792951DB936665D1A7E05"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"7:06 am Intra-Cellular Therapies beats by $0.17, beats on revs","publication_date":"2016-11-09 12:06:00 +0000","summary":"7:06 am Intra-Cellular Therapies beats by $0.17, beats on revs","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#itci"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies to Host Third Quarter 2016 Financial Results Conference Call and Webcast","publication_date":"2016-11-02 12:10:14 +0000","summary":"[at noodls] - NEW YORK, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, ...","url":"http://www.publicnow.com/view/FBB3213428D78F788D3B59E9725614E24B6B0E92"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Intra-Cellular Therapies Presents the ITI-007 Clinical Development Program in Schizophrenia at the CNS Summit 2016 Annual Conference","publication_date":"2016-10-31 12:00:00 +0000","summary":"[GlobeNewswire] - NEW YORK, Oct. 31, 2016-- Intra-Cellular Therapies, Inc. today announced presentation of results from its clinical development program in schizophrenia that has replicated the efficacy of ITI-007 60 mg ...","url":"http://finance.yahoo.com/news/intra-cellular-therapies-presents-iti-120000600.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Biotech's bad year","publication_date":"2016-10-06 18:17:00 +0000","summary":"Biotech's bad year","url":"http://finance.yahoo.com/video/biotechs-bad-181700529.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Biotech Stock Roundup: Summit Soars on Sarepta Deal, Regeneron Presents Data","publication_date":"2016-10-05 15:48:58 +0000","summary":"It was an eventful week for the biotech sector with companies like Regeneron REGN and Intra Cellular Therapies ITCI presenting data while Summit SMMT shot up on a collaboration agreement with Sarepta SRPT Recap of the Week s Most Important Stories Summit Shoots Up on","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-rcJwyaDxNo/biotech-stock-roundup-summit-soars-on-sarepta-deal-regeneron-presents-data-cm689126"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"5 Companies That Destroyed Shareholders Last Week","publication_date":"2016-10-02 14:10:00 +0000","summary":"5 Companies That Destroyed Shareholders Last Week","url":"http://247wallst.com/investing/2016/10/02/5-companies-that-destroyed-shareholders-last-week-10/"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Final Trade: CME, ITCI & more","publication_date":"2016-09-30 21:25:00 +0000","summary":"Final Trade: CME, ITCI & more","url":"http://finance.yahoo.com/video/final-trade-cme-itci-more-212500590.html"},{"ticker":"ITCI","figi_ticker":"ITCI:US","figi":"BBG0026ZFZC4","title":"Company News for September 30, 2016","publication_date":"2016-09-30 16:24:34 +0000","summary":"160 160 160 Shares of ConAgra Foods Inc CAG surged 7 2 after the company posted first quarter fiscal 2017 earnings per share of 0 61 above the Zacks Consensus Estimate of 0 48 160 160 160 Intra Cellular Therapies Inc s ITCI shares plummeted 63 6 after","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/axr6uou8LEo/company-news-for-september-30-2016-cm687187"}],"result_count":197,"page_size":100,"current_page":1,"total_pages":2,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"10.8"},{"x":"1494596100","y":"10.78"},{"x":"1494596400","y":"10.67"},{"x":"1494596700","y":"10.82"},{"x":"1494597000","y":"10.801"},{"x":"1494597300","y":"10.87"},{"x":"1494597600","y":"10.89"},{"x":"1494597900","y":"10.81"},{"x":"1494598200","y":"10.92"},{"x":"1494598500","y":"10.969"},{"x":"1494598800","y":"11.06"},{"x":"1494599100","y":"11.05"},{"x":"1494599400","y":"10.94"},{"x":"1494599700","y":"11.05"},{"x":"1494600000","y":"11.02"},{"x":"1494600300","y":"11.075"},{"x":"1494600600","y":"11.07"},{"x":"1494600900","y":"11.09"},{"x":"1494601200","y":"11.1721"},{"x":"1494601500","y":"11.2701"},{"x":"1494601800","y":"11.2536"},{"x":"1494602100","y":"11.28"},{"x":"1494602400","y":"11.28"},{"x":"1494602700","y":"11.23"},{"x":"1494603000","y":"11.23"},{"x":"1494603300","y":"11.23"},{"x":"1494603600","y":"11.24"},{"x":"1494603900","y":"11.21"},{"x":"1494604200","y":"11.2399"},{"x":"1494604500","y":"11.28"},{"x":"1494604800","y":"11.33"},{"x":"1494605100","y":"11.32"},{"x":"1494605400","y":"11.33"},{"x":"1494605700","y":"11.31"},{"x":"1494606000","y":"11.3"},{"x":"1494606300","y":"11.31"},{"x":"1494606600","y":"11.3"},{"x":"1494606900","y":"11.3"},{"x":"1494607200","y":"11.34"},{"x":"1494607500","y":"11.43"},{"x":"1494607800","y":"11.46"},{"x":"1494608100","y":"11.5"},{"x":"1494608400","y":"11.48"},{"x":"1494608700","y":"11.35"},{"x":"1494609000","y":"11.49"},{"x":"1494609300","y":"11.48"},{"x":"1494609600","y":"11.52"},{"x":"1494609900","y":"11.38"},{"x":"1494610200","y":"11.34"},{"x":"1494610500","y":"11.36"},{"x":"1494610800","y":"11.42"},{"x":"1494611100","y":"11.42"},{"x":"1494611400","y":"11.42"},{"x":"1494611700","y":"11.45"},{"x":"1494612000","y":"11.49"},{"x":"1494612300","y":"11.52"},{"x":"1494612600","y":"11.5399"},{"x":"1494612900","y":"11.503"},{"x":"1494613200","y":"11.48"},{"x":"1494613500","y":"11.41"},{"x":"1494613800","y":"11.405"},{"x":"1494614100","y":"11.44"},{"x":"1494614400","y":"11.43"},{"x":"1494614700","y":"11.42"},{"x":"1494615000","y":"11.42"},{"x":"1494615300","y":"11.41"},{"x":"1494615600","y":"11.395"},{"x":"1494615900","y":"11.375"},{"x":"1494616200","y":"11.375"},{"x":"1494616500","y":"11.35"},{"x":"1494616800","y":"11.335"},{"x":"1494617100","y":"11.34"},{"x":"1494617400","y":"11.251"},{"x":"1494617700","y":"11.2906"},{"x":"1494618000","y":"11.31"},{"x":"1494618300","y":"11.305"},{"x":"1494618600","y":"11.261"},{"x":"1494618900","y":"11.2601"},{"x":"1494619200","y":"11.3"} ], "color":"#03a9f4"}]},
{"id":"15","symbol": "NK","name": "NantKwest Inc","price": 3.98,"dollarChange": 0.8,"percentChange": 25.16,"open": 3.17,"high": 4.07,"low":3.111,"volume": 1313526,"avgVol": 332481.083333,"sharesShort": 3181455,"shortPercent": 3.872463,"marketCap": 259234356,"float": 82155862,"headlines":{"data":[{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest, Inc. :NK-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017","publication_date":"2017-05-10 14:52:41 +0000","summary":"Categories: Yahoo FinanceGet free summary analysis NantKwest, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of NantKwest, Inc. – Seres Therapeutics Inc, Momenta Pharmaceuticals, Inc. and Mateon Therapeutics, Inc. (MCRB-US, MNTA-US and MATN-US) that have also reported for this period. Highlights Summary numbers: Revenues of ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/beefb7b6-2704-3c86-8370-9a0731f30ac5/nantkwest-inc-nk-us-earnings-analysis-q1-2017-by-the-numbers-may-10-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest and NantCell Announce FDA Authorization for the NANT Cancer Vaccine Clinical Trials, the First Novel Combination of Innate and Adaptive Immunotherapy in Patients with Pancreatic Cancer","publication_date":"2017-05-09 11:00:00 +0000","summary":"NantCell and NantKwest Inc. , two pioneering, next generation, clinical-stage immunotherapy companies focused on harnessing the unique power of our immune system using natural killer cells to treat cancer, infectious diseases and inflammatory diseases, today announced that the U.S.","url":"http://finance.yahoo.com/news/nantkwest-nantcell-announce-fda-authorization-110000957.html?.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest reports 1Q loss","publication_date":"2017-05-09 10:00:50 +0000","summary":"On a per-share basis, the San Diego-based company said it had a loss of 30 cents. The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...","url":"http://finance.yahoo.com/news/nantkwest-reports-1q-loss-100050515.html?.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"ETFs with exposure to NantKwest, Inc. : May 4, 2017","publication_date":"2017-05-04 20:11:45 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to NantKwest, Inc. Here are 5 ETFs with the largest exposure to NK-US. Comparing the performance and risk of NantKwest, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/b6dc53d9-3b19-3006-9174-6e9b7e2e3635/etfs-with-exposure-to-nantkwest-inc-may-4-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"ETFs with exposure to NantKwest, Inc. : April 24, 2017","publication_date":"2017-04-24 18:37:45 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to NantKwest, Inc. Here are 5 ETFs with the largest exposure to NK-US. Comparing the performance and risk of NantKwest, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/5fad0982-db47-35d9-bb54-435bf89f3e1c/etfs-with-exposure-to-nantkwest-inc-april-24-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"ETFs with exposure to NantKwest, Inc. : April 7, 2017","publication_date":"2017-04-07 21:08:16 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to NantKwest, Inc. Here are 5 ETFs with the largest exposure to NK-US. Comparing the performance and risk of NantKwest, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/f9c6c15f-104c-3d87-acc2-8c164bd0e05c/etfs-with-exposure-to-nantkwest-inc-april-7-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"[$$] Funding Snapshot: Viracta Gets $18.4 Million from NantKwest for Cancer Drugs","publication_date":"2017-04-04 19:03:43 +0000","summary":"Viracta Therapeutics Inc.","url":"http://finance.yahoo.com/r/97f2cabc-99c0-3cfa-b61f-d47619192147/funding-snapshot-viracta-gets-18-4-million-from-nantkwest-for-cancer-drugs-1491332620?mod=yahoo_hs&yptr=yahoo&.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest and Viracta Therapeutics Announce Series B Financing and Immunotherapy Partnership","publication_date":"2017-04-04 12:00:00 +0000","summary":"CULVER CITY, Calif. and SAN DIEGO, April 04, 2017-- NantKwest, Inc. and Viracta Therapeutics, Inc. announced the initial closing of a Series B Preferred financing round of up to $18.4 million with NantKwest, ...","url":"http://finance.yahoo.com/news/nantkwest-viracta-therapeutics-announce-series-120000304.html?.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"ETFs with exposure to NantKwest, Inc. : March 27, 2017","publication_date":"2017-03-27 20:01:26 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to NantKwest, Inc. Here are 5 ETFs with the largest exposure to NK-US. Comparing the performance and risk of NantKwest, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/ee735f41-d545-31c2-909c-b4b1f660bfdb/etfs-with-exposure-to-nantkwest-inc-march-27-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"ETFs with exposure to NantKwest, Inc. : March 27, 2017","publication_date":"2017-03-27 20:01:26 +0000","summary":"ETFs with exposure to NantKwest, Inc. : March 27, 2017","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-nantkwest-inc-march-27-2017/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NANTKWEST, INC. Financials","publication_date":"2017-03-21 17:04:10 +0000","summary":"NANTKWEST, INC. Financials","url":"http://finance.yahoo.com/q/is?s=nk"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest, Inc. :NK-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017","publication_date":"2017-03-21 15:38:55 +0000","summary":"NantKwest, Inc. :NK-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017","url":"http://www.capitalcube.com/blog/index.php/nantkwest-inc-nk-us-earnings-analysis-q4-2016-by-the-numbers-march-21-2017/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest, Inc. :NK-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017","publication_date":"2017-03-21 15:38:55 +0000","summary":"Categories: Yahoo Finance Get free summary analysis NantKwest, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of NantKwest, Inc. – Neurocrine Biosciences, Inc., Momenta Pharmaceuticals, Inc. and Seres Therapeutics Inc (NBIX-US, MNTA-US and MCRB-US) that have also reported for this period. Highlights Summary numbers: Revenues of ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/7c0e4f81-7888-3e28-9844-3b87794ebbc8/nantkwest-inc-nk-us-earnings-analysis-q4-2016-by-the-numbers-march-21-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest, Inc. :NK-US: Earnings Analysis: 2016 By the Numbers : March 21, 2017","publication_date":"2017-03-21 13:59:06 +0000","summary":"NantKwest, Inc. :NK-US: Earnings Analysis: 2016 By the Numbers : March 21, 2017","url":"http://www.capitalcube.com/blog/index.php/nantkwest-inc-nk-us-earnings-analysis-2016-by-the-numbers-march-21-2017/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"7:03 am NantKwest confirms the FDA has granted Orphan Drug Designation to its activated natural killer cell therapy for treatment of patients with advanced Merkel cell carcinoma","publication_date":"2017-03-20 11:03:00 +0000","summary":"7:03 am NantKwest confirms the FDA has granted Orphan Drug Designation to its activated natural killer cell therapy for treatment of patients with advanced Merkel cell carcinoma","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#nk"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest Announces FDA Grant of Orphan Drug Designation for the Company’s aNK Natural Killer Cell Therapy in Merkel Cell Carcinoma","publication_date":"2017-03-20 11:00:00 +0000","summary":"[Business Wire] - NantKwest, Inc. , a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer cells to treat cancer, infectious diseases and inflammatory diseases, announced today that the FDA has granted Orphan Drug Designation to the company’s activated natural killer cell therapy for treatment of patients with advanced Merkel ...","url":"http://finance.yahoo.com/news/nantkwest-announces-fda-grant-orphan-110000232.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest Announces FDA Grant of Orphan Drug Designation for the Company’s aNK Natural Killer Cell Therapy in Merkel Cell Carcinoma","publication_date":"2017-03-20 11:00:00 +0000","summary":"NantKwest, Inc. , a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer cells to treat cancer, infectious diseases and inflammatory diseases, announced today that the FDA has granted Orphan Drug Designation to the company’s activated natural killer cell therapy for treatment of patients with advanced Merkel ...","url":"http://finance.yahoo.com/news/nantkwest-announces-fda-grant-orphan-110000232.html?.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NANTKWEST, INC. Files SEC form 10-K, Annual Report","publication_date":"2017-03-15 20:22:58 +0000","summary":"NANTKWEST, INC. Files SEC form 10-K, Annual Report","url":"http://biz.yahoo.com/e/170315/nk10-k.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest to Present at Upcoming Investor Conferences","publication_date":"2017-03-06 10:00:00 +0000","summary":"NantKwest today announced that members of the company’s management team will be presenting at the following upcoming investor conferences:","url":"http://finance.yahoo.com/news/nantkwest-present-upcoming-investor-conferences-100000598.html?.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest to Present at Upcoming Investor Conferences","publication_date":"2017-03-06 10:00:00 +0000","summary":"[Business Wire] - NantKwest today announced that members of the company’s management team will be presenting at the following upcoming investor conferences:","url":"http://finance.yahoo.com/news/nantkwest-present-upcoming-investor-conferences-100000598.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Implied IWO Analyst Target Price: $176","publication_date":"2017-02-24 15:50:35 +0000","summary":"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jJOPNSsaJ7M/implied-iwo-analyst-target-price-176-cm752717"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Wildcat Capital Management, LLC Buys Communications Sales & Leasing, Adverum ...","publication_date":"2017-02-16 20:53:22 +0000","summary":"Wildcat Capital Management LLC New Purchases CSAL ADVM NTLA GM Added Positions NH Reduced Positions CSGP IBB EDIT Sold Out TLT BABA FXY HYG EMB QQQ DXJ New Purchases CSAL ADVM NTLA GM New Purchases","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OTk1bqkbvdw/wildcat-capital-management-llc-buys-communications-sales-leasing-adverum-cm749189"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Biotech Premarket Movers: Amicus Therapeutics, Nantkwest and Organovo","publication_date":"2017-01-24 14:26:00 +0000","summary":"Biotech Premarket Movers: Amicus Therapeutics, Nantkwest and Organovo","url":"https://www.thestreet.com/story/13963644/1/biotech-premarket-movers-amicus-therapeutics-nantkwest-and-organovo.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest downgraded by Jefferies","publication_date":"2017-01-24 11:44:55 +0000","summary":"NantKwest downgraded by Jefferies","url":"http://finance.yahoo.com/q/ud?s=NK"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Landmark First-In-Human Clinical Study Launch Using a Genetically Engineered Natural Killer Cell for the Treatment of Cancer","publication_date":"2017-01-23 17:47:00 +0000","summary":"[Business Wire] - NantKwest Inc. , a pioneering, next-generation, clinical-stage immunotherapy company focused on harnessing the unique power of the immune system using natural killer cells to treat cancer, infectious diseases, and inflammatory diseases, today announced that the U.S.","url":"http://finance.yahoo.com/news/landmark-first-human-clinical-study-174700592.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Landmark First-In-Human Clinical Study Launch Using a Genetically Engineered Natural Killer Cell for the Treatment of Cancer","publication_date":"2017-01-23 17:47:00 +0000","summary":"NantKwest Inc. , a pioneering, next-generation, clinical-stage immunotherapy company focused on harnessing the unique power of the immune system using natural killer cells to treat cancer, infectious diseases, and inflammatory diseases, today announced that the U.S.","url":"http://finance.yahoo.com/news/landmark-first-human-clinical-study-174700592.html?.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest, Inc. – Value Analysis (NASDAQ:NK) : January 11, 2017","publication_date":"2017-01-11 16:18:41 +0000","summary":"NantKwest, Inc. – Value Analysis (NASDAQ:NK) : January 11, 2017","url":"http://www.capitalcube.com/blog/index.php/nantkwest-inc-value-analysis-nasdaqnk-january-11-2017/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest, Inc. – Value Analysis (NASDAQ:NK) : January 11, 2017","publication_date":"2017-01-11 16:18:41 +0000","summary":"Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives NantKwest, Inc. a score of 20. Our analysis is based on comparing NantKwest, Inc. with the following peers – Inergetics, Inc., NanoString Technologies, Inc. and Neurocrine Biosciences, Inc. (NRTI-US, NSTG-US and NBIX-US). Investment Outlook NantKwest, Inc. has a fundamental score of 20 and has a relative valuation ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/5c02133b-afe7-326d-b099-7a189a3cc1a5/nantkwest-inc-value-analysis-nasdaqnk-january-11-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest, Inc. breached its 50 day moving average in a Bullish Manner : NK-US : January 10, 2017","publication_date":"2017-01-10 12:19:51 +0000","summary":"NantKwest, Inc. breached its 50 day moving average in a Bullish Manner : NK-US : January 10, 2017","url":"http://www.capitalcube.com/blog/index.php/nantkwest-inc-breached-its-50-day-moving-average-in-a-bullish-manner-nk-us-january-10-2017/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest, Inc. breached its 50 day moving average in a Bullish Manner : NK-US : January 10, 2017","publication_date":"2017-01-10 12:19:51 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for NantKwest, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/b6ae496b-aa10-379c-8f31-b8a0291e3fb2/nantkwest-inc-breached-its-50-day-moving-average-in-a-bullish-manner-nk-us-january-10-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest to Host 2nd Annual Investor/Analyst Day Highlighting Industry Leading R&D and Clinical Programs","publication_date":"2016-12-19 10:11:09 +0000","summary":"[at noodls] - CULVER CITY, Calif.--(BUSINESS WIRE)--Dec. 19, 2016-- NantKwest (Nasdaq:NK), a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of the human immune ...","url":"http://www.publicnow.com/view/3D46099462B4BCE7091D9E605A1C45E2D2004BC5"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest to Host 2nd Annual Investor/Analyst Day Highlighting Industry Leading R&D and Clinical Programs","publication_date":"2016-12-19 10:00:00 +0000","summary":"NantKwest , a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of the human immune system using natural killer cells to treat cancer, infectious diseases and inflammatory diseases today announced that the company will be hosting an Investor/Analyst Day on January 8th in San Francisco.","url":"http://finance.yahoo.com/news/nantkwest-host-2nd-annual-investor-100000643.html?.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"ETFs with exposure to NantKwest, Inc. : December 16, 2016","publication_date":"2016-12-16 19:05:00 +0000","summary":"ETFs with exposure to NantKwest, Inc. : December 16, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-nantkwest-inc-december-16-2016/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"ETFs with exposure to NantKwest, Inc. : December 16, 2016","publication_date":"2016-12-16 19:05:00 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to NantKwest, Inc. Here are 5 ETFs with the largest exposure to NK-US. Comparing the performance and risk of NantKwest, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/1906725c-da4f-363b-b8db-e08139fa2800/etfs-with-exposure-to-nantkwest-inc-december-16-2016?yptr=yahoo&.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"How Nantkwest Inc (NK) Stacks Up Versus Peers","publication_date":"2016-12-16 05:13:49 +0000","summary":"The successful funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small-cap stocks that big investment banks don’t follow. Because of their pay structures, they have strong incentive to do the research necessary to […]","url":"http://finance.yahoo.com/r/3720897d-35fd-3d58-90a3-32797f3a1a2f/how-nantkwest-inc-nk-stacks-up-versus-peers-510986?yptr=yahoo&.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"How Nantkwest Inc (NK) Stacks Up Versus Peers","publication_date":"2016-12-16 05:13:49 +0000","summary":"How Nantkwest Inc (NK) Stacks Up Versus Peers","url":"http://www.insidermonkey.com/blog/how-nantkwest-inc-nk-stacks-up-versus-peers-510986/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest Announces Enhanced High-Affinity Activated Natural Killer (haNK) Cell Therapy in Preclinical Studies of HER2 Positive Breast Cancer at Presentation at the San Antonio Breast Cancer Symposium","publication_date":"2016-12-12 16:44:00 +0000","summary":"NantKwest Inc. , a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer cells to treat cancer, infectious diseases and inflammatory diseases, announced that the company presented results from a preclinical study on the company’s high affinity Natural Killer cell therapy program at the San Antonio Breast Cancer ...","url":"http://finance.yahoo.com/news/nantkwest-announces-enhanced-high-affinity-164400676.html?.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest Announces Enhanced High-Affinity Activated Natural Killer (haNK) Cell Therapy in Preclinical Studies of HER2 Positive Breast Cancer at Presentation at the San Antonio Breast Cancer Symposium","publication_date":"2016-12-12 16:44:00 +0000","summary":"[Business Wire] - NantKwest Inc. , a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer cells to treat cancer, infectious diseases and inflammatory diseases, announced that the company presented results from a preclinical study on the company’s high affinity Natural Killer cell therapy program at the San Antonio Breast Cancer ...","url":"http://finance.yahoo.com/news/nantkwest-announces-enhanced-high-affinity-164400676.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Why NantKwest (NK) Stock Might be a Great Pick","publication_date":"2016-12-08 15:00:10 +0000","summary":"One stock that might be an intriguing choice for investors right now is NantKwest Inc NK This is because this security in the Medical Biomedical Genetics space is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective This","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZSiiKneScMw/why-nantkwest-nk-stock-might-be-a-great-pick-cm718619"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Why NantKwest (NK) Stock Might be a Great Pick","publication_date":"2016-12-08 13:43:01 +0000","summary":"NantKwest (NK) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective.","url":"http://finance.yahoo.com/news/why-nantkwest-nk-stock-might-134301165.html?.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Why NantKwest (NK) Stock Might be a Great Pick","publication_date":"2016-12-08 13:43:01 +0000","summary":"Why NantKwest (NK) Stock Might be a Great Pick","url":"http://finance.yahoo.com/news/why-nantkwest-nk-stock-might-134301165.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest, Inc. breached its 50 day moving average in a Bearish Manner : NK-US : November 29, 2016","publication_date":"2016-11-29 12:27:11 +0000","summary":"NantKwest, Inc. breached its 50 day moving average in a Bearish Manner : NK-US : November 29, 2016","url":"http://www.capitalcube.com/blog/index.php/nantkwest-inc-breached-its-50-day-moving-average-in-a-bearish-manner-nk-us-november-29-2016/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest, Inc. breached its 50 day moving average in a Bearish Manner : NK-US : November 29, 2016","publication_date":"2016-11-29 12:27:11 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for NantKwest, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/07384879-4252-336a-ba22-cfe7736a50a0/nantkwest-inc-breached-its-50-day-moving-average-in-a-bearish-manner-nk-us-november-29-2016?yptr=yahoo&.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest to Present at the Piper Jaffray 28th Annual Health Care Conference","publication_date":"2016-11-28 18:13:00 +0000","summary":"NantKwest Inc. today announced that Company management will present at the Piper Jaffray 28th Annual Health Care Conference in New York, NY at 4:00 pm Eastern Time on Tuesday, November 29, 2016.","url":"http://finance.yahoo.com/news/nantkwest-present-piper-jaffray-28th-181300408.html?.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest to Present at the Piper Jaffray 28th Annual Health Care Conference","publication_date":"2016-11-28 18:13:00 +0000","summary":"[Business Wire] - NantKwest Inc. today announced that Company management will present at the Piper Jaffray 28th Annual Health Care Conference in New York, NY at 4:00 pm Eastern Time on Tuesday, November 29, 2016.","url":"http://finance.yahoo.com/news/nantkwest-present-piper-jaffray-28th-181300408.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"ETFs with exposure to NantKwest, Inc. : November 23, 2016","publication_date":"2016-11-23 18:17:10 +0000","summary":"ETFs with exposure to NantKwest, Inc. : November 23, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-nantkwest-inc-november-23-2016/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"ETFs with exposure to NantKwest, Inc. : November 23, 2016","publication_date":"2016-11-23 18:17:10 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to NantKwest, Inc. Here are 5 ETFs with the largest exposure to NK-US. Comparing the performance and risk of NantKwest, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/7b6ab377-b2bc-30c5-bc20-c538df8a4647/etfs-with-exposure-to-nantkwest-inc-november-23-2016?yptr=yahoo&.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Direct Injection of CAR-Engineered CD19.taNK Cells Demonstrating Potential “Vaccine” Protective Effect to be Highlighted in Oral Presentation at the 58th Annual Meeting of the American Society of Hematology","publication_date":"2016-11-23 01:17:00 +0000","summary":"[Business Wire] - NantKwest Inc. , a pioneering, next-generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer cells to treat cancer, infectious diseases and inflammatory diseases, today announced that the Company’s abstract reviewing data on the company’s CD19.taNK program has been accepted for an oral presentation at the upcoming 58th Annual ...","url":"http://finance.yahoo.com/news/direct-injection-car-engineered-cd19-011700935.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Direct Injection of CAR-Engineered CD19.taNK Cells Demonstrating Potential “Vaccine” Protective Effect to be Highlighted in Oral Presentation at the 58th Annual Meeting of the American Society of Hematology","publication_date":"2016-11-23 01:17:00 +0000","summary":"NantKwest Inc. , a pioneering, next-generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer cells to treat cancer, infectious diseases and inflammatory diseases, today announced that the Company’s abstract reviewing data on the company’s CD19.taNK program has been accepted for an oral presentation at the upcoming 58th Annual ...","url":"http://finance.yahoo.com/news/direct-injection-car-engineered-cd19-011700935.html?.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest Announces Landmark Study Published on high affinity haNK Cell Therapy in the Journal Oncotarget","publication_date":"2016-11-22 16:54:10 +0000","summary":"[at noodls] - Next Generation NK Cell Therapy Poised to Transition into Human Clinical Trials CULVER CITY, Calif.--(BUSINESS WIRE)--Nov. 22, 2016-- NantKwest Inc. (Nasdaq:NK), a pioneering, next generation, clinical-stage ...","url":"http://www.publicnow.com/view/6B7AF7294134FD24B2C88BB293E88B136333FA99"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest Announces Landmark Study Published on high affinity haNK Cell Therapy in the Journal Oncotarget","publication_date":"2016-11-22 16:43:00 +0000","summary":"NantKwest Inc. , a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of the immune system using natural killer cells to treat cancer, infectious diseases and inflammatory diseases, announced in a paper published today in the journal Oncotarget results of a research study conducted at the National Cancer Institute in collaboration with scientists ...","url":"http://finance.yahoo.com/news/nantkwest-announces-landmark-study-published-164300083.html?.tsrc=rss"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest, Inc. :NK-US: Earnings Analysis: Q3, 2016 By the Numbers : November 21, 2016","publication_date":"2016-11-21 15:38:09 +0000","summary":"NantKwest, Inc. :NK-US: Earnings Analysis: Q3, 2016 By the Numbers : November 21, 2016","url":"http://www.capitalcube.com/blog/index.php/nantkwest-inc-nk-us-earnings-analysis-q3-2016-by-the-numbers-november-21-2016/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest Announces Achievement of End Point in Merkel Cell Carcinoma Phase II Trial With Evidence of Efficacy of Activated Natural Killer (aNK) Cells in Solid Tumors","publication_date":"2016-11-14 21:17:13 +0000","summary":"[at noodls] - Promising Clinically Meaningful Responses Seen Including a Radiological Complete Response in Early Data Analysis Presented at the 31st Annual Meeting of the Society for Immunotherapy of Cancer CULVER CITY, ...","url":"http://www.publicnow.com/view/B589A9318CACDEAA81DCE8D0097B2F6C546638FF"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest, Inc. breached its 50 day moving average in a Bullish Manner : NK-US : November 11, 2016","publication_date":"2016-11-11 12:02:52 +0000","summary":"NantKwest, Inc. breached its 50 day moving average in a Bullish Manner : NK-US : November 11, 2016","url":"http://www.capitalcube.com/blog/index.php/nantkwest-inc-breached-its-50-day-moving-average-in-a-bullish-manner-nk-us-november-11-2016/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NANTKWEST, INC. Files SEC form 10-Q, Quarterly Report","publication_date":"2016-11-10 21:05:04 +0000","summary":"NANTKWEST, INC. Files SEC form 10-Q, Quarterly Report","url":"http://biz.yahoo.com/e/161110/nk10-q.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest to Present Data at the 58th Annual Meeting of the American Society of Hematology","publication_date":"2016-11-09 01:21:00 +0000","summary":"[Business Wire] - NantKwest Inc. , a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer cells to treat cancer, infectious diseases and inflammatory diseases, today announced several presentations at the upcoming 58th Annual Meeting of the American Society of Hematology in San Diego, CA, December 3-6, 2016.","url":"http://finance.yahoo.com/news/nantkwest-present-data-58th-annual-012100473.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"ETF’s with exposure to NantKwest, Inc. : October 24, 2016","publication_date":"2016-10-24 16:27:13 +0000","summary":"ETF’s with exposure to NantKwest, Inc. : October 24, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-nantkwest-inc-october-24-2016/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Better Buy: NantKwest, Inc. vs. Celldex Therapeutics, Inc.","publication_date":"2016-10-19 11:05:59 +0000","summary":"Better Buy: NantKwest, Inc. vs. Celldex Therapeutics, Inc.","url":"http://www.fool.com/investing/2016/10/18/better-buy-nantkwest-inc-vs-celldex-therapeutics-i.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Better Buy: NantKwest, Inc. vs. Celldex Therapeutics, Inc.","publication_date":"2016-10-18 12:47:52 +0000","summary":"Image source Getty Images A match up between NantKwest Inc NASDAQ NK and Celldex Therapeutics Inc NASDAQ CLDX might qualify for a biotech version of the TV show The Biggest Loser NantKwest has lost over 60 of its value in 2016 Celldex s shares have plunged","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HpDTUwUcZV4/better-buy-nantkwest-inc-vs-celldex-therapeutics-inc-cm694564"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Altor BioScience Corporation and NantKwest Inc. Announce Co-Development Agreement to Advance Innovative Natural Killer Cell Combination Immunotherapies for the Treatment of Cancer","publication_date":"2016-10-04 14:18:01 +0000","summary":"[at noodls] - Cancer moonshot 2020 milestone: novel-novel combination of GPS Cancer guided cell based NK cell therapy and fusion proteins in QUILT trial CULVER CITY, Calif. & MIRAMAR, Fla.--(BUSINESS WIRE)--Oct. 4, ...","url":"http://www.publicnow.com/view/D3EB78E604DB73BCD97AA1A7F029C3D7B35A2A57"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest, Inc. – Value Analysis (NASDAQ:NK) : October 3, 2016","publication_date":"2016-10-03 16:24:12 +0000","summary":"NantKwest, Inc. – Value Analysis (NASDAQ:NK) : October 3, 2016","url":"http://www.capitalcube.com/blog/index.php/nantkwest-inc-value-analysis-nasdaqnk-october-3-2016/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest Announces Presentations at the Upcoming 16th Annual Meeting of the Society for Natural Immunity","publication_date":"2016-10-03 11:00:00 +0000","summary":"[Business Wire] - NantKwest, Inc , a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of the immune system using natural killer cells to treat cancer, infectious diseases and inflammatory diseases, today announced that the company has been selected to present at NK2016, the 16th Annual Meeting of the Society for Natural Immunity in Taormina, Italy on October 2nd ...","url":"http://finance.yahoo.com/news/nantkwest-announces-presentations-upcoming-16th-110000518.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest, Inc. breached its 50 day moving average in a Bearish Manner : NK-US : September 30, 2016","publication_date":"2016-09-30 12:25:48 +0000","summary":"NantKwest, Inc. breached its 50 day moving average in a Bearish Manner : NK-US : September 30, 2016","url":"http://www.capitalcube.com/blog/index.php/nantkwest-inc-breached-its-50-day-moving-average-in-a-bearish-manner-nk-us-september-30-2016/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"ETF’s with exposure to NantKwest, Inc. : September 21, 2016","publication_date":"2016-09-21 14:51:56 +0000","summary":"ETF’s with exposure to NantKwest, Inc. : September 21, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-nantkwest-inc-september-21-2016/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest Announces Presentations at Upcoming Investment Conferences","publication_date":"2016-09-11 02:36:00 +0000","summary":"NantKwest Announces Presentations at Upcoming Investment Conferences","url":"http://uk.finance.yahoo.com/news/nantkwest-announces-presentations-upcoming-investment-023600061.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Are These 3 Clinical-Stage Biotechs Still Buys After Soaring in August?","publication_date":"2016-09-10 21:55:31 +0000","summary":"Are These 3 Clinical-Stage Biotechs Still Buys After Soaring in August?","url":"http://www.fool.com/investing/2016/09/09/are-these-3-clinical-stage-biotechs-still-buys-aft.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Are These 3 Clinical-Stage Biotechs Still Buys After Soaring in August?","publication_date":"2016-09-09 23:31:20 +0000","summary":"Image source Getty Images What happened Shares of clinical stage biotechs Agenus NASDAQ AGEN Arrowhead Pharmaceuticals Inc NASDAQ ARWR and NantKwest Inc NASDAQ NK all rose by double digits last month 160 according to data from S amp P Global","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IQdan6m1J0Q/are-these-3-clinical-stage-biotechs-still-buys-after-soaring-in-august-cm677301"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"ETF’s with exposure to NantKwest, Inc. : August 31, 2016","publication_date":"2016-08-31 15:39:29 +0000","summary":"ETF’s with exposure to NantKwest, Inc. : August 31, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-nantkwest-inc-august-31-2016/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NANTKWEST, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits","publication_date":"2016-08-29 10:09:30 +0000","summary":"NANTKWEST, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/160829/nk8-k.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"ETF’s with exposure to NantKwest, Inc. : August 19, 2016","publication_date":"2016-08-19 17:04:48 +0000","summary":"ETF’s with exposure to NantKwest, Inc. : August 19, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-nantkwest-inc-august-19-2016/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest, Inc. :NK-US: Earnings Analysis: Q2, 2016 By the Numbers : August 18, 2016","publication_date":"2016-08-18 15:05:15 +0000","summary":"NantKwest, Inc. :NK-US: Earnings Analysis: Q2, 2016 By the Numbers : August 18, 2016","url":"http://www.capitalcube.com/blog/index.php/nantkwest-inc-nk-us-earnings-analysis-q2-2016-by-the-numbers-august-18-2016/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest reports 2Q loss","publication_date":"2016-08-16 10:20:41 +0000","summary":"NantKwest reports 2Q loss","url":"http://sg.finance.yahoo.com/news/nantkwest-reports-2q-loss-102041862.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NANTKWEST, INC. Files SEC form 10-Q, Quarterly Report","publication_date":"2016-08-15 16:04:07 +0000","summary":"NANTKWEST, INC. Files SEC form 10-Q, Quarterly Report","url":"http://biz.yahoo.com/e/160815/nk10-q.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"These 5 Stocks Under $10 Are Set to Soar Higher","publication_date":"2016-07-28 14:08:00 +0000","summary":"These 5 Stocks Under $10 Are Set to Soar Higher","url":"https://www.thestreet.com/story/13656106/1/these-5-stocks-under-10-are-set-to-soar-higher.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Breakthrough Cancer Treatment Stocks Every Investor Ought to Know About","publication_date":"2016-07-23 19:07:16 +0000","summary":"Image source Kite Pharma. The war on cancer is moving into a new era as an improved understanding of cancer's genetic makeup ushers in new, next generation anti cancer weapons. Kite Pharma (NASDAQ","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QuFJOkdpahw/breakthrough-cancer-treatment-stocks-every-investor-ought-to-know-about-cm653759"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Breakthrough Cancer Treatment Stocks Every Investor Ought to Know About","publication_date":"2016-07-23 18:01:00 +0000","summary":"Breakthrough Cancer Treatment Stocks Every Investor Ought to Know About","url":"http://www.fool.com/investing/2016/07/23/breakthrough-cancer-stocks-every-investor-ought-to.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest, Inc. – Value Analysis (NASDAQ:NK) : July 19, 2016","publication_date":"2016-07-19 18:44:31 +0000","summary":"NantKwest, Inc. – Value Analysis (NASDAQ:NK) : July 19, 2016","url":"http://www.capitalcube.com/blog/index.php/nantkwest-inc-value-analysis-nasdaqnk-july-19-2016/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"ETF’s with exposure to NantKwest, Inc. : July 19, 2016","publication_date":"2016-07-19 16:52:54 +0000","summary":"ETF’s with exposure to NantKwest, Inc. : July 19, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-nantkwest-inc-july-19-2016/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Adding Up The Components: Russell 2000 Could Rise 10%","publication_date":"2016-07-14 12:51:18 +0000","summary":"The financial media loves to get predictions from experts about where they think a given stock market index is headed. Some experts look at technical analysis patterns, others look at valuation metrics, others apply a broad macro view of","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZnpLyzmaeyM/adding-up-the-components-russell-2000-could-rise-10-cm649046"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest, Inc. breached its 50 day moving average in a Bullish Manner : NK-US : July 13, 2016","publication_date":"2016-07-13 12:45:05 +0000","summary":"NantKwest, Inc. breached its 50 day moving average in a Bullish Manner : NK-US : July 13, 2016","url":"http://www.capitalcube.com/blog/index.php/nantkwest-inc-breached-its-50-day-moving-average-in-a-bullish-manner-nk-us-july-13-2016/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"ETF’s with exposure to NantKwest, Inc. : June 30, 2016","publication_date":"2016-06-30 16:23:03 +0000","summary":"ETF’s with exposure to NantKwest, Inc. : June 30, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-nantkwest-inc-june-30-2016/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Better Buy: NantKwest, Inc. vs. Ionis Pharmaceuticals","publication_date":"2016-06-28 14:50:13 +0000","summary":"Image source Getty Images. Since raising $207 million in a record setting IPO that valued it at $2.6 billion last summer, NantKwest (NASDAQ NK) stock has lost over 80% of its value. Ionis","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0M67hffGc9c/better-buy-nantkwest-inc-vs-ionis-pharmaceuticals-cm641962"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Better Buy: NantKwest, Inc. vs. Ionis Pharmaceuticals","publication_date":"2016-06-28 13:21:00 +0000","summary":"Better Buy: NantKwest, Inc. vs. Ionis Pharmaceuticals","url":"http://www.fool.com/investing/2016/06/28/better-buy-nantkwest-inc-vs-ionis-pharmaceuticals.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NANTKWEST, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders","publication_date":"2016-06-20 13:02:14 +0000","summary":"NANTKWEST, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders","url":"http://biz.yahoo.com/e/160620/nk8-k.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"ETF’s with exposure to NantKwest, Inc. : June 8, 2016","publication_date":"2016-06-08 18:25:02 +0000","summary":"ETF’s with exposure to NantKwest, Inc. : June 8, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-nantkwest-inc-june-8-2016/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"NantKwest, Inc. :NK-US: Earnings Analysis: Q1, 2016 By the Numbers : June 7, 2016","publication_date":"2016-06-07 15:07:24 +0000","summary":"NantKwest, Inc. :NK-US: Earnings Analysis: Q1, 2016 By the Numbers : June 7, 2016","url":"http://www.capitalcube.com/blog/index.php/nantkwest-inc-nk-us-earnings-analysis-q1-2016-by-the-numbers-june-7-2016/"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"US IPO Week Ahead: Billionaire doctor back with another IPO","publication_date":"2016-06-04 23:10:26 +0000","summary":"The shortened holiday week ahead will see two deals come to market, raising just over $100 million combined. Coming off 15 pricings in May, the seasonally strong June should see similar or improved market activity.  Renaissance Capital's IPO Calendar","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/37BzKEYZ1mY/us-ipo-week-ahead-billionaire-doctor-back-with-another-ipo-cm627763"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"US IPO Weekly Recap: Three healthcare IPOs led by billionaire-backed NantHealth's +33% pop","publication_date":"2016-06-04 23:00:13 +0000","summary":"The shortened holiday week saw three healthcare IPOs raise over $150 million, bringing the year to date total up to 34 offerings.Can't stop Nant NantHealth surges 33% in year's second best IPO debut Billionaire founder and CEO Patrick Soon","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C5WeYUmeUz4/us-ipo-weekly-recap-three-healthcare-ipos-led-by-billionaire-backed-nanthealths-33-pop-cm630479"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Cloud-based healthcare: NantHealth sets terms for $91 million IPO","publication_date":"2016-06-03 21:16:51 +0000","summary":"NantHealth, which provides cloud based healthcare data solutions to support clinical decisions, announced terms for its IPO on Tuesday. The Culver City, CA based company plans to raise $91 million by offering 6.5 million shares at a price range","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CRUTT3Onx9g/cloud-based-healthcare-nanthealth-sets-terms-for-91-million-ipo-cm625377"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Soon-Shiong's Latest Offering Is Risky","publication_date":"2016-06-02 19:32:47 +0000","summary":"Soon-Shiong's Latest Offering Is Risky","url":"http://www.bloomberg.com/gadfly/articles/2016-06-02/nanthealth-ipo-patrick-soon-shiong-s-risky-bet?cmpid=yhoo.headline"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Tribune Publishing Receives $70.5 Million Growth Capital Investment from Nant Capital","publication_date":"2016-05-23 11:16:05 +0000","summary":"[at noodls] - Nant Capital Founder, Dr. Patrick Soon-Shiong, Has Been Invited to Join the Tribune Publishing Board as Vice Chairman; Will Serve Beginning June 2, 2016 CHICAGO--(BUSINESS WIRE)-- Tribune Publishing Co. ...","url":"http://www.publicnow.com/view/B4A4C7E098388E81D536C33D816E152A33237B6D"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in NantKwest, Inc. of Class Action Lawsuit and Upcoming Deadline – NK","publication_date":"2016-05-20 20:47:02 +0000","summary":"[GlobeNewswire] - NEW YORK, May 20, 2016-- Pomerantz LLP announces that a class action lawsuit has been filed against NantKwest, Inc. and certain of its officers. The class action, filed in United States District Court, ...","url":"http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-204702310.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of NantKwest, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of May 23, 2016 - NK","publication_date":"2016-05-20 15:49:00 +0000","summary":"[PR Newswire] - NEW YORK, May 20, 2016 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of NantKwest, Inc. (\"NantKwest\" ...","url":"http://finance.yahoo.com/news/upcoming-deadline-levi-korsinsky-llp-154900356.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"EXPANDED CLASS PERIOD: Goldberg Law PC Files Securities Class Action Lawsuit Against NantKwest, Inc. and Encourages Investors with Losses to Contact the Firm","publication_date":"2016-05-19 20:03:00 +0000","summary":"[Business Wire] - Goldberg Law PC announces that it has filed a class action lawsuit in the United States District Court, Central District of California, against NantKwest, Inc.","url":"http://finance.yahoo.com/news/expanded-class-period-goldberg-law-200300133.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Thursday's ETF Movers: XME, IBB","publication_date":"2016-05-19 18:43:22 +0000","summary":"In trading on Thursday, the SPDR S&P Metals and Mining ETF ( XME ) is outperforming other ETFs, up about 1.1% on the day. Components of that ETF showing particular strength include shares of United States Steel ( X","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oMa-D8NNnrs/thursdays-etf-movers-xme-ibb-cm623655"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"The Law Offices of Howard G. Smith Announces an Expanded Class Period in the Securities Class Action Lawsuit Pending Against NantKwest, Inc.","publication_date":"2016-05-19 17:28:00 +0000","summary":"[Business Wire] - Law Offices of Howard G. Smith announces an expanded class period in the class action lawsuit filed on behalf of investors who purchased or otherwise acquired NantKwest, Inc. securities between July 28, 2015 and March 11, 2016, inclusive .","url":"http://finance.yahoo.com/news/law-offices-howard-g-smith-172800000.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit Against NantKwest, Inc. And Reminds Investors With Losses To Contact The Firm","publication_date":"2016-05-19 16:03:00 +0000","summary":"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / May 19, 2016 / Lundin Law PC announces a class action lawsuit has been filed against NantKwest, Inc. (\"NantKwest\" or the \"Company\") (Nasdaq: NK) concerning ...","url":"http://finance.yahoo.com/news/deadline-approaching-lundin-law-pc-160300208.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Nantkwest, Inc. (NK) and Lead Plaintiff Deadline: May 23, 2016","publication_date":"2016-05-19 14:02:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / May 19, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against Nantkwest, Inc. (\"Nantkwest\" or \"the Company\") (NASDAQ: NK). ...","url":"http://finance.yahoo.com/news/deadline-alert-bronstein-gewirtz-grossman-140200492.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"Glancy Prongay & Murray LLP Files Securities Class Action Lawsuit Against NantKwest, Inc.","publication_date":"2016-05-18 21:47:00 +0000","summary":"[Business Wire] - Glancy Prongay & Murray LLP announces that it has filed a class action lawsuit in the United States District Court for the Central District of California on behalf of a class of individuals who purchased NantKwest, Inc.","url":"http://finance.yahoo.com/news/glancy-prongay-murray-llp-files-214700243.html"},{"ticker":"NK","figi_ticker":"NK:US","figi":"BBG007T9DYW9","title":"INVESTOR ALERT: Rosen Law Firm Reminds NantKwest, Inc. Investors of Important May 23 Deadline In Class Action - NK","publication_date":"2016-05-18 16:34:35 +0000","summary":"[GlobeNewswire] - NEW YORK, May 18, 2016-- Rosen Law Firm, a global investor rights law firm, reminds purchasers of NantKwest, Inc. securities from September 10, 2015 through March 10, 2016, both dates inclusive of the ...","url":"http://finance.yahoo.com/news/investor-alert-rosen-law-firm-163435258.html"}],"result_count":122,"page_size":100,"current_page":1,"total_pages":2,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"3.16"},{"x":"1494596100","y":"3.135"},{"x":"1494596400","y":"3.13"},{"x":"1494596700","y":"3.154"},{"x":"1494597000","y":"3.17"},{"x":"1494597300","y":"3.22"},{"x":"1494597600","y":"3.2800000000000002"},{"x":"1494597900","y":"3.24"},{"x":"1494598200","y":"3.24"},{"x":"1494598500","y":"3.29"},{"x":"1494598800","y":"3.29"},{"x":"1494599100","y":"3.29"},{"x":"1494599400","y":"3.35"},{"x":"1494599700","y":"3.3132"},{"x":"1494600000","y":"3.35"},{"x":"1494600300","y":"3.3727"},{"x":"1494600600","y":"3.42"},{"x":"1494600900","y":"3.41"},{"x":"1494601200","y":"3.44"},{"x":"1494601500","y":"3.4699999999999998"},{"x":"1494601800","y":"3.4172000000000002"},{"x":"1494602100","y":"3.48"},{"x":"1494602400","y":"3.56"},{"x":"1494602700","y":"3.515"},{"x":"1494603000","y":"3.589"},{"x":"1494603300","y":"3.51"},{"x":"1494603600","y":"3.5254"},{"x":"1494603900","y":"3.5300000000000002"},{"x":"1494604200","y":"3.51"},{"x":"1494604500","y":"3.515"},{"x":"1494604800","y":"3.5"},{"x":"1494605100","y":"3.5"},{"x":"1494605700","y":"3.51"},{"x":"1494606000","y":"3.49"},{"x":"1494606300","y":"3.481"},{"x":"1494606600","y":"3.51"},{"x":"1494606900","y":"3.5"},{"x":"1494607200","y":"3.48"},{"x":"1494607500","y":"3.48"},{"x":"1494607800","y":"3.5300000000000002"},{"x":"1494608100","y":"3.5300000000000002"},{"x":"1494608400","y":"3.54"},{"x":"1494608700","y":"3.59"},{"x":"1494609000","y":"3.645"},{"x":"1494609300","y":"3.7"},{"x":"1494609600","y":"3.68"},{"x":"1494609900","y":"3.65"},{"x":"1494610200","y":"3.6607"},{"x":"1494610500","y":"3.7"},{"x":"1494610800","y":"3.75"},{"x":"1494611100","y":"3.73"},{"x":"1494611400","y":"3.7500999999999998"},{"x":"1494611700","y":"3.7556000000000003"},{"x":"1494612000","y":"3.7640000000000002"},{"x":"1494612300","y":"3.77"},{"x":"1494612600","y":"3.89"},{"x":"1494612900","y":"3.84"},{"x":"1494613200","y":"3.83"},{"x":"1494613500","y":"3.84"},{"x":"1494613800","y":"3.8844"},{"x":"1494614100","y":"3.89"},{"x":"1494614400","y":"3.88"},{"x":"1494614700","y":"3.81"},{"x":"1494615000","y":"3.84"},{"x":"1494615300","y":"3.833"},{"x":"1494615600","y":"3.89"},{"x":"1494615900","y":"3.8742"},{"x":"1494616200","y":"3.94"},{"x":"1494616500","y":"3.95"},{"x":"1494616800","y":"3.92"},{"x":"1494617100","y":"3.96"},{"x":"1494617400","y":"3.975"},{"x":"1494617700","y":"3.9802"},{"x":"1494618000","y":"4"},{"x":"1494618300","y":"4.0599"},{"x":"1494618600","y":"3.99"},{"x":"1494618900","y":"3.99"},{"x":"1494619200","y":"3.98"} ], "color":"#03a9f4"}]},
{"id":"16","symbol": "OCUL","name": "Ocular Therapeutix Inc","price": 9.64,"dollarChange": 1.24,"percentChange": 14.63,"open": 8.35,"high": 9.8793,"low":8.35,"volume": 1708945,"avgVol": 966066.283333,"sharesShort": 6341075,"shortPercent": 21.844546,"marketCap": 289120712,"float": 29028184,"headlines":{"data":[{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix™ Presented Phase 3 Data for DEXTENZA™ at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting","publication_date":"2017-05-11 12:00:00 +0000","summary":"Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye, presented ocular pain data from a pooled analysis from three Phase 3 clinical trials evaluating the efficacy and safety of DEXTENZA 0.4 mg for intracanalicular use, for the treatment of ocular pain and inflammation following ...","url":"http://finance.yahoo.com/news/ocular-therapeutix-presented-phase-3-120000399.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"InPlay from Briefing.com","publication_date":"2017-05-09 18:55:33 +0000","summary":"InPlay from Briefing.com","url":"http://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix™ Presents Preclinical Data on Pharmacokinetics, Efficacy and Tolerability of Sustained Release Intravitreal Tyrosine Kinase Inhibitor Hydrogel Depot (OTX-TKI) at the ARVO Annual Meeting","publication_date":"2017-05-09 18:49:00 +0000","summary":"Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye, today presented data from preclinical studies evaluating the efficacy, tolerability and pharmacokinetics of its sustained release intravitreal tyrosine kinase inhibitor depot using the Company’s proprietary bioresorbable ...","url":"http://finance.yahoo.com/news/ocular-therapeutix-presents-preclinical-data-184900229.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Why Ocular Therapeutix Inc Stock Jumped Higher Today","publication_date":"2017-05-08 16:48:09 +0000","summary":"Presentation of positive phase 3 data sent shares higher.","url":"http://finance.yahoo.com/r/cf94f41a-0158-351a-bd62-8e1e902837b1/why-ocular-therapeutix-inc-stock-jumped-higher-tod.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Betting on Adamis Pharmaceuticals and Ocular Therapeutix Ahead of FDA Decisions","publication_date":"2017-05-08 13:22:00 +0000","summary":"Read on to find out why these biotech firms could secure FDA victories.","url":"http://finance.yahoo.com/r/6e9f78f5-4818-3e28-983b-5a4ba77ca4ed/betting-adamis-pharmaceuticals-and-ocular-therapeutix-ahead-fda-decisions-admp-ocul?partner=YahooSA&yptr=yahoo&.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Today's Research Reports on Stocks to Watch: ImmunoGen and Ocular Therapeutix","publication_date":"2017-05-08 12:00:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / May 8, 2017 / Positive economic data and continued strength in corporate earnings pushed U.S. markets into the green Friday. The Dow Jones Industrial Average gained 0.26 percent ...","url":"http://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000612.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix™ Presents Additional Phase 3 Data and Patient Reported Outcomes Results for DEXTENZA™ at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium","publication_date":"2017-05-08 12:00:00 +0000","summary":"Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye, presented yesterday new data from its most recent Phase 3 study evaluating the safety and efficacy of DEXTENZA 0.4 mg for the treatment of ocular pain and inflammation following cataract surgery.","url":"http://finance.yahoo.com/news/ocular-therapeutix-presents-additional-phase-120000521.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Edited Transcript of OCUL earnings conference call or presentation 5-May-17 12:30pm GMT","publication_date":"2017-05-07 00:30:31 +0000","summary":"Q1 2017 Ocular Therapeutix Inc Earnings Call","url":"http://finance.yahoo.com/news/edited-transcript-ocul-earnings-conference-174101705.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Why Ocular Theraputix Inc. Got Hammered Today","publication_date":"2017-05-05 20:56:00 +0000","summary":"The FDA wants some changes at the biotech&apos;s manufacturing plant.","url":"http://finance.yahoo.com/r/b3ec4d5d-ac00-31ed-8d1f-7caf8067129b/why-ocular-theraputix-inc-got-hammered-today.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix reports 1Q loss","publication_date":"2017-05-05 11:36:24 +0000","summary":"The Bedford, Massachusetts-based company said it had a loss of 58 cents per share. The biotechnology company posted revenue of $475,000 in the period. Ocular Therapeutix shares have risen nearly 9 percent ...","url":"http://finance.yahoo.com/news/ocular-therapeutix-reports-1q-loss-113624322.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Investor Network: Ocular Therapeutix Inc to Host Earnings Call","publication_date":"2017-05-05 11:30:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / May 5, 2017 / Ocular Therapeutix Inc (NASDAQ: OCUL ) will be discussing their earnings results in their Q1 Earnings Call to be held May 5, 2017 at 8:30 AM Eastern Time. To listen ...","url":"http://finance.yahoo.com/news/investor-network-ocular-therapeutix-inc-113000128.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix™ Reports First Quarter 2017 Financial Results","publication_date":"2017-05-05 11:30:00 +0000","summary":"Ocular Therapeutix, Inc.  , a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye, today announced financial results for the first quarter ended March 31, 2017.","url":"http://finance.yahoo.com/news/ocular-therapeutix-reports-first-quarter-113000073.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix™ to Present Data on Anterior and Posterior Segment Drug Product Candidates at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting","publication_date":"2017-05-02 12:00:00 +0000","summary":"Ocular Therapeutix, Inc.  , a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye, today announced that 11 abstracts on drug product candidates incorporating its proprietary hydrogel platform technology will be presented at the Association for Research in Vision and Ophthalmology Annual Meeting, May ...","url":"http://finance.yahoo.com/news/ocular-therapeutix-present-data-anterior-120000963.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix™ to Report First Quarter 2017 Financial Results","publication_date":"2017-05-01 20:05:00 +0000","summary":"Ocular Therapeutix, Inc.  , a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will report first quarter 2017 financial results on Friday, May 5, 2017.","url":"http://finance.yahoo.com/news/ocular-therapeutix-report-first-quarter-200500765.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"ETFs with exposure to Ocular Therapeutix, Inc. : April 24, 2017","publication_date":"2017-04-24 18:39:04 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Ocular Therapeutix, Inc. Here are 5 ETFs with the largest exposure to OCUL-US. Comparing the performance and risk of Ocular Therapeutix, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/fdc5f8f0-b935-342c-8418-412c47902a6d/etfs-with-exposure-to-ocular-therapeutix-inc-april-24-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix™ to Present Additional Phase 3 Data and Patient Reported Outcomes Results for DEXTENZA™ at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium","publication_date":"2017-04-24 12:00:00 +0000","summary":"Ocular Therapeutix, Inc.  , a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye, today announced new data to be presented from its most recent Phase 3 study evaluating the efficacy and safety of DEXTENZA™ for intracanalicular use, for the treatment of ocular pain and inflammation following cataract ...","url":"http://finance.yahoo.com/news/ocular-therapeutix-present-additional-phase-120000627.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"ETFs with exposure to Ocular Therapeutix, Inc. : April 10, 2017","publication_date":"2017-04-10 17:52:00 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Ocular Therapeutix, Inc. Here are 5 ETFs with the largest exposure to OCUL-US. Comparing the performance and risk of Ocular Therapeutix, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/4b34ae62-f849-356d-ab91-ff7112fe5c21/etfs-with-exposure-to-ocular-therapeutix-inc-april-10-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix™ Appoints George Migausky as Interim Chief Financial Officer","publication_date":"2017-04-06 12:00:00 +0000","summary":"Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye, today announced the appointment of George Migausky as interim Chief Financial Officer.","url":"http://finance.yahoo.com/news/ocular-therapeutix-appoints-george-migausky-120000474.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"ETFs with exposure to Ocular Therapeutix, Inc. : March 27, 2017","publication_date":"2017-03-27 20:02:17 +0000","summary":"ETFs with exposure to Ocular Therapeutix, Inc. : March 27, 2017","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ocular-therapeutix-inc-march-27-2017/"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"ETFs with exposure to Ocular Therapeutix, Inc. : March 27, 2017","publication_date":"2017-03-27 20:02:17 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Ocular Therapeutix, Inc. Here are 5 ETFs with the largest exposure to OCUL-US. Comparing the performance and risk of Ocular Therapeutix, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/ed8389af-f001-37b2-8f5c-646afe0ea26f/etfs-with-exposure-to-ocular-therapeutix-inc-march-27-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"OCULAR THERAPEUTIX, INC Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2017-03-20 20:34:38 +0000","summary":"OCULAR THERAPEUTIX, INC Files SEC form 8-K, Change in Directors or Principal Officers","url":"http://biz.yahoo.com/e/170320/ocul8-k.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix, Inc. :OCUL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017","publication_date":"2017-03-20 15:54:33 +0000","summary":"Categories: Yahoo Finance Get free summary analysis Ocular Therapeutix, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Ocular Therapeutix, Inc. – Intersect ENT Inc and Anika Therapeutics, Inc. (XENT-US and ANIK-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 0.51 ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/63414876-b4f5-3c11-bf06-4bd840cec6c5/ocular-therapeutix-inc-ocul-us-earnings-analysis-q4-2016-by-the-numbers-march-20-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix, Inc. :OCUL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017","publication_date":"2017-03-20 15:54:33 +0000","summary":"Ocular Therapeutix, Inc. :OCUL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017","url":"http://www.capitalcube.com/blog/index.php/ocular-therapeutix-inc-ocul-us-earnings-analysis-q4-2016-by-the-numbers-march-20-2017/"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Positive Results Reported For Ocular Therapeutix Inc (OCUL) Dextenza Following Phase III Study","publication_date":"2017-03-17 18:00:42 +0000","summary":"Positive results for the Phase III study meant to test the experiences of patients using the eye insert known as Dextenza to relieve pain in a post-surgical situation have been recorded according to Ocular Therapeutix Inc (NASDAQ:OCUL), the manufacturer of the eye insert. As an insert that is placed non-invasively inside the eye, this drug that […]","url":"http://finance.yahoo.com/r/369cf42d-3329-323c-a582-3b7687ab2675/positive-results-reported-for-ocular-therapeutix-inc-ocul-dextenza-following-phase-iii-study-567226?yptr=yahoo&.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Positive Results Reported For Ocular Therapeutix Inc (OCUL) Dextenza Following Phase III Study","publication_date":"2017-03-17 18:00:42 +0000","summary":"Positive Results Reported For Ocular Therapeutix Inc (OCUL) Dextenza Following Phase III Study","url":"http://www.insidermonkey.com/blog/positive-results-reported-for-ocular-therapeutix-inc-ocul-dextenza-following-phase-iii-study-567226/"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Company Spotlight: Ocular Therapeutix","publication_date":"2017-03-17 06:13:00 +0000","summary":"Company Spotlight: Ocular Therapeutix","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nQVh6n_dOK4/company-spotlight-ocular-therapeutix-20170317-00165"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Gainers & Losers Of Mar.16: MCRB, PLSE, OCUL, PTCT, TROV...","publication_date":"2017-03-16 23:07:00 +0000","summary":"Gainers & Losers Of Mar.16: MCRB, PLSE, OCUL, PTCT, TROV...","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ovZg6avWJHo/gainers--losers-of-mar16-mcrb-plse-ocul-ptct-trov-20170316-01403"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Why Ocular Therapeutix Inc Saw its Share Price Jump Today","publication_date":"2017-03-16 22:06:44 +0000","summary":"What happened Ocular Therapeutix NASDAQ OCUL is up almost 12 at 3 21 p m EDT Thursday after the company reported positive patient experience for its eye insert Dextenza Wednesday morning That s on top of a 6 6 jump Wednesday So what The survey asked 25 patients","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wz0At57fJFI/why-ocular-therapeutix-inc-saw-its-share-price-jump-today-cm761928"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Why Ocular Therapeutix Inc Saw its Share Price Jump Today","publication_date":"2017-03-16 20:12:00 +0000","summary":"Why Ocular Therapeutix Inc Saw its Share Price Jump Today","url":"https://www.fool.com/investing/2017/03/16/why-ocular-therapeutix-inc-saw-its-share-price-jum.aspx"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Why Ocular Therapeutix Inc Saw its Share Price Jump Today","publication_date":"2017-03-16 20:12:00 +0000","summary":"Positive patient experience for the company's eye insert, Dextenza, sends shares higher.","url":"http://finance.yahoo.com/r/5bb4ceb2-5bb5-3827-a549-8001150c7082/why-ocular-therapeutix-inc-saw-its-share-price-jum.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"OCULAR THERAPEUTIX, INC Financials","publication_date":"2017-03-16 17:04:15 +0000","summary":"OCULAR THERAPEUTIX, INC Financials","url":"http://finance.yahoo.com/q/is?s=ocul"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular's Dextenza Reports Positive Study Results","publication_date":"2017-03-16 14:16:00 +0000","summary":"Ocular’s Dextenza fared well in a late-stage trial of post-surgical ocular pain management.","url":"http://finance.yahoo.com/r/fb5ef4f6-f964-32eb-81ec-3d2befa72c4d/oculars-dextenza-reports-positive-results-ocul-regn?partner=YahooSA&yptr=yahoo&.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular's Dextenza Reports Positive Study Results","publication_date":"2017-03-16 14:16:00 +0000","summary":"Ocular's Dextenza Reports Positive Study Results","url":"http://www.investopedia.com/news/oculars-dextenza-reports-positive-results-ocul-regn/?partner=YahooSA"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"After setback, Bedford eye care biotech has its sights set on FDA approval","publication_date":"2017-03-15 17:28:18 +0000","summary":"After setback, Bedford eye care biotech has its sights set on FDA approval","url":"http://www.bizjournals.com/boston/news/2017/03/15/after-setback-bedford-eyecare-biotech-has-its.html?ana=yahoo"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"After setback, Bedford eye care biotech has its sights set on FDA approval","publication_date":"2017-03-15 17:28:18 +0000","summary":"Less than a year after being rebuffed by the FDA, Bedford eye care biotech Ocular Therapeutix sees some light at the end of the tunnel for its lead drug. Ocular Therapeutix (OCUL) recently announced that regulators had set a target approval date of July 19 for Dextenza, a tiny insert that is placed in the eye and delivers a corticosteroid to treat pain following surgical procedures. As a result, Ocular Therapeutix believes that Dextenza marks a major improvement over traditional steroid eye drops, which must be administered several times a day.","url":"http://finance.yahoo.com/r/3bb98276-166d-3801-97b5-fa7ed582cb67/after-setback-bedford-eyecare-biotech-has-its.html?ana=yahoo&yptr=yahoo&.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"8:00 am Ocular Therapeutix announces 'positive' results of a patient experience study of DEXTENZA 0.4 mg for intracanalicular use","publication_date":"2017-03-15 12:00:00 +0000","summary":"8:00 am Ocular Therapeutix announces 'positive' results of a patient experience study of DEXTENZA 0.4 mg for intracanalicular use","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#ocul"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"New Publication Describes Positive Patient Experience in Study of Ocular Therapeutix’ DEXTENZA™ Following Cataract Surgery","publication_date":"2017-03-15 12:00:00 +0000","summary":"Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye, today announced positive results of a patient experience study of DEXTENZA™ 0.4 mg for intracanalicular use.","url":"http://finance.yahoo.com/news/publication-describes-positive-patient-experience-120000022.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"New Publication Describes Positive Patient Experience in Study of Ocular Therapeutix’ DEXTENZA™ Following Cataract Surgery","publication_date":"2017-03-15 12:00:00 +0000","summary":"[Business Wire] - Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye, today announced positive results of a patient experience study of DEXTENZA™ 0.4 mg for intracanalicular use.","url":"http://finance.yahoo.com/news/publication-describes-positive-patient-experience-120000022.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix, Inc. :OCUL-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017","publication_date":"2017-03-14 18:57:26 +0000","summary":"Ocular Therapeutix, Inc. :OCUL-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017","url":"http://www.capitalcube.com/blog/index.php/ocular-therapeutix-inc-ocul-us-earnings-analysis-2016-by-the-numbers-march-14-2017/"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix, Inc. :OCUL-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017","publication_date":"2017-03-14 18:57:26 +0000","summary":"Categories: Yahoo Finance Get free summary analysis Ocular Therapeutix, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Ocular Therapeutix, Inc. – Intersect ENT Inc and Anika Therapeutics, Inc. (XENT-US and ANIK-US) that have also reported for this period. Highlights Gross margins widened from 38.69% to ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/d3b15fc5-3697-3be6-8423-a3f4e16f878c/ocular-therapeutix-inc-ocul-us-earnings-analysis-2016-by-the-numbers-march-14-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Edited Transcript of OCUL earnings conference call or presentation 10-Mar-17 1:30pm GMT","publication_date":"2017-03-10 23:25:01 +0000","summary":"Edited Transcript of OCUL earnings conference call or presentation 10-Mar-17 1:30pm GMT","url":"http://finance.yahoo.com/news/edited-transcript-ocul-earnings-conference-232501843.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Edited Transcript of OCUL earnings conference call or presentation 10-Mar-17 1:30pm GMT","publication_date":"2017-03-10 23:25:01 +0000","summary":"Q4 2016 Ocular Therapeutix Inc Earnings Call","url":"http://finance.yahoo.com/news/edited-transcript-ocul-earnings-conference-232501843.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix Inc Earnings Call scheduled for 8:30 am ET today","publication_date":"2017-03-10 13:30:00 +0000","summary":"Ocular Therapeutix Inc Earnings Call scheduled for 8:30 am ET today","url":"http://biz.yahoo.com/cc/6/156066.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix reports 4Q loss","publication_date":"2017-03-10 12:58:38 +0000","summary":"On a per-share basis, the Bedford, Massachusetts-based company said it had a loss of 52 cents. Losses, adjusted for stock option expense, came to 45 cents per share. The biotechnology company posted revenue ...","url":"http://finance.yahoo.com/news/ocular-therapeutix-reports-4q-loss-125838125.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix reports 4Q loss","publication_date":"2017-03-10 12:58:38 +0000","summary":"Ocular Therapeutix reports 4Q loss","url":"http://sg.finance.yahoo.com/news/ocular-therapeutix-reports-4q-loss-125838717.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"OCULAR THERAPEUTIX, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E","publication_date":"2017-03-10 12:36:55 +0000","summary":"OCULAR THERAPEUTIX, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E","url":"http://biz.yahoo.com/e/170310/ocul8-k.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2016 Financial Results","publication_date":"2017-03-10 12:30:00 +0000","summary":"Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative drug products using its proprietary hydrogel platform technology for the treatment of diseases and conditions of the eye, today announced financial results for the fourth quarter of 2016 and the twelve months ended December 31, 2016.","url":"http://finance.yahoo.com/news/ocular-therapeutix-reports-fourth-quarter-123000593.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2016 Financial Results","publication_date":"2017-03-10 12:30:00 +0000","summary":"[Business Wire] - Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative drug products using its proprietary hydrogel platform technology for the treatment of diseases and conditions of the eye, today announced financial results for the fourth quarter of 2016 and the twelve months ended December 31, 2016.","url":"http://finance.yahoo.com/news/ocular-therapeutix-reports-fourth-quarter-123000593.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Q4 2016 Ocular Therapeutix Inc Earnings Release - Before Market Open","publication_date":"2017-03-10 12:07:05 +0000","summary":"Q4 2016 Ocular Therapeutix Inc Earnings Release - Before Market Open","url":"http://biz.yahoo.com/research/earncal/20170310.html?t=ocul"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Pre-Market Earnings Report for March 10, 2017 : MTN, PGEM, GCO, BKE, HIBB, TGLS, SRLP, CTRN, OCUL, KIRK, CNTY, VNRX","publication_date":"2017-03-09 21:13:15 +0000","summary":"The following companies are expected to report earnings prior to market open on 03 10 2017 Visit our Earnings Calendar for a full list of expected earnings releases Vail Resorts Inc MTN is reporting for the quarter ending January 31 2017 The","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NuG215VVAHE/pre-market-earnings-report-for-march-10-2017-mtn-pgem-gco-bke-hibb-tgls-srlp-ctrn-ocul-kirk-cnty-vnrx-cm758814"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix™ to Report Fourth Quarter and Full Year 2016 Financial Results","publication_date":"2017-03-08 14:00:00 +0000","summary":"[Business Wire] - Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2016, on Friday, March 10, 2017.","url":"http://finance.yahoo.com/news/ocular-therapeutix-report-fourth-quarter-140000748.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix™ to Report Fourth Quarter and Full Year 2016 Financial Results","publication_date":"2017-03-08 14:00:00 +0000","summary":"Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2016, on Friday, March 10, 2017.","url":"http://finance.yahoo.com/news/ocular-therapeutix-report-fourth-quarter-140000748.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Biotech Movers And Shakers: Ocular Therapeutix Inc (OCUL) And Argos Therapeutics Inc (ARGS)","publication_date":"2017-02-23 18:11:46 +0000","summary":"The biotechnology space has been a pretty volatile arena over the last few weeks, and especially when it comes to the smaller capitalization end of the sector. Companies have put out data both good and bad, and their respective market capitalizations have subsequently altered to reflect the wider market community’s interpretation of these reports. As […]","url":"http://finance.yahoo.com/r/1ede7fda-0b07-302a-8079-da7813c8137c/biotech-movers-and-shakers-ocular-therapeutix-inc-ocul-and-argos-therapeutics-inc-args-561892?yptr=yahoo&.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Biotech Movers And Shakers: Ocular Therapeutix Inc (OCUL) And Argos Therapeutics Inc (ARGS)","publication_date":"2017-02-23 18:11:46 +0000","summary":"Biotech Movers And Shakers: Ocular Therapeutix Inc (OCUL) And Argos Therapeutics Inc (ARGS)","url":"http://www.insidermonkey.com/blog/biotech-movers-and-shakers-ocular-therapeutix-inc-ocul-and-argos-therapeutics-inc-args-561892/"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Blog Coverage Ocular Therapeutix Announced FDA Acceptance of NDA Resubmission for its Product for the Treatment of Ocular Pain","publication_date":"2017-02-23 13:15:00 +0000","summary":"[Accesswire] - Upcoming AWS Coverage on Alnylam Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / February 23, 2017 / Active Wall St. blog coverage looks at the headline from Ocular Therapeutix, Inc. (NASDAQ: ...","url":"http://finance.yahoo.com/news/blog-coverage-ocular-therapeutix-announced-131500482.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Blog Coverage Ocular Therapeutix Announced FDA Acceptance of NDA Resubmission for its Product for the Treatment of Ocular Pain","publication_date":"2017-02-23 13:15:00 +0000","summary":"Upcoming AWS Coverage on Alnylam Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / February 23, 2017 / Active Wall St. blog coverage looks at the headline from Ocular Therapeutix, Inc. (NASDAQ: ...","url":"http://finance.yahoo.com/news/blog-coverage-ocular-therapeutix-announced-131500482.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"OCULAR THERAPEUTIX, INC Files SEC form 8-K, Other Events","publication_date":"2017-02-22 13:11:15 +0000","summary":"OCULAR THERAPEUTIX, INC Files SEC form 8-K, Other Events","url":"http://biz.yahoo.com/e/170222/ocul8-k.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix™ Announces FDA Acceptance of NDA Resubmission for DEXTENZA™ for the Treatment of Ocular Pain Occurring After Ophthalmic Surgery","publication_date":"2017-02-22 13:00:00 +0000","summary":"Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that the Company’s New Drug Application resubmission for DEXTENZA™ 0.4 mg for intracanalicular use, for the treatment of ocular pain occurring after ophthalmic surgery has been accepted as a filing for review by the U.S....","url":"http://finance.yahoo.com/news/ocular-therapeutix-announces-fda-acceptance-130000286.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix™ Announces FDA Acceptance of NDA Resubmission for DEXTENZA™ for the Treatment of Ocular Pain Occurring After Ophthalmic Surgery","publication_date":"2017-02-22 13:00:00 +0000","summary":"[Business Wire] - Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that the Company’s New Drug Application resubmission for DEXTENZA™ 0.4 mg for intracanalicular use, for the treatment of ocular pain occurring after ophthalmic surgery has been accepted as a filing for review by the U.S....","url":"http://finance.yahoo.com/news/ocular-therapeutix-announces-fda-acceptance-130000286.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Why Ocular Therapeutix Inc Jumped Higher Today","publication_date":"2017-02-10 23:18:13 +0000","summary":"What happened Ocular Therapeutix NASDAQ OCUL closed up 17 7 today after Cantor Fitzgerald initiated coverage on the biotech with an overweight rating and a price target of 35 Image source Getty Images So what Analyst Elemer Piros is excited about","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JlIEFjwyuZs/why-ocular-therapeutix-inc-jumped-higher-today-cm746591"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Why Ocular Therapeutix Inc Jumped Higher Today","publication_date":"2017-02-10 21:30:57 +0000","summary":"Why Ocular Therapeutix Inc Jumped Higher Today","url":"http://www.fool.com/investing/2017/02/10/why-ocular-therapeutix-inc-jumped-higher-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Why Ocular Therapeutix Inc Jumped Higher Today","publication_date":"2017-02-10 21:30:57 +0000","summary":"An analyst upgrade ahead of an FDA decision for its eye-pain medication sends shares higher.","url":"http://finance.yahoo.com/r/700949a3-a154-30f9-aae5-00379543dd1f/why-ocular-therapeutix-inc-jumped-higher-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2&yptr=yahoo&.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular TherapeutixTM to Present at Three Upcoming Investor Conferences","publication_date":"2017-02-09 21:05:00 +0000","summary":"Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye,","url":"http://finance.yahoo.com/news/ocular-therapeutixtm-present-three-upcoming-210500128.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular TherapeutixTM to Present at Three Upcoming Investor Conferences","publication_date":"2017-02-09 21:05:00 +0000","summary":"[Business Wire] - Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye,","url":"http://finance.yahoo.com/news/ocular-therapeutixtm-present-three-upcoming-210500128.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"SV Life Sciences Advisers, LLC Buys KalVista Pharmaceuticals, Sells Raptor Pharmaceutical","publication_date":"2017-02-08 09:17:03 +0000","summary":"SV Life Sciences Advisers LLC New Purchases KALV Reduced Positions OCUL Sold Out RPTP New Purchases KALV New Purchases KALV Reduced Positions OCUL Reduced Positions OCUL Sold Out RPTP Sold Out","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CFilzlAQTgo/sv-life-sciences-advisers-llc-buys-kalvista-pharmaceuticals-sells-raptor-pharmaceutical-cm744623"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"OCULAR THERAPEUTIX, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial State","publication_date":"2017-01-25 21:32:10 +0000","summary":"OCULAR THERAPEUTIX, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial State","url":"http://biz.yahoo.com/e/170125/ocul8-k.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"ETFs with exposure to Ocular Therapeutix, Inc. : January 25, 2017","publication_date":"2017-01-25 18:27:55 +0000","summary":"ETFs with exposure to Ocular Therapeutix, Inc. : January 25, 2017","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ocular-therapeutix-inc-january-25-2017/"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"ETFs with exposure to Ocular Therapeutix, Inc. : January 25, 2017","publication_date":"2017-01-25 18:27:55 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Ocular Therapeutix, Inc. Here are 5 ETFs with the largest exposure to OCUL-US. Comparing the performance and risk of Ocular Therapeutix, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/2b8fc615-50e7-3c81-b83c-74c7e2a50031/etfs-with-exposure-to-ocular-therapeutix-inc-january-25-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Gainers & Losers Of The Day: GNVC, NVIV, CLRB. AQB, BIOA...","publication_date":"2017-01-25 00:26:00 +0000","summary":"Gainers & Losers Of The Day: GNVC, NVIV, CLRB. AQB, BIOA...","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7IkfIqdddxg/gainers--losers-of-the-day-gnvc-nviv-clrb-aqb-bioa-20170125-00009"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Tuesday Sector Laggards: Drugs, Waste Management Stocks","publication_date":"2017-01-24 20:31:45 +0000","summary":"In trading on Tuesday drugs shares were relative laggards down on the day by about 0 6 Helping drag down the group were shares of Ocular Therapeutix OCUL off about 9 and shares of Novan NOVN off about 6 7 on the day Also lagging the market Tuesday are waste","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h7EIGTayCLQ/tuesday-sector-laggards-drugs-waste-management-stocks-cm737586"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutics Sinks Following Secondary Offering","publication_date":"2017-01-24 20:13:59 +0000","summary":"Ocular Therapeutics Sinks Following Secondary Offering","url":"http://finance.yahoo.com/news/ocular-therapeutics-sinks-following-secondary-201359317.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutics Sinks Following Secondary Offering","publication_date":"2017-01-24 20:13:59 +0000","summary":"Ocular Therapeutix, Inc. (NASDAQ: OCUL) saw its shares take a dive on Tuesday after the company announced the pricing of its secondary offering. The company is pricing its 3.57 million shares at $7 per ...","url":"http://finance.yahoo.com/news/ocular-therapeutics-sinks-following-secondary-201359317.html?.tsrc=rss"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Health Care Sector Update for 01/24/2017: OCUL,RMD,BIOA","publication_date":"2017-01-24 19:31:13 +0000","summary":"Top Health Care StocksTop Health Care Stocks JNJ 1 69 JNJ 1 69 PFE 1 14 PFE 1 14 MRK 0 17 MRK 0 17 ABT 1 04 ABT 1 04 AMGN 0 75 AMGN 0 75 Health care stocks were the lone industry sector in the S amp P 500 declining Tuesday with the NYSE Health Care Index dropping 0 7 while","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5dOQlQnl7w0/health-care-sector-update-for-01242017-oculrmdbioa-cm737557"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix, Inc. Announces Pricing of Public Offering of Common Stock","publication_date":"2017-01-24 13:00:00 +0000","summary":"[Business Wire] - Ocular Therapeutix, Inc. announced today the pricing of a registered underwritten public offering of 3,571,429 shares of its common stock at a public offering price of $7.00 per share pursuant to a shelf registration statement that was previously filed with and declared effective by the Securities and Exchange Commission .","url":"http://finance.yahoo.com/news/ocular-therapeutix-inc-announces-pricing-130000530.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix, Inc. Announces Public Offering of Common Stock","publication_date":"2017-01-23 21:01:00 +0000","summary":"[Business Wire] - Ocular Therapeutix, Inc. announced today that it has commenced a registered underwritten public offering of $25 million of shares of its common stock pursuant to a shelf registration statement that was previously filed with and declared effective by the Securities and Exchange Commission .","url":"http://finance.yahoo.com/news/ocular-therapeutix-inc-announces-public-210100203.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"OCULAR THERAPEUTIX, INC Files SEC form 8-K, Other Events","publication_date":"2017-01-23 13:26:20 +0000","summary":"OCULAR THERAPEUTIX, INC Files SEC form 8-K, Other Events","url":"http://biz.yahoo.com/e/170123/ocul8-k.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix™ Resubmits NDA for DEXTENZA™ for the Treatment of Ocular Pain Occurring After Ophthalmic Surgery","publication_date":"2017-01-23 13:15:00 +0000","summary":"[Business Wire] - Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it has resubmitted a New Drug Application to the U.S.","url":"http://finance.yahoo.com/news/ocular-therapeutix-resubmits-nda-dextenza-131500560.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"ETFs with exposure to Ocular Therapeutix, Inc. : January 9, 2017","publication_date":"2017-01-09 18:53:40 +0000","summary":"ETFs with exposure to Ocular Therapeutix, Inc. : January 9, 2017","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ocular-therapeutix-inc-january-9-2017/"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"6 Major FDA Decisions and Biopharma Catalysts Coming in January and February","publication_date":"2017-01-06 15:25:51 +0000","summary":"6 Major FDA Decisions and Biopharma Catalysts Coming in January and February","url":"http://finance.yahoo.com/news/6-major-fda-decisions-biopharma-152551867.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular (OCUL) Reports Positive Phase III Data on Eye Drug","publication_date":"2017-01-05 16:39:29 +0000","summary":"Shares of Ocular Therapeutix Inc OCUL were up 3 following the company s announcement of positive results from its third phase III trial on lead pipeline candidate 160 Dextenza 0 4 mg for the treatment of post surgical ocular inflammation and pain Notably Ocular has outperformed","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t_8-mg02eRk/ocular-ocul-reports-positive-phase-iii-data-on-eye-drug-cm729808"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular (OCUL) Reports Positive Phase III Data on Eye Drug","publication_date":"2017-01-05 14:40:02 +0000","summary":"Ocular (OCUL) Reports Positive Phase III Data on Eye Drug","url":"http://finance.yahoo.com/news/ocular-ocul-reports-positive-phase-144002716.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix Pulls Back Off Early Highs But Remains Positive","publication_date":"2017-01-04 14:00:00 +0000","summary":"Ocular Therapeutix Pulls Back Off Early Highs But Remains Positive","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pGnE-otwNkw/ocular-therapeutix-pulls-back-off-early-highs-but-remains-positive-20170104-00906"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix™ Announces Additional Successful Results for Phase 3 Clinical Trial of DEXTENZA™","publication_date":"2017-01-04 13:33:18 +0000","summary":"[at noodls] - Statistically significant secondary endpoint of absence of ocular flare confirms further evidence of reduction of inflammation BEDFORD, Mass.--(BUSINESS WIRE)--Jan. 4, 2017-- Ocular Therapeutix, Inc. (NASDAQ:OCUL), ...","url":"http://www.publicnow.com/view/5E7320396AAFAB4FD9C427DA54FC70FC418C9B4B"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix™ Announces Additional Successful Results for Phase 3 Clinical Trial of DEXTENZA™","publication_date":"2017-01-04 13:00:00 +0000","summary":"[Business Wire] - Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced additional positive secondary endpoint results from its most recent successful phase 3 clinical trial of DEXTENZA™ 0.4 mg, for the treatment of post-surgical ocular inflammation and pain.","url":"http://finance.yahoo.com/news/ocular-therapeutix-announces-additional-successful-130000823.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"ETFs with exposure to Ocular Therapeutix, Inc. : December 30, 2016","publication_date":"2016-12-30 16:18:54 +0000","summary":"ETFs with exposure to Ocular Therapeutix, Inc. : December 30, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ocular-therapeutix-inc-december-30-2016/"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"7 Key FDA Decisions and Catalysts Expected in January and February","publication_date":"2016-12-30 12:45:32 +0000","summary":"7 Key FDA Decisions and Catalysts Expected in January and February","url":"http://247wallst.com/healthcare-business/2016/12/30/7-key-fda-decisions-and-catalysts-expected-in-january-and-february/"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"How Ocular Therapeutix Inc (OCUL) Stacks Up Against Its Peers","publication_date":"2016-12-16 04:50:38 +0000","summary":"How Ocular Therapeutix Inc (OCUL) Stacks Up Against Its Peers","url":"http://www.insidermonkey.com/blog/how-ocular-therapeutix-inc-ocul-stacks-up-against-its-peers-510998/"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"OCULAR THERAPEUTIX, INC Files SEC form 8-K, Other Events","publication_date":"2016-12-14 21:38:32 +0000","summary":"OCULAR THERAPEUTIX, INC Files SEC form 8-K, Other Events","url":"http://biz.yahoo.com/e/161214/ocul8-k.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"ETFs with exposure to Ocular Therapeutix, Inc. : December 8, 2016","publication_date":"2016-12-08 17:53:17 +0000","summary":"ETFs with exposure to Ocular Therapeutix, Inc. : December 8, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ocular-therapeutix-inc-december-8-2016/"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"OCULAR THERAPEUTIX, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial State","publication_date":"2016-11-30 11:05:13 +0000","summary":"OCULAR THERAPEUTIX, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial State","url":"http://biz.yahoo.com/e/161130/ocul8-k.html"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"ETFs with exposure to Ocular Therapeutix, Inc. : November 28, 2016","publication_date":"2016-11-28 17:23:43 +0000","summary":"ETFs with exposure to Ocular Therapeutix, Inc. : November 28, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ocular-therapeutix-inc-november-28-2016/"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Stocks Pull Back Following Recent Upward Trend - U.S. Commentary","publication_date":"2016-11-28 16:22:00 +0000","summary":"Stocks Pull Back Following Recent Upward Trend - U.S. Commentary","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EKbjuwCY_Ug/stocks-pull-back-following-recent-upward-trend--us-commentary-20161128-00816"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Stocks Stuck In Negative Territory In Mid-Day Trading - U.S. Commentary","publication_date":"2016-11-28 11:57:00 +0000","summary":"Stocks Stuck In Negative Territory In Mid-Day Trading - U.S. Commentary","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IGuhb8uiXkk/stocks-stuck-in-negative-territory-in-midday-trading--us-commentary-20161128-00597"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix, Inc. :OCUL-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016","publication_date":"2016-11-23 15:15:32 +0000","summary":"Ocular Therapeutix, Inc. :OCUL-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016","url":"http://www.capitalcube.com/blog/index.php/ocular-therapeutix-inc-ocul-us-earnings-analysis-q3-2016-by-the-numbers-november-23-2016/"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"FDA Snubs DVAX, Keep An Eye On OCUL, It''s All Green For BLUE","publication_date":"2016-11-15 01:21:00 +0000","summary":"FDA Snubs DVAX, Keep An Eye On OCUL, It''s All Green For BLUE","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5kdvVrziyXY/fda-snubs-dvax-keep-an-eye-on-ocul-its-all-green-for-blue-20161115-00027"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"FDA Snubs DVAX, Keep An Eye On OCUL, It's All Green For BLUE","publication_date":"2016-11-15 01:21:00 +0000","summary":"FDA Snubs DVAX, Keep An Eye On OCUL, It's All Green For BLUE","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_6PcBqSY1LI/fda-snubs-dvax-keep-an-eye-on-ocul-its-all-green-for-blue-20161115-00028"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Notable Monday Option Activity: PBYI, OCUL, REGN","publication_date":"2016-11-14 22:28:59 +0000","summary":"Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Puma Biotechnology Inc Symbol PBYI where a total volume of 6 622 contracts has been traded thus far today a contract volume which is representative of approximately 662","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WUnVjKRfg6o/notable-monday-option-activity-pbyi-ocul-regn-cm709018"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix surges 14% on positive early clinical trial results","publication_date":"2016-11-14 13:27:34 +0000","summary":"Ocular Therapeutix surges 14% on positive early clinical trial results","url":"http://www.marketwatch.com/News/Story/Story.aspx?guid=E3840D42-0736-4155-8BAE-87B8CC0D9CB0&siteid=yhoof2"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Ocular Therapeutix™ Announces Successful Topline Results for Both Inflammation and Pain Primary Efficacy Endpoints from Phase 3 Clinical Trial of DEXTENZA™","publication_date":"2016-11-14 12:17:10 +0000","summary":"[at noodls] - Conference Call Today at 8:30 am Eastern Time BEDFORD, Mass.--(BUSINESS WIRE)--Nov. 14, 2016-- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization ...","url":"http://www.publicnow.com/view/7517A269454E2A126B06DF097D7898E40CC43172"},{"ticker":"OCUL","figi_ticker":"OCUL:US","figi":"BBG001J1BZV0","title":"Edited Transcript of OCUL earnings conference call or presentation 9-Nov-16 1:30pm GMT","publication_date":"2016-11-10 04:53:39 +0000","summary":"Edited Transcript of OCUL earnings conference call or presentation 9-Nov-16 1:30pm GMT","url":"http://finance.yahoo.com/news/edited-transcript-ocul-earnings-conference-045339894.html"}],"result_count":198,"page_size":100,"current_page":1,"total_pages":2,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"8.41"},{"x":"1494596100","y":"8.63"},{"x":"1494596400","y":"8.69"},{"x":"1494596700","y":"8.72"},{"x":"1494597000","y":"8.64"},{"x":"1494597300","y":"8.69"},{"x":"1494597600","y":"8.64"},{"x":"1494597900","y":"8.6"},{"x":"1494598200","y":"8.56"},{"x":"1494598500","y":"8.62"},{"x":"1494598800","y":"8.69"},{"x":"1494599100","y":"8.7019"},{"x":"1494599400","y":"8.6499"},{"x":"1494599700","y":"8.74"},{"x":"1494600000","y":"8.77"},{"x":"1494600300","y":"8.78"},{"x":"1494600600","y":"8.78"},{"x":"1494600900","y":"8.8"},{"x":"1494601200","y":"8.8799"},{"x":"1494601500","y":"8.94"},{"x":"1494601800","y":"8.9828"},{"x":"1494602100","y":"8.9101"},{"x":"1494602400","y":"8.97"},{"x":"1494602700","y":"9.025"},{"x":"1494603000","y":"9.0303"},{"x":"1494603300","y":"9.07"},{"x":"1494603600","y":"9.19"},{"x":"1494603900","y":"9.14"},{"x":"1494604200","y":"9.1762"},{"x":"1494604500","y":"9.234"},{"x":"1494604800","y":"9.188"},{"x":"1494605100","y":"9.19"},{"x":"1494605400","y":"9.1639"},{"x":"1494605700","y":"9.17"},{"x":"1494606000","y":"9.1"},{"x":"1494606300","y":"9.15"},{"x":"1494606600","y":"9.12"},{"x":"1494606900","y":"9.1201"},{"x":"1494607200","y":"9.15"},{"x":"1494607500","y":"9.1776"},{"x":"1494607800","y":"9.22"},{"x":"1494608100","y":"9.24"},{"x":"1494608400","y":"9.25"},{"x":"1494608700","y":"9.26"},{"x":"1494609000","y":"9.35"},{"x":"1494609300","y":"9.36"},{"x":"1494609600","y":"9.37"},{"x":"1494609900","y":"9.35"},{"x":"1494610200","y":"9.31"},{"x":"1494610500","y":"9.3399"},{"x":"1494610800","y":"9.34"},{"x":"1494611100","y":"9.43"},{"x":"1494611400","y":"9.4499"},{"x":"1494611700","y":"9.4332"},{"x":"1494612000","y":"9.4905"},{"x":"1494612300","y":"9.56"},{"x":"1494612600","y":"9.65"},{"x":"1494612900","y":"9.73"},{"x":"1494613200","y":"9.76"},{"x":"1494613500","y":"9.7939"},{"x":"1494613800","y":"9.7878"},{"x":"1494614100","y":"9.68"},{"x":"1494614400","y":"9.46"},{"x":"1494614700","y":"9.3808"},{"x":"1494615000","y":"9.54"},{"x":"1494615300","y":"9.53"},{"x":"1494615600","y":"9.54"},{"x":"1494615900","y":"9.45"},{"x":"1494616200","y":"9.49"},{"x":"1494616500","y":"9.48"},{"x":"1494616800","y":"9.56"},{"x":"1494617100","y":"9.5343"},{"x":"1494617400","y":"9.57"},{"x":"1494617700","y":"9.59"},{"x":"1494618000","y":"9.71"},{"x":"1494618300","y":"9.6301"},{"x":"1494618600","y":"9.61"},{"x":"1494618900","y":"9.62"},{"x":"1494619200","y":"9.64"} ], "color":"#03a9f4"}]},
{"id":"17","symbol": "RNN","name": "Rexahn Pharmaceuticals Inc","price": 4.23,"dollarChange": 0.27,"percentChange": 6.55,"open": 4.11,"high": 4.74,"low":4.01,"volume": 2265691,"avgVol": 718452.400000,"sharesShort": 1195343,"shortPercent": 4.706075,"marketCap": 102172058,"float": 25400000,"headlines":{"data":[{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Today's Research Reports on Stocks to Watch: Rexahn Pharmaceuticals and Depomed","publication_date":"2017-05-12 12:00:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / May 12, 2017 / Disappointing earnings from the consumer discretionary sector pressured markets lower Thursday. The Dow Jones Industrial Average hit an intraday low of 20,798.90 ...","url":"http://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000393.html?.tsrc=rss"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Gainers & Losers Of May 11: SGMO, RNN, XON, MNKD, NVCN...","publication_date":"2017-05-11 22:07:00 +0000","summary":"Gainers & Losers Of May 11: SGMO, RNN, XON, MNKD, NVCN...","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cjuSLLaUCqo/gainers--losers-of-may-11-sgmo-rnn-xon-mnkd-nvcn-20170511-01774"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Gainers & Losers Of May 9: VRX, ENDP, PTLA, SCYX, NXTM...","publication_date":"2017-05-09 20:55:00 +0000","summary":"Gainers & Losers Of May 9: VRX, ENDP, PTLA, SCYX, NXTM...","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/heAx42q9Jds/gainers--losers-of-may-9-vrx-endp-ptla-scyx-nxtm-20170509-02070"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals to Present RX-3117 Clinical Data at the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting","publication_date":"2017-05-08 13:00:00 +0000","summary":"ROCKVILLE, Md., May 08, 2017-- Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today announced that it ...","url":"http://finance.yahoo.com/news/rexahn-pharmaceuticals-present-rx-3117-130000320.html?.tsrc=rss"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Effects 1-for-10 Reverse Stock Split","publication_date":"2017-05-05 13:00:00 +0000","summary":"ROCKVILLE, Md., May 05, 2017-- Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today announced that the ...","url":"http://finance.yahoo.com/news/rexahn-effects-1-10-reverse-130000070.html?.tsrc=rss"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"InPlay from Briefing.com","publication_date":"2017-05-04 13:58:00 +0000","summary":"InPlay from Briefing.com","url":"http://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn reports 1Q loss","publication_date":"2017-05-04 13:44:47 +0000","summary":"The Rockville, Maryland-based company said it had a loss of 9 cents per share. Losses, adjusted for non-recurring costs, were 2 cents per share. The company's shares closed at 40 cents. A year ago, they ...","url":"http://finance.yahoo.com/news/rexahn-reports-1q-loss-134447571.html?.tsrc=rss"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update","publication_date":"2017-05-04 13:00:00 +0000","summary":"Completed Phase I dose-escalation study with Supinoxin™ in solid tumors. Initiated Phase IIa clinical trial of Supinoxin in Metastatic Triple Negative Breast Cancer. ROCKVILLE, Md., May 04, 2017-- Rexahn ...","url":"http://finance.yahoo.com/news/rexahn-pharmaceuticals-reports-first-quarter-130000826.html?.tsrc=rss"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"FDA Says No To INCY, ZTS Snaps Up NVET, MDXG On The Move","publication_date":"2017-04-17 00:24:00 +0000","summary":"FDA Says No To INCY, ZTS Snaps Up NVET, MDXG On The Move","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o5ZlrIoIdS8/fda-says-no-to-incy-zts-snaps-up-nvet-mdxg-on-the-move-20170417-00004"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Announces 1-for-10 Reverse Stock Split","publication_date":"2017-04-13 13:00:00 +0000","summary":"ROCKVILLE, Md., April 13, 2017-- Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today announced that ...","url":"http://finance.yahoo.com/news/rexahn-announces-1-10-reverse-130000134.html?.tsrc=rss"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Penny Stocks to Watch for April 2017 (ATRS, WRN)","publication_date":"2017-03-31 16:00:00 +0000","summary":"These ten penny stocks trading on U.S. public exchanges could gain substantial ground in April 2017 and the coming months.","url":"http://finance.yahoo.com/r/48658ee0-5635-381c-9098-24e60c13d00f/top-penny-stocks?partner=YahooSA&yptr=yahoo&.tsrc=rss"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Penny Stocks to Watch for April 2017 (ATRS, WRN)","publication_date":"2017-03-31 16:00:00 +0000","summary":"Penny Stocks to Watch for April 2017 (ATRS, WRN)","url":"http://www.investopedia.com/updates/top-penny-stocks/?partner=YahooSA"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"BioDelivery Sciences International and Rexahn Pharmaceuticals See Share Values Rise Slightly","publication_date":"2017-03-28 13:30:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 28, 2017 / These two stocks posted gains on Monday as they are likely to reduce losses going ahead. Both companies also moved forward with the FDA trials as their lead ...","url":"http://finance.yahoo.com/news/biodelivery-sciences-international-rexahn-pharmaceuticals-133000420.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"BioDelivery Sciences International and Rexahn Pharmaceuticals See Share Values Rise Slightly","publication_date":"2017-03-28 13:30:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / March 28, 2017 / These two stocks posted gains on Monday as they are likely to reduce losses going ahead. Both companies also moved forward with the FDA trials as their lead ...","url":"http://finance.yahoo.com/news/biodelivery-sciences-international-rexahn-pharmaceuticals-133000420.html?.tsrc=rss"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals (RNN) Jumps: Stock Moves Up 5.4%","publication_date":"2017-03-16 15:10:46 +0000","summary":"Rexahn Pharmaceuticals Inc RNN was a big mover last session as its shares rose above 5 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now up above 102 in the","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dFavl9b_d7w/rexahn-pharmaceuticals-rnn-jumps-stock-moves-up-54-cm761614"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Trade Volume Can Speak a Lot About Momentum of a Stock","publication_date":"2017-03-16 13:30:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / March 16, 2017 / Two biotech firms, Rexahn Pharmaceuticals and Novavax are low priced stocks with a number of interested investors, scoring close to 8 million and 6 million ...","url":"http://finance.yahoo.com/news/trade-volume-speak-lot-momentum-133000067.html?.tsrc=rss"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Trade Volume Can Speak a Lot About Momentum of a Stock","publication_date":"2017-03-16 13:30:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 16, 2017 / Two biotech firms, Rexahn Pharmaceuticals and Novavax are low priced stocks with a number of interested investors, scoring close to 8 million and 6 million ...","url":"http://finance.yahoo.com/news/trade-volume-speak-lot-momentum-133000067.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals (RNN) Jumps: Stock Moves Up 5.4%","publication_date":"2017-03-16 12:35:12 +0000","summary":"Rexahn Pharmaceuticals (RNN) Jumps: Stock Moves Up 5.4%","url":"http://finance.yahoo.com/news/rexahn-pharmaceuticals-rnn-jumps-stock-123512395.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals (RNN) Jumps: Stock Moves Up 5.4%","publication_date":"2017-03-16 12:35:12 +0000","summary":"Rexahn Pharmaceuticals, Inc. (RNN) moved big last session, as its shares rose above 5% on the day.","url":"http://finance.yahoo.com/news/rexahn-pharmaceuticals-rnn-jumps-stock-123512395.html?.tsrc=rss"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"REXAHN PHARMACEUTICALS, INC. Financials","publication_date":"2017-03-02 18:04:18 +0000","summary":"REXAHN PHARMACEUTICALS, INC. Financials","url":"http://finance.yahoo.com/q/is?s=rnn"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Reports Full Year 2016 Financial Results and Provides Corporate Update","publication_date":"2017-02-27 14:00:00 +0000","summary":"[GlobeNewswire] - Progressed Three Novel Targeted Anti-Cancer Therapies in Clinical Development. Completed stage 1 and initiated stage 2 of Phase IIa clinical trial of RX-3117 in Relapsed and Refractory Metastatic Pancreatic ...","url":"http://finance.yahoo.com/news/rexahn-pharmaceuticals-reports-full-2016-140000060.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Reports Full Year 2016 Financial Results and Provides Corporate Update","publication_date":"2017-02-27 14:00:00 +0000","summary":"Progressed Three Novel Targeted Anti-Cancer Therapies in Clinical Development. Completed stage 1 and initiated stage 2 of Phase IIa clinical trial of RX-3117 in Relapsed and Refractory Metastatic Pancreatic ...","url":"http://finance.yahoo.com/news/rexahn-pharmaceuticals-reports-full-2016-140000060.html?.tsrc=rss"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"REXAHN PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report","publication_date":"2017-02-24 21:19:17 +0000","summary":"REXAHN PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report","url":"http://biz.yahoo.com/e/170224/rnn10-k.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Doses First Patient in a Phase IIa Trial of Supinoxin™ in Patients with Metastatic Triple Negative Breast Cancer","publication_date":"2017-02-23 14:00:00 +0000","summary":"ROCKVILLE, Md., Feb. 23, 2017-- Rexahn Pharmaceuticals, Inc., today announced that is has begun enrolling patients into a Phase IIa clinical study of Supinoxin™ in metastatic triple negative breast cancer. ...","url":"http://finance.yahoo.com/news/rexahn-pharmaceuticals-doses-first-patient-140000123.html?.tsrc=rss"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Doses First Patient in a Phase IIa Trial of Supinoxin™ in Patients with Metastatic Triple Negative Breast Cancer","publication_date":"2017-02-23 14:00:00 +0000","summary":"[GlobeNewswire] - ROCKVILLE, Md., Feb. 23, 2017-- Rexahn Pharmaceuticals, Inc., today announced that is has begun enrolling patients into a Phase IIa clinical study of Supinoxin™ in metastatic triple negative breast cancer. ...","url":"http://finance.yahoo.com/news/rexahn-pharmaceuticals-doses-first-patient-140000123.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals to Present at the 2nd Annual Disruptive Growth & Healthcare Conference","publication_date":"2017-02-06 14:00:00 +0000","summary":"ROCKVILLE, MD / ACCESSWIRE / February 6, 2017 / Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, ...","url":"http://finance.yahoo.com/news/rexahn-pharmaceuticals-present-2nd-annual-140000041.html?.tsrc=rss"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals to Present at the 2nd Annual Disruptive Growth & Healthcare Conference","publication_date":"2017-02-06 14:00:00 +0000","summary":"[Accesswire] - ROCKVILLE, MD / ACCESSWIRE / February 6, 2017 / Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, ...","url":"http://finance.yahoo.com/news/rexahn-pharmaceuticals-present-2nd-annual-140000041.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"9:01 am Rexahn Pharmaceuticals updates on Phase IIa trial of RX-3117 in metastatic pancreatic cancer at ASCO Gastrointestinal Cancers Symposium","publication_date":"2017-01-22 14:01:00 +0000","summary":"9:01 am Rexahn Pharmaceuticals updates on Phase IIa trial of RX-3117 in metastatic pancreatic cancer at ASCO Gastrointestinal Cancers Symposium","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#rnn"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Presents an Update of the Ongoing Phase IIa Clinical Trial of RX-3117 in Metastatic Pancreatic Cancer at the American Society of Clinical Oncology (ASCO) 2017 Gastrointestinal Cancers Symposium","publication_date":"2017-01-20 14:00:00 +0000","summary":"ROCKVILLE, Md., Jan. 20, 2017-- Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing next generation targeted therapeutics for the treatment of cancer, today announced an ...","url":"http://finance.yahoo.com/news/rexahn-pharmaceuticals-presents-ongoing-phase-140000692.html?.tsrc=rss"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Presents an Update of the Ongoing Phase IIa Clinical Trial of RX-3117 in Metastatic Pancreatic Cancer at the American Society of Clinical Oncology (ASCO) 2017 Gastrointestinal Cancers Symposium","publication_date":"2017-01-20 14:00:00 +0000","summary":"[GlobeNewswire] - ROCKVILLE, Md., Jan. 20, 2017-- Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing next generation targeted therapeutics for the treatment of cancer, today announced an ...","url":"http://finance.yahoo.com/news/rexahn-pharmaceuticals-presents-ongoing-phase-140000692.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals to Present at Biotech Showcase™ 2017","publication_date":"2017-01-03 14:23:05 +0000","summary":"[at noodls] - January 3, 2017 ROCKVILLE, Md., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the ...","url":"http://www.publicnow.com/view/9BF64CA0DB992E26667EC1BA3175C97165B568EC"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals to Present at Biotech Showcase™ 2017","publication_date":"2017-01-03 14:00:00 +0000","summary":"[GlobeNewswire] - ROCKVILLE, Md., Jan. 03, 2017-- Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, announced today that Peter ...","url":"http://finance.yahoo.com/news/rexahn-pharmaceuticals-present-biotech-showcase-140000733.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Shareholder Director Nominations","publication_date":"2016-11-25 21:04:05 +0000","summary":"REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Shareholder Director Nominations","url":"http://biz.yahoo.com/e/161125/rnn8-k.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update","publication_date":"2016-11-07 14:14:08 +0000","summary":"[at noodls] - November 7, 2016 Preliminary Efficacy Data from Phase Ib/IIa Clinical Trial of RX-3117 in Metastatic Pancreatic Cancer presented at European Society for Medical Oncology (ESMO) Congress Initiates Stage ...","url":"http://www.publicnow.com/view/87DBBB644CB7034D0FE101378E2532F8644E6827"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn reports 3Q loss","publication_date":"2016-11-07 14:11:27 +0000","summary":"Rexahn reports 3Q loss","url":"http://sg.finance.yahoo.com/news/rexahn-reports-3q-loss-141127710.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"REXAHN PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report","publication_date":"2016-11-04 20:18:21 +0000","summary":"REXAHN PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report","url":"http://biz.yahoo.com/e/161104/rnn10-q.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Receives a Notice of Allowance from the U.S. Patent and Trademark Office for a Patent Covering the Manufacturing of RX-3117 — A Cancer Cell Specific Anticancer Agent","publication_date":"2016-10-31 13:23:05 +0000","summary":"[at noodls] - October 31, 2016 Rexahn Pharmaceuticals Receives a Notice of Allowance from the U.S. Patent and Trademark Office for a Patent Covering the Manufacturing of RX-3117 - A Cancer Cell Specific Anticancer Agent ...","url":"http://www.publicnow.com/view/21DB485C8DE81695C94398A793448FC27849A9E0"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Receives a Notice of Allowance from the U.S. Patent and Trademark Office for a Patent Covering the Manufacturing of RX-3117 – A Cancer Cell Specific Anticancer Agent","publication_date":"2016-10-31 13:00:00 +0000","summary":"[GlobeNewswire] - ROCKVILLE, Md., Oct. 31, 2016-- Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that it has received ...","url":"http://finance.yahoo.com/news/rexahn-pharmaceuticals-receives-notice-allowance-130000196.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Receives U.S. Patent for RX-21101: A Novel Nano-Polymer Conjugate of Docetaxel for the Targeted Treatment of Solid Tumors","publication_date":"2016-10-26 13:25:06 +0000","summary":"[at noodls] - October 26, 2016 Rexahn's proprietary nanotechnology drug conjugate platforms optimize chemotherapy effectiveness and reduce side effect liability ROCKVILLE, Md., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Rexahn ...","url":"http://www.publicnow.com/view/DFA24D7DBB7C3A151637C68FE27F763B6AB3497D"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Nears 52-Week Low (RNN)","publication_date":"2016-10-12 01:14:00 +0000","summary":"Rexahn Pharmaceuticals Nears 52-Week Low (RNN)","url":"http://www.investopedia.com/news/rexahn-pharmaceuticals-nears-52week-low-rnn/?partner=YahooSA"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Nears 52-Week Low (RNN)","publication_date":"2016-10-12 01:14:00 +0000","summary":"Rexahn Pharmaceuticals has seen its shares fall sharply over the last month. Can its latest trial data offer optimism for a rally?","url":"http://finance.yahoo.com/r/2ae86be0-00eb-33bd-bfc2-da2115279f81/rexahn-pharmaceuticals-nears-52week-low-rnn?partner=YahooSA&yptr=yahoo&.tsrc=rss"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Presents Preliminary Efficacy Data from Phase Ib/IIa Trial of RX-3117 in Metastatic Pancreatic Cancer and Supinoxin™ Phase I Trial at 2016 European Society for Medical Oncology (ESMO) Congress","publication_date":"2016-10-10 11:00:00 +0000","summary":"[GlobeNewswire] - RX-3117 showed Preliminary Efficacy in Pancreatic Cancer Patients for Whom Three or More Prior Therapies had been Ineffective. Supinoxin™ was Safe and Well Tolerated in Patients with Advanced and Metastatic ...","url":"http://finance.yahoo.com/news/rexahn-pharmaceuticals-presents-preliminary-efficacy-110000865.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals to Present Trial Data (RNN)","publication_date":"2016-10-06 18:19:00 +0000","summary":"Pancreatic cancer is one of the most aggressive diseases in the world. Rexahn Pharmaceuticals offers insight on its latest trials to treat this disease.","url":"http://finance.yahoo.com/r/d2ab5e31-5699-3af5-87d5-7fe4d0e4d8f1/rexahn-pharmaceuticals-present-trial-data-rnn?partner=YahooSA&yptr=yahoo&.tsrc=rss"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals to Present Trial Data (RNN)","publication_date":"2016-10-06 18:19:00 +0000","summary":"Rexahn Pharmaceuticals to Present Trial Data (RNN)","url":"http://www.investopedia.com/news/rexahn-pharmaceuticals-present-trial-data-rnn/?partner=YahooSA"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Key FDA Decisions and Trial Results Expected in October","publication_date":"2016-10-04 13:15:55 +0000","summary":"Key FDA Decisions and Trial Results Expected in October","url":"http://247wallst.com/healthcare-business/2016/10/04/key-fda-decisions-and-trial-results-expected-in-october-2/"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Key FDA Decisions and Trial Results Expected in October","publication_date":"2016-10-04 13:15:55 +0000","summary":"24/7 Wall St. has collected several big FDA decisions and mid-stage to late-stage trials that should be announced in October.","url":"http://finance.yahoo.com/r/f7aa07db-9c9b-3a9e-a10a-e62840a15920/key-fda-decisions-and-trial-results-expected-in-october-2?yptr=yahoo&.tsrc=rss"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Presents Preliminary Efficacy Data from Phase Ib/IIa Trial of RX-3117 in Metastatic Pancreatic Cancer and Supinoxin™ Phase I Trial at 2016 European Society for Medical Oncology (ESMO) Congress","publication_date":"2016-10-04 13:00:00 +0000","summary":"[GlobeNewswire] - ROCKVILLE, Md., Oct. 04, 2016-- Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing next generation targeted therapeutics for the treatment of cancer, today announced it ...","url":"http://finance.yahoo.com/news/rexahn-pharmaceuticals-presents-preliminary-efficacy-130000519.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals (RNN) Sees Hammer Chart Pattern: Time to Buy?","publication_date":"2016-09-26 16:23:00 +0000","summary":"Rexahn Pharmaceuticals Inc RNN has been struggling lately but the selling pressure may be coming to an end soon That is because RNN recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom What is a Hammer Chart Pattern A hammer chart pattern is","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tmpmuBLKr_M/rexahn-pharmaceuticals-rnn-sees-hammer-chart-pattern-time-to-buy-cm684526"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals (RNN) Sees Hammer Chart Pattern: Time to Buy?","publication_date":"2016-09-26 14:34:02 +0000","summary":"Rexahn Pharmaceuticals, Inc. (RNN) has been struggling lately, but the selling pressure may be coming to an end soon","url":"http://finance.yahoo.com/news/rexahn-pharmaceuticals-rnn-sees-hammer-143402597.html?.tsrc=rss"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals (RNN) Sees Hammer Chart Pattern: Time to Buy?","publication_date":"2016-09-26 14:34:02 +0000","summary":"Rexahn Pharmaceuticals (RNN) Sees Hammer Chart Pattern: Time to Buy?","url":"http://finance.yahoo.com/news/rexahn-pharmaceuticals-rnn-sees-hammer-143402597.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2016-09-20 20:59:50 +0000","summary":"REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/160920/rnn8-k.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Announces $6 Million Registered Direct Offering","publication_date":"2016-09-14 13:28:05 +0000","summary":"[at noodls] - September 14, 2016 ROCKVILLE, Md., Sept. 14, 2016 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN) today announced it has entered into a definitive agreement with institutional investors ...","url":"http://www.publicnow.com/view/C331A16B3D794DC3F6C4BE7005D6A03BEA895410"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equ","publication_date":"2016-09-14 13:08:53 +0000","summary":"REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equ","url":"http://biz.yahoo.com/e/160914/rnn8-k.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"RPRX On Track Across The Pond, CERC Gets Funded, Data Gives FOMX A Facelift","publication_date":"2016-09-13 03:19:00 +0000","summary":"RPRX On Track Across The Pond, CERC Gets Funded, Data Gives FOMX A Facelift","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9erYE7-344M/rprx-on-track-across-the-pond-cerc-gets-funded-data-gives-fomx-a-facelift-20160913-00097"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"RPRX On Track Across The Pond, CERC Gets Funded, Data Gives FOMX A Facelift","publication_date":"2016-09-13 03:19:00 +0000","summary":"RPRX On Track Across The Pond, CERC Gets Funded, Data Gives FOMX A Facelift","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-EPzd1eDAnQ/rprx-on-track-across-the-pond-cerc-gets-funded-data-gives-fomx-a-facelift-20160913-00098"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Initiates stage 2 of Phase Ib/IIa Clinical Trial of RX-3117 in Relapsed or Refractory Metastatic Pancreatic Cancer","publication_date":"2016-09-12 13:18:09 +0000","summary":"[at noodls] - September 12, 2016 Predefined Criteria for Preliminary Efficacy Achieved in Pancreatic Cancer Patients for Whom Three Prior Therapies had been Ineffective RX-3117 was Safe and Well Tolerated Results Have ...","url":"http://www.publicnow.com/view/9F74E4EAD1E39565D8F8BFA60B7E3A880EC73D5B"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","publication_date":"2016-09-12 13:09:11 +0000","summary":"REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/160912/rnn8-k.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals to Present at 18th Annual Rodman & Renshaw Global Investment Conference on September 12, 2016","publication_date":"2016-09-07 13:00:00 +0000","summary":"[GlobeNewswire] - ROCKVILLE, Md., Sept. 07, 2016-- Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that Peter Suzdak, ...","url":"http://finance.yahoo.com/news/rexahn-pharmaceuticals-present-18th-annual-130000828.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn reports 2Q loss","publication_date":"2016-08-08 13:15:28 +0000","summary":"Rexahn reports 2Q loss","url":"http://sg.finance.yahoo.com/news/rexahn-reports-2q-loss-131528293.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Reports Second Quarter 2016 Financial and Operational Results","publication_date":"2016-08-08 13:08:03 +0000","summary":"[at noodls] - ROCKVILLE, Md., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, ...","url":"http://www.publicnow.com/view/FB34F901C317ACE64A99AE7BEFE403FD8262E29A"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"REXAHN PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report","publication_date":"2016-08-05 20:11:41 +0000","summary":"REXAHN PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report","url":"http://biz.yahoo.com/e/160805/rnn10-q.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Strengthens Leadership Team","publication_date":"2016-07-11 13:23:04 +0000","summary":"[at noodls] - ROCKVILLE, Md., July 11, 2016 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, ...","url":"http://www.publicnow.com/view/3DE3259AC018892FD86571365FE69D47EB20537C"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","publication_date":"2016-07-11 13:09:45 +0000","summary":"REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/160711/rnn8-k.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals, Inc. :RNN-US: Earnings Analysis: Q1, 2016 By the Numbers : June 10, 2016","publication_date":"2016-06-10 21:04:30 +0000","summary":"Rexahn Pharmaceuticals, Inc. :RNN-US: Earnings Analysis: Q1, 2016 By the Numbers : June 10, 2016","url":"http://www.capitalcube.com/blog/index.php/rexahn-pharmaceuticals-inc-rnn-us-earnings-analysis-q1-2016-by-the-numbers-june-10-2016/"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to","publication_date":"2016-06-10 20:02:29 +0000","summary":"REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to","url":"http://biz.yahoo.com/e/160610/rnn8-k.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Presents Clinical Data for Three Novel Targeted Oncology Programs at the 2016 American Society of Clinical Oncology Annual Meeting","publication_date":"2016-06-06 13:18:04 +0000","summary":"[at noodls] - ROCKVILLE, Md., June 06, 2016 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, ...","url":"http://www.publicnow.com/view/B51B78D1169B8F3AD0A58353C54E3E2752389CB3"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals to Present at the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting","publication_date":"2016-05-23 13:56:07 +0000","summary":"[at noodls] - ROCKVILLE, Md., May 23, 2016 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, ...","url":"http://www.publicnow.com/view/D6810568694BAD125D8E1392A90B4E3E3653A185"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Drugs Deal a Death Blow to Solid Tumor Cancer","publication_date":"2016-05-19 13:20:00 +0000","summary":"Rexahn Drugs Deal a Death Blow to Solid Tumor Cancer","url":"http://news.investornetwork.com/2016/05/19/rexahn-drugs-deal-a-death-blow-to-solid-tumor-cancer/?1=1&1463664000"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn reports 1Q loss","publication_date":"2016-05-09 13:15:44 +0000","summary":"Rexahn reports 1Q loss","url":"http://sg.finance.yahoo.com/news/rexahn-reports-1q-loss-131544960.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Corporate Update","publication_date":"2016-05-09 13:08:06 +0000","summary":"[at noodls] - Progresses Novel Targeted Anti-Cancer Therapies in Clinical Development Initiates Phase Ib/IIa Clinical Trial of RX-3117 and Begins Enrollment in Phase IIa Randomized Clinical Trial of Archexin ROCKVILLE, ...","url":"http://www.publicnow.com/view/4C9EA5897AE62052F55C6A0A40CC3903C75F20DB"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"ROTH Capital Partners' Joseph Pantginis Interviewed by The Life Sciences Report","publication_date":"2016-04-28 13:00:00 +0000","summary":"[Marketwired] - ROTH Capital Partners' Joseph Pantginis falls into that old-fashioned category of analysts who believe that good data can't help but drive a stock, no matter how far into the depths it may have sunk. In ...","url":"http://finance.yahoo.com/news/roth-capital-partners-joseph-pantginis-130000862.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Presents Clinical Trial Results for Archexin® at the 2016 American Association for Cancer Research Annual Meeting","publication_date":"2016-04-20 13:11:10 +0000","summary":"[at noodls] - Data Featured at Late Breaking and Clinical Trials Session Suggest Potential Dose and Time Dependent Clinical Benefit of Archexinin Combination with Everolimus Additional Poster Presentations on RX-3117 ...","url":"http://www.publicnow.com/view/41A1396345D9CCD67E3F8DB2BA5B8B77B221FC06"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals to Present at the 2016 American Association for Cancer Research Annual Meeting","publication_date":"2016-04-13 15:07:30 +0000","summary":"[at noodls] - ROCKVILLE, Md., April 13, 2016 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, ...","url":"http://www.publicnow.com/view/7B3CBBBB8717D89A652B3B32B42A810D0BAB650F"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Announces Initiation of Phase Ib/IIa Clinical Trial of Its Novel Oral Anti-Cancer Therapeutic RX-3117 in the Treatment of Pancreatic and Bladder Cancer","publication_date":"2016-03-29 13:19:59 +0000","summary":"[at noodls] - ROCKVILLE, Md., March 29, 2016 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation targeted therapeutics for the treatment ...","url":"http://www.publicnow.com/view/8DC9D80F25FE09D357A4175BBE76A9C1BD97DC7E"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Presents Additional Data for Supinoxin for the Treatment of Triple Negative Breast Cancer at the 2016 Targeted Anticancer Therapeutics Congress","publication_date":"2016-03-24 13:10:22 +0000","summary":"[at noodls] - ROCKVILLE, Md., March 24, 2016 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, ...","url":"http://www.publicnow.com/view/42F4E3DA34A23CF1727F1B8848B33E064B2C86A5"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn reports 4Q loss","publication_date":"2016-03-14 13:51:35 +0000","summary":"Rexahn reports 4Q loss","url":"http://sg.finance.yahoo.com/news/rexahn-reports-4q-loss-135135466.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"REXAHN PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report","publication_date":"2016-03-14 10:10:34 +0000","summary":"REXAHN PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report","url":"http://biz.yahoo.com/e/160314/rnn10-k.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2016-03-02 22:51:24 +0000","summary":"REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/160302/rnn8-k.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"13G Filing: Sabby Capital Opens Large Position in Rexahn Pharmaceuticals, Inc. (RNN)","publication_date":"2016-02-29 19:00:56 +0000","summary":"13G Filing: Sabby Capital Opens Large Position in Rexahn Pharmaceuticals, Inc. (RNN)","url":"http://www.insidermonkey.com/blog/13g-filing-sabby-capital-opens-large-position-in-rexahn-pharmaceuticals-inc-rnn-435736/"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equ","publication_date":"2016-02-26 14:35:33 +0000","summary":"REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equ","url":"http://biz.yahoo.com/e/160226/rnn8-k.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Oral is Better: Rexahn Astounds with New Cancer Data","publication_date":"2016-02-23 16:45:00 +0000","summary":"[Accesswire] - Pill-Based Targeted Cancer Data for Pancreas, Kidney and Breast Show Efficacy and Safety NEW YORK, NY / ACCESSWIRE / February 23, 2016 / Cancer drug discovery is swelling to the point of overflow. Immunotherapies ...","url":"http://finance.yahoo.com/news/oral-better-rexahn-astounds-cancer-164500331.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals to Present at the 18th Annual BIO CEO & Investor Conference on Monday, February 8, 2016","publication_date":"2016-02-01 14:31:43 +0000","summary":"[at noodls] - ROCKVILLE, Md., Feb. 01, 2016 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, ...","url":"http://www.publicnow.com/view/770A3ADFF2BA6FE4DF611BF826037CC7189BD2DD"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Announces Supinoxin™ Poster Presentations at the 2016 Gastrointestinal Cancers Symposium","publication_date":"2016-01-25 14:17:07 +0000","summary":"[at noodls] - ROCKVILLE, Md., Jan. 25, 2016 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, ...","url":"http://www.publicnow.com/view/D6374D23B1516CB54D1A7EE93F86F7831CEB5934"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"BioWatch News' Alan Leong Interviewed by The Life Sciences Report","publication_date":"2016-01-22 14:00:00 +0000","summary":"[Marketwired] - Combining academic discipline with methodical due diligence, Alan Leong of BioWatch News undertakes a regimented review of each biotech and medtech stock he investigates. In some cases he will follow a ...","url":"http://finance.yahoo.com/news/biowatch-news-alan-leong-interviewed-140000067.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"New Preclinical Data for Supinoxin™ Show Oral Administration Produces Clinically Meaningful Tumor Growth Inhibition","publication_date":"2016-01-12 14:22:06 +0000","summary":"[at noodls] - ROCKVILLE, Md., Jan. 12, 2016 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, ...","url":"http://www.noodls.com/view/6ED27E4F201405C842D7CA2EAC80631A30B3E06D"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals' Archexin® Shows Dose-Dependent Tumor Reduction in a Phase IIa Clinical Study","publication_date":"2016-01-11 14:38:30 +0000","summary":"[at noodls] - ROCKVILLE, Md., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, ...","url":"http://www.noodls.com/view/18F6904C48CFEE03AB58F956670FB11B8B979683"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals to Present at Biotech Showcase™ 2016","publication_date":"2016-01-05 14:09:03 +0000","summary":"[at noodls] - ROCKVILLE, Md., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, ...","url":"http://www.noodls.com/view/14CEB83FA3E5DEF25D0A3D4074E1DC29B3A3A371"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"BioNap Consulting's Jason Napodano Interviewed by The Life Sciences Report","publication_date":"2015-12-18 14:00:00 +0000","summary":"[Marketwired] - Before starting his own firm in July, Jason Napodano spent more than 12 years at Zacks Investment Research producing highly detailed small-cap biotechnology research. Today, as owner and senior analyst ...","url":"http://finance.yahoo.com/news/bionap-consultings-jason-napodano-interviewed-140000223.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Announces New Data for Supinoxin™ Showing Potent Tumor Growth Inhibition","publication_date":"2015-12-14 14:22:31 +0000","summary":"[at noodls] - ROCKVILLE, Md., Dec. 14, 2015 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, ...","url":"http://www.noodls.com/view/B0DBEB7BAF2BD939E04518D812725CD39946E4A6"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Biotechs Under 20 Dollars Poised to Breakout","publication_date":"2015-11-23 20:07:00 +0000","summary":"[Accesswire] - LAS VEGAS, NV / ACCESSWIRE / November 23, 2015 / According to Global Analyst Reports, the world market for colorectal cancer is expected to reach $8.8 billion by 2020 and the global pancreatic cancer market ...","url":"http://finance.yahoo.com/news/biotechs-under-20-dollars-poised-200700004.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals to Present at the Stifel 2015 Healthcare Conference on November 18, 2015","publication_date":"2015-11-11 14:16:11 +0000","summary":"[at noodls] - ROCKVILLE, MD, Nov. 11, 2015 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, ...","url":"http://www.noodls.com/view/0530CB821C5D17899E2475B7C95389354DC466F3"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn reports 3Q loss","publication_date":"2015-11-03 14:37:35 +0000","summary":"Rexahn reports 3Q loss","url":"http://sg.finance.yahoo.com/news/rexahn-reports-3q-loss-143735446.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Corporate Update","publication_date":"2015-11-03 14:06:19 +0000","summary":"[at noodls] - Rexahn Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Corporate Update","url":"http://www.noodls.com/view/1DD551F6F171EA74561D7275621970DE40BE60CE"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals to Present at the 14th Annual BIO Investor Forum","publication_date":"2015-10-14 13:11:07 +0000","summary":"[at noodls] - ROCKVILLE, Md., Oct. 14, 2015 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, ...","url":"http://www.noodls.com/view/B42E6FD3AB00B47F3ECDB8A96F3EA9DD86E99763"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals Presents Preliminary Clinical Data for Supinoxin(TM) and RX-3117 Oncology Programs at the European Cancer Congress 2015","publication_date":"2015-09-28 13:17:11 +0000","summary":"[at noodls] - ROCKVILLE, Md., Sept. 28, 2015 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, ...","url":"http://www.noodls.com/view/09462BC6796B0CA93EFC7D19B5E73BD05F1EE20C"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals to Present Preliminary Clinical Data at the European Cancer Congress 2015","publication_date":"2015-09-25 13:24:01 +0000","summary":"[at noodls] - ROCKVILLE, Md., Sept. 25, 2015 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, ...","url":"http://www.noodls.com/view/AC3949B0A130956DB44B9339A5FF0DAFD892B9BE"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Tuesday Sector Leaders: Oil & Gas Exploration & Production, Biotechnology Stocks","publication_date":"2015-07-14 18:27:28 +0000","summary":"In trading on Tuesday, oil & gas exploration & production shares were relative leaders, up on the day by about 2.3%. Leading the group were shares of Magnum Hunter Resources ( MHR ), up about 12.3% and shares of","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Umpmbs39cc8/tuesday-sector-leaders-oil-gas-exploration-production-biotechnology-stocks-cm496300"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals (RNN): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape","publication_date":"2014-12-05 14:20:36 +0000","summary":"One stock that might be an intriguing choice for investors right now is Rexahn Pharmaceuticals, Inc. ( RNN ). This is because this security in the Medical and Biomedical space is seeing solid earnings estimate revision activity, and is","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/44qZPqhCMHk/rexahn-pharmaceuticals-rnn-strong-industry-solid-earnings-estimate-revisions-tale-of-the-tape-cm420130"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn posts 3Q loss","publication_date":"2014-11-13 14:18:52 +0000","summary":"Rexahn posts 3Q loss","url":"http://sg.finance.yahoo.com/news/rexahn-posts-3q-loss-141852685--finance.html"},{"ticker":"RNN","figi_ticker":"RNN:US","figi":"BBG000BT34Q3","title":"Rexahn Pharmaceuticals (RNN) Jumps: Stock Gains 10.2% - Tale of the Tape","publication_date":"2014-09-26 14:04:50 +0000","summary":"Rexahn Pharmaceuticals, Inc. ( RNN ) was a big mover last session, as the company saw its shares rise over 10% on the day. The move came on solid volume too with far more shares changing hands than in","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BCT9vnij7hg/rexahn-pharmaceuticals-rnn-jumps-stock-gains-102-tale-of-the-tape-cm395597"}],"result_count":111,"page_size":100,"current_page":1,"total_pages":2,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"4.07"},{"x":"1494596100","y":"4.257"},{"x":"1494596400","y":"4.3001"},{"x":"1494596700","y":"4.55"},{"x":"1494597000","y":"4.5388"},{"x":"1494597300","y":"4.44"},{"x":"1494597600","y":"4.5306"},{"x":"1494597900","y":"4.43"},{"x":"1494598200","y":"4.3608"},{"x":"1494598500","y":"4.3998"},{"x":"1494598800","y":"4.3999"},{"x":"1494599100","y":"4.3803"},{"x":"1494599400","y":"4.358"},{"x":"1494599700","y":"4.2521"},{"x":"1494600000","y":"4.3"},{"x":"1494600300","y":"4.27"},{"x":"1494600600","y":"4.23"},{"x":"1494600900","y":"4.23"},{"x":"1494601200","y":"4.22"},{"x":"1494601500","y":"4.2943999999999996"},{"x":"1494601800","y":"4.2311"},{"x":"1494602100","y":"4.22"},{"x":"1494602400","y":"4.26"},{"x":"1494602700","y":"4.2597"},{"x":"1494603000","y":"4.2702"},{"x":"1494603300","y":"4.3"},{"x":"1494603600","y":"4.369"},{"x":"1494603900","y":"4.39"},{"x":"1494604200","y":"4.35"},{"x":"1494604500","y":"4.3607"},{"x":"1494604800","y":"4.4115"},{"x":"1494605100","y":"4.34"},{"x":"1494605400","y":"4.39"},{"x":"1494605700","y":"4.3701"},{"x":"1494606000","y":"4.38"},{"x":"1494606300","y":"4.41"},{"x":"1494606600","y":"4.45"},{"x":"1494606900","y":"4.4498"},{"x":"1494607200","y":"4.49"},{"x":"1494607500","y":"4.4301"},{"x":"1494607800","y":"4.4389"},{"x":"1494608100","y":"4.4754"},{"x":"1494608400","y":"4.48"},{"x":"1494608700","y":"4.46"},{"x":"1494609000","y":"4.46"},{"x":"1494609300","y":"4.47"},{"x":"1494609600","y":"4.46"},{"x":"1494609900","y":"4.46"},{"x":"1494610200","y":"4.44"},{"x":"1494610500","y":"4.453"},{"x":"1494610800","y":"4.4656"},{"x":"1494611100","y":"4.45"},{"x":"1494611400","y":"4.42"},{"x":"1494611700","y":"4.4"},{"x":"1494612000","y":"4.4199"},{"x":"1494612300","y":"4.3375"},{"x":"1494612600","y":"4.33"},{"x":"1494612900","y":"4.32"},{"x":"1494613200","y":"4.32"},{"x":"1494613500","y":"4.322"},{"x":"1494613800","y":"4.3699"},{"x":"1494614100","y":"4.35"},{"x":"1494614400","y":"4.32"},{"x":"1494614700","y":"4.32"},{"x":"1494615000","y":"4.3158"},{"x":"1494615300","y":"4.3"},{"x":"1494615600","y":"4.2911"},{"x":"1494615900","y":"4.26"},{"x":"1494616200","y":"4.2401"},{"x":"1494616500","y":"4.28"},{"x":"1494616800","y":"4.25"},{"x":"1494617100","y":"4.22"},{"x":"1494617400","y":"4.2232"},{"x":"1494617700","y":"4.2"},{"x":"1494618000","y":"4.2199"},{"x":"1494618300","y":"4.26"},{"x":"1494618600","y":"4.28"},{"x":"1494618900","y":"4.23"} ], "color":"#03a9f4"}]},
{"id":"18","symbol": "SGMO","name": "Sangamo Therapeutics Inc","price": 8.2,"dollarChange": 1.2,"percentChange": 17.15,"open": 6.95,"high": 8.538499999999999,"low":6.9,"volume": 11402991,"avgVol": 1028951.033333,"sharesShort": 7748587,"shortPercent": 10.771023,"marketCap": 344565873,"float": 71939193,"headlines":{"data":[{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Today's Research Reports on Stocks to Watch: Conatus Pharmaceuticals and Sangamo Therapeutics","publication_date":"2017-05-12 12:00:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / May 12, 2017 / Conatus shares took a mean dive after the company disclosed a public offering of its stock at $5.50 per share. Sangamo Therapeutics on the other hand climbed ...","url":"http://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000337.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Edited Transcript of SGMO earnings conference call or presentation 10-May-17 9:00pm GMT","publication_date":"2017-05-12 00:16:05 +0000","summary":"Sangamo Therapeutics Inc Conference Call on Q1 2017 Earnings and Collaboration with Pfizer","url":"http://finance.yahoo.com/news/edited-transcript-sgmo-earnings-conference-024220955.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics, Inc. – Value Analysis (NASDAQ:SGMO) : May 11, 2017","publication_date":"2017-05-11 23:32:17 +0000","summary":"Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Sangamo Therapeutics, Inc. a score of 18. Our analysis is based on comparing Sangamo Therapeutics, Inc. with the following peers – Gilead Sciences, Inc., Alnylam Pharmaceuticals, Inc, Amgen Inc., Dow Chemical Company, Merck & Co., Inc., Johnson & Johnson, BioMarin Pharmaceutical Inc., Shire PLC Sponsored ADR, GenVec, ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/721c69be-0802-3a4d-88f9-3b1208702dc7/sangamo-therapeutics-inc-value-analysis-nasdaqsgmo-may-11-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Gainers & Losers Of May 11: SGMO, RNN, XON, MNKD, NVCN...","publication_date":"2017-05-11 22:07:00 +0000","summary":"Gainers & Losers Of May 11: SGMO, RNN, XON, MNKD, NVCN...","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cjuSLLaUCqo/gainers--losers-of-may-11-sgmo-rnn-xon-mnkd-nvcn-20170511-01774"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Health Care Sector Update for 05/11/2017: CNAT,SGMO,PFE,ITUS","publication_date":"2017-05-11 20:20:41 +0000","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 28 JNJ 0 28 PFE 0 03 PFE 0 03 ABT 1 48 ABT 1 48 MRK 0 81 MRK 0 81 AMGN 0 23 AMGN 0 23 Health care stocks resisted the worst of today s broader market declines with the NYSE Health Care Index falling less than 0 1 while shares","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wl8cBCieNt0/health-care-sector-update-for-05112017-cnatsgmopfeitus-cm788139"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Mid-Afternoon Market Update: Crude Oil Up 1.25%; Straight Path Shares Plunge","publication_date":"2017-05-11 19:50:42 +0000","summary":"Toward the end of trading Thursday the Dow traded down 0 23 percent to 20 894 99 while the NASDAQ declined 0 27 percent to 6 112 52 The S amp P also fell dropping 0 33 percent to 2 391 65 Leading and Lagging Sectors Non cyclical consumer goods amp services sector was the","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ym2mFznJX9M/mid-afternoon-market-update-crude-oil-up-125-straight-path-shares-plunge-cm788130"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Here's Why Sangamo Therapeutics Rocketed Up to 56.3% Higher Today","publication_date":"2017-05-11 19:03:12 +0000","summary":"What happened Shares of genome editing pioneer Sangamo Therapeutics NASDAQ SGMO soared over 56 this morning after the company announced a slew of updates from the first three months of this year and most importantly a new collaboration with Pfizer NYSE PFE in Hemophilia","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uXrRrQWcTKM/heres-why-sangamo-therapeutics-rocketed-up-to-563-higher-today-cm788065"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Health Care Sector Update for 05/11/2017: MNKD,SGMO,PFE,ITUS","publication_date":"2017-05-11 18:01:11 +0000","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 08 JNJ 0 08 PFE 0 21 PFE 0 21 ABT 1 21 ABT 1 21 MRK 0 78 MRK 0 78 AMGN 1 02 AMGN 1 02 Health care stocks were resisting the worst of Thursday s broader market declines with the NYSE Health Care Index falling about 0 2 while","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f2NnZKacb3U/health-care-sector-update-for-05112017-mnkdsgmopfeitus-cm788043"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Mid-Day Market Update: Snap Tumbles After Q1 Report; Sangamo Shares Surge","publication_date":"2017-05-11 17:15:42 +0000","summary":"Midway through trading Thursday the Dow traded down 0 57 percent to 20 823 37 while the NASDAQ declined 0 75 percent to 6 083 35 The S amp P also fell dropping 0 64 percent to 2 384 40 Leading and Lagging Sectors Non cyclical consumer goods amp services sector was the top","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TVPOB2j2tTU/mid-day-market-update-snap-tumbles-after-q1-report-sangamo-shares-surge-cm788039"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Here&apos;s Why Sangamo Therapeutics Rocketed Up to 56.3% Higher Today","publication_date":"2017-05-11 17:10:00 +0000","summary":"The company announced first-quarter 2017 financial results and a new collaboration with Pfizer.","url":"http://finance.yahoo.com/r/518ebc9d-9c0f-31b7-b8b1-e4b0eb45b211/heres-why-sangamo-therapeutics-rocketed-up-to-563.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Mid-Morning Market Update: Markets Open Lower; Macy's Profit Misses Expectations","publication_date":"2017-05-11 15:15:43 +0000","summary":"Following the market opening Thursday the Dow traded down 0 60 percent to 20 818 33 while the NASDAQ declined 0 68 percent to 6 087 65 The S amp P also fell dropping 0 60 percent to 2 385 12 Leading and Lagging Sectors Non cyclical consumer goods amp services sector was the","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/351Iry4z3EI/mid-morning-market-update-markets-open-lower-macys-profit-misses-expectations-cm787942"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Why Sangamo Therapeutics Is Surging","publication_date":"2017-05-11 14:30:38 +0000","summary":"Sangamo Therapeutics saw its shares skyrocket early on Thursday after a critical business update.","url":"http://finance.yahoo.com/news/why-sangamo-therapeutics-surging-143038610.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Pre-Market Most Active for May 11, 2017 : SNAP, NYRT, M, MT, AUO, CHK, NVDA, QQQ, HIMX, MSFT, SGMO, FB","publication_date":"2017-05-11 13:00:52 +0000","summary":"The NASDAQ 100 Pre Market Indicator is down 11 77 to 5 669 91 The total Pre Market volume is currently 16 908 208 shares traded The following are the most active stocks for the pre market session Snap Inc SNAP is 5 at 17 98 with 5 520 733 shares traded SNAP","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BEIo1vc9sZo/pre-market-most-active-for-may-11-2017-snap-nyrt-m-mt-auo-chk-nvda-qqq-himx-msft-sgmo-fb-cm787699"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"FDA Nod For MRK's Keytruda, SGMO Soars On Gene Therapy Deal, OMER Catches Eyes","publication_date":"2017-05-11 02:03:00 +0000","summary":"FDA Nod For MRK's Keytruda, SGMO Soars On Gene Therapy Deal, OMER Catches Eyes","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tOFbP1H8_NU/fda-nod-for-mrks-keytruda-sgmo-soars-on-gene-therapy-deal-omer-catches-eyes-20170511-00093"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo shares jump on Pfizer collaboration, quarterly results","publication_date":"2017-05-10 21:18:02 +0000","summary":"Sangamo Therapeutics Inc. shares surged after the gene therapy company reported a narrower-than-expected loss for the quarter and a collaboration with pharmaceutical giant Pfizer Inc. . Sangamo shares ...","url":"http://finance.yahoo.com/r/70e6e50a-b263-34c0-814b-6bb708fdd358/Story.aspx?guid=A7848EFA-8DA7-4B12-9EFE-222A2DFED4BD&siteid=yhoof2&yptr=yahoo&.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo reports 1Q loss","publication_date":"2017-05-10 20:48:39 +0000","summary":"On a per-share basis, the Richmond, California-based company said it had a loss of 23 cents. The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment ...","url":"http://finance.yahoo.com/news/sangamo-reports-1q-loss-204839752.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics And Pfizer Announce Collaboration For Hemophilia A Gene Therapy","publication_date":"2017-05-10 20:01:00 +0000","summary":"RICHMOND, Calif., May 10, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO) and Pfizer Inc. (PFE) today announced an exclusive, global collaboration and license agreement for the development and commercialization of gene therapy programs for Hemophilia A, including SB-525, one of Sangamo's four lead product candidates, which Sangamo expects will enter the clinic this quarter. \"Sangamo brings deep scientific and technical expertise across multiple genomic platforms, and we look forward to working together to advance this potentially transformative treatment for patients living with Hemophilia A,\" said Mikael Dolsten, MD, PhD, President of Worldwide Research and Development at Pfizer.","url":"http://finance.yahoo.com/news/sangamo-therapeutics-pfizer-announce-collaboration-200100659.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Reports First Quarter 2017 Financial Results","publication_date":"2017-05-10 20:01:00 +0000","summary":"RICHMOND, Calif., May 10, 2017 /PRNewswire/ --  Company Also Separately Announced Strategic Collaboration with Pfizer for Hemophilia A Phase 1/2 Gene Therapy Program Conference Call and Webcast at 5:00 ...","url":"http://finance.yahoo.com/news/sangamo-therapeutics-reports-first-quarter-200100892.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : SGMO-US : May 9, 2017","publication_date":"2017-05-09 12:51:49 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Sangamo Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/69ca8e1f-152f-33dc-8846-1e49d88cc2f4/sangamo-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-sgmo-us-may-9-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Blog Coverage: Sangamo Receives Special Regulatory Designation from FDA for Three of Its Program","publication_date":"2017-05-05 12:15:00 +0000","summary":"Upcoming AWS Coverage on Bio-Techne Post-Earnings Results LONDON, UK / ACCESSWIRE / May 5, 2017 / Active Wall St. blog coverage looks at the headline from Sangamo Therapeutics, Inc. (NASDAQ: SGMO ) as ...","url":"http://finance.yahoo.com/news/blog-coverage-sangamo-receives-special-121500448.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Announces Special Regulatory Designations from the FDA for Three Clinical Programs","publication_date":"2017-05-04 12:00:00 +0000","summary":"RICHMOND, Calif., May 4, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO), the leader in therapeutic genome editing, announced today that the Company has received notice from the U.S. Food and Drug Administration (FDA) of special regulatory designations for three of the Company's clinical programs. RPD provides incentives to develop drugs for the treatment of rare diseases primarily affecting children ages 18 years or younger.","url":"http://finance.yahoo.com/news/sangamo-therapeutics-announces-special-regulatory-120000139.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Announces First Quarter 2017 Conference Call And Webcast","publication_date":"2017-05-03 20:05:00 +0000","summary":"RICHMOND, Calif., May 3, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), the leader in therapeutic genome editing, announced today that the company will release its first quarter 2017 financial ...","url":"http://finance.yahoo.com/news/sangamo-therapeutics-announces-first-quarter-200500748.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Announces The Retirement Of Its Founder And Genome Editing Pioneer Edward Lanphier From The Board Of Directors","publication_date":"2017-04-25 20:01:00 +0000","summary":"RICHMOND, Calif., April 25, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO), the leader in therapeutic genome editing, today announced that its founder and Chairman Edward Lanphier is not standing for re-election as a director nominee of Sangamo's Board of Directors at the 2017 Annual Meeting of Stockholders. The announcement comes after a year-long transition period following Lanphier's retirement from Sangamo management in June 2016 after 21 years as President and Chief Executive Officer. \"Under Edward's leadership, Sangamo pioneered the field of genome editing with the development of ground-breaking technologies such as our zinc finger protein platform for therapeutic applications with the potential to fundamentally change the way medicine is practiced,\" said H. Stewart Parker, Sangamo director and nominee to succeed Lanphier as board chair following the Annual Meeting.","url":"http://finance.yahoo.com/news/sangamo-announces-retirement-founder-genome-200100751.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Stocks Remain Firmly Positive In Mid-Day Trading - U.S. Commentary","publication_date":"2017-04-25 11:59:00 +0000","summary":"Stocks Remain Firmly Positive In Mid-Day Trading - U.S. Commentary","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U_GaqGk32L8/stocks-remain-firmly-positive-in-midday-trading--us-commentary-20170425-01251"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Announces Presentations at 2017 Annual meeting of the American Society of Gene & Cell Therapy","publication_date":"2017-04-24 21:02:00 +0000","summary":"RICHMOND, Calif., April 24, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced that data from the Company's therapeutic and research programs ...","url":"http://finance.yahoo.com/news/sangamo-therapeutics-announces-presentations-2017-210200767.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Announces Participation In The ARM 5th Annual Cell & Gene Therapy Investor Day","publication_date":"2017-04-24 20:03:00 +0000","summary":"RICHMOND, Calif., April 24, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), the leader in therapeutic genome editing, announced today that Dr. Sandy Macrae, Sangamo's chief executive officer, ...","url":"http://finance.yahoo.com/news/sangamo-therapeutics-announces-participation-arm-200300898.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : SGMO-US : April 18, 2017","publication_date":"2017-04-18 12:31:08 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Sangamo Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/ef1fd796-acca-3299-aa22-bfca1d892421/sangamo-therapeutics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-sgmo-us-april-18-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"ETFs with exposure to Sangamo Therapeutics, Inc. : April 7, 2017","publication_date":"2017-04-07 21:27:44 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Sangamo Therapeutics, Inc. Here are 5 ETFs with the largest exposure to SGMO-US. Comparing the performance and risk of Sangamo Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/f0f438d9-a2d6-34f9-88a6-7cc340d75a47/etfs-with-exposure-to-sangamo-therapeutics-inc-april-7-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"7:33 am Sangamo Therapeutics announces the presentation of new human in vitro and animal model data demonstrating significant reduction of tau mRNA and tau protein expression using the Co's zinc finger protein transcription factor (ZFP-TF)-","publication_date":"2017-03-29 11:33:00 +0000","summary":"7:33 am Sangamo Therapeutics announces the presentation of new human in vitro and animal model data demonstrating significant reduction of tau mRNA and tau protein expression using the Co's zinc finger protein transcription factor (ZFP-TF)-","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#sgmo"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Announces Presentation of New Data Demonstrating Significant Reduction of Tau Expression Using Proprietary ZFP Gene Regulation Technology","publication_date":"2017-03-29 11:30:00 +0000","summary":"RICHMOND, Calif., March 29, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO), the leader in therapeutic genome editing, announced today the presentation of new human in vitro and animal model data demonstrating significant reduction of tau mRNA and tau protein expression using the Company's zinc finger protein transcription factor (ZFP-TF)-mediated gene regulation technology. The data were presented by Sangamo's collaborators from Massachusetts General Hospital Alzheimer's Disease Research Center and Harvard Medical School at the 13th International Conference on Alzheimer's & Parkinson's Diseases. \"Tau protein plays a critical role in certain devastating neurodegenerative diseases, including dementias such as Alzheimer's disease, and studies point to the potential for tau reduction to prevent neuronal loss and possibly even reverse Alzheimer's disease pathology,\" said Bradley Hyman, M.D., Ph.D., Director, Massachusetts Alzheimer's Disease Research Center and Alzheimer's Unit Director, MassGeneral Institute for Neurodegenerative Disease at Massachusetts General Hospital, and John B. Penney Jr., Professor of Neurology, Harvard Medical School.","url":"http://finance.yahoo.com/news/sangamo-therapeutics-announces-presentation-data-113000127.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Announces Presentation of New Data Demonstrating Significant Reduction of Tau Expression Using Proprietary ZFP Gene Regulation Technology","publication_date":"2017-03-29 11:30:00 +0000","summary":"[PR Newswire] - RICHMOND, Calif., March 29, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO), the leader in therapeutic genome editing, announced today the presentation of new human in vitro and animal model data demonstrating significant reduction of tau mRNA and tau protein expression using the Company's zinc finger protein transcription factor (ZFP-TF)-mediated gene regulation technology. The data were presented by Sangamo's collaborators from Massachusetts General Hospital Alzheimer's Disease Research Center and Harvard Medical School at the 13th International Conference on Alzheimer's & Parkinson's Diseases. \"Tau protein plays a critical role in certain devastating neurodegenerative diseases, including dementias such as Alzheimer's disease, and studies point to the potential for tau reduction to prevent neuronal loss and possibly even reverse Alzheimer's disease pathology,\" said Bradley Hyman, M.D., Ph.D., Director, Massachusetts Alzheimer's Disease Research Center and Alzheimer's Unit Director, MassGeneral Institute for Neurodegenerative Disease at Massachusetts General Hospital, and John B. Penney Jr., Professor of Neurology, Harvard Medical School.","url":"http://finance.yahoo.com/news/sangamo-therapeutics-announces-presentation-data-113000127.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"ETFs with exposure to Sangamo Therapeutics, Inc. : March 27, 2017","publication_date":"2017-03-27 20:05:49 +0000","summary":"ETFs with exposure to Sangamo Therapeutics, Inc. : March 27, 2017","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-sangamo-therapeutics-inc-march-27-2017/"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"ETFs with exposure to Sangamo Therapeutics, Inc. : March 27, 2017","publication_date":"2017-03-27 20:05:49 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Sangamo Therapeutics, Inc. Here are 5 ETFs with the largest exposure to SGMO-US. Comparing the performance and risk of Sangamo Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/75504f90-7dac-3c20-b3a1-ccae0c24fb15/etfs-with-exposure-to-sangamo-therapeutics-inc-march-27-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics, Inc. :SGMO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017","publication_date":"2017-03-21 13:26:06 +0000","summary":"Sangamo Therapeutics, Inc. :SGMO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017","url":"http://www.capitalcube.com/blog/index.php/sangamo-therapeutics-inc-sgmo-us-earnings-analysis-q4-2016-by-the-numbers-march-21-2017/"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics, Inc. :SGMO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017","publication_date":"2017-03-21 13:26:06 +0000","summary":"Categories: Yahoo Finance Get free summary analysis Sangamo Therapeutics, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Sangamo Therapeutics, Inc. – Gilead Sciences, Inc., Alnylam Pharmaceuticals, Inc, Amgen Inc., Dow Chemical Company, Merck & Co., Inc., Johnson & Johnson, BioMarin Pharmaceutical Inc., Shire PLC Sponsored ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/90310929-c442-3e59-9210-7ae2b5cc3613/sangamo-therapeutics-inc-sgmo-us-earnings-analysis-q4-2016-by-the-numbers-march-21-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"SANGAMO THERAPEUTICS, INC Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2017-03-20 21:08:20 +0000","summary":"SANGAMO THERAPEUTICS, INC Files SEC form 8-K, Change in Directors or Principal Officers","url":"http://biz.yahoo.com/e/170320/sgmo8-k.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics, Inc. :SGMO-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017","publication_date":"2017-03-14 18:30:17 +0000","summary":"Sangamo Therapeutics, Inc. :SGMO-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017","url":"http://www.capitalcube.com/blog/index.php/sangamo-therapeutics-inc-sgmo-us-earnings-analysis-2016-by-the-numbers-march-14-2017/"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics, Inc. :SGMO-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017","publication_date":"2017-03-14 18:30:17 +0000","summary":"Categories: Yahoo Finance Get free summary analysis Sangamo Therapeutics, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Sangamo Therapeutics, Inc. – Gilead Sciences, Inc., Alnylam Pharmaceuticals, Inc, Amgen Inc., Dow Chemical Company, Merck & Co., Inc., Johnson & Johnson, BioMarin Pharmaceutical Inc., Shire PLC Sponsored ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/24009f0c-8933-3634-9b6a-21038db83302/sangamo-therapeutics-inc-sgmo-us-earnings-analysis-2016-by-the-numbers-march-14-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"SANGAMO THERAPEUTICS, INC Financials","publication_date":"2017-03-07 18:04:17 +0000","summary":"SANGAMO THERAPEUTICS, INC Financials","url":"http://finance.yahoo.com/q/is?s=sgmo"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"FDA Approves Odactra, JUNO Abandons Rocket, VRML Abuzz, No Tremors For NDRM","publication_date":"2017-03-02 05:13:00 +0000","summary":"FDA Approves Odactra, JUNO Abandons Rocket, VRML Abuzz, No Tremors For NDRM","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AeyT2lhQlYg/fda-approves-odactra-juno-abandons-rocket-vrml-abuzz-no-tremors-for-ndrm-20170302-00244"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Announces Presentation At The Cowen And Company 37th Annual Health Care Conference","publication_date":"2017-03-01 21:05:00 +0000","summary":"RICHMOND, Calif., March 1, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), the leader in therapeutic genome editing, announced today that Sandy Macrae, M.B., Ch.B., Ph.D., Sangamo's chief ...","url":"http://finance.yahoo.com/news/sangamo-therapeutics-announces-presentation-cowen-210500139.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Announces Presentation At The Cowen And Company 37th Annual Health Care Conference","publication_date":"2017-03-01 21:05:00 +0000","summary":"[PR Newswire] - RICHMOND, Calif., March 1, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), the leader in therapeutic genome editing, announced today that Sandy Macrae, M.B., Ch.B., Ph.D., Sangamo's chief ...","url":"http://finance.yahoo.com/news/sangamo-therapeutics-announces-presentation-cowen-210500139.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Receives Orphan Drug Designation from the FDA for SB-913 Genome Editing Treatment for MPS II","publication_date":"2017-03-01 13:30:00 +0000","summary":"[PR Newswire] - RICHMOND, Calif., March 1, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO), the leader in therapeutic genome editing, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to SB-913, a genome editing product candidate for the treatment of Mucopolysaccharidosis Type II (MPS II), a rare lysosomal storage disorder. Orphan drug designations are granted to drugs and biologics intended to treat rare diseases with a patient population less than 200,000 in the U.S. The designation provides incentives to advance development and commercialization of rare disease drugs.","url":"http://finance.yahoo.com/news/sangamo-therapeutics-receives-orphan-drug-133000584.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Receives Orphan Drug Designation from the FDA for SB-913 Genome Editing Treatment for MPS II","publication_date":"2017-03-01 13:30:00 +0000","summary":"RICHMOND, Calif., March 1, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO), the leader in therapeutic genome editing, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to SB-913, a genome editing product candidate for the treatment of Mucopolysaccharidosis Type II (MPS II), a rare lysosomal storage disorder. Orphan drug designations are granted to drugs and biologics intended to treat rare diseases with a patient population less than 200,000 in the U.S. The designation provides incentives to advance development and commercialization of rare disease drugs.","url":"http://finance.yahoo.com/news/sangamo-therapeutics-receives-orphan-drug-133000584.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo reports 4Q loss","publication_date":"2017-02-28 12:53:31 +0000","summary":"The Richmond, California-based company said it had a loss of 14 cents per share. The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...","url":"http://finance.yahoo.com/news/sangamo-reports-4q-loss-125331270.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo reports 4Q loss","publication_date":"2017-02-28 12:53:31 +0000","summary":"Sangamo reports 4Q loss","url":"http://sg.finance.yahoo.com/news/sangamo-reports-4q-loss-125331695.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Q4 2016 Sangamo Therapeutics Inc Earnings Release - Before Market Open","publication_date":"2017-02-28 12:07:03 +0000","summary":"Q4 2016 Sangamo Therapeutics Inc Earnings Release - Before Market Open","url":"http://biz.yahoo.com/research/earncal/20170228.html?t=sgmo"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"SANGAMO THERAPEUTICS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or P","publication_date":"2017-02-28 12:03:30 +0000","summary":"SANGAMO THERAPEUTICS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or P","url":"http://biz.yahoo.com/e/170228/sgmo8-k.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Reports Fourth Quarter And Full Year 2016 Financial Results","publication_date":"2017-02-28 12:00:00 +0000","summary":"RICHMOND, Calif., Feb. 28, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, today reported its fourth quarter and full year 2016 financial results ...","url":"http://finance.yahoo.com/news/sangamo-therapeutics-reports-fourth-quarter-120000401.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Reports Fourth Quarter And Full Year 2016 Financial Results","publication_date":"2017-02-28 12:00:00 +0000","summary":"[PR Newswire] - RICHMOND, Calif., Feb. 28, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, today reported its fourth quarter and full year 2016 financial results ...","url":"http://finance.yahoo.com/news/sangamo-therapeutics-reports-fourth-quarter-120000401.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Announces Chief Financial Officer Succession","publication_date":"2017-02-27 21:30:00 +0000","summary":"[PR Newswire] - RICHMOND, Calif., Feb. 27, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO), the leader in therapeutic genome editing, today announced the appointment of Kathy Yi as senior vice president and chief financial officer, to succeed current executive vice president and chief financial officer H. Ward Wolff, who will be retiring from the company in early March. Ms. Yi, a chemical engineer by training, brings over 15 years of experience in corporate finance, including financial analysis in support of M&A, licensing and other business development activities. \"I am sincerely grateful to Ward for his support through my transition as CEO and for his dedicated service to Sangamo throughout the years,\" said Sandy Macrae, M.B., Ch.B., Ph.D., Sangamo's chief executive officer.","url":"http://finance.yahoo.com/news/sangamo-therapeutics-announces-chief-financial-213000118.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Announces Chief Financial Officer Succession","publication_date":"2017-02-27 21:30:00 +0000","summary":"RICHMOND, Calif., Feb. 27, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO), the leader in therapeutic genome editing, today announced the appointment of Kathy Yi as senior vice president and chief financial officer, to succeed current executive vice president and chief financial officer H. Ward Wolff, who will be retiring from the company in early March. Ms. Yi, a chemical engineer by training, brings over 15 years of experience in corporate finance, including financial analysis in support of M&A, licensing and other business development activities. \"I am sincerely grateful to Ward for his support through my transition as CEO and for his dedicated service to Sangamo throughout the years,\" said Sandy Macrae, M.B., Ch.B., Ph.D., Sangamo's chief executive officer.","url":"http://finance.yahoo.com/news/sangamo-therapeutics-announces-chief-financial-213000118.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Receives Rare Pediatric Disease Designation From FDA For SB-318 In Vivo Genome Editing Therapeutic For MPS I","publication_date":"2017-02-27 13:00:00 +0000","summary":"RICHMOND, Calif., Feb. 27, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO), the leader in therapeutic genome editing, today announced that the U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation for SB-318, the Company's in vivo genome editing product candidate for the treatment of Mucopolysaccharidosis Type I (MPS I), a lysosomal storage disorder. Rare pediatric disease designation is granted to drugs and biologics intended to treat orphan diseases affecting less than 200,000 patients in the U.S., primarily age 18 years or younger.","url":"http://finance.yahoo.com/news/sangamo-therapeutics-receives-rare-pediatric-130000310.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Receives Rare Pediatric Disease Designation From FDA For SB-318 In Vivo Genome Editing Therapeutic For MPS I","publication_date":"2017-02-27 13:00:00 +0000","summary":"[PR Newswire] - RICHMOND, Calif., Feb. 27, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO), the leader in therapeutic genome editing, today announced that the U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation for SB-318, the Company's in vivo genome editing product candidate for the treatment of Mucopolysaccharidosis Type I (MPS I), a lysosomal storage disorder. Rare pediatric disease designation is granted to drugs and biologics intended to treat orphan diseases affecting less than 200,000 patients in the U.S., primarily age 18 years or younger.","url":"http://finance.yahoo.com/news/sangamo-therapeutics-receives-rare-pediatric-130000310.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"SANGAMO THERAPEUTICS, INC Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2017-02-24 22:11:25 +0000","summary":"SANGAMO THERAPEUTICS, INC Files SEC form 8-K, Change in Directors or Principal Officers","url":"http://biz.yahoo.com/e/170224/sgmo8-k.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Announces Fourth Quarter And Full Year 2016 Conference Call And Webcast","publication_date":"2017-02-21 21:03:00 +0000","summary":"RICHMOND, Calif., Feb. 21, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), the leader in therapeutic genome editing, announced today that the company will release its fourth quarter and ...","url":"http://finance.yahoo.com/news/sangamo-therapeutics-announces-fourth-quarter-210300898.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Announces Fourth Quarter And Full Year 2016 Conference Call And Webcast","publication_date":"2017-02-21 21:03:00 +0000","summary":"[PR Newswire] - RICHMOND, Calif., Feb. 21, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), the leader in therapeutic genome editing, announced today that the company will release its fourth quarter and ...","url":"http://finance.yahoo.com/news/sangamo-therapeutics-announces-fourth-quarter-210300898.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Announces Upcoming Presentations At The 13th Annual WORLDSymposium™ Meeting","publication_date":"2017-02-08 21:03:00 +0000","summary":"[PR Newswire] - RICHMOND, Calif., Feb. 8, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), the leader in therapeutic genome editing, today announced upcoming oral and poster presentations at the 13 th Annual ...","url":"http://finance.yahoo.com/news/sangamo-therapeutics-announces-upcoming-presentations-210300810.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Announces Upcoming Presentations At The 13th Annual WORLDSymposium™ Meeting","publication_date":"2017-02-08 21:03:00 +0000","summary":"RICHMOND, Calif., Feb. 8, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), the leader in therapeutic genome editing, today announced upcoming oral and poster presentations at the 13 th Annual ...","url":"http://finance.yahoo.com/news/sangamo-therapeutics-announces-upcoming-presentations-210300810.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"ETFs with exposure to Sangamo Therapeutics, Inc. : January 20, 2017","publication_date":"2017-01-20 18:59:38 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Sangamo Therapeutics, Inc. Here are 5 ETFs with the largest exposure to SGMO-US. Comparing the performance and risk of Sangamo Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/c9ab578b-7755-3403-aea0-ebe61148e6f1/etfs-with-exposure-to-sangamo-therapeutics-inc-january-20-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"ETFs with exposure to Sangamo Therapeutics, Inc. : January 20, 2017","publication_date":"2017-01-20 18:59:38 +0000","summary":"ETFs with exposure to Sangamo Therapeutics, Inc. : January 20, 2017","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-sangamo-therapeutics-inc-january-20-2017/"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Mid-Morning Market Update: Markets Open Lower; Morgan Stanley Tops Q4 Estimates","publication_date":"2017-01-17 16:17:00 +0000","summary":"Following the market opening Tuesday the Dow traded down 0 33 percent to 19 820 99 while the NASDAQ declined 0 56 percent to 5 543 14 The S amp P also fell dropping 0 33 percent to 2 267 06 Leading and Lagging Sectors Utilities shares gained around 0 85 percent in trading","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9BHelqEtYCs/mid-morning-market-update-markets-open-lower-morgan-stanley-tops-q4-estimates-cm734250"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Biotech Premarket Movers: SGMO, IPXL, PTLA","publication_date":"2017-01-13 14:23:00 +0000","summary":"Biotech Premarket Movers: SGMO, IPXL, PTLA","url":"https://www.thestreet.com/story/13953596/1/biotech-premarket-movers-sgmo-ipxl-ptla.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Biotech Premarket Movers: SGMO, IPXL, PTLA","publication_date":"2017-01-13 14:23:00 +0000","summary":"Sangamo Therapeutics, Impax Laboratories and Portola Pharmaceutical are among the premarket movers in biotech.","url":"http://finance.yahoo.com/r/3ec436de-2952-311f-8297-527842b90683/biotech-premarket-movers-sgmo-ipxl-ptla.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Gainers & Losers Of The Day: TBIO, IMMU, SGMO, BIOC, APRI","publication_date":"2017-01-12 23:27:00 +0000","summary":"Gainers & Losers Of The Day: TBIO, IMMU, SGMO, BIOC, APRI","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tl8bE_NS0ZE/gainers--losers-of-the-day-tbio-immu-sgmo-bioc-apri-20170112-01005"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Thursday Sector Leaders: Precious Metals, Biotechnology Stocks","publication_date":"2017-01-12 19:57:28 +0000","summary":"In trading on Thursday precious metals shares were relative leaders up on the day by about 0 6 Leading the group were shares of Anglogold Ashanti AU up about 5 and shares of Gold Fields GFI up about 4 6 on the day Also showing relative strength are biotechnology shares","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kx_82HMax7I/thursday-sector-leaders-precious-metals-biotechnology-stocks-cm732939"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Biotech Premarket Movers: IPXL, SGMO, ARLZ","publication_date":"2017-01-11 14:08:00 +0000","summary":"Biotech Premarket Movers: IPXL, SGMO, ARLZ","url":"https://www.thestreet.com/story/13950269/1/biotech-premarket-movers-ipxl-sgmo-arlz.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Biotech Premarket Movers: IPXL, SGMO, ARLZ","publication_date":"2017-01-11 14:08:00 +0000","summary":"Impax Laboratories, Sangamo Therapeutics and Aralez Pharmaceuticals are among the premarket movers in biotech.","url":"http://finance.yahoo.com/r/c0bf5351-fcab-3b29-a0c1-91188c58ad75/biotech-premarket-movers-ipxl-sgmo-arlz.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Receives Orphan Drug Designation from the FDA for SB-318 Genome Editing Treatment for MPS I","publication_date":"2017-01-11 12:30:00 +0000","summary":"RICHMOND, Calif., Jan. 11, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO), the leader in therapeutic genome editing, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to SB-318, a genome editing product candidate for the treatment of Mucopolysaccharidosis Type I (MPS I), a rare lysosomal storage disorder. Orphan drug designations are granted to drugs and biologics intended to treat rare diseases. Using Sangamo's zinc finger nuclease (ZFN) genome editing technology, SB-318 is designed as a single treatment strategy intended to provide stable, continuous production of the IDUA enzyme for the lifetime of the patient.","url":"http://finance.yahoo.com/news/sangamo-therapeutics-receives-orphan-drug-123000748.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Receives Orphan Drug Designation from the FDA for SB-318 Genome Editing Treatment for MPS I","publication_date":"2017-01-11 12:30:00 +0000","summary":"[PR Newswire] - RICHMOND, Calif., Jan. 11, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO), the leader in therapeutic genome editing, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to SB-318, a genome editing product candidate for the treatment of Mucopolysaccharidosis Type I (MPS I), a rare lysosomal storage disorder. Orphan drug designations are granted to drugs and biologics intended to treat rare diseases. Using Sangamo's zinc finger nuclease (ZFN) genome editing technology, SB-318 is designed as a single treatment strategy intended to provide stable, continuous production of the IDUA enzyme for the lifetime of the patient.","url":"http://finance.yahoo.com/news/sangamo-therapeutics-receives-orphan-drug-123000748.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Presents Latest Advances In Zinc Finger Nuclease Platform Technology At Keystone Symposium On Precision Genome Engineering","publication_date":"2017-01-10 13:00:00 +0000","summary":"[PR Newswire] - RICHMOND, Calif., Jan. 10, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO), the leader in therapeutic genome editing, today announced the presentation of key improvements to its technology platform for engineering highly specific zinc finger nucleases (ZFNs) for therapeutic genome editing applications. The presentation was delivered January 9, 2017 by Edward Rebar, Ph.D., Sangamo's vice president, technology, an invited speaker at the Keystone Symposium on Precision Genome Engineering, which is being held this week in Breckenridge, CO. The data demonstrate genome editing of therapeutic gene targets in clinically relevant cell types, including high levels of targeted modification (80%) of the BCL11A enhancer in hematopoietic stem and progenitor cells at clinical scale with no significant off-target activity. Off-target activity was assessed using state of the art assays involving unbiased oligonucleotide capture methods followed by deep sequencing.","url":"http://finance.yahoo.com/news/sangamo-therapeutics-presents-latest-advances-130000849.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo Therapeutics Presents Latest Advances In Zinc Finger Nuclease Platform Technology At Keystone Symposium On Precision Genome Engineering","publication_date":"2017-01-10 13:00:00 +0000","summary":"RICHMOND, Calif., Jan. 10, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO), the leader in therapeutic genome editing, today announced the presentation of key improvements to its technology platform for engineering highly specific zinc finger nucleases (ZFNs) for  therapeutic genome editing applications. The presentation was delivered January 9, 2017 by Edward Rebar, Ph.D., Sangamo's vice president, technology, an invited speaker at the Keystone Symposium on Precision Genome Engineering, which is being held this week in Breckenridge, CO. The data demonstrate genome editing of therapeutic gene targets in clinically relevant cell types, including high levels of targeted modification (80%) of the BCL11A enhancer in hematopoietic stem and progenitor cells at clinical scale with no significant off-target activity.  Off-target activity was assessed using state of the art assays involving unbiased oligonucleotide capture methods followed by deep sequencing.","url":"http://finance.yahoo.com/news/sangamo-therapeutics-presents-latest-advances-130000849.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"SANGAMO BIOSCIENCES INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financia","publication_date":"2017-01-06 13:16:23 +0000","summary":"SANGAMO BIOSCIENCES INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financia","url":"http://biz.yahoo.com/e/170106/sgmo8-k.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo BioSciences Changes Name To Sangamo Therapeutics, Underscoring Focus On Clinical Development Of Genomic Therapies","publication_date":"2017-01-06 13:00:00 +0000","summary":"RICHMOND, Calif., Jan. 6, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO), the leader in therapeutic genome editing, announces that it has changed its corporate name, from \"Sangamo BioSciences, Inc.\" to \"Sangamo Therapeutics, Inc.\" Sangamo common stock will continue to trade on the NASDAQ Global Select Market under the current ticker symbol: \"SGMO.\" The new corporate name underscores Sangamo's focus on clinical development of genomic therapies using the Company's industry-leading platform technologies across genome editing, gene therapy, gene regulation and cell therapy.","url":"http://finance.yahoo.com/news/sangamo-biosciences-changes-name-sangamo-130000940.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo BioSciences Changes Name To Sangamo Therapeutics, Underscoring Focus On Clinical Development Of Genomic Therapies","publication_date":"2017-01-06 13:00:00 +0000","summary":"[PR Newswire] - RICHMOND, Calif., Jan. 6, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO), the leader in therapeutic genome editing, announces that it has changed its corporate name, from \"Sangamo BioSciences, Inc.\" to \"Sangamo Therapeutics, Inc.\" Sangamo common stock will continue to trade on the NASDAQ Global Select Market under the current ticker symbol: \"SGMO.\" The new corporate name underscores Sangamo's focus on clinical development of genomic therapies using the Company's industry-leading platform technologies across genome editing, gene therapy, gene regulation and cell therapy.","url":"http://finance.yahoo.com/news/sangamo-biosciences-changes-name-sangamo-130000940.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-525 Gene Therapy Program For Hemophilia A","publication_date":"2017-01-05 13:04:06 +0000","summary":"[at noodls] - RICHMOND, Calif., Jan. 5, 2017 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug ...","url":"http://www.publicnow.com/view/90BC4AEC831EF792BBEFDF370092D093890FE179"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-525 Gene Therapy Program For Hemophilia A","publication_date":"2017-01-05 13:00:00 +0000","summary":"RICHMOND, Calif., Jan. 5, 2017 /PRNewswire/ -- Sangamo BioSciences, Inc. (SGMO) today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug application (IND) for its SB-525 gene therapy program for the treatment of  hemophilia A. The IND is now active and enables clinical development to assess the safety, tolerability and potential efficacy of SB-525 in adults with hemophilia A. \"We are very pleased to begin 2017 with the announcement of an open IND for our SB-525 cDNA gene therapy and intend to initiate a clinical trial evaluating SB-525 as soon as possible,\" said Sandy Macrae, M.B., Ch.B., Ph.D., CEO of Sangamo. SB-525 is one of four lead development programs for which Sangamo is planning to conduct clinical trials in 2017.","url":"http://finance.yahoo.com/news/sangamo-biosciences-announces-fda-clearance-130000811.html?.tsrc=rss"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo BioSciences Announces Presentation At The 35th Annual J.P. Morgan Healthcare Conference","publication_date":"2017-01-04 21:05:00 +0000","summary":"[PR Newswire] - RICHMOND, Calif., Jan. 4, 2017 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced today that Sandy Macrae, M.B., Ch.B., Ph.D, Sangamo's chief ...","url":"http://finance.yahoo.com/news/sangamo-biosciences-announces-presentation-35th-210500822.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"ETFs with exposure to Sangamo BioSciences, Inc. : December 21, 2016","publication_date":"2016-12-21 17:49:26 +0000","summary":"ETFs with exposure to Sangamo BioSciences, Inc. : December 21, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-sangamo-biosciences-inc-december-21-2016/"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Mid-Afternoon Market Update: Worthington Drops On Earnings Miss; Fred's Shares Spike Higher","publication_date":"2016-12-20 21:07:12 +0000","summary":"Toward the end of trading Tuesday the Dow traded up 0 43 percent to 19 968 87 while the NASDAQ rose 0 39 percent to 5 478 97 The S amp P also rose gaining 0 29 percent to 2 269 15 Leading and Lagging Sectors Basic materials shares gained around 0 77 percent in trading on","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9jOf1Z0j4jw/mid-afternoon-market-update-worthington-drops-on-earnings-miss-freds-shares-spike-higher-cm724282"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Is Preferred Apartment Communities Inc. (APTS) A Good Stock to Buy?","publication_date":"2016-12-12 22:44:29 +0000","summary":"Is Preferred Apartment Communities Inc. (APTS) A Good Stock to Buy?","url":"http://www.insidermonkey.com/blog/is-preferred-apartment-communities-inc-apts-a-good-stock-to-buy-506770/"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"ETFs with exposure to Sangamo BioSciences, Inc. : December 9, 2016","publication_date":"2016-12-09 19:01:47 +0000","summary":"ETFs with exposure to Sangamo BioSciences, Inc. : December 9, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-sangamo-biosciences-inc-december-9-2016/"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Mid-Morning Market Update: Markets Edge Lower; Ciena Profit Misses Estimates","publication_date":"2016-12-08 16:46:00 +0000","summary":"Following the market opening Thursday the Dow traded down 0 03 percent to 19 544 19 while the NASDAQ declined 0 02 percent to 5 392 81 The S amp P also fell dropping 0 06 percent to 2 240 02 Leading and Lagging Sectors Thursday morning basic materials shares gained by 0","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bM4fhspblOA/mid-morning-market-update-markets-edge-lower-ciena-profit-misses-estimates-cm718714"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"SANGAMO BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial State","publication_date":"2016-12-07 22:13:45 +0000","summary":"SANGAMO BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial State","url":"http://biz.yahoo.com/e/161207/sgmo8-k.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo BioSciences Presents Hemophilia A Program Data At The 2016 American Society Of Hematology Meeting","publication_date":"2016-12-06 00:30:00 +0000","summary":"[PR Newswire] - RICHMOND, Calif., Dec. 5, 2016 /PRNewswire/ -- Sangamo BioSciences, Inc. (SGMO), the leader in therapeutic genome editing, announced the presentation of preclinical and manufacturing data that support SB-525, its gene therapy program for hemophilia A, at the 58th Annual Meeting of the American Society of Hematology (ASH) being held in San Diego, CA, from December 3-6, 2016. \"We have developed an improved gene therapy vector for treatment of hemophilia A which we believe is highly competitive, and we remain on track to file an Investigational New Drug (IND) application for our clinical program by the end of 2016,\" said Sandy Macrae, M.B., Ch.B., Ph.D., Sangamo's president and chief executive officer. \"This program illustrates Sangamo's drug development capabilities beyond our ZFP platform.","url":"http://finance.yahoo.com/news/sangamo-biosciences-presents-hemophilia-program-003000346.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"What Smart Money Thinks about EZCORP Inc (EZPW)?","publication_date":"2016-12-05 18:33:27 +0000","summary":"What Smart Money Thinks about EZCORP Inc (EZPW)?","url":"http://www.insidermonkey.com/blog/what-smart-money-thinks-about-ezcorp-inc-ezpw-497709/"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Is Sangamo Biosciences, Inc. (SGMO) a Good Stock to Invest in?","publication_date":"2016-12-04 17:40:52 +0000","summary":"Is Sangamo Biosciences, Inc. (SGMO) a Good Stock to Invest in?","url":"http://www.insidermonkey.com/blog/is-sangamo-biosciences-inc-sgmo-a-good-stock-to-invest-in-497362/"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Biogen Spinoff Gets Gene Therapy Drugs (BIIB, SGMO)","publication_date":"2016-12-02 17:35:00 +0000","summary":"Biogen Spinoff Gets Gene Therapy Drugs (BIIB, SGMO)","url":"http://www.investopedia.com/news/biogens-gene-therapy-pipeline-bolstered-biib/?partner=YahooSA"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo's Genome Editing Program for Hemoglobinopathies to Transfer to Biogen's Spin-Off Bioverativ","publication_date":"2016-12-01 15:23:04 +0000","summary":"[at noodls] - RICHMOND, Calif., Nov. 30, 2016 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO), a leader in therapeutic genome editing, announced today that its collaborative zinc finger nuclease (ZFN)-mediated ...","url":"http://www.publicnow.com/view/A16BED80E0B171E8A2073D75C09194096B5FC0B3"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo BioSciences Makes Key Leadership Appointments To Strengthen Clinical And Commercial Capabilities","publication_date":"2016-12-01 15:21:27 +0000","summary":"[at noodls] - RICHMOND, Calif., Dec. 1, 2016 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced today key leadership appointments to strengthen the company's ...","url":"http://www.publicnow.com/view/22B91EB734363B7C5852E3753C5ED7C80D74C225"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo's Genome Editing Program for Hemoglobinopathies to Transfer to Biogen's Spin-Off Bioverativ","publication_date":"2016-11-30 12:00:00 +0000","summary":"[PR Newswire] - RICHMOND, Calif., Nov. 30, 2016 /PRNewswire/ -- Sangamo BioSciences, Inc. (SGMO), a leader in therapeutic genome editing, announced today that its collaborative zinc finger nuclease (ZFN)-mediated genome editing program for hemoglobinopathies will transfer to Bioverativ. \"Our collaboration with Biogen has been very successful, and we are delighted that these programs will be transitioning to Bioverativ,\" said Sandy Macrae, M.B., Ch.B., Ph.D., Sangamo's president and chief executive officer.","url":"http://finance.yahoo.com/news/sangamos-genome-editing-program-hemoglobinopathies-120000231.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo BioSciences Announces Participation At Upcoming Investor Conferences","publication_date":"2016-11-10 21:11:12 +0000","summary":"[at noodls] - RICHMOND, Calif., Nov. 10, 2016 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced today that Sandy Macrae, M.B., Ch.B., Ph.D., Sangamo's president ...","url":"http://www.publicnow.com/view/7FF12BC509D6F7C2AE85FAD4D873CC7F99BBFD2E"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"ETF’s with exposure to Sangamo BioSciences, Inc. : November 1, 2016","publication_date":"2016-11-01 16:19:55 +0000","summary":"ETF’s with exposure to Sangamo BioSciences, Inc. : November 1, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-sangamo-biosciences-inc-november-1-2016/"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo BioSci downgraded by Wedbush","publication_date":"2016-11-01 10:42:13 +0000","summary":"Sangamo BioSci downgraded by Wedbush","url":"http://finance.yahoo.com/q/ud?s=SGMO"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo BioSciences, Inc. :SGMO-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016","publication_date":"2016-10-31 16:08:07 +0000","summary":"Sangamo BioSciences, Inc. :SGMO-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016","url":"http://www.capitalcube.com/blog/index.php/sangamo-biosciences-inc-sgmo-us-earnings-analysis-q3-2016-by-the-numbers-october-31-2016/"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"SANGAMO BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report","publication_date":"2016-10-27 20:39:02 +0000","summary":"SANGAMO BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report","url":"http://biz.yahoo.com/e/161027/sgmo10-q.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Edited Transcript of SGMO earnings conference call or presentation 26-Oct-16 9:00pm GMT","publication_date":"2016-10-27 03:09:54 +0000","summary":"Edited Transcript of SGMO earnings conference call or presentation 26-Oct-16 9:00pm GMT","url":"http://finance.yahoo.com/news/edited-transcript-sgmo-earnings-conference-030954114.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo reports 3Q loss","publication_date":"2016-10-26 21:11:05 +0000","summary":"Sangamo reports 3Q loss","url":"http://sg.finance.yahoo.com/news/sangamo-reports-3q-loss-211105967.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"SANGAMO BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E","publication_date":"2016-10-26 20:32:28 +0000","summary":"SANGAMO BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E","url":"http://biz.yahoo.com/e/161026/sgmo8-k.html"},{"ticker":"SGMO","figi_ticker":"SGMO:US","figi":"BBG000BHYT80","title":"Sangamo BioSciences Reports Third Quarter 2016 Financial Results","publication_date":"2016-10-26 20:15:09 +0000","summary":"[at noodls] - RICHMOND, Calif., Oct. 26, 2016 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, today reported its third quarter 2016 financial results and provided ...","url":"http://www.publicnow.com/view/11FD5F26B94202527C4ACB76C9FFD33F4389C95D"}],"result_count":173,"page_size":100,"current_page":1,"total_pages":2,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"7.25"},{"x":"1494596100","y":"7.175"},{"x":"1494596400","y":"7.375"},{"x":"1494596700","y":"7.4855"},{"x":"1494597000","y":"7.6"},{"x":"1494597300","y":"7.525"},{"x":"1494597600","y":"7.5387"},{"x":"1494597900","y":"7.6"},{"x":"1494598200","y":"7.5225"},{"x":"1494598500","y":"7.55"},{"x":"1494598800","y":"7.695"},{"x":"1494599100","y":"7.625"},{"x":"1494599400","y":"7.5888"},{"x":"1494599700","y":"7.575"},{"x":"1494600000","y":"7.725"},{"x":"1494600300","y":"7.725"},{"x":"1494600600","y":"7.95"},{"x":"1494600900","y":"7.995"},{"x":"1494601200","y":"8.175"},{"x":"1494601500","y":"8.195"},{"x":"1494601800","y":"8.475"},{"x":"1494602100","y":"8.25"},{"x":"1494602400","y":"8.125"},{"x":"1494602700","y":"8"},{"x":"1494603000","y":"8.05"},{"x":"1494603300","y":"8.0728"},{"x":"1494603600","y":"8.25"},{"x":"1494603900","y":"8.1217"},{"x":"1494604200","y":"7.9"},{"x":"1494604500","y":"7.975"},{"x":"1494604800","y":"7.825"},{"x":"1494605100","y":"7.97"},{"x":"1494605400","y":"7.9"},{"x":"1494605700","y":"7.9"},{"x":"1494606000","y":"7.9"},{"x":"1494606300","y":"7.8"},{"x":"1494606600","y":"8.045"},{"x":"1494606900","y":"7.926"},{"x":"1494607200","y":"8.05"},{"x":"1494607500","y":"8.075"},{"x":"1494607800","y":"8.08"},{"x":"1494608100","y":"8.05"},{"x":"1494608400","y":"7.95"},{"x":"1494608700","y":"8.005"},{"x":"1494609000","y":"8.05"},{"x":"1494609300","y":"7.95"},{"x":"1494609600","y":"8"},{"x":"1494609900","y":"8.025"},{"x":"1494610200","y":"7.975"},{"x":"1494610500","y":"8.05"},{"x":"1494610800","y":"8.055"},{"x":"1494611100","y":"8.05"},{"x":"1494611400","y":"8.1"},{"x":"1494611700","y":"8.155"},{"x":"1494612000","y":"8.2"},{"x":"1494612300","y":"8.225"},{"x":"1494612600","y":"8.3"},{"x":"1494612900","y":"8.225"},{"x":"1494613200","y":"8.225"},{"x":"1494613500","y":"8.25"},{"x":"1494613800","y":"8.25"},{"x":"1494614100","y":"8.35"},{"x":"1494614400","y":"8.2"},{"x":"1494614700","y":"8.225"},{"x":"1494615000","y":"8.2725"},{"x":"1494615300","y":"8.2"},{"x":"1494615600","y":"8.325"},{"x":"1494615900","y":"8.245"},{"x":"1494616200","y":"8.075"},{"x":"1494616500","y":"8.025"},{"x":"1494616800","y":"8.125"},{"x":"1494617100","y":"8.075"},{"x":"1494617400","y":"8.05"},{"x":"1494617700","y":"8.15"},{"x":"1494618000","y":"8.15"},{"x":"1494618300","y":"8.095"},{"x":"1494618600","y":"8.125"},{"x":"1494618900","y":"8.2"},{"x":"1494619200","y":"8.2"} ], "color":"#03a9f4"}]},
{"id":"19","symbol": "SGYP","name": "Synergy Pharmaceuticals Inc","price": 4.33,"dollarChange": 0.46,"percentChange": 11.6,"open": 3.87,"high": 4.38,"low":3.84,"volume": 7896707,"avgVol": 5888855.350000,"sharesShort": 68557572,"shortPercent": 30.476813,"marketCap": 926773156,"float": 224949941,"headlines":{"data":[{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharma reports 1Q loss","publication_date":"2017-05-10 22:44:31 +0000","summary":"On a per-share basis, the New York-based company said it had a loss of 30 cents. The biopharmaceutical company posted revenue of $98,000 in the period. In the final minutes of trading on Wednesday, the ...","url":"http://finance.yahoo.com/news/synergy-pharma-reports-1q-loss-224431198.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals Reports First Quarter 2017 Financial Results and Business Update","publication_date":"2017-05-10 20:54:00 +0000","summary":"Synergy Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal therapies, today reported its financial results and business update for the three months ended March 31, 2017.","url":"http://finance.yahoo.com/news/synergy-pharmaceuticals-reports-first-quarter-205400164.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"InPlay from Briefing.com","publication_date":"2017-05-09 16:52:43 +0000","summary":"InPlay from Briefing.com","url":"http://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Scores Again: Trulance Product Meets Phase 3 Endpoints In Second Indication","publication_date":"2017-05-09 15:46:36 +0000","summary":"Synergy Pharmaceuticals Inc (NASDAQ: SGYP ) presented positive results from its Phase 3 study of plecanatide for the treatment of irritable bowel syndrome with constipation (IBS-C). In two large studies, ...","url":"http://finance.yahoo.com/news/synergy-scores-again-trulance-product-154636456.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals to Present Positive TRULANCE™ (Plecanatide) Phase 3 Data at Digestive Disease Week (DDW) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)","publication_date":"2017-05-09 15:45:00 +0000","summary":"Synergy Pharmaceuticals Inc. announced today that the company will present late-breaking data from Phase 3 studies evaluating TRULANCE™ for the treatment of adults with irritable bowel syndrome with constipation at Digestive Disease Week , May 6-9, 2017, in Chicago.","url":"http://finance.yahoo.com/news/synergy-pharmaceuticals-present-positive-trulance-154500385.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Presents New Insights at Digestive Disease Week (DDW) Examining Patient and Physician Perceptions and Experiences with Chronic Idiopathic Constipation (CIC)","publication_date":"2017-05-07 14:30:00 +0000","summary":"Synergy Pharmaceuticals Inc. today announced new insights that highlighted the frustrations many patients with chronic idiopathic constipation feel with managing their condition.","url":"http://finance.yahoo.com/news/synergy-presents-insights-digestive-disease-143000769.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals to Present TRULANCE™ (Plecanatide) Phase 3 Data at Digestive Disease Week (DDW) for the Treatment of Adults with Chronic Idiopathic Constipation (CIC) with Moderate to Very Severe Bloating","publication_date":"2017-05-07 14:30:00 +0000","summary":"Synergy Pharmaceuticals Inc. announced today that the company will present new data from an analysis of patients with moderate to very severe bloating at baseline who participated in two Phase 3 studies evaluating TRULANCE™ for the treatment of adults with chronic idiopathic constipation .","url":"http://finance.yahoo.com/news/synergy-pharmaceuticals-present-trulance-plecanatide-143000564.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals to Highlight New Data for TRULANCE™ (Plecanatide) at Digestive Disease Week (DDW)","publication_date":"2017-05-01 12:00:00 +0000","summary":"Synergy Pharmaceuticals Inc. today announced that the company will present six abstracts, including a late-breaker oral presentation showing new data on TRULANCE for the treatment of adults with irritable bowel syndrome with constipation , at Digestive Disease Week , May 6-9, 2017, in Chicago.","url":"http://finance.yahoo.com/news/synergy-pharmaceuticals-highlight-data-trulance-120000256.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals to Present at the 42nd Annual Deutsche Bank Healthcare Conference","publication_date":"2017-04-24 12:00:00 +0000","summary":"Synergy Pharmaceuticals Inc. today announced that the company will present a corporate update at the 42nd Annual Deutsche Bank Healthcare Conference in Boston on Wednesday, May 3, 2017 at 12:50 p.m.","url":"http://finance.yahoo.com/news/synergy-pharmaceuticals-present-42nd-annual-120000619.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals Appoints Gary G. Gemignani as Chief Financial Officer","publication_date":"2017-04-17 12:00:00 +0000","summary":"Synergy Pharmaceuticals Inc. today announced that Gary G. Gemignani has been appointed as Executive Vice President and Chief Financial Officer, effective April 17, 2017.","url":"http://finance.yahoo.com/news/synergy-pharmaceuticals-appoints-gary-g-120000030.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Biotech Movers: Synergy, Biogen, Insys","publication_date":"2017-04-13 13:21:00 +0000","summary":"Synergy Pharmaceuticals, Biogen and Insys Therapeutics were among the biotech stock movers in premarket trading on Thursday.","url":"http://finance.yahoo.com/r/80393725-d8f1-3ae3-b1a8-600304f7fae3/biotech-movers-synergy-biogen-insys.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"AERI's Rocket Hits Target, ENTL Gets FDA Nod, NOVN Jumps On Positive Trial Data","publication_date":"2017-04-13 02:26:00 +0000","summary":"AERI's Rocket Hits Target, ENTL Gets FDA Nod, NOVN Jumps On Positive Trial Data","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n95SzSbHyvU/aeris-rocket-hits-target-entl-gets-fda-nod-novn-jumps-on-positive-trial-data-20170413-00053"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Health Care Sector Update for 04/12/2017: SGYP","publication_date":"2017-04-12 13:55:04 +0000","summary":"Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE 0 2 PFE 0 2 ABT 0 4 ABT 0 4 MRK flatMRK flat AMGN flatAMGN flat Health care shares were mainly unchanged in pre market trade on Wednesday Health care shares were mainly unchanged in pre market trade on Wednesday","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LtLMy-LN0nc/health-care-sector-update-for-04122017-sgyp-cm773128"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Biotech Movers: Neurocrine Biosciences Leaps on Drug Approval, Synergy Pharma Issued Three Patents","publication_date":"2017-04-12 13:32:00 +0000","summary":"The company's shares were up 24% ahead of market's open on an FDA approval.","url":"http://finance.yahoo.com/r/0f72a008-31dc-340d-b957-01c7d894bcb1/biotech-movers-neurocrine-biosciences-leaps-on-drug-approval-synergy-pharma-issued-three-patents.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals Announces Issuance of Three New Patents Expected to Extend TRULANCE™ (Plecanatide) Patent Protection Until 2032","publication_date":"2017-04-12 12:00:00 +0000","summary":"Synergy Pharmaceuticals Inc. today announced that the United States Patent and Trademark Office has issued three new patents covering TRULANCE . The first patent relates to the method for manufacturing TRULANCE and will expire March 1, 2032.","url":"http://finance.yahoo.com/news/synergy-pharmaceuticals-announces-issuance-three-120000031.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"[$$] Overheard","publication_date":"2017-04-07 00:46:30 +0000","summary":"“Conversations about poop will never be the same.” So says Synergy Pharmaceuticals in launching its Poop Troop cast of emoji characters depicting an array of 14 different bowel movements.","url":"http://finance.yahoo.com/r/149edbde-e82a-3ee2-8c88-17908dcd3709/SB21280836134675634271604583069181804364560.html?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Drug Company's New Poop Emojis Make a Splash","publication_date":"2017-04-06 14:56:41 +0000","summary":"With animated poop emojis with names like \"Plugged-Up Paulie\" and \"Mr. Smooth,\" Synergy Pharmaceuticals hopes its come up with a way to encourage people to talk about constipation.","url":"http://finance.yahoo.com/r/d4aeaa1f-9f23-331f-8ac7-838930ac1cf4/drug-companys-new-poop-emojis-make-a-splash?mod=yahoo_hs&yptr=yahoo&.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Trevena, Synergy Lead Biotech Movers","publication_date":"2017-04-06 14:32:00 +0000","summary":"Positive phase three data was a boon for Trevena, but Synergy's \"Poop Troop\" put pressure on its stock.","url":"http://finance.yahoo.com/r/c21c0489-b0de-3075-8bf2-b8d2be4ac2f4/trevena-synergy-lead-biotech-movers.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals Launches the Poop Troop, the First Emoji Keyboard Designed to Support Dialogue Around Chronic Idiopathic Constipation (CIC)","publication_date":"2017-04-06 13:06:00 +0000","summary":"Synergy Pharmaceuticals today announced the launch of the Poop Troop, a series of 14 animated emojis designed to encourage conversation and allow people to better express the physical and emotional impact of chronic idiopathic constipation .","url":"http://finance.yahoo.com/news/synergy-pharmaceuticals-launches-poop-troop-130600305.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Pre-Market Most Active for Apr 6, 2017 : BSBR, MT, MBLY, ZLTQ, BAC, QQQ, XIV, JAZZ, FTR, CHK, SKM, SGYP","publication_date":"2017-04-06 12:53:31 +0000","summary":"The NASDAQ 100 Pre Market Indicator is up 5 44 to 5 423 96 The total Pre Market volume is currently 7 538 721 shares traded The following are the most active stocks for the pre market session Banco Santander Brasil SA BSBR is 0 15 at 8 21 with 3 284 770 shares","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q7V6uYCyrlY/pre-market-most-active-for-apr-6-2017-bsbr-mt-mbly-zltq-bac-qqq-xiv-jazz-ftr-chk-skm-sgyp-cm770590"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Pre-Market Most Active for Mar 30, 2017 : CVE, LULU, FTR, DB, TNXP, MT, UN, CRBP, SGYP, BPMC, COP, DNR","publication_date":"2017-03-30 12:59:14 +0000","summary":"The NASDAQ 100 Pre Market Indicator is up 98 to 5 431 25 The total Pre Market volume is currently 11 534 831 shares traded The following are the most active stocks for the pre market session Cenovus Energy Inc CVE is 1 05 at 12 03 with 3 468 242 shares traded CVE","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MkQXvFE4Ev8/pre-market-most-active-for-mar-30-2017-cve-lulu-ftr-db-tnxp-mt-un-crbp-sgyp-bpmc-cop-dnr-cm767593"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Synergy Pharmaceuticals Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors","publication_date":"2017-03-30 11:14:00 +0000","summary":"NEW YORK, March 30, 2017 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty ...","url":"http://finance.yahoo.com/news/shareholder-alert-purcell-julie-lefkowitz-111400821.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Synergy Pharmaceuticals Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors","publication_date":"2017-03-30 11:14:00 +0000","summary":"[PR Newswire] - NEW YORK, March 30, 2017 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty ...","url":"http://finance.yahoo.com/news/shareholder-alert-purcell-julie-lefkowitz-111400821.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2017-03-27 12:31:26 +0000","summary":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170327/sgyp8-k.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"8:01 am Synergy Pharma submits supplemental New Drug Application for TRULANCE (plecanatide) for the treatment of adults with irritable bowel syndrome with constipation","publication_date":"2017-03-27 12:01:00 +0000","summary":"8:01 am Synergy Pharma submits supplemental New Drug Application for TRULANCE (plecanatide) for the treatment of adults with irritable bowel syndrome with constipation","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#sgyp"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals Submits Supplemental New Drug Application (sNDA) for TRULANCE™ (Plecanatide) for the Treatment of Adults with Irritable Bowel Syndrome with Constipation (IBS-C)","publication_date":"2017-03-27 12:00:00 +0000","summary":"[Business Wire] - Synergy Pharmaceuticals Inc. announced today that the company has submitted a supplemental New Drug Application for TRULANCE™ for the treatment of adults with irritable bowel syndrome with constipation .","url":"http://finance.yahoo.com/news/synergy-pharmaceuticals-submits-supplemental-drug-120000657.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals Submits Supplemental New Drug Application (sNDA) for TRULANCE™ (Plecanatide) for the Treatment of Adults with Irritable Bowel Syndrome with Constipation (IBS-C)","publication_date":"2017-03-27 12:00:00 +0000","summary":"Synergy Pharmaceuticals Inc. announced today that the company has submitted a supplemental New Drug Application for TRULANCE™ for the treatment of adults with irritable bowel syndrome with constipation .","url":"http://finance.yahoo.com/news/synergy-pharmaceuticals-submits-supplemental-drug-120000657.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Submits SNDA For TRULANCE For Irritable Bowel Syndrome With Constipation","publication_date":"2017-03-27 08:38:00 +0000","summary":"Synergy Submits SNDA For TRULANCE For Irritable Bowel Syndrome With Constipation","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/enW32sdJTfc/synergy-submits-snda-for-trulance-for-irritable-bowel-syndrome-with-constipation-20170327-00532"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","publication_date":"2017-03-21 18:46:48 +0000","summary":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170321/sgyp8-k.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"After Hours Most Active for Mar 17, 2017 : FTR, DNR, LYG, URBN, RJF, PG, PFE, ARE, TTWO, FSLR, HBAN, SGYP","publication_date":"2017-03-17 21:06:16 +0000","summary":"The NASDAQ 100 After Hours Indicator is up 85 to 5 409 61 The total After hours volume is currently 388 829 621 shares traded The following are the most active stocks for the after hours session Frontier Communications Corporation FTR is 0 01 at 2 46 with 142 471","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w6ni4IeK2EU/after-hours-most-active-for-mar-17-2017-ftr-dnr-lyg-urbn-rjf-pg-pfe-are-ttwo-fslr-hban-sgyp-cm762442"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"SGYP Crosses Below Key Moving Average Level","publication_date":"2017-03-17 17:07:08 +0000","summary":"In trading on Friday shares of Synergy Pharmaceuticals Inc Symbol SGYP crossed below their 200 day moving average of 5 08 changing hands as low as 5 02 per share Synergy Pharmaceuticals Inc shares are currently trading down about 3 6 on the day The chart below shows the one","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6L_pTVy-tHU/sgyp-crosses-below-key-moving-average-level-cm762309"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2017-03-14 13:32:11 +0000","summary":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170314/sgyp8-k.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals to Present at Oppenheimer 27th Annual Healthcare Conference","publication_date":"2017-03-14 12:30:00 +0000","summary":"[Business Wire] - Synergy Pharmaceuticals Inc. today announced that Marino Garcia, the company’s EVP and Chief Strategy Officer, will present a corporate update at the Oppenheimer 27th Annual Healthcare Conference on Tuesday, March 21, 2017 at 11:30 a.m.","url":"http://finance.yahoo.com/news/synergy-pharmaceuticals-present-oppenheimer-27th-123000303.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals to Present at Oppenheimer 27th Annual Healthcare Conference","publication_date":"2017-03-14 12:30:00 +0000","summary":"Synergy Pharmaceuticals Inc. today announced that Marino Garcia, the company’s EVP and Chief Strategy Officer, will present a corporate update at the Oppenheimer 27th Annual Healthcare Conference on Tuesday, March 21, 2017 at 11:30 a.m.","url":"http://finance.yahoo.com/news/synergy-pharmaceuticals-present-oppenheimer-27th-123000303.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals: Approval, Now What?","publication_date":"2017-03-13 14:08:16 +0000","summary":"Shares of Synergy Pharmaceuticals NASDAQ SGYP 160 are up more than 100 from their 2016 lows and the company finally received FDA approval of its drug Trulance plecanatide in January of this year However since the drug s approval the stock has traded down over 20 due to","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CCKVQ4IYkds/synergy-pharmaceuticals-approval-now-what-cm759912"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals: Approval, Now What?","publication_date":"2017-03-13 13:29:00 +0000","summary":"Is Synergy a buy on the post-approval dip?","url":"http://finance.yahoo.com/r/6affd217-291f-3bc9-84ec-8cce63ebb462/synergy-pharmaceuticals-approval-now-what.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals: Approval, Now What?","publication_date":"2017-03-13 13:29:00 +0000","summary":"Synergy Pharmaceuticals: Approval, Now What?","url":"http://www.fool.com/investing/2017/03/13/synergy-pharmaceuticals-approval-now-what.aspx"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"SYNERGY PHARMACEUTICALS, INC. Financials","publication_date":"2017-03-07 18:04:17 +0000","summary":"SYNERGY PHARMACEUTICALS, INC. Financials","url":"http://finance.yahoo.com/q/is?s=sgyp"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"CORRECTING and REPLACING Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Business Update","publication_date":"2017-03-02 21:45:00 +0000","summary":"Please replace the release, dated March 1, 2017, with the following corrected version due to multiple revisions in the Financial Results bullets and financial tables.","url":"http://finance.yahoo.com/news/correcting-replacing-synergy-pharmaceuticals-reports-214500956.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"CORRECTING and REPLACING Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Business Update","publication_date":"2017-03-02 21:45:00 +0000","summary":"[Business Wire] - Please replace the release, dated March 1, 2017, with the following corrected version due to multiple revisions in the Financial Results bullets and financial tables.","url":"http://finance.yahoo.com/news/correcting-replacing-synergy-pharmaceuticals-reports-214500956.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements","publication_date":"2017-03-02 21:02:21 +0000","summary":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements","url":"http://biz.yahoo.com/e/170302/sgyp8-k.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report","publication_date":"2017-03-01 22:15:02 +0000","summary":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report","url":"http://biz.yahoo.com/e/170301/sgyp10-k.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharma reports 4Q loss","publication_date":"2017-03-01 22:12:49 +0000","summary":"Synergy Pharma reports 4Q loss","url":"http://sg.finance.yahoo.com/news/synergy-pharma-reports-4q-loss-221249895.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharma reports 4Q loss","publication_date":"2017-03-01 22:12:49 +0000","summary":"The New York-based company said it had a loss of 31 cents per share. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was ...","url":"http://finance.yahoo.com/news/synergy-pharma-reports-4q-loss-221249394.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Business Update","publication_date":"2017-03-01 21:42:00 +0000","summary":"[Business Wire] - Synergy Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal therapies, today reported its financial results and business update for the full year and the three months ended December 31, 2016.","url":"http://finance.yahoo.com/news/synergy-pharmaceuticals-reports-fourth-quarter-214200709.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Business Update","publication_date":"2017-03-01 21:42:00 +0000","summary":"Synergy Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal therapies, today reported its financial results and business update for the full year and the three months ended December 31, 2016.","url":"http://finance.yahoo.com/news/synergy-pharmaceuticals-reports-fourth-quarter-214200709.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Did 50 Salespeople Leave Valeant? Wells Fargo Investigates","publication_date":"2017-02-23 16:07:00 +0000","summary":"Did 50 Salespeople Leave Valeant? Wells Fargo Investigates","url":"http://blogs.barrons.com/stockstowatchtoday/2017/02/23/did-50-salespeople-leave-valeant-wells-fargo-investigates/?mod=yahoobarrons&ru=yahoo"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Did 50 Salespeople Leave Valeant? Wells Fargo Investigates","publication_date":"2017-02-23 16:07:00 +0000","summary":"Wells Fargo's and his team reiterated an Underperform rating and $10 to $13 valuation range on Valeant Pharmaceuticals (VRX) Thursday, following talks with the firm about recents staffing moves. First they asked Valeant to address rumors in the industry that some 50 of its gastrointestinal (GI) salespeople recently left Valeant en masse to join Synergy Pharmaceuticals (SGYP) following the FDA’s approval of Synergy’s plecanatide in January. Maris writes: We reached out to Synergy Pharmaceuticals which would only comment that it has been very successful in hiring a large number of experienced salespeople, many with 10+ years in GI sales.","url":"http://finance.yahoo.com/r/21a95999-8ad3-314b-b6d1-055f87c2c3b0/did-50-salespeople-leave-valeant-wells-fargo-investigates?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Why President Trump Wants To Transform The FDA – And What It Could Mean For Biotech Stocks","publication_date":"2017-02-23 15:07:35 +0000","summary":"Why President Trump Wants To Transform The FDA – And What It Could Mean For Biotech Stocks","url":"http://www.insidermonkey.com/blog/why-president-trump-wants-to-transform-the-fda-and-what-it-could-mean-for-biotech-stocks-561604/"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","publication_date":"2017-02-15 15:37:42 +0000","summary":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170215/sgyp8-k.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"After Hours Most Active for Feb 10, 2017 : KMI, BAC, CTB, KO, WFT, KKR, FB, MENT, ARRY, MSFT, SGYP, MU","publication_date":"2017-02-10 21:57:31 +0000","summary":"The NASDAQ 100 After Hours Indicator is down 1 62 to 5 225 07 The total After hours volume is currently 30 103 756 shares traded The following are the most active stocks for the after hours session Kinder Morgan Inc KMI is 0 0317 at 22 45 with 8 050 347","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/58Jr5jKs7zI/after-hours-most-active-for-feb-10-2017-kmi-bac-ctb-ko-wft-kkr-fb-ment-arry-msft-sgyp-mu-cm746577"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2017-02-08 15:42:43 +0000","summary":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170208/sgyp8-k.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals to Present at Leerink Partners 6th Annual Global Healthcare Conference","publication_date":"2017-02-08 13:30:00 +0000","summary":"Synergy Pharmaceuticals Inc. today announced that Marino Garcia, the company’s EVP and Chief Strategy Officer, will participate in a fireside chat at Leerink Partners 6th Annual Global Healthcare Conference on Wednesday, February 15, 2017 at 11:00 a.m.","url":"http://finance.yahoo.com/news/synergy-pharmaceuticals-present-leerink-partners-133000300.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals to Present at Leerink Partners 6th Annual Global Healthcare Conference","publication_date":"2017-02-08 13:30:00 +0000","summary":"[Business Wire] - Synergy Pharmaceuticals Inc. today announced that Marino Garcia, the company’s EVP and Chief Strategy Officer, will participate in a fireside chat at Leerink Partners 6th Annual Global Healthcare Conference on Wednesday, February 15, 2017 at 11:00 a.m.","url":"http://finance.yahoo.com/news/synergy-pharmaceuticals-present-leerink-partners-133000300.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2017-02-07 17:31:06 +0000","summary":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170207/sgyp8-k.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Pivotal Phase 3 Data Results for TRULANCE™ (plecanatide) in the Treatment of Chronic Idiopathic Constipation (CIC) Published in American Journal of Gastroenterology","publication_date":"2017-02-07 14:30:00 +0000","summary":"Synergy Pharmaceuticals Inc. today announced that the American Journal of Gastroenterology has published detailed results from a pivotal Phase 3 trial that demonstrated the efficacy and safety of TRULANCE™ for the treatment of adults with chronic idiopathic constipation .","url":"http://finance.yahoo.com/news/pivotal-phase-3-data-results-143000324.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Pivotal Phase 3 Data Results for TRULANCE™ (plecanatide) in the Treatment of Chronic Idiopathic Constipation (CIC) Published in American Journal of Gastroenterology","publication_date":"2017-02-07 14:30:00 +0000","summary":"[Business Wire] - Synergy Pharmaceuticals Inc. today announced that the American Journal of Gastroenterology has published detailed results from a pivotal Phase 3 trial that demonstrated the efficacy and safety of TRULANCE™ for the treatment of adults with chronic idiopathic constipation .","url":"http://finance.yahoo.com/news/pivotal-phase-3-data-results-143000324.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"3 Beaten Biotech Stocks That Are Set to Rebound","publication_date":"2017-02-07 01:16:59 +0000","summary":"InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips There is nothing worse than getting stuck holding a speculative biotechnology stock just after it crashes That is the norm biotech stocks are inherently risky Their valuation depends on good clinical","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U_44DGj21r0/3-beaten-biotech-stocks-that-are-set-to-rebound-cm743935"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Price For Synergy Pharmaceuticals Inc (SGYP) Public Offering Announced","publication_date":"2017-02-03 11:22:02 +0000","summary":"Price For Synergy Pharmaceuticals Inc (SGYP) Public Offering Announced","url":"http://www.insidermonkey.com/blog/price-for-synergy-pharmaceuticals-inc-sgyp-public-offering-announced-530626/"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Price For Synergy Pharmaceuticals Inc (SGYP) Public Offering Announced","publication_date":"2017-02-03 11:22:02 +0000","summary":"Synergy Pharmaceuticals Inc (NASDAQ:SGYP) has revealed that the price of its common stock through its upcoming public offering will be $6.15 a share. This is before deductions have been made for commissions, discounts and other expenses incurred in the course of the issuance. In the public offering, there will be 20,325,204 shares made available. The […]","url":"http://finance.yahoo.com/r/228c9ae5-335d-364c-a536-1f9e79848f6e/price-for-synergy-pharmaceuticals-inc-sgyp-public-offering-announced-530626?yptr=yahoo&.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial","publication_date":"2017-02-02 21:44:28 +0000","summary":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial","url":"http://biz.yahoo.com/e/170202/sgyp8-k.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Prices Public Offering Of 20.33 Mln Shares At $6.15/Shr","publication_date":"2017-02-02 07:31:00 +0000","summary":"Synergy Prices Public Offering Of 20.33 Mln Shares At $6.15/Shr","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q4VIU8_Z44A/synergy-prices-public-offering-of-2033-mln-shares-at-615shr-20170202-00484"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Why Synergy Pharmaceuticals Shares Fell 14.6% Today","publication_date":"2017-02-02 00:31:32 +0000","summary":"IMAGE SOURCE GETTY IMAGES What happened Synergy Pharmaceuticals NASDAQ SGYP 160 announced a 125 million stock offering yesterday and shares slipped 14 6 today after the company announced it s pricing the offering at 6 15 per share So what","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hfE61LYRJJ4/why-synergy-pharmaceuticals-shares-fell-146-today-cm741916"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Why Synergy Pharmaceuticals Shares Fell 14.6% Today","publication_date":"2017-02-01 22:46:38 +0000","summary":"Investors moved to the sidelines after the company priced a dilutive stock offering.","url":"http://finance.yahoo.com/r/bb565b79-11c3-3917-804e-3b541991bac8/why-synergy-pharmaceuticals-shares-fell-146-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2&yptr=yahoo&.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Why Synergy Pharmaceuticals Shares Fell 14.6% Today","publication_date":"2017-02-01 22:46:38 +0000","summary":"Why Synergy Pharmaceuticals Shares Fell 14.6% Today","url":"http://www.fool.com/investing/general/2017/02/01/why-synergy-pharmaceuticals-shares-fell-146-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Gainers & Losers Of The Day: PULM, ETRM, SMMT, BVX, ARQL...","publication_date":"2017-02-01 22:29:00 +0000","summary":"Gainers & Losers Of The Day: PULM, ETRM, SMMT, BVX, ARQL...","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZB_dn9p9tLw/gainers--losers-of-the-day-pulm-etrm-smmt-bvx-arql-20170201-01814"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Health Care Sector Update for 02/01/2017: SGYP,SMMT,CATB","publication_date":"2017-02-01 18:51:31 +0000","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 47 JNJ 0 47 PFE 0 10 PFE 0 10 MRK 1 17 MRK 1 17 ABT 0 42 ABT 0 42 AMGN 1 55 AMGN 1 55 Health care stocks were little changed in afternoon trade Wednesday with the NYSE Health Care Index adding about 0 1 in value today while","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kAiR0L0ciDo/health-care-sector-update-for-02012017-sgypsmmtcatb-cm741745"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"How to Trade Hot Stocks Apple, Seadrill, Advanced Micro Devices","publication_date":"2017-02-01 17:18:00 +0000","summary":"Here's how to trade seven of the most active stocks on the market on Wednesday afternoon.","url":"http://finance.yahoo.com/r/6129fe7c-2f28-3259-a738-1449aa5ee0e6/how-to-trade-hot-stocks-apple-seadrill-advanced-micro-devices.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"How to Trade Hot Stocks Apple, Seadrill, Advanced Micro Devices","publication_date":"2017-02-01 17:18:00 +0000","summary":"How to Trade Hot Stocks Apple, Seadrill, Advanced Micro Devices","url":"https://www.thestreet.com/story/13974993/1/how-to-trade-hot-stocks-apple-seadrill-advanced-micro-devices.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals","publication_date":"2017-02-01 16:35:18 +0000","summary":"For Immediate Release Chicago IL February 01 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WJiBKnPfQLo/the-zacks-analyst-blog-highlights-synergy-pharmaceuticals-amgen-valeant-pharmaceuticals-international-celgene-and-lexicon-pharmaceuticals-cm741587"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Fail, win and then fail some more to become a winning trader","publication_date":"2017-02-01 14:50:33 +0000","summary":"Fail, win and then fail some more to become a winning trader","url":"http://finance.yahoo.com/tumblr/blog-fail-win-and-then-fail-some-more-to-become-a-145045350.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals","publication_date":"2017-02-01 14:30:02 +0000","summary":"The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals","url":"http://finance.yahoo.com/news/zacks-analyst-blog-highlights-synergy-143002700.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals","publication_date":"2017-02-01 14:30:02 +0000","summary":"The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals","url":"http://finance.yahoo.com/news/zacks-analyst-blog-highlights-synergy-143002700.html?.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Premarket Biotech Movers: Synergy, Arrowhead, BioCryst","publication_date":"2017-02-01 14:23:00 +0000","summary":"Premarket Biotech Movers: Synergy, Arrowhead, BioCryst","url":"https://www.thestreet.com/story/13974452/1/premarket-biotech-movers-synergy-arrowhead-biocryst.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Premarket Biotech Movers: Synergy, Arrowhead, BioCryst","publication_date":"2017-02-01 14:23:00 +0000","summary":"Synergy Pharmaceuticals, Arrowhead Pharmaceuticals and BioCryst Pharmaceuticals were among the biotech stock movers in premarket trading on Wednesday.","url":"http://finance.yahoo.com/r/f76b4c82-f4c6-34f1-ac6f-f62ddf279e72/premarket-biotech-movers-synergy-arrowhead-biocryst.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Pre-Market Most Active for Feb 1, 2017 : AAPL, SN, CHU, BAC, UNVR, SGYP, LOCK, VALE, TVIX, FB, FHB, XIV","publication_date":"2017-02-01 13:51:34 +0000","summary":"The NASDAQ 100 Pre Market Indicator is up 40 37 to 5 157 14 The total Pre Market volume is currently 10 141 339 shares traded The following are the most active stocks for the pre market session Apple Inc AAPL is 5 69 at 127 04 with 1 935 967 shares traded Over","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lzC7H68-O0U/pre-market-most-active-for-feb-1-2017-aapl-sn-chu-bac-unvr-sgyp-lock-vale-tvix-fb-fhb-xiv-cm741370"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharma stock sinks 12.5% after announcement of common stock offering","publication_date":"2017-02-01 13:17:52 +0000","summary":"Synergy Pharma stock sinks 12.5% after announcement of common stock offering","url":"http://www.marketwatch.com/News/Story/Story.aspx?guid=FCF3D73C-097A-4448-8022-188F1B55E54E&siteid=yhoof2"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharma stock sinks 12.5% after announcement of common stock offering","publication_date":"2017-02-01 13:17:52 +0000","summary":"Synergy Pharmaceuticals Inc. shares sunk 12.5% in pre-market trade Wednesday after the company said it would offer 20 million shares of its common stock at $6.15 per share. Synergy shares were priced at ...","url":"http://finance.yahoo.com/r/b1ca76ee-5b75-35af-825f-913434325408/Story.aspx?guid=FCF3D73C-097A-4448-8022-188F1B55E54E&siteid=yhoof2&yptr=yahoo&.tsrc=rss"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals Announces Pricing of Public Offering of Common Stock","publication_date":"2017-02-01 13:00:00 +0000","summary":"[Business Wire] - Synergy Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal therapies, today announced the pricing of its underwritten public offering of 20,325,204 shares of its common stock at a price to the public of $6.15 per share, before deducting underwriting discounts and commissions and other estimated offering expenses.","url":"http://finance.yahoo.com/news/synergy-pharmaceuticals-announces-pricing-public-130000012.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"After Hours Most Active for Jan 31, 2017 : AAPL, C, IBN, SGYP, WMB, T, WFT, MSFT, SIRI, GE, GPOR, INTC","publication_date":"2017-01-31 22:01:31 +0000","summary":"The NASDAQ 100 After Hours Indicator is up 16 96 to 5 133 73 The total After hours volume is currently 49 748 165 shares traded The following are the most active stocks for the after hours session Apple Inc AAPL is 3 35 at 124 70 with 4 063 082 shares traded","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2zv-sx_yGOI/after-hours-most-active-for-jan-31-2017-aapl-c-ibn-sgyp-wmb-t-wft-msft-siri-ge-gpor-intc-cm741175"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals Announces Proposed Public Offering of Common Stock","publication_date":"2017-01-31 21:01:00 +0000","summary":"[Business Wire] - Synergy Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal therapies, today announced an agreement to sell $125 million of its common stock to an underwriting syndicate led by Cantor Fitzgerald & Co., in a registered underwritten public offering.","url":"http://finance.yahoo.com/news/synergy-pharmaceuticals-announces-proposed-public-210100994.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"4 FDA Decisions to Watch Out for in Feb 2017","publication_date":"2017-01-31 13:33:30 +0000","summary":"Last year there was a notable dip in FDA novel drug approvals with the agency giving its nod to 22 treatments well below the 45 approvals in 2015 and 41 in 2014 So far in 2017 only one drug has gained approval Synergy Pharmaceuticals Inc s SGYP Trulance for the treatment of","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fs_oSg_FQn8/4-fda-decisions-to-watch-out-for-in-feb-2017-cm740607"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"4 FDA Decisions to Watch Out for in Feb 2017","publication_date":"2017-01-31 11:43:11 +0000","summary":"4 FDA Decisions to Watch Out for in Feb 2017","url":"http://finance.yahoo.com/news/4-fda-decisions-watch-feb-114311066.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Ironwood-Allergan Linzess Gets FDA Approval in Lower Dose","publication_date":"2017-01-27 16:36:22 +0000","summary":"Ironwood Pharmaceuticals Inc IRWD and partner Allergan plc AGN announced that the FDA has approved a lower dose strength of Linzess linaclotide 72 mcg for the treatment of adult patients with chronic idiopathic constipation CIC The lower dose is expected to be available in the U","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K3EBVP1WRgM/ironwood-allergan-linzess-gets-fda-approval-in-lower-dose-cm739395"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"5 Small-Cap Biotech Stocks to Buy in February","publication_date":"2017-01-26 21:28:51 +0000","summary":"5 Small-Cap Biotech Stocks to Buy in February","url":"http://www.fool.com/investing/2017/01/25/5-small-cap-biotech-stocks-to-buy-in-february.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Biotech Stocks Facing FDA Decision In February","publication_date":"2017-01-26 04:48:00 +0000","summary":"Biotech Stocks Facing FDA Decision In February","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dqQ5wiKja1s/biotech-stocks-facing-fda-decision-in-february-20170126-00181"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"5 Small-Cap Biotech Stocks to Buy in February","publication_date":"2017-01-25 22:32:04 +0000","summary":"Looking to add a few thrills to your investing portfolio Small cap biotech stocks should be a good place to start They come with significant risks but the potential rewards are great Here s why Celldex Therapeutics NASDAQ CLDX Geron NASDAQ GERN Halozyme","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fqiiWgVFwR8/5-small-cap-biotech-stocks-to-buy-in-february-cm738331"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"FDA Approves Trulance From Synergy Pharmaceuticals Inc (SGYP) To Battle With Allergan PLC (AGN) Linzess","publication_date":"2017-01-25 15:09:14 +0000","summary":"FDA Approves Trulance From Synergy Pharmaceuticals Inc (SGYP) To Battle With Allergan PLC (AGN) Linzess","url":"http://www.insidermonkey.com/blog/fda-approves-trulance-from-synergy-pharmaceuticals-inc-sgyp-to-battle-with-allergan-plc-agn-linzess-524187/"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"UPDATE 1-Synergy wins U.S. approval for constipation drug (Jan 19)","publication_date":"2017-01-24 16:23:19 +0000","summary":"[Reuters] - The U.S. Food and Drug Administration said on Thursday it had approved Synergy Pharmaceuticals Inc's drug to treat chronic idiopathic constipation (CIC). CIC, which affects 14 percent of the global population, is a type of gastrointestinal disorder where individuals have difficult and infrequent bowel movements. Trulance met the main goals of two late-stage studies in December on irritable bowel syndrome patients with constipation (IBS-C).","url":"http://finance.yahoo.com/news/1-synergy-wins-u-approval-162319240.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Are Options Traders Betting on a Big Move in Synergy Pharmaceuticals (SGYP) Stock?","publication_date":"2017-01-24 15:35:44 +0000","summary":"Investors in Synergy Pharmaceuticals Inc SGYP need to pay close attention to the stock based on moves in the options market lately That is because the Feb 17 th 2017 8 Call had some of the highest implied volatility of all equity options today 160 What is Implied","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C8QHY8R5-lQ/are-options-traders-betting-on-a-big-move-in-synergy-pharmaceuticals-sgyp-stock-cm737266"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Are Options Traders Betting on a Big Move in Synergy Pharmaceuticals (SGYP) Stock?","publication_date":"2017-01-24 13:32:01 +0000","summary":"Are Options Traders Betting on a Big Move in Synergy Pharmaceuticals (SGYP) Stock?","url":"http://finance.yahoo.com/news/options-traders-betting-big-move-133201790.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Bristol-Myers Squibb, Merck, Synergy Pharmaceuticals: Doug Kass' Views","publication_date":"2017-01-23 06:00:00 +0000","summary":"Bristol-Myers Squibb, Merck, Synergy Pharmaceuticals: Doug Kass' Views","url":"https://www.thestreet.com/story/13961393/1/bristol-myers-squibb-merck-synergy-pharmaceuticals-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Mid-Day Market Update: Crude Oil Up 2.8%; Bristol-Myers Squibb Shares Slide After Opdivo Decision","publication_date":"2017-01-20 18:17:24 +0000","summary":"Midway through trading Friday the Dow traded up 0 44 percent to 19 818 98 while the NASDAQ climbed 0 33 percent to 5 558 31 The S amp P also rose gaining 0 40 percent to 2 272 77 Leading and Lagging Sectors Non cyclical consumer goods amp services shares gained around 1 02","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xnrpjRnANNc/mid-day-market-update-crude-oil-up-28-bristol-myers-squibb-shares-slide-after-opdivo-decision-cm736135"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy (SGYP) Trulance Wins FDA Approval for Constipation","publication_date":"2017-01-20 15:43:10 +0000","summary":"Synergy Pharmaceuticals Inc SGYP announced that the FDA has approved one of its lead pipeline candidates Trulance plecanatide for the treatment of adults suffering from chronic idiopathic constipation CIC It is expected to hit U S market by the end of first quarter 2017 Synergy s","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nbJLHPzi1Sg/synergy-sgyp-trulance-wins-fda-approval-for-constipation-cm735927"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy Pharmaceuticals Secures Approval for Linzess Competitor","publication_date":"2017-01-20 15:37:00 +0000","summary":"Synergy Pharmaceuticals Secures Approval for Linzess Competitor","url":"https://www.thestreet.com/story/13960531/1/synergy-pharmaceuticals-secures-approval-for-linzess-competitor.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"FDA OKs Synergy Pharmaceuticals Constipation Drug","publication_date":"2017-01-20 14:37:00 +0000","summary":"FDA OKs Synergy Pharmaceuticals Constipation Drug","url":"http://www.investopedia.com/news/synergy-constipation-drug-gets-fda-approval-sgyp/?partner=YahooSA"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Pre-Market Most Active for Jan 20, 2017 : BMY, SGYP, PG, GE, BAC, MRK, FTI, QQQ, TVIX, AFAM, CSX, VOD","publication_date":"2017-01-20 13:57:11 +0000","summary":"The NASDAQ 100 Pre Market Indicator is up 8 69 to 5 059 86 The total Pre Market volume is currently 5 865 611 shares traded The following are the most active stocks for the pre market session Bristol Myers Squibb Company BMY is 4 06 at 51 43 with 1 661 206","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x5Sl5MY-LSw/pre-market-most-active-for-jan-20-2017-bmy-sgyp-pg-ge-bac-mrk-fti-qqq-tvix-afam-csx-vod-cm735871"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"Synergy (SGYP) Trulance Wins FDA Approval for Constipation","publication_date":"2017-01-20 13:38:01 +0000","summary":"Synergy (SGYP) Trulance Wins FDA Approval for Constipation","url":"http://finance.yahoo.com/news/synergy-sgyp-trulance-wins-fda-133801466.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","publication_date":"2017-01-20 11:03:23 +0000","summary":"SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","url":"http://biz.yahoo.com/e/170120/sgyp8-k.html"},{"ticker":"SGYP","figi_ticker":"SGYP:US","figi":"BBG000PR6951","title":"ADMP Waiting To See If 3rd Time Is Charm, FDA Nod For SGYP, Be All Ears For OTIC","publication_date":"2017-01-20 02:30:00 +0000","summary":"ADMP Waiting To See If 3rd Time Is Charm, FDA Nod For SGYP, Be All Ears For OTIC","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5V4t5bWZVv0/admp-waiting-to-see-if-3rd-time-is-charm-fda-nod-for-sgyp-be-all-ears-for-otic-20170120-00071"}],"result_count":276,"page_size":100,"current_page":1,"total_pages":3,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"3.92"},{"x":"1494596100","y":"3.96"},{"x":"1494596400","y":"3.985"},{"x":"1494596700","y":"4.07"},{"x":"1494597000","y":"4.0338"},{"x":"1494597300","y":"4.065"},{"x":"1494597600","y":"4.09"},{"x":"1494597900","y":"4.115"},{"x":"1494598200","y":"4.095"},{"x":"1494598500","y":"4.095"},{"x":"1494598800","y":"4.106"},{"x":"1494599100","y":"4.05"},{"x":"1494599400","y":"4.07"},{"x":"1494599700","y":"4.08"},{"x":"1494600000","y":"4.065"},{"x":"1494600300","y":"4.03"},{"x":"1494600600","y":"4.06"},{"x":"1494600900","y":"4.075"},{"x":"1494601200","y":"4.075"},{"x":"1494601500","y":"4.075"},{"x":"1494601800","y":"4.07"},{"x":"1494602100","y":"4.05"},{"x":"1494602400","y":"4.04"},{"x":"1494602700","y":"4.075"},{"x":"1494603000","y":"4.09"},{"x":"1494603300","y":"4.145"},{"x":"1494603600","y":"4.16"},{"x":"1494603900","y":"4.145"},{"x":"1494604200","y":"4.17"},{"x":"1494604500","y":"4.19"},{"x":"1494604800","y":"4.26"},{"x":"1494605100","y":"4.235"},{"x":"1494605400","y":"4.33"},{"x":"1494605700","y":"4.38"},{"x":"1494606000","y":"4.34"},{"x":"1494606300","y":"4.37"},{"x":"1494606600","y":"4.3301"},{"x":"1494606900","y":"4.295"},{"x":"1494607200","y":"4.345"},{"x":"1494607500","y":"4.345"},{"x":"1494607800","y":"4.3609"},{"x":"1494608100","y":"4.33"},{"x":"1494608400","y":"4.26"},{"x":"1494608700","y":"4.26"},{"x":"1494609000","y":"4.32"},{"x":"1494609300","y":"4.329"},{"x":"1494609600","y":"4.375"},{"x":"1494609900","y":"4.34"},{"x":"1494610200","y":"4.315"},{"x":"1494610500","y":"4.315"},{"x":"1494610800","y":"4.29"},{"x":"1494611100","y":"4.31"},{"x":"1494611400","y":"4.305"},{"x":"1494611700","y":"4.29"},{"x":"1494612000","y":"4.309"},{"x":"1494612300","y":"4.345"},{"x":"1494612600","y":"4.34"},{"x":"1494612900","y":"4.335"},{"x":"1494613200","y":"4.335"},{"x":"1494613500","y":"4.33"},{"x":"1494613800","y":"4.35"},{"x":"1494614100","y":"4.325"},{"x":"1494614400","y":"4.335"},{"x":"1494614700","y":"4.325"},{"x":"1494615000","y":"4.325"},{"x":"1494615300","y":"4.325"},{"x":"1494615600","y":"4.3288"},{"x":"1494615900","y":"4.305"},{"x":"1494616200","y":"4.325"},{"x":"1494616500","y":"4.32"},{"x":"1494616800","y":"4.3253"},{"x":"1494617100","y":"4.315"},{"x":"1494617400","y":"4.315"},{"x":"1494617700","y":"4.315"},{"x":"1494618000","y":"4.33"},{"x":"1494618300","y":"4.34"},{"x":"1494618600","y":"4.37"},{"x":"1494618900","y":"4.325"},{"x":"1494619200","y":"4.33"} ], "color":"#03a9f4"}]},
{"id":"20","symbol": "TANH","name": "Tantech Holdings Ltd","price": 2.3072,"dollarChange": 0.46,"percentChange": 24.72,"open": 1.8599999999999999,"high": 2.36,"low":1.8599999999999999,"volume": 347443,"avgVol": 64642.216667,"sharesShort": 53101,"shortPercent": 0.218415,"marketCap": 37734660,"float": 24311935,"headlines":{"data":[{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. Announces Fiscal Year 2016 Financial Results","publication_date":"2017-05-01 20:10:00 +0000","summary":"LISHUI, China, May 1, 2017 /PRNewswire/ -- Tantech Holdings Ltd. (NASDAQ: TANH), (\"Tantech\" or the \"Company\"), a leading alternative energy company through the use of bamboo-based charcoal ...","url":"http://finance.yahoo.com/news/tantech-holdings-ltd-announces-fiscal-201000607.html?.tsrc=rss"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"2:33 pm Tantech CEO Wang Zhengyu issues letter to shareholders to share the 'exciting progress at Tantech Holdings' and the co's plans for the upcoming year","publication_date":"2017-02-23 19:33:00 +0000","summary":"2:33 pm Tantech CEO Wang Zhengyu issues letter to shareholders to share the 'exciting progress at Tantech Holdings' and the co's plans for the upcoming year","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#tanh"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Chairman and CEO Sees Growth for Tantech Holdings","publication_date":"2017-02-23 19:30:00 +0000","summary":"[PR Newswire] - LISHUI, China, Feb. 23, 2017 /PRNewswire/ -- Tantech Holdings Limited (NASDAQ: TANH) (\"Tantech\" or \"the Company\"), a leading manufacturer of bamboo-based charcoal products, today announced ...","url":"http://finance.yahoo.com/news/tantech-chairman-ceo-sees-growth-193000799.html"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Chairman and CEO Sees Growth for Tantech Holdings","publication_date":"2017-02-23 19:30:00 +0000","summary":"LISHUI, China, Feb. 23, 2017 /PRNewswire/ -- Tantech Holdings Limited (NASDAQ: TANH) (\"Tantech\" or \"the Company\"), a leading manufacturer of bamboo-based charcoal products, today announced ...","url":"http://finance.yahoo.com/news/tantech-chairman-ceo-sees-growth-193000799.html?.tsrc=rss"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech-led Research Recognized by Zhejiang Science and Technology Department","publication_date":"2017-01-09 13:00:00 +0000","summary":"LISHUI, China, Jan. 9, 2017 /PRNewswire/ -- Recently, Tantech Holdings Ltd. (NASDAQ:TANH) (\"Tantech\" or the \"Company\"), a leading manufacturer of bamboo-based charcoal products, announced the research program led by its R&D center that focused on techniques converting agricultural residues into charcoal fuels has been included by the Science and Technology Department of Zhejiang Province into its key agricultural projects for the period from 2016 to 2018, and obtained 1.4 million yuan worth of subsidies from the provincial department. The program was initiated by Zhejiang Tantech Energy Technology Co., Ltd, a wholly-owned subsidiary of Tantech, and has received technical assistance from Zhejiang Forestry Academy and Zhejiang University of Technology.","url":"http://finance.yahoo.com/news/tantech-led-research-recognized-zhejiang-130000968.html?.tsrc=rss"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech-led Research Recognized by Zhejiang Science and Technology Department","publication_date":"2017-01-09 13:00:00 +0000","summary":"[PR Newswire] - LISHUI, China, Jan. 9, 2017 /PRNewswire/ -- Recently, Tantech Holdings Ltd. (NASDAQ:TANH) (\"Tantech\" or the \"Company\"), a leading manufacturer of bamboo-based charcoal products, announced the research program led by its R&D center that focused on techniques converting agricultural residues into charcoal fuels has been included by the Science and Technology Department of Zhejiang Province into its key agricultural projects for the period from 2016 to 2018, and obtained 1.4 million yuan worth of subsidies from the provincial department. The program was initiated by Zhejiang Tantech Energy Technology Co., Ltd, a wholly-owned subsidiary of Tantech, and has received technical assistance from Zhejiang Forestry Academy and Zhejiang University of Technology.","url":"http://finance.yahoo.com/news/tantech-led-research-recognized-zhejiang-130000968.html"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"TANTECH HOLDINGS LTD Financials","publication_date":"2016-12-24 18:04:05 +0000","summary":"TANTECH HOLDINGS LTD Financials","url":"http://finance.yahoo.com/q/is?s=tanh&annual"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. Announces Interim Six Month Financial Results For 2016","publication_date":"2016-12-22 22:00:00 +0000","summary":"[PR Newswire] - LISHUI, China, Dec. 22, 2016 /PRNewswire/ -- Tantech Holdings Ltd. (NASDAQ:TANH), (\"Tantech\" or the \"Company\"), a leading manufacturer of bamboo-based charcoal products, today announced ...","url":"http://finance.yahoo.com/news/tantech-holdings-ltd-announces-interim-220000846.html"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. Announces Interim Six Month Financial Results For 2016","publication_date":"2016-12-22 22:00:00 +0000","summary":"LISHUI, China, Dec. 22, 2016 /PRNewswire/ -- Tantech Holdings Ltd. (NASDAQ:TANH), (\"Tantech\" or the \"Company\"), a leading manufacturer of bamboo-based charcoal products, today announced ...","url":"http://finance.yahoo.com/news/tantech-holdings-ltd-announces-interim-220000846.html?.tsrc=rss"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Develops High Value Added Products With Great Absorption Capacity","publication_date":"2016-12-08 13:00:00 +0000","summary":"[PR Newswire] - LISHUI, China, Dec. 8, 2016 /PRNewswire/ -- Tantech Holdings Ltd. (TANH) (Nasdaq: TANH) (\"Tantech\" or the \"Company\") announced today that it has successfully developed the new generation of infrared bamboo charcoal bedding articles, which feature excellent absorption, infrared and self-warming properties. The new generation of infrared bamboo charcoal bedding articles includes bamboo charcoal fiber bedclothes, health-care mattress and pillows.","url":"http://finance.yahoo.com/news/tantech-develops-high-value-added-130000709.html"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Develops High Value Added Products With Great Absorption Capacity","publication_date":"2016-12-08 13:00:00 +0000","summary":"LISHUI, China, Dec. 8, 2016 /PRNewswire/ -- Tantech Holdings Ltd. (TANH) (Nasdaq: TANH) (\"Tantech\" or the \"Company\") announced today that it has successfully developed the new generation of infrared bamboo charcoal bedding articles, which feature excellent absorption, infrared and self-warming properties. The new generation of infrared bamboo charcoal bedding articles includes bamboo charcoal fiber bedclothes, health-care mattress and pillows.","url":"http://finance.yahoo.com/news/tantech-develops-high-value-added-130000709.html?.tsrc=rss"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech CEO delivers speech at 2016 China Concepts Stock Renaissance Forum","publication_date":"2016-11-21 13:00:00 +0000","summary":"[PR Newswire] - BEIJING, Nov. 21, 2016 /PRNewswire/ -- On Nov. 19, Wang Zhengyu, Chairman and Chief Executive of Tantech Holdings Ltd. (NASDAQ: TANH) (\"Tantech\" or the \"Company\"), a leading manufacturer of bamboo charcoal products, attended the 2016 China Concepts Stock Renaissance Forum (the \"Forum\") in Beijing. The forum was jointly organized People.cn, the online edition of People's Daily and Meimei Securities, owner of U.S. broker Whitewood Group. Peng Su, chief representative of New York Stock Exchange (NYSE) Beijing Office, delivered a keynote address on Investment Logic and Prospect of China Concepts Stock.","url":"http://finance.yahoo.com/news/tantech-ceo-delivers-speech-2016-130000374.html"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"TANH Obtains Official Approval for Three EV Models","publication_date":"2016-11-10 13:00:00 +0000","summary":"[PR Newswire] - LISHUI, China, Nov. 10, 2016 /PRNewswire/ -- Tantech Holdings Ltd (TANH) (the \"Company\" or \"TANH\") announced today that the Ministry of Industry and Information Technology of the People's Republic of China (MIIT) has included its three electric vehicle models in the \"Announcement of Road Motor Vehicle Manufacturing Enterprises and Products\" (No.284 and No. 285 New Product Catalog Announcement). The three vehicles are produced by the company's subsidiary Suzhou E Motors Buses Co., Ltd.","url":"http://finance.yahoo.com/news/tanh-obtains-official-approval-three-130000111.html"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. Seizes the Initiative in the Field of Green Vehicles","publication_date":"2016-10-03 12:00:00 +0000","summary":"[PR Newswire] - LISHUI, China, Oct. 3, 2016 /PRNewswire/ -- Tantech Holdings Ltd. (TANH) (\"Tantech\" or the \"Company\"), a leading manufacturer of bamboo-based charcoal products, announced today that it participated in the 2016 Chinese New Energy Vehicles Power Battery Industrial Technology Development Summit Forum (the \"Forum\") held in Suzhou City, Jiangsu Province on September 23, 2016. On the Forum, there were six brand new electric buses traveling through various venues being used as conference reception vehicles. The newly developed electric bus is none other than the flagship product of Suzhou E Motors Co., Ltd. (\"Suzhou E Motors\"), a specialty electric vehicles and power batteries manufacturer based in Zhangjiagang City, Jiangsu Province, and whose 100% acquisition by Tantech will soon be completed.","url":"http://finance.yahoo.com/news/tantech-holdings-ltd-seizes-initiative-120000298.html"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd.: Sudden move in price, will it continue?","publication_date":"2016-09-20 20:23:11 +0000","summary":"Categories: Yahoo Finance Tantech Holdings Ltd. relative valuation is UNDERVALUED and it has a fundamental analysis score of 75. Our analysis is based on comparing Tantech Holdings Ltd. with the following peers – NL Industries, Inc., Chemtura Corporation, FMC Corporation and PolyOne Corporation (NL-US, CHMT-US, FMC-US and POL-US). Tantech Holdings Ltd. has shown underwhelming performance overall, both over ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/e60a9dcd-5c08-3ef8-96cd-b3ef1e385038/tantech-holdings-ltd-sudden-move-in-price-will-it-continue?yptr=yahoo&.tsrc=rss"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd.: Sudden move in price, will it continue?","publication_date":"2016-09-20 20:23:11 +0000","summary":"Tantech Holdings Ltd.: Sudden move in price, will it continue?","url":"http://www.capitalcube.com/blog/index.php/tantech-holdings-ltd-sudden-move-in-price-will-it-continue/"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. Acquires 5% Minority Interest in Its PRC Operating Subsidiary","publication_date":"2016-06-24 12:00:00 +0000","summary":"[PR Newswire] - LISHUI, China, June 24, 2016 /PRNewswire/ -- Tantech Holdings Ltd. (NASDAQ: TANH) (\"Tantech\" or the \"Company\"), a leading manufacturer of bamboo-based charcoal products, announced today ...","url":"http://finance.yahoo.com/news/tantech-holdings-ltd-acquires-5-120000180.html"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd.: Gathering momentum, can it sustain its performance?","publication_date":"2016-06-21 20:29:49 +0000","summary":"Tantech Holdings Ltd.: Gathering momentum, can it sustain its performance?","url":"http://www.capitalcube.com/blog/index.php/tantech-holdings-ltd-gathering-momentum-can-it-sustain-its-performance/"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd.: Gathering momentum, can it sustain its performance?","publication_date":"2016-06-21 20:29:49 +0000","summary":"Tantech Holdings Ltd. relative valuation is NEUTRAL and it has a fundamental analysis score of 75.Our analysis is based on comparing Tantech Holdings Ltd. with the following peers – NL Industries, Inc., Chemtura Corporation, FMC Corporation and PolyOne Corporation (NL-US, CHMT-US, FMC-US and POL-US).Tantech Holdings Ltd. has shown underwhelming performance over the last one year […] \n<b>(Read more...)</b> The post Tantech Holdings Ltd.: Gathering momentum, can it sustain its performance? appeared first on CapitalCube.","url":"http://finance.yahoo.com/r/d9e4e044-c6b2-3438-a48b-832db31af810/tantech-holdings-ltd-gathering-momentum-can-it-sustain-its-performance?yptr=yahoo&.tsrc=rss"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. :TANH-US: Earnings Analysis: 2015 By the Numbers","publication_date":"2016-05-04 13:58:24 +0000","summary":"Tantech Holdings Ltd. :TANH-US: Earnings Analysis: 2015 By the Numbers","url":"http://www.capitalcube.com/blog/index.php/tantech-holdings-ltd-tanh-us-earnings-analysis-2015-by-the-numbers/"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. :TANH-US: Earnings Analysis: 2015 By the Numbers","publication_date":"2016-05-04 13:58:24 +0000","summary":"Click here to see latest analysisTantech Holdings Ltd. reports financial results for the year ended December 31, 2015.We analyze the earnings along side the following peers of Tantech Holdings Ltd. – Chemtura Corporation, FMC Corporation and PolyOne Corporation (CHMT-US, FMC-US and POL-US) that have also reported for this period.HighlightsGross margins narrowed from 31.51% to 28.70% […] \n<b>(Read more...)</b> The post Tantech Holdings Ltd. :TANH-US: Earnings Analysis: 2015 By the Numbers appeared first on CapitalCube.","url":"http://finance.yahoo.com/r/c25a8c32-36ca-30ba-86ab-1b26efd87ffb/tantech-holdings-ltd-tanh-us-earnings-analysis-2015-by-the-numbers?.tsrc=rss"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. Signs Definite Agreement to Acquire Suzhou E Motors","publication_date":"2016-05-02 13:00:00 +0000","summary":"[PR Newswire] - LISHUI, China, May 2, 2016 /PRNewswire/ -- Tantech Holdings Ltd. (NASDAQ: TANH) (\"Tantech\" or the \"Company\"), a leading manufacturer of bamboo-based charcoal products, announced today ...","url":"http://finance.yahoo.com/news/tantech-holdings-ltd-signs-definite-130000106.html"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. Announces Full Year 2015 Financial Results","publication_date":"2016-04-29 20:30:00 +0000","summary":"[PR Newswire] - LISHUI, China, April 29, 2016 /PRNewswire/-- Tantech Holdings Ltd. (NASDAQ:TANH), (\"Tantech\" or the \"Company\"), a leading manufacturer of bamboo-based charcoal products, today announced ...","url":"http://finance.yahoo.com/news/tantech-holdings-ltd-announces-full-203000528.html"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. CEO Elected as Vice Chair of the Newly Formed New Energy Vehicle Alliance of Zhejiang Province","publication_date":"2016-04-18 13:00:00 +0000","summary":"[PR Newswire] - LISHUI, China, April 18, 2016 /PRNewswire/ -- Tantech Holdings Ltd. (NASDAQ: TANH) (\"Tantech\" or the \"Company\"), a leading manufacturer of bamboo-based charcoal products, announced ...","url":"http://finance.yahoo.com/news/tantech-holdings-ltd-ceo-elected-130000835.html"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. Celebrated First Anniversary of IPO","publication_date":"2016-03-25 09:19:34 +0000","summary":"[at noodls] - ( Date:2016-3-25) On March.24, 2016, Tantech Holdings Ltd. (TANH) celebrated first Anniversary of IPO. Held in Lishui headquarters, the ceremony brought together corporate executives and employee representatives ...","url":"http://www.publicnow.com/view/D4FE63FD485F2AD3F629D1E6F7B131DA68FB33EA"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. Completes $8 million Private Placement","publication_date":"2016-03-07 13:00:00 +0000","summary":"[PR Newswire] - LISHUI, China, March 7, 2016 /PRNewswire/ -- Tantech Holdings Ltd. (NASDAQ: TANH) (\"Tantech\" or the \"Company\"), a leading manufacturer of bamboo-based charcoal products, announced today ...","url":"http://finance.yahoo.com/news/tantech-holdings-ltd-completes-8-130000155.html"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. Enters into Framework Agreement to Acquire Electric Vehicles Company","publication_date":"2016-01-28 08:38:15 +0000","summary":"[at noodls] - ( Date:2016-1-28) LISHUI, China, Jan. 27, 2016 /PRNewswire/ -- Tantech Holdings Ltd. (TANH) ('Tantech' or the 'Company'), a leading manufacturer of bamboo-based charcoal products, announced today that ...","url":"http://www.publicnow.com/view/A966F61C262A8615D161DF1F2A035852F3602D3C"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Shares Of Tantech Holdings Pop Following Acquisition Announcement","publication_date":"2016-01-27 18:27:03 +0000","summary":"Shares of Tantech Holdings Ltd (NASDAQ: TANH ), a small cap developer and manufacturer of bamboo-based charcoal products, were trading higher by more than 4 percent on Wednesday. Tantech Holdings reported ...","url":"http://finance.yahoo.com/news/shares-tantech-holdings-pop-following-182703328.html?.tsrc=rss"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Shares Of Tantech Holdings Pop Following Acquisition Announcement","publication_date":"2016-01-27 18:27:03 +0000","summary":"Shares Of Tantech Holdings Pop Following Acquisition Announcement","url":"http://finance.yahoo.com/news/shares-tantech-holdings-pop-following-182703328.html"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. Enters into Framework Agreement to Acquire Electric Vehicles Company","publication_date":"2016-01-27 13:40:00 +0000","summary":"[PR Newswire] - LISHUI, China, Jan. 27, 2016 /PRNewswire/ -- Tantech Holdings Ltd. (NASDAQ: TANH) (\"Tantech\" or the \"Company\"), a leading manufacturer of bamboo-based charcoal products, announced today ...","url":"http://finance.yahoo.com/news/tantech-holdings-ltd-enters-framework-134000742.html"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. Announces Interim Six Month Financial Results For 2015","publication_date":"2015-12-14 02:21:20 +0000","summary":"[at noodls] - ( Date:2015-12-14) LISHUI, China, Dec. 8, 2015 /PRNewswire/-- Tantech Holdings Ltd. (TANH), ('Tantech' or the 'Company'), a leading manufacturer of bamboo-based charcoal products, today announced its financial ...","url":"http://www.noodls.com/view/B107A88012F83A052B81B313FE7AD78C8D0C68A8"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. Announces Interim Six Month Financial Results For 2015","publication_date":"2015-12-08 21:30:00 +0000","summary":"[PR Newswire] - LISHUI, China, Dec. 8, 2015 /PRNewswire/-- Tantech Holdings Ltd. (NASDAQ:TANH), (\"Tantech\" or the \"Company\"), a leading manufacturer of bamboo-based charcoal products, today announced ...","url":"http://finance.yahoo.com/news/tantech-holdings-ltd-announces-interim-213000666.html"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"What's Moving the Markets - Research on Tantech Holdings, Platinum Group Metals, Limelight Networks, and PERION NETWORK","publication_date":"2015-11-23 13:15:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / November 23, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Tantech Holdings ...","url":"http://finance.yahoo.com/news/whats-moving-markets-research-tantech-131500876.html?.tsrc=rss"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"What's Moving the Markets - Research on Tantech Holdings, Platinum Group Metals, Limelight Networks, and PERION NETWORK","publication_date":"2015-11-23 13:15:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / November 23, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Tantech Holdings ...","url":"http://finance.yahoo.com/news/whats-moving-markets-research-tantech-131500876.html"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. CEO Delivers a Keynote Address at the 2015 Zhejiang Province New Energy Vehicle Forum","publication_date":"2015-11-18 03:07:14 +0000","summary":"[at noodls] - ( Date:2015-11-18) LISHUI, China, Nov. 17, 2015 /PRNewswire/ -- Tantech Holdings Ltd. (TANH) ('Tantech' or the 'Company'), a leading manufacturer of bamboo-based charcoal products, announced today that ...","url":"http://www.noodls.com/view/FE7D02FE7A782C0D5A91C3C805EAF992691CDF6A"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. CEO Delivers a Keynote Address at the 2015 Zhejiang Province New Energy Vehicle Forum","publication_date":"2015-11-17 21:30:00 +0000","summary":"[PR Newswire] - LISHUI, China, Nov. 17, 2015 /PRNewswire/ -- Tantech Holdings Ltd. (NASDAQ: TANH) (\"Tantech\" or the \"Company\"), a leading manufacturer of bamboo-based charcoal products, announced today ...","url":"http://finance.yahoo.com/news/tantech-holdings-ltd-ceo-delivers-213000669.html"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. Establishes Wholly-Owned PRC Subsidiary for its BBQ Products","publication_date":"2015-11-12 03:46:07 +0000","summary":"[at noodls] - ( Date:2015-11-4) LISHUI, China, Nov. 3, 2015 /PRNewswire/ -- Tantech Holdings Ltd. (TANH) ('Tantech' or the 'Company'), a leading manufacturer of bamboo-based charcoal products, announced today that it ...","url":"http://www.noodls.com/view/D33467DF7BB0353A1D2D72011D73AFCC5A337B3C"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Director Yefang Zhang was elected as a member of Zhejiang Entrepreneur Council","publication_date":"2015-11-05 02:48:09 +0000","summary":"[at noodls] - ( Date:2015-10-25) Oct.25, 2015, the inauguration ceremony of Zhejiang Entrepreneur Council was held in Hangzhou, Zhejiang. Ma Yun from Alibaba was elected as the first chairman and Director Yefang Zhang ...","url":"http://www.noodls.com/view/3A126C5066592C4769904F2A26580392615F7967"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings Ltd. breached its 50 day moving average in a Bearish Manner : September 23, 2015","publication_date":"2015-09-23 13:59:18 +0000","summary":"Tantech Holdings Ltd. breached its 50 day moving average in a Bearish Manner : September 23, 2015","url":"http://www.capitalcube.com/blog/index.php/tantech-holdings-ltd-breached-its-50-day-moving-average-in-a-bearish-manner-september-23-2015/"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Zhengyu Wang Attened 2015 Global Leadership Forum","publication_date":"2015-09-14 06:26:03 +0000","summary":"[at noodls] - ( Date:2015-9-14) August 27, 2015, Beijing, CHINA - Marcum Bernstein & Pinchuk LLP helds its 2015 Global Leadership Forum, more than 200 industrial leaders and experts attended the Forum. This one-day ...","url":"http://www.noodls.com/view/462070124A43C7B3EFE9B66F7AD7F452A3BC0963"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Thursday Sector Leaders: Chemicals, Precious Metals","publication_date":"2015-08-20 19:02:43 +0000","summary":"In trading on Thursday, chemicals shares were relative leaders, up on the day by about 9.1%. Leading the group were shares of Tantech Holdings ( TANH ) up about 2.9% on the day. Also showing relative strength are precious","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R2d2WnBSmMQ/thursday-sector-leaders-chemicals-precious-metals-cm511330"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Etsy, Party City, Virtu Likely to Shape IPO Landscape for Rest of 2015","publication_date":"2015-04-15 18:15:24 +0000","summary":"Etsy, Party City, Virtu Likely to Shape IPO Landscape for Rest of 2015","url":"http://247wallst.com/investing/2015/04/15/etsy-party-city-virtu-likely-to-shape-ipo-landscape-for-rest-of-2015/"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Week ahead: Up to 3 small IPOs could price during the week of April 6","publication_date":"2015-04-06 15:11:12 +0000","summary":"After an impressive IPO from GoDaddy last week , up to three IPOs could price this week. It appears unlikely that any will raise over $50 million.ViewRay ( VRAY ) had planned to go public during the last two","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wl8oZ-f64n0/week-ahead-up-to-3-small-ipos-could-price-during-the-week-of-april-6-cm462154"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"GoDaddy Tops IPO Issues for the Coming Week","publication_date":"2015-03-29 12:31:02 +0000","summary":"GoDaddy Tops IPO Issues for the Coming Week","url":"http://247wallst.com/investing/2015/03/29/godaddy-tops-ipo-issues-for-the-coming-week/"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Will GoDaddy Put Some Excitement Back in the IPO Market?","publication_date":"2015-03-27 13:15:08 +0000","summary":"Will GoDaddy Put Some Excitement Back in the IPO Market?","url":"http://247wallst.com/technology-3/2015/03/27/will-godaddy-put-some-excitement-back-in-the-ipo-market/"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Tantech Holdings prices IPO at $4, the low end of the range","publication_date":"2015-03-26 16:06:04 +0000","summary":"Tantech Holdings, a Chinese manufacturer of household bamboo charcoal products, raised $13 million by offering 3.2 million shares at $4, the low end of the range of $4 to $6. Tantech Holdings trades on the NASDAQ under the symbol","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8ofgH9NO6xs/tantech-holdings-prices-ipo-at-4-the-low-end-of-the-range-cm459240"},{"ticker":"TANH","figi_ticker":"TANH:US","figi":"BBG0074G7GQ3","title":"Mystery IPO Doubles On Debut","publication_date":"2015-03-24 19:31:59 +0000","summary":"Mystery IPO Doubles On Debut","url":"http://247wallst.com/investing/2015/03/24/mystery-ipo-doubles-on-debut/"}],"result_count":47,"page_size":100,"current_page":1,"total_pages":1,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"1.8599999999999999"},{"x":"1494596700","y":"1.9264999999999999"},{"x":"1494597600","y":"1.9001000000000001"},{"x":"1494598200","y":"1.95"},{"x":"1494598500","y":"1.95"},{"x":"1494599100","y":"2"},{"x":"1494599400","y":"2"},{"x":"1494599700","y":"1.99"},{"x":"1494600000","y":"2.03"},{"x":"1494600300","y":"2.017"},{"x":"1494600600","y":"2.06"},{"x":"1494600900","y":"2.01"},{"x":"1494601200","y":"1.99"},{"x":"1494601800","y":"1.99"},{"x":"1494602700","y":"2"},{"x":"1494603300","y":"2"},{"x":"1494603600","y":"2.0099"},{"x":"1494604500","y":"1.99"},{"x":"1494606300","y":"2.01"},{"x":"1494606600","y":"2.01"},{"x":"1494607800","y":"2.01"},{"x":"1494608100","y":"2.0118"},{"x":"1494608400","y":"2.032"},{"x":"1494608700","y":"2.05"},{"x":"1494609000","y":"2.051"},{"x":"1494609300","y":"2.1358"},{"x":"1494609600","y":"2.11"},{"x":"1494609900","y":"2.14"},{"x":"1494610800","y":"2.14"},{"x":"1494611400","y":"2.1289"},{"x":"1494611700","y":"2.14"},{"x":"1494612000","y":"2.13"},{"x":"1494612300","y":"2.18"},{"x":"1494612600","y":"2.2"},{"x":"1494612900","y":"2.23"},{"x":"1494613200","y":"2.2522"},{"x":"1494613500","y":"2.2586"},{"x":"1494613800","y":"2.3"},{"x":"1494614100","y":"2.3066"},{"x":"1494614400","y":"2.34"},{"x":"1494614700","y":"2.34"},{"x":"1494615000","y":"2.33"},{"x":"1494615300","y":"2.34"},{"x":"1494615600","y":"2.3289"},{"x":"1494615900","y":"2.24"},{"x":"1494616200","y":"2.2800000000000002"},{"x":"1494616500","y":"2.29"},{"x":"1494616800","y":"2.3"},{"x":"1494617100","y":"2.3"},{"x":"1494617400","y":"2.2896"},{"x":"1494617700","y":"2.32"},{"x":"1494618000","y":"2.34"},{"x":"1494618300","y":"2.34"},{"x":"1494618600","y":"2.32"},{"x":"1494618900","y":"2.3072"} ], "color":"#03a9f4"}]},
{"id":"21","symbol": "TGTX","name": "TG Therapeutics Inc","price": 11.75,"dollarChange": 0.7,"percentChange": 6.34,"open": 11.05,"high": 12.2,"low":11,"volume": 1480209,"avgVol": 2577806.250000,"sharesShort": 12849475,"shortPercent": 19.242901,"marketCap": 738321827,"float": 66775146,"headlines":{"data":[{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. :TGTX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017","publication_date":"2017-05-12 14:55:04 +0000","summary":"Categories: Yahoo FinanceGet free summary analysis TG Therapeutics, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of TG Therapeutics, Inc. – Navidea Biopharmaceuticals, Inc., Histogenics Corp. and Infinity Pharmaceuticals, Inc. (NAVB-US, HSGX-US and INFI-US) that have also reported for this period. Highlights Summary numbers: Revenues ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/7a318dc0-f646-3c20-a966-6503403e861f/tg-therapeutics-inc-tgtx-us-earnings-analysis-q1-2017-by-the-numbers-may-12-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. – Value Analysis (NASDAQ:TGTX) : May 11, 2017","publication_date":"2017-05-11 23:41:27 +0000","summary":"Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives TG Therapeutics, Inc. a score of 14. Our analysis is based on comparing TG Therapeutics, Inc. with the following peers – Dr. Reddy’s Laboratories Ltd. Sponsored ADR, Navidea Biopharmaceuticals, Inc., Histogenics Corp. and Infinity Pharmaceuticals, Inc. (RDY-US, NAVB-US, HSGX-US and INFI-US). Investment Outlook TG Therapeutics, Inc. has ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/0c4e74aa-7c7b-3925-8526-2a50266b587f/tg-therapeutics-inc-value-analysis-nasdaqtgtx-may-11-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : TGTX-US : May 10, 2017","publication_date":"2017-05-10 12:16:03 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for TG Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/aa01893a-336f-37e2-885f-ced5bd9100bf/tg-therapeutics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-tgtx-us-may-10-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"3 Intriguing Cancer Drugs With Data Coming at ASCO Next Month","publication_date":"2017-05-05 12:22:00 +0000","summary":"The annual American Society of Clinical Oncology meeting is always a market-moving event, and presentations on Epizyme, NewLink Genetics, and TG Therapeutics drugs could cause their shares to soar or plummet.","url":"http://finance.yahoo.com/r/94df97c9-2d2c-3115-972b-c0d390df65fc/3-intriguing-cancer-drugs-with-data-coming-at-asco.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics reports 1Q loss","publication_date":"2017-05-05 11:42:29 +0000","summary":"The New York-based company said it had a loss of 52 cents per share. The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was ...","url":"http://finance.yahoo.com/news/tg-therapeutics-reports-1q-loss-114229866.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. Provides Business Update and Reports First Quarter 2017 Financial Results","publication_date":"2017-05-05 11:30:00 +0000","summary":"NEW YORK, May 05, 2017-- TG Therapeutics, Inc. today announced its financial results for the first quarter ended March 31, 2017 and recent company developments.. Michael S. Weiss, the Company's Executive ...","url":"http://finance.yahoo.com/news/tg-therapeutics-inc-provides-business-113000947.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. to Host Conference Call on First Quarter 2017 Financial Results and Business Update","publication_date":"2017-05-03 20:30:00 +0000","summary":"NEW YORK, May 03, 2017-- TG Therapeutics, Inc., today announced that a conference call will be held on Friday May 5, 2017 at 8:30am ET to discuss results for the first quarter of 2017 and provide a business ...","url":"http://finance.yahoo.com/news/tg-therapeutics-inc-host-conference-203000376.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"3 Best Biotech Stocks During Trump's First 100 Days","publication_date":"2017-05-01 20:28:44 +0000","summary":"Donald Trump won the U S presidency on promises to lower drug prices Yet biotech stocks have outperformed the S amp P 500 since his move into the White House and some biotech stocks have more than doubled since his inauguration on Jan 20 Among the best performing of these","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xgwgadSMZw0/3-best-biotech-stocks-during-trumps-first-100-days-cm782239"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"3 Best Biotech Stocks During Trump&apos;s First 100 Days","publication_date":"2017-05-01 18:32:00 +0000","summary":"Big catalysts at Esperion Therapeutics, Aurinia Pharmaceuticals, and TG Therapeutics have resulted in eye-popping returns during the first 100 days of Donald Trump&apos;s presidency.","url":"http://finance.yahoo.com/r/ab4a4101-06de-3b9b-8601-1d6344c430bb/3-best-biotech-stocks-during-trumps-first-100-days.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics Announces Preliminary Results from Ongoing Phase 2 Study of TG-1101 (ublituximab) in Patients with Multiple Sclerosis at the American Academy of Neurology 69th Annual Meeting","publication_date":"2017-04-28 12:30:00 +0000","summary":"MS patients treated with TG-1101 exhibited median B-cell depletion of 99% at week 4. TG-1101 was well tolerated with no grade 3/ 4 adverse events reported, with median time on study of 5 months. NEW YORK, ...","url":"http://finance.yahoo.com/news/tg-therapeutics-announces-preliminary-results-123000407.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"ETFs with exposure to TG Therapeutics, Inc. : April 26, 2017","publication_date":"2017-04-26 19:38:56 +0000","summary":"Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to TG Therapeutics, Inc. Here are 5 ETFs with the largest exposure to TGTX-US. Comparing the performance and risk of TG Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/e224dae4-a0a2-3c24-93aa-ecd201c13a85/etfs-with-exposure-to-tg-therapeutics-inc-april-26-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Harry Boxer’s two infrastructure stocks to watch","publication_date":"2017-04-26 19:23:30 +0000","summary":"Caterpillar and Deere had big breakouts this week.","url":"http://finance.yahoo.com/r/8b91dcf2-5312-3615-9e3e-15f05d575984/Story.aspx?guid=769A422C-2AB3-11E7-8CDA-FE87270D57BA&siteid=yhoof2&yptr=yahoo&.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and TG Therapeutics","publication_date":"2017-04-26 11:30:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / April 26, 2017 / Strong corporate earnings continued to drive markets higher Tuesday. The NASDAQ Composite Index topped the 6,000 mark for the first time ever, hitting a high ...","url":"http://finance.yahoo.com/news/todays-research-reports-stocks-watch-113000048.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Why TG Therapeutics Inc. Jumped Higher Today","publication_date":"2017-04-25 22:59:00 +0000","summary":"An analyst initiation and upcoming data sends shares of the biotech higher.","url":"http://finance.yahoo.com/r/773bc1ea-86fb-3f98-9c7b-25ae8f3b2918/why-tg-therapeutics-inc-jumped-higher-today.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Potential FDA Controversy Brewing For TG Therapeutics?","publication_date":"2017-04-25 15:40:10 +0000","summary":"TG Therapeutics Inc (NASDAQ: TGTX ), a small-cap biopharmaceutical company focusing on treatments for B-cell malignancies and autoimmune diseases, was initiated with a Buy rating and $23 price target by ...","url":"http://finance.yahoo.com/news/potential-fda-controversy-brewing-tg-154010794.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. Recaps Schedule of Data Presentation at the Upcoming American Academy of Neurology 69th Annual Meeting","publication_date":"2017-04-24 11:30:00 +0000","summary":"NEW YORK, April 24, 2017-- TG Therapeutics, Inc., today recapped the presentation schedule for TG-1101, the Company’ s novel glycoengineered anti-CD20 monoclonal antibody, at the upcoming 69 th American ...","url":"http://finance.yahoo.com/news/tg-therapeutics-inc-recaps-schedule-113000273.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Physician Views Off-Label Use A 'Double-Edged Sword' For TG Therapeutics","publication_date":"2017-04-21 14:57:47 +0000","summary":"Reni Benjamin of Raymond James maintains a Strong Buy rating on TG Therapeutics Inc (NASDAQ: TGTX ) after hosting an investor meeting with Charles Farber, a notable physician at the Summit Medical Group. ...","url":"http://finance.yahoo.com/news/physician-views-off-label-double-145747280.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"If You Don't Buy These 5 Stocks Before Their Looming Breakout, It's Your Loss","publication_date":"2017-04-20 22:22:00 +0000","summary":"Here's how to potentially rake in some fat profits off a number of hot breakout setups.","url":"http://finance.yahoo.com/r/244447e3-f947-3080-ad66-4a11cd405378/trading-5-hot-charts-set-to-break-out-soon-for-profit.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. Announces Clinical Data Presentations at the Upcoming 53rd Annual Meeting of the American Society of Clinical Oncology","publication_date":"2017-04-20 18:00:00 +0000","summary":"NEW YORK, April 20, 2017-- TG Therapeutics, Inc., today announced that clinical abstracts featuring TG-1101 and TGR-1202 have been selected for presentation at the upcoming 53 rd Annual Meeting of the ...","url":"http://finance.yahoo.com/news/tg-therapeutics-inc-announces-clinical-180000857.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"FDA Drug Approvals on the Rise in 2017: Today's Research Reports on Sarepta Therapeutics and TG Therapeutics","publication_date":"2017-04-18 11:30:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / April 18, 2017 / The volatile Biotech Industry has continued to be home to some of the largest gainers on the market in 2017. President Trump's pledge for a faster FDA approval ...","url":"http://finance.yahoo.com/news/fda-drug-approvals-rise-2017-113000923.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Is the Options Market Predicting a Spike in TG Therapeutics (TGTX) Stock?","publication_date":"2017-04-07 14:59:40 +0000","summary":"Investors in TG Therapeutics Inc TGTX need to pay close attention to the stock based on moves in the options market lately That is because the April 21 st 2017 7 50 Call had some of the highest implied volatility of all equity options today What is Implied Volatility","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8BVIzVmWFrc/is-the-options-market-predicting-a-spike-in-tg-therapeutics-tgtx-stock-cm771328"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Is the Options Market Predicting a Spike in TG Therapeutics (TGTX) Stock?","publication_date":"2017-04-07 12:30:12 +0000","summary":"Options Market Predicting a Spike in TG Therapeutics (TGTX) Stock which has high level of implied volatility","url":"http://finance.yahoo.com/news/options-market-predicting-spike-tg-123012762.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics stock rises 2% on preclinical data for cancer drug","publication_date":"2017-04-04 17:22:38 +0000","summary":"TG Therapeutics Inc. shares rose 2.0% in afternoon trade Tuesday after the company presented preclinical data on its anti-PD-L1 monoclonal antibody, part of a class of immunotherapy drugs that try to use ...","url":"http://finance.yahoo.com/r/6c773ae1-5422-31ff-b371-c46a0152b156/Story.aspx?guid=8CDB80A4-AD93-4CE7-A996-0EDC68A652B5&siteid=yhoof2&yptr=yahoo&.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. Announces Preclinical Data Presentation on the Company’s Anti-PD-L1 Monoclonal Antibody at the American Association for Cancer Research Annual Meeting","publication_date":"2017-04-04 17:00:00 +0000","summary":"NEW YORK, April 04, 2017-- TG Therapeutics, Inc., today announced the first presentation of preclinical data on the Company’ s novel fully human anti-PD-L1 monoclonal antibody at the American Association ...","url":"http://finance.yahoo.com/news/tg-therapeutics-inc-announces-preclinical-170000150.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"3 Top Biotech Stocks to Buy in April","publication_date":"2017-04-03 21:36:32 +0000","summary":"The biotech sector is fraught with risk but that doesn t mean that every biotech stock should be avoided To help you identify a few potential winners we asked a team of healthcare experts to share a 160 biotech stock that they think is a smart buy right now They picked","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F6SH7Tg8XHk/3-top-biotech-stocks-to-buy-in-april-cm769250"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"3 Top Biotech Stocks to Buy in April","publication_date":"2017-04-03 20:23:00 +0000","summary":"3 Top Biotech Stocks to Buy in April","url":"https://www.fool.com/investing/2017/04/03/3-top-biotech-stocks-to-buy-in-april.aspx"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"3 Top Biotech Stocks to Buy in April","publication_date":"2017-04-03 20:23:00 +0000","summary":"Here&apos;s why our team of healthcare contributors thinks that TG Therapeutics, Alkermes, and Lexicon Pharmaceuticals are smart biotech bets right now.","url":"http://finance.yahoo.com/r/91fb5de4-86db-3f37-83ba-8cf9973f58c8/3-top-biotech-stocks-to-buy-in-april.aspx?yptr=yahoo&.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"5 Top Performing Stocks of the Best ETF of Q1","publication_date":"2017-03-30 17:01:18 +0000","summary":"After being stressed by the twin attacks of higher drug pricing and increased regulatory scrutiny the biotech sector has made a strong comeback in the first quarter of 2017 In fact BioShares Biotechnology Clinical Trials ETF BBC tops the list of the best performing ETFs of the quarter","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TNj-DlqZfj8/5-top-performing-stocks-of-the-best-etf-of-q1-cm767848"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"5 Top Performing Stocks of the Best ETF of Q1","publication_date":"2017-03-30 14:33:02 +0000","summary":"Inside the top performing stocks of biotech ETF that tops the list of the best performing ETFs of Q1.","url":"http://finance.yahoo.com/news/5-top-performing-stocks-best-143302932.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"5 Top Performing Stocks of the Best ETF of Q1","publication_date":"2017-03-30 14:33:02 +0000","summary":"5 Top Performing Stocks of the Best ETF of Q1","url":"http://finance.yahoo.com/news/5-top-performing-stocks-best-143302932.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"ETFs with exposure to TG Therapeutics, Inc. : March 27, 2017","publication_date":"2017-03-27 20:07:50 +0000","summary":"Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to TG Therapeutics, Inc. Here are 5 ETFs with the largest exposure to TGTX-US. Comparing the performance and risk of TG Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/8774d2f7-813b-35f4-9210-6f6ec1ab91bc/etfs-with-exposure-to-tg-therapeutics-inc-march-27-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"ETFs with exposure to TG Therapeutics, Inc. : March 27, 2017","publication_date":"2017-03-27 20:07:50 +0000","summary":"ETFs with exposure to TG Therapeutics, Inc. : March 27, 2017","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-tg-therapeutics-inc-march-27-2017/"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG THERAPEUTICS, INC. Financials","publication_date":"2017-03-22 17:04:11 +0000","summary":"TG THERAPEUTICS, INC. Financials","url":"http://finance.yahoo.com/q/is?s=tgtx"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. :TGTX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 22, 2017","publication_date":"2017-03-22 12:32:37 +0000","summary":"TG Therapeutics, Inc. :TGTX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 22, 2017","url":"http://www.capitalcube.com/blog/index.php/tg-therapeutics-inc-tgtx-us-earnings-analysis-q4-2016-by-the-numbers-march-22-2017/"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. :TGTX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 22, 2017","publication_date":"2017-03-22 12:32:37 +0000","summary":"Categories: Yahoo Finance Get free summary analysis TG Therapeutics, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of TG Therapeutics, Inc. – Dr. Reddy’s Laboratories Ltd. Sponsored ADR, Histogenics Corp. and Infinity Pharmaceuticals, Inc. (RDY-US, HSGX-US and INFI-US) that have also reported for this period. Highlights ... Read more \n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/3900dd74-7b7e-347c-99ab-6cf3bc6bc891/tg-therapeutics-inc-tgtx-us-earnings-analysis-q4-2016-by-the-numbers-march-22-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. Announces Preclinical Data Presentation at the 2017 American Association for Cancer Research (AACR) Annual Meeting","publication_date":"2017-03-20 11:30:00 +0000","summary":"[GlobeNewswire] - NEW YORK, March 20, 2017-- TG Therapeutics, Inc., today announced that preclinical data for the Company’ s anti-PD-L1 monoclonal antibody, has been selected for presentation at the upcoming American Association ...","url":"http://finance.yahoo.com/news/tg-therapeutics-inc-announces-preclinical-113000373.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. Announces Preclinical Data Presentation at the 2017 American Association for Cancer Research (AACR) Annual Meeting","publication_date":"2017-03-20 11:30:00 +0000","summary":"NEW YORK, March 20, 2017-- TG Therapeutics, Inc., today announced that preclinical data for the Company’ s anti-PD-L1 monoclonal antibody, has been selected for presentation at the upcoming American Association ...","url":"http://finance.yahoo.com/news/tg-therapeutics-inc-announces-preclinical-113000373.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Don't Let Offerings Blindside Your Thesis","publication_date":"2017-03-19 17:51:48 +0000","summary":"Don't Let Offerings Blindside Your Thesis","url":"http://finance.yahoo.com/news/dont-let-offerings-blindside-thesis-175148225.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. to Present at the 27th Annual Oppenheimer Healthcare Conference","publication_date":"2017-03-17 11:30:00 +0000","summary":"NEW YORK, March 17, 2017-- TG Therapeutics, Inc. today announced that Michael S. Weiss, the Company’ s Executive Chairman and Chief Executive Officer, will present at the 27 th Annual Oppenheimer Healthcare ...","url":"http://finance.yahoo.com/news/tg-therapeutics-inc-present-27th-113000054.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. to Present at the 27th Annual Oppenheimer Healthcare Conference","publication_date":"2017-03-17 11:30:00 +0000","summary":"[GlobeNewswire] - NEW YORK, March 17, 2017-- TG Therapeutics, Inc. today announced that Michael S. Weiss, the Company’ s Executive Chairman and Chief Executive Officer, will present at the 27 th Annual Oppenheimer Healthcare ...","url":"http://finance.yahoo.com/news/tg-therapeutics-inc-present-27th-113000054.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics and ImmunoGen are Models of Institutional Investor Attention","publication_date":"2017-03-16 13:30:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 16, 2017 / One question many investors have is how much emphasis should be put on insider trading reports and institutional investor activity. The recent activity of TG ...","url":"http://finance.yahoo.com/news/tg-therapeutics-immunogen-models-institutional-133000529.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics and ImmunoGen are Models of Institutional Investor Attention","publication_date":"2017-03-16 13:30:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / March 16, 2017 / One question many investors have is how much emphasis should be put on insider trading reports and institutional investor activity. The recent activity of TG ...","url":"http://finance.yahoo.com/news/tg-therapeutics-immunogen-models-institutional-133000529.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG THERAPEUTICS, INC. Files SEC form 10-K, Annual Report","publication_date":"2017-03-16 10:11:09 +0000","summary":"TG THERAPEUTICS, INC. Files SEC form 10-K, Annual Report","url":"http://biz.yahoo.com/e/170316/tgtx10-k.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. to Present at the 29th Annual ROTH Conference","publication_date":"2017-03-13 11:30:00 +0000","summary":"[GlobeNewswire] - NEW YORK, March 13, 2017-- TG Therapeutics, Inc. today announced that Michael S. Weiss, the Company’ s Executive Chairman and Chief Executive Officer, will present at the 29 th Annual ROTH Conference, ...","url":"http://finance.yahoo.com/news/tg-therapeutics-inc-present-29th-113000524.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. to Present at the 29th Annual ROTH Conference","publication_date":"2017-03-13 11:30:00 +0000","summary":"NEW YORK, March 13, 2017-- TG Therapeutics, Inc. today announced that Michael S. Weiss, the Company’ s Executive Chairman and Chief Executive Officer, will present at the 29 th Annual ROTH Conference, ...","url":"http://finance.yahoo.com/news/tg-therapeutics-inc-present-29th-113000524.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics reports 4Q loss","publication_date":"2017-03-10 12:54:38 +0000","summary":"The New York-based company said it had a loss of 48 cents per share. The biopharmaceutical company posted revenue of $38,100 in the period. Its adjusted revenue was $38,000, meeting Street forecasts. For ...","url":"http://finance.yahoo.com/news/tg-therapeutics-reports-4q-loss-125438814.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics reports 4Q loss","publication_date":"2017-03-10 12:54:38 +0000","summary":"TG Therapeutics reports 4Q loss","url":"http://sg.finance.yahoo.com/news/tg-therapeutics-reports-4q-loss-125438374.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Biotech Stock Mailbag: Puma's Rebound Explained, TG Therapeutics Approval Debate, Aurinia Next Steps","publication_date":"2017-03-10 12:37:00 +0000","summary":"TheStreet's Adam Feuerstein answers reader questions about biotech stocks.","url":"http://finance.yahoo.com/r/96c566ce-9f2f-33a8-b45d-18c5225eaef2/biotech-stock-mailbag-puma-s-rebound-explained-tg-therapeutics-approval-debate-aurinia-next-steps.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Biotech Stock Mailbag: Puma's Rebound Explained, TG Therapeutics Approval Debate, Aurinia Next Steps","publication_date":"2017-03-10 12:37:00 +0000","summary":"Biotech Stock Mailbag: Puma's Rebound Explained, TG Therapeutics Approval Debate, Aurinia Next Steps","url":"https://www.thestreet.com/story/14036467/1/biotech-stock-mailbag-puma-s-rebound-explained-tg-therapeutics-approval-debate-aurinia-next-steps.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG THERAPEUTICS, INC. Files SEC form 8-K, Other Events","publication_date":"2017-03-10 12:34:34 +0000","summary":"TG THERAPEUTICS, INC. Files SEC form 8-K, Other Events","url":"http://biz.yahoo.com/e/170310/tgtx8-k.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2016 Financial Results and Business Update","publication_date":"2017-03-10 12:30:00 +0000","summary":"Company solidifies balance sheet with approximately $89 M in gross proceeds through the combination of $57.5 M public offering and $31 M from at-the-market sales facility completed prior to the offering. ...","url":"http://finance.yahoo.com/news/tg-therapeutics-inc-announces-fourth-123000371.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2016 Financial Results and Business Update","publication_date":"2017-03-10 12:30:00 +0000","summary":"[GlobeNewswire] - Company solidifies balance sheet with approximately $89 M in gross proceeds through the combination of $57.5 M public offering and $31 M from at-the-market sales facility completed prior to the offering. ...","url":"http://finance.yahoo.com/news/tg-therapeutics-inc-announces-fourth-123000371.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Q4 2016 TG Therapeutics Inc Earnings Release - After Market Close","publication_date":"2017-03-10 12:07:04 +0000","summary":"Q4 2016 TG Therapeutics Inc Earnings Release - After Market Close","url":"http://biz.yahoo.com/research/earncal/20170310.html?t=tgtx"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Company Spotlight: TG Therapeutics Inc.","publication_date":"2017-03-10 01:18:00 +0000","summary":"Company Spotlight: TG Therapeutics Inc.","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-SbKGaGjb3I/company-spotlight-tg-therapeutics-inc-20170310-00021"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Gainers & Losers Of Mar.9: CBAY, IMMU, TGTX, NSPR, TNDM...","publication_date":"2017-03-09 22:43:00 +0000","summary":"Gainers & Losers Of Mar.9: CBAY, IMMU, TGTX, NSPR, TNDM...","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MXg1EYtqzFA/gainers--losers-of-mar9-cbay-immu-tgtx-nspr-tndm-20170309-01447"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Stateme","publication_date":"2017-03-09 22:06:09 +0000","summary":"TG THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Stateme","url":"http://biz.yahoo.com/e/170309/tgtx8-k.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Health Care Sector Update for 03/09/2017: TGTX,OCRX,NSPR","publication_date":"2017-03-09 21:32:46 +0000","summary":"Top Health Care StocksTop Health Care Stocks JNJ 1 44 JNJ 1 44 PFE 0 49 PFE 0 49 MRK 0 75 MRK 0 75 ABT 0 14 ABT 0 14 AMGN 0 60 AMGN 0 60 Health care stocks outpaced most other sectors in today s markets with the NYSE Health Care Index rising almost 0 7 while shares of health","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dolHsKJFTSY/health-care-sector-update-for-03092017-tgtxocrxnspr-cm758825"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. to Host Conference Call on Fourth Quarter and Year-End 2016 Financial Results and Business Update","publication_date":"2017-03-09 21:30:00 +0000","summary":"[GlobeNewswire] - NEW YORK, March 09, 2017-- TG Therapeutics, Inc., today announced that a conference call will be held tomorrow, Friday, March 10, 2017 at 8:30am ET to discuss results for the fourth quarter and year-end ...","url":"http://finance.yahoo.com/news/tg-therapeutics-inc-host-conference-213000510.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. to Host Conference Call on Fourth Quarter and Year-End 2016 Financial Results and Business Update","publication_date":"2017-03-09 21:30:00 +0000","summary":"NEW YORK, March 09, 2017-- TG Therapeutics, Inc., today announced that a conference call will be held tomorrow, Friday, March 10, 2017 at 8:30am ET to discuss results for the fourth quarter and year-end ...","url":"http://finance.yahoo.com/news/tg-therapeutics-inc-host-conference-213000510.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"9:20 am TG Therapeutics prices $50 mln share offering at $9.75/share","publication_date":"2017-03-09 14:20:00 +0000","summary":"9:20 am TG Therapeutics prices $50 mln share offering at $9.75/share","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#tgtx"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. Announces Pricing of $50 Million Public Offering of Common Stock","publication_date":"2017-03-09 14:19:53 +0000","summary":"NEW YORK, March 09, 2017-- TG Therapeutics, Inc. today announced the pricing of an underwritten public offering of 5,128,206 shares of its common stock at a price of $9.75 per share, with expected gross ...","url":"http://finance.yahoo.com/news/tg-therapeutics-inc-announces-pricing-141953079.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. Announces Pricing of $50 Million Public Offering of Common Stock","publication_date":"2017-03-09 14:19:53 +0000","summary":"[GlobeNewswire] - NEW YORK, March 09, 2017-- TG Therapeutics, Inc. today announced the pricing of an underwritten public offering of 5,128,206 shares of its common stock at a price of $9.75 per share, with expected gross ...","url":"http://finance.yahoo.com/news/tg-therapeutics-inc-announces-pricing-141953079.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics Announces Proposed Public Offering of Common Stock","publication_date":"2017-03-08 21:01:00 +0000","summary":"NEW YORK, March 08, 2017-- TG Therapeutics, a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases, ...","url":"http://finance.yahoo.com/news/tg-therapeutics-announces-proposed-public-210100382.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics Announces Proposed Public Offering of Common Stock","publication_date":"2017-03-08 21:01:00 +0000","summary":"[GlobeNewswire] - NEW YORK, March 08, 2017-- TG Therapeutics, a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases, ...","url":"http://finance.yahoo.com/news/tg-therapeutics-announces-proposed-public-210100382.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Cramer's lightning round: Best-in-show pipeline stocks","publication_date":"2017-03-08 00:20:46 +0000","summary":"Jim Cramer rattles off his take on caller favorite stocks, including this pipeline stock above the rest on Cramer's list.","url":"http://finance.yahoo.com/news/cramers-lightning-round-best-show-002046316.html?.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Cramer's lightning round: Best-in-show pipeline stocks","publication_date":"2017-03-08 00:20:46 +0000","summary":"Cramer's lightning round: Best-in-show pipeline stocks","url":"http://www.cnbc.com/id/104326834?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104326834"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Harry Boxer’s six biotechnology stocks to watch","publication_date":"2017-03-07 18:55:50 +0000","summary":"Harry Boxer’s six biotechnology stocks to watch","url":"http://www.marketwatch.com/News/Story/Story.aspx?guid=30E80700-0362-11E7-918D-62B4A59FE2AC&siteid=yhoof2"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Harry Boxer’s six biotechnology stocks to watch","publication_date":"2017-03-07 18:55:50 +0000","summary":"TG Therapeutics, Concert Pharmaceuticals, Kite Pharma and three other companies soared as much as 90%.","url":"http://finance.yahoo.com/r/c1390f09-319b-30ce-9657-4111d62738db/Story.aspx?guid=30E80700-0362-11E7-918D-62B4A59FE2AC&siteid=yhoof2&yptr=yahoo&.tsrc=rss"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Here’s What’s Next For TG Therapeutics Inc (TGTX)","publication_date":"2017-03-07 16:48:18 +0000","summary":"Here’s What’s Next For TG Therapeutics Inc (TGTX)","url":"http://www.insidermonkey.com/blog/heres-whats-next-for-tg-therapeutics-inc-tgtx-564320/"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"DEADLINE TODAY FOR TGTX INVESTORS: Khang & Khang LLP Announces Securities Class Action Lawsuit against TG Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-03-07 15:25:00 +0000","summary":"[Accesswire] - IRVINE, CA / ACCESSWIRE / March 7, 2017 / Khang & Khang LLP (the \"Firm\") announces the filing of a class action lawsuit against TG Therapeutics, Inc. (\"TG Therapeutics\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/deadline-today-tgtx-investors-khang-152500807.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Investors It Has Filed a Class Action Lawsuit Against TG Therapeutics, Inc. and Announces a Lead Plaintiff Deadline of March 7, 2017 - TGTX","publication_date":"2017-03-07 15:03:00 +0000","summary":"[PR Newswire] - NEW YORK, March 7, 2017 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of TG Therapeutics, Inc. ...","url":"http://finance.yahoo.com/news/deadline-today-levi-korsinsky-llp-150300178.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"NOVN Moves Ahead, PTCT Finally Achieves It, TGTX Gets GENUINE Reaction","publication_date":"2017-03-07 01:18:00 +0000","summary":"NOVN Moves Ahead, PTCT Finally Achieves It, TGTX Gets GENUINE Reaction","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dzsBSqo3jPg/novn-moves-ahead-ptct-finally-achieves-it-tgtx-gets-genuine-reaction-20170307-00031"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Why Range Resources, Central European Media Enterprises, and TG Therapeutics Jumped Today","publication_date":"2017-03-06 23:13:24 +0000","summary":"The stock market lost ground on Monday although as we ve seen countless times before in recent months major market benchmarks finished well off their lowest levels of the day Some on the Street pointed to the unwinding of some trades that had gained considerable ground following","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9eC4czp6goA/why-range-resources-central-european-media-enterprises-and-tg-therapeutics-jumped-today-cm756900"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics Inc (TGTX) Stock Soars on Leukemia Drug Study Results","publication_date":"2017-03-06 23:12:40 +0000","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips TG Therapeutics Inc NASDAQ TGTX shares were skyrocketing thanks to the company s recent clinical trial results Source Flickr The pharmaceutical giant unveiled how effective its lead cancer drug performed","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YFb7PgDxUGA/tg-therapeutics-inc-tgtx-stock-soars-on-leukemia-drug-study-results-cm756924"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Tyson and Deutsche Bank slide; Southwestern Energy jumps","publication_date":"2017-03-06 22:35:18 +0000","summary":"Tyson and Deutsche Bank slide; Southwestern Energy jumps","url":"http://sg.finance.yahoo.com/news/tyson-deutsche-bank-slide-southwestern-223518566.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Close Update: Wall Street Pares Losses But Weaker Finish Eyed as Politics, Rate Hike Weigh","publication_date":"2017-03-06 21:52:34 +0000","summary":"The main U S markets started the week lower paring losses in the latter part of the day but staying in the red with declines spread among almost all of the sectors on the S amp P 500 Risk aversion seemed to set in amid global and domestic political jitters as North Korea launched four","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4MThfm2IfxU/close-update-wall-street-pares-losses-but-weaker-finish-eyed-as-politics-rate-hike-weigh-cm756886"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Why Range Resources, Central European Media Enterprises, and TG Therapeutics Jumped Today","publication_date":"2017-03-06 21:35:00 +0000","summary":"[at Motley Fool] - Despite a down market, these stocks climbed. Find out why.","url":"http://www.fool.com/investing/2017/03/06/why-range-resources-central-european-media-enterpr.aspx"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Health Care Sector Update for 03/06/2017: CNCE,VTRX,TGTX,IONS","publication_date":"2017-03-06 21:32:38 +0000","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 07 JNJ 0 07 PFE 0 25 PFE 0 25 MRK 0 06 MRK 0 06 ABT 0 05 ABT 0 05 AMGN 0 21 AMGN 0 21 Health care stocks were moderately lower late Monday with the NYSE Health Care Index posting a 0 3 retreat while shares of health care","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aFkYFljUkq8/health-care-sector-update-for-03062017-cncevtrxtgtxions-cm756874"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics Surges 85% on Results From Study","publication_date":"2017-03-06 20:53:48 +0000","summary":"TG Therapeutics Surges 85% on Results From Study","url":"http://finance.yahoo.com/news/tg-therapeutics-surges-85-results-205348969.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Why TG Therapeutics Stock Exploded Higher Today","publication_date":"2017-03-06 20:13:38 +0000","summary":"What happened Shares of clinical stage biotech TG Therapeutics NASDAQ TGTX soared on Monday after the company announced that its experimental leukemia drug 160 TG 1101 ublituximab hit the mark in a late stage trial when used as part of a combination therapy that","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-19sFiLb_fM/why-tg-therapeutics-stock-exploded-higher-today-cm756823"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Gainers & Losers Of Mar.6: TGTX, CNCE, DXTR, KURA, ARGS...","publication_date":"2017-03-06 20:00:00 +0000","summary":"Gainers & Losers Of Mar.6: TGTX, CNCE, DXTR, KURA, ARGS...","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-FtD2qL1YxA/gainers--losers-of-mar6-tgtx-cnce-dxtr-kura-args-20170306-01394"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Health Care Sector Update for 03/06/2017: CORT,TGTX,IONS","publication_date":"2017-03-06 19:52:37 +0000","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 41 JNJ 0 41 PFE 0 25 PFE 0 25 MRK 0 18 MRK 0 18 ABT 0 10 ABT 0 10 AMGN 0 24 AMGN 0 24 Health care stocks still were slightly lower this afternoon reversing earlier declines with the NYSE Health Care Index posting a 0 3","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ITdr3xT_H38/health-care-sector-update-for-03062017-corttgtxions-cm756832"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Monday’s Top Health Care Stocks Screaming Higher","publication_date":"2017-03-06 18:45:34 +0000","summary":"Monday’s Top Health Care Stocks Screaming Higher","url":"http://finance.yahoo.com/news/monday-top-health-care-stocks-184534179.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"How to Trade Monday's Most Active Stocks - Snap, GM, TG Therapeutics and More","publication_date":"2017-03-06 18:36:00 +0000","summary":"How to Trade Monday's Most Active Stocks - Snap, GM, TG Therapeutics and More","url":"https://www.thestreet.com/story/14028584/1/how-to-trade-monday-s-most-active-stocks-snap-gm-tg-therapeutics-and-more.html?puc=yahoo&cm_ven=YAHOO"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Midday Update: Risk Aversion Prevails as N. Korea Fires Missiles, China Lowers Growth, Juppe Rules Out French Run","publication_date":"2017-03-06 18:32:41 +0000","summary":"The Dow Jones Industrial Average was trading lower for a third consecutive day as caution overtook Wall Street Monday morning after North Korea launched four ballistic missiles towards the Sea of Japan and China lowered its growth forecasts for the year The Dow Jones Industrial Average was","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m16J9YYSoAM/midday-update-risk-aversion-prevails-as-n-korea-fires-missiles-china-lowers-growth-juppe-rules-out-french-run-cm756777"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Why TG Therapeutics Stock Exploded Higher Today","publication_date":"2017-03-06 18:15:06 +0000","summary":"Why TG Therapeutics Stock Exploded Higher Today","url":"http://www.fool.com/investing/2017/03/06/why-tg-therapeutics-stock-exploded-higher-today.aspx"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against TG Therapeutics, Inc. and Strongly Advises Investors with Losses to Contact the Firm","publication_date":"2017-03-06 16:27:00 +0000","summary":"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / March 6, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against TG Therapeutics, Inc. (\"TG Therapeutics\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/important-investor-notice-lundin-law-162700636.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics' leukemia drug clears key study, shares pop","publication_date":"2017-03-06 15:35:39 +0000","summary":"TG Therapeutics' leukemia drug clears key study, shares pop","url":"http://finance.yahoo.com/news/tg-therapeutics-leukemia-drug-clears-123321547.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"Wall Street Tips Lower as Geopolitical Tensions Rise in Asia","publication_date":"2017-03-06 14:32:48 +0000","summary":"U S stock futures were pointing south on Monday following similar declines in the European equities market amid concerns of rising geopolitical tensions in Asia after North Korea fired four ballistic missiles off its east coast U S stock futures were pointing south on Monday following","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F2orSXbSktc/wall-street-tips-lower-as-geopolitical-tensions-rise-in-asia-cm756510"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"US Futures Point South as Geopolitical Tensions Rise in Asia","publication_date":"2017-03-06 13:52:33 +0000","summary":"U S stock futures were pointing south on Monday following similar declines in the European equities market amid concerns of rising geopolitical tensions in Asia after North Korea fired four ballistic missiles off its east coast U S stock futures were pointing south on Monday following","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yVjCBHjNmEk/us-futures-point-south-as-geopolitical-tensions-rise-in-asia-cm756477"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics' stock shoots up toward 5-month high after positive test results","publication_date":"2017-03-06 12:39:17 +0000","summary":"TG Therapeutics' stock shoots up toward 5-month high after positive test results","url":"http://www.marketwatch.com/News/Story/Story.aspx?guid=C7CEBC43-38F3-4A82-8031-76E1FE15A1F0&siteid=yhoof2"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG THERAPEUTICS, INC. Files SEC form 8-K, Other Events","publication_date":"2017-03-06 12:22:32 +0000","summary":"TG THERAPEUTICS, INC. Files SEC form 8-K, Other Events","url":"http://biz.yahoo.com/e/170306/tgtx8-k.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics' leukemia drug clears hurdle in key study","publication_date":"2017-03-06 12:14:03 +0000","summary":"TG Therapeutics' leukemia drug clears hurdle in key study","url":"http://finance.yahoo.com/news/tg-therapeutics-leukemia-drug-clears-121403627.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics Announces Positive Topline Data from Phase 3 GENUINE Study of TG-1101 in Combination with Ibrutinib in Patients with High Risk Chronic Lymphocytic Leukemia (CLL)","publication_date":"2017-03-06 12:00:00 +0000","summary":"[GlobeNewswire] - Study met its primary endpoint, with TG-1101 plus ibrutinib increasing Overall Response Rate by > 70% over ibrutinib alone. The combination was well tolerated with a safety profile consistent ...","url":"http://finance.yahoo.com/news/tg-therapeutics-announces-positive-topline-120000563.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics Inc. (TGTX) Has Soared To A New High On Phase 3 Study Results","publication_date":"2017-03-06 09:34:00 +0000","summary":"TG Therapeutics Inc. (TGTX) Has Soared To A New High On Phase 3 Study Results","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xAUSXt7mL0g/tg-therapeutics-inc-tgtx-has-soared-to-a-new-high-on-phase-3-study-results-20170306-00747"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in TG Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - TGTX","publication_date":"2017-03-04 01:05:00 +0000","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 3, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against TG Therapeutics, Inc. (\"TG Therapeutics\" or the \"Company\") (NASDAQ: ...","url":"http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-010500300.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TGTX INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving TG Therapeutics, Inc. and a Lead Plaintiff Deadline of March 7, 2017","publication_date":"2017-03-03 16:34:39 +0000","summary":"[GlobeNewswire] - NEW YORK, March 03, 2017-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased ...","url":"http://finance.yahoo.com/news/tgtx-investor-alert-law-offices-163439452.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TG Therapeutics, Inc. Announces Data Presentation at the Upcoming American Academy of Neurology 69th Annual Meeting","publication_date":"2017-03-03 12:30:00 +0000","summary":"[GlobeNewswire] - NEW YORK, March 03, 2017-- TG Therapeutics, Inc., today announced that updated data for TG-1101, the Company’ s novel glycoengineered anti-CD20 monoclonal antibody, has been selected for presentation at ...","url":"http://finance.yahoo.com/news/tg-therapeutics-inc-announces-data-123000558.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"TGTX Investors Deadline Alert: GPM Reminds Investors of the March 7 Deadline in the Class Action Lawsuit Against TG Therapeutics, Inc.","publication_date":"2017-03-02 19:06:00 +0000","summary":"[Business Wire] - Glancy Prongay & Murray LLP reminds investors of the March 13, 2017 deadline to file a lead plaintiff motion in the class action filed by GPM on behalf of a class of investors who purchased TG Therapeutics, Inc.","url":"http://finance.yahoo.com/news/tgtx-investors-deadline-alert-gpm-190600719.html"},{"ticker":"TGTX","figi_ticker":"TGTX:US","figi":"BBG000FVZQY1","title":"IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against TG Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm","publication_date":"2017-02-28 19:27:00 +0000","summary":"[Accesswire] - IRVINE, CA / ACCESSWIRE / February 28, 2017 / Khang & Khang LLP (the \"Firm\") announces the filing of a class action lawsuit against TG Therapeutics, Inc. (\"TG Therapeutics\" or the \"Company\") ...","url":"http://finance.yahoo.com/news/important-investor-alert-khang-khang-192700943.html"}],"result_count":284,"page_size":100,"current_page":1,"total_pages":3,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"11.075"},{"x":"1494596100","y":"11.1333"},{"x":"1494596400","y":"11.181"},{"x":"1494596700","y":"11.2"},{"x":"1494597000","y":"11.175"},{"x":"1494597300","y":"11.2"},{"x":"1494597600","y":"11.2"},{"x":"1494597900","y":"11.22"},{"x":"1494598200","y":"11.21"},{"x":"1494598500","y":"11.3"},{"x":"1494598800","y":"11.26"},{"x":"1494599100","y":"11.25"},{"x":"1494599400","y":"11.25"},{"x":"1494599700","y":"11.2733"},{"x":"1494600000","y":"11.25"},{"x":"1494600300","y":"11.275"},{"x":"1494600600","y":"11.275"},{"x":"1494600900","y":"11.3"},{"x":"1494601200","y":"11.4"},{"x":"1494601500","y":"11.5"},{"x":"1494601800","y":"11.46"},{"x":"1494602100","y":"11.55"},{"x":"1494602400","y":"11.65"},{"x":"1494602700","y":"11.675"},{"x":"1494603000","y":"11.68"},{"x":"1494603300","y":"11.65"},{"x":"1494603600","y":"11.65"},{"x":"1494603900","y":"11.675"},{"x":"1494604200","y":"11.6625"},{"x":"1494604500","y":"11.675"},{"x":"1494604800","y":"11.77"},{"x":"1494605100","y":"11.775"},{"x":"1494605400","y":"11.84"},{"x":"1494605700","y":"11.82"},{"x":"1494606000","y":"11.84"},{"x":"1494606300","y":"12"},{"x":"1494606600","y":"12.025"},{"x":"1494606900","y":"12.1"},{"x":"1494607200","y":"12.15"},{"x":"1494607500","y":"11.9"},{"x":"1494607800","y":"11.89"},{"x":"1494608100","y":"11.93"},{"x":"1494608400","y":"11.975"},{"x":"1494608700","y":"11.925"},{"x":"1494609000","y":"11.955"},{"x":"1494609300","y":"11.972"},{"x":"1494609600","y":"11.95"},{"x":"1494609900","y":"11.95"},{"x":"1494610200","y":"12.05"},{"x":"1494610500","y":"12.05"},{"x":"1494610800","y":"12.0169"},{"x":"1494611100","y":"12.03"},{"x":"1494611400","y":"11.9058"},{"x":"1494611700","y":"12"},{"x":"1494612000","y":"12"},{"x":"1494612300","y":"12.025"},{"x":"1494612600","y":"12.025"},{"x":"1494612900","y":"12"},{"x":"1494613200","y":"11.975"},{"x":"1494613500","y":"11.875"},{"x":"1494613800","y":"11.9721"},{"x":"1494614100","y":"12.025"},{"x":"1494614400","y":"11.96"},{"x":"1494614700","y":"11.975"},{"x":"1494615000","y":"11.975"},{"x":"1494615300","y":"12"},{"x":"1494615600","y":"11.9"},{"x":"1494615900","y":"11.85"},{"x":"1494616200","y":"11.9"},{"x":"1494616500","y":"11.85"},{"x":"1494616800","y":"11.8"},{"x":"1494617100","y":"11.825"},{"x":"1494617400","y":"11.8"},{"x":"1494617700","y":"11.7815"},{"x":"1494618000","y":"11.75"},{"x":"1494618300","y":"11.8"},{"x":"1494618600","y":"11.725"},{"x":"1494618900","y":"11.75"},{"x":"1494619200","y":"11.75"} ], "color":"#03a9f4"}]},
{"id":"22","symbol": "WPRT","name": "Westport Fuel Systems Inc - Common Shares","price": 1.47,"dollarChange": 0.12,"percentChange": 8.89,"open": 1.47,"high": 1.49,"low":1.33,"volume": 1222254,"avgVol": 709418.416667,"sharesShort": 6165865,"shortPercent": 5.599778,"marketCap": 149415232,"float": 110109092,"headlines":{"data":[{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems (WPRT) Q1 Loss Narrower than Expected","publication_date":"2017-05-12 13:34:01 +0000","summary":"Westport Fuel Systems Inc.&apos;s (WPRT) first-quarter 2017 loss from continuing operations came in at 12 cents per share, narrower than the year-ago loss of 38 cents.","url":"http://finance.yahoo.com/news/westport-fuel-systems-wprt-q1-133401936.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport reports 1Q loss","publication_date":"2017-05-11 21:51:43 +0000","summary":"On a per-share basis, the Vancouver, British Columbia-based company said it had a loss of 11 cents. Losses, adjusted to account for discontinued operations, came to 12 cents per share. The results surpassed ...","url":"http://finance.yahoo.com/news/westport-reports-1q-loss-215143488.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems Reports First Quarter 2017 Financial Results","publication_date":"2017-05-11 20:19:00 +0000","summary":"~2017 off to a strong start~ VANCOUVER, May 11, 2017 /PRNewswire/ - Westport Fuel Systems Inc. (\" Westport Fuel Systems \") (TSX:WPRT / Nasdaq:WPRT) reported financial results for the first quarter ...","url":"http://finance.yahoo.com/news/westport-fuel-systems-reports-first-201900088.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems (WPRT) Q1 Earnings: What's in Store?","publication_date":"2017-05-09 13:02:58 +0000","summary":"Westport Fuel Systems Inc WPRT will report first quarter 2017 results after the market closes on May 11 In the last quarter the company missed earnings by 60 The company has fallen short of expectations in three of the trailing four quarters with an average miss of 31 71 Let s see","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NfPEGDO2RXE/westport-fuel-systems-wprt-q1-earnings-whats-in-store-cm786372"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems (WPRT) Q1 Earnings: What&apos;s in Store?","publication_date":"2017-05-09 11:30:11 +0000","summary":"Westport Fuel Systems Inc. (WPRT) will report first-quarter 2017 results after the market closes on May 11.","url":"http://finance.yahoo.com/news/westport-fuel-systems-wprt-q1-113011021.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems to Announce First Quarter Results On Thursday, May 11, 2017","publication_date":"2017-05-04 20:05:00 +0000","summary":"VANCOUVER, May 4, 2017 /PRNewswire/ - Westport Fuel Systems Inc. (\" Westport Fuel Systems \") (TSX:WPRT / Nasdaq:WPRT) announced today that it will disclose its financial results for the first ...","url":"http://finance.yahoo.com/news/westport-fuel-systems-announce-first-200500189.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems Announces the Closing of the Sale of the IMPCO APU Assets","publication_date":"2017-05-01 12:00:00 +0000","summary":"Westport Fuel Systems Announces the Closing of the Sale of the IMPCO APU Assets","url":"http://finance.yahoo.com/news/westport-fuel-systems-announces-closing-120000713.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems Announces the Closing of the Sale of the IMPCO APU Assets","publication_date":"2017-05-01 12:00:00 +0000","summary":"VANCOUVER, May 1, 2017 /PRNewswire/ - Westport Fuel Systems Inc. (\" Westport Fuel Systems \") (TSX:WPRT / Nasdaq:WPRT) today announced the closing of its previously announced sale of the assets ...","url":"http://finance.yahoo.com/news/westport-fuel-systems-announces-closing-120000928.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport (WPRT) Up 21.5% Since Earnings Report: Can It Continue?","publication_date":"2017-04-27 11:00:11 +0000","summary":"Westport (WPRT) reported earnings 30 days ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.","url":"http://finance.yahoo.com/news/westport-wprt-21-5-since-110011202.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Today's Research Reports on Stocks to Watch: Westport Fuel Systems and Clean Energy","publication_date":"2017-04-19 11:30:00 +0000","summary":"NEW YORK, NY / ACCESSWIRE / April 19, 2017 / Westport Fuel Systems' shares declined 3.15 percent to close at $1.23 a share on Tuesday. The stock traded between $1.20 and $1.34 on volume of 1.06 million ...","url":"http://finance.yahoo.com/news/todays-research-reports-stocks-watch-113000107.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems (WPRT) Jumps: Stock Moves 19.8% Higher","publication_date":"2017-04-18 12:25:12 +0000","summary":"Westport Fuel Systems Inc. (WPRT) moved big last session, as its shares jumped almost 20% on the day.","url":"http://finance.yahoo.com/news/westport-fuel-systems-wprt-jumps-122512410.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Mid-Day Market Update: Dow Surges Over 100 Points; Oncomed Shares Slide","publication_date":"2017-04-17 17:39:38 +0000","summary":"Midway through trading Monday the Dow traded up 0 57 percent to 20 570 30 while the NASDAQ rose 0 62 percent to 5 841 01 The S amp P also rose gaining 0 55 percent to 2 341 73 Leading and Lagging Sectors On Monday the non cyclical consumer goods amp services sector proved to be","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E_UsFCC5cqk/mid-day-market-update-dow-surges-over-100-points-oncomed-shares-slide-cm774771"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Stock Futures Turn Positive; Empire State Manufacturing Index Dives in April","publication_date":"2017-04-17 13:55:16 +0000","summary":"Futures flipped to the plus column ahead of Monday s open as Wall Street struggles for direction amid lingering geopolitical tensions against the backdrop of Q1 earnings Early pressure on futures associated with continued saber rattling in North Korean and bearish U S economic data Friday","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oMxN4sKYy6U/stock-futures-turn-positive-empire-state-manufacturing-index-dives-in-april-cm774519"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems Announces the Signing of a Definitive Agreement to Sell its APU Assets for USD$70 million","publication_date":"2017-04-17 11:00:00 +0000","summary":"VANCOUVER, April 17, 2017 /PRNewswire/ - Westport Fuel Systems Inc. (\"Westport Fuel Systems\") (TSX:WPRT / Nasdaq:WPRT) today announced that it has entered into a definitive agreement to sell the assets of its Auxiliary Power Unit (\"APU\") business for $70 million United States dollars, subject to certain customary adjustments.  The transaction is expected to close within a few weeks.  The divestiture is consistent with Westport's strategy to streamline its business and product lines and focus on alternative fuel solutions for the transportation and automotive industries. J.P. Morgan acted as financial advisor for Westport Fuel Systems on the transaction.","url":"http://finance.yahoo.com/news/westport-fuel-systems-announces-signing-110000553.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems, Inc. :WPRT-US: Earnings Analysis: Q4, 2016 By the Numbers : April 7, 2017","publication_date":"2017-04-07 19:03:22 +0000","summary":"Categories: Yahoo FinanceGet free summary analysis Westport Fuel Systems, Inc. reports financial results for the quarter ended December 31, 2016. Highlights Summary numbers: Revenues of USD 80.40 million, Net Earnings of USD -44.76 million. Gross margins widened from 1.07% to 20.25% compared to the same period last year, operating (EBITDA) margins now -16.86% from -87.55%. Change in ... Read more\n<b>(Read more...)</b>","url":"http://finance.yahoo.com/r/43dea1d2-a836-32e5-b2db-ef68974556e8/westport-fuel-systems-inc-wprt-us-earnings-analysis-q4-2016-by-the-numbers-april-7-2017?yptr=yahoo&.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Is Westport Fuel Systems (WPRT) Stock a Solid Choice Right Now?","publication_date":"2017-03-29 14:02:16 +0000","summary":"One stock that might be an intriguing choice for investors right now is Westport Fuel Systems Inc WPRT This is because this security in the Automotive Original Equipment space is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QCbelMMYGXY/is-westport-fuel-systems-wprt-stock-a-solid-choice-right-now-cm767182"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Is Westport Fuel Systems (WPRT) Stock a Solid Choice Right Now?","publication_date":"2017-03-29 12:36:12 +0000","summary":"Is Westport Fuel Systems (WPRT) Stock a Solid Choice Right Now?","url":"http://finance.yahoo.com/news/westport-fuel-systems-wprt-stock-123612859.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Is Westport Fuel Systems (WPRT) Stock a Solid Choice Right Now?","publication_date":"2017-03-29 12:36:12 +0000","summary":"Westport Fuel Systems (WPRT) in the Automotive - Original Equipment space is seeing solid earnings estimate revisions, and is a great company from a Zacks Industry Rank perspective.","url":"http://finance.yahoo.com/news/westport-fuel-systems-wprt-stock-123612859.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Consumer Sector Update for 03/28/2017: ZNH,AAL,DRI,WPRT","publication_date":"2017-03-28 20:18:56 +0000","summary":"Top Consumer StocksTop Consumer Stocks WMT 0 83 WMT 0 83 MCD 0 17 MCD 0 17 DIS 0 72 DIS 0 72 CVS 0 26 CVS 0 26 KO 0 40 KO 0 40 Consumer stocks were mostly higher today with shares of consumer staples companies in the S amp P 500 adding over 0 3 in value while shares of","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/39otDqG6Uqk/consumer-sector-update-for-03282017-znhaaldriwprt-cm766892"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Consumer Sector Update for 03/28/2017: DECK,DRI,WPRT","publication_date":"2017-03-28 17:59:35 +0000","summary":"Top Consumer StocksTop Consumer Stocks WMT 0 77 WMT 0 77 MCD 0 12 MCD 0 12 DIS 0 44 DIS 0 44 CVS 0 24 CVS 0 24 KO 0 38 KO 0 38 Consumer stocks were mostly higher Tuesday with shares of consumer staples companies in the S amp P 500 adding nearly 0 2 in value while shares of","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LiHA9vS-iuI/consumer-sector-update-for-03282017-deckdriwprt-cm766799"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems (WPRT) Q4 Loss Wider than Expected","publication_date":"2017-03-28 15:03:32 +0000","summary":"Westport Fuel Systems Inc s WPRT adjusted loss came in at 24 cents per share in the fourth quarter of 2016 narrower than the year ago loss of 35 cents However the adjusted loss which excludes 19 cents from non recurring items was wider than the Zacks Consensus Estimate of a loss of","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oeidQwSkhSs/westport-fuel-systems-wprt-q4-loss-wider-than-expected-cm766558"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems (WPRT) Q4 Loss Wider than Expected","publication_date":"2017-03-28 13:01:01 +0000","summary":"Westport Fuel Systems Inc.'s (WPRT) adjusted loss came in at 24 cents per share in the fourth quarter of 2016, narrower than the year-ago loss of 35 cents.","url":"http://finance.yahoo.com/news/westport-fuel-systems-wprt-q4-130101475.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems (WPRT) Q4 Loss Wider than Expected","publication_date":"2017-03-28 13:01:01 +0000","summary":"Westport Fuel Systems (WPRT) Q4 Loss Wider than Expected","url":"http://finance.yahoo.com/news/westport-fuel-systems-wprt-q4-130101475.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport reports 4Q loss","publication_date":"2017-03-27 21:04:35 +0000","summary":"Westport reports 4Q loss","url":"http://sg.finance.yahoo.com/news/westport-reports-4q-loss-210435163.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport reports 4Q loss","publication_date":"2017-03-27 21:04:35 +0000","summary":"The Vancouver, British Columbia-based company said it had a loss of 43 cents per share. Losses, adjusted for non-recurring costs and asset impairment costs, were 24 cents per share. The maker of natural-gas ...","url":"http://finance.yahoo.com/news/westport-reports-4q-loss-210435055.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems Presents Unaudited Fourth Quarter and Fiscal 2016 Financial Results","publication_date":"2017-03-27 20:42:00 +0000","summary":"[PR Newswire] - ~ Solid finish to 2016; Taking action to address upcoming liquidity needs ~ VANCOUVER, March 27, 2017 /PRNewswire/ - Westport Fuel Systems Inc. (\" Westport Fuel Systems \") (TSX:WPRT / Nasdaq:WPRT) ...","url":"http://finance.yahoo.com/news/westport-fuel-systems-presents-unaudited-204200579.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems Presents Unaudited Fourth Quarter and Fiscal 2016 Financial Results","publication_date":"2017-03-27 20:42:00 +0000","summary":"Westport Fuel Systems Presents Unaudited Fourth Quarter and Fiscal 2016 Financial Results","url":"http://finance.yahoo.com/news/westport-fuel-systems-presents-unaudited-204200664.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"After-Hours Earnings Report for March 27, 2017 : RHT, SNX, RAVN, AVAL, WPRT, AUXO","publication_date":"2017-03-27 18:18:55 +0000","summary":"The following companies are expected to report earnings after hours on 03 27 2017 Visit our Earnings Calendar for a full list of expected earnings releases Red Hat Inc RHT is reporting for the quarter ending February 28 2017 The computer","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/giI6g89wjnM/after-hours-earnings-report-for-march-27-2017-rht-snx-ravn-aval-wprt-auxo-cm766127"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Can Westport Fuel Systems (WPRT) Spring a Surprise in Q4?","publication_date":"2017-03-24 15:02:38 +0000","summary":"Westport Fuel Systems Inc WPRT will report fourth quarter 2016 results after the market closes on Mar 27 In the last quarter the company posted a positive earnings surprise of 39 13 Let s see how things are shaping up for this announcement Westport Fuel Systems Inc Price","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y9x9tDMeg5o/can-westport-fuel-systems-wprt-spring-a-surprise-in-q4-cm765165"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Can Westport Fuel Systems (WPRT) Spring a Surprise in Q4?","publication_date":"2017-03-24 12:52:12 +0000","summary":"Can Westport Fuel Systems (WPRT) Spring a Surprise in Q4?","url":"http://finance.yahoo.com/news/westport-fuel-systems-wprt-spring-125212748.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Can Westport Fuel Systems (WPRT) Spring a Surprise in Q4?","publication_date":"2017-03-24 12:52:12 +0000","summary":"Westport Fuel Systems Inc. (WPRT) will report fourth-quarter 2016 results after the market closes on Mar 27.","url":"http://finance.yahoo.com/news/westport-fuel-systems-wprt-spring-125212748.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems to Announce Fourth Quarter and Fiscal 2016 Results on Monday March 27, 2017","publication_date":"2017-03-07 21:05:00 +0000","summary":"[CNW Group] - Westport Fuel Systems to Announce Fourth Quarter and Fiscal 2016 Results on Monday March 27, 2017","url":"http://finance.yahoo.com/news/westport-fuel-systems-announce-fourth-210500530.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems to Announce Fourth Quarter and Fiscal 2016 Results on Monday March 27, 2017","publication_date":"2017-03-07 21:05:00 +0000","summary":"VANCOUVER, March 7, 2017 /PRNewswire/ - Westport Fuel Systems Inc. (\" Westport Fuel Systems \") (TSX:WPRT / Nasdaq:WPRT) announced today that it will disclose its financial results for the fourth ...","url":"http://finance.yahoo.com/news/westport-fuel-systems-announce-fourth-210500840.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Receives Visit from King Carl XVI Gustaf of Sweden and Governor General of Canada","publication_date":"2017-02-23 15:00:00 +0000","summary":"~ A Recognition of Westport's Innovative Capabilities in Sustainable Transportation Solutions ~ VANCOUVER, Feb. 23, 2017 /CNW/ - Westport AB (\" Westport \"), a Westport Fuel Systems Inc. (\" ...","url":"http://finance.yahoo.com/news/westport-receives-visit-king-carl-150000518.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Receives Visit from King Carl XVI Gustaf of Sweden and Governor General of Canada","publication_date":"2017-02-23 15:00:00 +0000","summary":"[CNW Group] - Westport Receives Visit from King Carl XVI Gustaf of Sweden and Governor General of Canada","url":"http://finance.yahoo.com/news/westport-receives-visit-king-carl-150000886.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Tecogen Hires Engine Expert to Lead Fork Truck Development Work","publication_date":"2017-02-22 14:00:00 +0000","summary":"WALTHAM, Mass., Feb. 22, 2017 /PRNewswire/ --  Tecogen ® Inc. (the \"Company\", NASDAQ: TGEN) today announced that Alan B. Welch will join the Research & Development team as Project Manager. A ...","url":"http://finance.yahoo.com/news/tecogen-hires-engine-expert-lead-140000099.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Tecogen Hires Engine Expert to Lead Fork Truck Development Work","publication_date":"2017-02-22 14:00:00 +0000","summary":"[PR Newswire] - WALTHAM, Mass., Feb. 22, 2017 /PRNewswire/ -- Tecogen ® Inc. (the \"Company\", NASDAQ: TGEN) today announced that Alan B. Welch will join the Research & Development team as Project Manager. A ...","url":"http://finance.yahoo.com/news/tecogen-hires-engine-expert-lead-140000099.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"4:30 pm Westport Fuel Systems announces that Volvo Car (<a href=\"/q?s=vlvly\" name=\"vlvly\">VLVLY</a>) will expand the Bi-Fuel version of its new V90 station wagon in Belgium and Luxembourg","publication_date":"2017-02-07 21:30:00 +0000","summary":"4:30 pm Westport Fuel Systems announces that Volvo Car (<a href=\"/q?s=vlvly\" name=\"vlvly\">VLVLY</a>) will expand the Bi-Fuel version of its new V90 station wagon in Belgium and Luxembourg","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#wprt"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport and Volvo Car Expand V90 Bi-Fuel into Belgium and Luxembourg","publication_date":"2017-02-07 21:05:00 +0000","summary":"[CNW Group] - Westport and Volvo Car Expand V90 Bi-Fuel into Belgium and Luxembourg","url":"http://finance.yahoo.com/news/westport-volvo-car-expand-v90-210500100.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport and Volvo Car Expand V90 Bi-Fuel into Belgium and Luxembourg","publication_date":"2017-02-07 21:05:00 +0000","summary":"~Significant market opportunity with planned expansion in Europe~ VANCOUVER, Feb. 7, 2017 /PRNewswire/ - Westport AB (\" Westport \"), a Westport Fuel Systems Inc. (\" Westport Fuel Systems ...","url":"http://finance.yahoo.com/news/westport-volvo-car-expand-v90-210500348.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems Announces Change to Chairman of Board of Directors","publication_date":"2017-02-01 13:00:00 +0000","summary":"[CNW Group] - Westport Fuel Systems Announces Change to Chairman of Board of Directors","url":"http://finance.yahoo.com/news/westport-fuel-systems-announces-change-130000987.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems Announces Change to Chairman of Board of Directors","publication_date":"2017-02-01 13:00:00 +0000","summary":"VANCOUVER, Feb. 1, 2017 /PRNewswire/ - Westport Fuel Systems Inc. (\"Westport Fuel Systems\") (TSX:WPRT / Nasdaq:WPRT) today announced that Warren Baker has decided to step down as Chairman of the Board of Directors.  Dr. Baker will remain on the Westport Fuel Systems Board and will continue as Chair of the Nominating & Corporate Governance Committee. The Board has appointed Brenda Eprile, a director since October of 2013, as the new Chairman of the Board.","url":"http://finance.yahoo.com/news/westport-fuel-systems-announces-change-130000158.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems Commends New Study Outlining Pump-to-Wheels Methane Emissions from the Natural Gas-Fueled Heavy-Duty Transportation Sector","publication_date":"2017-01-11 21:05:00 +0000","summary":"~ Next Generation Technologies Significantly Reduce Methane Emissions ~ VANCOUVER, Jan. 11, 2017 /PRNewswire/ - Westport Fuel Systems Inc. (\" Westport Fuel Systems \") (TSX:WPRT / Nasdaq:WPRT) ...","url":"http://finance.yahoo.com/news/westport-fuel-systems-commends-study-210500270.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems Commends New Study Outlining Pump-to-Wheels Methane Emissions from the Natural Gas-Fueled Heavy-Duty Transportation Sector","publication_date":"2017-01-11 21:05:00 +0000","summary":"[PR Newswire] - ~ Next Generation Technologies Significantly Reduce Methane Emissions ~ VANCOUVER, Jan. 11, 2017 /PRNewswire/ - Westport Fuel Systems Inc. (\" Westport Fuel Systems \") (TSX:WPRT / Nasdaq:WPRT) ...","url":"http://finance.yahoo.com/news/westport-fuel-systems-commends-study-210500270.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Mariano Costamagna Transitions from Westport Fuel Systems Board of Directors","publication_date":"2017-01-09 13:00:00 +0000","summary":"~ Remains in Company Ambassador Role ~ VANCOUVER, Jan. 9, 2017 /PRNewswire/ - Westport Fuel Systems Inc. (\" Westport Fuel Systems \") (TSX:WPRT / Nasdaq:WPRT) announced today that Mariano Costamagna ...","url":"http://finance.yahoo.com/news/mariano-costamagna-transitions-westport-fuel-130000910.html?.tsrc=rss"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Mariano Costamagna Transitions from Westport Fuel Systems Board of Directors","publication_date":"2017-01-09 13:00:00 +0000","summary":"[CNW Group] - Mariano Costamagna Transitions from Westport Fuel Systems Board of Directors","url":"http://finance.yahoo.com/news/mariano-costamagna-transitions-westport-fuel-130000761.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Does AcelRx Pharmaceuticals Inc (ACRX) Stack Up Against Its Peers?","publication_date":"2016-12-15 06:58:33 +0000","summary":"Does AcelRx Pharmaceuticals Inc (ACRX) Stack Up Against Its Peers?","url":"http://www.insidermonkey.com/blog/does-acelrx-pharmaceuticals-inc-acrx-stack-up-against-its-peers-510093/"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Hedge Funds Are Betting On Rightside Group Ltd (NAME)","publication_date":"2016-12-10 13:52:40 +0000","summary":"Hedge Funds Are Betting On Rightside Group Ltd (NAME)","url":"http://www.insidermonkey.com/blog/hedge-funds-are-betting-on-rightside-group-ltd-name-504811/"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems, Inc. :WPRT-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016","publication_date":"2016-11-28 15:27:57 +0000","summary":"Westport Fuel Systems, Inc. :WPRT-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016","url":"http://www.capitalcube.com/blog/index.php/westport-fuel-systems-inc-wprt-us-earnings-analysis-q3-2016-by-the-numbers-november-28-2016/"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Capital Partners Adds Key Executives in Connecticut and London","publication_date":"2016-11-15 14:30:00 +0000","summary":"Westport Capital Partners Adds Key Executives in Connecticut and London","url":"http://uk.finance.yahoo.com/news/westport-capital-partners-adds-key-143000590.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems (WPRT) Posts Narrower Loss in Q3","publication_date":"2016-11-10 16:15:41 +0000","summary":"Westport Fuel Systems Inc WPRT recorded adjusted loss of 14 cents per share in the third quarter of 2016 narrower than the year ago loss of 29 cents Moreover the adjusted loss which excludes 16 cents from non recurring items was much narrower than the Zacks Consensus Estimate of a loss","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N8llmevdpL8/westport-fuel-systems-wprt-posts-narrower-loss-in-q3-cm707189"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems (WPRT) Posts Narrower Loss in Q3","publication_date":"2016-11-10 14:13:02 +0000","summary":"Westport Fuel Systems (WPRT) Posts Narrower Loss in Q3","url":"http://finance.yahoo.com/news/westport-fuel-systems-wprt-posts-141302397.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport reports 3Q loss","publication_date":"2016-11-09 21:39:08 +0000","summary":"Westport reports 3Q loss","url":"http://sg.finance.yahoo.com/news/westport-reports-3q-loss-213908108.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems Reports Third Quarter 2016 Financial Results","publication_date":"2016-11-09 21:21:15 +0000","summary":"[at noodls] - published: November 9, 2016 VANCOUVER, BC - Westport Fuel Systems Inc. ('Westport Fuel Systems') (TSX:WPT / Nasdaq:WPRT) reported financial results for the third quarter ended September 30, 2016 and provided ...","url":"http://www.publicnow.com/view/A6D4E34FA9A8131FA1C63EE9332D24739A399A9A"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems Announces TSX Ticker Symbol Change To “WPRT”","publication_date":"2016-11-07 21:20:26 +0000","summary":"[at noodls] - published: November 7, 2016 VANCOUVER, BC - Westport Fuel Systems Inc. ('Westport Fuel Systems') (TSX:WPT / Nasdaq:WPRT) today announced that effective at the opening of trading on Thursday, November 10, ...","url":"http://www.publicnow.com/view/91529494300FA305DF915428020DAF86583E44EA"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems Announces TSX Ticker Symbol Change to \"WPRT\"","publication_date":"2016-11-07 21:05:00 +0000","summary":"[PR Newswire] - The company requested the change to its ticker symbol in Canada following the new permissions introduced by the TSX that allow companies to use a four-letter symbol. Westport Fuel Systems previous trading symbol on the TSX was \"WPT\" and following this change, the company's TSX and NASDAQ trading symbols will be the same. Westport Fuel Systems engineers, manufactures and supplies the world's most advanced alternative fuel systems and components.","url":"http://finance.yahoo.com/news/westport-fuel-systems-announces-tsx-210500861.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Johnson Controls (JCI): Will its Earnings Disappoint in Q4?","publication_date":"2016-11-07 16:03:19 +0000","summary":"Johnson Controls International plc JCI is set to report fourth quarter ended Sep 30 2016 fiscal 2016 results on Nov 8 In the last quarter the company delivered a positive earnings surprise of 1 79 Let s see how things are shaping up for this announcement Factors Influencing","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y90V0c-1xSs/johnson-controls-jci-will-its-earnings-disappoint-in-q4-cm704922"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"What Awaits Westport Fuel (WPRT) in Q3 Earnings?","publication_date":"2016-11-07 16:02:40 +0000","summary":"Westport Fuel Systems Inc WPRT is expected to report third quarter 2016 results on Nov 9 In the last quarter the company posted a negative earnings surprise of 81 82 Let s see how things are shaping up for this announcement Factors Influencing this Quarter Westport Fuel","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OfnLJCwJohI/what-awaits-westport-fuel-wprt-in-q3-earnings-cm704912"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"What Awaits Westport Fuel (WPRT) in Q3 Earnings?","publication_date":"2016-11-07 13:25:01 +0000","summary":"What Awaits Westport Fuel (WPRT) in Q3 Earnings?","url":"http://finance.yahoo.com/news/awaits-westport-fuel-wprt-q3-132501139.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Johnson Controls (JCI): Will its Earnings Disappoint in Q4?","publication_date":"2016-11-07 13:17:01 +0000","summary":"Johnson Controls (JCI): Will its Earnings Disappoint in Q4?","url":"http://finance.yahoo.com/news/johnson-controls-jci-earnings-disappoint-131701859.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems To Announce Third Quarter Results On Wednesday, November 9, 2016","publication_date":"2016-11-02 20:22:10 +0000","summary":"[at noodls] - published: November 2, 2016 VANCOUVER, BC - Westport Fuel Systems Inc. ('Westport Fuel Systems') (TSX:WPT / Nasdaq:WPRT) announced todaythat it will disclose its financial results for the third quarter ...","url":"http://www.publicnow.com/view/12CD60586A5DD2931EDE65D2A1C87796327D9E0E"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems to announce third quarter results on Wednesday, November 9, 2016","publication_date":"2016-11-02 20:05:00 +0000","summary":"[CNW Group] - Westport Fuel Systems to announce third quarter results on Wednesday, November 9, 2016","url":"http://finance.yahoo.com/news/westport-fuel-systems-announce-third-200500354.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Why T. Boone Pickens Is Betting On Natural Gas Vehicles","publication_date":"2016-10-27 21:03:00 +0000","summary":"Why T. Boone Pickens Is Betting On Natural Gas Vehicles","url":"http://www.forbes.com/sites/kenkam/2016/10/27/why-t-boone-pickens-is-betting-on-natural-gas-vehicles/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Why Hydrogen Fuel Could Succeed Where Natural Gas Failed","publication_date":"2016-10-15 16:31:46 +0000","summary":"Why Hydrogen Fuel Could Succeed Where Natural Gas Failed","url":"http://www.fool.com/investing/2016/10/14/why-hydrogen-fuel-could-succeed-where-natural-gas.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Why Hydrogen Fuel Could Succeed Where Natural Gas Failed","publication_date":"2016-10-14 17:42:33 +0000","summary":"Image source Getty Images Just a few years ago natural gas fuel was supposed to take over everything from trucking to small cars in the U S But it has so far failed to take significant market share in the U S and Clean Energy Fuels NASDAQ CLNE and Westport Fuel Systems","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y9McEiIyoFc/why-hydrogen-fuel-could-succeed-where-natural-gas-failed-cm693549"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Consumer Sector Update for 10/14/2016: WPRT,CMI,REED,NHTC","publication_date":"2016-10-14 17:41:20 +0000","summary":"Top Consumer StocksTop Consumer Stocks WMT 0 67 WMT 0 67 MCD 0 56 MCD 0 56 DIS 0 43 DIS 0 43 CVS 0 93 CVS 0 93 KO 0 06 KO 0 06 Consumer stocks were edging higher this afternoon with shares of consumer staples companies in the S amp P 500 adding about 0 2 while shares of","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n4UU4-E8Wl4/consumer-sector-update-for-10142016-wprtcmireednhtc-cm693559"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Cummins Westport Begins Production of ISL G Near Zero Natural Gas Engine","publication_date":"2016-10-13 20:05:00 +0000","summary":"[PR Newswire] - - North America's First Commercially Available Near Zero NOx MidRange Engine - TORONTO, Oct. 13, 2016 /PRNewswire/ - Cummins Westport Inc. (CWI) today announced that orders are being processed and production ...","url":"http://finance.yahoo.com/news/cummins-westport-begins-production-isl-200500356.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Cummins Westport Begins Production of ISL G Near Zero Natural Gas Engine","publication_date":"2016-10-13 20:05:00 +0000","summary":"[CNW Group] - Cummins Westport Begins Production of ISL G Near Zero Natural Gas Engine","url":"http://finance.yahoo.com/news/cummins-westport-begins-production-isl-200500093.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Forget Westport Fuel Systems Inc.: These 2 Stocks Are Better Buys","publication_date":"2016-09-28 20:22:39 +0000","summary":"Westport s stock price and high risk makes it a likely value trap today Image source Getty Images While natural gas isn t likely to ever be a mainstream fuel for automobiles it has proven to be an excellent alternative to gasoline and diesel for medium and heavy duty vehicles","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VhnEqcqf8uo/forget-westport-fuel-systems-inc-these-2-stocks-are-better-buys-cm686184"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Forget Westport Fuel Systems Inc.: These 2 Stocks Are Better Buys","publication_date":"2016-09-28 19:02:11 +0000","summary":"Forget Westport Fuel Systems Inc.: These 2 Stocks Are Better Buys","url":"http://www.fool.com/investing/2016/09/28/forget-westport-fuel-systems-inc-these-2-stocks-ar.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel (WPRT) Inks Supply Contract for LPG System","publication_date":"2016-09-28 13:22:40 +0000","summary":"Westport Fuel Systems Inc WPRT announced that one of its distributors has signed a new multi year contract with Honda Turkey to supply liquefied petroleum gas LPG systems for a new model of Civic Eco that is set to debut next month Honda HMC has been offering LPG after market conversions","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cbmVaVJiLkE/westport-fuel-wprt-inks-supply-contract-for-lpg-system-cm685868"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel (WPRT) Inks Supply Contract for LPG System","publication_date":"2016-09-28 12:17:12 +0000","summary":"Westport Fuel (WPRT) Inks Supply Contract for LPG System","url":"http://finance.yahoo.com/news/westport-fuel-wprt-inks-supply-121712007.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems Announces Supply Agreement with Honda Turkey","publication_date":"2016-09-27 12:09:09 +0000","summary":"[at noodls] - published: September 27, 2016 Vancouver, BC - Westport Fuel Systems Inc. ('Westport Fuel Systems') (TSX:WPT / Nasdaq:WPRT) today announced the signing of a new multi-year agreement between a distributor ...","url":"http://www.publicnow.com/view/8C58928469E33145E7AC673624A095D5ADD7E226"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems Appoints New Director","publication_date":"2016-09-26 20:29:08 +0000","summary":"[at noodls] - published: September 26, 2016 VANCOUVER, BC - Westport Fuel Systems Inc. ('Westport Fuel Systems') (TSX:WPT / Nasdaq:WPRT) announced that Scott R. Mackie, President of Qualitor Inc.'s International Brakes ...","url":"http://www.publicnow.com/view/F0CCD3C691689AA7E58F46B17BCAC5BE9428ED01"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Hennessy Advisors, Inc. Acquires The Westport Funds Bringing Assets Under Management to $6.8 Billion","publication_date":"2016-09-23 21:02:02 +0000","summary":"[at noodls] - Hennessy Advisors, Inc. to Acquire The Westport Funds May 2, 2016- Hennessy Advisors, Inc. (NASDAQ: HNNA) today announced that it has signed a definitive agreement with Westport Advisers, LLC to purchase ...","url":"http://www.publicnow.com/view/D65040C751B97536EE0A8AAD4AB71E46B1623AF0"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"IMPCO Technologies Releases Hydrogen Integrated Tank Valve/Regulator","publication_date":"2016-09-13 21:08:10 +0000","summary":"[at noodls] - published: September 13, 2016 Kitchener, ON - IMPCO Technologies, Inc., a global leader in the alternative fuel industry and a division of Westport Fuel Systems Inc., has confirmed the release of a new ...","url":"http://www.publicnow.com/view/DD78E824C577D0C2F9839AA56D7269B1D140CEF7"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"ETF’s with exposure to Westport Fuel Systems, Inc. : August 29, 2016","publication_date":"2016-08-29 16:13:22 +0000","summary":"ETF’s with exposure to Westport Fuel Systems, Inc. : August 29, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-westport-fuel-systems-inc-august-29-2016/"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems Provides Economical Environmental Solutions","publication_date":"2016-08-23 20:18:10 +0000","summary":"[at noodls] - published: August 23, 2016 VANCOUVER, BC - Westport Fuel Systems Inc. ('Westport Fuel Systems') (TSX:WPT / Nasdaq:WPRT) provides the next-generation natural gas engine and vehicle technology solutions ...","url":"http://www.publicnow.com/view/B77B89C73514A648E1D3B26B440AD7F736B9E2DD"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems Provides Economical Environmental Solutions","publication_date":"2016-08-23 20:05:00 +0000","summary":"[PR Newswire] - ~ Supports new standards for greenhouse gas emissions & fuel efficiency ~ VANCOUVER, Aug. 23, 2016 /PRNewswire/ - Westport Fuel Systems Inc. (\" Westport Fuel Systems \") (TSX:WPT / Nasdaq:WPRT) ...","url":"http://finance.yahoo.com/news/westport-fuel-systems-provides-economical-200500135.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"3 Stocks We Wouldn't Touch With a 10-Foot Pole","publication_date":"2016-08-22 18:46:52 +0000","summary":"Image Source Getty Images. A crucial and perhaps underappreciated part of building a healthy portfolio that can stand the test of time is knowing which stocks not to buy. Companies with shaky balance sheets or","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/acIV5ajnYf0/3-stocks-we-wouldnt-touch-with-a-10-foot-pole-cm668612"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"3 Stocks We Wouldn't Touch With a 10-Foot Pole","publication_date":"2016-08-22 17:08:00 +0000","summary":"3 Stocks We Wouldn't Touch With a 10-Foot Pole","url":"http://www.fool.com/investing/2016/08/22/3-stocks-we-wouldnt-touch-with-a-10-foot-pole.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems to Sell Portion of Joint Venture Interest for Approximately $11 Million","publication_date":"2016-08-22 12:18:06 +0000","summary":"[at noodls] - published: August 22, 2016 VANCOUVER, BC - Westport Fuel Systems Inc. ('Westport Fuel Systems') (TSX:WPT / Nasdaq:WPRT) announced that it has entered into agreements to sell an 11.7% interest in the Weichai ...","url":"http://www.publicnow.com/view/37D27FD60AD3E2399C075B76799DC547C6987EB9"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems to Sell Portion of Joint Venture Interest for Approximately $11 Million","publication_date":"2016-08-22 12:00:00 +0000","summary":"[CNW Group] - Westport Fuel Systems to Sell Portion of Joint Venture Interest for Approximately $11 Million","url":"http://finance.yahoo.com/news/westport-fuel-systems-sell-portion-120000458.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"ETF’s with exposure to Westport Fuel Systems, Inc. : August 16, 2016","publication_date":"2016-08-16 16:52:35 +0000","summary":"ETF’s with exposure to Westport Fuel Systems, Inc. : August 16, 2016","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-westport-fuel-systems-inc-august-16-2016/"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems, Inc. :WPRT-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016","publication_date":"2016-08-15 17:36:46 +0000","summary":"Westport Fuel Systems, Inc. :WPRT-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016","url":"http://www.capitalcube.com/blog/index.php/westport-fuel-systems-inc-wprt-us-earnings-analysis-q2-2016-by-the-numbers-august-15-2016/"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems' Loss Remains Despite Merger Gains","publication_date":"2016-08-15 15:41:15 +0000","summary":"On Aug 12, 2016, we issued an updated research report on Westport Fuel Systems Inc.WPRT . It's expected the merged company will enjoy significant savings of cost and effort, and long term benefits in achieving its goals. While the","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tJ2sR88dI4E/westport-fuel-systems-loss-remains-despite-merger-gains-cm665342"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems' Loss Remains Despite Merger Gains","publication_date":"2016-08-15 13:15:01 +0000","summary":"Westport Fuel Systems' Loss Remains Despite Merger Gains","url":"http://finance.yahoo.com/news/westport-fuel-systems-loss-remains-131501922.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems (WPRT) Q2 Adjusted Loss Widens Y/Y","publication_date":"2016-08-10 13:52:59 +0000","summary":"Westport Fuel Systems Inc.WPRT recorded adjusted loss of 40 cents per share in the second quarter of 2016, wider than the year ago loss of 27 cents. Moreover, the adjusted loss, which excludes 44 cents from non recurring items,","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9sbY09Z3VHg/westport-fuel-systems-wprt-q2-adjusted-loss-widens-yy-cm663277"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems (WPRT) Q2 Adjusted Loss Widens Y/Y","publication_date":"2016-08-10 12:34:12 +0000","summary":"Westport Fuel Systems (WPRT) Q2 Adjusted Loss Widens Y/Y","url":"http://finance.yahoo.com/news/westport-fuel-systems-wprt-q2-123412913.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems (WPRT) Posts Q2 Adjusted Loss","publication_date":"2016-08-09 15:38:47 +0000","summary":"Westport Fuel Systems Inc.WPRT is a developer and supplier of alternative fuel, low emissions transportation technologies. The company was formed by the merger of Westport Innovations Inc. and Fuel Systems Solutions, Inc. Westport Fuel Systems has strategic relationships with","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GUGeatXO4CY/westport-fuel-systems-wprt-posts-q2-adjusted-loss-cm662545"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems (WPRT) Posts Q2 Adjusted Loss","publication_date":"2016-08-09 13:10:01 +0000","summary":"Westport Fuel Systems (WPRT) Posts Q2 Adjusted Loss","url":"http://finance.yahoo.com/news/westport-fuel-systems-wprt-posts-131001221.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport Fuel Systems Reports Second Quarter 2016 Financial Results","publication_date":"2016-08-09 12:00:07 +0000","summary":"[at noodls] - published: August 9, 2016 VANCOUVER, BC - Westport Fuel Systems Inc. ('Westport Fuel Systems') (TSX:WPT / Nasdaq:WPRT) reported financial results for the quarter ended June 30, 2016. The quarter and year-to-date ...","url":"http://www.publicnow.com/view/C99252A339675FC83DFAC74033929893C99B673F"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Westport misses 2Q profit forecasts","publication_date":"2016-08-09 11:49:25 +0000","summary":"Westport misses 2Q profit forecasts","url":"http://sg.finance.yahoo.com/news/westport-misses-2q-profit-forecasts-114925714.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Better Buy: Westport Fuel Systems Inc. vs. Navistar International Corp.","publication_date":"2016-08-08 20:17:29 +0000","summary":"You might not pit Westport Fuel SystemsInc. (NASDAQ WPRT) and Navistar International Corp. (NYSE NAV) against each other when it comes to making an investing choice, but the two companies have a lot in common.","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zvaso1U76hc/better-buy-westport-fuel-systems-inc-vs-navistar-international-corp-cm662065"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Auto Stocks' Aug 9 Earnings Preview: HZN, MPAA, WPRT","publication_date":"2016-08-08 14:18:37 +0000","summary":"The Q2 earnings season is nearly over for the auto sector, with only a few companies left to report. Considering the companies that reported earnings through Aug 5, the auto sector has been the second best performer among the","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ltyGjqSshHk/auto-stocks-aug-9-earnings-preview-hzn-mpaa-wprt-cm661645"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Auto Stocks' Aug 9 Earnings Preview: HZN, MPAA, WPRT","publication_date":"2016-08-08 12:34:12 +0000","summary":"Auto Stocks' Aug 9 Earnings Preview: HZN, MPAA, WPRT","url":"http://finance.yahoo.com/news/auto-stocks-aug-9-earnings-123412528.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Cooper Tire (CTB) Q2 Earnings May Beat: Stock to Gain?","publication_date":"2016-08-02 17:58:19 +0000","summary":"Cooper Tire & Rubber Co.CTB is set to report second quarter 2016 results on Aug 4. In the last quarter, this tire manufacturer posted a positive earnings surprise of 5%. Let us see how things are shaping up for","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QgAqWa-Otyc/cooper-tire-ctb-q2-earnings-may-beat-stock-to-gain-cm658853"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Auto Stocks' Earnings Slated on Aug 3: TSLA, DLPH & More","publication_date":"2016-08-02 13:56:54 +0000","summary":"The auto sector has been the second best performer in terms of earnings among the 16 Zacks sectors so far. As of Jul 29, nearly 81.8% of the sector's companies had reported results. These companies recorded 18.8% year over","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-6t8QvKJiEk/auto-stocks-earnings-slated-on-aug-3-tsla-dlph-more-cm658755"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"Cooper Tire (CTB) Q2 Earnings May Beat: Stock to Gain?","publication_date":"2016-08-02 13:48:01 +0000","summary":"Cooper Tire (CTB) Q2 Earnings May Beat: Stock to Gain?","url":"http://finance.yahoo.com/news/cooper-tire-ctb-q2-earnings-134801795.html"},{"ticker":"WPRT","figi_ticker":"WPRT:CT","figi":"BBG000BBDTZ6","title":"What Awaits Westport Innovations (WPRT) in Q2 Earnings?","publication_date":"2016-08-02 12:56:19 +0000","summary":"Westport Innovations Inc.WPRT is expected to report second quarter 2016 results on Aug 3. In the last quarter, the company posted a negative earnings surprise of 24.14%. Let's see how things are shaping up for this announcement.Why a Likely","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mBWGXg3NQAQ/what-awaits-westport-innovations-wprt-in-q2-earnings-cm658629"}],"result_count":139,"page_size":100,"current_page":1,"total_pages":2,"api_call_credits":1}, "chart":[{"values":[ {"x":"1494595800","y":"1.4"},{"x":"1494596100","y":"1.3907"},{"x":"1494596400","y":"1.34"},{"x":"1494596700","y":"1.35"},{"x":"1494597000","y":"1.379"},{"x":"1494597300","y":"1.42"},{"x":"1494597600","y":"1.43"},{"x":"1494597900","y":"1.45"},{"x":"1494598200","y":"1.4601"},{"x":"1494598500","y":"1.4661"},{"x":"1494598800","y":"1.4689999999999999"},{"x":"1494599100","y":"1.45"},{"x":"1494599400","y":"1.45"},{"x":"1494599700","y":"1.47"},{"x":"1494600000","y":"1.45"},{"x":"1494600300","y":"1.45"},{"x":"1494600600","y":"1.45"},{"x":"1494600900","y":"1.4402"},{"x":"1494601200","y":"1.4364"},{"x":"1494601500","y":"1.4399"},{"x":"1494601800","y":"1.44"},{"x":"1494602100","y":"1.45"},{"x":"1494602400","y":"1.45"},{"x":"1494602700","y":"1.46"},{"x":"1494603000","y":"1.44"},{"x":"1494603300","y":"1.45"},{"x":"1494603600","y":"1.46"},{"x":"1494603900","y":"1.47"},{"x":"1494604200","y":"1.46"},{"x":"1494604500","y":"1.47"},{"x":"1494604800","y":"1.47"},{"x":"1494605100","y":"1.4689999999999999"},{"x":"1494605400","y":"1.46"},{"x":"1494605700","y":"1.47"},{"x":"1494606300","y":"1.478"},{"x":"1494606600","y":"1.4699"},{"x":"1494606900","y":"1.4641"},{"x":"1494607200","y":"1.47"},{"x":"1494607500","y":"1.47"},{"x":"1494607800","y":"1.4659"},{"x":"1494608100","y":"1.46"},{"x":"1494608400","y":"1.4501"},{"x":"1494608700","y":"1.45"},{"x":"1494609000","y":"1.4501"},{"x":"1494609300","y":"1.43"},{"x":"1494609600","y":"1.44"},{"x":"1494609900","y":"1.44"},{"x":"1494610200","y":"1.45"},{"x":"1494610500","y":"1.45"},{"x":"1494610800","y":"1.46"},{"x":"1494611100","y":"1.46"},{"x":"1494611400","y":"1.4511"},{"x":"1494611700","y":"1.4536"},{"x":"1494612000","y":"1.445"},{"x":"1494612300","y":"1.44"},{"x":"1494612600","y":"1.4449"},{"x":"1494612900","y":"1.45"},{"x":"1494613200","y":"1.45"},{"x":"1494613500","y":"1.445"},{"x":"1494613800","y":"1.45"},{"x":"1494614100","y":"1.45"},{"x":"1494614400","y":"1.45"},{"x":"1494614700","y":"1.45"},{"x":"1494615000","y":"1.45"},{"x":"1494615300","y":"1.4465"},{"x":"1494615600","y":"1.44"},{"x":"1494615900","y":"1.45"},{"x":"1494616200","y":"1.48"},{"x":"1494616500","y":"1.47"},{"x":"1494616800","y":"1.4701"},{"x":"1494617100","y":"1.48"},{"x":"1494617400","y":"1.4793"},{"x":"1494617700","y":"1.48"},{"x":"1494618000","y":"1.48"},{"x":"1494618300","y":"1.48"},{"x":"1494618600","y":"1.4769"},{"x":"1494618900","y":"1.48"},{"x":"1494619200","y":"1.47"} ], "color":"#03a9f4"}]},
{"meta":{"list":"Market Movers","updated":"Fri May 12 16:00:37 EDT 2017"}}
]
